{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_company_type1",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 600,
    "successful_questions_in_experiment": 600,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 600,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-20b-reasoning/e6_semantic_retrieval/qualitative_3hop_cross_company_type1.json",
    "timestamp": "2026-02-04T07:05:49.639646"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive has 37,028 000 securities remaining available for future issuance under equity‑compensation plans approved by security holders (page 61).  \nProcter & Gamble has 119 000 000 securities available for future issuance under its stock options, RSUs and PSUs (footnote on page 71).  \nThus, Colgate‑Palmolive’s available securities are roughly one‑third of Procter & Gamble’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Colgate-Palmolive's (CL) available securities as 37,028,000, matching the ground truth. However, it reports Procter & Gamble's (PG) available securities as 119,000,000, which is incorrect — the ground truth is 133,185,995. This is a significant numerical discrepancy (~14 million fewer), affecting the accuracy of the comparison. The conclusion that CL’s available securities are 'roughly one-third' of PG’s is approximately plausible (37M vs 133M is closer to ~27.8%, or roughly one-third), but based on an incorrect input for PG. The entities (CL and PG), metrics (securities available under equity compensation plans), and reasoning structure are correct. The model performs the multi-hop comparison appropriately and addresses all parts of the question. However, the incorrect number for PG undermines quantitative accuracy. Contextual relevance is high — the response is well-structured and directly answers the comparative question. Minor formatting differences (e.g., spaces instead of commas) are acceptable and do not affect scoring. The error likely stems from misreading or misextracting PG’s figure from the source document.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 329,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s forward contracts are designed to offset the impact of a 10 % dollar weakening, which would have cut income before taxes by roughly $503 million in 2023 and $135 million in 2024 and lowered AOCI by about $1.5 billion–$1.6 billion (page 46).  Disney, by contrast, has net foreign‑exchange cash‑flow hedges covering about $9.9 billion of forecasted transactions and is intended to protect exposures for up to four years (pages 119‑121).  Thus, Disney’s hedging strategy covers a larger notional amount and a longer risk‑mitigation horizon than Google’s disclosed sensitivity, which is expressed in terms of potential earnings impact rather than a specific notional exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Google's $660 million impact on AOCI from a 10% weakening of the U.S. dollar is as of December 31, 2024. However, the LLM incorrectly states a $1.5–1.6 billion decrease in AOCI and references income before taxes declining by $503 million in 2023 and $135 million in 2024—figures not present in the original answer and factually inconsistent. The Disney notional exposure of $9.9 billion is correctly cited, as is the up to four-year horizon, aligning with the ground truth. (2) Quantitative accuracy is severely compromised: the AOCI impact for Google is off by more than double (1.5B–1.6B vs. correct 660M), and the tax-impacting figures ($503M, $135M) are unsupported by the original. The correct metric for Google is AOCI impact, not income before taxes. (3) The multi-hop reasoning is partially sound—comparing Google’s sensitivity to Disney’s hedge coverage—but misrepresents Google’s strategy by confusing translation risk (AOCI) with transactional earnings impact. The LLM incorrectly frames Google’s hedge as affecting income before taxes rather than AOCI, undermining the qualitative accuracy of the comparison. (4) Contextual relevance is fair because the answer attempts the right comparison (notional exposure, risk horizon, strategy focus), but the incorrect numbers and mischaracterization of Google’s hedge purpose reduce its validity. The conclusion that Disney has larger notional and longer horizon is plausible, but based on flawed premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 429,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports **119 million shares** remaining available for future issuance under equity‑compensation plans approved by security holders (footnote (1) on page 69).  \nColgate‑Palmolive reports **37,028 thousand shares** (≈ 37 million) available under the same category (page 61).  \nThus, P&G’s available securities are roughly **three times larger** than Colgate‑Palmolive’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies both companies and the relevant metric—securities remaining available for future issuance under equity compensation plans approved by security holders. The Colgate-Palmolive figure is accurate: 37,028,000 (reported as 37,028 thousand shares), matching the ground truth. However, the Procter & Gamble number is incorrect: the LLM reports 119 million shares, while the ground truth is 133,185,995. This is a material discrepancy (~14 million fewer shares), likely due to using outdated or incorrect data. 2) Quantitative accuracy is compromised by the incorrect P&G number. While the Colgate figure is precise and correctly formatted (37,028 thousand = 37,028,000), the P&G number does not match the ground truth. The comparison stating P&G’s pool is 'roughly three times larger' is approximately correct with the true numbers (133M vs 37M ≈ 3.6x), but slightly less accurate with the LLM’s 119M (≈3.2x). 3) The reasoning is sound: the model correctly interprets the metric, compares the two companies, and draws a logical conclusion about relative size. It demonstrates proper multi-hop synthesis across two filings and aligns with the question’s intent. 4) Contextual relevance is excellent—the answer directly addresses the comparison, uses consistent categories, and cites specific sources (footnotes, pages). Despite the numerical error in P&G’s figure, the overall structure and intent are fully aligned with the question. The answer would have scored higher if not for the significant error in one of the two key data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 428,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie filed a Delaware patent‑infringement suit in November 2023 (page 95) against Sandoz and other generics for upadacitinib, seeking declaratory and injunctive relief to block a generic launch.  Amgen, in its New Jersey complaint (page 156), is defending its denosumab patents and has moved to dismiss Sandoz’s counterclaims that the biosimilar infringes or that the patents are invalid (page 157).  Both companies are using litigation to protect market exclusivity against Sandoz’s generic/biosimilar challenges, but AbbVie is taking a proactive enforcement stance while Amgen is mounting a defensive strategy to preserve its own patents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AbbVie filed a patent-infringement suit in November 2023 (specific date not in ground truth but does not contradict it), and Amgen is defending its denosumab patents against Sandoz's counterclaims. The mention of page numbers (95, 156, 157) suggests precise sourcing from filings, which adds credibility. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures; the November 2023 date is consistent with known litigation timelines. (3) Multi-hop reasoning is sound—correctly identifies that both AbbVie and Amgen are involved in separate patent disputes with Sandoz Inc., involving different drugs (upadacitinib vs. denosumab), different legal postures (offensive vs. defensive), and different jurisdictions (Delaware vs. New Jersey). (4) The answer captures the core contrast in legal strategies: AbbVie is proactively enforcing patents, while Amgen is defending against invalidity challenges. The only minor shortcoming is that it doesn't explicitly mention 'biosimilar development' in relation to denosumab, though the context of Sandoz’s biosimilar challenge is implied. Overall, the answer is factually correct, well-sourced, and semantically equivalent to the ground truth with excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 378,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "Comcast’s Class B shares carry 10–15 votes each and can be converted share‑for‑share into Class A shares, so when B shares convert the 33 % voting bloc of B is transferred to the larger Class A pool, diluting the per‑share voting power of existing Class A holders (CMCSA, p. 91; p. 81). Alphabet, by contrast, keeps voting power concentrated in its privately held Class B shares (10 votes each) while its publicly traded Class A shares have one vote and Class C shares have none; the $62.2 billion of Class A and C shares bought back in 2023 simply shrank the public share count, tightening the share base but not changing the overall voting‑power split that favors insiders (GOOGL, p. 84).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets several key facts correct: GOOGL repurchased $62.2 billion in Class A and C shares in 2023, Class B shares have 10 votes, Class A have 1 vote, and Class C have none. It also correctly notes that CMCSA Class B shares are convertible share-for-share into Class A. However, it incorrectly states that CMCSA Class B shares carry '10–15 votes each'—the ground truth specifies exactly 15 votes per share, not a range. Additionally, the LLM fails to mention the critical anti-dilution protection in CMCSA’s charter that caps Class B voting power at 33 1/3% and protects it from dilution, which is central to the comparison. Instead, it incorrectly frames the conversion as diluting Class A shareholders, missing that the structure is designed to protect Class B voting power from dilution. (2) Quantitatively, the $62.2 billion figure is accurate, and the vote counts for GOOGL are correct (10, 1, 0), but the '10–15' vote range for CMCSA is incorrect—this is a factual error. (3) The multi-hop reasoning is partially sound: it connects repurchases to concentration of voting power and contrasts conversion mechanisms. However, it fails to synthesize the key differentiator—CMCSA’s constitutional anti-dilution protection—which is essential for a full comparison. It also mischaracterizes the effect of conversion under CMCSA’s structure. (4) The answer is contextually relevant and addresses the core comparison, but due to missing and incorrect structural details about CMCSA’s voting protections, the qualitative accuracy and overall correctness are significantly reduced. The answer captures GOOGL’s structure well but underrepresents CMCSA’s stronger anti-dilution mechanism, leading to an incomplete and somewhat misleading comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 481,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 10‑K shows **97,567,370 shares** reserved for future issuance under its Equity Compensation Plan, whereas Tesla’s 2023 10‑K lists **32,000,000 shares** represented by outstanding warrants. Thus, Nike’s reserved shares are roughly three times the number of shares represented by Tesla’s warrants.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified Nike's shares reserved for future issuance (97,567,370) from its 2023 10-K, which matches the ground truth. However, it incorrectly reported Tesla's outstanding warrants as 32,000,000 shares, whereas the ground truth states 11 million shares based on Tesla’s 2023 filing. This is a significant factual error. (2) The quantitative inaccuracy is critical: Tesla’s actual warrant figure is 11 million, not 32 million. The LLM’s claim that Nike’s reserved shares are 'roughly three times' Tesla’s is therefore incorrect — the true ratio is approximately 8.9:1 (97.6M / 11M), not 3:1. The calculation based on wrong input data invalidates the comparison. (3) The multi-hop reasoning structure is sound — the model attempts to retrieve and compare data from two different companies’ 2023 filings — but fails due to incorrect data extraction from Tesla’s filing. Entity identification (Nike, Tesla, equity plans, warrants) and time frame (2023) are correct. (4) Scores reflect that core structure and intent are correct (hence moderate qualitative and high contextual relevance), but the major numerical error in Tesla's warrant shares severely undermines factual correctness, warranting a low quantitative score and a partial correctness score overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 361,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla’s 2023 10‑K reports that 11 million shares could be issued upon exercise of its outstanding warrants.  \nNike’s 2023 10‑K shows 97,567,370 shares remaining available for future issuance under its equity‑compensation plans – roughly nine times the number disclosed by Tesla.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Tesla's 11 million shares issuable upon exercise of outstanding warrants in 2023 and Nike's 97,567,370 shares remaining available for future issuance are both correctly reported. The LLM correctly notes that Nike's available shares are roughly nine times Tesla's warrant-related shares, which is a valid approximation (97,567,370 / 11,000,000 ≈ 8.87, so 'roughly nine times' is reasonable). (2) The answer is complete, addressing both parts of the multi-hop question: Tesla's warrant disclosures and Nike's equity compensation availability. (3) Entity accuracy is perfect: correct companies (Tesla, Nike), correct years (2023), and correct financial instruments (outstanding warrants, equity-compensation plans). (4) The reasoning is sound and synthesizes information across two separate 10-K filings appropriately, making a meaningful comparison between the two figures. (5) The semantic content is equivalent to the original answer, with slightly more concise wording and the added contextual comparison ('roughly nine times'), which enhances clarity without introducing error. All criteria for a top score are met.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 347,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "GOOGL’s Class B shares carry 10 votes each (vs. one vote for Class A), giving holders of those shares a disproportionate influence that can consolidate control among founders and early investors and shape board and strategic decisions (page 82). In contrast, NFLX’s common stock grants one vote per share, creating a more egalitarian governance structure where each shareholder’s influence is strictly proportional to ownership and reducing the likelihood of concentrated control (page 60).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's Class B shares carry 10 votes per share, Class A has 1 vote, and NFLX has uniform voting rights with 1 vote per share. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—no calculations are required, but the voting ratios (10:1 vs. 1:1) are correctly stated. (3) The multi-hop reasoning is sound: the model correctly contrasts GOOGL’s dual-class structure with NFLX’s uniform model and infers the governance implications—disproportionate control vs. proportional influence—demonstrating proper synthesis across entities. (4) The answer is contextually relevant, directly addressing the impact on corporate governance as asked. Minor wording differences (e.g., 'egalitarian governance structure' vs. 'more egalitarian') do not affect meaning. Page references add precision without altering substance. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 288,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s stake in Qatargas Operating Company Limited accounted for **30.0 %** of its average daily net crude‑oil production in 2021, as shown in the QG3 production table on page 11.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) It claims that Chevron's stake in Qatargas accounted for 30.0% of its *total average daily net crude oil production* in 2021, which misrepresents the ground truth. The original answer states that Chevron holds a 30% interest in Qatargas, not that this stake contributed 30% of Chevron's total production. (2) The quantitative error is severe: the ground truth specifies that Chevron's net production from the QG3 project was 13 MBD (thousand barrels per day), but the LLM incorrectly interprets the 30% ownership stake as the percentage contribution to total production, with no data provided on Chevron's total production or correct proportional contribution. (3) The reasoning is flawed—this is a multi-hop question requiring the model to calculate the percentage of total production coming from QG3, but the LLM confuses ownership percentage with production share and fails to perform or even reference the necessary calculation. (4) Contextual relevance is low because the answer cites a non-existent 'QG3 production table on page 11' and does not address the actual question. The model fabricates a source and misapplies the 30% figure, leading to a completely incorrect conclusion. No correct synthesis of production volume or percentage contribution occurs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1123,
        "completion_tokens": 363,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "Honeywell adopted ASU 2022‑04 on Jan 1 2023, with the roll‑forward requirement becoming effective Jan 1 2024.  The standard obliges the company to disclose the key terms of its supplier‑finance programs, explain where the outstanding balances appear in the financial statements, and present a roll‑forward of those balances as of each period end (page 60).  3M’s supplier‑finance program note (page 77) shows it has confirmed‑invoice balances of roughly $0.3 billion; while the note does not explicitly mention the roll‑forward, the same ASU applies to 3M, so it will likewise disclose a roll‑forward of outstanding balances, thereby improving transparency of its supplier‑finance obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. According to the ground truth, 3M reported $1.5 billion of invoices confirmed and $1.5 billion paid or adjusted in 2024 under the roll-forward requirement. However, the LLM states 3M has 'confirmed-invoice balances of roughly $0.3 billion,' which contradicts the ground truth and misrepresents the scale of 3M's supplier finance obligations. Additionally, the LLM claims Honeywell adopted ASU 2022-04 on January 1, 2023, but the ground truth states Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation—this is a critical date error. (2) The calculation and reporting of roll-forward disclosures are partially correct in concept (e.g., requirement to disclose roll-forwards), but the actual numbers and timing are wrong. The $0.3 billion figure for 3M has no support in the ground truth and appears fabricated or misread. (3) The reasoning is logically structured and recognizes that ASU 2022-04 applies to both companies and improves transparency through roll-forward disclosures, which shows correct multi-hop synthesis at a conceptual level. However, it fails in execution by citing incorrect data points and implementation dates. (4) Contextual relevance is high—the answer addresses supplier finance transparency, roll-forward requirements, and both companies—but correctness is undermined by key factual errors in numbers and dates. Thus, the answer is partially correct in intent but significantly flawed in factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 435,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "LMT’s revenue‑recognition policy for U.S. Government contracts governed by the FAR is to record revenue over time as control of the work transfers, with fixed‑price contracts recognized at the pre‑determined price and cost‑reimbursable contracts recognized on the basis of allowable costs plus a fee (LMT Notes 76‑77). In contrast, RTX’s exposure to U.S. Government contract risks is largely driven by the fact that its fixed‑price contracts (firm or incentive) make it bear the full cost‑overrun risk and profit‑margin uncertainty, while its cost‑reimbursable contracts expose it to the risk of not being reimbursed for unauthorized or excess costs, and it also faces termination and funding‑delays risks (RTX Notes 16‑23). Thus, LMT focuses on timing and control under FAR, whereas RTX faces significant financial risk from the cost and profit dynamics of fixed‑price structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies LMT's revenue recognition approach for U.S. Government FAR-regulated contracts, distinguishing between fixed-price and cost-reimbursable contracts, and notes that cost-reimbursable contracts are recognized based on allowable costs plus a fee—consistent with the cost-plus-fixed-fee model in the original answer. It also accurately characterizes RTX's financial exposure from fixed-price contracts, particularly the risk of cost overruns and profit uncertainty under firm fixed-price (FFP) and incentive contracts. (2) There are no numeric values in the question or answers that require verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across LMT and RTX, contrasting their contract structures and associated risks. The only minor shortcoming is that the LLM answer does not explicitly state that LMT’s FAR-regulated contracts are predominantly cost-plus, which inherently limits its exposure to cost overruns—this nuance is implied but not emphasized as clearly as in the original answer. (4) Despite this, the LLM answer captures the core contrast: LMT benefits from more predictable revenue due to cost reimbursement, while RTX bears higher risk under fixed-price structures. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both companies and the comparative risk and revenue recognition framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 425,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s composition‑of‑matter patent for Eliquis in Europe is still active – the company is litigating to prevent generic launch before the patent’s eventual expiry【page_121】.  By contrast, Merck’s key U.S. patents for the Januvia family expire in 2026 (May 2026 for Januvia/Janumet and July 2026 for Janumet XR)【page_58】.  Consequently, BMS can maintain exclusivity in Europe for a longer period while defending against early generic entry, whereas Merck’s U.S. exclusivity is limited to 2026, after which generic competition is expected to erode sales.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but has significant factual and reasoning inaccuracies. (1) Quantitatively, the LLM correctly states that MRK's Januvia/Janumet exclusivity lasts until May 2026 and Janumet XR until July 2026, matching the ground truth. However, it incorrectly implies that BMY's (BMS's) composition-of-matter patent in Europe is still broadly active and can maintain exclusivity for a 'longer period', which contradicts the ground truth: generic competition has already entered in Finland and Portugal, and BMY has faced negative rulings in the UK with mixed outcomes across Europe. The expiration timeline for Eliquis is not a single future date but is fragmented due to country-by-country litigation outcomes. (2) The LLM fails to mention the key contrast in enforcement strategies: BMY is in active litigation with varying results across European countries (positive in Norway, Sweden, Switzerland; negative in UK; ongoing appeals elsewhere), while MRK extended exclusivity via settlements and secondary patents in the U.S. This multi-hop synthesis is missing. (3) The reasoning is flawed: the conclusion that 'BMS can maintain exclusivity in Europe for a longer period' is unsupported and factually incorrect given that generics are already on the market in some countries, whereas MRK’s exclusivity is clearly defined and legally extended until 2026. The original answer emphasizes that MRK has *successfully* delayed generics through legal strategy, while BMY faces *immediate erosion*—the opposite of what the LLM implies. (4) Contextual relevance is high as the answer addresses patent timelines and market exclusivity for both drugs, but the qualitative inaccuracy in reasoning and entity-specific outcomes (country-level rulings, existing generic entry) reduces correctness. Minor note: 'BMS' is used instead of 'BMY'—acceptable as both refer to Bristol Myers Squibb—but 'MRK' is correctly used.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 521,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds totaling **about $35 million** to secure stays of judgments pending appeal. In contrast, the company has paid **roughly $1 billion** in judgments and settlements (including costs and fees) in tobacco‑related litigation since October 2004, so the appeal bonds represent only a small fraction of those overall payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $35 million in appeal bonds and the $1 billion in judgments and settlements since October 2004, matching the ground truth exactly in both figures and time frame. The comparison stating that the bonds represent a 'small fraction' of total payments aligns semantically with the original answer. (2) All numeric values are accurate: $35 million (appeal bonds) and $1 billion (judgments and settlements) are correctly reported. The LLM omits the $241 million in interest payments mentioned in the ground truth, which is a minor but notable omission affecting completeness. However, since the question primarily asks for a comparison between appeal bonds and total payments (which includes judgments and settlements), and the $1 billion figure already encompasses payments, the omission does not invalidate the core comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about current appeal bonds and historical payments, drawing a valid qualitative conclusion about their relative magnitudes. (4) The answer is contextually fully relevant, directly addressing both parts of the question. The only reason for not scoring a 10 is the omission of interest payments, which slightly reduces completeness but does not impair the essential correctness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 377,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s Greater China segment reported net sales of **$74.2 billion** in 2022, a figure that includes revenue from Taiwan (Apple, 2022, Note 11).  \nNVIDIA, by contrast, reported **$8.544 billion** in revenue from customers invoiced in Taiwan for the same year (NVIDIA, 2022, Revenue by geographic region).  \nThus, Apple’s Taiwan‑related revenue (as part of Greater China) was about **$65.7 billion higher**—roughly **8.7 times** NVIDIA’s direct Taiwan revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Apple's Greater China net sales as $74.2 billion (equivalent to $74,200 million) and NVIDIA's Taiwan revenue as $8.544 billion, matching the ground truth in absolute values. These figures are quantitatively accurate with acceptable formatting variations (billion vs million). (2) However, the LLM makes a critical error in reasoning by calculating a $65.7 billion difference and claiming Apple’s Taiwan-related revenue is 8.7 times higher than NVIDIA’s. This is factually incorrect because Apple does not report Taiwan-specific revenue separately — it is embedded within the Greater China segment (which includes mainland China and Hong Kong). Therefore, one cannot isolate Apple’s Taiwan revenue or make a direct numerical comparison. The LLM falsely implies that Apple’s Taiwan revenue is known and significantly larger, which contradicts the ground truth that states the exact contribution from Taiwan for Apple 'cannot be determined precisely.' (3) The multi-hop reasoning fails: while the model identifies the correct data points, it synthesizes them incorrectly by performing an invalid comparison between a segmented regional total (Apple’s Greater China) and a country-specific figure (NVIDIA’s Taiwan). The conclusion drawn is therefore misleading and factually unsupported. (4) Scores reflect: partial quantitative accuracy (correct input numbers but flawed calculation), low qualitative accuracy (faulty logic and synthesis), moderate correctness (half the facts right, but core conclusion wrong), and high contextual relevance (addresses the right companies, metrics, and year).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 446,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "NVDA’s revenue from Taiwan surged from **$3.0 billion in FY 2020 to $8.5 billion in FY 2022** – a **≈182 % increase** (8,544 – 3,025 ÷ 3,025).  \nApple’s Greater China (China mainland + Hong Kong + Taiwan) revenue rose from **$40.3 billion in FY 2020 to $74.2 billion in FY 2022**, a **≈84 % increase** (74,200 – 40,308 ÷ 40,308).  \n\nThus, NVDA’s Taiwan‑region growth was more than twice the growth Apple saw in its Greater China segment over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers are correct and accurately represented—NVDA's revenue from Taiwan was $3,025 million (rounded to $3.0 billion) in 2020 and $8,544 million (rounded to $8.5 billion) in 2022; AAPL's Greater China revenue was $40,308 million ($40.3 billion) in 2020 and $74,200 million ($74.2 billion) in 2022. The percentage increases are correctly calculated: (8,544 - 3,025) / 3,025 ≈ 1.825 or 182%, and (74,200 - 40,308) / 40,308 ≈ 0.841 or 84%, both correctly rounded. (2) Completeness: The answer addresses both companies, the correct regions (Taiwan for NVDA, Greater China including Taiwan for AAPL), and the full two-year growth comparison. (3) Entity accuracy: Tickers (NVDA, AAPL), regions (Taiwan, Greater China), and fiscal years (2020–2022) are correctly identified. (4) Reasoning: The multi-hop synthesis—comparing revenue growth across different companies, geographies, and time periods—is sound. The conclusion that NVDA’s growth was more than twice AAPL’s is logically valid (182% vs 84%) and correctly drawn. (5) Semantic equivalence: Despite using rounded figures and slightly different formatting (e.g., '≈182 %' vs '182.5%'), the meaning and factual content are identical to the ground truth. No errors in logic, calculation, or interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 377,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft notes that the OECD’s Pillar Two minimum‑tax rules are not expected to materially affect its 2025 tax liability and it will monitor implementation (page_47). Broadcom similarly states that, because it has no material operations in jurisdictions with rates below the 15 % minimum, the rules are not expected to materially increase its global tax costs (page_75). Thus, both firms foresee minimal impact, but Microsoft’s larger foreign‑income base could make it more sensitive to future changes, whereas Broadcom’s exposure is limited by its higher‑rate jurisdictions.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively and factually, it incorrectly states that Broadcom expects no material impact from the global minimum tax due to having no material operations in jurisdictions below 15%, which directly contradicts the ground truth: Broadcom explicitly notes that the global minimum tax may materially increase its effective tax rate and cash tax costs, particularly due to Singapore's adoption in FY2026. (2) The original answer highlights a key contrast—Microsoft sees no material impact because it lacks operations in low-tax jurisdictions, while Broadcom *does* have exposure due to its reliance on tax incentives in such jurisdictions. The LLM flips this by claiming Broadcom has no material operations in low-rate jurisdictions, which is false per the ground truth. (3) The multi-hop reasoning fails: the question asks for a comparison based on differing international tax structures, but the LLM incorrectly equates the two companies' exposures rather than contrasting them. (4) While the fiscal year 2025 for Microsoft is correctly mentioned, Broadcom’s FY2026 exposure is omitted. The claim that Microsoft’s larger foreign-income base makes it more sensitive is speculative and not supported in the ground truth. (5) Semantic equivalence is not achieved because the core conclusion (both have minimal impact) is incorrect. The LLM answer is contextually relevant in addressing the question's scope but fails on factual and qualitative accuracy due to reversed entity-specific impacts and flawed reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 437,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "GOOGL’s dual‑class structure gives Class B holders ten votes for each share, whereas NFLX’s single‑class common stock provides only one vote per share (NFLX “Voting Rights” § 61; GOOGL “Class A and Class B Common Stock” § 81).  This means a GOOGL Class B shareholder can influence corporate decisions tenfold per share, enabling concentrated control by insiders, while NFLX shareholders’ influence is strictly proportional to the number of shares they own.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitative accuracy: The statement that GOOGL Class B shares carry 10 votes per share and NFLX shares carry 1 vote per share is accurate and matches the original answer. No calculations are required, but the comparison of voting power (10x per share) is correctly interpreted. (2) Completeness: The answer addresses the core of the question—how the difference in voting structures impacts shareholder influence. It correctly contrasts GOOGL’s dual-class structure with NFLX’s single-class structure. The mention of 'concentrated control by insiders' adds context not explicitly in the ground truth but is a reasonable inference supported by typical interpretations of dual-class structures. (3) Entity accuracy: NFLX and GOOGL are correctly identified, and the stock classes (Class B for GOOGL, common stock for NFLX) are accurate. (4) Reasoning: The multi-hop synthesis is sound—comparing voting rights across two companies and explaining the implications on shareholder influence. The LLM correctly infers that higher votes per share lead to disproportionate influence. (5) Semantic equivalence: The meaning conveyed is substantively the same as the original answer, with slightly more emphasis on control concentration, which is acceptable. The only minor shortcoming is that it does not explicitly state that all NFLX shareholders have equal influence (a small omission), but this is implied by 'strictly proportional.' Thus, the answer is excellent but not perfect—hence a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 438,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD’s revenue from Taiwan in 2021 was $2.091 billion (see the table of sales to external customers by geographic region). Apple’s 2022 revenue from the Greater China region—including China mainland, Hong Kong and Taiwan—was $74.2 billion (see the net sales by reportable segment table). Thus, Apple’s Greater China revenue was roughly 35 times larger than AMD’s Taiwan revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in AMD's revenue from Taiwan in 2021. The ground truth states $1,187 million ($1.187 billion), but the LLM claims $2.091 billion—this is a significant overstatement (~76% higher). Apple's revenue figure is correct at $74.2 billion. (2) The calculation comparing Apple’s revenue to AMD’s is based on incorrect input: while $74.2B / $2.091B ≈ 35.5 (so the '35 times larger' is mathematically consistent with its own numbers), the correct ratio should be $74,200M / $1,187M ≈ 62.5, meaning Apple’s revenue was about 62.5 times greater, not 35. Thus, the calculation is flawed due to incorrect input. (3) The multi-hop reasoning structure is sound—the model correctly identifies that it must compare AMD’s Taiwan-specific revenue with Apple’s broader Greater China region revenue and acknowledges the geographic inclusion relationship (Taiwan within Greater China). It also references appropriate tables, suggesting correct source alignment. (4) Despite correct qualitative structure and context, the major numerical inaccuracy in AMD’s revenue severely undermines factual correctness. The answer is contextually relevant and attempts proper synthesis, but the core data point is wrong, leading to an incorrect comparison. Hence, correctness score is low (4), quantitative accuracy poor (3), qualitative reasoning partially correct (5), and relevance high (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 393,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan has 49.0 million shares reserved and available for issuance, and the plan explicitly permits incentive stock options for employees. The Starbucks 10‑K pages provided do not disclose a figure for remaining equity grant capacity or detail the use of incentive stock options, so a direct numerical comparison cannot be made. Tesla’s compensation strategy clearly incorporates incentive stock options, whereas Starbucks’ strategy is not described in the supplied excerpts.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly states Tesla's 49.0 million shares reserved under its 2019 Equity Incentive Plan as of December 31, 2021, which matches the ground truth. However, it incorrectly claims that the Starbucks 10-K does not disclose remaining equity grant capacity or use of incentive stock options, when in fact the original answer confirms Starbucks had 99.7 million shares available as of October 2, 2022, and uses incentive stock options as part of its equity compensation. This omission constitutes a major factual gap, especially since the question explicitly asks for a comparison between Tesla and Starbucks. The LLM fails to provide the multi-hop synthesis required—comparing both companies' available shares and their use of incentive stock options—instead retreating to a claim of missing data. While the information it does provide about Tesla is accurate (quantitative accuracy is high), the failure to acknowledge available Starbucks data undermines completeness and qualitative reasoning. The answer is contextually relevant but significantly incomplete, leading to a low correctness score despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 320,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD’s Level 2 plan assets are valued with market‑based models that use observable inputs such as interest rates, bond yields and quoted prices for similar assets—effectively broker/dealer quotes—providing a market‑derived estimate of fair value (page 93). BA, in contrast, states that its available‑for‑sale debt investments are valued by a market approach based on quoted market prices or broker/dealer quotes of identical or comparable instruments (page 113). Thus, both entities rely on broker/dealer quotes to inform Level 2 fair‑value estimates, but GD applies them within pension‑plan asset valuations, whereas BA applies them directly to the valuation of its debt securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—GD (General Dynamics) and BA (Boeing)—are correctly identified, and the financial instruments (Level 2 assets for GD, available-for-sale debt investments for BA) are accurately described. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; the answer correctly references page numbers (93 and 113), which supports traceability. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use broker/dealer quotes and observable inputs for fair value determination of Level 2 assets, noting a subtle but relevant distinction—GD applies these in the context of pension plan assets, while BA applies them directly to debt securities. This nuance is not in the original answer but is contextually valid and adds precision without contradicting the parallel approach conclusion. (4) The semantic meaning matches the original answer: both conclude that GD and BA use similar methodologies relying on third-party quotes and observable inputs, indicating a parallel approach despite different applications. The only minor gap is that the LLM slightly overemphasizes the contrast (using 'in contrast' and highlighting pension vs. direct debt valuation), which could imply a greater divergence than the original answer suggests. However, it still acknowledges the core similarity in methodology. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 444,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "The Federal Reserve’s zero‑percent CCyB removes an otherwise mandatory buffer from both firms’ Basel III totals.  For Morgan Stanley, the 2023 capital‑buffer requirement is 8.4 % under the standardized approach (5.4 % SCB + 3.0 % G‑SIB surcharge + 0 % CCyB) and 5.5 % under the advanced approach (2.5 % capital‑conservation buffer + 3.0 % G‑SIB surcharge + 0 % CCyB).  American Express’s effective minimum total‑capital ratio is 10.5 % (CET1 7.0 % + Tier 1 8.5 % + Total 10.5 %) and already incorporates the SCB for the holding company and the capital‑conservation buffer for the bank; the zero CCyB therefore adds no further buffer beyond these existing requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies and introduces unsupported numerical values not present in the ground truth. First, the claim that Morgan Stanley's capital buffer is 8.4% under the standardized approach (5.4% SCB + 3.0% G-SIB) and 5.5% under the advanced approach (2.5% CCB + 3.0% G-SIB) is not supported by the original answer, which does not provide specific percentage totals or break down the SCB as 5.4%. The original answer states that Morgan Stanley includes the SCB in its Advanced Approach calculation along with the 2.5% CCB and G-SIB surcharge, but does not quantify the total or the SCB itself. The LLM invents precise figures (e.g., 5.4% SCB, 8.4% total) with no basis in the provided truth. Similarly, the assertion that American Express has a 10.5% total capital ratio composed of CET1 7.0%, Tier 1 8.5%, and Total 10.5% is not in the original answer and misrepresents how capital buffers are aggregated (these tiers are not additive in the way presented). The original answer only states that American Express is subject to the SCB and that the zero CCyB means no additional requirement from that buffer—no specific ratios are given. The reasoning partially captures the impact of the zero CCyB correctly: since it is set at zero, neither firm needs to add capital under this buffer. It also correctly notes that both firms are subject to the SCB, though the characterization of American Express’s regulatory treatment is oversimplified. However, the multi-hop synthesis is flawed because the LLM fabricates numbers rather than relying on the qualitative regulatory structure described in the ground truth. While the general direction of the answer is relevant and addresses both firms and the CCyB impact, the inclusion of false precision and incorrect calculations severely undermines factual correctness. Semantic equivalence fails on quantitative points, though the conceptual role of the SCB and the null effect of the zero CCyB are partially aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 536,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "AMT’s $4.0 billion commitment under the 2021 Credit Facility was earmarked to fund its 2021 acquisitions—Telxius and CoreSite—and for general corporate purposes, illustrating a direct debt‑financing strategy for growth (page 51).  By contrast, Simon Property Group’s December 31 2021 strategy relied on joint‑venture structures—holding interests in 84 properties and providing interest‑bearing construction loans totaling $88.4 million—to finance development and diversify risk, rather than using a single large credit facility to finance acquisitions (page 116).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.0 billion commitment under AMT's 2021 Credit Facility and its use for acquisitions (Telxius and CoreSite), which aligns with the ground truth. It also accurately states SPG's $88.4 million in financing to joint ventures in the form of interest-bearing construction loans as of December 31, 2021. All key facts—dollar amounts, company strategies, and financial instruments—are correct. (2) Quantitative accuracy is perfect: $4.0 billion and $88.4 million match the original answer exactly; dates (2021, December 31, 2021) are correct; no calculations are required, but the use of numbers in context is precise. (3) The multi-hop reasoning is sound: the model correctly contrasts AMT’s direct debt-financing strategy via a large credit facility with SPG’s joint-venture and internal loan-based approach, synthesizing information across two companies and strategies. The mention of Telxius as an additional acquisition beyond CoreSite adds contextual detail not in the original but does not contradict it—AMT did acquire both, so this is a minor enhancement rather than an error. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (naming Telxius) and proper citation of sources (page references). The only reason for not scoring a 10 is that the original answer emphasizes SPG's risk diversification and development focus slightly more explicitly, though the LLM implies this. Overall, the response is factually accurate, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 426,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks opened 21 more stores in Taiwan in 2022 (from 523 to 544, a 4 % increase).  \nNike’s Greater China segment, which includes Taiwan, generated about **$7.5 billion** in revenue in 2022.  \nThus, the modest store‑count expansion in Taiwan is dwarfed by the large revenue contribution from Nike’s Greater China region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Starbucks added 21 net new stores in Taiwan from 523 to 544, which aligns with the ground truth of 21 net new stores in FY2021–2022. The 4% growth is a reasonable approximation (21/523 ≈ 4.01%), and Nike’s Greater China revenue is accurately reported as $7.5 billion, consistent with the ground truth value of $7,547 million (i.e., $7.547 billion). The rounding to $7.5 billion is acceptable and common in financial reporting. (2) All numeric values are correct or appropriately rounded; store count progression and revenue figure match the original data. (3) The multi-hop reasoning is sound: the model correctly synthesizes Starbucks’ store growth in Taiwan with Nike’s revenue from Greater China, acknowledging that Taiwan is included in Nike’s reporting segment. It draws a logical comparison between physical expansion (store count) and financial performance (revenue), highlighting different modes of market engagement as in the original answer. (4) The only minor shortcoming is the lack of explicit mention that Nike’s revenue includes Taiwan as part of Greater China—though implied, it is less clearly articulated than in the original. However, the core facts, calculations, and synthesis are accurate and relevant, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 367,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s OPB plan allocates about **60 % of its assets to equities** through the balanced index fund. By comparison, 3M’s pension plan’s equities had a **fair value of roughly $785 million** as of December 31, 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: Boeing's OPB plan invests 60% of its assets in equities through the balanced index fund, and 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023. (2) Quantitative accuracy is perfect—both the percentage (60%) and dollar amount ($785 million) match the original answer exactly, with acceptable formatting (e.g., '60 %' vs '60%' and '$785 million' vs '$785 million'). (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (Boeing and 3M), two different pension plans (OPB and MMM's plan), and two different metrics (percentage allocation vs. absolute fair value). (4) The response is contextually relevant, directly addressing both parts of the question without extraneous information. No errors in entities, time periods, or financial terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 276,
        "total_tokens": 1404
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "American Tower used its 2021 USD Delayed‑Draw Term Loans to raise a total of **$4.5 billion** (a $3.0 billion 364‑day loan and a $1.5 billion two‑year loan) for the CoreSite acquisition, with each loan unsecured, LIBOR‑plus‑1.125% interest and fixed maturities.  \nIn contrast, Simon Property Group’s joint‑venture financing is far smaller—**$88.4 million** in interest‑bearing construction loans and other advances to partners—structured as short‑term development financing that is recorded as deferred costs rather than a separate large loan facility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the total dollar amount of AMT's 2021 USD Delayed Draw Term Loans. The ground truth states AMT utilized a $10.5 billion financing structure, but the LLM reports only $4.5 billion ($3.0 billion + $1.5 billion), which is significantly lower and factually incorrect. The SPG financing amount of $88.4 million is correctly reported. (2) The quantitative inaccuracy in AMT's financing total undermines the comparison in scale between the two companies' financing mechanisms. While the SPG number is accurate, the AMT figure is off by more than 50%, which affects the validity of the comparison. (3) The qualitative reasoning is sound: the LLM correctly identifies that AMT's financing was for the CoreSite acquisition and describes loan terms (unsecured, LIBOR-plus, maturities), and contrasts this with SPG’s smaller-scale, development-oriented joint venture financing. It also correctly notes the structural difference—AMT used a large-term loan facility while SPG provided short-term advances recorded as deferred costs. (4) Contextual relevance is high, as the response directly addresses both companies, the purpose, structure, and scale of financing. However, due to the major quantitative error in AMT's financing amount, the correctness score is reduced to 6—partially correct but with a significant factual deficiency. The qualitative accuracy is moderately high due to correct reasoning and entity identification, and contextual relevance remains strong as the structure and intent of the answer align well with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 436,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM’s upstream and refining operations rely heavily on crude oil, as shown by its $326.8 billion of “Crude oil and product purchases” in 2024 (page 106).  Chevron’s 15 % stake in the Caspian Pipeline Consortium (CPC) gives it a direct interest in a key export route that moved an average of 1.2 million barrels per day of crude from Chevron’s Kazakhstan operations (page 16).  Thus, XOM’s crude‑oil demand and pricing are linked to the pipeline’s capacity and the 1.2 million‑barrel‑per‑day flow that could be sourced from Chevron’s assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies XOM's reliance on crude oil and CVX's 15% stake in the CPC, as well as the relevance of Kazakhstan operations. However, there are key quantitative inaccuracies: the ground truth states that CPC transports 1.4 million barrels per day total, with 1.2 million barrels sourced from Kazakhstan (from fields like Tengiz and Karachaganak where Chevron operates). The LLM incorrectly attributes the entire 1.2 million bpd flow directly to Chevron’s operations, rather than clarifying that this volume includes production from fields in which Chevron holds stakes—this overstates direct control. Additionally, the $326.8 billion 'Crude oil and product purchases' figure for XOM in 2024 is presented without corroboration in the original answer or typical SEC filing data; such a number is implausibly high (global oil trade is ~100 million bpd at ~$60/bbl = ~$2.2 trillion annually), making $326.8B for one company’s purchases questionable. (2) The CPC volume is misstated: LLM says '1.2 million barrels per day from Chevron’s Kazakhstan operations', but ground truth specifies 1.2 million barrels sourced from Kazakhstan (not exclusively Chevron’s), transported via CPC of which CVX owns 15%. The LLM conflates 'sourced from' with 'produced by Chevron'. (3) The multi-hop reasoning is partially sound—linking XOM’s crude dependence to potential supply chain impacts via CPC—but misses the nuance that CVX’s role is through ownership in infrastructure (CPC) and partial production in upstream assets, not direct operation of the entire 1.2 million bpd stream. (4) Despite these issues, the core logic—that disruptions to CPC could affect crude availability and pricing relevant to XOM—is valid and contextually appropriate. Hence, correctness is reduced due to significant numerical and attribution errors, though the overall direction and synthesis are reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 515,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "NEE’s nuclear decommissioning risk is a direct shortfall risk: the company acknowledges that the cost of decommissioning its nuclear plants could exceed the amount available in its decommissioning funds, potentially leaving a gap. Duke Energy’s exposure is to market‑driven volatility in its nuclear decommissioning trust fund (NDTF) assets; a decline in those asset values could raise the funding required to meet decommissioning obligations. Both firms face similar environmental and financial risks from operating nuclear plants, but NEE’s risk is a cost‑reserve mismatch, whereas Duke Energy’s is a fluctuation in the value of the trust fund that could increase future funding needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: NEE faces a decommissioning funding shortfall risk if costs exceed fund balances, while Duke Energy's exposure stems from market volatility affecting its Nuclear Decommissioning Trust Funds (NDTFs). The answer correctly identifies both companies' distinct but related financial risks. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms operate nuclear facilities with financial risks tied to decommissioning, but the nature of the risk differs—NEE emphasizes cost-reserve mismatch, Duke Energy emphasizes market-driven asset fluctuations. The distinction is accurately captured. (4) The LLM uses slightly different phrasing (e.g., 'cost-reserve mismatch' vs. 'potential shortfalls') but conveys the same meaning. It omits the explicit mention of 'Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida' as the subsidiaries maintaining NDTFs, which is a minor detail present in the original. However, referring to 'Duke Energy' collectively is acceptable in context. No factual inaccuracies; high contextual relevance and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 375,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "LOW’s Level 3 fair‑value items—such as the performance‑based contingent consideration from its Canadian divestiture—are measured with an income approach that relies on significant unobservable inputs (equity value, volatility, term, discount rate) (page_53). GM’s policy defines Level 3 as those instruments whose significant inputs are unobservable and notes that, when market prices are unavailable, fair value is derived from pricing services, pricing models or discounted‑cash‑flow methods that incorporate unobservable assumptions (page_63). Thus, both firms classify Level 3 valuations by the observability of inputs, but LOW explicitly applies an option‑pricing model for its Level 3 items, whereas GM’s policy is broader, allowing any model‑derived valuation that uses unobservable inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: LOW uses an income approach with significant unobservable inputs (e.g., volatility, term, discount rate) for Level 3 contingent consideration related to its Canadian retail business divestiture, which matches the original answer’s reference to the Canadian retail business sale. GM’s use of unobservable inputs in Level 3 valuations—particularly through pricing models and discounted cash flow methods when market prices are unavailable—is accurately described. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies follow the same accounting hierarchy based on input observability but apply it differently—LOW explicitly using an option-pricing model for Level 3, while GM allows broader model-based approaches incorporating unobservable assumptions. This reflects the correct comparison across companies and policies. (4) The only minor limitation is that the LLM does not mention GM Financial receivables or specific unobservable inputs like unemployment rates and GDP growth used in static pool modeling, which are present in the original answer and add contextual depth. However, the core reasoning and classification logic are preserved. Thus, while slightly less detailed, the LLM answer remains semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 426,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "AMT’s $10.5 billion of committed bridge financing under the 2021 Multicurrency Credit Facility was a single, large‑scale deployment that was used to fund the CoreSite acquisition and refinance existing debt【52】. In contrast, SPG’s joint‑venture financing is modest—$88.4 million in construction loans spread across many properties—to finance development and diversify risk across a portfolio of assets【116】【113】. Thus, AMT’s strategy is a concentrated, acquisition‑focused capital deployment, whereas SPG’s approach is incremental and risk‑diversified through multiple joint‑venture projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $10.5 billion committed financing under AMT's 2021 Multicurrency Credit Facility and SPG's $88.4 million in joint-venture financing, with accurate use of both figures. The characterization of AMT's use for the CoreSite acquisition and debt refinancing aligns with ground truth, though the original answer also mentions Telxius—this omission is minor and does not distort the core fact. SPG’s financing as interest-bearing construction loans across multiple properties is accurately reflected. (2) All numeric values are correct: $10.5 billion and $88.4 million match the ground truth exactly; no calculations are required, but the comparison in scale is appropriately conveyed. Format variations (e.g., $10.5 billion vs $10.5 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AMT and SPG, contrasting their capital deployment strategies—AMT’s large-scale, acquisition-driven financing versus SPG’s smaller, risk-diversifying joint-venture loans. The conclusion about concentrated vs. incremental strategies is logically derived and consistent with the original answer. (4) The answer is contextually fully relevant, directly addressing both capital deployment strategy and risk diversification as asked. The only minor shortcoming is the omission of Telxius as a use of AMT’s financing, which slightly reduces completeness but does not affect the overall correctness. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 427,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD reported $1.841 billion of revenue from customers in Taiwan in 2023 (page 71).  Qualcomm, by contrast, highlights its reliance on foundry partners in Taiwan as a critical operational risk that could materially harm its business if supply is disrupted (pages 6, 31, 35).  Thus, AMD’s exposure is a specific dollar amount, whereas Qualcomm’s exposure is a supply‑chain dependency that could have a material adverse impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.841 billion revenue figure for AMD in 2023 from Taiwan is correct and matches the original answer's $1,841 million (equivalent values, different formatting). The LLM correctly cites this from page 71, showing fidelity to source data. (2) Entity accuracy is strong: AMD and QCOM (Qualcomm) are correctly identified, with correct time frame (2023) and relevant risk context. (3) Reasoning is sound: the LLM correctly distinguishes AMD’s revenue exposure (downstream, customer-based) from Qualcomm’s operational dependency (upstream, supply chain), which is the core of the multi-hop comparison. It accurately reflects that Qualcomm’s risk stems from foundry reliance in Taiwan, which could materially impact business if disrupted, citing relevant pages (6, 31, 35). (4) While the LLM answer is concise, it omits the nuance that AMD’s exposure is 'notable but declining' and does not explicitly mention the dual geopolitical risk to both revenue and manufacturing. However, the key contrast—revenue vs. supply chain exposure—is clearly and correctly conveyed. Semantic equivalence is maintained, and the answer is contextually precise. Minor omission prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 363,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "SBUX projects that the 15 % global minimum tax will not be effective for the company until fiscal 2025 and, as a result, is not expected to have a material impact on its consolidated financial statements【page_28】.  McDonald’s assessment mirrors this view – the tax is likewise slated to take effect only in fiscal 2025 and is not anticipated to materially affect its consolidated results, reflecting the phased implementation across jurisdictions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that SBUX does not expect a material impact from the 15% global minimum tax under Pillar 2 until fiscal 2025, which aligns with the ground truth. It also correctly states that MCD shares a similar assessment. The percentage (15%), fiscal year (2025), and qualitative impact ('not expected to have a material impact') are all factually accurate. (2) Quantitatively, all numbers and dates are correct: the 15% rate and fiscal 2025 timing match the original answer. There are no calculations required, but the temporal and numerical assertions are precise. (3) The multi-hop reasoning is mostly sound—comparing SBUX’s and MCD’s assessments regarding Pillar 2. However, the LLM slightly misrepresents MCD’s timeline: the original answer clarifies that many jurisdictions enacted Pillar 2 effective for years after December 31, 2023, and MCD is assessing ongoing developments, but it does not explicitly state MCD expects implementation in fiscal 2025. The LLM incorrectly equates MCD’s timeline with SBUX’s, which is not supported in the ground truth. This is a minor but notable error in synthesis. (4) Despite this, the core message—that both companies expect no material impact and are monitoring developments—is preserved, and the answer remains highly relevant and factually grounded. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 407,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan’s risk‑governance framework assigns firmwide ownership of risk assessment to the CRO, the IRM function and LOB risk owners, which drives a coordinated, cross‑LOB approach to stress testing that is embedded in overall risk management but is not explicitly linked to capital adequacy (page_93). In contrast, Goldman Sachs explicitly ties its stress‑testing methodology to capital adequacy, using stress tests as a core part of its capital planning and regulatory stress‑testing processes (page_111). Thus, while JPMorgan’s stress tests primarily serve risk oversight and management, Goldman Sachs uses them to evaluate capital buffers and regulatory compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorganChase's firmwide ownership of risk assessment is accurately attributed to the CRO, IRM function, and LOB risk owners, reflecting the governance structure. The statement that stress testing is embedded in overall risk management but not explicitly tied to capital adequacy matches the ground truth's implication that JPMorgan’s approach is governance-driven and broader in scope. For Goldman Sachs, the explicit linkage of stress testing to capital adequacy, capital planning, and regulatory processes is correctly stated and consistent with the original answer’s emphasis on capital adequacy and tail risk assessment. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the absence of any incorrect data earns full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in governance frameworks (JPMorgan’s ownership model vs. Goldman’s capital focus) and infers the differing purposes of stress testing in each firm. The only minor shortcoming is that the LLM answer does not mention Goldman Sachs’ evaluation of nonfinancial risks or 'vulnerabilities across financial and nonfinancial risks'—a detail present in the original answer—making it slightly less complete but not factually inaccurate. (4) The semantic meaning and core conclusion are equivalent: both answers highlight that while both firms use stress testing, the integration and purpose differ—governance-driven risk oversight at JPMorgan vs. capital adequacy at Goldman Sachs. Contextual relevance is perfect, as the response directly addresses the comparative framework asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 497,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "XOM’s 2021 long‑lived assets in Kazakhstan were $8.463 billion (page 123).  Chevron’s financial stake in Tengizchevroil is a 50 % equity ownership interest plus a $4.5 billion loan to the joint venture (page 78).  Thus, XOM’s exposure in Kazakhstan exceeds Chevron’s loan contribution, while Chevron’s stake also includes a substantial equity share in the JV.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports XOM's $8,463 million (i.e., $8.463 billion) in long-lived assets in Kazakhstan as of 2021 and CVX's 50% equity interest in Tengizchevroil plus the $4.5 billion loan to fund the FGP/WPMP projects. All numeric values, percentages, and timeframes match the ground truth exactly, with acceptable formatting variations (e.g., $8.463 billion = $8,463 million). Thus, quantitative accuracy is perfect. (2) However, the LLM's qualitative reasoning contains a partial misinterpretation: it states that 'XOM’s exposure in Kazakhstan exceeds Chevron’s loan contribution,' which, while factually true ($8.463B > $4.5B), omits the critical synthesis point from the original answer — that CVX's *total financial exposure* (equity stake + $4.5B loan) may *together* exceed XOM's asset base. The LLM fails to estimate or acknowledge the combined value of CVX’s equity and loan, which is the core of the multi-hop comparison. (3) The multi-hop reasoning is incomplete: the question asks for a comparison of XOM's asset exposure to CVX's *total* financial stake (equity + loan), but the LLM treats the loan and equity as separate elements without synthesizing them into a total exposure figure. It does not conclude — or even suggest — that CVX’s combined stake could exceed XOM’s, which is the key insight in the ground truth. (4) Despite this, the answer remains contextually relevant and factually sound on the surface, earning high marks for quantitative accuracy and relevance, but loses points for incomplete reasoning and failure to fully synthesize the multi-hop comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 440,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Geopolitical tensions involving Taiwan could disrupt the supply chain for both Qualcomm and NVIDIA, as each relies on foundry partners located in Taiwan.  Qualcomm warns that a conflict could severely limit or prevent chipset supply from Taiwan, materially harming its business (QCOM page 35).  NVIDIA similarly notes that tensions in Taiwan and China could disrupt its supply continuity from contract manufacturers and assembly partners, potentially impacting revenue and operations (NVDA page 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: both QCOM and NVDA rely on foundry partners in Taiwan, and geopolitical tensions could disrupt their supply chains, leading to material adverse impacts. The LLM correctly identifies that QCOM could face severe supply limitations (citing page 35) and NVDA notes risks to supply continuity (citing page 17), which matches the original answer's substance. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures from both companies, correctly linking their shared dependency on Taiwanese foundries to potential supply disruptions. The only minor omission is that the original answer elaborates slightly more on the downstream impacts—such as fulfilling customer orders and harm to revenues and market positions—though the LLM does mention 'impacting revenue and operations,' which captures the essence. (4) The answer is highly contextually relevant, directly addressing how geopolitical tensions affect both companies' supply chains via their foundry partners in Taiwan. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; minor completeness gap prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 380,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company’s 2023 10‑K notes that new or revised environmental laws could force higher compliance spending, which is often passed through regulated rates.  The filing warns that “increased costs that are recovered through regulated rates could contribute to reduced demand for electricity and natural gas” and that “many commercial and industrial customers may also be affected by existing and future environmental requirements, which for some may have the potential to reduce their demand for electricity or natural gas” (see pages 26 and 89).  In contrast, Duke Energy’s risk‑factor discussion explicitly identifies industrial customers as a key source of demand volatility, noting that “declines in demand for electricity or natural gas…especially as industrial customers reduce production and, therefore, consumption of electricity and the use of natural gas” (page 27).  Thus, Southern Company’s potential demand shift is driven by regulatory‑cost‑induced rate increases, whereas Duke Energy’s exposure is tied to broader economic swings that affect industrial usage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Southern Company's exposure to reduced industrial demand due to environmental compliance costs passed through regulated rates is accurately described, with direct citations from pages 26 and 89 of its 10-K. Duke Energy's risk factor regarding industrial demand volatility due to production declines is correctly cited from page 27. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk factors from two different companies, distinguishing between regulatory-cost-driven demand reduction (Southern) and economically driven industrial demand volatility (Duke). The core distinction in exposure types is preserved. (4) The LLM uses slightly different phrasing (e.g., 'regulatory-cost-induced rate increases' vs. 'regulatory cost pass-through effects') but maintains semantic equivalence. One minor point preventing a perfect 10 is the omission of the explicit mention that industrial customers face their own compliance costs (beyond just rate increases), which slightly reduces completeness in qualitative nuance. However, the reference to customers being 'affected by existing and future environmental requirements' captures this adequately. Overall, the answer is factually correct, well-contextualized, and directly responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 416,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "NKE’s foreign‑exchange cash‑flow hedges have a notional value of $9.9 billion (page 121), which is roughly twice the size of McDonald’s reported net‑asset exposures—about $4.9 billion when the five largest currency balances on page 24 are summed. This suggests that NKE maintains a more aggressive hedging program relative to the magnitude of McDonald’s exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. First, the claim that MCD's net asset exposures total $4.9 billion—derived by summing the five largest currency balances on 'page 24'—is not supported by the ground truth, which does not provide any specific dollar amount for MCD's net asset exposures. The original answer makes no mention of a $4.9 billion figure or any comparable aggregate exposure value for MCD, nor does it allow for such a calculation. Therefore, the comparison stating that NKE's $9.9 billion in hedges is 'roughly twice' MCD's exposure is fabricated and incorrect. Second, the LLM introduces specific document page numbers (121 and 24), which are not part of the provided context and cannot be verified, suggesting hallucination. While the LLM correctly identifies that NKE uses $9.9 billion in notional hedges and attempts to contrast NKE's derivative-based strategy with MCD's balance sheet-based approach, it misrepresents the nature and magnitude of MCD's exposure. The qualitative insight about differing risk management strategies (hedging vs. net asset balancing) aligns partially with the original answer, giving it some relevance. However, the core quantitative claim is false, and the reasoning is based on unsourced calculations, undermining the overall correctness. The answer fails the multi-hop requirement by not accurately synthesizing comparable data points—no actual figure for MCD’s net asset exposure is given in the ground truth, so no valid numerical comparison can be made.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 421,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "Coca‑Cola’s exposure to Ukraine is limited to Coca‑Cola HBC’s operations, which account for less than 1 % of Coca‑Cola’s consolidated net sales and earnings (KO_10k_2022, page 24). In contrast, Procter & Gamble’s manufacturing and supply‑chain in Ukraine is a core part of its operations, implying a more substantial reliance on Ukrainian facilities for production and logistics (PG_10k_2022, page 13).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the claim that Coca-Cola HBC's operations in Ukraine account for 'less than 1% of Coca-Cola’s consolidated net sales and earnings' is not supported by the original answer, which states that Coca-Cola HBC is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers—though the specific percentage attributable to Ukraine alone may indeed be small. However, the LLM incorrectly implies this minor financial contribution equates to overall limited exposure, missing the operational significance of bottler networks. (2) The most critical error is in the characterization of Procter & Gamble’s operations: the LLM claims P&G's Ukraine operations are 'a core part of its operations,' which directly contradicts the original answer stating that Ukraine accounts for less than 1% of P&G’s net assets and poses only limited risk. This misrepresents P&G’s exposure as substantial when it is actually minimal. (3) Qualitatively, the multi-hop reasoning fails—while both companies face supply chain risks, the LLM incorrectly frames Coca-Cola as having indirect but minor exposure and P&G as having major direct reliance, reversing the correct comparative logic. The original answer clarifies that while Coca-Cola’s exposure is indirect (via a key bottler), P&G’s is direct but small in scale. (4) Contextually, the answer addresses the question’s structure and cites 10-K pages, suggesting relevance, but the factual inversion of P&G’s reliance level severely undermines accuracy. Minor formatting variations in numbers are acceptable, but directional misstatements of corporate exposure cannot be overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 477,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "Combined exposure to commercial mortgage‑backed securities (CMBS) as of December 31 2023 is **$12,025 million** – the sum of MetLife’s $1,103 million fair‑value CMBS and Bank of America’s $10,922 million amortized‑cost CMBS. MetLife’s fair‑value CMBS is far lower than Bank of America’s amortized‑cost CMBS for the same category.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numbers. According to the ground truth, MET's fair value exposure to CMBS was $4,551 million, but the LLM incorrectly states it as $1,103 million. This leads to an incorrect combined exposure of $12,025 million instead of the correct $15,473 million. BAC's amortized cost of $10,922 million is correctly reported. (2) Calculations are based on incorrect inputs: $1,103M + $10,922M = $12,025M is arithmetically correct, but the sum is invalid due to the wrong MET value. The correct sum is $4,551M + $10,922M = $15,473M. (3) The multi-hop reasoning is partially sound in structure—LLM attempts to combine MET’s fair value and BAC’s amortized cost and makes a comparison—but fails due to incorrect data retrieval for MET. The distinction between fair value and amortized cost is acknowledged, showing understanding of accounting differences. (4) Correctness and quantitative accuracy are severely penalized due to the wrong MET figure and resulting miscalculation. Qualitative accuracy is moderate because the reasoning framework and entity identification (MET, BAC, CMBS, accounting treatments) are correct. Contextual relevance is high as the answer addresses all parts of the question with appropriate structure and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 362,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Cyber‑intrusion threats to the six reactors that Southern Company’s Alabama and Georgia units operate can trigger NRC‑mandated security upgrades, fines or even shutdowns, which raise compliance costs and erode the value of the decommissioning‑trust assets that fund future plant closures.  Duke Energy faces a similar risk: a cyber breach at its nuclear sites would increase regulatory scrutiny and the need for costly security measures, tightening the performance of its Nuclear Decommissioning Trust Fund and threatening the capital and operating budgets required to renew reactor licenses and meet its net‑zero strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core financial and operational risks posed by cyber intrusion to both Duke Energy and Southern Company, and correctly identifies the linkage between cybersecurity threats, compliance costs, decommissioning trusts, and financial impacts. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages, dates) in either answer, so no inaccuracies exist—thus a score of 10 for quantitative accuracy. However, the LLM introduces a specific claim not present in the ground truth: that Southern Company operates 'six reactors' in Alabama and Georgia. While Southern Company does operate multiple reactors (e.g., at Vogtle and Farley), the exact number is not confirmed in the original answer, making this a minor overprecision or unsupported detail. Additionally, the LLM links cyber breaches directly to erosion of decommissioning-trust asset values, which is plausible but not explicitly stated in the ground truth; the original answer only notes that trust performance is subject to market fluctuations, not cyber events. The LLM also adds strategic context about Duke Energy’s 'net-zero strategy' and 'license renewal' budgets, which are reasonable inferences but not part of the original answer. These additions enhance relevance but slightly deviate from the evidence-based synthesis expected in multi-hop reasoning. The core multi-hop logic—cyber risks → regulatory/compliance costs → financial strain on trusts and operations—is sound and correctly attributed to both companies, supporting a high qualitative accuracy score. Contextual relevance is strong as the response directly addresses the financial obligations and operational strategies in light of cyber risks. However, due to unsupported specifics (reactor count) and some inferential overreach in causal chains, the correctness score is 7 rather than higher.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 515,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "At Home Depot, dividend equivalents accrue on unvested restricted‑stock units and are paid out as **additional shares on the vesting date** (page 69), so the company issues extra shares whenever RSUs vest.  In contrast, Lowe’s variable‑notional ASR agreements deliver **additional shares at settlement**; in fiscal 2021 the company received a total of 7.5 million additional shares under its ASR agreements (page 64).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mechanism at HD—dividend equivalents on unvested RSUs are paid out as additional shares upon vesting—and contrasts it with LOW's ASR agreements delivering additional shares at settlement. This captures the core distinction in how additional shares are issued at each company. (2) However, there is a quantitative inaccuracy: the LLM states LOW received a total of 7.5 million additional shares in fiscal 2021 under ASR agreements, but the ground truth specifies 0.2M (Q1), 1.6M (Q4), and 4M (Q2), which sum to 5.8 million, not 7.5 million. This error affects the precision of the numeric response. Additionally, the LLM omits the specific quarterly breakdown, reducing completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (HD and LOW), two distinct financial mechanisms (dividend equivalents on RSUs vs. ASR agreements), and ties them to share issuance. It correctly attributes HD's share increase to employee compensation practices and LOW's to capital return strategy, even if not explicitly stated in the same terms. (4) Despite the numerical miscalculation, the answer is contextually relevant and semantically close to the original, with accurate entity identification (HD, LOW, RSUs, ASR, fiscal 2021) and correct page references. The reasoning and structure are strong, warranting a high correctness score, but the arithmetic error prevents a 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 408,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "Ernst & Young LLP applied sensitivity analyses in both audits.  For AT&T, the firm tested how changes in terminal‑growth rates, EBITDA margins and the weighted‑average cost of capital would alter the fair‑value estimate of the $67,854 million goodwill balance, thereby gauging the robustness of the impairment test.  For Netflix, the firm evaluated how shifts in projected viewing‑hour consumption would affect the amortization of content assets, using sensitivity analyses to assess the impact of those assumptions on the recorded amortization.  Thus, while both firms used similar techniques to scrutinize management’s forward‑looking estimates, AT&T’s analysis focused on goodwill valuation and Netflix’s on content amortization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T's $67,854 million goodwill balance is accurately cited, and the use of sensitivity analyses on terminal growth rates, WACC, and EBITDA margins for goodwill impairment testing is consistent with the original. For Netflix, the focus on projected viewing-hour consumption affecting content amortization is correctly identified. The shared auditor (implied to be Ernst & Young) is plausibly stated and contextually valid. (2) Quantitative accuracy is perfect: the $67,854 million figure is correctly reported with appropriate formatting variations allowed. No calculations are required, and all numbers match. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies use sensitivity analyses in their audits by the same firm but apply them to different accounting estimates—goodwill for AT&T and content amortization for Netflix. The comparison is logically drawn and reflects the distinct business models and key assumptions. (4) Minor deduction in qualitative accuracy due to the explicit naming of Ernst & Young, which was not specified in the original answer (though plausible and likely correct, it adds unverified detail). Otherwise, the reasoning, entity identification, and synthesis are excellent. Contextual relevance is full, as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 399,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard frames fintechs as a potential threat: it warns that regulations such as PSD2 can enable third‑party platforms to route payments directly between issuers and acquirers, thereby “disintermediating” its network and reducing demand for its products【page 31】.  The company also cautions that fintech partners could build competing platforms that bypass Mastercard’s services, a risk amplified by emerging regulations and data‑localization rules【page 32】【page 35】.  By contrast, Visa adopts a partnership‑oriented stance, actively collaborating with fintechs, digital players and large tech firms to embed its network‑of‑networks strategy into new flows (e.g., Visa Direct, tokenization) and to capture emerging payment channels while navigating regulatory changes【page 16】.  Thus, Mastercard is defensive, protecting its core network from disintermediation, whereas Visa is proactive, leveraging fintech alliances to remain competitive in a regulatory‑driven ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies Mastercard's concern about disintermediation due to fintechs building competing platforms, especially under regulatory frameworks like PSD2 in the EEA, which enables third-party providers to bypass traditional networks. This matches the ground truth's emphasis on regulatory-driven risks and data-sharing concerns. (2) The LLM accurately contrasts this with Visa's proactive, partnership-based strategy, correctly citing Visa’s 'network of networks' approach and its collaborations with fintechs and digital players to stay central in the ecosystem. The mention of Visa Direct and tokenization adds relevant detail consistent with the strategic integration described in the original answer. (3) Multi-hop reasoning is sound: the model synthesizes information across regulatory, competitive, and strategic dimensions for both companies, correctly identifying the dual role of fintechs as both partners and competitors, particularly for Visa. (4) There are no numeric values to verify, so quantitative accuracy is 10 by default. Qualitative accuracy is 9 because while all key points are covered, the LLM slightly downplays the explicit mention of local financial institutions in Visa’s strategy, which is present in the original answer. However, this does not detract significantly from the overall correctness. Contextual relevance is perfect—the response directly addresses the comparative strategic postures of Mastercard and Visa in the context of regulatory-driven competition. Minor wording differences do not affect semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 452,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "McDonald’s 2023 10‑K notes that the OECD’s 15 % global minimum tax (Pillar 2) will not be effective for the company until fiscal 2025 and is not expected to materially affect its consolidated financial statements (see page 20).  Starbucks’ 10‑K does not contain a Pillar 2 discussion in the pages provided, so no specific impact or effective‑date guidance is available for comparison.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the information in the ground truth. (1) Quantitatively, it incorrectly states that McDonald's (MCD) does not expect a material impact starting in fiscal 2025, while the original answer states that MCD acknowledged implementation in countries with an effective date after December 31, 2023, not 2025. The LLM incorrectly attributes the 2025 effective date to MCD, when in fact it is SBUX (Starbucks) that noted Pillar 2 will not be effective until fiscal 2025. This is a critical entity-date misassignment. (2) The LLM claims that Starbucks’ 10-K does not contain a Pillar 2 discussion, which contradicts the ground truth stating SBUX explicitly noted the fiscal 2025 impact and no material effect. This omission leads to a major completeness failure. (3) The reasoning is flawed: the LLM fails to perform the required multi-hop comparison between MCD and SBUX under Pillar 2, instead incorrectly reversing or missing key details. It does not mention the OECD’s 15% framework or the country-by-country application, nor does it address differing implementation timelines as a factor in differential impact. (4) While the answer is relevant to the topic and mentions the OECD and materiality, the core facts are misattributed, leading to a low correctness score. The only accurate element is the mention of non-material impact, but even this is undermined by incorrect effective dates and misassigned entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 410,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company (BTC) reported a Common Equity Tier 1 (CET1) ratio of **151.9 %** and a Tier 1 ratio of **151.9 %** (total capital ratio 153.2 %) as of December 31 2024—well above the U.S. regulatory minimums and the “well‑capitalized” thresholds.  \nIn contrast, American Express’s regulatory capital ratios for the same period were **CET1 10.5 %** (Company) / 11.6 % (National Bank) and **Tier 1 11.2 %** (Company) / 11.6 % (National Bank), with a total capital ratio of 13.2 %.  \nThus BTC’s capital adequacy position is markedly stronger and far exceeds American Express’s ratios.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. According to the ground truth, no specific numerical capital ratios for BlackRock Institutional Trust Company (BTC) were provided—only that BTC exceeded regulatory requirements. However, the LLM assigns precise values (CET1 and Tier 1 ratios of 151.9%), which are not present in the original answer and are implausibly high for any bank (typical CET1 ratios range from 10–15%). These numbers appear fabricated or grossly misrepresented. For American Express, the LLM provides specific ratios (e.g., CET1 10.5% at company level, 11.6% at National Bank), but the ground truth does not include these exact figures, only that AXP met 'well-capitalized' thresholds. While these values may be plausible, they are not confirmed by the ground truth and thus cannot be considered accurate. (2) Calculations and comparisons: The conclusion that BTC's capital position 'markedly exceeds' AXP's is speculative and based on incorrect data. Given the fabricated 151.9% ratios, the comparison is invalid. Even if BTC were well capitalized, a ratio over 150% is not realistic under Basel III frameworks. (3) Multi-hop reasoning: The model attempts to synthesize across two regulated entities subject to U.S. banking rules, correctly identifying that both are under OCC/Fed oversight, which aligns with the ground truth. It addresses the comparative capital adequacy question, fulfilling the multi-hop intent. (4) Despite correct contextual framing (regulatory bodies, general capital strength), the severe quantitative errors undermine the factual basis of the response. The answer is overly specific with false precision, leading to a low correctness and quantitative accuracy score. Qualitative accuracy is moderate due to correct entity identification and regulatory context. Contextual relevance is high as the structure and intent match the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 522,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "SPG’s $88.4 million in construction loans to joint‑venture partners (page 49) is a modest, project‑level financing tool, whereas AMT drew $7.8 billion from its 2021 Multicurrency Credit Facility (page 104) to fund large acquisitions such as Telxius and CoreSite. This contrast shows that SPG focuses on incremental, development‑stage financing, while AMT relies on a sizable credit line to support aggressive, acquisition‑driven growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies SPG's $88.4 million in construction loans to joint ventures and AMT's $7.8 billion draw from the 2021 Multicurrency Credit Facility, both accurate figures from the ground truth. The mention of Telxius and CoreSite acquisitions aligns with the original answer. The only minor omission is the specific breakdown of €2.4 billion ($2.9 billion) within AMT's total draw, which adds granularity but does not alter the core factual accuracy.\n\n2) Quantitatively, all numbers are correct: $88.4 million and $7.8 billion match the ground truth exactly. The LLM does not attempt to recalculate or misrepresent the euro-to-dollar conversion, avoiding potential error. The time frame (implied as of December 31, 2021, via context) is consistent.\n\n3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (SPG and AMT), two financial instruments (construction loans vs. multicurrency credit facility), and two growth strategies (development financing vs. acquisition-driven growth). The conclusion about SPG’s incremental vs. AMT’s aggressive strategy is logically derived and semantically equivalent to the original.\n\n4) The answer is contextually relevant and fully addresses both parts of the question: the comparison of financing amounts and the inference about growth strategies. Wording differs slightly (e.g., 'modest, project-level financing tool' vs. 'internally financing development') but conveys the same meaning. The reference to 'page 49' and 'page 104' suggests proper sourcing, though not required.\n\nOverall, this is a highly accurate, well-reasoned response with only a slight loss in completeness for omitting the euro component of AMT’s borrowing, which is a secondary detail. Hence, a 9/10 on correctness and qualitative accuracy, full marks on quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 507,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "CSCO’s $0.5 billion interest‑rate swap is a fair‑value hedge that offsets the fair‑value changes of the $500 million fixed‑rate senior note, effectively eliminating that portion’s sensitivity to market‑rate movements (see CSCO Notes 13‑14). In contrast, AVGO’s $56.3 billion of fixed‑rate senior notes are not hedged; a 50‑basis‑point change in rates would shift their fair value by roughly $1.7 billion (≈$34 million per basis point), indicating substantial residual interest‑rate sensitivity (see AVGO Note 49).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in phrasing. (1) All key facts are correct: CSCO’s $0.5 billion interest rate swap hedges a portion of its fixed-rate senior notes, converting fixed to floating rates (implied via SOFR in original, explicitly stated as fair-value hedge here), thereby eliminating sensitivity for that portion. AVGO has $56.3 billion in fixed-rate senior notes, which are not hedged, and a 50-basis-point rate change impacts fair value by $1.7 billion—exactly matching the ground truth. The derived sensitivity of ~$34 million per basis point is a correct calculation ($1.7B / 50 = $34M) and adds precision without contradicting the original. (2) Quantitative accuracy is perfect: all dollar amounts ($0.5B, $56.3B, $1.7B), basis points (50), and derived figures are correct. Date (November 3, 2024) is not mentioned in LLM answer but is not critical to the comparison of sensitivities. (3) Multi-hop reasoning is sound: the model correctly synthesizes that CSCO reduces interest rate risk via hedging while AVGO retains significant exposure due to lack of hedging. The use of 'fair-value hedge' and reference to specific notes (CSCO Notes 13–14, AVGO Note 49) suggests accurate sourcing. (4) Semantic equivalence is strong; the LLM even enhances the answer with a per-basis-point breakdown. Only reason for not scoring 10 is the slightly more technical phrasing (e.g., 'eliminating that portion’s sensitivity') without explicitly mentioning SOFR or the floating rate mechanism, though this is implied in 'fair-value hedge'. Overall, the answer is factually complete, contextually relevant, and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 466,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "Nike uses option and forward contracts as cash‑flow hedges of its foreign‑currency assets, liabilities and forecasted transactions; the unrealized gains and losses on those contracts are recorded in AOCI and reclassified to earnings when the hedged transaction occurs (NKE p. 48; p. 110).  Tesla, by contrast, has sizable foreign‑currency‑denominated intercompany balances that are largely unhedged, so foreign‑exchange gains and losses appear directly in other income (Tesla p. 44‑46) and its hedging activity produces only modest deferred gains in AOCI (≈ $99 million) (Tesla p. 45).  Thus, Nike’s option‑based hedging shifts volatility to AOCI, whereas Tesla’s exposure leads to more immediate foreign‑exchange impact in the income statement with smaller AOCI deferrals.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core contrast between NKE and TSLA in foreign currency hedging strategies and their impact on financial statements. It accurately states that NKE uses option and forward contracts as cash flow hedges with gains/losses deferred in AOCI, and that TSLA largely does not hedge, leading to FX volatility in 'other income (expense), net.' However, there is a critical quantitative error: the LLM attributes the $99 million in net deferred gains expected to be reclassified within twelve months to TSLA (citing Tesla p. 45), while the ground truth clearly assigns this figure to NKE. This is a significant misattribution, as the $99 million deferred gain is a key data point for NKE’s hedging program, not TSLA’s. Additionally, the LLM omits NKE’s $9.9 billion in notional amount of foreign exchange hedges, a major quantitative indicator of the scale of NKE’s hedging activity. While the qualitative reasoning and structure are sound—correctly identifying the accounting treatment (AOCI deferral vs. income statement impact) and contrasting proactive vs. reactive strategies—the misassignment of the $99 million and omission of the $9.9 billion notional amount undermine quantitative accuracy. The answer remains contextually relevant and synthesizes multi-hop information (NKE’s hedging instruments and accounting treatment vs. TSLA’s exposure and lack of hedging), but the numerical inaccuracies prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 399,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s Five‑Year Credit Agreement names Citibank, N.A. as the administrative agent (originally dated 30 Oct 2019) and was amended on 25 Aug 2022.  Caterpillar’s 5‑Year Facility likewise lists Citibank, N.A. as the agent (the administrative role) with the facility first executed on 1 Sep 2022 and amended on 31 Aug 2023.  Thus, Citibank performs the same administrative function in both agreements, but Boeing’s arrangement is older and was revised roughly three years after inception, whereas Caterpillar’s was revised about a year after its inception.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing's Five-Year Credit Agreement was dated October 30, 2019, and amended on August 25, 2022, with Citibank, N.A. as administrative agent. Caterpillar's 5-Year Facility was dated September 1, 2022, with an amendment on August 31, 2023, and Citibank, N.A. as agent. These dates and roles match the original answer exactly. (2) Quantitative accuracy is perfect—dates are correctly reported with no calculation errors. (3) The reasoning is sound: the LLM correctly identifies that Citibank plays a comparable administrative role in both agreements and notes the different timelines for amendments (Boeing ~3 years after original agreement, Caterpillar ~1 year after), which reflects accurate multi-hop synthesis across two companies and their respective credit agreements. (4) The only minor shortcoming is that the LLM omits Boeing’s dual role as both administrative agent and joint lead arranger, which adds a slight nuance to Citibank’s more extensive role at Boeing compared to Caterpillar. However, this does not undermine the core correctness. The answer remains semantically equivalent in substance and fully addresses the comparison in roles and amendment timelines. Hence, high scores across all dimensions with a 9/10 on correctness and qualitative accuracy due to the small omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 386,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock is entitled to one vote per share (see the Voting Rights section on page 60).  \nMeta’s Class B common stock carries ten votes per share (as disclosed in the 10‑K on page 1).  \nThus, each Meta Class B share has nine more votes than a Netflix common‑stock share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in both factual content and reasoning. (1) Quantitatively, the voting rights per share are accurately reported: Netflix's common stock has 1 vote per share, and Meta's Class B common stock has 10 votes per share. The difference of 9 more votes per Meta Class B share is correctly calculated. (2) The answer is complete, addressing both companies' voting structures and making the explicit comparison requested. (3) Entities are correctly identified—Netflix, Meta, common stock, and Class B common stock—with no confusion between companies or share classes. (4) The multi-hop reasoning is sound: the model correctly synthesizes information from two separate company disclosures and computes the comparative voting power difference. The semantic meaning is equivalent to the original answer, with added precision in stating the numerical difference. All aspects of the question are addressed accurately and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 281,
        "total_tokens": 1426
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY’s 2023 U.S. gross revenues were 23 % sourced through Cardinal Health, making the wholesaler a key distribution channel (page 80). CVS, in contrast, consolidates Red Oak Sourcing, LLC—a VIE in which Cardinal Health also owns 50 %—because CVS is the primary beneficiary and directs the entity’s activities (page 20). Thus, while BMY’s reliance is a contractual distribution relationship, CVS’s consolidation reflects a joint‑ownership partnership; both companies’ financials are influenced by Cardinal Health’s operations, but the nature of the exposure differs.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that BMY relies on Cardinal Health for 23% of its distribution in 2023 and that CVS consolidates Red Oak Sourcing due to being the primary beneficiary, with Cardinal Health owning 50%. These core facts are accurate and match the ground truth. However, the LLM mischaracterizes the 23% as 'U.S. gross revenues' sourced through Cardinal Health, whereas the original answer specifies it as part of BMY’s 'distribution network'—a critical distinction. Distribution share does not equate to revenue sourcing, which introduces a factual inaccuracy in interpretation. (2) Quantitatively, all numbers are correct: 23%, 50% ownership, and 2023 timeframe align with the ground truth. The LLM does not mention the $183 million in annual payments from Cardinal to CVS, which is a missing quantitative element from the original answer and relevant to the financial interdependency. (3) The multi-hop reasoning is partially sound: the model connects BMY–Cardinal, Cardinal–Red Oak, and CVS–Red Oak relationships correctly. However, it fails to explain the indirect financial and operational interdependency—specifically how CVS’s consolidation and receipt of payments from Cardinal could influence Cardinal’s ability or pricing in serving BMY. This weakens the synthesis. (4) Contextual relevance is high, as the answer addresses the structural ties and differing nature of exposure. The omission of the financial flow ($183M) and misrepresentation of the 23% metric prevent a higher score. Overall, the answer is factually strong but misses key nuances in both quantitative completeness and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 449,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s RIS segment, which includes life‑ and annuity‑based products, shows adjusted‑earnings swings under rising‑rate scenarios (−$10 m in 2022, +$15 m in 2023, +$10 m in 2024) (page 61), but its core Life Insurance line is in Group Benefits, whose renewable‑term policies are less sensitive to rate changes and can be repriced to offset margin compression (page 186). By contrast, AIG’s Life Insurance reserves were hit by a $166 m unfavorable update in 2021 driven by earned‑rate changes to universal‑life products, and a shift in interest rates can trigger additional funding needs for its Life and Retirement companies (pages 134‑142).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and misalignments with the ground truth. It incorrectly states that MetLife's core Life Insurance line is in Group Benefits and less sensitive to rate changes, which contradicts the ground truth that MetLife's Retirement and Income Solutions (RIS) segment includes life insurance products and is directly exposed to interest rate risk. The provided adjusted-earnings swings (−$10M in 2022, +$15M in 2023, +$10M in 2024) are not mentioned in the original answer and appear to be fabricated or misattributed. (2) Quantitatively, the LLM claims a $166M unfavorable update for AIG in 2021, whereas the ground truth reports a $106M favorable impact from actuarial assumption updates. This is a significant error in both direction (favorable vs. unfavorable) and magnitude ($166M vs $106M). No such figures appear in the original answer, and no supporting data is provided in the evaluation context. (3) The reasoning is flawed in its multi-hop synthesis: it separates MetLife’s Life Insurance from RIS, while the ground truth explicitly ties life insurance exposure to RIS and interest rate dynamics. It also fails to mention MetLife’s ALM (asset-liability management) strategies, which are a key part of the original comparison. For AIG, it introduces 'funding needs' and 'earned-rate changes' not present in the ground truth, while omitting the actual driver—policy fee modeling. (4) Despite these issues, the answer is contextually relevant, addressing interest rate impacts on both companies’ life insurance lines and attempting a comparison. However, due to major quantitative errors, incorrect entity mappings, and flawed reasoning, the overall correctness is low. Minor credit is given for recognizing that both firms are sensitive to interest rate dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 495,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 10‑K lists a series of long‑term, multi‑year agreements with Panasonic that cover the supply of battery cells and related pricing and production terms.  The core is a 2011 supply agreement (Amendment 1 in 2013, a 2014 agreement, and a 2014 general‑terms and conditions document), followed by a 2015 letter adding a co‑party, a 2016 amendment to the Gigafactory general terms, an amended and restated 2020 general‑terms agreement, a production‑pricing agreement, and specific pricing agreements for Japan cells (2019) and Gigafactory 2170 cells (2020) and a 2021 Japan‑cell pricing agreement.  In contrast, the GM 10‑K pages provided do not disclose any specific battery‑supply contracts or detailed sourcing dependencies; GM’s battery sourcing relationships are not detailed in the excerpts supplied, so Tesla’s agreements are explicit and long‑term while GM’s battery sourcing dependencies remain undisclosed in the provided documents.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. It correctly identifies Tesla's battery supply agreements with Panasonic, including the 2011 Supply Agreement and subsequent amendments, as well as the 2019 and 2021 pricing agreements for Japan-sourced cells and the 2020 pricing agreement for Gigafactory 2170 cells. The mention of additional documents like the 2013 amendment, 2014 agreements, 2015 co-party letter, and 2016 and 2020 Gigafactory-related amendments adds detail not contradicted by the ground truth, though the original answer does not list all these specifics—this extra detail does not reduce accuracy but reflects deeper parsing of filings. The comparison to General Motors is correct: GM’s filings do not disclose specific battery supply agreements, and the LLM appropriately notes this lack of disclosure in the provided documents. Quantitatively, all dates and agreement types are accurate, with no calculation errors (not applicable here). The reasoning is sound, demonstrating multi-hop synthesis between Tesla’s detailed contractual disclosures and GM’s absence of such details. The answer is contextually fully relevant, addressing both parts of the question. The only reason for not scoring a 10 is that the LLM includes some granular agreement details (e.g., 2013 amendment, 2015 co-party letter) that, while likely accurate, are not confirmed in the ground truth, slightly exceeding the verified scope. However, this does not introduce error, so the score remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 417,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "MDLZ reports that it holds 46 commodity contracts that are quoted on active exchanges and are therefore classified as Level 1 financial assets (MDLZ 10‑K, page 112).  These exchange‑traded futures and options are used explicitly to hedge the price risk of key inputs such as cocoa, sugar and wheat (page 94).  In contrast, Costco discloses that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis (COST 10‑K, page 51), implying its hedging strategy relies on other instruments—such as currency forwards, swaps or non‑exchange‑traded derivatives—rather than exchange‑traded futures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies MDLZ's use of commodity futures classified as Level 1 financial assets, citing 46 contracts and referencing exchange-trading (Level 1 due to quoted prices), which matches the knowledge graph's assertion about MDLZ's hedging strategy for cocoa, sugar, and energy. While the original answer does not specify the number '46', this detail is consistent with being Level 1 and exchange-traded, and does not contradict the ground truth—rather, it adds specificity. (2) The COST disclosure is accurately represented: the LLM correctly states that COST held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of its 10-K filing (page 51), matching the original answer’s claim. The date (August 28, 2022) is omitted in the LLM answer but is not critical to the core comparison. (3) The multi-hop reasoning is sound: the model correctly contrasts MDLZ’s use of exchange-traded (Level 1) instruments with COST’s non-use of such instruments, and logically infers that COST likely uses other derivatives like forwards or swaps, which is a reasonable interpretation supported by the absence of Level 1 assets. (4) Semantic equivalence is maintained: though the LLM adds minor details (e.g., 'wheat' instead of 'energy'—a slight variance but still a valid input cost), the core contrast in risk management strategies is preserved and accurately synthesized. The answer is fully contextually relevant, directly addressing the comparative risk management strategies involving financial instruments. Minor deductions in quantitative and qualitative accuracy due to the wheat/energy discrepancy and omission of the exact date, but not enough to affect correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 489,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s Rule 10b5‑1(c) plans involve a larger potential volume and a longer vesting window than Broadcom’s.  Apple’s Jeff Williams plan allows sale of up to 100,000 shares with vesting from April 2025 to October 2025 and expires December 15 2025, while Deirdre O’Brien’s plan covers shares vesting from April 2025 to October 2026 and expires December 31 2026.  In contrast, Broadcom’s single plan, adopted by Diane Bryant, permits sale of up to 15,000 shares and expires September 12 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Correct individuals are identified: Jeff Williams and Deirdre O'Brien for Apple, Diane M. Bryant for Broadcom. (2) Quantitative accuracy: The share volumes (100,000 for Williams, 15,000 for Bryant) are correct. O'Brien's vesting period (April 2025 to October 2026) and expiration (December 31, 2026) match the ground truth. Williams' plan expiration is stated as December 15, 2025, which is not in the original answer—this is a minor discrepancy, as the ground truth only specifies 'up to October 1, 2025' for vesting and 'expiration dates in 2025' without a specific date. This slight over-precision is acceptable but not fully verifiable, hence not a full error. (3) The adoption timing is partially missing: the LLM omits that Apple executives entered plans in August 2024 and Broadcom's in September 2024—this is a minor omission affecting completeness but not the core comparison. (4) The qualitative reasoning is sound: the LLM correctly infers that Apple’s plans involve larger volume and longer duration, which is the key comparative insight. (5) Contextual relevance is excellent—the answer directly addresses volume and timing as asked. Minor lack of adoption month details and slight over-specification of Williams' expiration date prevent a perfect 10, but overall the answer is factually strong and semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 400,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both credit agreements name JPMorgan Chase Bank, N.A. as a syndication agent – the bank is the party that coordinates the syndication and distribution of the five‑year credit lines for each company.  This common role shows that JPMorgan Chase is a shared lender and facilitator in both 3M’s May 11, 2023 Five‑Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five‑Year Credit Agreement, underscoring a consistent banking relationship across the two firms.  (Honeywell: Exhibit 10.68; 3M: credit agreement referenced on page 114.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: JPMorgan Chase Bank, N.A. is correctly identified as the syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. The dates and roles are accurately stated. (2) Quantitative accuracy is perfect—dates (May 11, 2023; March 20, 2023) and entity names are exact matches; no numerical calculations were required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate credit agreements from different companies to identify a shared banking relationship. It accurately infers that JPMorgan’s role as syndication agent in both deals indicates a consistent and strategic banking relationship. (4) The only minor shortcoming is the slight overstatement in calling JPMorgan a 'shared lender'—the syndication agent role does not necessarily imply that the bank is a lender (though it often participates), and the original answer focuses more precisely on the coordinating/administrative role. However, this does not materially misrepresent the relationship. The inclusion of exhibit references (Honeywell: Exhibit 10.68; 3M: page 114) adds contextual support. Overall, the answer is semantically equivalent to the ground truth with high completeness, accuracy, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 389,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU and U.S. sanctions that target Belarus’s tobacco sector restrict the trade of goods used for tobacco production and impose broader economic restrictions on Belarusian entities, which could limit Coca‑Cola HBC’s ability to import, export or finance its bottling operations in the country【page_52】.  Because Coca‑Cola HBC is one of Coca‑Cola’s five largest bottlers and contributes a sizable share of the company’s worldwide unit‑case volume (the top five partners together account for 41 % of total volume【page_7】), any operational slowdown in Belarus would reduce Coca‑Cola HBC’s local volume and, in turn, shrink Coca‑Cola’s overall unit‑case volume.  Thus, sanctions‑induced disruptions to Coca‑Cola HBC could have a measurable negative impact on Coca‑Cola’s global sales volume.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM correctly states that the top five bottlers, including Coca-Cola HBC, account for 41% of The Coca-Cola Company’s total unit case volume, matching the original answer’s 2021 figure. While the original specifies Coca-Cola HBC alone represents 41%, the LLM generalizes this to the top five bottlers collectively, which is still factually supported and contextually reasonable, though slightly less precise on HBC’s individual contribution. (2) The LLM correctly identifies the nature of EU/U.S. sanctions on Belarus’s tobacco sector and their potential to disrupt supply chains and operations, accurately linking this to Coca-Cola HBC’s operational risks in Belarus. (3) The reasoning is sound: it traces the impact from sanctions → economic restrictions → operational constraints for Coca-Cola HBC → reduced unit case volume → negative effect on The Coca-Cola Company’s global volume. This multi-hop logic synthesizes the interdependencies correctly. (4) The answer is contextually excellent, addressing both parts of the question: the impact on Coca-Cola HBC in Belarus and the implication for KO’s overall volume. The only minor shortcoming is the slight ambiguity in attributing the 41% to the top five bottlers rather than explicitly to Coca-Cola HBC as in the original, which slightly reduces quantitative precision. However, since the overall impact logic remains valid and the number is correctly cited from the source, the answer earns a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 428,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "Capital One’s interchange fee income comes largely from debit‑card transactions processed on Mastercard’s four‑party network, so the Fed’s October 2023 proposal to cut the U.S. debit interchange cap by 28‑30 % would directly lower the maximum fee it can earn on those transactions (V_10k_2023, p. 24; MA_10k_2023, p. 16). Because the company’s revenue from interchange is tied to Mastercard’s rates, the reduction could shrink its interchange income by a comparable share of the debit‑card portion of its fee revenue (MA_10k_2023, p. 21). Ongoing litigation and regulatory scrutiny of Visa and Mastercard—including the Federal Reserve’s proposed rule to further lower the cap and merchant‑led antitrust suits—could compound this effect, potentially forcing additional fee cuts or refunds that would further erode Capital One’s interchange earnings (COF_10k_2023, p. 39).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 28%-30% reduction in U.S. debit interchange rate caps is accurately cited, and the reference to October 2023 for the Federal Reserve’s proposal matches public record. There are no calculation errors. (2) The answer correctly identifies the entities involved—Capital One (COF), Mastercard (MA), and Visa—and their roles in the four-party network. It accurately reflects that Capital One’s interchange income is tied to Mastercard’s rate structure, which is subject to regulatory and litigation risks. (3) The multi-hop reasoning is sound: it connects the Fed’s proposed rule change → impact on Mastercard’s interchange caps → direct effect on Capital One’s fee income, and then layers in ongoing litigation and regulatory scrutiny as compounding risks. The use of specific 10-K page references (e.g., COF_10k_2023, p. 39) indicates proper sourcing from the knowledge graph. (4) While the original answer emphasizes the multidistrict litigation more explicitly, the LLM captures the same concept via 'merchant-led antitrust suits' and regulatory scrutiny, maintaining semantic equivalence. The only minor shortcoming is slightly less emphasis on the structural vulnerability of the four-party model compared to the original, but the core logic and synthesis remain intact. Thus, the answer is factually complete, contextually relevant, and quantitatively precise, warranting a 9/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 422,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy’s variable‑rate debt and LIBOR‑indexed swaps mean the company has not yet adopted ASU 2020‑04; it is still evaluating optional expedients and notes that the transition “is not expected to materially impact the financial statements” (page 137).  Southern Company, which also references LIBOR in debt and hedging arrangements, has elected to apply the amendments to eligible debt modifications and expects no material impact, effectively adopting the guidance earlier than Duke Energy (page 194).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and captures the key elements of both companies' approaches to ASU 2020-04 in relation to LIBOR-indexed contracts. It correctly states that Duke Energy has not yet adopted the standard and is still evaluating optional expedients, with no material impact expected—consistent with the ground truth. It also accurately notes Southern Company’s application of the amendments to eligible debt modifications and its expectation of no material impact. The citation of specific page numbers (137, 194) suggests document fidelity, though these are not verifiable from the ground truth provided. Quantitatively, there are no errors in numbers or dates; however, the ground truth emphasizes Duke Energy’s deadline of December 31, 2022, for applying optional expedients—a time-bound window that the LLM answer omits. This is a notable qualitative gap, as the original answer hinges on comparing Duke’s time-limited evaluation window versus Southern’s ongoing assessment. The LLM instead concludes that Southern adopted 'earlier' than Duke, which is a reasonable inference but not explicitly supported in the ground truth—Southern is described as still assessing uncertainty. Thus, while the core facts are accurate (qualitative accuracy slightly reduced due to overinterpretation of adoption timing), the multi-hop synthesis between the two companies’ timelines is incomplete. Contextual relevance is high, as the response directly addresses the influence of LIBOR exposure on adoption timelines and financial impact for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 430,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "At Coca‑Cola (KO), the Black‑Scholes‑Merton model is used to estimate the fair value of each stock‑option grant, with weighted‑average inputs of dividend yield (≈3 %), expected volatility (≈18 %), risk‑free rate (≈4 % in 2023) and a 6‑year term; the resulting fair value is expensed straight‑line over the vesting period and reported as stock‑based‑compensation expense and a liability on the balance sheet.  \nColgate‑Palmolive (CL) applies weighted‑average actuarial assumptions—discount rate (≈5.4 % U.S., 4.35 % international), expected long‑term return on plan assets (≈6.5 % U.S., 4.66 % international), compensation‑increase rate, ESOP growth, medical‑cost trend and interest‑crediting rate—to calculate pension service, interest and actuarial gains/losses, which drive the pension expense in income and the pension liability on the balance sheet.  Thus, KO’s model uses market‑derived option parameters to set compensation expense, while CL’s assumptions are actuarial projections that determine pension cost and liability.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies the use of the Black-Scholes-Merton model at KO for stock option valuation and the use of weighted-average assumptions at CL for pension cost calculations, capturing the core contrast in financial reporting applications. However, there are notable quantitative inaccuracies: the risk-free rate for KO is stated as '≈4%' in 2023, but the ground truth does not specify this number, and more critically, the original answer cites specific CL pension assumptions (discount rate: 5.66%, expected return: 6.25%, compensation increase: 3.50% in 2023), while the LLM provides different values (e.g., 5.4% U.S. discount rate, 6.5% return) and adds unspecified inputs like 'ESOP growth' and 'medical-cost trend', which are not in the ground truth. (2) The LLM introduces approximate values not present in the original answer and splits U.S. vs. international rates for CL, which the ground truth does not do. The KO inputs (dividend yield ≈3%, volatility ≈18%, 6-year term) are plausible but not explicitly confirmed in the original answer, which only states that such assumptions are used without specifying values. (3) The reasoning is sound in distinguishing KO’s application of the model for equity compensation (with expense recognition) versus CL’s actuarial use for pension liabilities, correctly identifying the financial reporting implications (expense and liability impacts). This reflects accurate multi-hop synthesis across two companies and domains (equity compensation vs. pension accounting). (4) Despite incorrect or unverified numerical inputs, the qualitative and conceptual comparison is strong and contextually relevant. The answer captures the essence of how weighted-average assumptions are used differently in valuation models versus actuarial calculations. The correctness score is reduced due to unsupported numbers, but not severely penalized because the conceptual framework and reporting implications are well-explained and semantically aligned with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 543,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "AMT’s $525 million Series 2015‑2 Notes are secured by a package that includes mortgages, personal property and, notably, the equity interests of its wholly‑owned subsidiaries (GTP Acquisition Partners) [page_117].  In contrast, Simon Property Group actively monetizes its equity holdings—selling or exchanging interests in its portfolio—which in 2021 generated an $18.8 million gain on the sale of equity interests [page_63].  Thus, AMT retains the equity interests as collateral to back its debt, while SPG converts those same equity positions into cash, realizing a profit from the disposals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT used equity interests in GTP Acquisition Partners as collateral for the $525.0 million Series 2015-2 Notes, and SPG realized an $18.8 million gain from disposal of equity interests in 2021. The dollar amounts and years match the original answer exactly. (2) Quantitative accuracy is perfect: $525 million and $18.8 million are correctly cited with proper context and year (2021). (3) The multi-hop reasoning is sound—correctly contrasting AMT’s secured financing strategy (retaining equity as collateral) with SPG’s monetization via disposals (converting equity to cash with profit). The synthesis across two companies and financial strategies is accurate. (4) Minor deduction in qualitative accuracy due to slightly less detail on the scope of collateral (e.g., 'security interest in substantially all personal property' and 'subsidiaries of GTP Acquisition Partners' is omitted), but the essential point about subsidiary equity being used as collateral is preserved. Wording differs but semantic meaning aligns fully. Contextual relevance is excellent—directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 346,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips reports reserves and production only by region, so its Africa operations—including Nigeria—are included in the Africa totals (see the Africa totals in the production table on page 153 and reserves by region on page 134) and the company does not disclose country‑specific reserve figures or rely on production‑sharing contracts. In contrast, ExxonMobil reports reserves separately for production‑sharing arrangements and its Nigerian PSCs are 30‑year contracts with a 10‑year exploration phase and a 20‑year production phase, subject to partial relinquishment (see page 31).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the ground truth. (1) It incorrectly states that ConocoPhillips does not rely on production-sharing contracts (PSCs) in Nigeria, while the original answer confirms that ConocoPhillips operates under PSCs with 30-year terms, including relinquishment requirements. This is a major factual error. (2) The claim that ConocoPhillips does not disclose country-specific reserves is not supported in the ground truth and misrepresents the company's reporting practices in the context of the question. (3) The LLM incorrectly attributes the 30-year PSC structure (10-year exploration, 20-year production) solely to ExxonMobil, while the ground truth states this term structure applies to PSCs in Nigeria generally—relevant to both companies. (4) The original answer highlights a key distinction: ExxonMobil reports 12% of its proved reserves as tied to PSCs with price-sensitive reserve fluctuations, which the LLM omits entirely—this is a critical missing quantitative and conceptual point. (5) The LLM answer references specific document pages (e.g., page 134, 153, 31), which are not part of the provided knowledge and appear fabricated, undermining credibility. (6) While the answer attempts a comparison between the two companies’ reporting and contractual structures, the reasoning is flawed due to incorrect entity attribution and missing multi-hop synthesis (e.g., both are exposed to PSCs, but with different reporting implications). The contextual relevance is moderate because it addresses reserve reporting and contract terms, but the factual foundation is unsound. Quantitative accuracy is low because the 12% reserve figure from ExxonMobil is missing, and the contractual term is misattributed. Overall, the answer is partially responsive but fundamentally incorrect on key facts and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 508,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM’s 10‑K focuses on a hybrid‑cloud and AI strategy for enterprise digital transformation, but it does not detail specific generative‑AI products or a low‑power edge‑device commercialization plan (see page 3).  Qualcomm, by contrast, explicitly invests in AI and machine‑learning techniques embedded in its high‑performance, low‑power Snapdragon SoCs and a cloud‑computing initiative, commercializing these assets through IP licensing and chip sales to OEMs for on‑device generative‑AI and edge‑cloud use (see pages 6, 7, 11).  Thus, IBM pursues a software‑service‑centric AI model, while Qualcomm targets a hardware‑centric, high‑performance, low‑power edge‑AI commercialization strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its qualitative comparison between IBM and Qualcomm (QCOM), correctly identifying IBM's enterprise software- and service-centric AI strategy focused on hybrid cloud and digital transformation, versus Qualcomm's hardware-centric approach embedding generative AI into low-power, high-performance Snapdragon SoCs for edge devices. The answer accurately reflects that Qualcomm commercializes through chip sales and IP licensing to OEMs, integrating edge and cloud computing—consistent with the ground truth. However, the LLM answer omits the specific quantitative projection from the original answer: that generative AI-capable smartphones will rise from 19% in 2024 to 46% in 2027. While this data point is not essential to the core strategic contrast, its absence reduces completeness on commercialization scale and forward-looking market impact. There are no errors in entity identification (IBM, QCOM, Snapdragon, OEMs), reasoning is sound, and the multi-hop synthesis between the two companies’ strategies is logically presented. Wording differs but maintains semantic equivalence on key strategic differentiators. Quantitative accuracy is perfect as no incorrect numbers are introduced. Contextual relevance is strong—every part of the response addresses the question directly. The omission of the smartphone penetration forecast prevents a top score, but the core strategic contrast is well-executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 397,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy’s nuclear decommissioning exposure is tied to the market value of its nuclear decommissioning trust funds; a decline in those assets’ performance could raise the funding requirement for decommissioning and hurt its financial position (page 35).  NextEra Energy mitigates nuclear risk by maintaining dedicated decommissioning funds and external insurance coverage, but notes that decommissioning costs could exceed the fund’s value and that the funds’ performance is also market‑dependent (page 30).  Thus, while both companies rely on market performance for trust‑funded obligations, Duke Energy faces a direct shortfall risk, whereas NextEra relies on a combination of funds and insurance to cushion that risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: both Duke Energy and NextEra Energy have nuclear decommissioning obligations funded through trusts that are exposed to market risk; underperformance could lead to funding shortfalls. The LLM correctly identifies that NextEra uses both decommissioning funds and insurance, while Duke faces more direct financial exposure. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in calculations or figures. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies, compares their risk exposure, and draws a reasonable distinction in risk management approaches—Duke’s direct market-linked shortfall risk vs. NextEra’s use of insurance as a buffer. This nuance is not explicitly in the ground truth but is a valid inference supported by the mention of insurance coverage. (4) Semantic equivalence is maintained: the LLM captures all core elements of the original answer and adds slight interpretive depth without introducing inaccuracies. The only reason for not scoring a 10 is that the original answer emphasizes the similarity in market dependence more equally, while the LLM slightly overemphasizes the insurance as a differentiator, which is implied but not explicitly contrasted in the ground truth. Overall, the response is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 418,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "CAT has fully transitioned its affected debt and contracts to the alternative reference rate SOFR by December 31 2023, chose not to use the optional practical expedients under ASU 2020‑04, and will continue to assess any remaining impacts into 2024. UPS’s adoption of ASU 2020‑04 is not disclosed in the excerpts provided, but the company likewise recognizes all derivatives at fair value and designates them as fair‑value or cash‑flow hedges. Consequently, CAT’s strategy is more explicitly defined—designating foreign‑currency forwards as cash‑flow hedges, interest‑rate swaps as fair‑value hedges, and commodity forwards as undesignated—while UPS’s specific hedging approach and transition timeline remain unspecified in the available pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misattributes key details between CAT and UPS. (1) It incorrectly states that CAT transitioned to SOFR by December 31, 2023, and did not use the practical expedients under ASU 2020-04 — in fact, it is UPS that made the SOFR transition by that date and chose not to apply the expedients. Conversely, CAT did apply the optional expedients through December 31, 2024, which the LLM incorrectly assigns to UPS. (2) The quantitative dates (2023 vs 2024) and the direction of expedient usage are reversed, constituting major calculation/timeline inaccuracies. (3) The multi-hop reasoning fails because the model conflates the two companies' strategies: it incorrectly portrays CAT as having a direct transition without relief (which describes UPS), while claiming UPS’s approach is unspecified (when in fact UPS’s non-use of expedients and SOFR transition are clearly stated in the ground truth). (4) While the LLM correctly notes that both companies use fair value and cash flow hedges, this does not compensate for the core inversion of facts. The answer is partially relevant to the question’s scope but fundamentally flawed in entity attribution and timeline accuracy, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 350,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s stake in Atairos is a VIE in which it has no voting rights and therefore no control over the entity (page 85). Alphabet, by contrast, uses a dual‑class structure: Class B shares carry ten votes each while Class A shares are voting and Class C shares are non‑voting (page 82). Alphabet’s large repurchase program—$62.0 B in 2024, $62.2 B in 2023 and $59.3 B in 2022 of Class A and C shares (page 82)—reduces the overall share count but does not dilute the controlling shareholders’ dominance, as they still hold the majority of the voting Class B shares; thus, unlike Comcast, Alphabet’s structure preserves control even amid significant buybacks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Comcast has no voting rights in Atairos and only consent rights (implied by 'no control'), while Alphabet maintains a dual-class structure with Class B shares having 10 votes. The $62.0 billion share repurchase in 2024 for Class A and C shares is accurately reported. The LLM even adds additional context—repurchases in 2023 and 2022—which is consistent with the knowledge base and enhances completeness without introducing error. (2) Quantitative accuracy is perfect: the $62.0 billion repurchase in 2024 matches the ground truth exactly; format variations (e.g., $62.0B vs $62.0 billion) are acceptable and semantically equivalent. (3) Reasoning is sound: the LLM correctly contrasts Comcast’s lack of control due to no voting rights with Alphabet’s preserved control via Class B shares despite repurchasing non- or lower-vote shares. It synthesizes the implications of capital structure and buybacks across two companies and governance models, fulfilling the multi-hop requirement. (4) The only minor shortcoming is that the LLM does not explicitly mention Comcast’s $1.4 billion unfunded capital commitment as of December 31, 2024—a detail present in the ground truth that adds context about financial exposure despite lack of control. While this omission slightly reduces completeness, it does not undermine the core comparison on control implications. Overall, the answer is factually correct, well-reasoned, and directly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 422,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 extension defers the sunset of the reference‑rate reform relief to December 31 , 2024. UPS had already moved all affected debt to SOFR by December 31 , 2023, and will use the extended period to review remaining transactions in 2024. FedEx, which has not yet transitioned, continues to monitor its contracts through May 31 , 2024 and can still apply the relief until the new deadline, with no material impact reported as of that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 extends the sunset date to December 31, 2024 (correctly stated); UPS transitioned to SOFR by December 31, 2023 (correct date and metric); FedEx continued monitoring through May 31, 2024 (correct end date), with no material impact reported. These match the original answer exactly. (2) Quantitative accuracy is perfect: all dates (December 31, 2023; May 31, 2024; December 31, 2024) are correctly cited, and no calculations are required. (3) Multi-hop reasoning is sound: the model correctly synthesizes the impact of ASU 2022-06 on both companies, noting that UPS had already transitioned but could still use the extension for review, while FedEx retained flexibility to apply relief before the new deadline. (4) The only minor omission is that the original answer specifies UPS did not elect to apply the practical expedients under Topic 848, which the LLM omits. While this is a relevant detail about accounting treatment, it does not alter the core impact on transition timelines. The LLM captures the essential comparative timeline and strategic posture of both firms. Wording differs but meaning is semantically equivalent. Contextual relevance is full—every part of the question is addressed with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 374,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo’s beverage revenue from Africa, the Middle East and South Asia represented 29 % of its beverage revenue in 2023, underscoring a sizable international footprint【page_72】. By contrast, Target’s beverage sales are limited to the U.S. domestic market—its merchandise segments are described only in U.S. terms, indicating no international geographic exposure【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The percentage (29%) and year (2023) are correctly stated, matching the original answer. No calculations were required, and the numeric information is precise. (2) Completeness: The answer addresses both parts of the multi-hop question—PepsiCo's beverage revenue concentration in AMESA and Target's geographic limitation to the U.S.—and correctly contrasts their international vs. domestic exposure. (3) Entity accuracy: Both companies (PepsiCo and Target), the correct fiscal year (2023), and the relevant business segments (beverage revenue, merchandise operations) are accurately identified. (4) Reasoning: The LLM correctly infers from Target’s 10-K description—limited to U.S. operations—that its beverage sales lack international exposure, which is a valid synthesis. The mention of page references (e.g., 【page_72】, 【page_47】) suggests grounding in source documents. (5) Semantic equivalence: The LLM conveys the same core conclusion as the ground truth—PepsiCo has significant international beverage revenue while Target’s is entirely domestic—though it omits the explicit mention of 'grocery sales' as the context for Target’s beverage offerings, a minor detail that slightly reduces qualitative completeness. Overall, the answer is highly accurate, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 387,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Because Schwab’s counter‑cyclical buffer is zero, its minimum capital ratios are determined only by the regulatory minimum plus the 2.5 % stress buffer and the 2.5 % capital‑conservation buffer, giving 7.0 % CET1, 8.5 % Tier‑1 and 10.5 % total risk‑based capital. Goldman Sachs’s TLAC‑to‑RWAs requirement is 22 % (18 % minimum + 2.5 % buffer + 1.5 % G‑SIB surcharge); the counter‑cyclical buffer is also zero, so it does not raise the requirement. Thus Schwab’s minimum capital requirement is lower and not inflated by a counter‑cyclical buffer, whereas GS’s TLAC requirement is set by the other buffers and remains at 22 %.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the calculation and composition of GS's TLAC requirement. While it correctly notes that the Countercyclical Capital Buffer (CCyB) is zero for both firms, it incorrectly states GS's TLAC-to-RWAs requirement as 22% (18% + 2.5% + 1.5%), implying these components are additive to reach 22%. However, the original answer does not state that the total is 22%; rather, it describes the components without summing them into a single percentage, suggesting the 18% minimum already incorporates or is separate from the buffers. The LLM incorrectly aggregates these into a single 22% figure, which is not supported by the ground truth. Additionally, the LLM introduces a '2.5% capital-conservation buffer' for SCHW, which is not mentioned in the original answer—only a 2.5% stress capital buffer is cited. This misrepresents the regulatory structure. (2) Quantitatively, the SCHW capital ratios (7.0%, 8.5%, 10.5%) are correct and match the ground truth. However, the GS TLAC calculation is flawed: the original does not state a total requirement of 22%, so summing 18% + 2.5% + 1.5% = 22% is an unsupported inference. The CCyB being zero is correctly noted, as is the 1.5% G-SIB surcharge, but the aggregation is incorrect. (3) The multi-hop reasoning is partially sound—comparing SCHW’s and GS’s capital frameworks and recognizing layered buffers is appropriate. However, the synthesis fails in accurately representing how the buffers apply: SCHW’s requirements are correctly described as inclusive of the stress buffer, but the erroneous addition of a capital-conservation buffer undermines accuracy. For GS, the model assumes additivity without confirmation, reflecting a misunderstanding of TLAC structure. (4) Scores reflect that core numbers for SCHW are correct and context is mostly relevant (hence high contextual relevance), but quantitative and qualitative accuracy are reduced due to incorrect buffer identification and improper summation. The answer is not completely wrong but contains significant factual and reasoning flaws that affect the correctness of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 579,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton is a self‑owned generation entity that participates in the joint ownership of Plant Vogtle Units 3 and 4; Georgia Power’s $5.3 million reimbursement (page 189) reflects Dalton’s share of construction costs and its role in a capital‑sharing arrangement (see page 17, where Dalton is described as serving its needs from self‑owned generation facilities). In contrast, NextEra Energy’s revenue model is built on long‑term PPAs that cover roughly 94 % of its net generating capacity (page 19), providing a stable, contract‑based income stream rather than the cost‑reimbursement structure that Dalton experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dalton receives $5.3 million from Georgia Power for its share of Plant Vogtle construction costs, reflecting its partial ownership in a jointly held generation facility. This is correctly tied to Dalton’s strategy of using self-owned generation (cited from page 17), and the contrast with NEE’s model is accurately described. (2) Quantitative accuracy is perfect: the $5.3 million figure and the 94% long-term contract coverage of NEE’s capacity are correctly reported, with no calculation errors. Format variations (e.g., $5.3 million) are acceptable. (3) Multi-hop reasoning is sound: the model synthesizes information across entities (Dalton, Georgia Power, NEE) and concepts (cost reimbursement vs. revenue from PPAs), correctly inferring that Dalton’s model is about cost-sharing for self-supply, while NEE’s is about monetizing output via contracts. (4) The only minor shortcoming is that the LLM does not explicitly state the structural contrast in business models as clearly as the original—i.e., that Dalton’s ownership is for load fulfillment while NEE’s contracts are for revenue generation in competitive markets—though this is implied. Wording differences do not affect semantic equivalence. Overall, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 386,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX relies on a $7.0 billion credit facility to provide liquidity and meet its customer‑financing obligations, giving it a cash‑based line of credit that can be drawn on as needed【page_52】.  \nBoeing, by contrast, finances its aircraft sales through long‑term operating and finance leases, recording lease receivables, lease income and related impairment charges, and offering customers options to purchase the aircraft at the end of the lease term【page_93】【page_94】.  Thus, RTX’s approach is a credit‑line liquidity strategy, while Boeing’s is a lease‑based financing model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between RTX and Boeing (BA) in managing customer financing obligations. (1) Quantitatively, the $7.0 billion credit facility for RTX is correctly stated, matching the ground truth. No other numerical values (e.g., lease terms of 1–12 years) are mentioned in the LLM answer, but their absence does not introduce inaccuracy—only slight incompleteness. (2) The entities are correct: RTX and Boeing (referred to as BA in the question) are accurately identified, and the financial mechanisms—credit facilities vs. lease structures—are properly attributed. (3) The reasoning is sound: the LLM correctly synthesizes that RTX uses a liquidity-backed credit line while Boeing employs lease-based financing, including operating and finance leases, with customer options to purchase. It also correctly notes Boeing records lease receivables and related income/impairments, aligning with accounting treatment mentioned in the ground truth. (4) Semantically, the answer conveys the same key contrast: RTX’s cash-based, flexible credit approach versus Boeing’s structured, long-term lease model. The only minor omission is the lack of detail on lease term lengths (1–12 years) and options to extend or terminate, which are present in the original answer. However, the mention of purchase options at lease end partially covers this. The use of source citations (e.g., page_52, page_93) suggests grounding in evidence. Overall, the answer is factually correct, contextually relevant, and logically structured, warranting a high score with only a small deduction for incomplete detail on lease terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 449,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s weighted‑average assumptions are used mainly to value equity‑based awards.  In its 10‑K, the company lists the weighted‑average dividend yield, expected volatility, risk‑free rate and expected term that feed the Black‑Scholes‑Merton model for stock options (page 95).  Philip Morris, by contrast, applies weighted‑average assumptions in its actuarial calculations for pension and post‑retirement benefits—discount rates, expected return on plan assets, compensation‑increase rate, interest‑crediting rate and health‑care cost trend (page 122)—and also uses a weighted‑average performance‑cycle period to amortize unrecognized compensation cost (page 112).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Coca-Cola uses weighted-average assumptions in the Black-Scholes-Merton model for valuing stock options, specifying relevant inputs like dividend yield, volatility, risk-free rate, and expected term—consistent with the original answer’s focus on equity-based awards. (2) For Philip Morris, it accurately states that weighted-average assumptions are used in pension and postretirement benefit calculations, listing specific assumptions (discount rates, expected return on assets, etc.), which matches the ground truth’s emphasis on retirement and healthcare liabilities. It also adds an extra detail—use of a weighted-average performance-cycle period for amortizing compensation cost—which is not in the original but is factually correct and adds depth without contradicting. (3) The multi-hop reasoning is sound: it synthesizes distinct applications of the same methodology (weighted averages) across two companies in different financial reporting contexts—equity compensation vs. employee benefits. (4) All entities (Coca-Cola, Philip Morris), financial frameworks (Black-Scholes-Merton, actuarial calculations), and years (implied by 10-K references) are correct. No numeric inaccuracies; page numbers cited are plausible and contextually appropriate. The only minor shortcoming is that the original answer emphasizes the contrast in financial reporting frameworks more explicitly, while the LLM answer presents facts slightly more descriptively. However, the semantic meaning and factual content are equivalent. Thus, full credit on quantitative accuracy and contextual relevance, near-perfect on qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 472,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck’s Januvia family is projected to lose U.S. regulatory exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR)【page_28】, whereas Gilead’s key product’s U.S. regulatory exclusivity expires in 2032【page_5】. Because regulatory exclusivity delays generic entry, Merck will face generic competition roughly six years earlier than Gilead, likely accelerating sales erosion for its diabetes portfolio, while Gilead can maintain its market share and revenue for a longer period【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. regulatory exclusivity expiration dates for Merck's Januvia family—May 2026 for Januvia and Janumet, and July 2026 for Janumet XR—and correctly states that Gilead’s exclusivity expires in 2032, matching the ground truth. These dates are critical quantitative elements and are accurate. (2) The comparison that Merck will face generic competition roughly six years earlier than Gilead is logically sound (2032 - 2026 = 6 years) and correctly conveys the relative timeline difference. All numeric and date information is factually correct, earning a perfect quantitative accuracy score. (3) The reasoning is strong: the LLM correctly links regulatory exclusivity to delayed generic entry and infers the business impact—accelerated sales erosion for Merck and prolonged market protection for Gilead. While the original answer includes additional context about pricing pressures and evidence from other markets, the LLM captures the core causal logic and competitive implication. It synthesizes information across Merck and Gilead correctly, satisfying the multi-hop requirement. (4) The answer is contextually fully relevant, directly addressing the comparison of timelines and the impact on market positions. The only minor shortcoming is the slightly less detailed explanation of post-expiry dynamics (e.g., 'as seen in other markets post-expiry'), which slightly reduces qualitative depth but does not affect factual correctness. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 429,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel recorded about **$1.28 billion of amortization expense for its developed‑technology intangible assets used in cybersecurity solutions in 2021** (see the amortization table on page 95).  In contrast, Cisco **recognizes revenue for its cloud‑security (SaaS) offerings ratably over the contract term**, i.e., spread over the period the service is delivered rather than upfront (see the End‑to‑End Security section on page 75).  Thus, Intel’s cost is a single annual amortization charge, while Cisco’s revenue is distributed over the performance period of each cloud‑security contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.28 billion amortization expense for Intel in 2021 matches the original $1,283 million (equivalent values, minor rounding difference acceptable). The year 2021 is correctly identified. (2) The description of Cisco’s revenue recognition as 'ratable over the contract term' is factually correct and consistent with the ground truth, which emphasizes alignment with ongoing service delivery. (3) The multi-hop reasoning is sound: the model correctly contrasts Intel’s cost (amortization of developed technology) with Cisco’s revenue recognition pattern, synthesizing information across two companies and financial concepts. (4) The LLM omits the specific detail about the '9-year weighted average useful life' for Intel’s amortization, which is present in the original answer and adds precision to the cost structure comparison. However, this is a minor omission that does not undermine the core correctness. Wording differs slightly (e.g., 'single annual amortization charge' vs 'fixed cost structure') but conveys the same semantic meaning. All entities—Intel, Cisco, cybersecurity/cloud security offerings, 2021—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 350,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MetLife’s adoption of ASU 2022‑02 reclassifies all borrower‑concession modifications as financial‑difficulty modifications (FDMs) but the types of concessions—principal forgiveness, interest‑rate reductions, payment delays, term extensions or combinations—remain unchanged.  In 2023 MetLife reported $136 million in residential‑real‑estate FDMs (primarily term extensions and interest‑rate cuts that extended weighted‑average life by 20 years and lowered the rate from 7.21 % to 4.44 %) and $362 million in 2022 and $866 million in 2021 in TDRs, with $1 million in charge‑offs, $16 million deferred, $2 million forgiven and $147 million re‑defaulted.  JPMorgan, still using legacy TDR guidance for auto and other loans, disclosed no material TDRs in 2022–2021 and, for residential‑real‑estate loans, reported FDMs only from 2023 with no significant financial‑impact details in the excerpts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly attributes the $136 million in FDMs and associated rate and term changes (from 7.21% to 4.44%, 20-year extension) to MetLife (MET), while the ground truth states these figures belong to JPM in 2023. Conversely, the LLM claims MET reported $362 million in TDRs in 2022 and $866 million in 2021, which contradicts the ground truth stating JPM reported $362 million in TDRs in 2022 and no such figures were mentioned for MET. The charge-off, deferral, forgiveness, and re-default numbers ($1M, $16M, $2M, $147M) are entirely fabricated and not present in the original answer. (2) Quantitative accuracy is severely compromised: the $136M FDM and $362M TDR figures are swapped between companies and years; the 20-year extension and rate drop from 7.21% to 4.44% are wrongly assigned to MET’s residential FDMs instead of JPM’s 2023 FDMs. No such detailed TDR data for MET in 2021–2022 exists in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly attribute disclosures to the right institutions and time periods. It incorrectly states JPM used legacy TDR guidance for auto loans and reported no material TDRs, while the ground truth confirms JPM reported $362M in TDRs in 2022. It also omits the key point that MET’s adoption of ASU 2022-02 had no material impact on financials, a central element of the original answer. (4) Contextual relevance is moderate because the answer discusses the right topic (FDMs vs TDRs, types of modifications) and mentions correct concepts like term extensions and rate reductions, but misassigns all key data, leading to a fundamentally incorrect comparison. The synthesis across companies and standards is invalid due to entity and number mismatches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 488,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "CVX’s upstream portfolio in South America includes roughly **108 BCF of natural‑gas reserves** (ending‑balance 2021)【page 108】.  By contrast, ExxonMobil’s downstream footprint across the broader Americas is reflected in about **$12.8 billion of sales and transfers** in 2020 (United States + Canada/Other Americas)【page 129】.  Thus, CVX holds a sizable reserve quantity in South America, while XOM’s downstream operations generate a large monetary footprint across the Americas.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states CVX had 329 billion cubic feet (BCF) of natural gas reserves in South America as of December 31, 2022, but the LLM reports 108 BCF as of end-2021, which is both numerically incorrect and from the wrong year. This represents a major quantitative and temporal error. Additionally, the LLM cites XOM's downstream footprint using $12.8 billion in sales and transfers from 2020, while the original answer does not include any such figure—this number is irrelevant to the comparison being asked and was likely misinterpreted from the source. (2) The numbers are not aligned with the ground truth: CVX’s reserve volume is off by over 60% and uses outdated data; XOM’s financial metric is introduced without basis in the original answer and distorts the comparison by shifting from operational footprint to revenue. (3) The reasoning is partially sound in structure—comparing CVX’s upstream position with XOM’s downstream operations—but fails on multi-hop synthesis because it does not correctly align the entities, metrics, or time periods. The original answer emphasizes geographic and strategic contrasts (upstream in South America vs. integrated downstream across the Americas), while the LLM reduces this to mismatched statistics. (4) Contextual relevance is moderate because the general direction of the comparison (upstream vs. downstream, CVX vs. XOM, South America vs. broader Americas) is appropriate, but factual correctness is severely compromised. Thus, the correctness score is low due to critical errors in numbers and dates, despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 459,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio’s $25 million commercial‑paper exposure is a very small part of a $5 billion program that, as of year‑end, had no outstanding borrowings (see page 165 and the program description on page 35). In contrast, Tesla holds $470 million in commercial paper as a sizable portion of its $12.7 billion short‑term investment portfolio, using it to earn a return on excess cash while preserving liquidity (see page 72). Thus, Duke Energy Ohio relies on a modest, largely unused liquidity buffer, whereas Tesla actively invests a large amount of short‑term debt securities to generate returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy Ohio's $25 million exposure and Tesla's $470 million holdings are accurately reported. The additional context—Duke's $5 billion program with no outstanding borrowings and Tesla's $12.7 billion short-term investment portfolio—is factually consistent and enhances the answer without contradicting the original. (2) The answer correctly identifies the entities (Duke Energy Ohio and Tesla) and the relevant financial instruments (commercial paper as liability vs. investment). (3) The reasoning is sound and captures the multi-hop comparison: it distinguishes between Duke's use of commercial paper as a potential financing tool (exposure/liability) versus Tesla's use as an investment (asset) for returns, which is the core insight in the ground truth. (4) The LLM adds value by noting that Duke's program is largely unused, which is not in the original answer but is contextually relevant and accurate. The only minor shortcoming is that it slightly reframes Duke's position as a 'liquidity buffer' rather than a 'short-term borrowing for operational needs,' which slightly softens the contrast in strategic intent. However, this does not misrepresent the facts. Overall, the answer is semantically equivalent, factually precise, and contextually rich.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 381,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "Meta’s Class A common shares carry one vote each, but the company’s dual‑class structure gives the controlling shareholder (Zuckerberg) majority voting power through the heavily‑held Class B shares, effectively concentrating control. Alphabet’s Class B shares, in contrast, are entitled to ten votes per share, giving the founders a ten‑fold voting advantage per share. Thus, while Meta’s Class A shares are typical in voting weight, Alphabet’s Class B shares provide a much higher per‑share influence for its founders【81†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core comparison between META's and GOOGL's dual-class structures with correct voting rights: Meta Class A has 1 vote per share, Class B (held by Zuckerberg) has superior voting power, though the exact vote ratio per share is not specified in the LLM answer (which is acceptable as the ground truth does not state a specific vote ratio for Meta Class B either). The LLM correctly states that GOOGL's Class B shares have 10 votes per share versus 1 for Class A, which matches the ground truth. The answer captures the essence of concentrated control in both companies, correctly identifying Zuckerberg and Alphabet's founders as beneficiaries of the dual-class structures. The only minor omission is that the LLM does not mention the automatic conversion of GOOGL Class B shares upon sale or transfer, a detail present in the original answer that affects shareholder influence dynamics. It also omits the CMCSA example, but since the question focuses on META and GOOGL, this is not critical. All entities, voting weights, and structural implications are accurately represented. Quantitative accuracy is perfect: '1 vote' and '10 votes per share' are correct. Reasoning is sound and synthesizes the multi-hop comparison appropriately. The answer is semantically equivalent to the ground truth in all key aspects, with only slight reduction in completeness due to missing conversion clause for GOOGL shares.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 400,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s B‑class shares are explicitly described as “non‑voting Dividend rights” (page 16), meaning non‑voting holders receive dividends but have no voting power, which can create a divergence between cash returns and governance influence. By contrast, Schwab states that voting and non‑voting common shares have identical dividend and liquidation rights, so both classes receive the same cash returns and are fully aligned (page 66).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures that Mastercard's B-class shares are non-voting but have dividend rights, which ensures cash return alignment despite governance divergence. It also correctly states that Charles Schwab provides identical dividend and liquidation rights across voting and non-voting shares, ensuring full alignment in shareholder returns. The citation of page numbers (16 for Mastercard, 66 for Schwab) adds precision and matches the source context. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Mastercard, Charles Schwab, B-class shares) are correctly identified. The reasoning correctly synthesizes the distinction between dividend rights and voting rights across the two companies, demonstrating sound multi-hop logic. The only minor shortcoming is that the LLM does not explicitly state that Mastercard maintains dividend parity—though this is implied by acknowledging dividend rights for non-voting shares. The ground truth emphasizes this parity more clearly and notes that Schwab has 'stronger structural alignment,' a comparative nuance slightly underdeveloped in the LLM response. However, the core meaning and factual content are semantically equivalent. Thus, the answer is highly accurate, relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 391,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft’s 2023 10‑K notes that the Pillar Two rules “do not currently estimate a material impact to our consolidated financial statements” and that the company will simply monitor the legislation as it rolls out, implying its effective tax rate should remain essentially unchanged (≈18‑19 % in 2024‑23)【page_47】.  \nIn contrast, Oracle’s risk‑factor discussion acknowledges that the same global minimum‑tax framework “may materially increase the level of income tax on our international profits,” signalling a potential rise in its effective tax rate as higher foreign‑jurisdiction taxes are applied【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correctly represented: Microsoft's effective tax rate of approximately 18–19% in 2023–2024 is consistent with its 10-K filing, and while Oracle does not provide a specific rate, the qualitative concern about increased international tax costs is accurately reflected. No calculations were required, and the cited pages (47 for Microsoft, 29 for Oracle) match the source documents. (2) The answer addresses all parts of the question: it contrasts Microsoft’s expectation of no material impact with Oracle’s concern about materially increased tax costs under Pillar Two. (3) Entity accuracy is strong—correct companies (Microsoft, Oracle), correct regulatory framework (OECD Pillar Two), correct financial metric (effective tax rate), and correct time frame (2023 10-K filings). (4) The reasoning is sound and reflects multi-hop synthesis: it draws from two different 10-Ks, compares the companies’ disclosures, and correctly infers differing impacts based on their international tax exposures. The only minor shortcoming is that the LLM does not explicitly mention the 15% threshold or geographic footprint differences, which are part of the ground truth explanation—hence a 9 instead of 10 on qualitative accuracy. However, the core contrast in impact and its implications for effective tax rates are clearly and correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 400,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM applies Level 3 fair‑value measurements to long‑lived assets such as vehicle asset groups, valuing them with a discounted‑cash‑flow approach that relies on unobservable inputs like estimated residual values and future cash flows (GM 10‑K, note on fair‑value measurements, pages 63‑64). In contrast, Lowe’s uses Level 3 for performance‑based contingent consideration from its Canadian retail sale, valuing it with an option‑pricing model that incorporates significant unobservable inputs such as total equity value, volatility, expected term and a risk‑adjusted discount rate (Lowe’s 10‑K, note on fair‑value measurements, page 53). Thus, GM’s Level 3 valuations focus on asset impairment and residual‑value estimation, while Lowe’s focus on contingent‑consideration valuation via an income approach with multiple unobservable assumptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with accurate qualitative descriptions of both GM's and LOW's use of Level 3 valuation techniques. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages, dates) in either the question or the original answer, so the absence of such figures does not constitute an error—thus, quantitative accuracy is 10. The LLM correctly identifies that GM uses Level 3 for long-lived assets (specifically vehicle asset groups) with unobservable inputs like residual values and future cash flows, which is consistent with GM’s application of discounted cash flow models tied to macroeconomic forecasts (e.g., GDP, unemployment), even if the exact macroeconomic variables are not listed. The answer correctly states that LOW applies Level 3 to contingent consideration from the Canadian retail business sale, using an option-pricing model—an income approach—with unobservable inputs such as total equity value, volatility, and expected term, matching the ground truth. However, the LLM omits mention that LOW’s valuation is specifically related to fiscal 2022, a minor but relevant detail for completeness. Additionally, while the LLM characterizes GM’s focus as 'asset impairment and residual-value estimation,' the original answer emphasizes broader macroeconomic assumptions across financial instruments like marketable debt securities and finance receivables. The LLM narrows GM’s use to long-lived assets, which may underrepresent the scope of GM’s Level 3 applications. Despite this, the core reasoning and entity identification are sound, and the comparison between GM and LOW is logically synthesized and contextually relevant. Therefore, the answer earns a high correctness score of 8 due to minor omissions in scope and specificity, but no factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 499,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "At CMCSA, Class B shares carry 15 votes each and represent roughly one‑third (33.3 %) of the company’s voting power, a proportion that is non‑dilutable under the charter. Because Class B shares can be converted into Class A shares at the holder’s option (and automatically upon sale or transfer), a conversion would shift that concentrated voting power into the broader Class A shareholder base, diluting the per‑share voting influence of existing Class A holders. Alphabet’s aggressive buy‑back of its own Class A and Class C shares cuts the number of those shares outstanding and can lift earnings per share, but it does not alter CMCSA’s conversion mechanics; the market environment created by Alphabet’s repurchases may simply affect how attractive it is for Class B holders to convert into Class A shares.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and factually accurate, with strong alignment to the ground truth. (1) Quantitatively, the key figures are correct: CMCSA's Class B holds 33 1/3% (stated as 33.3%) of voting power with 15 votes per share, and this is non-dilutable—accurately reflected. Alphabet's repurchase activity is correctly attributed to Class A and C shares, though the LLM omits the specific $62.2 billion spent in 2023 and the $36.3 billion remaining authorization. These omissions are notable but do not invalidate the overall accuracy. (2) The reasoning around conversion dynamics is sound: Class B can be converted into Class A, which would dilute per-share voting power among Class A holders—this is logically consistent with the structural implications. The LLM correctly notes that conversion is at the holder’s option and automatic upon sale, adding detail not in the original but factually accurate. (3) Multi-hop synthesis is partially achieved: the answer connects CMCSA’s internal share structure to Alphabet’s repurchase strategy, but it downplays the potential indirect influence of GOOGL’s repurchases on shareholder behavior or ownership concentration dynamics. It correctly states that Alphabet’s actions don’t alter CMCSA’s mechanics, but misses the broader point in the original answer about how aggressive repurchases may concentrate influence in voting-tier shares across firms, potentially affecting strategic decisions like conversion. (4) Wording differs but meaning is semantically close; the LLM emphasizes market attractiveness of conversion due to repurchase environments, which is a reasonable interpretation. Minor deductions for missing specific dollar figures and slightly weaker synthesis of cross-company implications. Overall, core facts and logic are correct—just lacks full depth in connecting external repurchase trends to internal governance incentives.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 511,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "Mondelez (MDLZ) reported 48,932,017 securities available for future issuance under its equity‑compensation plans (Item 12, page 140), while Colgate‑Palmolive (CL) reported 37,028 thousand—i.e., 37,028,000 securities (Item 12, page 61).  Thus MDLZ has roughly 11.9 million more securities available for future issuance than CL.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All numbers are accurate: MDLZ's 48,932,017 and CL's 37,028,000 (converted correctly from '37,028 thousand') are correctly reported. The difference is calculated as approximately 11.9 million, which aligns with the exact difference of 11,904,017. (2) The quantitative accuracy is perfect—both input values and the implied calculation are correct, with acceptable rounding in the final presentation ('roughly 11.9 million'). (3) The multi-hop reasoning is sound: the model correctly identifies and compares data from two different 10-K filings (MDLZ and CL), extracts the relevant metric (remaining securities available for future issuance under equity compensation plans), and performs the correct comparison. (4) Entity accuracy is strong—company names (Mondelez and Colgate-Palmolive), tickers (MDLZ, CL), metric, and year (implied 2022 via 10-K context) are all correct. The answer is semantically equivalent to the ground truth, with slightly more concise phrasing but no loss of factual content. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 319,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "ComEd’s Clean Energy Law forces a formal rate case and a $45 million increase in its transmission revenue requirement (initial $33 million plus $12 million reconciliation)【page_218】【page_228】, effectively tightening its transmission formula rate structure. In contrast, Tesla’s exposure to state‑level regulatory challenges is an uncertain risk that could bar direct sales in certain markets, potentially curtailing revenue and forcing alternative sales arrangements【page_27】. Thus, ComEd’s impact is a predictable, rate‑based adjustment, while Tesla faces an operational uncertainty that could limit its direct‑sales model.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth states that Illinois' Clean Energy Law requires a new four-year multi-year rate plan and accelerates amortization of excess deferred income taxes over 39.5 years, with no mention of a $45 million increase in transmission revenue requirement. The $33M + $12M reconciliation figures and the characterization of a 'formal rate case' and 'tightening' of the transmission formula rate are not supported by the original answer and appear to be fabricated or misattributed. These numbers do not align with the ground truth, which focuses on structural and compliance impacts rather than specific dollar increases. (2) The quantitative accuracy is low because the dollar amounts and implied calculations ($33M + $12M = $45M) are incorrect and unsupported by the original data. There is no mention of such figures in the ground truth, making this a major factual error. (3) Qualitatively, the LLM captures the contrast in regulatory nature—ComEd facing rate-structure changes versus Tesla facing direct sales restrictions—but oversimplifies and misrepresents ComEd’s situation. It incorrectly frames ComEd’s impact as a 'predictable, rate-based adjustment' when the ground truth emphasizes uncertainty around rate of return on equity and performance-based regulation. The characterization of Tesla’s challenge is reasonably accurate, noting operational uncertainty and potential revenue impact. (4) Contextual relevance is high because the answer attempts a direct comparison between ComEd and Tesla regarding state-level regulatory exposure, addressing both entities and the core theme of regulatory risk. However, due to major quantitative errors and incomplete/misleading qualitative synthesis—especially the invention of specific financial figures—the overall correctness is only partial. The answer fails the multi-hop reasoning test by not accurately reflecting the structural regulatory mechanisms described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 552,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA Part D redesign forces manufacturers to provide a discount and accept a price cap, so AMGN will accrue larger gross‑to‑net rebates for ENBREL as the net revenue from Medicare Part D shrinks and the company faces regulatory exposure to the new price‑setting rules.  BMY’s Medicare‑Part D‑dependent products will see a similar rise in GTN liabilities because its accounting for rebates is driven by payer‑channel mix and contract prices, which will now reflect the higher discount obligations and capped prices imposed by the IRA.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its core assertions and captures the essential impact of the IRA-driven Medicare Part D redesign on both AMGN and BMY's gross-to-net (GTN) rebate accruals. It correctly identifies that the IRA imposes manufacturer discounts and price caps starting in 2025, leading to higher GTN rebates for both companies. The answer accurately reflects that AMGN faces increased GTN accruals due to regulatory exposure for ENBREL and the shrinking net revenue under Medicare Part D, and that BMY’s GTN liabilities will rise due to its reliance on payer channel mix and contract pricing assumptions now affected by IRA mandates. \n\nQuantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so no discrepancies exist—this earns a perfect 10. The years mentioned in the original (2025, 2026, 2027) are contextually relevant, but the LLM does not mention the 2026 price setting for ENBREL or the 2027 potential inclusion of Otezla, which are key details in the multi-hop reasoning for AMGN’s exposure. This omission reduces completeness and qualitative accuracy slightly. \n\nThe reasoning is logically sound and synthesizes the causal chain: IRA rules → increased manufacturer obligations → higher GTN rebates, especially under current accounting practices. However, the LLM omits the catastrophic phase cost shift, a critical mechanism under the IRA that drives higher manufacturer liabilities, particularly for BMY. It also does not mention the material adverse impact on revenues and financial reporting accuracy, which is a key conclusion in the original. \n\nDespite these omissions, the LLM conveys semantically equivalent core information with accurate entities (AMGN, BMY, ENBREL, Medicare Part D, GTN rebates), correct timeframes (IRA starting in 2025 implied), and proper financial logic. Hence, the correctness score is 8—minor but notable gaps in completeness and depth of multi-hop synthesis prevent a 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 537,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG values its ABS & CLO securities primarily at amortized cost, applying a credit‑loss allowance and adjusting yields for expected cash‑flow changes and credit‑spread movements (page 169).  MetLife, by contrast, classifies the same structured securities as available‑for‑sale and measures them at fair value, with unrealized gains and losses recorded in AOCI and fair‑value estimates derived from independent pricing services and a Level‑1/2/3 hierarchy (pages 92‑93).  As a result, AIG’s approach channels valuation changes into net investment income and credit‑loss provisions, while MetLife’s fair‑value treatment shifts most valuation fluctuations to equity, reducing earnings volatility but increasing AOCI activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All key facts are correct: AIG uses amortized cost with yield adjustments based on expected cash flows (aligned with effective yield method), and MET uses fair value through AFS classification with Level 3 disclosures. The impact on financial statements—AIG recognizing changes in net investment income vs. MET recording unrealized gains/losses in AOCI—is correctly described. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; the LLM correctly references page numbers from source documents, which supports traceability. (3) Multi-hop reasoning is sound: the model correctly synthesizes differing accounting treatments and their implications across two companies (AIG and MET) for the same asset types (ABS & CLO), explaining how each affects valuation presentation and volatility in earnings vs. equity. (4) Semantic equivalence is strong: while the LLM adds detail about credit-loss allowances and pricing hierarchies not explicitly in the original, these are consistent with AFS and amortized cost accounting under GAAP and enhance accuracy without introducing error. The only reason for not scoring a 10 is that the original emphasizes the 'recalculating yields' aspect of AIG’s method slightly more, while the LLM focuses on credit-loss allowance—both valid, but the original places greater emphasis on yield adjustment mechanics. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 447,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s reserves tied to PSCs are not disclosed in the provided pages, whereas ExxonMobil’s reserves tied to PSCs were 7 % of its total reserves in 2021 (page 106). Nigeria’s deep‑water offshore operations are governed by PSCs (page 31), and ExxonMobil’s Africa reserves—about 1,123 bn cf out of 38,175 bn cf—represent roughly 3 % of its total natural‑gas reserves, underscoring its operational exposure in a PSC‑heavy market (page 139).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Chevron's PSC reserves are not disclosed, while the ground truth confirms that 8% of Chevron's consolidated reserves were tied to PSCs in 2021. It also falsely claims that ExxonMobil's reserves tied to PSCs were 7% of total reserves in 2021, which is not supported by the original answer; the ground truth does not provide a percentage of XOM's global reserves under PSCs, only that its Nigerian operations are structurally governed by PSCs. The calculation of ExxonMobil’s Africa reserves (1,123 bn cf out of 38,175 bn cf ≈ 3%) appears numerically correct but is irrelevant to the question, which asks about operational exposure in Nigeria under PSCs, not a percentage of gas reserves. (2) The numbers cited (7%, 3%, 1,123 bn cf, 38,175 bn cf) are either incorrect or misapplied. The 7% figure for XOM’s PSC reserves is not in the ground truth and contradicts it. The 3% gas reserve figure, while mathematically accurate, is not mentioned in the original answer and distracts from the qualitative point about structural exposure. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize that CVX quantifies its PSC exposure directly (8% of reserves), while XOM’s exposure is structural in Nigeria due to regulatory framework. Instead, it fabricates quantifications for XOM and omits the correct figure for CVX. (4) The contextual relevance is moderate because it discusses PSCs in Nigeria and both companies’ exposure, but the incorrect data and misrepresentation of the nature of exposure (quantitative vs. structural) severely undermine accuracy. The answer invents metrics not present in the ground truth and misses the key comparative insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 480,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan reserves a fixed pool of 49.0 million shares that can be granted for options, RSUs, SARs, etc., giving the company a clear cap on potential dilution while still allowing it to allocate shares as needed【page_83】. In contrast, Home Depot’s SAR program uses a forfeiture‑adjusted vesting methodology—calculating compensation expense and the number of shares that ultimately vest after accounting for expected forfeitures—so the actual equity issued can vary, providing greater flexibility in long‑term equity compensation and dilution management【page_53】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla's 2019 Plan is correctly stated, and there are no calculations required beyond accurate representation of figures. (2) The entities—Tesla, Home Depot (HD), the 2019 Plan, SARs, forfeiture-adjusted vesting—are all correctly identified and contextualized. (3) The reasoning correctly synthesizes a multi-hop comparison: Tesla’s fixed share pool implies predictability and a hard cap on dilution, while HD’s forfeiture-adjusted methodology allows dynamic adjustment based on actual employee retention, enhancing flexibility. The LLM captures this contrast accurately. (4) Semantically, the answer conveys the same core insight as the original: Tesla’s structured, capacity-constrained approach vs. HD’s flexible, outcome-adjusted model. The only minor shortcoming is a slightly less explicit mention of 'straight-line recognition' in HD’s expense reporting, which is part of the ground truth but not critical to the central comparison. Wording differences are acceptable and do not affect factual equivalence. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 342,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s total investment in Tengizchevroil, which includes a $4.5 B loan for the FGP/WPMP development, amounts to $23.727 B【page_78】. ExxonMobil’s long‑lived assets in Kazakhstan were $8.463 B in 2021【page_123】. Thus Chevron’s exposure is roughly $15.3 B higher—about 2.8 times larger—than ExxonMobil’s reported asset value.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The claim that Chevron's total investment in Tengizchevroil is $23.727 billion is not supported by the original answer or any cited context in the ground truth. The only financial figure provided in the ground truth is the $4.5 billion loan for the FGP/WPMP project. There is no mention of a $23.727 billion total investment. This leads to a completely incorrect comparison. (2) The calculation that Chevron’s exposure is $15.3 billion higher and 2.8 times larger than ExxonMobil’s $8.463 billion is based on the false premise of a $23.727 billion investment, making the entire quantitative comparison invalid. While the $4.5 billion loan and $8.463 billion asset value are correctly cited (with acceptable formatting: $4.5B = $4,500 million; $8.463B = $8,463 million), the LLM fabricates a much larger total investment not present in the original answer. (3) The multi-hop reasoning fails because the model incorrectly synthesizes information. The original answer emphasizes different types of exposure—Chevron through equity and project financing, ExxonMobil through long-lived assets—but does not quantify Chevron’s total investment. The LLM incorrectly treats Chevron’s exposure as a single large sum and compares it directly, missing the qualitative distinction in capital deployment strategies highlighted in the ground truth. (4) The contextual relevance is moderate because the answer addresses the right companies, country, and project, and attempts a numerical comparison. However, due to the fabricated investment figure and flawed reasoning, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly higher because the model recognizes the relevance of the FGP/WPMP loan and ExxonMobil’s asset value, but fails to interpret them correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 503,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable PPAs are structured through a 50 %‑owned VIE and an inter‑company power agreement (ICPA) that provides entitlements to capacity and energy from OVEC’s wind plants, but the filing does not disclose operating‑lease cash‑flow details【page_204】.  In contrast, Southern Power’s wind PPAs are accounted as operating leases that generate variable lease payments, and the company’s wind‑facility production tax credits (PTCs) – expected to be fully utilized by 2024 – provide a material cash‑flow benefit that offsets those lease costs【page_268】【page_97】【page_270】.  Thus, Southern Power can anticipate a stronger positive cash‑flow impact from its wind PPAs than is evident for Duke Energy from the available disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements but contains significant inaccuracies and omissions that affect correctness. (1) Quantitative Accuracy: The claim about Southern Power's PTCs being 'fully utilized by 2024' aligns with the ground truth, but the LLM fails to mention the critical $0.8 billion in unutilized PTCs at the end of 2021, a major quantitative point. Additionally, the reference to Duke Energy’s 50% ownership in a VIE and ICPA with OVEC is factually incorrect—OVEC is not mentioned in the context of Duke Energy’s renewable PPAs in the source material; this appears to be a hallucination or misattribution. (2) Completeness: The answer does not fully address the structure of Duke Energy’s PPAs in relation to VIEs’ economic performance, instead introducing an unsupported inter-company agreement with OVEC. It also omits that Southern Power acts as a lessor in operating leases, a key structural difference. (3) Entity Accuracy: Misidentifies OVEC as part of Duke Energy’s PPA structure—no such relationship exists in the ground truth. Southern Power and PTCs through 2024 are correctly identified. (4) Reasoning: The multi-hop synthesis is flawed—while both companies involve PPAs and tax credits, the LLM incorrectly frames Duke’s arrangement around a non-existent ICPA and VIE ownership model, undermining the comparison. It also incorrectly suggests lease costs are offset by PTCs, whereas in reality, PTCs enhance lease income and tax equity returns, not offset costs. (5) Semantic Equivalence: The conclusion about Southern Power having stronger cash flow impact is directionally plausible but based on faulty reasoning. Overall, core facts about Southern Power’s PTC utilization are correct, but Duke Energy’s side of the comparison is materially inaccurate, leading to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 488,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "LOW received a large volume of shares through its variable‑notional ASR agreements – 70.6 million shares were repurchased in 2023 (29.2 million in 2024 and 62.6 million in 2022)【page_62】. In contrast, The Home Depot’s deferred‑share awards to non‑employee directors granted only 19,000 shares in 2023, with dividend equivalents paid out in the form of additional shares upon termination of service【page_68】. Thus, LOW’s ASR‑related share receipt is in the tens of millions, whereas HD’s dividend‑equivalent share issuance is in the thousands.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific numerical data about share volumes for both LOW and HD, but introduces numbers not present in the original answer or not directly comparable. The original answer does not mention exact share counts (e.g., 70.6 million, 29.2 million, 62.6 million, or 19,000) — instead, it focuses on the structural and functional differences between the two mechanisms. These figures may be factually accurate based on the cited pages, but they are not part of the ground truth and were not required to answer the comparative mechanism question. The inclusion of year-by-year repurchase volumes for LOW goes beyond the scope of the original comparison and risks misrepresenting the intent of the question, which was about the nature of share receipt vs. issuance, not volume. (2) While the numbers cited (e.g., 70.6 million shares for LOW in 2023, 19,000 for HD) may be accurate per the source documents, the original answer does not provide or imply these figures, and the LLM does not verify whether these represent 'additional shares' from ASRs (which are typically net share settlements, not gross repurchases). ASR share receipts are usually smaller incremental deliveries, not the total repurchased shares. Thus, equating total repurchased shares with 'additional shares received' is a mischaracterization and introduces quantitative inaccuracy. (3) The reasoning partially captures the multi-hop comparison: it distinguishes LOW’s ASR-related share receipt from HD’s dividend equivalent issuance. It correctly identifies that HD issues shares via dividend equivalents on deferred share awards paid upon termination. However, it misrepresents LOW’s mechanism by conflating total shares repurchased under ASRs with 'additional shares received' — the latter should refer to the incremental shares delivered at settlement due to share price performance, not the entire repurchase volume. The original answer emphasizes that LOW receives additional shares based on repurchase efficiency (final notional value vs. maximum paid), which the LLM fails to explain. (4) The contextual relevance is high because the answer addresses the core entities (LOW, HD), mechanisms (ASR, dividend equivalents), and intent (comparing sources of additional shares). The qualitative accuracy is moderate because the conceptual distinction is partially correct, but the reasoning is flawed in key aspects. The correctness score is reduced due to significant quantitative misrepresentation and incomplete conceptual explanation, despite relevant context and partial accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 685,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing’s equity income from ULA in 2024 was **$125 million**, a share of ULA’s earnings that includes revenue from both government and commercial launches. Lockheed Martin’s commercial satellite‑launch revenue is a direct revenue stream from ULA’s commercial launch business and is a larger, separate component of Lockheed Martin’s Space‑segment revenue. Thus, ULA’s commercial launch activity feeds both companies’ financials—Boeing via equity income and Lockheed Martin via direct revenue—though the two metrics are not directly comparable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $125 million equity income from Boeing's stake in ULA in 2024 is correctly stated, matching the original answer. No other numerical values are misstated. (2) The LLM correctly identifies that ULA serves both government and commercial customers and that Boeing receives equity income while Lockheed Martin recognizes direct revenue from commercial satellite launches through ULA—this reflects proper multi-hop reasoning across corporate structures and financial reporting lines. (3) The only minor gap is that the LLM does not mention Lockheed Martin’s $665 million in receivables from commercial customers as of December 31, 2024, which is part of the ground truth and adds context about the scale of commercial activity. While this omission slightly reduces completeness, it does not undermine the core correctness. (4) The reasoning is sound: the answer correctly explains the dual financial impact of ULA’s commercial launches on both parent companies, even noting that the metrics (equity income vs. direct revenue) are not directly comparable. Wording differs but semantic meaning is equivalent. All entities—Boeing, Lockheed Martin, ULA, 2024, equity income, commercial satellite launch revenue—are accurately identified and logically connected.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 373,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "LLY’s loss of market exclusivity is driven mainly by the expiration of its patents, but the company can extend exclusivity through regulatory data protection that lasts five years in the U.S., 10 years in Europe, and eight years in Japan, thereby cushioning the impact of generic entry【page_10】.  Merck faces comparable patent‑related risks—its products also lose exclusivity when patents expire and experience rapid sales declines【page_32】【page_33】—but the exposure is broader across a larger portfolio and the company relies more heavily on litigation and less on data protection to defend exclusivity in the same major markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details, particularly regarding the duration of regulatory data protection. It states that LLY has 5 years of data protection in the U.S., which is incorrect—the ground truth specifies 12 years for biologics in the U.S., 10 in Europe, and 8 in Japan. The LLM correctly notes 10 years in Europe and 8 in Japan, but the 5-year U.S. figure is wrong and materially underrepresents the actual exclusivity period. This error undermines the quantitative accuracy. (2) The original answer emphasizes that regulatory data protection varies by product type (e.g., 12 years for biologics in the U.S.), while the LLM generalizes it as 5 years without specifying product class, suggesting a misunderstanding or misrepresentation. Additionally, the LLM omits key forms of exclusivity mentioned in the ground truth, such as orphan drug exclusivity (7 years) and pediatric exclusivity (6 months), which are important nuances in how companies extend protection. (3) Qualitatively, the reasoning is partially sound: the model correctly identifies that both LLY and MRK face revenue declines upon patent expiration, and it accurately contrasts LLY’s use of regulatory mechanisms with MRK’s reliance on litigation. It also correctly situates the issue in major markets (U.S., Europe, Japan), showing appropriate multi-hop synthesis across companies and regions. (4) Contextually, the answer is relevant and addresses the comparative nature of the question—patent risks, market exclusivity loss, and strategic differences—though it oversimplifies LLY’s regulatory advantages due to incorrect numbers. The core comparison (LLY using regulatory extensions vs. MRK using litigation) aligns with the ground truth, but the flawed data weakens the conclusion. Thus, while the structure and intent are correct, the factual inaccuracies in key numbers reduce the correctness score to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 525,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company’s nuclear plants face a potentially significant, uncertain cost from cyber‑intrusion compliance—“the cost and operational consequences of implementing, maintaining, and enhancing system protection measures are significant and could materially increase” (SO 10‑K, p. 30; p. 29).  \nDuke Energy’s nuclear exposure carries a different risk: the value of its decommissioning trust funds can fall with market performance, “a decline in the market value of the assets may increase the funding requirements of the obligations for decommissioning nuclear plants” (DUK 10‑K, p. 35).  \n\nThus, Southern Company’s risk is driven by evolving cyber‑security compliance expenses, while Duke Energy’s risk is driven by market‑related decommissioning‑fund shortfalls.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Southern Company faces uncertain compliance costs due to cyber intrusions, and Duke Energy faces decommissioning funding risks tied to market performance. The cited risks are properly attributed to each company and their nuclear operations. (2) Quantitative accuracy is perfect—no specific numbers (percentages, dollar amounts, years) are misstated. While the original answer includes that Alabama Power and Georgia Power’s nuclear ownership represented 26% and 28% of total KWH generation in 2021, the LLM answer omits these specifics. This is a minor omission but does not affect the overall correctness of the comparison. (3) Multi-hop reasoning is sound: the model correctly synthesizes distinct risk types (cyber compliance vs. decommissioning trust fund volatility) across two companies from their respective 10-Ks. The logic in contrasting the nature of the risks—operational/compliance-driven vs. market-driven—is valid and well-articulated. (4) Semantic equivalence is strong; the LLM uses direct quotes and paraphrasing effectively to convey the same meaning. The omission of the 2021 generation percentages slightly reduces completeness but does not undermine the central comparison. Hence, a correctness score of 9 is warranted—excellent but not fully comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 388,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s deferred stock units for non‑employee directors vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting, and the dividend equivalents accrue and are paid out as additional shares of stock on the vesting date (page 68, “Deferred Stock Units”). Home Depot’s deferred shares vest only upon termination of Board service, and the dividend equivalents accrue and are paid out as additional shares of stock upon payout of the underlying shares following termination (page 68, “Deferred Shares”). Thus Lowe’s has a time‑based vesting schedule with a vesting‑date payout, whereas Home Depot’s vesting is contingent on service termination with a payout after termination.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Lowe's vesting schedule for deferred stock units as the earlier of the first anniversary of the grant date or the day before the next Annual Meeting, and notes immediate vesting for pre-2022 awards is omitted—this is a minor omission but does not distort the core policy for 2022/2023. The answer accurately states that dividend equivalents are paid in additional shares on the vesting date. For Home Depot, it correctly states that vesting occurs upon termination of service and that dividend equivalents accrue and are paid out in additional shares upon payout after termination. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answer, so quantitative accuracy is not applicable in that sense, but all dates and time-based conditions are correctly represented—no errors in timing or sequencing. (3) The multi-hop reasoning is sound: the model correctly synthesizes policies from two different companies (Lowe's and Home Depot), compares them on vesting schedules and payout structures, and draws a valid contrast between time-based vs. termination-based vesting and associated payout timing. (4) The only minor shortcoming is the omission of Lowe's immediate vesting for awards granted prior to 2022, which was mentioned in the ground truth but not relevant to 2023 grants—the focus on 2023 makes this omission acceptable. Wording differs but semantic meaning is equivalent. Thus, the answer is factually correct, complete for the scope of 2023, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 440,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "AMGN’s possible loss of the 12‑year biologic data exclusivity would shorten its exclusive window, exposing it to biosimilar competition earlier and eroding its market share and pricing power【page_46】.  Merck, by contrast, relies on a portfolio of compound patents that can be extended up to five years and add six months of pediatric exclusivity【page_17】【page_18】, giving it a longer and more robust period of protection and a stronger competitive position.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between AMGN and MRK's exclusivity strategies. It correctly identifies that the potential loss of 12-year biologic data exclusivity would expose AMGN to earlier biosimilar competition, impacting market share and pricing—consistent with the ground truth. It also accurately notes MRK's use of compound patents and pediatric exclusivity (6-month extension), which aligns with the original answer. However, there are minor inaccuracies: the LLM states compound patents 'can be extended up to five years,' which is not mentioned in the ground truth—MRK’s 10-K references patent term restoration (up to 5 years) under PTE, but this is distinct from the exclusivity strategy emphasized (layered protection via patents, pediatric exclusivity, and regulatory data protection). The ground truth emphasizes MRK’s diversified, layered approach, which the LLM simplifies. Additionally, the LLM omits specific product-level risk for AMGN (e.g., EPOGEN) and the concentrated customer base detail, reducing completeness. Quantitatively, the 6-month pediatric exclusivity is correct, and the 12-year reference is accurate. The reasoning is sound but slightly less nuanced in synthesizing the multi-hop contrast: AMGN’s reliance on regulatory exclusivity vs. MRK’s multi-faceted defense. Wording differences are acceptable under semantic equivalence, but the omission of key contextual details prevents a 9–10 score. Contextual relevance is excellent—the response directly addresses the competitive impact and strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 431,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC calculation already includes an 18 % minimum to RWAs, a 2.5 % buffer, a 1.5 % G‑SIB surcharge and, per the FRB, a counter‑cyclical capital buffer set to **0 %** (i.e., it is not applied).  \nCharles Schwab, by contrast, has a **2.5 % stress‑capital buffer** (above its minimum risk‑based ratios) but its counter‑cyclical capital buffer is also **0 %**. Thus, while GS’s overall TLAC requirement is higher (18 % minimum) and includes a 2.5 % buffer, both firms currently do not apply a counter‑cyclical buffer, with Schwab’s 2.5 % buffer being a separate stress‑capital requirement rather than a counter‑cyclical component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages are correct: Goldman Sachs (GS) has an 18% minimum TLAC to RWAs, includes a 2.5% buffer, a 1.5% G-SIB surcharge, and a 0% countercyclical capital buffer as set by the Federal Reserve—this matches regulatory disclosures. Schwab (SCHW) has a 2.5% stress capital buffer and a 0% countercyclical buffer as of the reported period (December 31, 2024), which is correctly stated. (2) The LLM correctly notes that both firms are operating under a 0% countercyclical buffer, which is consistent with the original answer. (3) The reasoning is sound: it distinguishes GS’s TLAC-inclusive buffer framework from SCHW’s separate stress capital buffer, correctly identifying that SCHW’s 2.5% is not part of TLAC but a distinct regulatory requirement. (4) The only minor shortcoming is that the LLM introduces a 1.5% G-SIB surcharge for GS not explicitly mentioned in the original answer, which, while likely accurate, is extraneous and not part of the ground truth comparison. This does not detract from correctness but slightly over-specifies GS’s TLAC composition. Overall, the answer captures the core comparison accurately—both firms have a 0% countercyclical buffer, but differ in how they apply other buffers within their capital frameworks—making it semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 387,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "XOM’s exposure in Kazakhstan is a dollar amount – its long‑lived assets in the country total **$7.728 billion** (page 93).  By contrast, Chevron’s involvement in the region is measured by ownership, holding a **50 % interest in Tengizchevroil (TCO)**, the operator of the Tengiz and Korolev fields in Kazakhstan (page 15).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between XOM's asset exposure and CVX's stake in TCO. (1) Quantitatively, the $7.728 billion in long-lived assets for XOM matches the ground truth of $7,728 million (equivalent values, different formatting), and CVX's 50% interest in TCO is factually correct. (2) The entities are correctly identified: XOM (ExxonMobil), CVX (Chevron), TCO (Tengizchevroil), and the relevant operations in Kazakhstan. (3) The reasoning correctly contrasts direct asset ownership (XOM) versus equity stake in a joint venture (CVX via TCO), which is the key multi-hop insight. (4) The answer is contextually relevant and directly addresses the comparison asked. The only minor omission is that the LLM does not mention TCO's Future Growth Project (FGP) mechanical completion in 2023 or the Karachaganak Expansion Project, which are part of CVX’s strategic positioning per the original answer. While these details add depth, their absence does not undermine the core factual correctness of the comparison. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 334,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company notes that, while it has elected to apply ASU 2020‑04 to its debt and hedging arrangements, “the ultimate outcome of the transition cannot be determined at this time” and it is still evaluating the impact on its financial statements (see pages 194‑195). In contrast, NextEra Energy states that it has begun applying the same standard to its LIBOR‑referenced contracts, has not yet observed a material effect, and will continue to evaluate the transition through 2022 (see page 79). Thus, Southern Company expresses uncertainty about the financial impact, whereas NextEra Energy is actively applying the guidance and monitoring its effects, though it also acknowledges that the full impact remains unknown.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Southern Company's (SO) uncertainty about the financial impact of transitioning from LIBOR, citing its statement that 'the ultimate outcome of the transition cannot be determined at this time'—matching the original answer verbatim in substance. It also accurately reflects NextEra Energy's (NEE) position: actively applying ASU 2020-04 to its interest rate contracts and not observing a material effect yet, while continuing evaluation through 2022. (2) There are no numeric values, dates, or financial figures in dispute; the mention of '2022' as the ongoing evaluation period is consistent with typical disclosure timelines and does not contradict the ground truth, which does not specify a year. Page references (194–195 for SO, 79 for NEE) add precision and are acceptable as long as they don’t conflict with facts—here, they enhance credibility without introducing error. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies regarding the same accounting standard (ASU 2020-04) and compares their implementation postures—SO in evaluation mode with uncertainty, NEE in active application mode. The conclusion that both are navigating the same transition but with differing levels of implementation clarity matches the original answer’s intent. (4) The only minor shortcoming is that the LLM slightly softens the contrast by saying NEE 'will continue to evaluate the transition through 2022,' which introduces a forward-looking element not present in the ground truth, whereas the original emphasizes NEE’s 'definitive implementation stance.' However, this does not invalidate the core accuracy. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight nuance differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 514,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "META’s dual‑class structure gives the controlling shareholder (Zuckerberg) the ability to control all matters requiring stockholder approval even when he owns less than a majority of shares, and the certificate of incorporation imposes numerous limits on minority shareholders—restricting board‑vacancy appointments, removal of directors, special‑meeting calls, and written‑consent actions (page 50).  Alphabet’s dual‑class scheme also gives Class B shares 10 votes per share, but its certificate of incorporation contains explicit safeguards: amendments that would adversely affect a class must be approved by that class, and the board must obtain unanimous consent before any such amendment can be put to a vote, ensuring minority shareholders retain veto power over changes that impact them (pages 81‑82).  Thus, while both companies use dual‑class voting, META’s provisions are far more restrictive to minority interests, whereas Alphabet’s charter includes protective mechanisms that require minority shareholder approval for material changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that META's dual-class structure entrenches control with Zuckerberg and limits minority shareholder rights through restrictions on board appointments, director removal, special meetings, and written consents—consistent with the controlled company structure described in the original answer. It also accurately contrasts this with GOOGL's governance framework, noting that amendments affecting a class require approval by that class and unanimous board consent before proposal, which protects minority shareholders. (2) There are no numeric values (e.g., percentages, vote counts) in the LLM answer that conflict with the ground truth; while the original mentions a 'two-thirds majority' threshold for META when Class B voting power drops below 35%, this specific detail is omitted in the LLM response. However, this is a minor omission rather than an error, as the core structural disadvantage to minority shareholders is still clearly conveyed. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance provisions from both META and GOOGL, compares their implications for minority shareholders, and draws a valid conclusion about relative restrictiveness. (4) The answer is contextually precise, directly addressing the comparative governance frameworks and their impact on minority interests. The only reason for not scoring a 10 is the slight incompleteness regarding META’s two-thirds amendment threshold, which adds nuance to anti-takeover protections. Overall, the semantic meaning and factual content are substantially equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 457,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "PepsiCo’s exposure to the OECD’s 15 % global minimum tax could lift its effective tax rate because the company already pays a sizable U.S. tax burden and operates in many jurisdictions where the new rules will apply, potentially raising its overall tax provision (page 25).  \nAltria, by contrast, derives almost all of its revenue from the United States (substantially all net revenues are U.S.‑based, page 82) and has only modest foreign tax exposure (foreign NOLs of $38 million versus $644 million U.S. NOLs, page 81), so the global minimum tax is likely to have a smaller impact on its effective tax rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Altria's foreign NOL of $38 million and U.S. NOL of $644 million are accurately cited (allowing for format variation: $38 million = $38M), and the 15% global minimum tax rate is correctly stated. No incorrect figures are presented. (2) The answer correctly identifies that PepsiCo has significant international operations subject to the OECD rules, which may increase its effective tax rate, consistent with the original answer. It also correctly contrasts Altria’s minimal foreign exposure and U.S.-centric revenue base, leading to limited impact from the global minimum tax. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies’ tax profiles, leveraging their differing international exposures to assess the differential impact of the OECD framework. (4) While the original answer includes a specific dollar figure for Altria’s federal tax payments ($2,346 million), the LLM answer omits this detail but compensates by citing NOL data and revenue localization, which support the same conclusion. This is a minor omission but does not undermine the core correctness. Wording differs but semantic meaning and factual content are equivalent. The LLM cites page numbers (25, 81, 82), suggesting grounding in source documents, enhancing credibility. Overall, the response is factually correct, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 411,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "AbbVie’s orphan‑drug designation gives its orphan‑indicated products an additional seven‑year period of FDA exclusivity (page 6), which delays the entry of generic competitors even after the compound patents expire.  Eli Lilly uses the same mechanism for products such as Onureg, where the seven‑year orphan exclusivity is the basis for its projected market‑exclusivity date (page 9).  Consequently, both companies can rely on orphan‑drug exclusivity to reduce generic competition risk, though the protection ends after the seven‑year window, after which generics may seek approval.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: the seven-year orphan drug exclusivity period is correctly stated, consistent with both the U.S. regulatory framework and the referenced 10-Ks. (2) The answer correctly identifies that both AbbVie and Eli Lilly leverage orphan drug exclusivity to delay generic competition beyond patent expiration, using Eli Lilly’s Onureg as a specific example (though the ground truth does not name specific drugs, this detail is plausible and adds relevance). (3) The multi-hop reasoning is sound—linking AbbVie’s risk of generic competition to the broader regulatory mechanism that Eli Lilly also uses—but the LLM omits a key point from the original answer: the risk to AbbVie is not just the expiration of exclusivity, but also potential weakening due to patent challenges, regulatory changes, or compulsory licensing, as explicitly stated in AbbVie’s 10-K. This omission reduces completeness and depth of risk analysis. (4) The answer is contextually relevant and well-structured, but slightly less comprehensive in conveying the full scope of regulatory and legal vulnerabilities mentioned in the original. Wording differences are acceptable and semantically equivalent in most places. Overall, core facts and logic are correct, but minor gaps in completeness prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 383,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca‑Cola FEMSA operated in Argentina’s federal capital and surrounding areas in 2021 (KO page 7), so KO’s equity‑method investee sales—including the $14.5 billion of sales to equity investees in 2021 (KO page 89)—contained revenue generated from that Argentine footprint, giving KO an indirect exposure to Argentina’s economic conditions. By contrast, PepsiCo’s own operations in Argentina exposed it directly to the country’s economic volatility, a risk explicitly noted in its 2021 risk‑factor discussion (PEP page 40).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, aligning with the ground truth. It accurately states KO's sales to equity method investees as $14.5 billion (matching the ground truth $14,471 million, rounded appropriately). The answer correctly contrasts KO's indirect exposure via equity investee sales with PEP's direct operational exposure in Argentina. (2) Quantitatively, the $14.5 billion figure is a valid rounding of $14,471 million and is correctly attributed to 2021. No calculations are required beyond this, and the number is accurately presented. (3) The multi-hop reasoning is sound: the model connects Coca-Cola FEMSA's operational footprint in Argentina to KO's indirect exposure through equity investee sales, and separately identifies PEP's direct exposure due to its own operations and associated risks noted in its filing. The synthesis across KO and PEP filings is logical and supports the comparative conclusion. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the nature of Argentina's economic volatility (e.g., currency controls and inflationary pressures) in the same detail as the ground truth, though it references 'economic volatility' and cites PEP's risk-factor discussion. This slight omission in contextual depth prevents a perfect 10 on qualitative accuracy, but the core reasoning and facts remain fully intact. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 430,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s acquisition of Cerevel gives it exclusive global rights to emraclidine under Pfizer patents, allowing the company to earn up to $1.6 billion in milestone payments and tiered royalties to sustain that exclusivity (page 68). However, the $4.5 billion intangible‑asset impairment recorded for emraclidine (page 69) signals that the patent‑based protection could erode, making AbbVie’s exclusivity more contingent on maintaining the license and meeting milestones. In contrast, Merck’s Januvia strategy relied on remaining patent claims and a regulatory exclusivity period that keeps the drug protected in the U.S. until May 2026 (Janumet) and July 2026 (Janumet XR) (page 58), yet it already lost exclusivity in the EU and faces generics in China, illustrating that regulatory exclusivity can extend protection but does not fully shield against earlier market entry in other regions (page 83).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unverified information not present in the ground truth. Most notably, it claims AbbVie can earn '$1.6 billion in milestone payments and tiered royalties' — this figure is not mentioned in the original answer and lacks support from the provided context. Additionally, the mention of 'tiered royalties' and 'sustain that exclusivity' misrepresents the nature of the licensing arrangement, which was an exclusive global license under Pfizer patents, not a royalty/milestone-based exclusivity model. The $4.5 billion impairment charge is correctly cited, supporting the idea of failed commercial expectations. However, the comparison with Merck contains a mix-up: the original answer specifies Januvia and Janumet (not Janumet alone) as protected until May 2026, and Janumet XR until July 2026; the LLM incorrectly attributes May 2026 to Janumet only and omits Januvia. It also adds unsupported claims about EU and China generic entry (page 83 reference), which are not in the ground truth and introduce external details that may be plausible but are not part of the verified answer. (2) Quantitative accuracy is partially correct: $4.5 billion impairment is accurate; dates (May 2026, July 2026) are mostly correct but misassigned to wrong drugs. The $1.6 billion milestone figure is entirely fabricated or misattributed and fails verification. (3) Multi-hop reasoning is partially sound — the model attempts to compare AbbVie’s patent licensing strategy with Merck’s IP extension strategy, which aligns with the question. However, it distorts the mechanisms (royalties vs. patent litigation/settlement) and adds unverified geographic exclusivity details, weakening the synthesis. (4) Correctness score is 6 due to correct identification of core events (acquisition, impairment, Merck’s extended exclusivity) but significant factual errors in financial figures and drug-specific timelines. Quantitative accuracy is low (5) due to the invented $1.6B figure and misattribution of dates. Qualitative accuracy is 7 because the reasoning framework is logical and addresses the strategic contrast, albeit with incorrect details. Contextual relevance is high (9) as the response stays focused on the question’s theme of patent reliance and exclusivity strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 620,
        "total_tokens": 2190
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % stake in the Caspian Pipeline Consortium gives it access to a pipeline that can move roughly 1.4 million barrels of crude per day (1.2 m from Kazakhstan and 0.2 m from Russia) and the CPC’s debottlenecking project further boosts that throughput, thereby expanding Chevron’s export capacity【page_16】. In contrast, ConocoPhillips’ upstream business is driven by its own crude‑oil production, as shown by the large production‑costs and exploration‑expenses that dominate its operating expenses and underscore its reliance on upstream output【page_150】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and its relevance to crude oil export capacity, as well as the debottlenecking project. However, it inaccurately states the total pipeline capacity as 1.4 million barrels per day (1.2 million from Kazakhstan and 0.2 million from Russia), while the ground truth specifies only the 1.2 million bpd from Kazakhstan as relevant to Chevron’s exports—there is no mention in the original answer of a 0.2 million bpd contribution from Russia being accessible to Chevron. This introduces a factual overstatement in capacity attribution. Additionally, the original answer links the CPC throughput increase directly to Chevron’s Future Growth Project (FGP) ramp-up in early 2025, which the LLM omits, weakening the forward-looking strategic connection. (2) The quantitative error lies in the breakdown and total volume: the ground truth does not state a 1.4 million bpd capacity figure or split it by country in this context; thus, the 1.2 + 0.2 = 1.4 million bpd calculation is unsupported and misleading. The January 2023 debottlenecking completion date is implied but not explicitly stated in the LLM answer. (3) The qualitative reasoning is sound in contrasting Chevron’s indirect export infrastructure exposure via CPC with ConocoPhillips’ direct reliance on crude production. The use of upstream costs and exploration expenses as evidence for ConocoPhillips’ dependency aligns with the original logic, though the original answer relies more on asset base and revenue composition. (4) Despite the numerical inaccuracy, the core multi-hop comparison—Chevron’s infrastructure-based exposure vs. ConocoPhillips’ production-based model—is preserved, and the answer remains contextually relevant and largely complete. Hence, correctness is reduced primarily due to the incorrect capacity figure and missing FGP linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 511,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle’s MySQL HeatWave is a fully‑managed cloud database that embeds generative‑AI, real‑time analytics and transactions on Oracle Cloud’s global data‑center network (Oracle 10‑K, p. 12‑15). Qualcomm, by contrast, is building generative‑AI directly into its Snapdragon SoCs for smartphones, PCs, automotive and IoT devices, using the cloud mainly for model updates and data sharing while its “cloud computing processing initiative” underpins that edge‑centric strategy (Qualcomm 10‑K, p. 7). Both firms invest heavily in cloud infrastructure, but Oracle’s AI is cloud‑centric, whereas Qualcomm’s vision places generative AI on the device with cloud support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service on OCI, while Qualcomm focuses on on-device AI via Snapdragon SoCs with cloud support for updates and coordination. The LLM correctly identifies Oracle's cloud-centric model versus Qualcomm's edge-first strategy. (2) Quantitative accuracy is perfect—no numerical claims were made in the LLM answer that contradict or misrepresent the ground truth (e.g., the 19% to 46% smartphone projection for 2024–2027 is not mentioned, but the LLM does not fabricate or misstate any numbers). Since the LLM didn't include those stats, it avoids inaccuracy but also doesn't gain full completeness points. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Oracle and Qualcomm's 10-Ks, contrasting their AI deployment strategies (cloud vs. edge) and acknowledging both companies' cloud investments. (4) Semantic equivalence is strong—while the LLM omits the specific percentage projections for generative AI smartphones, it captures the core strategic contrast and technological positioning accurately. The mention of Qualcomm’s 'cloud computing processing initiative' in the QSI segment and Oracle’s OCI infrastructure is consistent with the original. The answer is slightly less complete due to missing forward-looking market expectations (46% by 2027), but this does not detract from the overall correctness of the comparison. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 452,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart’s firm commitments for inventory and utility purchases (disclosed on page 120) are legally binding contracts that lock in quantities and prices, giving the company predictable cash‑outflows and reducing uncertainty in operating costs. In contrast, Colgate‑Palmolive’s option contracts (described on page 90) are financial derivatives used to hedge foreign‑currency exposure on purchases, assets, liabilities and foreign‑subsidiary investments, allowing the firm to lock in favorable rates and limit cash‑flow volatility from currency swings. While Walmart’s commitments focus on operational cost certainty, Colgate‑Palmolive’s options provide flexibility to mitigate currency risk, both mechanisms serving to stabilize cash flows but through different means.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core distinction between Walmart's use of firm commitments and Colgate-Palmolive's use of option contracts in managing financial exposure. It accurately states that Walmart’s firm commitments lock in prices and quantities for inventory and utilities, leading to predictable cash outflows, while Colgate uses option contracts to hedge foreign exchange risk. The absence of specific dollar amounts ($15.9 billion) in the LLM answer is a minor omission but does not distort the factual comparison. (2) Quantitative accuracy is high—while the LLM does not include the $15.9 billion figure from the ground truth, it does not introduce any incorrect numbers, and no calculations are required. The omission is contextual rather than erroneous. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies and two types of financial instruments (firm commitments vs. options), linking them to cash flow risk mitigation. It correctly identifies that Walmart relies on operational certainty through binding contracts, while Colgate uses financial derivatives for flexibility in currency risk management. (4) The answer is semantically equivalent to the ground truth in intent and substance, with only a slight reduction in completeness due to the missing dollar amount. All entities (Walmart, Colgate-Palmolive, firm commitments, option contracts), their uses, and business rationales are accurately represented. Contextual relevance is perfect—the response directly addresses the comparison asked in the question and explains how each firm manages cash flow risks differently.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 453,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley uses credit‑default swaps (CDS) as a direct hedge against the risk of default on reference entities, with the firm’s CDS portfolio sized by the credit and correlation risk it manages across single‑name, index and basket contracts (see MS 10‑K, p. 111).  Capital One, by contrast, values its Level 3 net derivative assets through discounted‑cash‑flow models that rely on default‑rate assumptions (53–163 % range, weighted average ≈ 4 %) as a key unobservable input (see COF 10‑K, p. 208).  Because both institutions’ exposures are driven by credit‑event probabilities, a default triggers a payoff or loss on Morgan Stanley’s CDS and simultaneously shifts Capital One’s valuation of its derivative assets, making each highly sensitive to credit‑event outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Morgan Stanley uses CDS to hedge default risk, and Capital One relies on default rate assumptions (4% weighted average, 53–163% range) in valuing Level 3 net derivative assets. These numbers match the original answer exactly, with only a minor formatting difference (53–163% vs 53–163%) that does not affect meaning. (2) Quantitative accuracy is perfect: the 4% weighted average and 53–163% range are correctly cited, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—both firms are linked through sensitivity to credit events, with Morgan Stanley’s CDS positions directly impacted by defaults and Capital One’s valuations indirectly affected via model assumptions. The synthesis across institutions and mechanisms is logically coherent. (4) The only minor shortcoming is a slight lack of detail on Morgan Stanley’s risk management practices (e.g., monitoring aggregate market risk limits), which are mentioned in the original but not the LLM answer. However, this does not detract from the core insight. Wording differs but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the relationship between the two institutions’ credit risk exposures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 369,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s Georgia distribution network is part of its 35,700‑mile pipeline system and 28,800‑mile service‑line system (page 39), indicating a larger overall capital base than Southern Company Gas’s 50 % stake in the 7,000‑mile Southern Natural Gas (SNG) pipeline that directly supplies Georgia (pages 13, 301). While Duke Energy’s assets provide local distribution reliability within the state, Southern Company Gas’s SNG investment delivers a critical interstate supply corridor that enhances Georgia’s supply diversity and resilience, reflecting each company’s exposure to the state’s energy market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. The ground truth states Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia. However, the LLM claims Duke has a 35,700-mile pipeline system and a 28,800-mile service-line system, citing page 39, which does not align with the verified data. These figures appear to be misinterpreted or taken out of context—possibly representing system-wide totals across multiple states rather than Georgia-specific assets. This overstatement significantly affects the capital scale comparison. (2) The LLM correctly identifies Southern Company Gas’s 50% stake in the 7,000-mile SNG pipeline, which is accurate and consistent with the original answer. However, it fails to mention that SNG connects Gulf Coast supply basins to markets including Georgia and feeds regional utilities like Duke, a key point in the multi-hop reasoning about infrastructure integration. (3) The qualitative reasoning is partially sound: the distinction between Duke’s local distribution role and SNG’s supply-corridor function is correctly framed in terms of reliability contributions. However, the LLM omits critical synthesis points—specifically, that SNG supports Duke and other utilities, creating an interdependent network. It also fails to reference Southern Power’s 97% investment coverage ratio through 2028, a key indicator of revenue stability tied to SNG-related assets, weakening the financial resilience comparison. (4) Contextual relevance is high—the answer addresses capital scale and reliability contributions in Georgia’s energy market. While the reasoning framework is logical and the entities (Duke Energy, Southern Company Gas, SNG) are correctly identified, the numerical inaccuracies and missing financial metric reduce factual correctness. The answer suggests a stronger capital position for Duke without substantiating Georgia-specific figures, leading to a misleading comparison. Thus, the correctness score is 6 due to partial factual accuracy and incomplete multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 564,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "Union Pacific noted that the 2024 Louisiana corporate‑tax‑rate‑reduction law cut its deferred‑tax expense by **$34 million**.  The same amount was attributed to Arkansas’s comparable legislation, so the two states together produced a $34 million reduction—meaning Louisiana and Arkansas had essentially equal, combined impact on deferred tax expense.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $34 million reduction in deferred tax expense due to Louisiana's 2024 tax rate reduction, which matches the ground truth. It also correctly states that Arkansas had a comparable impact of $34 million. However, it incorrectly implies that the combined impact of Louisiana and Arkansas was $34 million total (i.e., $34M together), when in fact each state contributed a $34 million reduction, meaning the total impact should be $68 million if summed. The ground truth states that Louisiana's impact was $34M and that Arkansas had a 'comparable adjustment,' which means a similar-sized reduction, not that they jointly caused a $34M reduction. (2) Quantitatively, the individual figures ($34M for Louisiana, $34M for Arkansas) are accurate, but the synthesis implies an incorrect total due to ambiguous phrasing: 'the two states together produced a $34 million reduction' is factually wrong. This is a critical error in interpretation. (3) The multi-hop reasoning is partially flawed: while the model identifies both legislative impacts correctly, it fails to properly synthesize that they are separate, additive effects. Instead, it merges them into a single $34M effect, undermining the logical comparison. (4) Contextual relevance is perfect—the answer addresses both parts of the question (Louisiana and Arkansas impacts) and stays focused on Union Pacific's deferred tax expense. Due to the significant error in combining the two states' impacts, the correctness score is reduced to 7, as the core numbers are right but the overall conclusion is misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 440,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Meta’s Class B common shares carry 10 votes per share, giving holders a concentrated voting power that can dominate board and corporate decisions, whereas Google’s Class A shares are limited to one vote per share, reflecting a more dispersed governance structure (GOOGL page 82). In merger or consolidation scenarios, Visa’s Class B shares illustrate how a high‑vote class can still face voting restrictions—Class B holders may only vote on specific matters such as mergers, limiting their ability to block or approve such transactions (Visa page 90). These differences mean Meta’s governance is highly centralized and can decisively shape corporate actions, while Google’s governance is more distributed, and the merger‑specific limitations on high‑vote shares demonstrate how corporate governance can be constrained even for powerful classes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents key aspects of the corporate structures of both META and GOOGL. (1) It incorrectly states that Meta’s Class B shares carry 10 votes per share; in reality, Meta’s Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This is the opposite of what the LLM claims. (2) The answer incorrectly references Visa’s Class B shares (a completely different company not mentioned in the question or ground truth), introducing irrelevant and misleading information. There is no justification for bringing in Visa in this comparison between META and GOOGL. (3) The claim that Meta’s Class B shares have 10 votes per share is factually wrong—this confuses Meta with companies like Google (which actually has Class B shares with 10 votes, but they are non-public). GOOGL’s Class A shares do correctly have one vote per share, which the LLM gets right, but it fails to contrast this with the correct structure at Meta. (4) The multi-hop reasoning is fundamentally flawed: instead of contrasting Meta’s limited voting rights for Class B shares in mergers with GOOGL’s consistent one-vote-per-share structure, the model fabricates a scenario involving Visa and misattributes structural features. (5) The conclusion about Meta having centralized control is partially valid, but it is based on incorrect premises. The answer fails to accurately describe the conditional activation of voting rights in merger scenarios for Meta’s Class B shares, which is a key point in the ground truth. Overall, the answer is mostly incorrect due to major factual inaccuracies, introduction of irrelevant entities, and flawed reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 490,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. payer restrictions that shift costs to patients and demand higher rebates—illustrated by Repatha’s step‑therapy, prior‑authorization and copay‑accumulator rules (page 41)—raise the magnitude and uncertainty of gross‑to‑net deductions.  Under GAAP, Pfizer would estimate and record those deductions at the time of sale and recognize revenue only net of the estimates when a significant reversal is not probable (policy described by Gilead on page 48), which can delay or lower reported revenue for cardiovascular products facing similar formulary and affordability constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the impact of U.S. payer restrictions—such as step-therapy, prior authorization, and copay accumulators—on revenue recognition, citing specific mechanisms that increase gross-to-net deductions. These dynamics are accurately tied to Repatha (as in the original) and extended to Pfizer's potential cardiovascular products. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised; all references to page numbers (e.g., page 41, 48) are consistent with source-based reasoning and do not involve calculations. (3) The multi-hop reasoning is sound: it connects payer restrictions (observed with Repatha) → impact on gross-to-net deductions → application of GAAP revenue recognition rules → implications for Pfizer’s revenue strategy. It appropriately references Gilead’s policy as an illustrative example of how companies account for these dynamics, which supports the inference about Pfizer’s likely approach. (4) The answer is semantically equivalent to the original, though slightly more focused on accounting mechanics (GAAP, timing of estimates) than on broader strategic considerations like 'revenue integrity' or 'patient affordability trends.' This is a minor omission in emphasis, not a factual error. The LLM correctly infers that similar market access challenges would lead to similar revenue recognition complexities. No incorrect entities or facts are introduced. The contextual relevance is excellent, directly addressing the core question about how payer dynamics affect revenue recognition strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 448,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 % interest in the Caspian Pipeline Consortium (CPC) gives it a proportional share of the pipeline throughput that will rise when TCO’s Future Growth Project (FGP) ramps up to full production in 2025 – the CPC transports about 1.4 million barrels per day (≈1.2 million from Kazakhstan) 【page_16】. This exposure is limited to the pipeline’s capacity and represents only a small fraction of Chevron’s overall portfolio, whereas ConocoPhillips’ upstream business is broadly dependent on crude oil as a primary product and raw material, making its exposure to crude‑oil supply and demand much more pervasive across its operations 【page_16】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and links it to increased throughput from TCO's FGP project ramp-up in 2025, which aligns with the ground truth. It also accurately contrasts Chevron’s limited, indirect exposure with COP’s broader dependence on crude oil. However, it omits Chevron’s 15% ownership in TCO itself — a key multi-hop element in the original answer — focusing only on the CPC pipeline stake. This weakens the explanation of how Chevron benefits from production growth at the source. (2) Quantitatively, the LLM introduces new data not in the ground truth: '1.4 million barrels per day' and '1.2 million from Kazakhstan'. While these may be factually accurate, they are not present in the original answer and introduce unsupported precision. The date 'first half of 2025' and 'ramp up within three months' from the ground truth are partially captured as 'ramps up to full production in 2025', which is acceptable but less specific. (3) The reasoning is partially sound but incomplete: it connects Chevron’s CPC interest to higher throughput but fails to synthesize the dual-layer exposure (TCO ownership + CPC stake) that the original answer emphasizes. The comparison to COP is well-handled, correctly noting COP’s direct and pervasive reliance on crude oil. (4) The contextual relevance is high because the answer addresses the core contrast in exposure types. However, the omission of Chevron’s equity stake in TCO — the first hop in the chain — reduces qualitative and overall correctness, as it misrepresents the nature of Chevron’s exposure as purely pipeline-based rather than also production-based. Hence, scores reflect a mostly accurate but incomplete multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 474,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs’ hotel exposure is limited to roughly $1.7 billion—about 5 % of its $34.8 billion commercial‑real‑estate loan and commitment portfolio【page_118】—and is part of a broader loan‑based strategy.  \nMetLife, by contrast, holds $3.65 billion in real‑estate funds that invest across a wide mix of property types; hotels account for about 5.3 % (≈$700 million) of its real‑estate holdings【page_94】.  Thus, while GS’s hotel exposure is a small slice of its loan book, MetLife’s real‑estate funds are a core, diversified investment vehicle that includes a modest hotel allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MetLife holds $13.3 billion in real estate investments including hotel-focused funds, but the LLM incorrectly reports MetLife's total real estate funds as $3.65 billion and claims hotels account for $700 million (5.3%) of holdings—none of which aligns with the original answer. Similarly, the LLM asserts Goldman Sachs has $1.7 billion in hotel-related loans (5% of a $34.8 billion portfolio), but this specific breakdown is not present in the ground truth, which only states Goldman has 'significant credit exposure' without quantifying it. These numbers appear fabricated or misattributed. (2) Calculations are internally consistent in the LLM answer (e.g., 5.3% of $13.3B ≈ $700M would be accurate if that were the basis, but the LLM uses $3.65B instead), but the foundational data is incorrect. The original answer does not provide percentages or exact allocations, so deriving 5.3% and $700M is unsupported. (3) The multi-hop reasoning is partially sound—LLM correctly distinguishes between Goldman’s lending exposure and MetLife’s investment via funds—but fails to base this analysis on accurate data. The strategic contrast is relevant but undermined by incorrect figures. (4) The contextual relevance is moderate because the structure and intent of the comparison match the question, but the severe quantitative errors and lack of fidelity to the source material drastically reduce correctness. The LLM invents precise numbers absent from the ground truth and misrepresents the scale and composition of both firms’ exposures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 447,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "Boeing’s pension plan holds limited‑partnership interests in private‑equity, private‑debt and real‑estate funds that normally carry 10‑15‑year terms, giving the plan a long‑term illiquid exposure (see BA_10k_2023 page 92). UPS’s pension plan invests in similar real‑estate LPs with the same 10‑15‑year horizon, but it also has roughly $3.3 billion of unfunded commitments to those LPs that must be funded over the next 3‑6 years, adding a higher liquidity risk than Boeing’s fully funded LP positions (UPS_10k_2023 page 89).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing (BA) has limited partnership investments with 10–15 year terms (cited from BA_10k_2023 p.92), and UPS has $3.3 billion in unfunded commitments to real estate LPs with similar 10–15 year horizons (cited from UPS_10k_2023 p.89). The dollar amount, timeframes, and structural illiquidity are correctly reported. (2) Quantitative accuracy is perfect: $3.3 billion is correctly stated, and the 10–15 year partnership terms are consistent with the original answer. (3) The multi-hop reasoning is sound—comparing BA’s fully funded, long-term LP investments with UPS’s unfunded commitments shows an understanding of differing liquidity risk profiles. The LLM correctly infers that UPS faces higher near-term liquidity risk due to the obligation to fund $3.3 billion over 3–6 years, while BA’s positions are fully funded, which adds nuance not explicitly in the ground truth but logically valid and supported by the filings. (4) The only minor shortcoming is that the original answer emphasizes the shared structural illiquidity more symmetrically, while the LLM focuses more on the contrast. However, this does not reduce factual accuracy—rather, it adds analytical depth. Wording differs but semantic meaning and factual content are equivalent. No factual errors; minor deduction from 10 to 9 due to slightly less emphasis on the commonality of risk structure, though the contrast is valid and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 414,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "CMCSA’s dual‑class structure splits voting power roughly 66 %/34 % between Class A and Class B shares, with the sole Class B shareholder holding about one‑third of the votes (each Class B share carries 15 votes). In contrast, META’s dual‑class structure gives Mr Zuckerberg control over matters requiring stockholder approval even though Class B shares represent less than 35 % of voting power, concentrating control more heavily relative to his share ownership.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between META and CMCSA's dual-class voting structures. (1) Quantitatively, it correctly states that CMCSA's Class B shares have 15 votes per share and implies the 66 2/3% voting power for Class A (stated as roughly 66%), which aligns with the ground truth. It accurately notes that META's Class B shares control key decisions even when below 35% of voting power. The only minor imprecision is the lack of explicit mention that Class B at CMCSA is owned entirely by Brian L. Roberts and is non-dilutable, which adds context to control concentration. (2) The numbers are accurate: 'less than 35%' for META and '15 votes per Class B share' at CMCSA are correctly cited. The 66%/34% split at CMCSA is a valid approximation of 66 2/3% vs. 33 1/3%. (3) Reasoning is sound—LLM correctly infers that META concentrates control more heavily relative to ownership, especially compared to CMCSA where Class A shareholders collectively hold significant voting power. However, it omits the specific anti-takeover provision at META requiring majority Class B approval for change-of-control transactions, a key governance difference. (4) Despite these omissions, the answer conveys the essential contrast in control concentration and shareholder influence. Wording differs but meaning is semantically equivalent on core points. Contextual relevance is perfect—directly addresses the comparison asked. Minor completeness gaps prevent a 9–10 on correctness, but overall highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 420,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PEP’s U.S. qualified defined‑benefit plan allocates roughly 15 % of its $11.7 billion in plan assets to U.S. government securities (page 99) as part of a diversified portfolio that targets a 7.4 % long‑term return and uses derivatives to hedge interest‑rate and currency risk (page 98). In contrast, Costco’s short‑term holdings are almost entirely in U.S. government and agency securities with maturities of 3 months to 5 years, a policy designed to preserve principal and generate modest yields, with a 100‑basis‑point interest‑rate shift having an immaterial impact on fair value (page 31). Thus, PEP pursues a higher‑return, actively managed strategy with broader diversification and hedging, while Costco opts for a conservative, low‑risk, liquidity‑focused approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and aligns well with the ground truth. It accurately captures PEP's allocation to government securities as part of a diversified strategy targeting a 7.4% long-term return, and correctly contrasts this with COST's conservative, short-term focus on capital preservation. The only minor deviation is that the LLM estimates PEP's allocation as 'roughly 15%' of $11.7 billion (~$1.755 billion), while the ground truth specifies $1.812 billion—this is a small discrepancy (about 3% difference) likely due to rounding or source interpretation, but not material. (2) All other numbers are consistent: 7.4% return target, use of derivatives for hedging (interest rate and currency), short-duration instruments with maturities from 3 months to 5 years for COST, and the 100-basis-point rate shift having immaterial impact—all match or are semantically equivalent to the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PEP’s defined benefit plan strategy and COST’s short-term investment policy, comparing risk management (hedging vs. duration control) and return objectives (growth vs. preservation). (4) The answer is highly relevant, directly addressing the comparative aspects of risk and return strategy. The slight imprecision in the dollar amount prevents a perfect 10, but core facts, entities, years (2023 implied), and logic are correct. Thus, scores reflect high accuracy with minor quantitative leeway.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 414,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s fixed‑income portfolio contains $9 million in mortgage‑ and asset‑backed securities, which is only about 0.06 % of its $15.4 billion fixed‑income holdings. In contrast, NextEra Energy’s pension plan targets 32 % of total assets for fixed‑income investments—a much larger allocation that would include mortgage‑backed securities as part of that 32 %.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states Southern Company's $9 million allocation to mortgage- and asset-backed securities, it incorrectly reports the total fixed income portfolio as $15.4 billion, whereas the ground truth specifies $6,154 million ($6.154 billion). This leads to an incorrect percentage calculation: the LLM reports ~0.06%, but the correct figure is approximately 0.146% (9/6154), which the original answer correctly rounds to 'less than 0.15%'. The LLM's calculation of 9/15400 ≈ 0.058% is mathematically correct but based on a wrong total, undermining factual accuracy. (2) The mention of 'mortgage- and asset-backed securities' introduces a broader category than the original answer's specific 'mortgage-backed securities', which may conflate distinct asset classes. (3) On qualitative accuracy, the LLM correctly identifies that NextEra Energy targets 32% allocation to fixed income within its pension plan and that mortgage-backed securities are included under fixed income—this aligns with the ground truth. The comparison in intent (actual vs. target allocation) is logically framed. (4) Contextual relevance is high: the answer addresses the core comparison between Southern Company’s actual allocation and NextEra’s target framework, correctly identifying both companies and the relevant financial context. However, the major error in the total portfolio size and resulting percentage significantly undermines the correctness score, as this is a key quantitative comparison. Despite correct directional reasoning, the factual inaccuracy in a core number limits the score to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 455,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla’s 10‑K lists a series of formal agreements that tie its Gigafactory to Panasonic: a 2011 supply agreement (and a 2013 amendment), a production‑pricing agreement, an investment‑letter agreement, a set of general terms and conditions, and specific cell‑pricing agreements for 2019 (Japan cells), 2020 (Gigafactory 2170 cells) and 2021 (Japan cells).  It also includes lease and lease‑amendment agreements for the Gigafactory premises.  In contrast, the GM 10‑K pages provided do not disclose any battery‑supplier agreements or contractual depth, indicating that GM’s battery sourcing is less formally integrated or documented than Tesla’s partnership with Panasonic.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies in dates and agreement details. It correctly identifies the existence of multiple pricing and supply agreements between Tesla and Panasonic, including the 2020 and 2021 pricing agreements for Gigafactory 2170 and Japan cells, which matches the original answer. However, it incorrectly references a '2011 supply agreement' and '2013 amendment' that are not mentioned in the ground truth, and includes a '2019 pricing agreement (Japan cells)' not present in the original. The ground truth specifies the 'Amended and Restated General Terms and Conditions' as of June 10, 2020, which the LLM mentions only generally. The lease agreements are correctly noted. On the GM side, the LLM accurately observes no disclosed battery-supplier agreements in the provided 10-K, correctly concluding less formal integration compared to Tesla. This reflects sound multi-hop reasoning across Tesla and GM filings. While the core factual conclusion about comparative supplier integration is correct and semantically equivalent, the inclusion of unverified earlier agreements (2011, 2013, 2019) reduces quantitative and qualitative accuracy slightly. Wording differences are acceptable under semantic equivalence, and the overall context and intent of the answer are fully relevant and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 381,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s exposure in Nigeria is tax‑related: the company has unresolved tax positions with audits that have not been finalized since 2007, and its $5.3 billion of unrecognized tax benefits could be adjusted once the audits conclude (see page 82). In contrast, Exxon’s risk in Nigeria is contractual, stemming from the 30‑year production‑sharing contracts that include a 10‑year exploration phase, a 20‑year production period, partial relinquishment at the end of exploration, and possible extensions under the Petroleum Industry Act (see page 31). Thus, Chevron faces uncertain tax‑liability adjustments, while Exxon faces defined but still‑subject‑to‑regulatory and operational risks under its PSC terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $5.3 billion figure matches the original $5,288 million (rounded appropriately), and the 30-year PSC structure with 10-year exploration and 20-year production periods is correctly stated. The reference to the Petroleum Industry Act aligns with the context of possible extensions under relinquishment provisions. (2) The LLM correctly identifies Chevron's tax exposure and Exxon's contractual risk under PSCs, accurately distinguishing between tax liability uncertainty and operational/contractual risk. (3) Multi-hop reasoning is sound: it synthesizes Chevron’s unresolved tax audits (with specific dollar exposure and audit lag) and Exxon’s PSC terms, correctly contrasting the nature of risks. (4) Minor omission: the original mentions that 12% of Exxon’s proved reserves are under PSCs and that production volumes fluctuate inversely with prices—this detail is missing in the LLM answer, slightly reducing completeness. However, the core contrast in risk types is preserved. Wording differs but meaning is semantically equivalent. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 328,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla reported $470 million of commercial paper at year‑end 2023, held as a short‑term investment in its cash and short‑term assets. In contrast, Duke Energy Ohio disclosed only $25 million of commercial paper, classified as a short‑term debt obligation (short‑term obligations classified as long‑term debt). Thus Tesla’s commercial‑paper exposure is roughly 19 times larger and is an asset rather than a liability for Duke Energy Ohio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Tesla's $470 million in commercial paper as of year-end 2023 is accurately reported, and Duke Energy Ohio's $25 million is also correct. The numbers match the original answer exactly, and formatting variations (e.g., $470 million) are acceptable. (2) The calculation comparing Tesla’s amount to Duke Energy Ohio’s (470 / 25 = 18.8, rounded to 'roughly 19 times larger') is reasonable and correctly interpreted. (3) The qualitative distinction between Tesla holding commercial paper as a short-term investment (an asset) versus Duke Energy Ohio having it as a debt obligation (a liability) is correctly identified and adds valuable insight, even going slightly beyond the original answer. (4) The only minor shortcoming is that the LLM refers to Duke Energy Ohio’s classification as 'short-term obligations classified as long-term debt,' which may be technically precise but could confuse the reader; the original answer more clearly frames it as 'outstanding' commercial paper. However, this does not undermine the factual correctness. Multi-hop reasoning is sound—information is correctly synthesized across two companies and their differing financial treatments. The answer is fully relevant and addresses the comparative aspect of the question. Thus, the answer earns a 9/10 for correctness due to excellent quantitative accuracy and strong qualitative reasoning, with only slight room for clarity improvement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 415,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan’s climate‑risk framework (page 148) identifies transition‑risk drivers—policy shifts, new technologies and changing consumer preferences—that could trigger heightened regulatory scrutiny and, consequently, greater compliance obligations, a risk the firm mitigates through a dedicated climate‑risk committee and its integrated ERM. In contrast, Morgan Stanley explicitly notes on page 61 that transition risk can expose it to reputational, compliance and litigation risk from increased legal and regulatory scrutiny tied to climate‑related disclosures, indicating a more direct regulatory impact on its compliance risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan's recognition of transition risk (policy, technology, consumer preferences) leading to regulatory scrutiny and compliance risk is accurately described, as is its mitigation via a dedicated climate-risk committee and integration into enterprise risk management (ERM). Morgan Stanley’s disclosure that transition risk leads to reputational, compliance, and litigation risks due to regulatory scrutiny is correctly cited, including the specific mention of page 61. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms, linking their respective approaches to transition risk and compliance risk. It contrasts JPMorgan’s proactive, framework-driven approach with Morgan Stanley’s emphasis on regulatory enforcement and disclosure-related risks, which matches the original answer’s comparative analysis. (4) The only minor shortcoming is that the LLM answer does not explicitly mention JPMorgan’s Climate Risk Management function by name or its use of stress testing and metrics, which are included in the ground truth. However, the reference to an 'integrated ERM' and a 'dedicated climate-risk committee' captures the essence. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 425,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s PSCs are 30‑year contracts that combine a 10‑year exploration phase with a 20‑year production phase, require partial relinquishment at the end of exploration, and are governed by the Petroleum Industry Act (page 31). For ConocoPhillips, this means its deep‑water projects must be scheduled and financed within that 30‑year window and must manage relinquishment obligations, affecting capital planning and risk management. For Chevron, the 30‑year PSC framework requires that reserves in Nigeria be reported as PSC‑related reserves (7‑11 % of total reserves, page 106), with estimates based on the 10‑year exploration and 20‑year production terms and adjusted for relinquishment and potential extensions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Nigeria's 30-year PSCs with a 10-year exploration and 20-year production phase, partial relinquishment requirements under the Petroleum Industry Act, and the impact on both ConocoPhillips and Chevron are accurately described. (2) Quantitative accuracy is excellent: the LLM correctly states that 7–11% of Chevron’s reserves are PSC-related, which aligns with the ground truth range of 8–10% (the slight variation is within reasonable rounding/reporting differences and is semantically equivalent). The structural timeline (10 + 20 years) is correct. (3) Multi-hop reasoning is sound: the model correctly links Nigeria’s regulatory framework to ConocoPhillips’ operational planning and to Chevron’s reserve accounting practices, demonstrating synthesis across entities and regulatory context. (4) The only minor shortcoming is that the LLM does not explicitly mention the possibility of contract extension under certain conditions, which is included in the original answer. However, it does note 'potential extensions,' which captures the idea. The reference to 'page 31' and 'page 106' suggests source anchoring, which adds credibility. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a small deduction for slight incompleteness in describing contract extension terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 396,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing’s 2023 10‑K notes that U.S. government contracts are “frequently modified, curtailed or terminated” (page 14), meaning that any change to a government‑contract that involves a reference‑rate adjustment would fall under ASU 2022‑06; the company, however, reports no material impact or explicit application of the standard in its 2023 filing.  FedEx, in contrast, has applied ASU 2022‑06 to contract modifications that replace LIBOR, stating that the guidance has “reduced the operational and financial impacts of contract modifications” and has not materially affected its consolidated financial statements (pages 93 and 167).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, there are no numeric inaccuracies. While the original answer mentions that 37% of Boeing's revenues are under government contracts, the LLM answer does not include this specific percentage, which is a minor omission. However, no incorrect numbers are presented, so quantitative accuracy is high. (2) The LLM correctly identifies that Boeing faces frequent government contract modifications and that such modifications involving reference rate adjustments would fall under ASU 2022-06, but notes no material impact—consistent with the ground truth. It also accurately states that FedEx applied ASU 2022-06 to LIBOR-related contract changes and experienced no material effect, citing specific pages from the 10-K. (3) The multi-hop reasoning is sound: the model correctly contrasts Boeing’s exposure to government contracts with FedEx’s different context (no government contract risk), while showing both companies’ application (or lack of material impact) from ASU 2022-06. (4) The only shortcoming is the missing 37% revenue exposure figure for Boeing, which reduces completeness slightly. Additionally, the LLM references the 2023 10-K, while the ground truth specifies data as of May 31, 2024—this is a minor temporal misalignment but not a critical error, as ASU 2022-06’s extension through 2024 is still contextually valid. Overall, the answer is factually accurate, well-reasoned, and contextually appropriate, warranting a high correctness score with a small deduction for missing detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 433,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil’s offshore acreage in Angola totals 2.9 million net acres (of a 3.0‑million‑acre portfolio).  Chevron owns a 36.4 % stake in Angola LNG, and that affiliate produced a $166 million loss in its upstream earnings for 2021.  Thus, while ExxonMobil controls a sizable acreage base, Chevron’s share of Angola LNG resulted in a negative earnings contribution that year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative domain. While it correctly states ExxonMobil's 2.9 million net offshore acres in Angola (matching the ground truth), it introduces a figure not present in the original answer—Chevron's 36.4% stake in Angola LNG—which is unsupported by the provided ground truth. More critically, the LLM claims Chevron's Angola LNG affiliate reported a '$166 million loss' in upstream earnings for 2021, which directly contradicts the original answer stating that Angola LNG contributed to 'upstream-related earnings improvements' due to higher performance. This is a major factual error that inverts the financial outcome. The ground truth does not provide any specific dollar amount or percentage stake for Chevron in Angola LNG, nor does it report a loss. The qualitative reasoning attempts multi-hop synthesis by comparing acreage to earnings impact, but the flawed data undermines the logic. The contextual relevance is fair because the answer addresses both ExxonMobil's acreage and Chevron's earnings link to Angola LNG, but the incorrect characterization of earnings as negative severely distorts the conclusion. Minor formatting like '2.9 million' vs '2.9 million' is acceptable, but incorrect numbers and stakes cannot be overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 365,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture’s $6.6 billion spent on 46 acquisitions to scale industry solutions is slightly lower than Microsoft’s revenue from its Enterprise and Partner Services segment in fiscal 2024, which totaled $7.594 billion (including industry solutions).  In other words, Accenture’s investment is roughly $1 billion less – about 87 % of Microsoft’s revenue from that segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Accenture's $6.6 billion investment in 46 acquisitions and Microsoft's $7.594 billion in 'Enterprise and Partner Services' revenue (which includes industry solutions) in fiscal 2024 are accurately reported. (2) The quantitative comparison is precise: $6.6B is indeed approximately 87% of $7.594B, and the difference is correctly characterized as roughly $1 billion less. Calculations and number formats are accurate and appropriately presented. (3) The multi-hop reasoning—comparing Accenture’s investment in industry solutions via acquisitions to Microsoft’s revenue from a segment that includes industry solutions—is sound and correctly synthesizes data across two companies and strategies. (4) While the LLM omits the broader strategic interpretation present in the original answer (e.g., differing growth strategies), it still provides a clear, factually correct, and contextually relevant comparison. The omission of the interpretive layer slightly reduces qualitative depth but does not affect factual correctness. Hence, a score of 9 is warranted—excellent accuracy with minor room for richer contextual synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 342,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy Ohio’s FERC‑approved dividend policy requires that its equity—after removing the effects of push‑down accounting—remain at or above 30 % of total capital (page 147).  Southern Company’s SNG pipeline, which will cost $3 billion and obligates the company to a 50 % cost share that also needs FERC approval (pages 90‑92), will need to adopt a comparable capital‑structure discipline: it must monitor its equity ratio, adjust for any accounting changes, and structure financing or dividend plans so that the equity level stays above the threshold that FERC will require for the joint‑venture.  By mirroring Duke Energy’s approach—regular equity‑ratio monitoring, push‑down accounting adjustments, and pre‑approval of dividend or cost‑share arrangements—Southern Company can better secure FERC approval and safeguard its financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: Duke Energy Ohio's 30% equity threshold under FERC-approved policies, the $3 billion cost of the SNG pipeline, Southern Company's 50% cost share, and the need for FERC approval. These match the ground truth exactly. (2) Quantitative accuracy is perfect: percentages (30%, 50%), dollar amount ($3 billion), and references to specific pages (147, 90–92) are accurate and consistent with the source. No calculations are required, but the financial parameters are correctly stated. (3) The multi-hop reasoning is sound—linking Duke Energy’s regulatory experience with equity thresholds to Southern Company’s planning for a similarly structured FERC-regulated project demonstrates valid cross-entity synthesis. The LLM infers that Southern Company should adopt similar capital-structure discipline, which is a logical extension of the ground truth. It adds value by specifying actionable steps (monitoring equity ratios, adjusting for accounting changes, pre-approving arrangements), which are reasonable extrapolations, though slightly more prescriptive than the original answer. (4) The only minor deviation is that the LLM implies Southern Company 'must' adopt comparable discipline, while the original answer frames it as 'may reference'—a slight difference in certainty level. However, this does not undermine factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 449,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS discloses that corporate bonds are valued using matrix pricing as a Level 2 fair‑value input when broker quotes are not available【page_89】. In contrast, 3M’s valuation methodology for corporate debt instruments relies on either the yields on comparable securities of issuers with similar credit ratings or a discounted‑cash‑flow model that uses observable inputs, rather than explicitly citing matrix pricing【page_101】. Thus, UPS treats matrix pricing as a distinct Level 2 input, while 3M uses a comparable‑yield/DCF approach that is conceptually similar but not labeled as matrix pricing.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding MMM's (3M's) use of matrix pricing. The original answer (ground truth) states that MMM *does* use matrix pricing when broker quotes are unavailable, applying it via yields from comparable securities or discounted cash flow models. However, the LLM answer incorrectly claims that 3M does *not* explicitly cite matrix pricing and instead uses a 'comparable-yield/DCF approach' as a distinct method. This misrepresents the relationship: matrix pricing *is* the technique that often relies on comparable yields or DCF models using observable inputs, and both the ground truth and standard accounting practice confirm that MMM does use matrix pricing. The LLM answer creates a false distinction between matrix pricing and the methods MMM uses, when in fact those methods are components of matrix pricing. Entity accuracy is correct (UPS and MMM/3M, Level 2 inputs), and the citation of fair value hierarchy levels and fallback use when broker quotes are unavailable is accurate. There are no numerical values to verify, so quantitative accuracy is not applicable but assumed correct. The reasoning fails on the multi-hop synthesis: it should have recognized that both companies use matrix pricing under Level 2, with MMM incorporating additional risk adjustments not mentioned by UPS. Instead, the LLM incorrectly frames MMM’s methodology as an alternative to matrix pricing. This undermines the qualitative accuracy despite relevant context and proper sourcing references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 426,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "Verizon’s 2024 deal with Vertical Bridge involved a $2.8 billion upfront payment that was split into $2.0 billion of prepaid rent and an $830 million financing obligation for the portion of towers Verizon still occupies, and Verizon continues to own and operate those towers while leasing back capacity. In contrast, AT&T’s 2013 sale‑leaseback with Crown Castle produced $4.827 billion of cash that was recorded solely as a financing obligation; AT&T did not transfer control of the towers, Crown Castle had exclusive rights to lease and operate them, and AT&T sub‑leased capacity. Thus, Verizon’s transaction included a prepaid‑rent component and retained more direct operational control over the towers it occupies, whereas AT&T’s transaction was a pure financing obligation with Crown Castle handling tower operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 is correctly split into $2.0 billion in prepaid rent and $830 million in financing obligation; the 2013 AT&T transaction with Crown Castle is accurately reported as a $4.827 billion cash payment recorded entirely as a financing obligation. These numbers match the ground truth exactly, and formatting is consistent. (2) The qualitative analysis is strong: the LLM correctly identifies that both companies retained control and ownership on their balance sheets, and that depreciation continues (implied in the original answer via the $608 million figure at end of 2024, though not explicitly mentioned in LLM answer). The distinction in financing structure—dual treatment (prepaid rent + financing) for VZ vs. pure financing obligation for T—is correctly highlighted. (3) Multi-hop reasoning is sound: the model synthesizes information across two different companies (VZ and T), two different years (2024 and 2013), and two different transactions, correctly comparing their accounting treatments and operational control implications. (4) Minor omission: the LLM does not mention that AT&T continued to depreciate the tower assets ($608 million at end of 2024), which is a small but relevant detail from the original answer. Also, the interest rate of ~3.9% in T’s deal is not included. However, these omissions do not undermine the core accuracy of the comparison. The LLM slightly reframes operational control—saying Crown Castle had 'exclusive rights to lease and operate'—which is consistent with T retaining control but ceding operational management, though the original emphasizes T retained control and depreciation rights. Overall, the answer is factually correct, well-structured, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 541,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "Merck’s filing notes that the IRS examination of its 2017‑2018 returns, which include the one‑time TCJA transition tax, could trigger a **significant** tax liability, though the amount is not disclosed (MRK page 127).  \nMedtronic’s 2024 tax provision shows a BEAT‑related impact of **0.3 % of U.S. taxable income**—about **$2.3 million** based on $750 million U.S. income before tax—reflecting the TCJA’s minimum‑tax requirement (MDT page 85).  \nThus, Merck faces an uncertain, potentially large liability, whereas Medtronic’s BEAT impact is a modest, predictable expense.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between MRK's potential TCJA-related tax liability and MDT's BEAT impact in 2024. However, there are minor quantitative inaccuracies that reduce precision. First, the LLM states MDT's BEAT impact is '0.3% of U.S. taxable income' and estimates it as '$2.3 million based on $750 million U.S. income before tax.' The original answer states a 0.3% increase in effective tax rate due to BEAT, not 0.3% of taxable income—this is a meaningful distinction. The $2.3 million figure does not appear in the ground truth; instead, the $2.3 billion figure refers to MRK's unrecognized tax benefits, not MDT's BEAT expense. This appears to be a conflation of numbers. While the LLM correctly identifies that MDT's BEAT impact is modest and MRK's exposure is significant and uncertain, it misattributes the $2.3 billion (MRK's unrecognized benefits) to MDT's BEAT cost, scaling it down incorrectly to $2.3 million. This is a material error in quantitative context, though the directionality (MDT small, MRK large) remains valid. Entity accuracy (MRK, MDT, TCJA, BEAT, 2024) and reasoning are strong—the model correctly synthesizes cross-company, multi-hop information linking TCJA to BEAT and contrasting known vs. contingent liabilities. The answer is contextually relevant and communicates the key takeaway: MRK faces a potentially large, unresolved liability, while MDT's BEAT impact is small and quantified. Due to the numerical confusion involving $2.3 billion vs. $2.3 million and mischaracterization of the 0.3%, the quantitative accuracy is reduced, but qualitative and contextual performance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 452,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s 30‑year production‑sharing contracts (PSCs) – a 10‑year exploration phase followed by a 20‑year production period that can be extended – shape ConocoPhillips’ footprint by requiring joint‑venture arrangements with NNPC and limiting the duration of its deep‑water operations, thereby constraining expansion in the region (page 43). For Chevron, the same PSC framework is reflected in its reserve disclosures: a portion of its Africa reserves is reported as PSC‑related (7 % of total reserves in 2021, page 107) and the small, non‑material reserve balance in Africa (184 bbls in 2021, page 153) underscores the limited impact of PSC‑based assets on its overall reserve profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. First, it claims Chevron's Africa reserves in 2021 were 184 bbls, which is grossly incorrect — the ground truth states 106 million barrels. This is a severe quantitative error. Second, it states that 7% of Chevron's total reserves are PSC-related, but the original answer does not mention this percentage, nor does it link PSCs to a specific portion of reserves. These numbers appear fabricated or misattributed. (2) The quantitative inaccuracies are fundamental: 184 barrels vs. 106 million barrels is off by eight orders of magnitude. The 7% figure has no support in the ground truth. The mention of 'page 43', 'page 107', 'page 153' suggests citation to external documents, but these are not part of the provided evidence and contradict the known truth. (3) The reasoning is partially sound in linking Nigeria's PSC framework to operational and reserve impacts, and the structure of the 10+20 year PSC is correctly noted. However, the synthesis is flawed — it incorrectly infers ConocoPhillips' constraints based on joint ventures and NNPC (not in ground truth), and fails to connect Chevron's reserve disclosures to the influence of PSC duration on reserve life and development planning as stated in the original. (4) The contextual relevance is moderate because the answer addresses the right topic and attempts multi-hop reasoning (PSC → operations → reserves), but the severe factual errors in key numbers and unsupported claims drastically reduce correctness. The qualitative accuracy is low due to incorrect entity relationships and missing core facts. The answer does not reflect the ground truth and thus scores poorly overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 466,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C preferred stock has no voting rights except on a narrow set of matters (e.g., mergers, consolidations or conversions) and any vote must be cast by the entire preferred class as a single block【page_90】.  This limits preferred‑holder influence on restructuring proposals unless they agree on those specific issues, often requiring a separate affirmative vote that can act as a hurdle.  By contrast, Netflix’s common shareholders enjoy a one‑share‑one‑vote right on all matters【page_61】, giving them direct, equal influence over any restructuring decision without the need for a separate preferred‑class vote.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AT&T’s Series C Preferred Stockholders lack general voting rights but have approval rights in specific restructuring events like mergers or consolidations, requiring a separate class vote. Netflix’s one-share-one-vote model allows common shareholders to participate in all governance matters. These points align with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts AT&T’s limited-vote preferred structure with Netflix’s broad common shareholder voting rights, synthesizing governance implications across two companies. (4) The only minor difference is that the LLM answer emphasizes the 'entire preferred class voting as a block' and mentions 'conversions,' which are not explicitly in the ground truth but are consistent with SEC filing disclosures and do not contradict the original answer. This adds slight nuance without inaccuracy. Overall, the response is complete, contextually relevant, and conveys the same meaning as the original answer with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 354,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Pfizer’s Enbrel portfolio is set to lose its core product patents in 2028 (fusion‑protein) and 2029 (DNA‑encoding) (page 12), after which the company will have to compete with lower‑priced biosimilars.  To blunt that revenue loss, Pfizer can lean on the 2037 formulation patent (page 14) and any remaining 12‑year BPCIA regulatory exclusivity (page 9), which together can postpone biosimilar entry.  AbbVie’s strategy of pursuing patent‑term restoration and leveraging BPCIA exclusivity for biologics (page 9) illustrates how Pfizer might similarly seek extensions and new indications to sustain revenue beyond the core patent expirations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key dates—2028 for the fusion protein patent, 2029 for the DNA-encoding patent, and 2037 for the formulation patent—are correctly stated, matching the original answer exactly. The mention of 12-year BPCIA regulatory exclusivity is contextually appropriate and consistent with biologics exclusivity rules, though the original answer did not specify the 12-year term; however, this is a correct general fact and supports the reasoning. (2) Quantitative accuracy is perfect: all years and timelines are correct, and no calculations were required. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Pfizer's patent expiration timeline with AbbVie's more aggressive lifecycle management strategy, drawing a logical inference that Pfizer could adopt similar tactics. The reference to 'seeking extensions and new indications' mirrors the original's suggestion of secondary patents and regulatory extensions. (4) The only minor shortcoming is that the LLM does not explicitly mention the Hatch-Waxman Act or the potential 5-year patent term restoration and 14-year total exclusivity as detailed in the original, which slightly reduces qualitative completeness. However, the core strategic comparison is preserved. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight omission of specificity in AbbVie's strategy details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 408,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore refinery produces about **1.9 million metric tons of ethylene per year**. The documents do not disclose the ethylene‑manufacturing capacity of the Map Ta Phut Olefins joint venture that Chevron indirectly supports, so a direct numerical comparison cannot be made.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year, matching the ground truth exactly. It also accurately acknowledges that the ethylene manufacturing capacity of the Map Ta Phut Olefins joint venture — which Chevron indirectly supports through a 32.77% stake — is not disclosed in the available evidence, making a direct comparison impossible. While the LLM omits the specific percentage of Chevron's ownership (32.77%), this detail is not required to answer the core question about capacity comparison, which hinges on available capacity data rather than ownership share. The reasoning is sound: without the total capacity of the joint venture or the attributable capacity to Chevron, a numerical comparison cannot be made. The answer is semantically equivalent to the ground truth in terms of actionable information. Quantitative accuracy is perfect. Contextual relevance is high, as the response directly addresses the limits of available data. The only minor gap is the omission of the ownership percentage, which slightly affects completeness but does not detract from the correctness of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 336,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company’s disallowance of capital investments at Nicor Gas in Illinois produced a pre‑tax charge of roughly **$96 million** (about $72 million after tax) 【page_302】.  By contrast, NextEra Energy’s infrastructure footprint in Illinois is measured in physical assets – the company owns **about 90 miles of rate‑regulated transmission lines** (plus a few substations) 【page_16】.  Thus, the Southern Company’s hit is a sizable monetary loss, whereas NextEra’s presence in the state is a modest 90‑mile transmission network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the infrastructure scale of NextEra Energy. It states that NextEra owns 'about 90 miles of rate-regulated transmission lines' in Illinois, whereas the ground truth specifies that NextEra operates 90 thousand miles of transmission lines across multiple states, including Illinois. The LLM incorrectly reduces '90 thousand miles' to '90 miles', introducing a 1,000-fold error in scale. Additionally, the LLM fails to clarify that the 90 thousand miles spans Illinois, Indiana, Kentucky, New Hampshire, and New York, thus misrepresenting the geographic scope. (2) The $96 million pre-tax charge for Southern Company is correctly reported, and the after-tax estimate of $72 million, while not in the original answer, is a reasonable approximation and not penalized. However, the core infrastructure metric is catastrophically wrong. (3) The multi-hop reasoning is flawed: the question asks for a comparison between Southern Company’s financial impact and NextEra’s infrastructure scale in Illinois. The LLM attempts this but uses an incorrect magnitude for NextEra’s assets, undermining the entire comparison. It also fails to mention Nicor Gas’s 34.7 thousand miles of gas pipelines serving 2.3 million customers, which is key context for Southern Company’s operations. (4) Due to the severe quantitative inaccuracy in a central figure, the correctness score is low at 3. The contextual relevance is moderate because the answer attempts the right comparison and cites relevant entities, but the qualitative and quantitative accuracy scores are low due to the magnitude of the error in infrastructure length.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 456,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "As of December 31 2021, Coca‑Cola’s investment in CCEP (carrying value $3,578 million) represented roughly 20 % of its total equity‑method investments ($17,598 million)【page_55】【page_89】. CCEP operates bottling and distribution facilities in Iceland, a market where Costco also has a retail presence【page_7】, underscoring that Coca‑Cola’s sizable stake in CCEP is tied to a region that overlaps with Costco’s operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that KO's stake in CCEP represented 20% of KO's total equity-method investments, while the ground truth specifies that KO owned approximately 19% of CCEP — a different metric. The LLM confuses the percentage of KO’s total equity investments represented by CCEP (20%) with the actual ownership stake in CCEP (19%). These are two distinct percentages: one is KO’s internal portfolio composition, the other is its ownership share in CCEP. The ground truth focuses on the latter (19% ownership in CCEP), which is the direct answer to the first part of the question. The LLM provides a related but incorrect figure in context. (2) The quantitative values cited — $3,578 million and $17,598 million — may be factually accurate from the filing, and their ratio (~20.3%) supports the 20% claim, but this does not answer the specific question about KO’s ownership percentage in CCEP. Thus, while the calculation is accurate, it addresses a different question. (3) The qualitative reasoning about CCEP operating in Iceland and overlapping with COST’s presence is correct and reflects proper multi-hop synthesis between KO → CCEP → Iceland operations and COST → Iceland operations. The conclusion about geographic market overlap is logically sound and semantically aligned with the ground truth. (4) The contextual relevance is high because the answer addresses both parts of the question and draws a meaningful connection. However, the primary factual error in the key percentage reduces the correctness and quantitative accuracy scores. The qualitative accuracy remains high due to sound reasoning and entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 454,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy’s direct exposure to electricity‑price volatility is sizable – its bulk‑power purchases and sales are hedged with a notional volume of 13,608 GWh of electricity derivatives, indicating a substantial, market‑wide sensitivity.  By contrast, Southern Company’s exposure is indirect and limited to the 100 MW of year‑round capacity that Alabama Power supplies to its subsidiary PowerSouth under a 2021 agreement – a small, isolated portion of PowerSouth’s >1,600 MW generating portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported quantitative data not present in the ground truth. (1) Quantitative inaccuracy: The claim that Duke Energy hedges with '13,608 GWh of electricity derivatives' is not supported by the original answer or any referenced data; this specific figure is entirely fabricated. Similarly, stating PowerSouth has a '>1,600 MW generating portfolio' is not in the ground truth and cannot be verified from the provided information. (2) Entity and temporal accuracy: While both companies and the 100 MW / 2021 agreement are correctly identified, the original answer specifies the capacity service starts in 2024, which the LLM omits. (3) Reasoning and completeness: The LLM correctly identifies Duke Energy's direct exposure versus Southern Company's indirect exposure, but fails to explain the mechanisms (e.g., fuel adjustment clauses, formula-based contracts, regulatory deferrals for Duke; coordinated planning and shared dispatch for Southern). Instead, it oversimplifies Southern’s exposure as merely a 'small, isolated portion' without capturing the operational coordination and risk-mitigation structure described in the original. (4) Semantic equivalence: The core contrast (direct vs. indirect exposure) is preserved, but the LLM adds unverified numbers and omits key explanatory mechanisms, undermining factual reliability. The answer is contextually relevant and addresses the comparison, but with major factual gaps and inventions, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 423,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 net new stores in Taiwan (from 523 to 544) during FY 2022, a modest expansion of its physical footprint.  \nNike’s Greater China region – which includes Taiwan – generated $6.679 billion in revenue for the same year.  \nThus, while Starbucks’ Taiwan store count grew by a few dozen outlets, Nike’s Greater China segment contributed a sizable $6.7 billion in sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Starbucks' net increase of 21 stores in Taiwan and the final store count of 544 in FY2022, which matches the ground truth. However, it incorrectly states Nike's Greater China revenue as $6.679 billion, whereas the ground truth reports $7.547 billion—a significant discrepancy of over $800 million. The LLM rounds this to $6.7 billion, compounding the inaccuracy. (2) The store count numbers are accurate: 523 to 544 implies a net increase of 21, which is correct. But the revenue figure for Nike’s Greater China is factually wrong, despite correct metric identification (revenue, correct region, correct fiscal year). (3) The multi-hop reasoning is logically structured—comparing Starbucks’ physical expansion in Taiwan to Nike’s financial performance in the broader Greater China region (which includes Taiwan). The model correctly acknowledges that Taiwan is part of Greater China, satisfying the required synthesis. However, the incorrect revenue number undermines the validity of the comparison. (4) The contextual relevance is high because the answer addresses both parts of the question and attempts the necessary cross-company, cross-metric comparison. Qualitative reasoning is sound but based on flawed data. Quantitative accuracy is low due to the major revenue error. Correctness score is reduced to 6 due to this significant factual error, despite otherwise correct structure and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 399,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 requires a buyer to disclose the key terms of its supplier‑finance program, the balance‑sheet presentation of related amounts, the confirmed amount outstanding at period‑end, and roll‑forward information. 3M’s Note 16 (page 77) shows the $0.3 billion of confirmed invoices as part of accounts payable and reports that $1.5 billion of invoices were confirmed and $1.5 billion paid in 2024, thereby making the obligation fully visible.  FedEx’s 10‑K pages provided (34, 75, 92, 106, 112) contain no supplier‑finance‑program note or reference to ASU 2022‑04, so its disclosure of such obligations is less explicit and offers lower transparency compared to 3M.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has a critical factual error in the comparison between 3M and FedEx. While it correctly identifies that ASU 2022-04 requires disclosures such as key terms, balance sheet presentation, roll-forward, and period-end amounts, and correctly states 3M's $0.3 billion confirmed invoice obligations and their inclusion in accounts payable, it incorrectly asserts that FedEx’s 10-K contains no mention of supplier finance programs or ASU 2022-04. The ground truth confirms that FedEx *did* adopt ASU 2022-04 effective June 1, 2023, and *did* include disclosures about its supplier finance program. The LLM’s claim of lower transparency for FedEx is therefore factually incorrect. (2) Quantitatively, the $0.3 billion figure for 3M is accurate, and the $1.5 billion confirmed and paid in 2024 (implying roll-forward data) aligns with enhanced disclosure requirements. However, the LLM introduces $1.5 billion in activity not present in the original answer, which may be factual but cannot be verified against the ground truth provided. The core number ($0.3B) is correct. (3) The multi-hop reasoning fails at the synthesis stage: the model correctly interprets ASU 2022-04’s impact on 3M but incorrectly evaluates FedEx’s compliance and transparency, leading to a flawed comparative conclusion. The original answer states both companies enhanced transparency under the standard; the LLM contradicts this with unsupported claims about FedEx’s lack of disclosure. (4) The contextual relevance is fair—the response addresses supplier finance disclosures and transparency—but the incorrect FedEx assessment undermines the qualitative and overall correctness. The answer would be stronger if it had aligned with the ground truth that both firms adopted the standard and improved transparency.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 498,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both companies give a small group of shareholders outsized voting power that can override the interests of the rest of the equity holders.  At Comcast, each Class B share carries 15 votes, giving the controlling shareholder (Roberts) a veto over board elections and other shareholder‑approved actions that minority holders cannot counter.  At Meta, the charter requires that until Class B shares fall below 35 % of the combined voting power, any change‑of‑control transaction must be approved by a majority of Class B votes, allowing Zuckerberg to block takeovers or amendments that minority shareholders might support.  In each case the concentration of voting rights exposes minority shareholders to governance risks such as reduced accountability, limited influence over corporate decisions, and the potential for self‑serving actions by the controlling class.  (CMCSA p. 33; META p. 50)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B shares have a 15-vote-per-share advantage, leading to disproportionate control (specifically 33⅓% voting power, implied via the 15:1 structure and ownership concentration), and META requires Class B approval for change-of-control transactions as long as they hold at least 35% of voting power. These numbers match the ground truth exactly. (2) The answer correctly identifies the controlling shareholders (Roberts at CMCSA, Zuckerberg at META) and explains how their voting rights create governance risks. (3) Multi-hop reasoning is sound: the model synthesizes governance mechanisms across two companies, identifies the common theme of concentrated voting power, and links it to minority shareholder risks such as reduced accountability, limited influence, and potential self-dealing. (4) The answer includes additional relevant detail (e.g., veto over board elections, requirement for Class B approval on change-of-control) that enhances accuracy without introducing error. Wording differs slightly but meaning is preserved. All aspects of the question are addressed with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 345,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "V’s U.S. pension plan had $733 million in Level 2 assets in 2022, of which $319 million were collective investment funds—about **43.5 %** of the Level 2 portfolio (page 87).  \nIn contrast, COF’s “other securities” are primarily mortgage‑backed and other fixed‑income instruments, carrying a weighted‑average yield of **1.57 %** (page 162). Thus, V’s allocation is more equity‑heavy and diversified, likely offering lower yields, whereas COF’s focus on fixed‑income “other securities” delivers a higher, more predictable yield profile.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains a critical error in the percentage calculation due to an incorrect total for Level 2 assets. The ground truth states that V's total U.S. pension plan assets were $960 million, not $733 million. The $319 million in collective investment funds is correctly reported, but the percentage is miscalculated: 319 / 960 ≈ 33.2%, not 319 / 733 ≈ 43.5%. This is a significant quantitative error. (2) The COF data is accurate: $2,834 million in 'other securities' with a 1.57% weighted-average yield is correctly cited (though rounded to $2,834 million vs. LLM's omission of the exact figure). However, the LLM incorrectly characterizes COF's 'other securities' as having a 'higher, more predictable yield profile'—this contradicts the ground truth, which implies a lower yield (1.57%) compared to potentially higher-yielding equity-focused collective funds. (3) The multi-hop reasoning is partially sound: the model attempts to compare investment focus (equity-heavy vs. fixed-income), which aligns with the ground truth's implication of different risk-return profiles. However, the conclusion about yield profile is reversed—collective funds likely have higher yield potential due to equity exposure, not lower, making the reasoning flawed. (4) Contextual relevance is strong: the answer addresses both parts of the question, cites correct entities (V, COF), correct year (2022), and correct financial instruments. Wording and structure are clear and relevant, but factual inaccuracies in calculation and yield interpretation reduce overall correctness. The model appears to confuse Level 2 assets with total U.S. pension assets, leading to cascading errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 455,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Microsoft’s risk‑factor discussion notes that Saudi Arabia’s data‑localization requirements “may result in increased costs or require additional changes to our business practices that result in reduced revenue and profitability” (page 29).  Adobe, in the pages provided, does not disclose any compliance costs or financial exposure related to Saudi data‑localization (no mention is found in pages 29, 30, 31, 33 or 89).  This contrast suggests Microsoft is preparing for a higher regulatory burden—likely driving more region‑specific cloud infrastructure and compliance spending—whereas Adobe’s cloud strategy appears less impacted by Saudi data‑localization, implying a more globally‑oriented data‑center approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no quantitative errors per se, as it does not present any incorrect numbers, dates, or financial figures—thus scoring high on quantitative accuracy. However, the qualitative accuracy is severely compromised due to a critical factual error: the LLM claims that Adobe does not disclose any compliance costs or mention Saudi data-localization in the provided pages, stating 'no mention is found in pages 29, 30, 31, 33 or 89.' This contradicts the ground truth, which explicitly cites Adobe's 10-K (ADBE_10k_2024.pdf) acknowledging exposure to Saudi Arabia's data localization laws and their potential adverse impact. The original answer confirms that Adobe does mention Saudi Arabia as a jurisdiction with data localization requirements that could impact its business and financial condition. Therefore, the LLM incorrectly assesses Adobe’s risk disclosure as absent, leading to a flawed comparison. The reasoning is thus unsound: it concludes that Adobe is less impacted and has a more globally oriented cloud strategy, when in fact the ground truth reveals Adobe faces significant compliance risks through its enterprise customer contracts in Saudi Arabia. Microsoft’s exposure is correctly characterized in terms of increased costs and engineering burden, aligning with the original answer. While the LLM attempts multi-hop reasoning by comparing two companies’ regulatory exposures, the synthesis fails because one side of the comparison is based on a false negative. Contextual relevance is moderate—the answer addresses the right topic and attempts a strategic comparison—but the conclusion is misleading due to incorrect premises. Overall, the answer is partially relevant but factually incorrect on a key point, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 480,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy’s sale of KO Transmission’s 90‑mile pipeline (which was a FERC‑regulated interstate line) removed that asset from its balance sheet and therefore cut its exposure to FERC’s transmission‑rate and reliability rules – the company no longer has to file rate‑case or compliance reports for that pipeline.  In contrast, Southern Company’s 2023 capital‑expenditure plan still relies on FERC‑approved construction and rate‑setting for its new and existing plants, so any changes in FERC rules or rate‑case decisions could raise costs or delay projects (see the 2023 capital‑expenditure schedule and the company’s note that its construction programs are subject to regulatory approvals).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core impact of Duke Energy's divestiture on FERC exposure and contrasts it with Southern Company's ongoing regulatory risks. However, it omits the specific divestiture date (February 1, 2023) and the detail that the sale was for approximately book value—both present in the original answer. These are factual omissions affecting quantitative and qualitative completeness. The mention of a '90-mile pipeline' is not in the ground truth and may be an unsupported addition. (2) No explicit dollar amounts or percentages were stated in either answer, so numerical accuracy is not violated, but the absence of the key date (February 1, 2023) and the book value detail reduces quantitative precision. The LLM does not contradict any numbers but fails to include all verifiable facts. (3) The multi-hop reasoning is sound: the model correctly infers that divesting a FERC-regulated asset reduces regulatory exposure and contrasts this with Southern Company’s continued exposure through capital expenditures subject to FERC approval. It appropriately references Southern Company’s reliance on regulatory approvals and potential cost impacts. (4) The answer is contextually excellent—directly addressing both companies, the regulatory mechanism (FERC), and the contrast in risk exposure. The reasoning is logically structured and semantically aligned with the original, though slightly less precise due to missing details. Thus, correctness is high but not perfect due to omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 420,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS’s $2.7 billion in unfunded commitments to private‑debt and private‑equity funds (page 93) represents a large, long‑term, illiquid exposure that will only be funded over the next 3–6 years and cannot be redeemed until the end of each partnership term. In contrast, Caterpillar’s $55 million of NAV‑measured assets for other post‑retirement benefit plans (page 102) is a much smaller, more liquid mix of public‑market securities—primarily U.S. and non‑U.S. equities, a modest amount of corporate bonds, and cash/short‑term instruments—reflecting a conventional, diversified investment strategy. Thus, UPS’s commitment is far less liquid and more focused on alternative, higher‑return assets, whereas Caterpillar’s allocation is more liquid and aligned with traditional public‑market investing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $2.7 billion for UPS’s unfunded commitments and $55 million for Caterpillar’s NAV-measured assets. These match the original answer exactly, and format variations (e.g., $2.7 billion vs $2.7B) are acceptable. (2) The LLM correctly identifies the entities—UPS and Caterpillar—and their respective financial disclosures, including the nature of the investments (private debt/equity vs. public securities). (3) The reasoning is sound: it correctly contrasts the illiquidity and long-term nature of UPS’s commitments (with 3–6 year funding period and no redemption until term end) with Caterpillar’s more liquid, diversified public-market portfolio. The LLM slightly differs by specifying 'U.S. and non-U.S. equities' instead of the ground truth’s 'U.S. corporate bonds and short-term instruments,' but this does not contradict—Caterpillar’s portfolio can include both. The core qualitative point—that Caterpillar uses more liquid, traditional assets while UPS focuses on illiquid alternatives—is preserved. (4) The answer fully addresses the question’s two dimensions: liquidity and investment strategy. The only minor deviation is the emphasis on 'higher-return assets' for UPS, which is a reasonable inference but not explicitly stated in the ground truth. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop synthesis across companies and investment types.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 417,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet repurchases only its Class A and Class C shares (page 84) while retaining Class B shares that carry ten votes per share (page 81).  In contrast, Netflix’s common stock is a single‑class structure with one vote per share for all holders (page 61).  Alphabet’s approach—keeping the high‑voting Class B shares in circulation while buying back the lower‑voting classes—suggests a governance strategy that preserves concentrated control for founders and insiders while still providing liquidity and capital return to other shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Alphabet repurchased Class A and C shares while retaining Class B shares with 10 votes per share, and Netflix has a single class of common stock with one vote per share. The dollar amount of $62.2 billion in repurchases is missing from the LLM answer, which is present in the original answer; however, the absence of this specific figure does not undermine the core reasoning or conclusion. (2) Quantitative accuracy is strong—no incorrect numbers are stated, and the structural details (10 votes vs. 1 vote) are correct. The only omission is the $62.2 billion figure, which slightly affects completeness but not overall correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Alphabet’s share structure and repurchase behavior and contrasts it with Netflix’s uniform voting rights. The inference about governance strategy—preserving control for insiders while returning capital—is logically supported and matches the original answer’s implication. (4) Contextual relevance is excellent; the response directly addresses the contrast in governance structures and the strategic implications. The minor omission of the repurchase dollar amount prevents a perfect score, but the reasoning, entity accuracy, and qualitative insights are otherwise fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 395,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "Coca‑Cola’s 2022 effective tax rate was 21.0 %, and the Tax Reform Act’s GILTI provisions added roughly 0.5 percentage points to that rate (page 107 of KO_10k_2022).  Philip Morris International’s 2021 effective tax rate was 21.1 %, and the corporate‑income‑tax reduction in the Philippines reduced the rate by about 0.3 percentage points (page 107 of PM_10k_2022).  Thus, the GILTI impact on Coca‑Cola was larger than the benefit PMI gained from the Philippine tax cut.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Coca-Cola's GILTI provisions caused a $431 million net tax expense, resulting in a 4.4% impact on its effective tax rate. However, the LLM claims the impact was only 0.5 percentage points, which is drastically incorrect. Similarly, for Philip Morris International (PMI), the ground truth states the Philippine tax rate reduction contributed to a 0.1 percentage point decrease in its 2021 effective tax rate (which was 21.8%), but the LLM incorrectly reports a 0.3 percentage point reduction and states PMI’s effective tax rate was 21.1%, both of which are wrong. (2) The quantitative values are almost entirely incorrect: the GILTI impact is off by nearly 4 percentage points (0.5 vs 4.4), the PMI tax benefit is overstated (0.3 vs 0.1), and the reported effective tax rates for both companies are inaccurate (Coca-Cola: 21.0% vs actual not stated in ground truth; PMI: 21.1% vs 21.8%). (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the actual magnitude of tax impacts across the two companies and incorrectly compares a 0.5pt increase to a 0.3pt decrease, when in reality the GILTI impact on Coca-Cola (4.4pt increase) was vastly larger than PMI’s 0.1pt benefit. (4) Despite referencing document pages and attempting a comparison, the answer is mostly incorrect factually, leading to a low correctness score. Contextual relevance is moderate because it addresses the right companies, years, and general topic, but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 430,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "The $3.1 billion of mortgage loans that BAC sold to the GSEs in 2023 simply reduced BAC’s own servicing exposure to those loans.  MET’s $12.392 billion pass‑through RMBS portfolio is secured by the same underlying mortgage loans, which are serviced by institutions such as BAC, so the sale does not alter the collateral that backs the securities.  Consequently, MET’s risk exposure to the RMBS remains tied to the credit quality of the underlying loans rather than to BAC’s loan‑sale activity, although any future changes in BAC’s servicing capacity or the GSEs’ role could indirectly influence the performance of the pass‑through securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 and MET’s $12.392 billion portfolio of pass-through MBS, both of which match the ground truth numerically and contextually. These values are accurately reported with correct units and entities, satisfying quantitative accuracy. (2) The answer correctly notes that the sale reduces BAC’s servicing exposure and does not change the collateral backing MET’s securities—this is factually sound. However, it downplays the potential risk linkage between BAC’s role as a servicer and MET’s portfolio performance. The ground truth emphasizes that if BAC experiences servicing issues (e.g., cybersecurity incidents or breaches), this could disrupt cash flows and affect MET’s MBS value. The LLM answer acknowledges possible future changes but frames the connection more weakly as indirect, missing the direct risk channel through servicing obligations. (3) The multi-hop reasoning is partially sound: it connects BAC’s loan sales to GSEs, recognizes BAC’s role as a servicer, and links that to the collateral backing MET’s MBS. However, it fails to fully synthesize the causal chain—servicing quality directly impacts cash flow reliability in pass-through securities, so BAC’s operational risks *do* translate into exposure for MET, even if the collateral itself isn’t altered. This omission reduces qualitative accuracy. (4) Contextual relevance is high because the response stays focused on the relationship between BAC’s actions and MET’s risk, uses correct financial terminology (e.g., 'pass-through RMBS', 'servicing capacity'), and addresses the core dynamic. Overall, the answer is factually solid on numbers and entities but underrepresents the direct risk exposure mechanism described in the ground truth, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 501,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "Nike’s embedded derivatives are classified as Level 3, meaning they are valued with non‑market‑based assumptions (e.g., actuarial estimates and extrapolated yield curves) that increase valuation complexity【page_83】. In contrast, Lowe’s fair‑value measurements rely on observable market inputs—quoted prices, benchmark yields, broker‑dealer quotes—so they are less complex and depend less on non‑market‑based assumptions【page_56】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that NKE's embedded derivatives are classified as Level 3 due to non-market-based assumptions, and contrasts this with LOW's use of observable inputs, which aligns with the ground truth. There are no numeric inaccuracies—though the LLM does not include the specific $5 million figure for NKE's embedded derivatives, it does not misstate any numbers, so quantitative accuracy is high. The qualitative accuracy is slightly reduced because the LLM omits key details: (1) it fails to mention that NKE's Level 3 classification specifically involves policyholder behavior and extrapolation beyond observable limits, (2) it incorrectly implies that MET_10k_2022's actuarial inputs (from a different company, MetLife) are directly comparable to NKE’s, when the original answer uses MET as an illustrative example, not as LOW’s data, and (3) it does not clarify that LOW reported no material nonrecurring fair value measurements, which is central to the comparison. The LLM simplifies LOW’s inputs accurately (quoted prices, benchmark yields, etc.), but the reasoning leap from 'observable inputs' to 'less reliance on unobservable assumptions' is valid and contextually appropriate. The answer is semantically aligned in direction but lacks full completeness and precision in multi-hop synthesis, particularly in distinguishing among NKE, LOW, and the illustrative MET example. Thus, while the core comparison is correct, omissions and slight conflation of sources prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 415,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "GD values its fixed‑rate notes with pricing models that use observable market data (interest‑rate curves, credit spreads, and comparable securities), a Level 2 approach that still relies on verifiable inputs. In contrast, Lockheed Martin’s $4,951 million of private‑equity holdings are Level 3 assets whose NAV is derived from valuation models that incorporate unobservable inputs that cannot be corroborated by market data. Thus, GD’s Level 3‑style valuations are based on observable inputs, whereas LMT’s Level 3 valuations depend on unobservable inputs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $4,951 million figure for LMT's private equity holdings is accurate, and no other numerical values are misstated. (2) The qualitative description correctly contrasts GD's use of observable inputs (interest-rate curves, credit spreads, comparable securities) with LMT's use of unobservable inputs for its Level 3 private equity assets valued via NAV. However, the LLM introduces a minor inaccuracy by characterizing GD's approach as a 'Level 2 approach'—the original answer and SEC filings clarify these fixed-rate notes are classified as Level 3 assets, even if they use observable inputs. This misclassification of the hierarchy level slightly undermines the reasoning, as Level 3 is defined by significant unobservable inputs, but the model notes GD uses observable inputs in a Level 3 context, which reflects nuance in practice. (3) The multi-hop reasoning is sound: the model correctly identifies both companies, their respective asset types, valuation methodologies, and the contrast in input observability. (4) Despite the slight misstep in categorization, the core factual comparison—GD relying on more market-validated inputs vs. LMT using unobservable inputs for Level 3 assets—is preserved, warranting a high correctness score. Wording differs but meaning is semantically equivalent on key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 387,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder litigation has spanned several years: a federal action was filed in September 2019, a motion to dismiss was filed in January 2020 and partially granted in April 2020, and the case has proceeded through interlocutory appeal, Ninth Circuit review, a Supreme Court vacatur and remand in June 2023, and a final dismissal with prejudice in February 2025. In contrast, Disney’s antitrust litigation in the Biddle and Fendelander actions began in November 2022, with motions to dismiss filed in January 2023 that were partially granted in June 2024; the parties consolidated the complaints in October 2023, and a motion to dismiss the consolidated complaint filed in December 2023 was also partially granted in June 2024 (DIS 10‑K, p. 116). Thus, Slack’s case has a longer, more complex procedural history, while Disney’s strategy has focused on early, successive motions to dismiss within a shorter timeframe.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core procedural timelines and comparative strategy between Slack and Disney, correctly identifying the multi-year nature of Slack's litigation and Disney's use of successive motions to dismiss. However, there are key quantitative inaccuracies: (1) The original answer states that the Ninth Circuit reversed and dismissed Slack’s case with prejudice on February 10, 2025—this is correct, but the LLM incorrectly attributes a Supreme Court 'vacatur and remand in June 2023' as part of the procedural history, which is not in the ground truth (the Supreme Court action is not mentioned in the original answer, only the Ninth Circuit reversal in 2025). (2) For Disney, the LLM claims the January 2023 motions were 'partially granted in June 2024', but the original answer states they were ruled on by September 30, 2023 (granted in part, denied in part)—a significant date error. Additionally, the LLM combines the two Disney rulings into a single 'partially granted in June 2024' outcome, conflating the December 2023 motion (which was ruled on June 25, 2024) with the earlier one. The consolidation date (October 2023) is plausible but not in the original answer. The qualitative reasoning is sound—correctly contrasting Slack’s longer, appellate-heavy path with Disney’s repeated early motions—and the entities (Slack, Disney, Biddle, Fendelander) are accurate. The answer is contextually relevant and synthesizes across litigation timelines, but the date and procedural errors reduce quantitative accuracy. Semantic equivalence is mostly preserved, but not fully due to incorrect Supreme Court involvement and merged rulings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 449,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel’s Hong Kong operations give the company a tax benefit that lowered its effective tax rate by roughly 5.9 percentage points in 2021 (the “Non‑US income taxed at different rates” line on the tax‑rate table).  By contrast, Apple’s Greater China segment – which includes Hong Kong – generated $74.2 billion of net sales in 2022.  Thus, Intel’s benefit is expressed as a rate reduction, whereas Apple’s contribution is a large dollar revenue figure that already incorporates Hong Kong’s sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $74.2 billion net sales figure for Apple's Greater China region in 2022 is correct and matches the original answer. The 5.9 percentage point reduction in Intel's effective tax rate due to non-US income, including from Hong Kong, is a specific and accurate detail not present in the original answer but factually consistent with Intel's 2021 tax disclosures—this adds precision rather than introducing error. (2) The years differ slightly—Intel's data is from 2021, Apple's from 2022—but this is acceptable as the question does not require identical time periods, and the LLM correctly attributes each figure to the right year. (3) Entity accuracy is strong: both companies, regions (Hong Kong, Greater China), and financial metrics (tax rate reduction, net sales) are correctly identified. (4) The reasoning correctly synthesizes multi-hop information: it contrasts Intel’s tax benefit (a rate impact) with Apple’s revenue contribution (a dollar amount), noting that Hong Kong is included in Apple’s reporting—a key nuance. The only minor shortcoming is that the original answer mentions Hong Kong’s statutory tax rate range (12.5%–24.0%), which the LLM omits; however, this is contextual detail rather than core factual content. Overall, the LLM conveys semantically equivalent and factually correct information with strong reasoning and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 399,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "The HB 951 70 % CO₂‑reduction mandate forces Duke Energy to embed a carbon plan into its Carolinas Resource Plan, resulting in a portfolio that retires coal by 2035, expands renewables and storage, and extends nuclear operations to meet the target (pages 69, 70, 71).  This regulatory requirement directly shapes Duke’s resource mix and timeline, compelling a shift to lower‑carbon generation and a phased exit from coal (page 71).  By contrast, NextEra Energy’s 10‑K does not disclose any significant operations or exposure in North Carolina, indicating that the HB 951 regulation does not directly affect NextEra’s activities in the state (pages 18, 41, 45, 109, 110).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical factual error in the comparison with NextEra Energy, undermining the multi-hop reasoning. Quantitatively, the 70% CO₂ reduction target, 2030 deadline, coal retirement by 2035, and references to Duke Energy's Portfolio 3 (implied by pages 69–71) are accurate and align with the ground truth. The description of Duke Energy’s response—retiring coal, expanding renewables, storage, and nuclear—is factually sound and contextually relevant. However, the claim that 'NextEra Energy’s 10-K does not disclose any significant operations or exposure in North Carolina' is incorrect. The ground truth explicitly states that NextEra *does* operate in North Carolina and is exposed to the same regulatory environment, though not directly subject to HB 951. This is a major qualitative inaccuracy, as it misrepresents a key part of the comparative analysis. The reasoning fails in the cross-company synthesis: while correctly noting that HB 951 does not directly apply to NextEra, it incorrectly infers no operational exposure, contradicting the ground truth. This undermines the conclusion about differentiated regulatory burdens. The answer is well-structured and contextually relevant to the question, but the error in entity exposure significantly reduces overall correctness despite accurate numbers and solid understanding of Duke Energy’s obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 387,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ’s weighted‑average assumptions are actuarial in nature – they use a weighted‑average discount rate (5.53 % for U.S. plans in 2023, 6.07 % for non‑U.S. plans) and a weighted‑average health‑care cost‑trend rate (7.00 % for U.S. plans in 2023, 5.98 % for non‑U.S. plans) to estimate net periodic post‑retirement health‑care costs and future benefit payments (MDLZ, Note 107). KO, in contrast, applies weighted‑average market assumptions—risk‑free interest rate, expected volatility, dividend yield, and expected term—to calculate the fair value of stock options under the Black‑Scholes‑Merton model and expense them over the vesting period (KO, Note 95). Thus, MDLZ’s assumptions focus on discounting and cost trends for benefits, while KO’s focus on market variables for option pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies MDLZ's use of weighted-average assumptions for postretirement healthcare costs, specifying relevant actuarial assumptions like discount rates (5.53% U.S., 6.07% non-U.S.) and healthcare cost-trend rates (7.00% U.S., 5.98% non-U.S.) in 2023, which are consistent with typical disclosures in Note 107 of MDLZ's 10-K. While the original answer includes dollar amounts for net periodic costs ($14M, $12M, benefit of $5M), the LLM omits these specific figures but captures the conceptual application accurately. (2) For KO, the LLM correctly states that weighted-average assumptions (risk-free rate, volatility, dividend yield, expected term) are used in the Black-Scholes-Merton model to value stock options, with expense recognition over a four-year vesting period (implied in Note 95), matching the ground truth. (3) The multi-hop reasoning is sound: it contrasts MDLZ’s actuarial, liability-focused assumptions with KO’s market-based, equity-compensation valuation approach, correctly identifying the differing financial contexts. (4) Minor deduction in quantitative accuracy due to omission of the specific dollar amounts of postretirement costs/benefits over the three years mentioned in the original answer. However, the LLM compensates with more granular assumption details (specific percentages) not in the original, enhancing depth. Overall, the answer is semantically equivalent and contextually precise, earning high marks across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 424,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan’s derivatives exposure is modest and tightly collateralised – after ISDA‑master netting and margin, the firm’s net derivative assets are $183 million and liabilities $19 million (page 261), and the Dodd‑Frank margin and netting rules give it a clear, low‑liquidity‑risk framework. By contrast, Bank of America’s resolution‑planning obligations under the Orderly Liquidation Authority require it to maintain capital and liquidity buffers, limit inter‑company funding, and may trigger FDIC‑imposed liquidity restrictions if the parent is deemed in distress (pages 12–13, 160), creating a broader, potentially tighter liquidity constraint during financial distress.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$183 million in net derivative assets and $19 million in liabilities—that are not present in the original answer (ground truth) and cannot be verified against it. These figures may be factually accurate in context but are not supported by the provided ground truth, which focuses on regulatory frameworks rather than quantitative exposure. This undermines quantitative accuracy. (2) The original answer emphasizes structural regulatory constraints: JPMorgan’s exposure is framed around enforceable set-off and close-out netting under ISDA agreements limited by the Orderly Liquidation Authority (OLA), while Bank of America’s obligations involve resolution plans with a 'single point of entry' model restricting liquidity flows from subsidiaries. The LLM captures the general idea of liquidity constraints but misaligns the emphasis—citing collateralization and netting efficiency as reducing risk, whereas the ground truth highlights regulatory limitations on netting enforceability and intercompany liquidity. (3) The multi-hop reasoning is partially sound: the model correctly associates Dodd-Frank with derivatives regulation for JPMorgan and OLA with resolution planning for Bank of America. However, it fails to synthesize the key parallel—both firms face restrictions on liquidity during distress due to OLA constraints on netting (JPMorgan) and intercompany transfers (Bank of America). Instead, it frames JPMorgan’s framework as low-risk due to collateral and netting, which contradicts the ground truth’s emphasis on regulatory constraints limiting those very mechanisms. (4) Contextual relevance is high—the response addresses derivatives, Dodd-Frank, OLA, liquidity risk, and both banks—but qualitative accuracy is reduced by incorrect emphasis and unsupported numbers. While the LLM cites 'pages 261, 12–13, 160', these references are not evaluable here but suggest sourcing from actual filings; however, the divergence from the ground truth in substance lowers correctness. Overall, the answer is partially correct with significant omissions and potential factual mismatches in quantitative claims, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 591,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio still holds significant coal inventory—Duke Energy Ohio reports 23 million‑barrel coal in its 2024 inventory (page 124)—showing the state’s ongoing reliance on coal.  That context amplifies regulatory pressure on oil majors: ExxonMobil’s exposure to a 33 % EU “coal‑surplus‑profit” tax (page 115) pushes it to curtail coal‑related operations worldwide, whereas Chevron’s 2024 expansion of renewable natural‑gas projects in Ohio (page 19) is a targeted effort to replace coal with cleaner fuels in that market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states Duke Energy Ohio's coal inventory as '23 million-barrel coal'—this is wrong in both unit and context. The original answer specifies $23 million in coal inventory (a financial value), not 23 million barrels (a volume measure for oil), which is a critical error. Second, the LLM claims XOM faced a '33% EU coal-surplus-profit tax'—this percentage is not mentioned in the ground truth, which states a $1.8 billion after-tax charge due to the EU tax but does not specify the rate. This introduces a fabricated quantitative detail. (2) The year 2024 is correctly attributed to CVX's renewable natural gas projects and Duke Energy's inventory date (December 31, 2024), which aligns with the original. The mention of Chevron’s 2024 RNG investments in Ohio is accurate and matches the Brightmark RNG Holdings LLC detail in spirit, though the subsidiary name is omitted. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that Ohio’s continued coal use creates a strategic backdrop for energy transition decisions, and contrasts XOM’s regulatory pressure with CVX’s proactive investment. However, it misattributes the nature of the EU tax (calling it a 'coal-surplus-profit' tax, while the original frames it as targeting surplus profits broadly, not just coal) and incorrectly quantifies it. Also, the original emphasizes XOM’s $1.8B charge as a key driver, which the LLM omits entirely, weakening the factual foundation of its claim. (4) Despite these errors, the LLM captures the strategic contrast between XOM and CVX—reactive compliance vs. proactive investment—and correctly situates Ohio’s coal reliance as a contextual factor. The reasoning flow is logical and relevant, but undermined by key quantitative inaccuracies. Hence, correctness is reduced to 6 due to major number/entity errors, though the overall narrative direction is aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 528,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "MS’s CLNs are hybrid notes that embed credit protection sold by the issuer to the investor; the investor receives periodic payments and, if a credit event on the reference entity occurs, the issuer pays the difference between the note’s par value and the fair value of the defaulted reference obligation, so the principal may be reduced (MS 10‑K, page 109). JPM’s credit‑related notes are structured similarly – the issuer purchases protection from the investor, makes periodic payments, and on a credit event pays the difference between par and the fair value of the defaulted reference obligation, leaving the investor with a reduced principal (JPM 10‑K, page 224). Thus, the payout mechanics upon a credit event are essentially the same, differing only in which party sells the protection.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a fundamental misrepresentation of the roles of MS and JPM in their respective credit-linked note (CLN) structures, which undermines the correctness of the comparison. According to the ground truth, Morgan Stanley (MS) *purchases* credit protection from the issuer (i.e., acts as the buyer of protection), while JPMorgan (JPM) *sells* credit protection (i.e., acts as the seller). However, the LLM incorrectly states that in MS’s CLNs, the *issuer sells protection to the investor*, implying MS is the seller, which contradicts the ground truth. Similarly, it claims in JPM’s notes the *issuer purchases protection from the investor*, implying JPM is the buyer—again reversing the actual roles. This error inverts the economic positions of the banks and misaligns the payout mechanics in terms of risk exposure. While the description of the payout—'difference between par and fair value of the defaulted obligation'—is quantitatively and mechanically accurate for both, and page citations are plausibly referenced, the core reasoning about who sells vs. buys protection is reversed. This is a critical qualitative error in a multi-hop comparison question focused on risk transfer and payout obligations. The conclusion that 'the payout mechanics are essentially the same, differing only in which party sells the protection' is misleading because the structure and risk transfer direction differ fundamentally, even if the cash flow formula appears similar. Thus, while the mechanical description of the payout is correct (supporting a moderate quantitative accuracy score), the entity roles and reasoning are flawed, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 461,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both Georgia Power Company and Florida Power & Light Company satisfy the criteria of General Instruction I.(1)(a) and (b) and therefore file their 2022 Form 10‑K with the reduced‑disclosure format. Georgia Power, as a Southern Company subsidiary, is listed among several registrants that file together and its reduced disclosure is governed by General Instructions I(2)(b), (c), and (d). Florida Power & Light, a NextEra Energy subsidiary, is singled out in its combined filing and its reduced disclosure is governed by General Instruction I(2)(b).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core factual assertions: both Georgia Power Company and Florida Power & Light Company qualify for the reduced disclosure format under General Instruction I.(1)(a) and (b) of Form 10-K in their 2022 filings, and both are subsidiaries filing in combined formats. The mention of Georgia Power being part of a multi-registrant filing with Southern Company and governed by General Instructions I(2)(b), (c), and (d) is accurate. However, the LLM incorrectly states that Florida Power & Light Company's reduced disclosure is governed only by General Instruction I(2)(b), whereas the ground truth does not specify any difference in the applicable subparts of I(2) between the two companies—both should be eligible under the same reduced format provisions. Additionally, the LLM omits a key differentiating detail: Florida Power & Light files in a combined form with only one other registrant (NextEra Energy, Inc.), which owns all 1,000 shares of its common stock—a specific structural distinction highlighted in the original answer. While the omission does not invalidate the main conclusion, it reduces completeness in comparing the two companies' filing structures. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound on the main point of eligibility. The answer remains contextually relevant and semantically close to the ground truth, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 401,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX recognizes revenue on U.S. government fixed‑price contracts over time, using a percentage‑of‑completion method that creates contract assets for performance‑based payments (PBPs) and contract liabilities for progress payments, and it treats contract modifications as part of the existing contract on a cumulative catch‑up or prospective basis.  In contrast, GD’s filings state that the Cost Accounting Standards (CAS) govern the allocation of costs to contracts, but they do not provide specific details on how performance‑based payments or contract modifications affect that cost allocation.  Thus, RTX’s approach is explicitly tied to payment terms and modification accounting, whereas GD’s cost‑allocation practice is governed by CAS with less disclosed detail on payment or modification impacts.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of RTX's revenue recognition practices under FAR, including the use of percentage-of-completion accounting, contract assets/liabilities related to performance-based and progress payments, and treatment of contract modifications. It correctly identifies that GD follows Cost Accounting Standards (CAS) for cost allocation, which is consistent with the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (RTX, GD, FAR, CAS, PBPs) are correctly referenced. The answer is contextually relevant and directly addresses the comparison question. However, it omits a key point from the original answer: both companies are subject to government audits and must manage contract modifications in response to broader FAR-mandated acquisition processes (e.g., planning, competition). Additionally, the original emphasizes that RTX highlights impacts on contract assets/liabilities while GD emphasizes compliance and auditability—this nuance is partially captured but not fully synthesized. While the LLM correctly notes GD's lack of disclosed detail, it doesn't fully convey the symmetry in regulatory framework application. Thus, the answer is strong but slightly less complete in multi-hop synthesis, warranting a score of 8 rather than 9-10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 371,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "Alphabet’s Class A shares carry one vote each, while Class B shares carry ten votes per share, giving Class B holders a concentrated voting advantage (see GOOGL page 82). In contrast, Comcast reports that it has no voting rights in its Atairos investment, a VIE that it accounts for under the equity method (see CMCSA page 85). Thus, Alphabet’s dual‑class structure enables a minority of shareholders to wield outsized control, whereas Comcast’s investment in Atairos is largely passive, limiting its ability to influence that entity’s governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: Class A shares have 1 vote, Class B have 10 votes at GOOGL; CMCSA has no voting rights in Atairos. These match the original answer exactly. (2) The answer correctly identifies the dual-class structure at GOOGL and contrasts it with CMCSA's lack of voting control in Atairos, noting the equity method accounting and VIE status—details consistent with the knowledge graph. (3) Multi-hop reasoning is sound: it synthesizes information across GOOGL and CMCSA filings to compare governance structures, correctly concluding that GOOGL concentrates control via share classes while CMCSA lacks influence in Atairos. (4) Minor deduction in qualitative accuracy due to slightly less explicit emphasis on the broader corporate governance implication—while 'passive investment' and 'outsized control' are mentioned, the original answer more clearly articulates the structural contrast in governance mechanisms. However, the LLM answer remains semantically equivalent and factually complete. No issues with entity accuracy (GOOGL, CMCSA, Atairos, equity method) or contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 339,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2022 filing shows that 33 % of its 2021 gross product sales were through McKesson (page 114), a concrete concentration risk that could be disrupted if McKesson faces financial or operational problems (page 46).  Merck’s 2022 risk disclosures similarly flag concentration of sales at certain wholesalers and a single dialysis‑clinic business as a risk (page 14) but do not provide a specific percentage; the filing merely notes that such concentration could negatively affect the business (page 31).  Thus, Amgen’s reliance on McKesson represents a more quantifiable and potentially higher‑impact distribution concentration risk than Merck’s broader, less‑specified disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Amgen's 2022 filing states McKesson accounted for 33% of its 2021 gross product sales, matching the ground truth exactly. It accurately references the risk of financial or operational disruption from reliance on McKesson, consistent with Amgen's disclosure about dependence on three major U.S. distributors. Regarding Merck, the LLM correctly notes that while Merck’s 2022 filing acknowledges concentration risk in distribution (e.g., reliance on certain wholesalers and a single dialysis-clinic business), it does not provide a specific percentage—this aligns with the ground truth, which also lacks a quantified figure for Merck. (2) All numbers and years are accurate: '33%' in 2021 for Amgen is correct; no incorrect calculations were made. The LLM avoids inventing a percentage for Merck, which is appropriate. (3) The multi-hop reasoning is sound: the model synthesizes Amgen’s specific quantitative exposure with Merck’s more general qualitative risk disclosure, then compares them to conclude that Amgen’s risk is more quantifiable and potentially higher impact. This is a logical inference supported by the data. The only minor shortcoming is that the LLM does not explicitly mention Merck’s broader statement about 'third-party relationships and outsourcing' affecting safety/efficacy, which the ground truth includes for industry context. While not critical to the core comparison, this omission slightly reduces completeness. (4) The answer is highly factually accurate, well-reasoned, and directly responsive. The contextual relevance is strong as it directly addresses the comparative risk disclosure question with precise citations and appropriate caution where data is lacking. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 505,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips’ exposure to Alba Plant LLC is a guarantee liability.  At December 31 2024 the maximum potential future payments under the guarantee were about $116 million, with a carrying value of roughly $4 million.  This reflects the risk associated with processing third‑party gas and Chevron’s condensate production at the Alba Unit in Equatorial Guinea.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $116 million maximum potential future payments and $4 million carrying value are accurately reported, consistent with ConocoPhillips' 2024 10-K. The date (December 31, 2024) is appropriate and matches the reporting period. (2) The LLM correctly identifies ConocoPhillips' financial exposure via its guarantee for Alba Plant LLC, which is the core of the question. It also correctly ties the exposure to third-party gas processing and Chevron’s condensate production, reflecting the multi-hop linkage between Chevron’s upstream operations and ConocoPhillips’ downstream financial liability. (3) The qualitative reasoning is sound: the guarantee liability arises from agreements to process gas that includes Chevron’s condensate, and the risk is properly contextualized. However, the LLM omits ConocoPhillips’ 52.2% ownership interest in Alba Plant LLC, which is a relevant detail from the original answer that adds context to the nature of the exposure. While not critical to the core financial figure, it is part of the full picture. (4) Contextual relevance is excellent—the answer directly addresses ConocoPhillips’ financial exposure, the source of risk, and the connection to Chevron’s production. The omission of the ownership percentage prevents a perfect score, but all key financial and operational facts are correct and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 403,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics’ Level 2 assets are valued with a market‑approach model that incorporates observable inputs—interest rates, bond yields and quoted prices for comparable securities (page 83). By contrast, Union Pacific’s real‑estate funds are valued at net asset value using models that rely on unobservable inputs and periodic appraisals, a typical practice for 8‑ to 10‑year‑term private real‑estate vehicles (pages 57 and 88). Thus GD’s Level 2 valuations are more transparent and less model‑dependent than UP’s real‑estate NAV valuations, which are inherently more subjective.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts beyond Union Pacific's $30 million real estate allocation are mentioned in the original answer, and the LLM correctly omits numerical values that aren't in the source—no incorrect numbers are introduced. The absence of the $30M figure in the LLM response is a minor omission but does not distort the comparison. (2) The entities—General Dynamics (GD), Union Pacific (UP), Level 2 assets, real estate funds, NAV, observable vs unobservable inputs—are all correctly identified and contextualized. (3) The multi-hop reasoning is sound: the model correctly links GD’s use of observable inputs (interest rates, bond yields) for Level 2 assets to market-based valuation models, and contrasts this with UP’s use of NAV for real estate funds, which rely on unobservable inputs and long-term appraisals (8–10 years), citing typical practices. (4) The LLM adds interpretive value by concluding that GD’s valuations are more transparent and less model-dependent, which is a reasonable inference from the contrast in input types and does not overstate the facts. The only minor shortcoming is the omission of the specific $30 million figure from Union Pacific’s allocation mentioned in the original answer, which slightly reduces completeness. However, since the focus is on the methodological contrast rather than the amount, this does not significantly detract from correctness. Semantic equivalence is maintained, and contextual relevance is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 426,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role in Costco’s program is that of the **issuer** of a co‑branded credit card (Exhibit 10.8**), providing the credit facility, underwriting and card‑processing services. In contrast, in Colgate’s five‑year credit agreement Citibank acts only as the **administrative agent and arranger** (Exhibit 10‑I), overseeing the loan syndication and handling administrative tasks for the lenders but not serving as the primary lender. Thus, the Costco arrangement gives Citibank a direct credit‑issuing role, whereas the Colgate arrangement limits it to a supervisory, administrative capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the essential distinction between Citibank's roles in the two financial arrangements. (1) It correctly identifies Citibank as the issuer in the Costco co-branded credit card program and as administrative agent and arranger for Colgate's credit agreement, which aligns with the ground truth. The nature of the roles—direct credit issuance vs. administrative oversight—is accurately contrasted. (2) There are no numeric values, dates, or financial figures in the LLM answer, so quantitative accuracy is not compromised; the absence of the amendment dates (October 11, 2023 for Costco, November 4, 2022 for Colgate) and the count of twelve amendments since 2015 is a minor omission but does not affect the core factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the Costco relationship is a consumer-facing credit product where Citibank takes on underwriting and issuance risk, while the Colgate role is limited to administrative and coordination functions in a syndicated corporate loan—this reflects proper understanding across two distinct financial arrangements. (4) The answer is contextually relevant and directly addresses the question about differing natures of involvement. The use of exhibit references (Exhibit 10.8, Exhibit 10-I) adds precision, though not present in the original, they do not detract. The only reason for not scoring a 10 is the omission of the ongoing, amended nature of the Costco program, which adds context about the longevity and evolution of that partnership, slightly enriching the original answer. However, the core functional distinction is fully preserved, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 464,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "Chevron’s stake in QatarEnergy LNG (N3) produced an average of 13 million barrels of crude oil per day in 2023.  With Chevron’s 30 % ownership, its net daily crude‑oil contribution is 13 × 0.30 ≈ 3.9 million barrels per day.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual elements are accurate: Chevron's 30% ownership in QatarEnergy LNG, the 13 million barrels per day (MBD) average daily net crude oil production, and the resulting 3.9 million barrels per day net contribution are all correctly stated. (2) The calculation (13 × 0.30 = 3.9) is accurate and properly reflects the net daily crude oil production attributable to Chevron. Minor formatting differences (e.g., 'million barrels per day' vs 'MBD') do not affect meaning and are semantically equivalent. (3) The multi-hop reasoning—combining ownership percentage with production volume to derive net contribution—is sound and correctly executed. (4) The answer is complete, contextually relevant, and conveys the same information as the original answer with clear, logical presentation. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1122,
        "completion_tokens": 265,
        "total_tokens": 1387
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar values its Level 3 non‑U.S. pension assets with pricing models that “reflect the assumptions a market participant would use” (page 102).  Lockheed Martin, by contrast, values its Level 3 fixed‑income holdings with a discounted‑cash‑flow model that relies on projected annuity payments and discount rates (page 89).  Thus, Caterpillar’s approach is market‑participant‑based for pension instruments, while Lockheed Martin’s method explicitly models cash‑flow projections and discount rates for fixed‑income securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core differences between Caterpillar and Lockheed Martin's Level 3 valuation methodologies. (1) It correctly identifies Caterpillar's use of pricing models based on market participant assumptions for non-U.S. pension assets and Lockheed Martin's use of discounted cash flow models for fixed income investments. The key inputs—projected annuity payments and discount rates—are accurately attributed to Lockheed Martin. (2) There are no numeric values in the question or ground truth requiring calculation, so quantitative accuracy is not applicable in a numerical sense, but all referenced details (e.g., page numbers) align with source documentation and are correctly presented. (3) The multi-hop reasoning is sound: the model synthesizes information from two different companies and asset types, correctly contrasting their approaches. The only minor shortcoming is that the LLM omits mention of Lockheed Martin’s use of 'indicative quotes from vendors and brokers' as part of its methodology, which is included in the ground truth and adds nuance to its broader set of techniques. This omission slightly reduces completeness but does not distort the overall accuracy. (4) The answer remains contextually precise, directly addressing the comparison of inputs and approaches for Level 3 assets. Wording differs from the original answer but maintains semantic equivalence. Thus, the correctness score is 9 due to high accuracy with a minor omission in methodological breadth for Lockheed Martin.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 422,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel’s formulation patents expire in 2037 (page 12), which will likely allow biosimilar entrants and erode revenue from that product within Pfizer’s Specialty Care segment that houses the inflammation‑and‑immunology portfolio (page 10).  If Specialty Care is already concentrated on a few high‑margin products, the loss of Enbrel could heighten revenue‑concentration risk; however, Bristol Myers Squibb’s strategy of investing in future‑pipeline assets rather than relying on existing products (as noted in its 10‑K) may lessen its dependence on Enbrel and help Pfizer diversify its revenue base.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2037 patent expiration for Enbrel and its placement within Pfizer's Specialty Care segment, which aligns with the ground truth. These factual elements are accurate. However, a critical error occurs in the reasoning: the LLM incorrectly states that Bristol Myers Squibb’s external innovation strategy 'may lessen its dependence on Enbrel and help Pfizer diversify its revenue base.' This is factually and logically flawed—Bristol Myers Squibb (BMY) does not own Enbrel (Pfizer does, via a legacy agreement with Amgen), and BMY’s strategy cannot directly help Pfizer diversify its revenue. This misattributes strategic impact across companies, fundamentally undermining the multi-hop logic. (2) Quantitatively, the date '2037' is correct and matches the ground truth; no other numbers are present. Format and references to pages (e.g., page 12, 10) suggest document support, though not required for scoring. (3) The multi-hop reasoning fails: while the model connects Enbrel’s patent cliff to revenue concentration risk in Pfizer’s segment (valid), it incorrectly links BMY’s pipeline strategy to Pfizer’s diversification, reversing competitive dynamics. The ground truth correctly frames BMY as a potential competitive threat in the immunology space post-2037, not a collaborator or aid to Pfizer. (4) Correctness is scored at 5 due to partially correct facts but major reasoning errors; quantitative accuracy is 10 as all dates are correct; qualitative accuracy is 5 due to flawed entity-relation logic; contextual relevance is 8 because the answer addresses the right themes and structure but misrepresents the intercompany relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 460,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework explicitly incorporates scenario‑based modeling and sensitivity analysis to assess stress impacts on its portfolios (see page 83). In contrast, the COF excerpts focus on CECL‑based expected‑credit‑loss calculations and regulatory‑capital adjustments, with no explicit reference to scenario‑based modeling or sensitivity analysis in its credit‑loss forecasting methodology (page 10).",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that COF does not use scenario-based modeling or sensitivity analysis, which directly contradicts the ground truth. The original answer states that COF explicitly uses scenario-based forecasting models for its allowance for credit losses (ACL), incorporating both quantitative forecasts and qualitative adjustments based on current and forward-looking economic conditions. While the LLM correctly identifies AIG's use of scenario and sensitivity analysis for market risk (supported by a page reference), it incorrectly asserts that COF does not employ such methods—this is a critical error in qualitative accuracy. There are no numeric values in the LLM answer, but since the ground truth includes a specific dollar amount ($13.0 billion ACL as of December 31, 2024) that the LLM omits entirely, this represents a significant omission in completeness and factual coverage. The reasoning fails the multi-hop requirement: instead of comparing AIG’s and COF’s respective uses of scenario/sensitivity analysis across market vs. credit risk, it incorrectly concludes a lack of overlap. The contextual relevance is moderate because it addresses the general topic and cites sections, but the substantive comparison is flawed. Overall, the answer misrepresents a key fact and thus cannot score highly on correctness despite technically accurate phrasing about AIG.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 389,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm’s exposure is broad: the company must comply with U.S. Export Administration Regulations (EAR) and ITAR for all advanced semiconductor products, and any failure to obtain the required licenses can delay shipments or trigger penalties【page_35】.  \nAMD’s exposure is product‑specific: new BIS rules bar the export of certain high‑performance computing items (e.g., Instinct GPUs and Versal VC2802/VE2802 FPGAs) to China and require a Notified Advanced Computing (NAC) notification for Versal VC2602/VE2602 FPGAs shipped to China or to customers whose ultimate parent is in a D5 country【page_33】.  Thus Qualcomm faces a general export‑control risk across its semiconductor portfolio, while AMD faces explicit, China‑targeted restrictions on particular high‑performance FPGA and GPU products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key distinction between Qualcomm's broad exposure to EAR regulations and AMD's specific export constraints on certain FPGA products. Qualcomm's general regulatory risk under EAR (and ITAR) is accurately described, aligning with the ground truth's emphasis on a broad regulatory profile. For AMD, the answer correctly identifies the requirement to file a Notified Advanced Computing (NAC) notification for Versal VC2602/VE2602 FPGAs destined for China or D5-country parented customers, which matches the original answer. However, the LLM introduces a minor inaccuracy by referencing 'Versal VC2802/VE2802 FPGAs' as being barred from export, which is not mentioned in the ground truth—only VC2602 and VE2602 are specified. This product name discrepancy affects precision but does not undermine the core reasoning. The mention of 'Instinct GPUs' adds context consistent with AMD's high-performance computing constraints but is not part of the original comparison, making it supplementary but not incorrect. Quantitative accuracy is high: no numerical values are misstated, and the 25-day NAC requirement is implied correctly through the reference to BIS rules and notification timing (though not explicitly stated as 25 days, it's reasonably captured). The multi-hop reasoning is sound—comparing the scope and specificity of export controls across two companies in similar markets—and the synthesis across regulatory frameworks and product lines is appropriate. The answer is semantically equivalent in intent and meaning, with only minor overprecision on FPGA model numbers. Thus, the correctness score is 8 due to the product model error, but all other dimensions remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 468,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "Comcast’s 10‑K shows that it gave up its board seats and “substantially all voting rights” in Hulu, handing Disney full operational control while keeping a minority economic stake (CMCSA page 85).  Meta’s 10‑K, by contrast, uses a dual‑class share structure—Class A shares with one vote and other shares with multiple votes—so the company can raise capital while keeping decision‑making power concentrated in a small group of shareholders (Meta page 1).",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core contrast: CMCSA relinquished voting rights and board seats in Hulu, transferring control to Disney while retaining an economic stake, whereas META uses a dual-class structure to concentrate voting power. This addresses the main conceptual comparison in the question. However, the LLM omits key quantitative details from the ground truth: the 2019 relinquishment date, the $27.5 billion minimum equity value guarantee, and the $8.6 billion payment from Disney in 2023. These are critical financial specifics that ground the strategic trade-off CMCSA made, and their absence significantly reduces quantitative accuracy. While the LLM correctly references the dual-class structure at META with differential voting rights, it does not specify that Class B shares carry 10 votes per share, a key detail in understanding the extent of control retention. The entity identification (CMCSA, META, Hulu, Disney) and years (implied 2019 via context) are accurate. The reasoning is logically sound and synthesizes information across the two companies’ strategies, correctly framing the contrast between external control transfer (CMCSA) and internal control preservation (META). The answer is semantically aligned with the ground truth in broad strokes but lacks precision in numbers and some strategic context (e.g., the put/call arrangement). Wording differences are acceptable, but missing financial figures and structural specifics prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 409,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs’ $113.9 billion in broker‑dealer assets (shown on page 106) underscore the scale of its retail brokerage business, so the firm relies on a comprehensive risk‑management and compliance framework that segregates assets, provides independent oversight and robust internal controls to mitigate conflicts of interest under Regulation Best Interest.  In contrast, Morgan Stanley’s compliance framework is set out in its broker‑dealer and investment adviser regulation section (pages 8–9), where the firm describes the policies, procedures and monitoring it uses to ensure that broker‑dealer recommendations are made in the best interest of retail customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Goldman Sachs' $113.9 billion in broker-dealer assets, matching the ground truth in amount and context (as of December 2024, though the LLM does not specify the date, it references the correct figure from the filing). No calculation is required, and the number is accurate. (2) The LLM accurately references page 106 for Goldman Sachs and pages 8–9 for Morgan Stanley, indicating proper sourcing from the 10-K filings, which supports credibility. (3) The LLM captures the core of both firms' compliance with Regulation Best Interest and correctly frames their conflict-of-interest management frameworks. It notes Goldman’s reliance on segregation, oversight, and internal controls, and Morgan Stanley’s use of policies, procedures, and monitoring—both consistent with the ground truth. However, the LLM omits key comparative elements present in the original answer: it does not mention that both firms face similar regulatory scrutiny or litigation risk, nor does it address how Goldman’s larger asset base may necessitate more extensive monitoring than Morgan Stanley’s, which is a central point in the ground truth comparison. (4) While the LLM provides factually correct and relevant information, it falls short in fully synthesizing the multi-hop comparison—linking asset size to regulatory burden and comparative compliance intensity. This limits qualitative accuracy despite strong factual grounding. The answer remains contextually relevant and semantically aligned on core compliance obligations, warranting high but not top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 435,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan to add fab capacity and attract foundry customers is challenged by Samsung’s own IC development, which reduces Samsung’s need for external foundry services and limits the customer pool Intel can capture (Intel 10‑K, p. 54). For Qualcomm, Samsung’s vertical integration cuts into the demand from a major external IC customer, heightening the risk that its semiconductor revenue—heavily dependent on such customers—could decline (Qualcomm 10‑K, pp. 19‑20).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core dynamics: Intel's IDM 2.0 strategy involving capacity expansion to attract foundry customers, Samsung's in-house IC development limiting its need for external foundries (including Intel), and the potential negative impact on Qualcomm due to reduced demand from Samsung as a customer. These key entities and relationships are accurately represented. (2) There are no numeric values, dates, or financial figures in either the ground truth or the LLM answer, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is partially sound but incomplete. The LLM captures the Intel-Samsung and Samsung-Qualcomm links but omits the broader implication that Samsung’s vertical integration could lead to increased market competition for Qualcomm if Samsung sells its chips beyond internal use. It also misses the second-order effect where Intel, facing limited customer acquisition, might lower foundry prices, thereby affecting the overall semiconductor pricing environment and indirectly impacting Qualcomm’s cost or competitive positioning. This missing synthesis reduces the qualitative accuracy. (4) Contextual relevance is high—the answer stays focused on the three companies and the strategic interplay. However, the omission of indirect pricing effects and competitive market expansion by Samsung limits completeness. Thus, correctness is 7: core facts are right, but important implications from the ground truth are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 422,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "Verizon’s sale of about 11,300 towers to American Tower for a $5 billion upfront payment (page 73) gives the carrier immediate cash and a financing obligation while it retains a 10‑year lease‑back of capacity, preserving long‑term operational control of its network infrastructure. In contrast, Netflix does not make a comparable upfront outlay; it pays ongoing licensing fees for exclusive content, which grants it strategic control over its catalog but exposes it to the risk of content withdrawal and the need to renegotiate rights (page 10). Thus, Verizon trades capital for infrastructure ownership and long‑term lease control, whereas Netflix trades ongoing costs for content differentiation and subscriber retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong factual and semantic alignment. (1) Quantitatively, all key figures are correct: the $5 billion upfront payment and the 11,300 towers are accurately reported, matching the original answer. The reference to 'page 73' and 'page 10' suggests proper sourcing from filings, though page numbers are not part of the ground truth and do not affect accuracy. (2) The answer correctly contrasts VZ's capital-generating transaction (upfront cash inflow) with NFLX's ongoing cost structure (licensing fees), capturing the fundamental difference in financial impact. (3) Multi-hop reasoning is sound: it synthesizes VZ's asset monetization with retained operational control and contrasts it with NFLX's strategic reliance on exclusive content as a cost center. The only minor shortcoming is that the LLM does not explicitly state that VZ continues to depreciate the towers (an important accounting nuance), nor does it clearly emphasize that NFLX’s strategy involves no upfront revenue but rather financial commitments—phrasing that slightly weakens the contrast in strategic financial impact. However, the core logic and entities (VZ, NFLX, American Tower, exclusive rights, lease-back, operational control, content withdrawal risk) are all correctly identified and compared. (4) The answer is contextually relevant, directly addressing both the upfront capital impact and long-term strategic control dimensions of the question. Wording differs slightly (e.g., 'financing obligation' is not in the original and slightly misleading; VZ had no obligation—it received cash), but the overall meaning remains factually sound. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance, and a 9 for qualitative accuracy due to minor omission of depreciation and imprecise phrasing around financial obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 523,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "KO’s effective tax rate rose by 0.8 percentage points in 2021 (the most recent year disclosed) because the company elected to recognize the tax effects of the Tax Reform Act’s Global Intangible Low‑Taxed Income (GILTI) provisions in the period, which added to its tax expense【107†L1-L13】【107†L14-L20】.  In contrast, PEP’s operations in the Philippines were helped by a corporate income‑tax‑rate reduction enacted in the first quarter of 2021, which lowered its effective tax rate and improved profitability in that market【49†L1-L7】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it states that KO's effective tax rate rose by 0.8 percentage points in 2021, but the ground truth specifies a 1.2% impact in 2022 due to GILTI-related pretax charges of $710 million. The year (2021 vs 2022) and the magnitude (0.8 vs 1.2 percentage points) are both incorrect. Additionally, the LLM fails to mention the $710 million pretax charge related to equity method investee impairments, a key factual component. (2) For PEP, the LLM correctly identifies that the corporate tax rate reduction in the Philippines (enacted Q1 2021) had a favorable impact on PEP's effective tax rate and operations, aligning with the ground truth. However, it omits the detail that this contributed to low-single-digit growth in the market and does not acknowledge that the exact magnitude of the tax rate reduction's impact was unspecified but notable. (3) The multi-hop reasoning is partially sound—linking U.S. tax policy (GILTI) to KO’s U.S. tax burden and local tax changes in the Philippines to PEP’s local operations—but the incorrect year and quantitative figures undermine the synthesis. The contrast between GILTI increasing KO's tax burden versus local tax cuts benefiting PEP is conceptually captured, but with flawed data. (4) The contextual relevance is high as the answer addresses both companies and the relevant tax provisions. However, due to significant quantitative errors and missing key financial figures, the correctness score is moderate. The qualitative accuracy is acceptable but not strong due to misaligned data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 439,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The $1.3 billion of retained earnings at Nicor Gas is “restricted” by regulation, meaning Nicor Gas cannot use that amount to pay dividends or loans to affiliates.  Consequently, Southern Company’s ability to receive dividend income from Nicor Gas is limited to the portion of Nicor’s earnings that is not restricted, effectively reducing the potential dividend payout from that key subsidiary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitative accuracy is perfect: the $1.3 billion figure is correctly cited and no calculations are required. (2) The answer correctly identifies that Nicor Gas is a regulated subsidiary under Southern Company Gas and that the $1.3 billion in retained earnings is restricted from being distributed as dividends or loans to affiliates. (3) The reasoning is sound: it logically connects the restriction on retained earnings to a reduced dividend payout capacity, which in turn limits Southern Company's dividend income. This captures the core multi-hop relationship: restricted earnings → limited dividends → reduced cash inflow to parent. (4) While the LLM answer omits a minor detail about the broader impact on Southern Company’s consolidated cash flows and financial flexibility (mentioned in the original answer), it still captures the essential causal chain and entity relationships. The omission does not undermine the correctness of the main conclusion. Therefore, the answer is semantically equivalent in key aspects and deserves a high score, though not perfect due to slight incompleteness in contextual implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 338,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "GM disclosed compliance‑related costs of **$1.0 billion in 2024, $0.7 billion in 2023, and $0.5 billion in 2022** to meet evolving safety and emissions standards under the National Traffic and Motor Vehicle Safety Act (page 12). Tesla’s 2024 10‑K does not provide a specific dollar figure for safety‑related compliance costs; it only notes that regulatory changes could increase costs (page 27). Thus, GM’s safety‑compliance expenses are quantifiable and higher, whereas Tesla’s are acknowledged as a potential cost driver but remain undisclosed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The LLM claims GM disclosed compliance costs of $1.0 billion in 2024, $0.7 billion in 2023, and $0.5 billion in 2022. However, the original answer (ground truth) does not include any specific dollar figures for compliance costs for either GM or Tesla. There is no mention of these exact numbers in the ground truth, and no such figures are supported by the knowledge graph. This fabrication of precise financial data severely compromises quantitative accuracy. (2) COMPLETENESS: The question asks for a comparison of Tesla’s and GM’s compliance costs in the context of evolving safety standards and regulatory complexity under the National Traffic and Motor Vehicle Safety Act. The ground truth emphasizes that both companies face rising costs due to global regulatory divergence, with GM highlighting lack of harmonization as a key cost driver. The LLM answer incorrectly implies GM provides quantified safety-compliance costs, which is not confirmed in the ground truth, and misrepresents Tesla’s disclosure as merely a generic risk factor, missing the specific discussion of Autopilot and FSD regulatory challenges. (3) ENTITY & CONTEXTUAL ACCURACY: While the companies (Tesla, GM) and the regulatory framework (National Traffic and Motor Vehicle Safety Act) are correctly identified, the LLM introduces unverified details (e.g., page numbers, exact dollar amounts) not present in the ground truth. (4) REASONING: The multi-hop reasoning fails because the LLM invents numerical data to create a false contrast (GM has quantifiable costs, Tesla does not), whereas the ground truth makes no such numerical comparison and instead focuses on qualitative similarities in how both firms are affected by global regulatory complexity. The conclusion that GM’s costs are 'higher' is unsupported. (5) SEMANTIC EQUIVALENCE: The LLM answer diverges significantly in meaning by introducing false precision and a misleading comparison. Overall, the answer is partially relevant but factually incorrect in critical aspects, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 577,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics has recorded $305 million in other contract costs as a deferred asset under FAR, meaning the costs are not yet allocated to contracts and will only be recognized when they can be matched to future work—this reduces current expenses but could become a future liability if backlog shrinks. In contrast, Raytheon Technologies’ fixed‑price U.S. government contracts expose the company to immediate cost‑overrun risk, as any excess costs beyond the agreed price directly erode profit and can trigger negative profit adjustments. Thus, GD’s approach defers risk to the future, while RTX’s approach places the risk on the present profitability of each contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $305 million figure is correctly stated and attributed to General Dynamics' deferred contract costs under FAR, with no calculation required. Format is consistent and precise. (2) The answer correctly identifies the key contrast: General Dynamics defers costs as an asset with future allocability, while Raytheon (RTX) bears immediate risk of cost overruns on fixed-price contracts. This captures the core financial risk distinction. (3) Multi-hop reasoning is sound—synthesizing GD’s cost-deferral model under FAR with RTX’s exposure on firm fixed-price contracts, and contrasting their risk timing (deferred vs. immediate). The mention of potential future liability if backlog shrinks adds nuance not in the original but is a reasonable inference. (4) Minor deduction in qualitative accuracy because the original emphasizes that GD’s recovery is expected through existing backlog and follow-on contracts, and explicitly notes FFP contracts as a significant portion of RTX’s portfolio—details slightly more precise than the LLM’s summary. However, the LLM conveys semantically equivalent information with correct entities, logic, and context. No factual errors; wording differences are acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 360,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue climbed from $10,058 million in 2019 to $13,461 million in 2021, a compound annual growth rate of roughly **15.7 %**. Apple’s Greater China segment grew from $68,366 million in 2020 to $74,200 million in 2021, an 8.5 % one‑year increase (≈8.5 % CAGR over the two‑year span if 2019 data were available). Consequently, Intel’s Taiwan growth outpaced Apple’s Greater China growth by about **7 percentage points**.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While Intel's Taiwan revenue figures ($10,058M in 2019 and $13,461M in 2021) and its CAGR (~15.7% vs. correct 15.6%) are approximately correct, Apple's data is completely wrong. The LLM incorrectly uses Apple's 2020–2021 revenue growth ($68,366M in 2020 to $74,200M in 2021), ignoring the required 2019–2021 period. The correct Apple Greater China revenue was $40,308M in 2019 and $68,366M in 2021, yielding a CAGR of ~30.8%, not the 8.5% claimed. (2) Calculations: Intel's CAGR is slightly miscalculated (15.7% vs. 15.6%), but more critically, the LLM fails to compute Apple's actual CAGR over 2019–2021, instead using a one-year growth rate and misrepresenting it as a two-year CAGR. The conclusion that Intel outpaced Apple is false—Apple grew at more than double Intel's rate. (3) Multi-hop reasoning is flawed: the question requires comparing CAGRs over the same 2019–2021 period for both companies, but the LLM uses mismatched timeframes (2019–2021 for Intel, 2020–2021 for Apple), failing to synthesize the correct data points. (4) Scores justified: Correctness is low (2/10) due to major factual and calculation errors; Quantitative accuracy is poor (3/10) due to wrong numbers and incorrect CAGR logic; Qualitative accuracy is low (2/10) due to flawed reasoning and entity/timeframe mismatches; Contextual relevance is moderate (5/10) as the answer addresses the right companies and metric but with incorrect data and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 415,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s $70 billion repurchase authorization (page 82) cuts the number of Class A and C shares outstanding, which can lift the share price and earnings‑per‑share and therefore make converting a Class B share into a Class A share more attractive for Class B holders.  Meta’s own 2024 filing (page 1) shows its Class A base (~2.19 billion shares) far exceeds its Class B base (~344 million shares), meaning a one‑for‑one conversion would add only a small number of shares to a large pool and the repurchase program would offset any dilution—so Class B shareholders will weigh the potential price premium against the requirement to sell or transfer the newly acquired Class A shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Meta's Class A (~2.19 billion) and Class B (~344 million) shares match the original answer's 2,189,898,148 and 343,761,117, respectively, with acceptable rounding. The $70 billion repurchase figure is correctly cited. (2) The reasoning correctly identifies that Alphabet's repurchase of Class A shares could increase their value, making conversion from Class B to Class A more attractive due to potential price appreciation. (3) The multi-hop synthesis between Alphabet’s repurchase program and Meta’s capital structure is logically sound: the LLM correctly contrasts the relative size of Meta’s Class A float, noting that conversion would add only a small number of shares to a large pool, thus reducing scarcity effects. (4) The answer mentions the requirement for Class B shareholders to sell or transfer newly acquired Class A shares post-conversion, which adds nuance not explicitly in the ground truth but is contextually valid. The only minor shortcoming is that it does not explicitly state that Meta's large Class A float may *temper urgency* for conversion compared to Alphabet—though this is implied in the discussion of dilution and repurchase offset. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 378,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo’s RSUs accrue dividend equivalents that are paid in cash (without interest) when the award vests and becomes payable, and the awards vest on the third anniversary of the grant date and are subject to forfeiture if employment conditions are not met【page_92】.  Philip Morris International’s RSUs also earn dividend equivalents, but the filing does not state that they are paid in cash upon vesting or that they are tied to employment‑based forfeiture, so the company’s financial obligation is not explicitly disclosed as a cash outflow at vesting【page_110】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key details and contains incomplete or inaccurate reasoning, particularly regarding Philip Morris International (PMI). (1) Correctly identifies that PepsiCo accrues dividend equivalents paid in cash upon vesting and that RSUs vest on the third anniversary of the grant date. However, the ground truth does not specify that PepsiCo's awards vest on the third anniversary—this detail is incorrectly attributed with no support in the original answer, which only states that dividend equivalents are paid upon vesting. (2) For PMI, the LLM claims the filing does not state whether dividend equivalents are paid in cash upon vesting or tied to employment-based forfeiture, implying uncertainty. However, the original answer confirms PMI *does* accrue dividend equivalents on RSUs and had $160 million in unrecognized compensation costs as of December 31, 2023—this financial obligation is a critical quantitative fact entirely missing from the LLM response. (3) The LLM fails to mention that PMI’s RSUs generally vest on the third anniversary of the grant date and do not carry voting rights—key vesting condition details. (4) The statement that PMI’s financial obligation is 'not explicitly disclosed as a cash outflow at vesting' contradicts the ground truth, which implies such obligations are recognized through amortization of $160 million in costs. (5) Quantitative accuracy is scored higher because no incorrect numbers are stated—just omission of the $160M figure. (6) Multi-hop synthesis is weak: the model fails to connect PMI’s dividend equivalents to its financial obligations and vesting timeline. While contextually relevant and mostly well-reasoned, the omissions and one incorrect detail (PepsiCo vesting timing) reduce correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 492,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "DHR values its private‑investment holdings at net asset value (NAV) and, when NAV is not available, applies discounted‑cash‑flow, earnings, market‑multiple or appraisal methods—an approach that the company admits can yield different fair‑value measurements because of the estimates and assumptions involved (pages 98‑99).  Eli Lilly records acquired intangible assets at fair value, using management’s estimates of fair value for those assets, a process that likewise requires significant judgment and can materially affect reported amounts (page 68).  Both disclosures highlight that the valuation methods are inherently subjective and that the resulting figures can materially influence the companies’ financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both DHR's and LLY's valuation methods and correctly identifies the inherent subjectivity in both approaches. It accurately reflects that DHR uses NAV and, when unavailable, applies discounted cash flow, earnings multiples, or appraisals, citing the associated estimation uncertainty (pages 98–99). It also correctly states that LLY values acquired intangible assets at fair value using management estimates requiring significant judgment (page 68), aligning with the ground truth. However, the LLM answer omits the specific $3.80 billion charge for IPR&D in 2023, a key quantitative detail from the original answer that demonstrates the material impact of LLY’s valuation process. While the qualitative reasoning and entity identification (DHR, LLY, valuation methods, subjectivity) are sound and contextually relevant, this omission reduces completeness. The multi-hop synthesis—comparing two companies’ fair value methodologies and their disclosed uncertainties—is well executed, but the lack of the concrete LLY financial figure prevents a top score. All non-numeric content is semantically equivalent to the ground truth, and no incorrect facts or numbers are introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 345,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "NVIDIA generated **$8.544 billion** in revenue from Taiwan in 2022 (see NVIDIA 10‑K, page 100).  \nApple reported **$74.2 billion** in net sales for its Greater China segment in 2022 (which includes Taiwan, see Apple 10‑K, page 52). Thus, Apple’s Greater China revenue is roughly **8.7 times larger** than NVIDIA’s Taiwan revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures are accurate: NVIDIA's $8,544 million is correctly reported as $8.544 billion, and Apple's $74,200 million is correctly reported as $74.2 billion—both are equivalent representations. The comparison stating Apple’s revenue is 'roughly 8.7 times larger' is mathematically sound: 74.2 / 8.544 ≈ 8.68, which rounds to 8.7. (2) The answer is complete, addressing both companies' revenues, the relevant year (2022), and the geographic scope (Taiwan vs. Greater China including Taiwan). (3) Entity accuracy is correct: NVIDIA and Apple are properly identified, with accurate financial metrics (revenue/net sales) and correct geographic segments. (4) The multi-hop reasoning is sound—the model correctly synthesizes that Apple includes Taiwan within Greater China, and thus the comparison involves different levels of geographic granularity, even if not explicitly restated in the same terms as the original answer. The conclusion effectively communicates the relative scale. (5) The semantic meaning is equivalent to the ground truth, with added clarity in the numerical comparison. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 349,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "Comcast’s Class B shares carry a non‑dilutable 33.33 % of the company’s voting power and are wholly owned by CEO Brian L. Roberts, giving him effective control (see CMCSA pages 35 and 38). In contrast, Alphabet’s Class A shares are widely held—300 million shares outstanding with no special voting rights and no single shareholder holding a controlling stake—resulting in a dispersed ownership structure (see GOOGL page 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the 33.33% voting power (equivalent to 33⅓%) for CMCSA's Class B stock and the ~300 million shares outstanding for GOOGL (300,754,904 rounded to 300 million is acceptable for summary purposes) are accurate. The statement that Brian L. Roberts wholly owns the Class B shares aligns with the original. (2) The LLM correctly identifies that CMCSA Class B shares carry super-voting rights (implied by non-dilutable 33.33% control) and are concentrated, while GOOGL Class A shares are widely held with no controlling stake or special voting rights—this captures the essence of the governance contrast. (3) Multi-hop reasoning is sound: the model synthesizes ownership concentration at CMCSA with dispersed structure at GOOGL and draws a valid comparison in control dynamics. (4) Minor deduction in qualitative accuracy because the LLM omits explicit mention that CMCSA Class B shares carry 15 votes per share (a detail in the ground truth that explains the super-voting mechanism), though the effect (effective control) is correctly inferred. Otherwise, entity names (CMCSA, GOOGL), roles (Brian L. Roberts as CEO), and contextual details (page references) are accurate and relevant. The answer is concise and directly responsive to the comparative governance question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 387,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "UnitedHealth Group’s equity‑compensation plans approved by shareholders show 25 million shares that could be issued upon exercise of outstanding options and 241 million shares still available for future issuance, giving a ratio of **≈9.6 : 1** (241 / 25).  \nJohnson & Johnson’s similar plans list 133.8 million shares issuable upon exercise and 240.3 million shares remaining, a ratio of **≈1.8 : 1** (240.3 / 133.8). Thus, UnitedHealth Group’s ratio is roughly five times higher than Johnson & Johnson’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key numbers for both companies: UnitedHealth Group's 25 million issuable and 241 million remaining available shares, and Johnson & Johnson's approximately 133.8 million and 240.3 million, which closely match the ground truth values of 133,794,708 and 240,344,013. The rounding is reasonable and does not affect factual accuracy. (2) Calculations are accurate: 241 / 25 ≈ 9.64 → reported as ≈9.6:1 (acceptable rounding); 240.3 / 133.8 ≈ 1.795 → reported as ≈1.8:1, which is correct. The comparison that UnitedHealth Group’s ratio is roughly five times higher is logically sound (9.6 / 1.8 ≈ 5.33). (3) Multi-hop reasoning is correct—information from two different companies and their respective equity plans is synthesized properly to compute and compare ratios. (4) All entities (UnitedHealth Group, Johnson & Johnson, equity compensation plans, shares issuable, remaining available) are correctly identified and contextualized. The only minor limitation is the slight rounding of Johnson & Johnson’s figures without explicit mention of exact values, but this does not detract from overall correctness. Hence, the answer is factually accurate, complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 353,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD’s risk is mainly a supply‑chain issue: the company “depends on third‑party companies for the design, manufacture and supply of motherboards, graphics cards, software, memory and other components” (AMD 10‑K, p. 28), a risk that could disrupt delivery but is not tied to a single customer’s sales.  By contrast, Intel’s 2021 data show Dell Inc. alone accounted for 21 % of its net revenue, a clear revenue‑concentration risk (Intel 10‑K, p. 87).  Thus, Intel faces a higher concentration risk from one customer than AMD, whose revenue concentration is not highlighted and is likely more diversified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 21% of Intel's net revenue from Dell Inc. in 2021 is accurately cited, matching the original answer. The fiscal year (2021) and entity (Dell Inc.) are correct. (2) The LLM correctly identifies AMD's reliance on third-party suppliers for motherboards and other components, citing the appropriate risk (supply chain disruption), and contrasts it with Intel's customer concentration risk. It correctly notes that AMD does not have a highlighted revenue concentration risk, implying diversified customer exposure, which is consistent with the ground truth. (3) The multi-hop reasoning is sound: it synthesizes information from AMD’s and Intel’s respective 10-K filings to compare two different types of business risks—supply chain vs. customer concentration—across companies. (4) The only minor shortcoming is that the LLM does not explicitly mention Intel’s accounts receivable exposure to Dell, which is included in the original answer and adds depth to the revenue concentration risk. However, this omission does not undermine the core correctness of the comparison. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 376,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Union Pacific’s 2024 filing notes that Louisiana’s corporate‑tax cut lowered its deferred‑tax expense by $34 million (page 29) – a direct tax‑burden reduction that benefits the company because it operates a yard in Livonia, Louisiana (page 18). Boeing, by contrast, has no reported Louisiana tax exposure in its 10‑K, and its financial performance is tied to federal defense appropriations and broader legislative dynamics (page 10), so the state tax cut does not materially affect Boeing’s financial exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense is correctly reported, matching the original answer. The reference to Union Pacific’s operations in Livonia, Louisiana, is factually correct and supports the direct benefit. (2) The answer correctly identifies that Boeing has no direct exposure to Louisiana’s tax changes and ties its financial exposure to federal appropriations and legislative dynamics, consistent with the ground truth. (3) The multi-hop reasoning is sound: it synthesizes Union Pacific’s operational presence with the tax law change and contrasts it with Boeing’s lack of state-level exposure and reliance on federal funding. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the broader legislative dynamics linking Louisiana’s tax policy environment to federal budget uncertainty—though it implies it by referencing 'broader legislative dynamics.' This slight omission in contextual linkage prevents a perfect 10 on qualitative accuracy. Otherwise, all entities, years, and financial metrics are correct, and the answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 341,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s charter is straightforward – every share of common stock carries one vote (see page 60).  Meta’s 10‑K discloses a dual‑class structure, with Class A and Class B common stock that carry different voting rights (page 1).  Charter Communications’ notes explain that its Class A shares also have one vote per share, while its Class B shares carry a number of votes tied to Charter Holdings units, illustrating how a dual‑class structure can create unequal voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Netflix has a one-vote-per-share model, Meta has a dual-class structure with different voting rights (though exact voting power not specified), and Charter’s Class A has one vote per share while Class B voting rights are tied to Charter Holdings units. These points align with the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to voting rights (1 vote per share, variable rights) are correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance models across Netflix, Meta, and Charter, drawing a valid contrast between Netflix’s egalitarian structure and the tiered systems of the others. It accurately notes that Meta discloses a dual-class structure but does not specify exact voting rights—consistent with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that Meta’s lack of specification on voting power contrasts with Charter’s detailed disclosure, which slightly weakens the comparative analysis. However, this nuance is implied rather than omitted. Wording differs but semantic meaning is equivalent. All entities (Netflix, Meta, Charter Communications), stock classes, and governance features are correctly identified. The answer is fully relevant and responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 416,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP’s filing notes that exchange‑traded commodity futures are cash‑settled daily, so the fair value used is the daily settlement price quoted on the exchange (page 107). MDLZ’s Level‑1 liabilities are valued using quoted market prices from commodity exchanges (page 112), meaning the same daily settlement price serves as the observable input. Thus the daily cash‑settlement mechanism simply reinforces MDLZ’s existing Level‑1 valuation approach, ensuring that fair values are based on up‑to‑date, observable market prices without altering the methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: PEP’s 2022 filing states that exchange-traded commodity futures are cash-settled daily (page 107), and MDLZ values its Level 1 financial liabilities using quoted market prices from commodity exchanges (page 112). These details match the original answer. (2) There are no numeric values requiring calculation, but references to page numbers and mechanisms (daily cash settlement, use of exchange quotes) are correctly cited and consistent with the source documents. Format variations are not applicable here, but the answer correctly interprets 'quoted market prices' as observable inputs tied to daily settlement prices. (3) The multi-hop reasoning is sound: the model correctly links PEP’s description of market practice to MDLZ’s valuation methodology, recognizing that the daily cash-settlement mechanism underpins the use of observable prices without changing the Level 1 classification. The conclusion that this mechanism 'reinforces' rather than alters MDLZ’s approach is logically consistent with the original answer’s claim that it 'directly informs' the methodology. (4) Minor deduction in qualitative accuracy due to slightly less explicit emphasis on the balance sheet exclusion mentioned in PEP’s filing (i.e., not being included in year-end tables), which adds nuance to the market practice point. However, this does not undermine the core correctness. Overall, the answer is highly relevant, precise, and synthesizes across both companies and filings appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 435,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s 2022 net sales in the Greater China region (which includes China mainland, Hong Kong and Taiwan) were **$74.2 billion**【page_25】.  \nAMD’s 2022 sales in Taiwan are not disclosed in the AMD 10‑K pages that were provided, so a direct numeric comparison cannot be made.  \nGiven the available data, Apple’s Greater China sales are far larger than AMD’s likely Taiwan‑only sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Apple's 2022 net sales in the Greater China region as $74.2 billion (equivalent to $74,200 million), which matches the ground truth in both value and context. However, it incorrectly states that AMD’s 2022 sales in Taiwan are not disclosed, when in fact the ground truth explicitly provides AMD’s 2022 Taiwan sales as $2,091 million. This is a critical factual omission that undermines the answer’s correctness. (2) Quantitatively, the Apple figure is accurate and properly formatted ($74.2 billion = $74,200 million), but the failure to report AMD’s disclosed number breaks the comparative analysis. The claim that 'AMD’s 2022 sales in Taiwan are not disclosed' contradicts the ground truth and suggests a failure to access or interpret the provided data. (3) The reasoning is partially sound in structure—comparing Apple’s regional sales to AMD’s country-specific sales—but fails on multi-hop synthesis because it does not integrate the known AMD figure. The conclusion that Apple’s sales are 'far larger' is directionally correct but unsupported by the cited evidence in the LLM’s response. (4) The contextual relevance is fair because the answer addresses the geographic and market exposure question, but the omission of a key data point severely limits its usefulness. Correctness is scored low due to the failure to report a central fact required for the comparison, despite partial numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 401,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy records environmental‑remediation costs as operating expenses unless a regulator has approved a recovery mechanism, and it only sets up reserves when losses become probable and estimable (see the “Reserves for Environmental Remediation” table on page 163).  In contrast, Southern Company Gas’s natural‑gas utilities have specific regulatory riders that allow the recovery of environmental‑remediation costs as part of their approved cost‑recovery mechanisms (see page 22).  Consequently, Duke Energy’s exposure to remediation liabilities is higher and less recoverable, whereas Southern Company Gas can offset those costs through its regulatory rate‑adjustment framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy expenses remediation costs as incurred unless recovery is probable, and only establishes reserves when losses are probable and estimable. Southern Company Gas has specific regulatory riders allowing recovery of environmental remediation costs in its natural gas utilities. These points match the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts Duke's contingent, less predictable cost recovery with Southern Company Gas's structured, approved recovery mechanisms, leading to the valid conclusion that Southern has lower direct exposure. The mention of specific document pages (e.g., page 163, page 22) adds precision, though not required. (4) The only reason for not scoring a perfect 10 is minor wording: the LLM refers to 'Southern Company Gas' throughout, while the original answer distinguishes 'Southern Company' more broadly but specifies its gas utilities—this is a nuance, not an error, as the context refers to the gas segment. Overall, the semantic meaning, factual content, and reasoning are equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 371,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "LOW’s fair‑value measurement of financial assets and liabilities relies on broker‑dealer quotes as observable inputs to Level‑2 pricing models (see page 54). GM, in contrast, uses valuation models to estimate product warranty reserves, with internal controls over the models and assumptions (see page 56). Both companies employ industry‑standard models, but LOW applies them to market‑based fair‑value measurement, while GM applies them to forecast future warranty costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinctions between LOW and GM's use of valuation models as described in the ground truth. (1) All factual elements are correct: LOW uses broker/dealer quotes as observable inputs for Level 2 fair value measurements, which aligns with market-based, industry-standard pricing models using observable data. GM uses valuation models for warranty reserves involving internal assumptions and controls. The entities (LOW, GM), financial concepts (Level 2 fair value, warranty reserves), and document references (page 54, page 56) are accurate. (2) There are no numeric values requiring verification in either the ground truth or LLM answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound—correctly contrasting LOW’s market-driven, observable-input approach with GM’s forecast-driven, assumption-heavy method. The LLM captures the key difference in judgment vs. market data reliance, though it omits specific details like 'warranty claims frequency' or 'issuer spreads' mentioned in the original. This minor lack of granularity slightly reduces qualitative completeness but does not affect correctness. (4) The answer is contextually fully relevant, directly addressing the comparison of model usage across firms and applications. Wording differs but semantic meaning matches. Minor omission of specific assumptions in GM's model prevents a perfect 10, but overall the response is factually correct, well-reasoned, and complete at a high level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 418,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Under the Basel III Finalization Proposal, both Capital One and Citigroup will be required to calculate risk‑weighted assets under the new Expanded Risk‑Based Approach and the existing Standardized Approach and use the lower of the two ratios for each capital metric (page 48).  The proposal’s effective date of July 1 2025, with a three‑year transition period, is expected to tighten regulatory capital for both banks; for Citi the change is projected to materially raise its CET1, Tier 1 and total capital ratios and affect its TLAC, external long‑term debt and GSIB surcharge calculations (page 48).  Capital One, while subject to the same lower‑ratio rule, will likely see a smaller increase in capital requirements due to its comparatively lower risk‑weighted asset base (page 121).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all key dates (July 1, 2025 effective date, three-year transition) are accurate, and there are no numerical errors. The mention of page references (e.g., page 48, 121) suggests source fidelity, though these are not part of the ground truth evaluation. (2) The core requirement—calculating risk-based capital under both the Expanded Risk-Based Approach and the existing Standardized Approach, using the lower of the two ratios—is correctly stated. (3) The answer correctly identifies that Citigroup would face a material increase in capital requirements (CET1, Tier 1, total capital), impacting TLAC, debt, and GSIB surcharge, which is consistent with the ground truth’s statement about a 'material' increase. (4) For Capital One, the answer correctly notes the phased-in transition and implies a smaller impact due to its lower risk-weighted asset base, which aligns with the ground truth’s focus on a three-year transition. However, the LLM omits the explicit statement that both banks must comply with all capital buffer requirements regardless of which approach yields the lower ratio—a key constraint mentioned in the original answer. This omission slightly weakens completeness and multi-hop synthesis, as the interaction between the lower-ratio rule and buffer requirements is part of the regulatory impact. (5) The reasoning is sound and reflects proper multi-hop synthesis across both banks and regulatory mechanisms. Wording differs but maintains semantic equivalence on major points. Overall, the answer is factually strong, contextually relevant, and accurately captures the differential impact on the two banks, meriting a high score with a slight deduction for missing the capital buffer compliance nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 501,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips’ condensate exposure comes through its 52.2 % stake in Alba Plant LLC, a joint‑venture that extracts and sells condensate from the Alba Unit natural‑gas stream 【page_12】.  By contrast, Chevron’s 2024 10‑K shows no condensate reserves, implying it has no direct condensate‑production volumes 【page_108】.  Thus, ConocoPhillips has a tangible condensate‑production exposure via its joint venture, whereas Chevron does not produce condensate directly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 52.2% stake in Alba Plant LLC is correctly reported, and the absence of condensate reserves in Chevron's 2024 10-K is accurately stated. No calculations are required, but the comparison is factually sound. (2) The answer addresses all parts of the multi-hop question: it identifies ConocoPhillips' indirect exposure via Alba Plant LLC and contrasts it with Chevron's lack of direct condensate production, based on the 2024 filing. (3) Multi-hop reasoning is correct—synthesizing ConocoPhillips' equity interest with Chevron's disclosed reserves requires cross-company, cross-document analysis, which the model performs accurately. (4) The only minor limitation is that the LLM does not explicitly mention that Chevron also reports zero condensate production (not just reserves), nor does it reference 'Equity in earnings of affiliates' as the income line item, which adds slight contextual depth in the original answer. However, stating 'no condensate reserves' implies no production, especially in context, so this does not constitute a factual error. Wording differences are semantically equivalent. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 354,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "AVGO’s 10‑K does not reference ASU 2020‑04; the company continues to recognize revenue when performance obligations are satisfied under ASC 606, so the update had no material effect on its revenue‑recognition accounting (see AVGO page 62).  \nOracle, by contrast, finalized adoption of ASU 2020‑04 in FY 2024, which provides optional relief for contracts and contract modifications affected by reference‑rate reform (e.g., LIBOR replacement) and applies to modifications made between March 12 2020 and December 31 2024, but the guidance had no material impact on Oracle’s consolidated financial statements or notes (see ORCL pages 72 and 167).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all dates (March 12, 2020, to December 31, 2024), fiscal periods (ORCL's FY 2024 adoption), and the key fact of 'no material impact' on financial statements are correct. Number formats and dates match or are semantically equivalent. (2) The answer correctly identifies that ORCL adopted ASU 2020-04 with optional relief for reference rate reform (e.g., LIBOR), and that it had no material effect—both in financial statements and notes—aligning with the original answer. (3) For AVGO, the LLM states its 10-K does not reference ASU 2020-04 and that there was no material effect, which is consistent with the ground truth that AVGO applied the guidance but reported no material impact. However, the LLM omits AVGO’s specific practices around standalone selling prices and prospective/cumulative accounting for modifications, which are part of the original answer. This is a minor omission in qualitative detail but does not undermine the correctness. (4) The reasoning is sound: it distinguishes between AVGO’s lack of reference (implying no change) and ORCL’s explicit adoption, and correctly ties ASU 2020-04 to reference rate reform and contract modifications. The multi-hop synthesis across two companies and the ASU’s impact is well executed. (5) Contextual relevance is perfect—the response directly addresses both parts of the question: impact on AVGO’s revenue recognition and ORCL’s financial reporting in relation to reference rate reform. The only reason for not scoring a 10 is the omission of AVGO’s methodological details on standalone selling prices and allocation in bundled arrangements, which are part of the original answer’s qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 480,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "META’s dual‑class structure gives Mr. Zuckerberg the ability to control corporate decisions even when he owns less than a majority of the company’s shares, limiting the voting power of Class A holders and making that class less attractive (page 50).  Comcast, by contrast, issues Class B shares that carry 15 votes each and represent a fixed, non‑dilutable 33 ⅓ % of total voting power; those shares are convertible share‑for‑share into Class A, allowing holders to increase their influence but without the same concentrated control that META’s structure provides (page 91).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences between META's and CMCSA's dual-class structures. Quantitatively, it accurately states CMCSA's Class B shares carry 15 votes and represent a non-dilutable 33⅓% of total voting power, and correctly notes the share-for-share convertibility into Class A. It also correctly identifies that META's structure gives Zuckerberg outsized control, disadvantaging Class A shareholders. However, the LLM omits a key detail from the ground truth: META's requirement for a majority of Class B shares to approve change-of-control transactions until their voting power falls below 35%. This is a significant governance mechanism that strengthens the comparison and reflects deeper multi-hop synthesis. While the LLM conveys that META’s control is more concentrated, it does not fully explain the structural rigidity (class-specific vote requirements) that entrenches control, instead attributing it generally to 'concentrated control.' The reasoning is sound and entities are correct (META, CMCSA, Class A/B shares), and the answer is highly relevant to the question. Minor omission prevents a top score, but core facts and numbers are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 335,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PEP notes that its exchange‑traded commodity futures are cash‑settled daily and therefore are not shown in the recurring fair‑value table (page 107), although they are classified as Level 1 assets (page 112). In contrast, Costco’s 2022 note states that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis (page 51), indicating it does not hold such futures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: PEP uses exchange-traded commodity futures that are cash-settled daily and excludes them from its recurring fair value table, consistent with the original answer (December 25, 2021 date omitted but implied contextually). These are classified as Level 1 assets, aligning with MDLZ's definition referenced in the ground truth. COST’s disclosure as of August 28, 2022, correctly states no Level 1 or Level 3 financial assets/liabilities measured at fair value on a recurring basis. (2) No numeric inaccuracies: although exact dates are slightly different in phrasing (not explicitly stated in LLM answer), the fiscal periods are contextually accurate and do not affect the substance. (3) Multi-hop reasoning is sound—correctly synthesizes PEP’s treatment of futures, their classification as Level 1, and contrasts with COST’s absence of such holdings. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention MDLZ’s role in defining Level 1 assets (a subtle but present link in the ground truth), though the conclusion remains valid. Otherwise, the answer is concise, factually correct, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 353,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs reported **$1.634 billion** in securities loaned with maturities of 31‑90 days (GS 10‑K, page 187). Morgan Stanley reported a **total of $13.946 billion** in securities loaned (MS 10‑K, page 149). Thus, GS’s short‑term lending exposure is only about 12 % of MS’s total securities‑loaned program, indicating a comparatively lower exposure to short‑term securities‑lending risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Goldman Sachs has $1,634 million (or $1.634 billion) in securities loaned with maturities of 31-90 days, which the LLM correctly reports. However, the LLM incorrectly states that Morgan Stanley reported a total of $13.946 billion in securities loaned, which is completely inaccurate—ground truth shows Morgan Stanley’s total securities loaned (U.S. and Non-U.S. combined) is $281 million. This is a severe quantitative error. (2) The calculation comparing Goldman Sachs’ $1.634 billion to Morgan Stanley’s $13.946 billion is therefore invalid. The correct comparison is $1,634M (GS) vs $281M (MS), meaning GS has over 5.8 times more in short-term securities lent than MS, not 12% as claimed. The LLM’s conclusion is the inverse of the correct inference. (3) The multi-hop reasoning fails because the model used an incorrect value for Morgan Stanley, breaking the entire comparative analysis. The synthesis across companies is structurally sound but based on false data. (4) The contextual relevance is partially maintained because the answer attempts the right comparison and cites relevant metrics, but due to the massive numerical inaccuracy and reversed conclusion, the correctness and qualitative accuracy scores are extremely low. Quantitative accuracy is near zero because the core financial figure for Morgan Stanley is wrong by an order of magnitude.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 401,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided 8.16 % interest in Alabama Power’s Plant Miller Units 1 and 2 represents 8.16 % of its owned generating capacity (page 17). In comparison, Duke Energy generated 22,344 GWh of electricity in 2021 (page 187).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: (1) The 8.16% undivided interest in Plant Miller Units 1 and 2 is correctly stated; (2) Duke Energy's 2021 generation of 22,344 GWh is accurately reported. These numbers are factually correct and properly attributed. The answer addresses both parts of the multi-hop question—PowerSouth's ownership percentage and Duke Energy's total generation—demonstrating sound synthesis across entities. The only minor shortcoming is that the LLM does not explicitly clarify that the 8.16% refers to PowerSouth’s interest in the plant, not 8.16% of its total owned capacity (the original answer notes this contributes to over 1,600 MWs of capacity, which provides context the LLM omits). However, the statement 'represents 8.16% of its owned generating capacity' could be misinterpreted as claiming that the entire capacity is 8.16%, rather than that 8.16% is the ownership stake in a larger plant. Despite this slight ambiguity, the core facts and multi-hop comparison are correct, and the answer remains semantically aligned with the ground truth. No calculation errors. Contextual relevance is strong with proper page references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 340,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "NIKE’s $11.6 billion of cash and short‑term fixed‑income securities is largely investment‑grade and has a weighted‑average maturity of only 65 days (page 50), so its exposure to interest‑rate movements is modest.  By contrast, McDonald’s valuation models for derivatives and other assets rely on observable market inputs—including interest‑rate yield curves (page 47)—making its earnings and asset values more sensitive to changes in those curves, even though the exact size of its fixed‑income portfolio is not disclosed in the excerpt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: NIKE's $11.6 billion in short-term fixed-income investments is accurately cited, and the additional detail about a 65-day weighted-average maturity (though not in the original answer) does not contradict it and may come from the referenced page 50 of the filing. The absence of a disclosed fixed-income portfolio size for McDonald’s is correctly noted. (2) The use of observable market inputs like interest rate yield curves for McDonald’s derivatives valuation is correctly attributed to page 47, matching the original answer’s claim about reliance on pricing models with observable data. (3) The reasoning is sound: the LLM correctly differentiates the nature of interest rate risk—NIKE’s exposure through investment returns vs. McDonald’s through derivative valuations—and draws a logical comparison about relative sensitivity, concluding that McDonald’s may be more sensitive due to model dependence, even without portfolio size disclosure. (4) The answer is semantically equivalent to the original, adding minor contextual details (maturity, page references) that enhance precision without introducing errors. The only minor gap is that the original emphasizes both companies use observable inputs for fair value measurements, a point slightly underemphasized in the LLM answer, but not omitted entirely. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 419,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s common stock gives every share one vote (page 60), so all shareholders have equal influence on board and policy decisions, encouraging broader engagement and accountability. Alphabet’s multi‑class scheme gives Class A shares one vote but Class B shares ten votes (page 82), concentrating control in the hands of founders and insiders and limiting ordinary shareholders’ ability to sway governance. Thus, Netflix’s uniform voting rights foster more participatory governance, while Alphabet’s differential structure can insulate management from shareholder pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Netflix's one-vote-per-share policy and Alphabet's Class A (1 vote) and Class B (10 votes) structure are accurately described. (2) Quantitative accuracy is perfect—'one vote per share' and 'ten votes per share' match the ground truth exactly; no calculations required. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance implications across two companies, contrasting Netflix’s egalitarian model with Alphabet’s insider-concentrated control. (4) The answer addresses all parts of the question: it compares voting structures and explains their impact on shareholder governance dynamics. The only minor limitation is slightly less explicit mention of 'insiders or major shareholders' compared to the original, but 'founders and insiders' is equivalent. Wording differs but meaning is preserved. No factual errors or omissions affecting correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 283,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "AbbVie’s Imbruvica is one of the first drugs the IRA will set a Medicare Part D price for (page 19), which could sharply cut reimbursement and accelerate revenue erosion, forcing AbbVie to adjust pricing, pursue alternative reimbursement mechanisms and accelerate new‑product development. Johnson & Johnson’s XARELTO is also on the CMS “Selected Drug” list (page 11), but J&J’s broader portfolio and lower concentration of Medicare sales may allow it to absorb the price cut more readily, though it will still need to tweak pricing and reimbursement strategies to protect its revenue mix. Thus, the IRA’s price‑setting provisions could compel AbbVie to shift its revenue strategy more aggressively than J&J, which can rely on a more diversified product base to mitigate the impact.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and reasoning. (1) Both Imbruvica (AbbVie) and XARELTO (Johnson & Johnson) are correctly identified as being on the CMS Selected Drug list under the IRA’s price-setting provisions, with accurate implications for Medicare Part D reimbursement. There are no specific numeric values (e.g., dollar amounts, percentages, or exact years like 2026) in the LLM answer, but it does not fabricate any—instead, it omits the specific 2026 start date mentioned in the original answer. This omission is minor but prevents a perfect score. (2) Quantitative accuracy is high: while the LLM references 'page 19' and 'page 11', these are likely document citations and not factual claims about financials or dates, so they don’t detract from accuracy. No incorrect numbers are presented. (3) The multi-hop reasoning is sound—LLM correctly infers that AbbVie may face greater strategic pressure due to Imbruvica's significance, while J&J’s diversified portfolio may buffer XARELTO’s impact. However, the LLM omits J&J’s litigation challenge, a key strategic differentiator highlighted in the ground truth, which reflects a gap in qualitative completeness. (4) Contextual relevance is excellent: the response directly addresses how the IRA impacts each company’s revenue strategy based on Medicare exposure. Overall, the answer captures the core contrast in strategic responses, though it misses the nuance of J&J’s legal challenge and AbbVie’s concern about pre-patent revenue erosion. These omissions reduce qualitative accuracy slightly but do not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 451,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi’s compliance‑risk governance embeds climate‑risk oversight into its independent risk framework.  The Independent Compliance Risk Management (ICRM) unit, which reports to the CRO and the Board Risk Committee, works with the Independent Risk Management (IRM) and the Climate Risk Committee (co‑chaired by the CRO and Chief Sustainability Officer) to weave transition‑climate considerations into credit‑ and liquidity‑risk controls, ensuring that compliance standards and risk appetite are updated to reflect the potential amplification of those risks.  Program‑level Enterprise Compliance units set priorities and standards that explicitly address climate‑related compliance exposures, thereby mitigating the credit and liquidity impact identified in Morgan Stanley’s disclosures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, addressing the core of how Citi's governance structure integrates climate risk into compliance and risk management frameworks. It correctly identifies key governance units (ICRM, IRM, Climate Risk Committee), reporting lines (CRO, Board Risk Committee), and the integration of transition climate risks into credit and liquidity risk controls. There are no numeric values in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. However, the original ground truth emphasizes specific mechanisms such as the Board and Executive Management Team’s role in ERM, the function of Internal Audit reporting to the Citi Audit Committee, and the alignment with regulatory expectations on climate disclosures. The LLM answer omits these specific governance elements and instead introduces the 'Climate Risk Committee' and 'Program-level Enterprise Compliance units' without direct corroboration from the original answer. While these may be accurate to Citi’s actual structure, they are not present in the provided ground truth, leading to a partial mismatch in qualitative accuracy. The reasoning is sound in linking transition risks to credit and liquidity impacts as noted in Morgan Stanley’s disclosures, but the synthesis relies on inferred rather than stated structures from the original. Thus, while the LLM provides a coherent and relevant response, it does not fully align with the specific governance mechanisms outlined in the ground truth, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 433,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "QCOM’s 30 % of licensing revenue comes from a handful of Chinese OEMs, so its supply chain is exposed to geopolitical and trade‑policy risks, supply disruptions in China, and the possibility that those OEMs may default on royalty payments or fail to renew licenses (QCOM, Risk Factors, Chinese OEMs, p.17; p.24; p.27).  In contrast, TXN’s plan to build additional 300‑mm fabs gives it lower cost and greater control of its own production but adds capital‑intensive fixed‑cost exposure and the risk of under‑utilization if demand falls (TXN, Item 5, p.7; p.19; p.24).  Thus, QCOM faces external, market‑specific supply‑chain volatility, while TXN’s risk is internal capacity management and cost‑structure sensitivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% licensing revenue figure from Chinese OEMs is correctly stated, matching the original answer. No other numerical values are present, and all are accurate. (2) The LLM correctly identifies QCOM's exposure to geopolitical risks, trade policy, and license renewal risks tied to Chinese OEMs, which is consistent with the ground truth’s emphasis on contractual and geopolitical risks. It also accurately describes TXN’s strategy of building 300mm fabs (RFAB2, LFAB1, SM1 are implied in 'additional 300-mm fabs') to gain control over production, reducing reliance on external foundries. (3) The reasoning is sound: the contrast between QCOM’s external, market-driven risks and TXN’s internal, capacity-driven risks is logically synthesized across the two companies’ strategies. The LLM captures the multi-hop element by comparing revenue model risks (QCOM) vs. manufacturing strategy risks (TXN). (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention 'vertical integration' or 'reduced dependency on external foundries' as clearly as the original, and omits naming the specific facilities (RFAB2, etc.), though the meaning is preserved. However, the core contrast in risk profiles is correctly and clearly articulated. Wording differs but semantic equivalence is strong. Contextual relevance is perfect—directly addresses the comparative supply chain risk question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 410,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company says that ASU 2020‑04 will be monitored for its effect on interest‑rate derivatives and PPAs that currently reference LIBOR, but it does not expect any material impact and will continue to evaluate the transition to an alternative rate. Duke Energy likewise reviews the guidance for its LIBOR‑indexed swaps and variable‑rate debt, assessing optional expedients and alternative indices, but also concludes that the change is unlikely to have a material effect on its financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and captures the essential comparison between Southern Company and Duke Energy regarding ASU 2020-04. Both companies are correctly identified as evaluating the standard in relation to interest rate derivatives and LIBOR-indexed financial instruments, with neither expecting a material impact—this aligns with the ground truth. The mention of PPAs by the LLM is not present in the original answer but does not contradict it, as Southern Company's evaluation in Note 14 could include such contracts; however, this addition slightly extends beyond the provided information. Duke Energy’s assessment of optional expedients for LIBOR-indexed swaps and variable-rate debt is accurately reflected. The conclusion that the impact is not expected to be material matches the original, where Duke Energy specifically notes this. The only minor shortcoming is that the LLM omits Duke Energy's note about the assessment potentially extending beyond the 2023 LIBOR phase-out, which adds temporal context missing in the response. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are introduced), and the reasoning correctly synthesizes the multi-hop comparison across companies and financial instruments. Wording differs but maintains semantic equivalence on key points. Thus, the answer is strong but slightly less complete than the original in contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 398,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "AMZN’s 2024 10‑K (page 9) notes that it holds cash equivalents and market‑able securities in British Pounds and Euros, leaving those balances exposed to U.S.‑Dollar fluctuations without any explicit hedging disclosed.  By contrast, Nike’s 2024 10‑K (page 48) explains that it manages foreign‑currency exposures on a portfolio basis and uses currency forward and option contracts—particularly options—to hedge the remaining forecasted cash‑flow impacts, thereby actively reducing volatility.  Thus, AMZN’s exposure is largely passive, whereas Nike relies on option contracts as part of a proactive hedging strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros, specifically citing cash equivalents and marketable securities, and notes the lack of explicit hedging disclosure—consistent with the ground truth. It accurately contrasts this with NKE’s use of option contracts to hedge forecasted cash flows, highlighting a proactive strategy. (2) There are no numeric values, percentages, or dates in dispute; the reference to '2024 10-K' for both companies is consistent with the expected reporting year and acceptable in absence of contradictory evidence. Page numbers (9 for AMZN, 48 for NKE) are plausible and do not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMZN and NKE), compares their foreign exchange risk management approaches, and draws a valid conclusion about passive vs. proactive strategies. The only minor shortcoming is that the original answer mentions NKE hedges 'product costs, external sales, and other costs' and specifies balance sheet exposures, while the LLM answer generalizes to 'forecasted cash-flow impacts'—slightly less detailed but still semantically aligned. (4) The answer is fully relevant, directly addressing the comparison of AMZN’s exposure and NKE’s reliance on options. Overall, the response is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for minor omission of hedging scope details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 446,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta’s 10‑K lists only Class A common stock, which carries one vote per share, and no publicly traded Class B shares are disclosed—so there is no differential voting power between classes at Meta. In contrast, Alphabet’s GOOGL has Class A shares with one vote each and Class B shares with ten votes each, giving Class B a ten‑fold voting advantage over Class A【META_10k_2024.pdf page 1】【GOOGL_10k_2024.pdf page 82】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It falsely claims that Meta has only Class A common stock with one vote per share and no publicly traded Class B shares, which is inaccurate. According to the ground truth, Meta has both Class A and Class B shares, with Class B holding 33 1/3% of total voting power despite being a smaller share count because each Class B share has 15 votes. The LLM incorrectly states there is no differential voting power at Meta, when in fact there is a significant one. (2) Quantitatively, the LLM misrepresents Meta’s structure entirely—missing the 66 2/3% vs. 33 1/3% voting power split and the 15-vote-per-Class-B-share fact. It correctly notes GOOGL’s Class A (1 vote) and Class B (10 votes) structure, but even here it fails to mention that no specific percentage distribution is provided in the original answer, which the LLM omits. (3) The reasoning is flawed: the LLM fails the multi-hop comparison by incorrectly asserting Meta lacks dual-class voting, thus invalidating the comparative analysis. The conclusion that GOOGL has a tenfold advantage while Meta has none is factually wrong, as Meta actually gives Class B shares a 15x voting advantage. (4) Contextual relevance is moderate because the answer addresses the right topic (voting rights at Meta and Google) and cites document sources, but the factual inaccuracies severely undermine its usefulness. The answer fails to capture the core dynamic: Meta gives more relative influence to Class B than GOOGL does, which is the key insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 426,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s investment in SNG’s $3 billion pipeline project is subject to FERC approval, a regulatory constraint that could delay or modify the project and requires Southern Company Gas to commit roughly $1.5 billion of its own capital. In contrast, Duke Energy Ohio’s FERC approval relates to dividend payments, imposing a regulatory constraint that limits dividends to equity accounts and mandates that equity (after push‑down adjustments) remain at least 30 % of total capital, affecting its capital structure rather than a large capital outlay. Thus, SO faces a project‑level regulatory hurdle with significant capital exposure, while DUK Ohio faces a dividend‑distribution hurdle that constrains its use of capital but does not involve a new capital investment.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3 billion pipeline project by SNG requiring FERC approval and Duke Energy Ohio's (DUK) FERC/PUCO dividend restrictions tied to maintaining at least 30% equity in capital structure. However, the LLM states Southern Company Gas must commit 'roughly $1.5 billion,' which is an inference based on 50% ownership of a $3 billion project. While logically derived, the original answer specifies Southern Company's (SO) actual investment in SNG as $1,245 million as of December 31, 2024—not $1.5 billion—making the quantitative claim inaccurate. The $1.5 billion figure conflates committed capital for the pipeline with total investment in SNG. (2) The 30% equity requirement and FERC/PUCO context for DUK are correctly reported. No other numbers (e.g., dates like 2029 delay) are mentioned in the LLM answer, so while not incorrect, they are omitted. (3) The multi-hop reasoning is strong: the model correctly synthesizes that SO’s regulatory constraint is project-timing and capital-outlay related, while DUK’s is capital-structure and dividend-distribution related. The comparison of regulatory impact—project execution vs. financial policy—is logically sound and well-articulated. (4) The answer is highly contextually relevant, directly addressing the comparison of regulatory constraints and capital implications. Due to the significant but not critical error in the capital amount (inferred vs. actual), the correctness score is 8 rather than 9 or 10. Quantitative accuracy is penalized more due to the incorrect dollar figure, though the reasoning and qualitative synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 449,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s repurchased $13.1 billion of common stock in 2021 via an Accelerated Share Repurchase (ASR) with a financial institution, returning cash to shareholders and reducing shares outstanding【page_23】【page_24】. By contrast, Home Depot’s dividend‑equivalent program accrues on performance shares and restricted‑stock units and is paid in additional shares upon vesting, distributing value through equity rather than direct cash payouts【page_69】【page_70】. Thus, Lowe’s mechanism directly returns cash to shareholders, while Home Depot’s mechanism provides equity‑based dividends to employees that indirectly benefit shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that Lowe’s repurchased $13.1 billion of stock in 2021 via an ASR, but the ground truth indicates that Lowe’s authorized $13.0 billion in additional repurchases in December 2021 (not executed as a full $13.1B ASR), and separately executed a $3.0 billion ASR. The $13.1B figure is incorrect in both amount and characterization. Additionally, the LLM implies the entire $13.1B was spent in 2021, while the original answer notes the authorization brought the total since 2020 to $28.0B — a detail missing in the LLM response. (2) The LLM correctly identifies Home Depot’s dividend equivalent mechanism — accruing on unvested performance shares and RSUs and being paid in additional shares upon vesting — which aligns with the ground truth. This qualitative aspect is accurately conveyed. (3) The multi-hop reasoning is partially sound: the model correctly contrasts Lowe’s use of financial institutions for share repurchases with Home Depot’s equity-based dividend equivalents. However, it misrepresents the scale and nature of Lowe’s activity by conflating authorization with execution and overstating the ASR size. (4) While the core conceptual contrast — direct cash return via repurchases vs. equity-based distribution — is valid and contextually relevant, the factual foundation is weakened by incorrect figures. The LLM also incorrectly frames Lowe’s ASR as a direct return to shareholders, whereas ASRs primarily reduce shares outstanding and are not direct cash distributions to public shareholders. The qualitative accuracy is moderate due to correct terminology and structure, but undermined by key factual errors. Contextual relevance is high as the response directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 487,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "ASU 2022‑04 requires a buyer that uses supplier‑finance programs to disclose the program’s key terms, the balance‑sheet presentation of related amounts, the confirmed amount outstanding at period‑end, and a roll‑forward of those amounts.  Caterpillar’s 2024 10‑K satisfies this by presenting the confirmed obligation ($830 million) and a detailed roll‑forward of amounts due 2025‑2029 and thereafter (Note 19, pages 112‑113).  Honeywell notes that it adopted the standard on Jan 1 2023 and that the roll‑forward disclosure is required effective Jan 1 2024 (page 60); the 2024 filing will therefore include a roll‑forward, though the specific roll‑forward table is not shown in the excerpt provided.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: Caterpillar's $830 million obligation is accurately reported, and the January 1, 2024 effective date for the rollforward requirement is correctly cited. The mention of Caterpillar’s 2024 10-K and Note 19 (pages 112–113) adds precise sourcing. (2) The LLM correctly identifies that Honeywell adopted ASU 2022-04 on January 1, 2023, and acknowledges that the rollforward disclosure becomes effective January 1, 2024, which matches the standard’s phased implementation. It correctly states that Honeywell’s 2024 filing will include the rollforward, even if not shown in the excerpt—this is consistent with the original answer’s assertion that Honeywell adopted the requirement for 2024. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies and correctly applies the timeline of ASU 2022-04’s provisions, distinguishing between adoption date and effective date of specific disclosures. (4) The only minor shortcoming is that the original answer implies Honeywell’s obligations would be 'similarly detailed,' but the LLM does not confirm whether Honeywell actually disclosed a specific obligation amount in 2024—though it appropriately qualifies that the rollforward 'will therefore include' the table, noting absence due to excerpt limitations. This cautious phrasing avoids overstatement and maintains accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 433,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C’s $49.5 bn of fixed‑rate credit‑card loans due within one year (page 86) is a modest exposure that amounts to only about 0.25 % of the $20 trillion global opportunity Visa sees in converting non‑card payments into digital credentials (page 8). Visa’s strategy is to accelerate growth by expanding credit‑card issuance across its network, aiming to capture a far larger share of that opportunity than the size of Company C’s current loan portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains a significant quantitative error: it describes Company C's $49,549 million as $49.5 billion, which is correct in magnitude ($49.549 billion), but then states this is 'about 0.25% of the $20 trillion opportunity'. However, $49.549 billion divided by $20 trillion equals 0.2477%, which rounds to 0.25%—this calculation is mathematically accurate. However, the characterization of this as a 'modest exposure' is interpretive and not present in the original answer, potentially misrepresenting the significance of the amount. (2) The original answer does not make a percentage comparison to the $20 trillion opportunity; instead, it focuses on alignment between Company C’s short-term credit exposure and Visa’s strategic growth goals. The LLM introduces a new quantitative comparison not in the ground truth, which, while calculable, shifts the emphasis. Additionally, the LLM refers to 'fixed-rate credit-card loans', a detail not present in the original answer and unsupported by the provided context. (3) The multi-hop reasoning is partially sound—linking Company C’s loan portfolio to Visa’s broader strategy is valid—but the LLM incorrectly implies that the size of Company C’s portfolio is directly comparable to the total $20 trillion opportunity, which spans all non-card payments globally and is not a benchmark for individual loan portfolios. The original answer makes a more nuanced connection focused on strategic alignment rather than size comparison. (4) Despite the reasoning leap and unsupported characterization ('modest'), the core facts—Company C’s $49.5B in credit card loans and Visa’s $20T opportunity—are correctly cited, and the general strategic connection is relevant, warranting moderate scores in qualitative accuracy and high in contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 487,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution revenues are weather‑sensitive because consumption rises in the heating season, but the company limits exposure through regulatory rate design that decouples fixed costs from volumes and by using weather‑and‑revenue‑normalization mechanisms and weather‑derivative instruments to smooth volume swings within typical ranges【page_200】【page_85】. In contrast, NextEra Energy’s electricity demand is also weather‑driven—especially during severe events that can spike demand or cause outages—but the company mitigates this risk with cost‑recovery provisions for restoration, insurance coverage, load‑shedding options, winterization of critical assets, and hedging/trading tools【page_26】. Thus, while both utilities face weather‑related revenue volatility, Southern Company relies mainly on regulatory mechanisms and derivative hedges, whereas NextEra Energy employs a broader mix of operational, financial, and insurance strategies to manage weather exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details—there are no specific numbers (e.g., percentages, dollar amounts, years) in the LLM response that contradict the ground truth, and no incorrect calculations are made. The ground truth mentions a 6.2% decrease in net income for Southern Company Gas in 2023, but the LLM answer does not include this specific figure. While this is a minor omission, it does not introduce inaccuracy, as the LLM correctly identifies weather sensitivity and mitigation mechanisms without asserting incorrect data. Thus, quantitative accuracy is high (10/10). Qualitatively, the LLM correctly identifies both companies, their respective weather exposures (gas consumption for Southern, electricity demand and operational risks for NextEra), and their mitigation strategies. It accurately contrasts Southern’s use of weather normalization and derivatives with NextEra’s broader operational and financial tools. However, the LLM understates the severity and nature of NextEra’s exposure—particularly hurricane-related infrastructure risks in Florida—which the ground truth emphasizes as a more immediate and severe threat compared to Southern’s managed volume risk. This nuance in risk severity and operational impact is downplayed, affecting the depth of the comparison (hence 8/10 for qualitative accuracy). Contextual relevance is strong: the answer directly addresses the comparative question, synthesizes information across both companies, and focuses on risk mitigation strategies as required. The reasoning is sound and logically structured, though it could more explicitly acknowledge that NextEra faces not just demand volatility but physical operational threats, making its exposure inherently more disruptive. Overall, the answer is correct in substance and well-aligned with the question, meriting a correctness score of 8/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 507,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s 2024 revenue of $25.9 billion was roughly 60 % from franchised restaurants ($15.7 billion) and other affiliate‑related fees, yet the company does not consolidate those affiliates (equity in unconsolidated affiliates was $‑157 million)【page_40】【page_18】【page_48】.  GM’s cross‑over production strategy relies on non‑consolidated affiliates that supply parts and vehicles; the $90 million of automotive sales recorded from these affiliates is only about 0.06 % of GM’s $144 billion automotive revenue, and the affiliates are joint‑venture production partners rather than operating units【page_77】【page_106】【page_15】.  Thus, McDonald’s affiliate model is a major revenue driver with a franchise‑operated structure, whereas GM’s affiliate production role is a minor revenue contributor focused on manufacturing and supply‑chain integration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer attempts a multi-hop comparison between McDonald's and GM's use of nonconsolidated affiliates but introduces significant quantitative inaccuracies that undermine factual correctness. (1) The claim that McDonald’s 2024 revenue was $25.9 billion with $15.7 billion (60%) from franchised restaurants and affiliate fees is not supported by the ground truth, which does not provide specific revenue figures or percentages—this level of numerical precision is fabricated or misattributed. The mention of 'equity in unconsolidated affiliates was -$157 million' and GM’s '$90 million of automotive sales' from affiliates contributing 0.06% to $144 billion automotive revenue introduces highly specific numbers not present in the original answer, making them unverifiable and likely incorrect. (2) These calculations (e.g., 0.06% of $144B ≈ $86.4M, close to $90M) suggest made-up data rather than extraction from actual filings, violating quantitative accuracy. (3) Qualitatively, the reasoning is sound: the model correctly identifies that McDonald’s relies on franchising with royalty-based recurring revenue while GM uses nonconsolidated affiliates for production and supply chain, resulting in transactional revenue. This reflects proper synthesis of operational models. (4) Contextually, the response is highly relevant, directly comparing revenue contribution and operational structure as asked. However, the inclusion of unsupported financial figures severely reduces overall correctness. While the conceptual framework matches the ground truth, the invented metrics make the answer partially misleading. Minor note: 'crossovers' in the question are reduced to general 'automotive sales' without explicit confirmation that the $90M relates specifically to crossovers. Thus, the answer earns moderate scores for qualitative reasoning and relevance but is penalized heavily on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 513,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "CMCSA’s Class B shares carry a guaranteed 33 ⅓ % of the company’s aggregate voting power that cannot be diluted by issuing additional classes of common stock (Note 11, p. 91).  While the shares are convertible on a share‑for‑share basis into Class A, the conversion is subject to restrictions and is not automatically triggered by sale or transfer.  In contrast, Alphabet’s Class B shares may be converted at any time at the holder’s option and automatically convert upon sale or transfer to Class A (Note 11, p. 82), providing a more flexible, transfer‑triggered conversion mechanism rather than a fixed voting‑power protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: CMCSA's Class B has a non-dilutable 33 1/3% voting power, and the share-for-share conversion is accurately described. GOOGL's Class B shares having 10 votes per share is implied in the context of enhanced voting rights, though not explicitly stated in the LLM answer—however, this detail was not critical to the comparison at hand. (2) The LLM correctly identifies the structural difference in conversion: CMCSA’s conversion is restricted but not automatic upon transfer, while GOOGL’s Class B automatically converts to Class A upon sale or transfer, which is correctly cited from Note 11, p. 82. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (CMCSA and GOOGL), compares voting power protection mechanisms, and contrasts conversion triggers (voluntary/transfer-triggered vs. restricted/non-automatic). (4) The answer captures the core insight: CMCSA provides structural, non-dilutable voting protection, whereas GOOGL’s protection is contingent on holding, making CMCSA’s Class B more resilient to voting dilution. The only minor omission is not explicitly stating that GOOGL’s Class B has 10 votes per share (present in ground truth), but the contrast in conversion mechanics and voting durability is well conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison in voting dilution protection and conversion policies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 430,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "AXP’s Level 3 securities are debt instruments issued by community‑development financial institutions that are not traded in active markets.  The firm values them with internal credit models and treats the carrying value as a proxy for fair value unless it detects default indicators, so the fair‑value inputs are unobservable and highly sensitive to illiquid market conditions (see AXP pages 146‑147 and 145).  If MS holds or trades these securities, the same illiquid, model‑based valuations can make it difficult for MS to accurately value, hedge or reduce exposure during a devaluation, and its own risk‑management framework—already stressed by concentration, model uncertainty and limited hedging in illiquid markets (see MS pages 13, 14, 22)—may be unable to fully capture or mitigate the resulting losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) It correctly identifies AXP's use of internal credit models and unobservable inputs for valuing Level 3 securities, specifically mentioning debt securities from community-development financial institutions, which aligns with the original answer. It also notes the reliance on carrying value as a proxy for fair value in the absence of default indicators, consistent with AXP's disclosures. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: it connects AXP’s valuation methodology to the risks in illiquid markets and correctly infers how this could impact MS’s risk management, referencing model uncertainty, hedging challenges, and valuation difficulties during devaluation—key points from MS_10k_2024.pdf. The only minor omission is the specific mention of the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations, which is present in the original but absent in the LLM response. This reduces completeness slightly but does not undermine the core correctness. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: how AXP’s methodology creates risk in illiquid markets and how that affects MS’s market risk management. Wording differs but meaning is preserved. Overall, the LLM synthesizes across AXP and MS filings logically and accurately, meriting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 433,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron’s Level 2 derivatives are priced with internal discounted‑cash‑flow models that rely mainly on observable market inputs—interest‑rate curves, yield curves and foreign‑exchange rates—so management judgment is limited to model calibration. Exxon, by contrast, values the upstream assets it acquired from Pioneer with discounted‑cash‑flow models that depend on many non‑observable inputs—future production volumes, commodity prices, drilling and development costs, and risk‑adjusted discount rates—requiring substantial management judgment and scenario analysis.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative comparison between Chevron's and Exxon's valuation approaches, with accurate emphasis on observable vs. unobservable inputs and the degree of management judgment. Quantitatively, there are no numbers, dates, or financial figures to verify, so quantitative accuracy is not compromised—scored as 10. Contextual relevance is strong, as the response directly addresses the question about valuation approaches, observable inputs, and management judgment—scored 10. However, there is a key factual discrepancy in the qualitative accuracy: the LLM states that Chevron uses 'internal discounted-cash-flow models' for Level 2 derivatives, while the ground truth specifies that Chevron relies on third-party broker quotes, industry pricing services, and exchanges—not internal models. Although observable inputs like interest and FX rates are correctly noted, attributing Chevron's valuation to internal DCF models misrepresents the source and methodology, implying more internal modeling than supported by the ground truth. This introduces inaccuracy in the reasoning chain, particularly in the multi-hop comparison of subjectivity and model reliance. The core contrast—Chevron's more objective, market-based inputs vs. Exxon's judgment-heavy, forward-looking DCF—is preserved, justifying a correctness score of 7. Qualitative accuracy is also 7 due to this significant but not fundamental error in methodology attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 403,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Southern Power finances its solar projects through tax‑equity partnerships that capture the federal ITC, and the resulting PPAs are recorded as operating leases that generate variable lease payments tied to energy output (see pages 97, 270, 269). Duke Energy, by contrast, negotiates PPAs for its renewable projects within VIEs that are financed by debt guarantees and tax‑equity arrangements, with Duke Energy acting as the primary beneficiary; the tax credits are allocated to the tax‑equity partner under the HLBV methodology (see page 204). Thus, while both companies use PPAs to fund solar assets, Southern Power’s structure relies on direct investment and lease accounting to capture tax credits, whereas Duke Energy’s structure relies on VIEs and tax‑equity financing that shifts the tax benefits to the partner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Power use PPAs in financing solar assets; Southern Power treats PPAs as operating leases and utilizes tax-equity partnerships to capture federal tax credits (ITCs/PTCs); Duke Energy structures its projects through VIEs with tax-equity financing and acts as primary beneficiary, allocating tax credits to partners via HLBV. (2) Quantitative accuracy is perfect—no specific numbers are misstated, and while the $1.2 billion in unutilized tax credits at Southern Company is mentioned in the original answer, the LLM answer does not contradict this; it simply omits the figure without introducing error. This omission is minor and does not affect core correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across entities (Duke vs. Southern), financial structures (VIEs vs. direct investment), accounting treatment (operating leases), and tax credit allocation mechanisms. (4) Semantic equivalence is strong—the LLM conveys the same key contrast: Southern Power directly integrates tax credits into its investment model via lease accounting and tax equity, while Duke Energy relies on VIEs and shifts tax benefits to partners. The only minor gap is the absence of the $1.2 billion unutilized credit figure, which slightly reduces completeness but not enough to undermine the overall accuracy. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 433,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s charter gives holders of Class A common stock the right to elect three‑quarters of the Board, concentrating a large share of governance power in a single shareholder class (see NKE page 27).  \nHome Depot, by contrast, grants voting rights to employees who receive restricted‑stock awards at the grant date, so voting influence is dispersed among many awardees and is tied to vesting schedules (see HD page 67).  Thus, Nike’s structure centralizes board control, whereas Home Depot’s approach distributes voting power more broadly, though still providing employees with a direct governance voice.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that NKE's Class A common stock elects three-quarters of the Board, matching the original answer exactly. No calculations are required, and all factual claims about voting rights are consistent. (2) The LLM accurately identifies both companies (NKE and HD) and their respective governance mechanisms—centralized control in NKE via Class A shares and broader distribution in HD through restricted stock awards with voting rights at grant date. (3) The reasoning is sound: it correctly contrasts centralized vs. distributed governance influence, capturing the multi-hop comparison between the two firms' voting structures. (4) The only minor omission is that the LLM does not explicitly mention that neither company allows Class B or C shareholders to vote on most matters, which is included in the original answer and adds a small but relevant contextual layer. However, this does not detract significantly from the overall correctness. The LLM also correctly cites source pages (27 for NKE, 67 for HD), indicating proper grounding. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction for partial completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 379,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix hedges its forecasted foreign‑currency revenue transactions with forward contracts, and its own VAR model estimates a currency‑sensitive exposure of roughly **$40 million** at year‑end 2024 (see Note 49 and the VAR table on page 60).  Disney’s 10‑K does not disclose a comparable VAR figure for currency‑sensitive instruments in the pages provided, so a direct numerical comparison cannot be made.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the ground truth. (1) Quantitatively, the LLM incorrectly states that Netflix's VAR exposure is $40 million at year-end 2024, which is not supported by the original answer or any cited data in the context; the ground truth reports a $293 million loss for Netflix in 2023 from foreign currency transactions, not a VAR estimate of $40 million. Additionally, the LLM claims Disney does not disclose a comparable VAR figure, but the original answer explicitly states Disney's VAR estimate decreased from $284 million in 2023 to $255 million in 2024—key data points that contradict the LLM's assertion. (2) The LLM invents a source reference ('Note 49', 'page 60') not present in the provided context, undermining credibility. (3) Qualitatively, the reasoning is flawed: the question asks for a comparison between Netflix’s hedging of forecasted revenue transactions and Disney’s VAR model scope; the original answer correctly notes that Disney’s VAR model excludes forecasted transactions while Netflix actively hedges them—this critical distinction is missed by the LLM. Instead, the LLM incorrectly frames the issue as a lack of disclosure, failing to perform the necessary multi-hop synthesis between the two companies’ methodologies. (4) Contextually, the answer is partially relevant—it addresses hedging instruments and VAR—but due to incorrect numbers and misrepresentation of available data, it leads to an erroneous conclusion. The core of the comparison (Netflix hedges forecasted revenues, Disney’s VAR excludes them) is absent, making the response substantially incorrect despite touching on related concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 462,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "MDLZ’s VAR model estimates the expected return distribution by observing interest‑rate, currency‑exchange and commodity‑price movements over the **prior quarter** for the 12/31/24 and 12/31/23 calculations, and uses each of the **four preceding quarters** to compute average, high and low VAR figures (MDLZ 10‑K, p. 66).  PMI’s VAR calculation follows the same pattern – it relies on the **preceding quarter** of interest‑rate and forward‑currency movements for the 12/31/24 and 12/31/23 figures, and on the **four preceding quarters** for its annual average, high and low values (PM 10‑K, p. 77).  Thus, both firms base their one‑day risk estimates on recent quarterly data, implying comparable short‑term risk‑assessment horizons, though MDLZ explicitly incorporates commodity‑price volatility while PMI focuses on interest‑rate and currency factors.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the time periods used by both MDLZ and PM for VAR calculations — the prior quarter for year-end values and four preceding quarters for averages. These timeframes match the ground truth, so quantitative accuracy is high. However, the LLM incorrectly states that PM uses the four preceding quarters for average, high, and low VAR amounts, which contradicts the original answer stating that PM 'primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts' — implying PM does use four quarters for those metrics, so this part is actually consistent. The main error lies in the interpretation: the LLM concludes that both firms have 'comparable short-term risk-assessment horizons', while the ground truth emphasizes that MDLZ's explicit use of a multi-quarter approach for average VAR suggests a slightly extended risk assessment horizon compared to PM. This misrepresents the comparative implication required by the question. (2) All numbers, dates (12/31/24, 12/31/23), and time periods (prior quarter, four preceding quarters) are accurate and correctly cited. No calculation errors. (3) The multi-hop reasoning is partially sound — the model correctly retrieves time periods from both companies’ 10-Ks — but fails in synthesizing the comparative implication about risk assessment horizons. The original answer draws a nuanced distinction in horizon length based on MDLZ’s explicit multi-quarter averaging, which the LLM overlooks in favor of asserting comparability. (4) Contextual relevance is high because the response addresses both companies, the correct metrics, and timeframes. However, the qualitative inaccuracy in reasoning and conclusion reduces overall correctness. Thus, correctness_score is 6 due to a partially incorrect conclusion despite factual accuracy in data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 517,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "The $0.6 billion goodwill impairment recorded by Disney in fiscal 2024 was the result of management’s discounted‑cash‑flow valuation of its entertainment linear networks and DTC services reporting unit, and the auditor evaluated the significant assumptions underlying that model—future revenues, operating expenses, margins, terminal growth rates and discount rates—using specialized professionals and extensive procedures to assess their reasonableness. In contrast, Netflix’s auditor tested significant assumptions in the content‑amortization model by evaluating the amortization method, testing assumptions about historical and forecasted viewing patterns, and performing sensitivity analyses, focusing on the controls over the amortization process rather than a valuation model.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge and fiscal 2024 timing are accurately stated. No calculations are required, and all numbers match. (2) The entity accuracy is strong: DIS (Disney) and NFLX (Netflix) are correctly identified, as are the relevant auditors (implied to be the same, PwC, though not explicitly repeated in the LLM answer). The financial metrics—goodwill impairment, content amortization, discount rates, terminal growth rates, viewing patterns—are all correctly used. (3) The reasoning is sound and captures the multi-hop nature: it correctly links DIS’s impairment to assumptions in a discounted cash flow model and describes auditor evaluation procedures, then contrasts this with NFLX’s content amortization model and auditor focus on viewing patterns and controls. However, the LLM answer introduces a minor inaccuracy by implying the impairment was for both 'entertainment linear networks and DTC services reporting unit'—the ground truth specifies only 'entertainment linear networks.' This overgeneralization slightly misrepresents the scope. Additionally, while the ground truth emphasizes that both audits used sensitivity analyses and specialized professionals, the LLM downplays this commonality by framing the approaches as more contrasting than similar. (4) Despite these nuances, the answer is contextually relevant, factually accurate in numbers and core concepts, and conveys most of the key points. The correctness score is 8 due to the partial mismatch in reporting unit scope and understatement of methodological similarities, but not enough to drop into the 'partially correct' range.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 466,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "Gilead’s Merck collaboration is a straightforward 60 %/40 % cost‑sharing arrangement for development and commercialization, with revenue split equally until sales hit $2 B (oral) or $3.5 B (injectable) and then 65 % for Gilead above those thresholds; no milestone payments are disclosed (page 74). By contrast, the Arcellx deal involves a large upfront cash outlay ($313 M) and an equity investment ($299 M), shared development and commercialization costs, a 50/50 U.S. profit split, and up to $1.5 B in performance‑based development and regulatory milestone payments (page 74). Thus, the Merck agreement relies mainly on cost and revenue sharing, whereas Arcellx requires significant upfront and milestone‑based financial commitments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $313M upfront payment and $299M equity investment to Arcellx in 2023, and the $68M milestone payment in 2024, which aligns with the ground truth. However, it incorrectly states that the Arcellx deal includes 'up to $1.5B in performance-based milestone payments'—this figure is not present in the original answer and introduces new, unsupported information. Additionally, the LLM claims revenue is split equally until certain sales thresholds ($2B oral, $3.5B injectable) are reached in the Merck agreement, followed by a shift to 65% for Gilead—this level of detail on revenue sharing thresholds and post-threshold splits is absent from the ground truth and appears to be fabricated or misattributed. The original answer states only that Merck and Gilead share development and commercialization costs at 60%/40% with no material expenses through 2024, and implies revenue sharing upon approval, but provides no specific sales thresholds or changing percentages. (2) While the upfront and milestone figures for Arcellx are accurate, the inclusion of the $1.5B potential milestones and detailed revenue tiering for Merck significantly undermines quantitative accuracy. These numbers are not minor discrepancies but represent major additions not supported by the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly contrasts the cost-sharing model with Merck against the more financially committed structure with Arcellx involving upfront and milestone payments. It captures the essence of different financial structures—shared cost vs. upfront investment—but overreaches by introducing unverified financial mechanics. (4) Despite the incorrect numerical additions, the core qualitative comparison—that the Arcellx deal involves greater upfront financial commitment while the Merck deal is based on cost and revenue sharing—is consistent with the original answer. The contextual relevance is high as it directly addresses the comparison asked in the question. However, the introduction of unsupported figures reduces factual correctness, warranting a score of 7 for overall correctness—core facts are right, but significant embellishments affect accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 598,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s 2020 and 2021 multi‑year pricing agreements with Panasonic (see Exhibit 10.36†† and 10.35††/10.37†† on page 107) lock in cell prices for the Gigafactory 2170 and Japan‑sourced cells, giving the company strong contractual stability and long‑term cost predictability. In contrast, the GM 10‑K excerpts (pages 54‑78) do not disclose any long‑term battery supply contracts, implying that GM’s battery procurement cost exposure is less defined and likely more exposed to market price volatility, with lower contractual stability and predictability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Tesla's multi-year pricing agreements with Panasonic for both Gigafactory 2170 and Japan-sourced cells, citing 2020 agreements (though it mentions 2021, which is slightly off—ground truth specifies June 9, 2020, and December 29, 2020, both in 2020). This is a minor date discrepancy but does not materially alter the conclusion. (2) The LLM references specific exhibit numbers (10.35††, 10.36††, 10.37††) and page 107, which adds detail not in the ground truth but does not contradict it; however, the ground truth does not specify these exhibit numbers, so this could be overprecision if unsupported. (3) The comparison to GM is sound: the LLM correctly notes that GM’s 10-K (pages 54–78, with key info on 78 per ground truth) lacks disclosure of long-term battery contracts, leading to higher exposure to volatility—this aligns with the ground truth’s assessment of GM’s greater cost exposure and lower predictability. (4) The reasoning is logically sound and synthesizes information across Tesla and GM filings, correctly inferring that absence of disclosed long-term agreements implies lower contractual stability. The answer is semantically equivalent to the original, with only minor over-specification of exhibits and a slight date range expansion (2020 vs 2020–2021). No calculation errors. All entities (Tesla, Panasonic, GM, battery cell types, risk profile implications) are correct. The answer fully addresses the question’s focus on contractual stability and cost predictability. Minor deduction from 10 to 9 due to the slight date inaccuracy and unverified exhibit references, but overall excellent fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 472,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola actively uses non‑derivative instruments to hedge the foreign‑exchange risk of its net investments in foreign subsidiaries, thereby reducing but not eliminating the impact of currency fluctuations on its earnings (page 30). Procter & Gamble, by contrast, reports significant exposure to foreign‑exchange fluctuations from translation and transaction risks but does not disclose hedging; the resulting gains or losses appear as foreign‑currency translation items in other comprehensive income (pages 21 and 38). Thus, while both companies operate in the United Kingdom and Germany, Coca‑Cola’s hedging strategy mitigates currency risk more directly than Procter & Gamble’s largely unhedged exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Coca-Cola uses non-derivative instruments (e.g., foreign currency-denominated debt) to hedge foreign exchange risk related to net investments in foreign subsidiaries, which matches the original answer. It also correctly notes that Procter & Gamble has significant exposure to foreign exchange fluctuations due to its international operations in markets like the UK and Germany. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and compares their hedging approaches. However, a minor inaccuracy exists: the LLM claims P&G 'does not disclose hedging,' which contradicts the original answer stating P&G 'employs strategies to manage these risks.' In reality, P&G does employ hedging strategies (including derivatives), but the original answer emphasizes that despite these, FX movements still materially impact results. The LLM understates P&G’s risk management efforts, implying it is 'largely unhedged,' which is not fully supported. (4) Despite this nuance, the core comparison—that Coca-Cola has a more structured approach using non-derivative hedges while P&G reports greater sensitivity to FX volatility—is valid. The answer is contextually relevant, addresses all parts of the question, and conveys a semantically close interpretation. Hence, correctness is high but not perfect due to the overstatement of P&G's lack of hedging.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 444,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s exposure in Maryland is driven by the state’s PDAB law, which gives the Maryland PDAB authority to set upper payment limits on certain drugs, potentially capping reimbursement for Amgen’s products and tightening its pricing strategy (Amgen 2023 10‑K, p. 18).  Gilead’s risk in the same state is primarily operational: its CAR‑T manufacturing plant in Maryland faces quality‑and‑regulatory risks that could disrupt supply, while the company also contends with broader state‑level pricing pressures that could affect its pricing strategy (Gilead 2023 10‑K, pp. 19‑21).  Thus, Amgen’s risk is a state‑mandated pricing cap, whereas Gilead’s risk is manufacturing reliability and potential supply disruptions, with pricing concerns as a secondary factor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Amgen's exposure to Maryland’s PDAB laws, which authorize upper payment limits affecting pricing strategy and rebate obligations, citing the correct regulatory context. It also accurately notes Gilead’s operational risks due to its CAR T-cell therapy manufacturing facility in Maryland, emphasizing quality control, regulatory compliance, and supply disruption risks. (2) There are no numeric values, dates, or financial figures in the original or LLM answer that require verification—both avoid making specific numerical claims, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Amgen faces pricing and regulatory risk (primarily through PDAB and broader pricing frameworks), while Gilead’s exposure is operational due to complex manufacturing, even though both face some level of pricing pressure. The LLM slightly underemphasizes the connection between the Inflation Reduction Act and ENBREL’s inclusion in Medicare price negotiation, which is part of Amgen’s broader pricing risk context, but this does not invalidate the core accuracy. (4) The answer is contextually relevant, directly comparing the two companies’ risk profiles in Maryland across pricing and operations. Wording differs slightly but maintains semantic equivalence. One minor point: the LLM frames pricing pressures for Gilead as 'secondary,' which is reasonable but not explicitly confirmed in the ground truth. Overall, the answer is factually correct, well-reasoned, and complete with only slight nuance missing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 466,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s separate accounts are managed by sub‑advisors that have discretion to trade, and the firm diversifies across multiple asset categories and managers while using derivatives to reduce risk (AIG 10‑K, p. 304).  \nMetLife’s ERISA plan assets are allocated to a diversified mix of fixed‑maturity securities (≈85 % for pension plans, 95 % for post‑retirement benefits), equities (≈7 %) and alternatives (≈8 %) with actual allocations close to the targets (MetLife 10‑K, p. 305); the filing does not describe sub‑advisory discretion, but the diversified allocation itself serves as the primary risk‑mitigation tool.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but has significant omissions and inaccuracies, particularly in quantitative details and multi-hop synthesis. (1) Quantitative Accuracy: The claim that MetLife allocates '≈85% for pension plans, 95% for post-retirement benefits' to fixed maturities and '≈7% equities, ≈8% alternatives' is not supported by the ground truth, which does not provide specific allocation percentages. These numbers appear fabricated or misattributed, severely undermining numerical accuracy. (2) Completeness: The question asks for a comparison between AIG's use of separate accounts and MET's use of investment management firms, focusing on diversification and risk mitigation via sub-advisory discretion. The LLM correctly notes AIG’s use of sub-advisors with trading discretion and derivatives for risk reduction (aligned with ground truth), but incorrectly states that MetLife’s 10-K 'does not describe sub-advisory discretion'—this contradicts the ground truth, which explicitly states MET engages investment management firms with discretionary authority. This is a critical omission. (3) Entity Accuracy: The companies (AIG and MET/MetLife) are correctly identified, and the reference to 10-K pages is plausible, though not verifiable from the provided data. (4) Reasoning: The multi-hop comparison is partially sound—both firms use diversified asset classes and derivatives—but fails in key synthesis: it misses that both use discretionary sub-advisors and that MET’s strategy explicitly targets funded status and volatility reduction. The LLM also fails to note that both restrict derivatives to risk mitigation and duration management. (5) Semantic Equivalence: While some concepts (diversification, risk mitigation) are correctly conveyed, the inclusion of unsupported percentages and the denial of sub-advisory discretion in MET’s case make the answer misleading. Overall, core ideas are present but marred by factual errors and incomplete reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 534,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "NKE’s Class B common shares are largely non‑voting; they only vote on a handful of defined matters such as certain mergers or amendments to the certificate of incorporation (page 90).  By contrast, Home Depot’s restricted‑stock awards give recipients voting rights from the grant date, allowing them to vote on all matters—including board elections and takeover proposals (page 67).  Consequently, NKE’s Class B holders have limited influence over board composition or takeover defenses, whereas HD’s restricted‑stock holders can actively shape those governance decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies that NKE's Class B shares have limited voting rights, only on specific matters like mergers or charter amendments, while HD's restricted stock awards grant full voting rights from the grant date. This directly addresses the impact on investor influence over corporate governance, including board composition and takeover defenses. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes structural differences in voting rights between two companies (NKE and HD) and draws the logical conclusion about differential influence on governance. The mention of 'page 90' and 'page 67' suggests accurate sourcing from the 10-K filings, aligning with document-based evidence. (4) The only minor shortcoming is a slight lack of specificity regarding *who* controls the board at NKE (i.e., Class A shareholders), which is mentioned in the ground truth but omitted in the LLM response. However, the key point—that Class B holders cannot influence board elections—is clearly stated. Wording differs slightly but maintains semantic equivalence. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 383,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "META’s Class B common stock carries ten votes per share, giving those holders a higher voting power than NFLX’s single‑class common stock, which is entitled to one vote per share on all matters to be voted on by the company’s stockholders. NFLX’s voting‑rights policy imposes no special restrictions beyond the one‑vote rule, whereas META’s policy limits Class B voting to ten votes per share and notes that the shares are not publicly traded and may be subject to transfer restrictions until litigation is resolved.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the voting structures of both META and NFLX. (1) Quantitatively, the claim that META's Class B stock has 'ten votes per share' is incorrect according to the ground truth, which states that Class B shares only have voting rights on specific, limited matters—not a blanket ten votes per share. The 'ten votes per share' detail is not supported by the original answer and appears to be fabricated or confused with another company's structure (e.g., Google). (2) The answer incorrectly implies that NFLX has a single class of stock with one vote per share on all matters—which is factually correct—but fails to contrast this with META’s restrictive framework accurately. Instead of highlighting the limited scope of voting rights for META Class B (only on specific issues like charter amendments or core business exits), it focuses on vote count and transfer restrictions unrelated to the question. (3) Multi-hop reasoning is flawed: the question asks for a comparison of voting *structures* and *limitations*, but the LLM conflates voting power (votes per share) with voting *eligibility* (on which matters voting occurs). The original answer emphasizes that META Class B only votes on defined matters, whereas the LLM suggests broad voting power with higher weight, which is the opposite of the truth. (4) Contextual relevance is moderate because it addresses both companies and the topic of voting rights, but the core factual misrepresentation of META’s voting mechanism severely undermines correctness. The mention of 'litigation' and 'transfer restrictions' is extraneous and not part of the original comparison. Overall, the answer fails on key factual and conceptual levels despite some surface-level relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 483,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "PM uses the parametric delta‑gamma approximation to estimate the fair‑value impact of interest‑rate and currency movements on its portfolio, assuming normal market conditions, a 95 % confidence interval and a one‑day holding period (PM 10‑K, p. 81).  Mondelēz International applies the same technique in its VAR model to estimate the potential one‑day loss in pre‑tax earnings from interest‑rate, currency and commodity price movements under the identical assumptions (MDLZ 10‑K, p. 64).  Thus, both firms use the same statistical framework, but PM reports a fair‑value impact on positions, whereas MDLZ reports an earnings impact and also includes commodity exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions, with a 95% confidence interval and one-day holding period for VAR estimation. These quantitative assumptions match the original answer exactly. (2) The LLM correctly identifies that PM assesses fair-value impact on portfolio positions due to interest rate and currency movements, while MDLZ focuses on pre-tax earnings impact and includes commodity price exposures—this distinction is explicitly noted in the ground truth. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies (PM and MDLZ), compares their use of the same technique, and highlights differences in reporting focus (fair value vs. earnings) and scope (commodities included only by MDLZ). (4) The only minor omission is that the original answer specifies both companies base their models on movements in the prior quarter for year-end VAR calculations—a detail not mentioned in the LLM response. However, this does not affect the core comparison about methodology, assumptions, or outcomes. Wording differs but semantic meaning is equivalent. No factual or calculation errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 357,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America’s Advanced Approach requires a 2.5 % Capital Conservation Buffer (CCB) as part of its Basel III regulatory minimum for CET 1 capital, while American Express relies on a 2.5 % Stress Capital Buffer (SCB) under its Standardized Approach (the SCB rose to 3.4 % in 2022). Both buffers are added to the 4.5 % CET 1 minimum and the 2.5 % G‑SIB surcharge to meet the same regulatory minimum, but they are applied under different Basel III approaches and have slightly different percentages over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bank of America uses the 2.5% Capital Conservation Buffer (CCB) under the Advanced Approach and that American Express uses the Stress Capital Buffer (SCB) under the Standardized Approach, which aligns with the ground truth. However, it introduces specific quantitative claims not present in the original answer—namely that the SCB is 2.5% and rose to 3.4% in 2022, and that both buffers are added to a 4.5% CET1 minimum and a 2.5% G-SIB surcharge. These details are absent from the ground truth and cannot be verified from the provided information, making them potentially inaccurate or unsupported. (2) The quantitative accuracy is compromised because the original answer does not specify the size of American Express’s SCB or any historical changes (e.g., 3.4% in 2022), nor does it mention the G-SIB surcharge or CET1 baseline calculations. These additions, while plausible in a broader regulatory context, go beyond the knowledge graph’s ground truth and introduce unverified data. (3) The reasoning is partially sound: the model correctly distinguishes between the two banks’ regulatory approaches and buffer types, showing appropriate multi-hop synthesis. However, it overreaches by constructing a detailed capital structure comparison that isn’t supported by the original answer, undermining factual reliability. (4) The contextual relevance is high because the response directly addresses the comparison asked in the question and uses appropriate terminology. The qualitative accuracy is moderate because the core conceptual distinction is correct, but the unsupported numerical details reduce overall correctness. Hence, the correctness score is 6—partially correct but with significant factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 481,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "LMT applies a discounted‑cash‑flow (DCF) model only to Level‑3 fixed‑income holdings, treating the discount rate as a key input but the filing gives no explicit sensitivity analysis. Honeywell, by contrast, uses a DCF to value goodwill and indefinite‑life intangibles and states that it performs sensitivity analyses on the discount rate; even a 0.25‑percentage‑point shift can materially alter the fair‑value estimate and, for its pension plans, can change ongoing expense by roughly $15‑$16 million and projected benefit obligation by about $214‑$222 million. Thus, while both companies rely on the discount rate, Honeywell explicitly quantifies its sensitivity, whereas LMT’s sensitivity is not disclosed.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and reasoning, accurately distinguishing between LMT's and HON's use of the discounted cash flow (DCF) approach in different contexts—Level 3 fixed income investments for LMT and goodwill/intangible asset impairment for HON. It correctly identifies that both companies rely on the discount rate as a key assumption and that HON explicitly performs and discloses sensitivity analyses, while LMT does not provide explicit sensitivity analysis in its filings. This aligns with the ground truth, which notes that both firms acknowledge sensitivity to discount rate changes, but only HON details such sensitivity quantitatively.\n\nHowever, the quantitative accuracy is slightly compromised. The LLM introduces specific figures—'a 0.25-percentage-point shift' affecting pension expenses by '$15–$16 million' and projected benefit obligations by '$214–$222 million'—which, while potentially accurate in HON's filings, are not present in the original ground truth answer derived from the knowledge graph. Since the original answer does not include these numbers, their inclusion introduces unverified quantitative claims, reducing confidence in strict factual alignment. The ground truth only states that HON 'performs sensitivity analyses' and acknowledges sensitivity to discount rate changes, without quantifying the impact.\n\nThe reasoning is sound and the multi-hop synthesis across two companies and applications of DCF is well executed. The answer correctly contrasts disclosure practices (explicit quantification by HON vs. lack thereof by LMT), which is a valid inference from the original answer. Contextual relevance is excellent, directly addressing the comparison of significance and sensitivity of discount rate assumptions.\n\nThus, while the core facts and comparative insight are correct (deserving a high score), the introduction of unsupported numerical details prevents a top score on quantitative accuracy, pulling the overall correctness to 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 542,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "CMCSA’s Class B shares each carry 10 votes (non‑dilutable) and can be converted share‑for‑share into Class A; buying back Class B shares therefore shrinks the total voting pool and can raise the proportion of voting power held by the remaining shares, potentially consolidating control. Alphabet’s Class B shares also carry 10 votes but automatically convert to Class A shares with only one vote, so any conversion would dilute voting power; repurchasing Alphabet’s Class A and C shares does not alter the Class B voting pool, but conversion would offset any concentration effect.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that CMCSA’s Class B shares carry '10 votes'—the ground truth specifies 15 votes per Class B share. Second, it misrepresents the non-dilutable voting power: the original answer states Class B maintains a fixed 33 1/3% of total voting power, not that each share has non-dilutable votes (a structural distinction). The LLM also omits the $62.0 billion repurchase amount by Alphabet in 2024, a key quantitative detail. (2) The calculation and numeric elements are partially wrong: '10 votes' vs. correct '15 votes' is a significant error. The repurchase amount of $62.0 billion is entirely missing. No calculations are performed in the LLM answer, but the numbers cited are incorrect. (3) The multi-hop reasoning is partially sound—LLM correctly identifies that share repurchases can affect voting concentration and contrasts conversion mechanisms between CMCSA and Alphabet. However, it mischaracterizes the mechanism: CMCSA’s Class B voting power increases relatively when Class A shares are repurchased due to fixed percentage entitlement, not because repurchasing Class B shrinks the pool (the LLM incorrectly suggests repurchasing Class B shares, which is not the focus of the original reasoning). The LLM also fails to note that CMCSA’s Class B to A conversion is share-for-share without dilution, while Alphabet’s conversion involves 10:1 voting dilution. (4) Contextual relevance is high—the answer addresses voting power, share repurchases, and dual-class structures at both companies. However, due to key factual and quantitative errors, especially vote count and repurchase amount, and flawed reasoning about which share class is repurchased, the correctness score is limited to 4. Qualitative accuracy is moderate due to correct conceptual framing but flawed details. Quantitative accuracy is low due to incorrect vote count and missing dollar figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 528,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "TGT’s beverage business accounts for roughly 22 % of its total net sales (the “Food & Beverage” line is $23.8 bn of $106.6 bn in 2024【page_49】), which is slightly below PepsiCo’s beverage revenue share in the APAC region—23 % of APAC net revenue【page_73】. Thus, TGT’s beverage mix is comparable but marginally lower than PepsiCo’s APAC beverage contribution.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that TGT does not break down beverage sales separately from its broader grocery segment, yet the LLM claims TGT’s beverage business accounts for 22% of total net sales with specific figures ($23.8B of $106.6B), which contradicts the original answer and is unsupported by the provided context. This number appears fabricated or misattributed. (2) The PEP beverage revenue contribution of 23% in APAC is correctly cited, and the region-specific focus aligns with the question. However, the LLM fails to mention PEP's APAC revenue of $10 million in 2024, a key data point in the ground truth. More critically, the LLM incorrectly compares TGT’s global beverage mix (which isn’t reported) to PEP’s regional (APAC) beverage contribution, creating a misleading comparison. (3) The multi-hop reasoning is flawed: the model should have recognized that TGT does not disclose beverage sales separately for APAC or globally, making any percentage or dollar figure for TGT’s beverage mix speculative. Instead, it invents a precise breakdown, failing to synthesize the absence of data as a key insight. (4) While the LLM attempts to address the comparison between TGT and PEP in the APAC market, it fundamentally misrepresents TGT’s reporting structure and introduces false precision. The contextual relevance is moderate because it discusses the right companies and topic, but the incorrect data and flawed logic severely undermine the answer’s validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 423,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "Amgen’s $5.2 billion intangible‑asset carrying value for Otezla could be impaired if Medicare price negotiations under the IRA lower the drug’s reimbursement, reducing sales and profitability. Because BMY also markets Otezla under a licensing agreement, any price cuts would cut Amgen’s royalty or licensing revenue from BMY, further weakening the recoverability of the intangible asset. [AMGN_10k_2024 page 137] [AMGN_10k_2024 page 36] [BMY_10k_2024 page 5]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Amgen's $5.2 billion intangible asset valuation for Otezla is at risk due to Medicare price negotiations under the IRA starting in 2027, which could reduce revenue and impair the asset. The involvement of BMY through a licensing agreement is correctly noted, and the impact on Amgen’s royalty income is logically tied to the pricing pressure. (2) Quantitative accuracy is perfect: the $5.2 billion figure is correctly cited, and no incorrect numbers or dates are present. While the LLM does not explicitly state 'January 1, 2027' or '2027' as in the original, it refers to the general impact of IRA negotiations, which is contextually sufficient given the focus on financial implications rather than precise timing. (3) Multi-hop reasoning is sound: the model correctly synthesizes that BMY markets Otezla under license, that price reductions would affect overall sales, and that this in turn impacts Amgen’s revenue and asset recoverability. It also cites supporting document pages from both AMGN and BMY 10-Ks, indicating proper cross-entity sourcing. (4) The only minor shortcoming is that the LLM does not explicitly quote Amgen’s own statement about future changes in estimates potentially impacting recoverability, which slightly reduces qualitative completeness. However, the core reasoning and conclusion are equivalent. Wording differs but semantic meaning matches. Contextual relevance is excellent—directly addresses all parts of the question with appropriate financial and regulatory nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 438,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD’s FPGA line—particularly the Versal portfolio and legacy Virtex/Spartan families—is sold as part of its data‑center portfolio and is a significant component of the hardware that large public‑cloud and hyperscale private data‑center operators purchase (see AMD 10‑K, page 11).  In contrast, Intel’s Altera business, now a standalone “all‑other” segment (Intel 10‑K, page 69), offers programmable semiconductors that serve a broader set of embedded, communications, cloud and enterprise markets, but it is not positioned as a core data‑center FPGA supplier within Intel’s main CPU and foundry operations (Intel 10‑K, page 23).  Thus, while AMD’s FPGA production is tightly integrated into its hyperscale data‑center strategy, Intel’s Altera FPGA offerings are part of a separate, more diversified business that Intel has spun out to focus on its own core semiconductor activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD produces FPGAs (Versal, Virtex, Spartan) that are integrated into hyperscale data center infrastructure, particularly for AI workloads, which matches the original answer's emphasis on AMD's direct role in hyperscale data centers. Intel operates Altera as a standalone business (referred to as an 'all-other' segment), which serves broader markets including cloud and enterprise, but is not tightly integrated into Intel’s core data center CPU operations—this reflects the strategic separation described in the ground truth, including potential monetization like an IPO. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable but assumed correct by absence. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across AMD and Intel’s 10-K filings to contrast their strategic positioning—AMD’s integration vs. Intel’s separation of FPGA operations. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Intel’s pursuit of monetization opportunities (e.g., potential IPO) for Altera, which is a small but relevant detail from the original answer. However, referencing Altera as a standalone 'all-other' segment implies this strategic distancing. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 411,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "CMCSA’s Class B shares are only 44.6 million but each carries 15 votes, giving them 33 % of the company’s voting power and all of that power is concentrated in a single holder, Brian L. Roberts【page_2】【page_38】. Alphabet’s Class A shares, in contrast, are far more numerous (over 1.8 billion) and each has one vote, with ownership spread among many shareholders and no single holder controlling a large portion of the voting power【page_1】. Thus, CMCSA’s voting structure is highly concentrated, whereas Alphabet’s is dispersed.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states CMCSA’s Class B shares are '44.6 million' — this is incorrect; the original answer does not specify the number of Class B shares, only that they represent 33⅓% of voting power. Additionally, the claim that each Class B share carries '15 votes' is not supported by the ground truth and introduces fabricated data. For GOOGL, the LLM incorrectly states there are 'over 1.8 billion' Class A shares outstanding, whereas the ground truth specifies 300,754,904 as of January 25, 2022 — a major discrepancy. The market value of $1,451.1 billion as of June 30, 2021, is omitted entirely. (2) Number verification: The 33% voting power at CMCSA is approximately correct (rounding of 33⅓%), and the concentration in Brian L. Roberts is accurate. However, the share counts and vote multiples are entirely wrong. (3) Multi-hop reasoning is partially sound: the model correctly identifies that CMCSA has concentrated voting control while GOOGL has broad distribution, and it draws a valid contrast in ownership structure. It correctly links voting power to stock class design, satisfying the comparative aspect of the question. (4) Despite incorrect numbers, the core qualitative insight — concentrated vs. dispersed control — is preserved, justifying a moderate correctness score. The answer remains contextually relevant and addresses the structural comparison, but the severe quantitative errors undermine factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 414,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "BMS’s Keytruda royalty rate falls from 6.5 % to 2.5 % after 2023 (Keytruda license agreement, page 90), cutting the royalty income it derives from Keytruda sales and thereby reducing its revenue exposure to Merck.  Merck remains a partner in co‑developing combination therapies—such as Keytruda + V940 with Moderna and ADCs with Daiichi Sankyo (page 90)—but those arrangements involve shared costs and profit‑sharing rather than direct royalties, so while BMS still benefits from those collaborations, the overall revenue dependency on Merck is modestly lowered.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the royalty rate drop from 6.5% to 2.5% starting after 2023 (i.e., January 1, 2024) is accurately reported. No calculations are required, but the directional impact (reduced royalty income) is correctly inferred. (2) The LLM correctly identifies Merck’s co-development of Keytruda combination therapies, specifically mentioning V940 with Moderna (aligned with ground truth), and notes shared cost/profit structures. It also adds ADCs with Daiichi Sankyo, which may be contextually relevant but not directly tied to Keytruda in the ground truth—this is a minor addition but not factually incorrect. (3) The reasoning is sound: the LLM correctly synthesizes that reduced royalty rates lower BMS’s revenue dependency on Merck, even though BMS still benefits indirectly through collaborations. The logic that shared-cost partnerships do not generate direct royalties is valid and supports the conclusion. (4) The only minor gap is that the LLM does not explicitly mention Ono (co-licensor with BMS) or emphasize that the royalty reduction directly affects income from Keytruda’s global sales, which is a key point in the original answer. However, the core financial impact and reduced dependency are clearly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is high as all information directly addresses the question’s focus on revenue dependency and co-development implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 419,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "Caterpillar’s 10‑K notes that it has adopted ASU 2022‑06 (Reference‑Rate Reform) and that the guidance extends the optional relief for contract modifications that replace a reference rate through 12/31/2024 (see page 67). Under this standard, such modifications are no longer required to be re‑measured for time‑value effects, thereby reducing the operational and financial impact of the change. Boeing’s 2023 risk disclosure highlights that U.S. government contracts can be modified or terminated at the government’s discretion; the ASU would therefore lessen the accounting impact of any U.S. government contract modification that involves a reference‑rate change, potentially mitigating that material risk—though it does not eliminate the risk of other types of contract changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: ASU 2022-06 extends relief for contract modifications related to reference rate reform through December 31, 2024—this date is correctly stated. The mention of Caterpillar (CAT) adopting the standard in its 10-K (page 67 cited) matches the original answer’s assertion that CAT listed it as adopted. Boeing (BA) is correctly identified as having disclosed U.S. government contract risks in 2023, and the nature of those risks (modifications/terminations at discretion) is accurately reflected. (2) Quantitatively, all dates and references are correct. While the original answer includes the specific figure that 37% of BA’s 2023 revenues came from U.S. government contracts, the LLM answer omits this percentage. This is a minor omission but does not undermine the core reasoning or conclusion. No calculations are required, and all stated facts are numerically accurate. (3) The multi-hop reasoning is sound: the model correctly links CAT’s adoption of ASU 2022-06 to the accounting treatment of contract modifications, connects it to BA’s risk disclosure about U.S. government contracts, and explains how the standard reduces accounting complexity for reference-rate-related changes. It appropriately notes that while the ASU mitigates accounting impact for rate-related modifications, it doesn’t eliminate broader contract change risks. (4) The answer is contextually relevant and directly addresses the question’s focus on how ASU 2022-06 affects treatment of contract modifications in the context of BA’s disclosed risk. The only reason for not scoring a 10 is the omission of the 37% revenue figure, which adds contextual weight in the original answer but is not critical to the central logic. Overall, the answer demonstrates strong synthesis and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 506,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "Both companies kept the towers on their books and continued to depreciate them, and they treated the proceeds as financing obligations. AT&T’s 2013 Crown Castle deal recorded the entire $4.8 billion cash proceeds as a single financing obligation with an effective‑interest rate of ~3.9 % (page 93), while Verizon’s 2024 Vertical Bridge transaction split the $2.8 billion upfront payment into $2.0 billion of prepaid rent for the capacity transferred and an $830 million financing obligation for the portion of towers it still occupies (page 73). Thus, AT&T’s obligation is larger and fully financed, whereas Verizon’s obligation is smaller and partially offset by prepaid rent.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Correctly identifies that both AT&T (not Verizon in 2013) and Verizon retained depreciation responsibilities and treated proceeds as financing obligations, with towers remaining on their balance sheets. (2) Quantitatively, the $4.8 billion AT&T figure is correctly cited (ground truth: $4.827 billion — minor rounding acceptable), and Verizon’s $2.8 billion total with $830 million financing obligation is accurate. The split into $2.0 billion prepaid rent is correctly inferred ($2.8B - $0.83B = $1.97B ≈ $2.0B, acceptable rounding). The 3.9% effective interest rate for AT&T is correctly stated. (3) Multi-hop reasoning is sound: the model correctly contrasts AT&T’s full financing obligation with Verizon’s partial obligation and prepaid rent treatment, highlighting the structural difference. (4) One minor error: the LLM incorrectly attributes the 2013 deal to Verizon instead of AT&T in the opening comparison, which is a significant entity mix-up but corrected later when discussing each deal individually. This reduces quantitative and qualitative accuracy slightly. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 350,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo’s Asia Pacific, Australia and New Zealand region includes its own bottling plants and distribution facilities, giving the company a direct operational presence in New Zealand’s beverage market (pages 5–6). In contrast, Coca‑Cola’s influence in the same market is indirect; the company owns about 19 % of Coca‑Cola Europacific Partners (CCEP), the bottler that bottles and distributes Coca‑Cola products in New Zealand (page 69). Thus, PepsiCo operates directly in New Zealand, while Coca‑Cola relies on its equity stake in CCEP to shape the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 19% stake in CCEP is correctly reported, and no other numerical values are in dispute. The reference to pages 5–6 and 69 suggests proper sourcing from the document, though page numbers are not part of the ground truth evaluation. (2) The answer correctly identifies PEP's direct operational presence in New Zealand through its APAC structure and notes its own bottling and distribution infrastructure, which matches the ground truth's assertion of 'direct operational presence.' (3) It accurately contrasts this with KO's indirect influence via its 19% equity stake in CCEP, the entity responsible for bottling and distributing Coca-Cola products in New Zealand. (4) The reasoning correctly synthesizes the distinction between direct operational control (PEP) and indirect financial influence (KO through CCEP), capturing the core multi-hop comparison. The only minor shortcoming is that the LLM answer does not explicitly mention that KO's stake allows it to 'influence CCEP's operations indirectly' beyond shaping the market, a nuance present in the original answer. However, the phrase 'rely on its equity stake... to shape the market' conveys a similar idea, just with slightly less precision on governance influence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with complete coverage of the key entities and relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 410,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG estimates the fair value of mortgage‑backed securities (RMBS, CMBS, CLO/ABS, etc.) by applying internal valuation models, dealer quotations, and discounted‑cash‑flow analyses that incorporate credit, liquidity, and pre‑payment assumptions (AIG 10‑K, Item 8, page 113; page 125). Schwab, by contrast, relies on independent third‑party pricing services that provide prices based on observable trades and broker‑dealer quotes, using those quotes as the primary fair‑value basis for commercial mortgage‑backed securities and only adjusting when the quotes are inconsistent with fair value (Schwab 10‑K, Note 2, page 81). In short, AIG’s approach is internally model‑driven, whereas Schwab’s is largely quote‑based from external pricing services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies AIG's use of internal valuation models, including inputs like credit, liquidity, and prepayment assumptions, and references dealer quotations and discounted cash flow analyses—consistent with the original answer's emphasis on internal models and third-party inputs. It accurately contrasts this with SCHW's reliance on third-party pricing services and broker/dealer quotes, noting that Schwab uses these as the primary basis and adjusts only when inconsistent with fair value. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised; all references to filing locations (e.g., 10-K pages) are consistent and plausible. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AIG and SCHW filings, comparing their distinct approaches—internally modeled vs. externally quoted pricing—for similar asset classes. (4) The LLM omits the reference to GILD’s supporting evidence about industry practices, which adds contextual depth in the original answer about the convergence of practices across firms. However, this is a minor omission that does not detract from the core factual comparison. Wording differs but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a high score with only slight deduction for incomplete synthesis of broader industry context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 424,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO values its Level 2 securities—asset‑backed securities, corporate bonds and municipal bonds—using market‑corroborated pricing or matrix pricing (or other models) that incorporate observable inputs such as yield curves (see AVGO page 80).  \nAdobe, for its fixed‑income available‑for‑sale debt, relies on matrix pricing from independent vendors and explicitly uses benchmark yields, issuer spreads, interest rates and Treasury or swap curves as observable inputs (see Adobe page 71).  \nThus, both firms use observable market inputs like yield curves and benchmark rates in their fair‑value calculations, but AVGO applies this to a broader mix of Level 2 securities, while Adobe’s matrix‑pricing focus is concentrated on its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both AVGO and ADBE use observable market inputs such as yield curves, benchmark rates, interest rates, and issuer spreads for valuing Level 2 securities. The mention of matrix pricing for ADBE and its use of independent vendors matches the original answer. AVGO's use of market-corroborated pricing, matrix pricing, or other models with observable inputs is consistent with the ground truth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ methodologies, identifying shared reliance on observable inputs while noting a difference in scope—AVGO applying the methodology to a broader mix of securities (e.g., asset-backed, corporate, municipal bonds) versus ADBE’s focus on fixed-income available-for-sale debt. This nuance is not explicitly in the original answer but is a reasonable inference supported by context and does not contradict the ground truth. (4) Semantic equivalence is maintained: the core conclusion—that both companies rely on similar observable market data for Level 2 valuations—is preserved. The slight expansion on AVGO’s broader security types adds detail without introducing inaccuracy. Only a minor deduction in qualitative accuracy due to this added inference, which, while plausible, isn't fully confirmed in the original answer. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 457,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC accounts for roughly **12 % of Coca‑Cola’s non‑U.S. unit case volume**.  \nIt coordinates distribution in **28 operational countries**—including the Czech Republic—across its bottling and distribution network.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The percentage of Coca-Cola's non-U.S. unit case volume managed by Coca-Cola HBC is stated as 12%, but the ground truth is 17%. Similarly, the number of countries where distribution is coordinated is reported as 28, whereas the correct number is 30. These quantitative errors undermine the core of the answer. (2) Both key numbers—12% vs 17% and 28 vs 30 countries—are incorrect. There is no indication of approximation or rounding that would justify such discrepancies; these are definitive figures that must match exactly. Even allowing for format flexibility, the values themselves are factually wrong. (3) While the LLM correctly identifies Coca-Cola HBC as the entity managing distribution and correctly includes the Czech Republic as part of the operational footprint, it fails in the multi-hop synthesis required to report accurate figures derived from cross-document or cross-entity data. The reasoning structure is sound—answering both parts of the question—but based on incorrect data. (4) The contextual relevance is high because the answer addresses both sub-questions and refers to the correct entities and scope (non-U.S. volume, distribution coordination, inclusion of Czech Republic). However, due to major quantitative errors, the correctness and accuracy scores are low. A correct answer must reflect precise figures from the knowledge graph, especially for financial and operational metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 409,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "NextEra’s 31.9 % stake in a 303‑mile pipeline under construction in West Virginia and Virginia (page 17) shows a growth‑oriented strategy that seeks to add transmission capacity to its natural‑gas portfolio, but the project remains contingent on regulatory approvals and legal challenges that have already prompted impairment charges. In contrast, Duke Energy’s 50 % equity interest in Hardy Storage (page 19) reflects a more conservative, regulated‑asset approach focused on mature storage infrastructure with established FERC cost‑recovery mechanisms. Together, the two positions illustrate divergent risk appetites: Duke Energy prioritizes stable, regulated infrastructure, while NextEra pursues new, higher‑risk projects amid significant regulatory and market headwinds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia are accurately reported. The numbers (percentages, mileage) match the original answer exactly. (2) Quantitative accuracy is perfect—no calculation errors, and all figures are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes strategic differences between Duke’s focus on regulated, stable storage infrastructure and NextEra’s higher-risk expansion strategy involving a pipeline under construction with regulatory hurdles. It appropriately references FERC cost-recovery mechanisms and notes legal challenges and impairment charges, which adds depth. (4) The only minor shortcoming is that the LLM answer does not explicitly name the pipeline project or reiterate that both investments are in the same region (West Virginia), though this is implied. It also omits Duke’s broader context of investing in other FERC-regulated assets like Pine Needle, which slightly reduces qualitative completeness. However, the core contrast in strategic approaches—regulated stability vs. growth amid uncertainty—is clearly and correctly conveyed. Wording differs but semantic equivalence is strong. Contextual relevance is excellent as it directly addresses the question’s focus on divergent strategies, regulatory challenges, and market dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 414,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "META’s 10‑K lists 2,189,898,148 Class A shares and 343,761,117 Class B shares (page 1) but does not disclose a voting ratio, implying that Class B shares carry more votes than Class A shares. Alphabet, by contrast, explicitly gives each Class B share 10 votes versus 1 for Class A (page 82) and repurchased $62 billion of shares in 2024 (page 82), which further concentrates ownership among the relatively small number of high‑voting Class B holders. Thus, both firms exhibit ownership concentration, with META’s undisclosed but higher‑voting Class B shares and Alphabet’s 10:1 ratio plus large repurchases amplifying control for a minority of shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: META's Class A and Class B share counts (2,189,898,148 and 343,761,117) are accurately cited, and GOOGL's 10:1 voting ratio and $62.0 billion 2024 share repurchases are correctly reported. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—no calculations were required, but all numeric values match the original answer exactly. (3) The reasoning is sound: the LLM correctly identifies that META does not disclose its voting ratio but implies higher voting rights for Class B, contrasts this with GOOGL’s explicit 10:1 ratio, and notes that share repurchases by GOOGL amplify ownership concentration. The multi-hop synthesis across companies and metrics (voting structure + repurchases) is logically coherent. (4) The only minor shortcoming is that the LLM does not explicitly state that GOOGL's repurchases were 'predominantly from Class A and Class C' shares, which slightly reduces completeness in explaining how repurchases affect ownership concentration. However, the core implication—that repurchases concentrate control—is correctly conveyed. Overall, the answer is semantically equivalent to the ground truth with excellent contextual relevance and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 365,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The Swiss Federal Act on Tax Reform (TRAF) gave J&J a net benefit of roughly **$0.4 billion, lowering its 2020 effective tax rate by about 2.6 %**.  \nMerck’s 2021 Swiss tax holiday produced a much larger benefit – the foreign‑earnings differential in its 2021 tax reconciliation shows a **$1.45 billion (≈10.4 %) tax benefit**, roughly three‑to‑four times the magnitude of J&J’s benefit.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that JNJ's effective tax rate decreased by 1.9% due to TRAF in 2020, but the LLM claims a 2.6% decrease, which is incorrect. Additionally, the $0.4 billion benefit figure for JNJ is not present in the original answer and cannot be verified against the provided truth. For MRK, the original answer mentions a Swiss tax holiday starting in 2021 but provides no specific dollar amount or percentage impact; however, the LLM asserts a $1.45 billion benefit and a 10.4% tax benefit, which are unsupported by the ground truth. These quantitative claims are entirely fabricated or misattributed. (2) The calculations and comparisons (e.g., 'three-to-four times the magnitude') are based on incorrect inputs and thus invalid. The original answer does not provide enough data to support such a comparison. (3) While the LLM correctly identifies the general mechanisms—TRAF for JNJ in 2020 and a Swiss tax holiday for MRK starting in 2021—the multi-hop synthesis is flawed because it invents precise financial impacts rather than acknowledging the lack of comparable quantitative data. The reasoning fails because it substitutes unsupported numbers for qualitative insights. (4) Despite the factual errors, the answer is contextually relevant: it addresses both companies, the correct tax regimes, and the right years, showing understanding of the question’s structure. However, the invention of specific dollar amounts and percentages severely undermines correctness. The qualitative accuracy is low due to incorrect entity-specific metrics, though the conceptual framework (different mechanisms, different years) aligns with the truth. Final scores reflect major penalties on quantitative accuracy and overall correctness due to unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 498,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "MCD’s 10‑K does not disclose any specific foreign‑currency‑asset hedging program or the size of such positions; the company only discusses risk‑analysis of potential currency moves (page 24).  By contrast, Nike actively uses options and forwards to hedge forecasted foreign‑currency transactions, with a net cash‑flow‑hedge notional of $9.9 billion in 2024 (page 4) and an explicit objective of reducing earnings and cash‑flow volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misattributes key information between MCD and NKE. (1) Quantitatively, it incorrectly assigns the $9.9 billion notional amount of net foreign exchange cash flow hedges to NKE, when this figure belongs to MCD as of September 28, 2024, according to the ground truth. The LLM reverses the companies' roles in reporting this number. (2) The claim that 'MCD’s 10-K does not disclose any specific foreign-currency-asset hedging program' directly contradicts the ground truth, which states MCD uses options and forwards to hedge forecasted transactions with $9.9 billion in notional hedges. This is a major factual error. (3) Qualitatively, the reasoning is flawed: the LLM fails to correctly distinguish the strategic objectives — MCD focuses on protecting foreign currency net assets, while NKE targets transactional exposures and cost stability. Instead, the LLM incorrectly portrays NKE as having the $9.9 billion program and implies MCD does not use such instruments, undermining the comparison. (4) Contextually, the answer attempts to address the question’s structure (comparing hedging practices using options, notional amounts, objectives), so relevance is moderate. However, due to swapped entities, incorrect numbers, and reversed disclosures, the core of the response is factually unsound. Minor point: both mention use of options/forwards, which is directionally correct, but this does not offset the major errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 406,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The G500’s exclusive use of RTX’s PW800 engine gives the aircraft a modern, efficient powerplant that delivers higher thrust, lower fuel burn and reduced emissions—performance gains that help General Dynamics market the G500 as a next‑generation replacement for the older G450 and G550 models【page_4】【page_5】.  The PW800’s exclusive partnership also guarantees a reliable supply chain and support, reinforcing GD’s strategy to leverage advanced technology and sustainability in its new business‑jet lineup【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the exclusive use of RTX's PW800 engine on the G500 and explains how this supports General Dynamics' strategy by highlighting improved performance (higher thrust, lower fuel burn, reduced emissions), which positions the G500 as a next-generation replacement for the G450 and G550. The mention of supply chain reliability and support adds value and is consistent with strategic advantages of exclusive partnerships. The answer also correctly attributes the engine to RTX (via Pratt & Whitney Canada, implied through context) and links the technological advancement to GD’s broader strategy in modernizing its business jet lineup. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are in dispute). The only minor shortcoming is that the LLM does not explicitly mention the 'clean-sheet design', 'new wing', or 'advanced avionics' from the original answer, which are key elements of the G500’s differentiation. However, the focus on the engine’s role in enabling next-gen performance captures the core of the multi-hop reasoning: (1) PW800 is exclusive to G500, (2) it delivers superior performance, (3) this helps GD position the aircraft as a modern replacement. Thus, while slightly less comprehensive, the LLM answer remains semantically equivalent in intent and factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 393,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "Comcast’s charter gives each Class B share 15 votes, which represents roughly 33 % of the combined voting power and is “generally non‑dilutable” under its articles of incorporation; the remaining 66 % is held by Class A shares. Meta’s charter gives each Class B share 10 votes versus 1 vote for Class A, but the filing does not state a non‑dilutable provision or a fixed percentage split—its voting power is determined by the 10‑to‑1 vote ratio rather than a set percentage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key distinctions between META's and CMCSA's dual-class structures. (1) Quantitatively, all numbers are correct: CMCSA's Class B has 15 votes per share and holds 33 1/3% (rounded to 'roughly 33%') of voting power, with Class A holding 66 2/3% ('remaining 66%'). The 10-to-1 vote ratio for Meta’s Class B vs. Class A is correctly stated. (2) The answer correctly notes that CMCSA has a non-dilutable provision tied to its articles of incorporation preserving voting percentages, while Meta’s structure relies on the voting ratio without a fixed percentage or explicit non-dilution clause. (3) Multi-hop reasoning is sound—comparing voting power mechanisms, vote ratios, and dilution protections across two companies. (4) Minor deduction in qualitative accuracy because the LLM omits that CMCSA’s Class B is 'beneficially owned entirely by Brian L. Roberts,' a detail in the ground truth that adds context about control concentration. However, this does not undermine the core comparison about structural differences in voting power and non-dilutability. Wording differences (e.g., 'generally non-dilutable' vs. 'specifically tied') are semantically acceptable. Overall, the answer is factually correct, complete in substance, and directly responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 361,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "BMY’s Revlimid faces a substantial risk of losing exclusivity in Europe because generic entrants can challenge its patents and the company has already agreed to earlier‑than‑expected entry in the UK and other EU markets (see BMY page 36).  By contrast, LLY relies on orphan‑drug data protection, which grants a seven‑year exclusivity period independent of patent validity and therefore is less vulnerable to patent litigation, though it can still be curtailed by regulatory changes (see LLY page 10).  In short, BMY’s exclusivity is more exposed to patent‑challenge risk, whereas LLY’s data‑protection strategy offers a more predictable but still regulatory‑dependent safeguard.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: BMY's Revlimid faced early generic entry in Europe due to patent settlements, with specific reference to the UK and EU markets; LLY uses orphan drug data protection providing seven years of exclusivity independent of patents. While the LLM does not specify the exact dates (January 18 and February 18, 2022), it correctly identifies the nature and timing implications of early entry without contradicting the ground truth. (2) Quantitative accuracy is strong: the seven-year exclusivity period for orphan drugs is correctly stated, and no incorrect numbers or calculations are present. The absence of exact dates is a minor omission but does not affect factual correctness, as the focus is on the structural comparison of IP strategies. (3) Multi-hop reasoning is sound: the model correctly synthesizes that BMY relies on patent-based exclusivity vulnerable to litigation and settlement, while LLY benefits from regulatory data protection that is more insulated from patent challenges. This contrast is logically drawn and aligns with the knowledge graph. (4) The answer is contextually relevant, directly addressing the comparative risk profile of IP strategies for both companies. Wording differs slightly (e.g., 'less vulnerable to patent litigation' vs. 'independent of patent expiration'), but semantic equivalence is maintained. One point deducted from qualitative accuracy due to lack of explicit mention of the 2022 entry dates, which are part of the factual record in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 441,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "Morgan Stanley’s asset‑management fees are directly tied to the value of client holdings, and the firm estimates that a 10 % decline in investment values would cut its investment‑management‑related revenues by about **$571 million** (2024), showing a clear revenue sensitivity to fixed‑income market swings. PayPal, by contrast, exposes itself to market risk mainly through the valuation of its derivatives and debt securities, which are priced with Level‑2 models that rely on observable inputs such as interest‑rate curves and credit spreads; the company holds roughly **$17.3 billion** of notional derivatives and **$1.5 billion** in corporate debt, but it does not report a comparable revenue‑impact figure, indicating a more valuation‑based rather than direct revenue sensitivity.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between MS's revenue sensitivity and PYPL's valuation-based market risk exposure, showing good contextual understanding and relevance. However, significant quantitative inaccuracies undermine the correctness. The $571 million figure for MS's revenue impact from a 10% decline is not present in the original answer (ground truth) and cannot be verified from the provided information; no such estimate is mentioned in the ground truth, making this a fabricated or misattributed number. Similarly, the $17.3 billion notional derivatives and $1.5 billion corporate debt holdings for PYPL are specific figures absent from the original answer, introducing unsupported data. While both companies use pricing models with observable inputs (interest rates, credit spreads), the LLM fails to mention PYPL's election of the fair value option for foreign currency-denominated debt securities—a key differentiator in its direct market exposure—which is a notable omission in the qualitative comparison. The reasoning correctly identifies that MS’s exposure is indirect via fees while PYPL’s is more valuation-driven, aligning with the ground truth’s logic, but misses the full nuance that PYPL’s fair value election leads to direct P&L volatility. Thus, while the conceptual framework is sound and relevant, the inclusion of unverified numbers and missing key differentiating disclosures reduces factual accuracy, especially on quantitative grounds.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 405,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle’s MySQL HeatWave now bundles generative‑AI inference with real‑time analytics and transactions, showing its strategy to embed AI directly into enterprise data platforms for on‑device AI use cases such as fault detection and predictive analytics (page_12, page_11). Qualcomm’s QSI segment’s strategic investments in IoT, together with its Snapdragon AI engine and Hexagon NPU that run complex models at low power, underscore its focus on embedding on‑device AI into consumer and industrial edge devices for real‑time, privacy‑preserving processing (page_7).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Oracle's integration of generative AI into MySQL HeatWave as part of its enterprise data platform strategy and Qualcomm's focus on on-device AI via Snapdragon and Hexagon NPU for edge devices. However, it omits key quantitative projections from the ground truth—specifically, Qualcomm's forecast that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. This is a significant omission in quantitative context. (2) No incorrect numbers are present; the LLM does not introduce any false quantitative data, so quantitative accuracy is high. But the absence of the 19% and 46% figures, which are central to Qualcomm’s strategy projection, reduces completeness. (3) The multi-hop reasoning is partially sound: the model correctly identifies Oracle’s enterprise cloud-AI integration and Qualcomm’s edge-AI focus in IoT and consumer devices. However, it fails to fully synthesize the contrast in market focus (enterprise vs. consumer/IoT) with supporting data, weakening the comparative analysis. (4) The answer remains contextually relevant and semantically aligned in direction, but the lack of specific forward-looking data from Qualcomm and less precise framing of Oracle’s managed cloud service (referred to as 'on-device' which may conflate with edge devices) slightly misrepresents the deployment model. Oracle’s solution is cloud-based with AI embedded in the data platform, not strictly 'on-device' as implied. Thus, while core facts are accurate, omissions and slight mischaracterization reduce correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 442,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe’s risk‑factor disclosures (page 23) warn that the EU AI Act could force costly changes to its AI development, raising compliance costs and potentially delaying new AI features.  This regulatory burden could slow Adobe’s ability to innovate and deploy AI‑powered products at the same pace as Salesforce, whose Agentforce platform (page 6) underpins AI‑driven sales and service capabilities with fewer constraints, potentially widening the competitive gap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core of the ground truth. (1) All factual elements are correct: Adobe anticipates costly changes and compliance burdens from the EU AI Act, which may delay AI development; Salesforce’s Agentforce platform is central to its AI-driven sales and service offerings. The LLM correctly identifies the competitive risk to Adobe if innovation slows. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes Adobe’s regulatory risks with Salesforce’s AI reliance and infers a potential competitive disadvantage for Adobe. The only minor omission is that the ground truth notes the EU AI Act will be implemented in phases through 2030 and that both companies face similar regulatory pressures (per GS_10k_2024), which the LLM answer does not mention. Also, the deeper integration of Agentforce across Salesforce’s platform as a resilience factor is slightly underdeveloped. (4) Despite these small gaps, the LLM answer is contextually precise, directly addressing the competitive dynamics posed by regulatory costs. Wording differs but semantic meaning aligns closely with the original. Hence, a 9/10 for correctness and qualitative accuracy, full marks for contextual relevance and quantitative accuracy (no numbers, but no inaccuracies).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 391,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "HD’s deferred‑share awards to non‑employee directors grant an additional share for each dividend equivalent paid when the underlying shares are finally issued, giving directors a direct equity‑based payout (page 68). In contrast, LOW’s variable‑notional ASR agreements provide the company with extra shares from a third‑party repurchase at finalization, which the company can cancel or hold, thereby reducing outstanding shares or providing cash rather than directly allocating shares to stakeholders (page 62). Thus, HD’s structure delivers stock‑based value directly to directors, while LOW’s structure indirectly benefits shareholders through share‑repurchase mechanics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that HD issues additional shares as dividend equivalents to non-employee directors upon payout of deferred shares, which aligns with the original answer's description of stock-based compensation tied to director retention. It also correctly states that LOW receives additional shares through variable notional ASR agreements from third parties, which is consistent with the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (HD and LOW), two distinct mechanisms (deferred share payouts vs. ASR agreements), and two stakeholder contexts (direct compensation to directors vs. capital return to shareholders). The only minor shortcoming is that the LLM answer does not explicitly state that LOW’s additional shares are tied to 'repurchase efficiency and final notional value calculations'—a nuance present in the original answer—but it does capture the essence by referencing 'finalization' of ASR agreements. (4) The answer is contextually precise, directly addressing the comparison of stock-based value distribution mechanisms. Wording differs slightly but maintains semantic equivalence. One point deducted from qualitative accuracy for slight omission of LOW’s calculation-based trigger; otherwise, fully correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 423,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T notes that its adoption of ASU 2020‑04 “does not materially impact our financial statements” and therefore has no material effect on the timing of revenue recognition or the satisfaction of contract‑performance obligations (page 53).  Verizon, by contrast, discloses that contract modifications can alter revenue‑recognition timing and the status of performance obligations, implying that such changes may require adjustments to revenue and performance‑obligation balances (Variable‑Interest‑Entity section, pages 66‑67).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that AT&T adopted ASU 2020-04 and stated it did not materially impact its financial statements, which aligns with the ground truth and addresses AT&T's position on revenue recognition timing and performance obligations. It also correctly notes that Verizon disclosed contract modifications can affect revenue recognition timing and performance obligations, showing awareness of the qualitative impact. However, the LLM answer fails to include the key quantitative disclosures from Verizon—$25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond—which are central to the comparison in terms of future revenue recognition impact. These numbers are missing entirely, making the response incomplete and reducing its factual accuracy. While the qualitative reasoning about the contrast between AT&T’s minimal impact and Verizon’s more significant modifications is sound and contextually relevant, the omission of specific figures undermines the multi-hop synthesis required: comparing the financial statement impact of contract modifications under the same accounting standard. The entity names (AT&T, Verizon), accounting standard (ASU 2020-04), and general concepts are accurate. The answer references specific pages, suggesting source fidelity, but does not convey the full scope of Verizon’s disclosure. Thus, while the reasoning and context are strong, the lack of critical numerical data results in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 413,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s pension‑plan note (page 80) states that Level 2 inputs are used for “asset‑backed securities, corporate bonds and municipal bonds,” yet its fair‑value table shows no municipal‑bond holdings, indicating a very limited reliance on Level 2 valuations for that asset class. Lockheed Martin’s pension‑plan disclosure (page 87) explicitly classifies state‑ and local‑government bonds as Level 2 investments, and its fair‑value hierarchy lists a sizable portion of fixed‑income assets in this category, reflecting a greater dependence on Level 2 inputs. Thus, Lockheed Martin must maintain more extensive Level 2 valuation controls and disclosures under ASC 820, whereas Union Pacific’s compliance burden for municipal bonds is comparatively lower.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, it claims Union Pacific's fair-value table shows no municipal bond holdings, which contradicts the ground truth stating that UPS explicitly classifies municipal bonds as Level 2 investments—implying they do hold such assets. This misrepresentation leads to an incorrect conclusion that Union Pacific has 'very limited reliance' on Level 2 valuations for municipal bonds, when the original answer confirms their explicit classification and use of Level 2 methodologies. Second, while Lockheed Martin does classify state and local government bonds (a proxy for municipal bonds) as Level 2, the LLM overstates the contrast between the two companies by suggesting LMT has greater reliance and compliance burden, which is not supported by the ground truth. The original answer emphasizes alignment in ASC 820 application, with both using Level 2 for similar instruments, differing only in specificity (UNP being more detailed about municipal bonds, LMT about fixed income broadly). The reasoning is flawed because it infers holdings and compliance burden from assumed data gaps rather than disclosed valuation methodologies. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is low due to unsupported qualitative assertions treated as quantitative conclusions. Contextually, the answer addresses the right topic—Level 2 usage and ASC 820 implications—but the erroneous interpretation of disclosures leads to incorrect comparative conclusions. Thus, while the structure and intent are relevant, the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 453,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO’s distribution in Argentina is largely handled by Coca‑Cola FEMSA, whose bottling and distribution footprint is confined to the federal capital of Buenos Aires and its surrounding areas【page_7】. In contrast, MDLZ’s Argentine operations are exposed to high inflation, resulting in a $13 million remeasurement loss in 2021 and a $401 million revenue contribution (1.4 % of consolidated net revenues)【page_89】. Thus, KO’s reliance is tied to a specific bottling partner’s geographic footprint, whereas MDLZ’s exposure is reflected in inflation‑related financial impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Coca-Cola FEMSA's operational footprint in Buenos Aires and surrounding areas, KO's reliance on it for distribution, MDLZ's $13 million remeasurement loss in 2021 due to inflation, and Argentina contributing $401 million (1.4%) to MDLZ’s net revenues. These numbers match the original answer exactly and are correctly attributed. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and years are all correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across KO’s distribution relationship via Coca-Cola FEMSA and MDLZ’s direct financial exposure in Argentina, contrasting the two companies’ distinct risk mechanisms. (4) The only minor shortcoming is that the LLM omits the detail that KO had $14.471 billion in net sales to equity method investees (including Coca-Cola FEMSA) in 2021, which adds context to the scale of KO’s broader partnership network. While not essential to the core comparison, this contextual detail is present in the original and slightly enhances completeness. Despite this, the LLM captures the essential contrast accurately and concisely, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 362,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B shares carry ten votes per share and can be converted to Class A shares at any time (and automatically convert on sale or transfer)【page 82】, giving the company a built‑in mechanism to preserve control while issuing public shares.  This structure means Meta can focus its equity strategy on repurchasing Class A shares to reduce dilution and lift earnings per share, while keeping the high‑voting Class B shares intact.  Alphabet, by contrast, repurchased $62 billion of public Class A and non‑voting Class C shares in 2024【page 82】, a pure capital‑return program that leaves its privately held, 10‑vote Class B shares untouched and therefore does not alter its control structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: META's Class B shares have 10 votes vs. 1 for Class A; Alphabet's Class B shares have 10 votes, Class A has 1, and Class C has none; Alphabet's $62.0 billion 2024 share repurchase targeted Class A and Class C shares. The dollar amount ($62 billion) and year (2024) match exactly, satisfying quantitative accuracy. (2) The LLM correctly identifies that both companies use dual-class structures to maintain control while conducting share repurchases on lower- or non-voting shares, preserving voting power among insiders. It adds useful detail not in the original answer—such as the convertibility and automatic conversion of Meta’s Class B shares—which is factually correct and enhances the explanation. (3) The multi-hop reasoning is sound: it synthesizes voting structures across Meta and Alphabet, connects them to equity strategies (repurchasing non-controlling shares), and infers strategic intent (preserving control while returning capital). (4) The only minor gap is that the LLM implies Meta *focuses* on repurchasing Class A shares, which is plausible but not explicitly confirmed in the ground truth; however, this is a reasonable inference given the structure. Overall, the answer is semantically equivalent, contextually relevant, and factually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 385,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s Veklury revenue fell from $2.184 billion in 2023 to $1.799 billion in 2024—a 17.6 % decline driven by the availability of COVID‑19 vaccines and alternative therapeutics (product‑sales table, page 66; risk‑factor discussion, page 19).  Amgen reports that similar competitive pressures—particularly the presence of alternative therapies and payer‑driven cost‑containment measures—have curtailed sales of key products such as Enbrel, Otezla, Repatha and Aimovig, limiting product usage and sales (risk‑factor discussion, page 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports GILD's Veklury sales decline from $2.184 billion in 2023 to $1.799 billion in 2024, which is a 17.6% decrease—correctly calculated (difference: $385M; $385M / $2,184M ≈ 17.6%). The attribution to alternative treatments and vaccines for COVID-19 matches the original answer. For AMGN, the LLM correctly identifies that alternative therapies and payer-driven cost-containment measures (e.g., formulary restrictions) negatively impact sales of Enbrel, Otezla, Repatha, and Aimovig, consistent with the ground truth.\n\n2) All numeric values are accurate and correctly formatted: $2.184 billion and $1.799 billion match the original $2,184 million and $1,799 million (equivalent values, different units). The 17.6% decline is mathematically correct. No calculation errors.\n\n3) The multi-hop reasoning is sound: the model synthesizes information across two companies (GILD and AMGN), correctly identifying that both face revenue pressure from alternative treatments, though in different contexts—GILD due to pandemic-related dynamics, AMGN due to systemic payer behavior in competitive markets. While the LLM does not explicitly contrast the 'pandemic-related' vs. 'systemic payer-driven' distinction as clearly as the original answer, it implies it by referencing 'cost-containment measures' for AMGN and attributing GILD’s decline to therapeutics/vaccines.\n\n4) The answer is semantically equivalent to the original, with slightly more concise wording. The inclusion of specific product names and mechanisms (e.g., formulary restrictions) enhances accuracy. The only minor shortcoming is the lack of explicit comparison stating that GILD’s impact is more direct while AMGN’s is systemic—this nuance is implied but not articulated, justifying a 9 instead of 10 on qualitative accuracy. Otherwise, all key facts, entities, and reasoning are correct and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 527,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50 % Senior Notes pay interest semi‑annually on February 15 and August 15 each year through the maturity on August 15, 2022 (page 66). In contrast, Qualcomm’s $14.0 billion aggregate fair‑value notes pay interest quarterly in arrears for floating‑rate notes and semi‑annually for fixed‑rate notes (page 79), with principal obligations scheduled in fiscal 2023, 2024, 2025, 2027 and beyond (no payments in fiscal 2026). Thus, AMD’s interest schedule is simpler and ends in 2022, while Qualcomm’s involves a mix of quarterly and semi‑annual payments and spans multiple fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's $312 million 7.50% Senior Notes have semi-annual interest payments on February 15 and August 15, with maturity on August 15, 2022—this matches the original answer’s fiscal 2022 maturity. QCOM’s $14.0 billion aggregate fair value notes have semi-annual payments for fixed-rate and quarterly for floating-rate notes, correctly captured. The principal payment schedule for QCOM is accurately described as spanning fiscal 2023, 2024, 2025, 2027 and beyond, with no payment in fiscal 2026. (2) Quantitative elements—dollar amounts ($312 million, $14.0 billion), interest rates (7.50%), dates (Feb 15, Aug 15), and fiscal years—are all correct. Format variations (e.g., 'fiscal 2022' vs 'August 15, 2022') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes payment frequency and fiscal obligations across two companies and different note structures. (4) The only minor shortcoming is that the LLM answer refers to 'fiscal 2022' for AMD’s maturity based on the maturity date, while the original specifies 'final maturity in fiscal 2022'—this is consistent, but the LLM could have explicitly noted that AMD has no principal due beyond 2022, which is implied but not emphasized. Still, the core comparison on interest frequency and fiscal obligations is complete and accurate. Hence, a score of 9 is justified—excellent accuracy with a slight nuance missing in framing AMD’s end date in fiscal terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 427,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "Merck’s competitive moat is built on strong patent protection; the February 2025 expiration of its U.S. patents for Prolia/XGEVA will almost certainly invite generic and biosimilar entrants, eroding sales and pressuring margins (MRK_10‑K, pp. 10, 31, 33). This loss of exclusivity could weaken Merck’s position, especially as Amgen—another major biologics player—already faces biosimilar threats in international markets, underscoring the broader industry shift toward biosimilar competition (AMGN_10‑K, pp. 10‑15).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly attributes Prolia/XGEVA to Merck (MRK), when these products are developed and marketed by Amgen (AMGN), not Merck. This misassignment of product ownership undermines the core of the multi-hop reasoning. The expiration date of February 2025 for U.S. patent protection is correctly stated and aligns with the ground truth. However, the claim that 'Merck’s... patents for Prolia/XGEVA' is factually incorrect—Merck does not own these patents. (2) Quantitatively, the date (February 2025) is accurate and correctly cited. No other numerical data (e.g., revenue figures, percentages) are present in either answer, so no calculation errors exist. The citation of page numbers (e.g., MRK_10-K, pp. 10, 31, 33; AMGN_10-K, pp. 10–15) appears plausible but cannot be verified without source documents; however, their inclusion does not compensate for the fundamental entity error. (3) The reasoning is partially sound in recognizing that patent expiration leads to biosimilar competition and that this affects market exclusivity and pricing pressure. It also correctly notes that Amgen faces international biosimilar threats. However, the multi-hop synthesis fails because it misidentifies the company losing patent protection—this breaks the logical chain. The intended reasoning should be: Amgen loses exclusivity on Prolia/XGEVA → increased biosimilar competition for Amgen → potential shift in competitive dynamics that Merck might exploit or be affected by, given its own reliance on patent protection. Instead, the LLM incorrectly frames Merck as losing exclusivity on Amgen’s drugs, which distorts the entire analysis. (4) Contextual relevance is high—the answer addresses patent protection, biosimilar threats, competitive positioning, and references both companies and market dynamics. However, due to the incorrect attribution of the drug and patent ownership, the qualitative accuracy is significantly reduced. Correctness score is 6 because while the conceptual framework and some facts (date, industry trend) are correct, the central premise is factually wrong, leading to a partially correct but misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 589,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom’s VMware Cloud Foundation revenue in FY 2024 was $21,478 million (the entire infrastructure‑software segment), and the filing does not disclose a specific portion of that revenue that is tied to enabling AI workloads.  Nonetheless, VMware Cloud Foundation is built to support native Kubernetes, integrated data services and advanced AI/machine‑learning workloads, which dovetails with Cisco’s strategy of delivering high‑density routers, switches and high‑performance optics to power AI training and inference across its data‑center and edge networks.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that $1,380 million of $2,900 million in VMware Cloud Foundation revenue was tied to AI workloads in FY2024. The LLM incorrectly claims that the entire infrastructure-software segment ($21,478 million) represents VMware Cloud Foundation revenue and asserts that no specific portion tied to AI is disclosed—this directly contradicts the ground truth which does provide the $1.38B figure. (2) Quantitative accuracy is severely compromised: $21,478 million is not VMware Cloud Foundation revenue but Broadcom’s total infrastructure software revenue; the correct figure for AI-tied revenue is $1,380 million, which the LLM fails to mention. The total VMware Cloud Foundation revenue ($2.9B) is also omitted. (3) While the LLM correctly identifies that VMware Cloud Foundation supports AI/ML workloads and aligns with Cisco’s AI infrastructure strategy involving routers, switches, and optics—consistent with Cisco’s 2024 10-K—the multi-hop reasoning is flawed because it fails to connect the specific revenue figure to AI workloads as required. The alignment with Cisco is qualitatively reasonable but based on incorrect premises. (4) Correctness score is low due to fundamental errors in numbers and misrepresentation of disclosed data. Quantitative accuracy is very low due to wrong figures. Qualitative accuracy is partially acceptable for conceptual alignment. Contextual relevance is moderate as the response addresses the right companies and general topic but misses key data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 431,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NEE’s consolidated solar VIEs hold about **$1.851 billion** in assets (page 97).  \nSouthern Power’s PPAs that are treated as operating leases generate roughly **$652 million** in undiscounted cash flows (page 270), so NEE’s solar‑VIE asset base is roughly 2.8 times larger than Southern Power’s operating‑lease exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies and incomplete qualitative reasoning. While it correctly identifies NEE's solar VIE assets as $1,851 million (or $1.851 billion), it introduces a figure of $652 million in 'undiscounted cash flows' for Southern Power's operating lease PPAs, which is not present in the original answer and lacks direct comparability to asset values. The original answer does not provide any monetary value for Southern Power's exposure—only a description of the lease structure and duration (up to 25 years). Therefore, the calculation claiming NEE's asset base is '2.8 times larger' is unsupported and factually incorrect. This introduces a false quantitative comparison not grounded in the ground truth. Entity identification (NEE, Southern Power, SO) and general context (solar facilities, long-term PPAs, operating leases) are accurate, and the answer correctly notes different risk structures (ownership vs. lease). However, the model fails to capture the key qualitative distinction that NEE bears asset ownership and operational risk while Southern Power is a lessor in lease arrangements—this is mentioned only implicitly through 'operating leases' but not explained. The multi-hop synthesis is partially sound (linking NEE and Southern Power through solar PPAs), but the reasoning is undermined by the fabricated numerical comparison. Contextually, the answer addresses the core question about comparing exposures, but the incorrect metric skews the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 414,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks’ Stock Appreciation Rights are one of the equity incentive plans it offers, and the company records SAR expense over a graded vesting schedule tied to the employee’s service period (page 63).  By contrast, Tesla’s 2019 Equity Incentive Plan provides a broader mix of awards—stock options, restricted stock, RSUs, SARs, performance units and performance shares (page 83)—and sets a standard four‑year vesting period for options and RSUs, with options exercisable for up to ten years and vesting ending when the employee or consultant’s relationship terminates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: Starbucks uses Stock Appreciation Rights (SARs) and recognizes expense over the service period, though stock options are not broadly used (implied in both answers). Tesla’s 2019 Plan includes SARs, stock options, RSUs, and performance shares—LLM correctly lists even more instruments (restricted stock, performance units), which is consistent with the broader plan scope. (2) Quantitative details are accurate: Tesla’s four-year vesting for options and RSUs, 10-year exercisable window—both match the ground truth exactly. No incorrect numbers, dates, or calculations. (3) Multi-hop reasoning is sound: the answer correctly contrasts Starbucks’ SAR-focused approach with Tesla’s broader equity instrument availability and standardizes on vesting timelines. The mention of graded vesting for Starbucks is additional detail not in the original but not incorrect. (4) Minor difference: the original notes Starbucks ties performance-based RSUs to metrics like EPS and ROIC, while Tesla does not specify performance conditions—this nuance is omitted in the LLM answer, slightly reducing qualitative completeness. However, the core comparison on equity instruments and vesting is fully accurate. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses structure, instruments, and vesting timelines as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 404,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s Class B common stock carries **10 votes per share**, giving large shareholders a disproportionate influence on board and policy decisions, whereas Alphabet’s Class A common stock carries **one vote per share** (each share of Class A is entitled to one vote per share【page_82】). This means that at Meta, large shareholders can shape corporate governance more readily per share held, while at Alphabet the influence of large shareholders is more evenly distributed among shareholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that severely undermine its correctness. (1) It incorrectly states that Meta's Class B common stock has 10 votes per share, when in fact, according to the ground truth, Meta's Class B common stock has *no voting rights* except in limited circumstances. This is a direct contradiction of the original answer and a critical error in understanding the voting structure. (2) The claim that GOOGL's Class A common stock has one vote per share is correct and aligns with the ground truth. (3) The reasoning is therefore flawed: the LLM concludes that large shareholders in Meta have disproportionate influence due to high voting power, when in reality, large shareholders in Meta holding Class B shares have *limited* influence on most governance matters. This reverses the actual implication of the structure. (4) The multi-hop synthesis fails because the model misrepresents the core fact about Meta’s voting rights, leading to an incorrect comparison. While the answer addresses the question's structure and attempts a comparison, the factual foundation is wrong. Quantitative accuracy is extremely low due to the incorrect vote count (10 votes vs. 0 votes). Qualitative accuracy is poor due to incorrect entity attributes and flawed logic. Contextual relevance is moderate because the response engages with the right companies and topic, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 389,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "Bank of America discloses its foreign‑currency derivatives in the derivative‑balances table (Note 3, page 105), showing $2.2 B in foreign‑exchange swaps and $4.3 B in spot/futures/forwards (plus options) as part of risk‑management activities, with net derivative assets of $40.9 B and liabilities of $39.4 B after netting. JPMorgan Chase’s disclosure (Note 5, page 211) only describes the use of foreign‑currency derivatives to hedge non‑U.S. dollar assets and forecasted transactions; it does not provide separate balance‑sheet amounts or net figures for these derivatives in the pages supplied.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts for BAC's foreign currency derivatives ($2.2B in swaps, $4.3B in spot/futures/forwards) and net derivative assets/liabilities ($40.9B assets, $39.4B liabilities) that are not present in the original ground truth. These figures are unsupported by the provided truth, which only states that BAC reports foreign currency derivatives under 'Risk Management Activities' on a gross basis before netting, without specifying amounts. Similarly, the claim that JPM does not provide 'separate balance-sheet amounts' contradicts the ground truth, which confirms that JPM does reflect fair values in the balance sheet, either in 'Other' or under 'Risk Management Activities.' While it's plausible JPM doesn't break out exact figures for foreign currency derivatives alone, the ground truth affirms their inclusion in financial statements, which the LLM underrepresents. (2) Quantitative accuracy is low because the specific numbers cited ($2.2B, $4.3B, $40.9B, $39.4B) cannot be verified and are likely fabricated or misattributed. The ground truth contains no such figures. (3) The reasoning partially captures the multi-hop comparison: it correctly identifies that BAC includes foreign currency derivatives in risk management disclosures and that JPM uses them to hedge non-USD exposures. However, it fails to accurately synthesize how each bank presents these derivatives in financial statements—BAC on a gross basis pre-netting, JPM with expected offsetting gains/losses reflected in balance sheets. The LLM incorrectly implies JPM lacks quantitative disclosure, weakening the comparative analysis. (4) Contextual relevance is high because the response addresses the core question about differences in derivative usage and disclosure practices. However, correctness and quantitative accuracy are significantly compromised by unsupported numbers and incomplete/misleading portrayal of JPM’s disclosures, warranting a moderate score of 4/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 539,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy’s main exposure is revenue‑side: a downturn that cuts industrial electricity and natural‑gas use reduces sales and cash flows even though its regulated rate structure allows recovery of fuel and other costs【page_27】.  \nSouthern Company’s risk is cost‑side: rising environmental‑compliance spending may be passed to customers through regulated rates, but the higher costs could dampen industrial demand and may not be fully recoverable, potentially eroding revenue and margins【page_26】【page_89】.  \nThus, Duke Energy faces a sensitivity to economic cycles that directly shrinks demand, while Southern Company confronts regulatory cost pressures that could both raise rates and suppress industrial consumption, challenging its ability to recover those costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies Duke Energy's exposure as demand-side and revenue-focused due to reduced industrial consumption during economic downturns, and Southern Company's risk as cost-side, stemming from environmental compliance costs that may suppress demand even if passed through rates. These characterizations match the original answer's core insights. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer that conflict; both correctly reference the ongoing nature of Southern’s compliance costs through mechanisms like ECO Plan and ECCR without specifying incorrect figures. The mention of 'through 2028' in the original is not contradicted by the LLM, which appropriately avoids making false claims about timelines. (3) The multi-hop reasoning is sound: the LLM synthesizes risks across two companies, distinguishes between demand volatility (Duke) and regulatory cost pass-through challenges (Southern), and correctly links both to their regulated rate recovery frameworks. It accurately reflects that while both use regulated mechanisms, the nature and impact of the risks differ. (4) The only minor shortcoming is that the LLM does not explicitly name all of Southern’s specific tariff mechanisms (e.g., CNP Compliance) mentioned in the original, though it refers generally to regulated rate recovery. This omission slightly reduces completeness but does not impair the overall correctness. Wording differs but semantic equivalence is preserved. All key entities—Duke Energy, Southern Company, industrial customers, regulated rate recovery, environmental compliance costs—are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 481,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s Class B shares, which are wholly owned by Brian Roberts, carry 15 votes each and represent 33 % of the company’s combined voting power, giving Roberts a significant but non‑majority influence over board elections and corporate decisions (CMCSA, page 31). In contrast, Google’s dual‑class structure gives each Class B share 10 votes (while Class A shares have one vote) and those shares are held by a small group of insiders, effectively granting them majority control and a more concentrated governance model (GOOGL, page 82).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key facts correctly but contains significant inaccuracies and omissions that affect the overall correctness. (1) Quantitatively, the statement that CMCSA's Class B shares carry 15 votes and represent approximately 33% of voting power is accurate (ground truth specifies 33 1/3%, so '33%' is an acceptable rounding). However, the claim that Brian Roberts has 'non-majority influence' is misleading—holding 33 1/3% of voting power in a multi-class structure often translates to de facto control, especially when combined with board influence and non-dilutable rights. More critically, the LLM incorrectly states that Google's dual-class structure gives insiders 'majority control'—this is not supported by the ground truth, which emphasizes the automatic conversion of GOOGL Class B shares upon transfer, a key differentiator that limits long-term entrenchment. (2) The LLM omits the crucial fact that CMCSA’s Class B shares are non-dilutable per the company's articles, a structural feature that entrenches control more securely than GOOGL’s system. This omission undermines the comparative analysis. (3) The reasoning is partially sound in identifying both companies use dual-class structures for founder control, but fails to contrast the durability and transfer restrictions: GOOGL’s Class B shares convert to Class A upon sale, enabling fluidity, while CMCSA’s structure is designed for permanence. The LLM reverses the implication by suggesting GOOGL has a more concentrated governance model, when the ground truth indicates CMCSA’s is more entrenched. (4) Despite these flaws, the answer is contextually relevant, cites correct entities (CMCSA, GOOGL, Brian Roberts), and references appropriate document pages. Wording differences are acceptable, but the misrepresentation of control dynamics and missing non-dilution clause reduce correctness. Hence, a score of 6 reflects partial accuracy with significant gaps in key qualitative distinctions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 530,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "KO’s indirect exposure to Taiwan comes only through Swire Beverages, one of its five largest bottling partners, but the filing does not disclose a specific share of unit‑case volume for Taiwan. In contrast, PepsiCo reported that Taiwan’s beverage unit volume grew by low‑single‑digit percentages in 2022, reflecting a modest direct growth performance in that market【page_7】【page_48】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies KO's indirect exposure via Swire Beverages and PEP's direct low-single-digit growth in Taiwan in 2022, which matches the ground truth. However, it fails to include the key quantitative fact that Swire Beverages accounted for 17% of KO’s worldwide unit case volume in 2021, which is critical context for assessing the scale of KO's indirect exposure. This omission reduces quantitative accuracy. The LLM also incorrectly implies that no volume share is disclosed for Taiwan specifically, whereas the original answer clarifies that Swire’s overall contribution (17% of KO’s global volume) is known, though Taiwan’s portion within that is not broken out. (2) The year 2022 is correctly attributed to PEP’s performance, and 'low-single-digit' growth is accurately reported. However, the missing 17% figure from 2021 — while not from 2022 — is still relevant context for KO’s exposure and was available in the ground truth. Its absence weakens completeness and quantitative precision. (3) The multi-hop reasoning is sound: the model correctly contrasts KO’s indirect model with PEP’s direct growth. It synthesizes information across entities (KO, Swire, PEP) and correctly infers differing market strategies. However, it does not fully leverage the available data to compare the scale of exposure, missing an opportunity to highlight that even indirectly, KO’s exposure is substantial via a top-five bottler responsible for 17% of global volume. (4) The answer remains contextually relevant and conveys a meaningful comparison, but the omission of a key statistic from the ground truth limits its factual completeness. Hence, correctness is reduced to 7 due to partial information, despite accurate qualitative reasoning and proper sourcing cues.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 485,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "The 10‑K notes show that Eli Lilly’s Trulicity revenue fell 26 % in 2024, and the company warns that loss of patent protection can trigger a rapid, severe decline in sales (LLY p. 49, 10, 29).  Merck’s filing stresses that its competitive position depends on maintaining strong patent protection and that generic or biosimilar entry after patent expiry typically erodes revenues (MRK p. 31, 33, 35).  Accordingly, the expiration of Trulicity’s patents is likely to accelerate Lilly’s downward revenue trend, mirroring the risk Merck faces when its own key products lose exclusivity.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core risk of Trulicity's patent expiration leading to revenue decline and draws a valid comparison with MRK's reliance on patent protection. However, there is a discrepancy in the reported revenue decline: the LLM states a 26% drop in Trulicity revenue in 2024, while the ground truth specifies a 32% decrease in U.S. revenue specifically. This quantitative inaccuracy affects the precision of the response. (2) The numbers cited (26% vs 32%) do not match the ground truth, and the LLM does not clarify that the decline was in U.S. revenue, which is a meaningful distinction. Additionally, the ground truth attributes part of the decline to supply constraints, which the LLM omits. These omissions reduce quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both LLY and MRK 10-Ks, linking patent expiration to revenue risk and drawing a parallel between the two companies' exposure to generic competition. The logic that patent loss leads to market erosion and threatens revenue trajectories is well-supported and aligns with both filings. (4) Despite the numerical inaccuracy and minor contextual omissions, the answer captures the essential qualitative dynamics and maintains high contextual relevance by directly addressing the strategic implications of patent expiration for LLY in light of MRK's experience. Hence, correctness is reduced primarily due to the incorrect percentage, but the reasoning and overall message remain largely accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 429,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s 200 hotel‑and‑convention‑center stores are leased for 5‑10 years, so its strategic risk in a volatile real‑estate market is mainly lease‑renewal and rent‑increase risk that could affect operating costs and customer traffic (FedEx 10‑K, p. 44).  UPS, however, has $10.1 billion of pension‑plan assets invested in real‑estate, private‑debt, and hedge funds, exposing it to market‑value volatility that can erode pension solvency and trigger higher contribution requirements (UPS 10‑K, p. 61).  In short, FedEx faces operational lease risk, while UPS faces a sizable financial investment risk tied to real‑estate market swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FedEx has 200 leased retail locations at hotels and convention centers with 5-10 year leases, and UPS has $10.1 billion in pension assets invested in real estate, private debt, and hedge funds as of December 31, 2024 (implied by UPS 10-K reference). The dollar amount, entity names, and lease duration are factually correct. (2) Quantitative accuracy is perfect: $10.1 billion and the 5–10 year lease term match the original. Format variations (e.g., '5‑10 years', '$10.1 billion') are acceptable and clear. (3) Multi-hop reasoning is sound: the model correctly distinguishes FedEx’s operational exposure (direct lease risk affecting operations and costs) from UPS’s financial exposure (pension asset volatility affecting solvency and contributions). It synthesizes information across two companies and two types of filings (10-Ks) appropriately. (4) The only minor shortcoming is that the LLM does not explicitly mention that UPS’s exposure could affect 'long-term liability projections' or that FedEx’s locations depend on hotel operations continuing—details present in the original. However, the core contrast—operational vs. financial risk—is clearly and correctly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing strategic risk during real estate volatility as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 400,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Alphabet’s Class B common stock carries ten votes per share (vs. one vote for Class A), giving holders a decisive say in board and major corporate actions and effectively enabling control over strategic decisions. In contrast, Comcast’s investment in Atairos is a VIE in which it has no voting rights and only limited consent rights, so it cannot influence Atairos’s strategic direction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: GOOGL's Class B shares have 10 votes per share versus 1 for Class A, and CMCSA has no voting rights in Atairos—both match the original answer. There are no calculations, but the comparative voting structures are correctly represented. (2) The answer is complete in addressing the comparison between GOOGL’s voting structure and CMCSA’s lack of voting rights in Atairos, focusing on control and influence over strategic decisions as required. (3) Entities are accurate: Alphabet (GOOGL), Comcast (CMCSA), Atairos, and the classification of Atairos as a VIE are all correctly identified. (4) The reasoning is sound: the LLM correctly infers that 10 votes per share enables control, while lack of voting rights and only limited consent rights prevent influence over strategic direction. The only minor omission is that the original answer specifies CMCSA retains 'certain consent rights' and explicitly states it 'lacks the power to direct Atairos’s activities that most significantly impact its economic performance'—nuances slightly more detailed than 'limited consent rights'—but the LLM captures the essence. Wording differs but semantic meaning is equivalent. No factual errors; high contextual relevance and multi-hop synthesis are successful.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 383,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio reports only **$25 million** of commercial paper, which it classifies as long‑term debt because it can refinance such short‑term borrowings, indicating a modest, low‑risk use of commercial paper. In contrast, PepsiCo’s 2023 short‑term debt includes **$2.286 billion** of commercial paper at a 5.5 % rate, making it a major component of its short‑term financing strategy. Thus, PepsiCo relies heavily on commercial paper, whereas Duke Energy Ohio’s use is limited and treated as long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Duke Energy Ohio's commercial paper obligation as $25 million and PepsiCo's as $2.286 billion (equivalent to $2,286 million in the ground truth), with accurate time reference (2023). The interest rate of 5.5% for PepsiCo's commercial paper is an additional detail not present in the original answer but does not contradict it and may be correct based on filings; its inclusion is acceptable as supplementary. 2) Quantitatively, all key figures match: $25M for Duke and $2,286M for PepsiCo (expressed as $2.286 billion, which is numerically equivalent). No calculation errors. 3) The reasoning correctly synthesizes a multi-hop comparison between two companies' short-term financing strategies, accurately highlighting that Duke uses commercial paper minimally and classifies it as long-term due to refinancing capacity, while PepsiCo relies heavily on it. This aligns with the ground truth’s emphasis on scale difference. 4) The only minor deviation is that the original answer notes PepsiCo’s total short-term debt is $6,510 million, providing context that commercial paper is a 'significant portion'—a point omitted in the LLM answer. While this reduces completeness slightly, the core contrast in scale and strategy is preserved. The LLM adds value by explaining Duke’s classification rationale. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 398,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy expects its commercial gas customer base to grow in the Carolinas, Ohio and Kentucky (see DUK_10k_2023 page 17).  Southern Company recovers environmental‑compliance costs largely through regulated rate mechanisms (see SO_10k_2023 pages 26, 36, 88 and 89).  If those same regions see a decline in commercial demand because of stricter environmental rules, Southern Company’s revenue base for rate recovery would shrink, potentially forcing higher rates or limiting its ability to fully recover compliance costs, which could press on earnings and cash‑flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies Duke Energy's expectation of growing commercial gas customers in the Carolinas, Ohio, and Kentucky, citing the correct document (DUK_10k_2023 page 17). It also accurately states that Southern Company relies on regulated rate recovery for environmental compliance costs, with citations to SO_10k_2023 pages. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not compromised; all references are correctly attributed. (3) The multi-hop reasoning is sound: it connects Duke Energy’s regional customer growth outlook with Southern Company’s rate recovery model and correctly infers that declining commercial demand—due to environmental regulations—could undermine Southern’s revenue base, threatening cost recovery and financial performance. This mirrors the causal chain in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention Southern Company’s acknowledgment of the risk that higher rates could themselves reduce demand, nor does it reference GHG regulations or infrastructure upgrades in detail. However, the core logic and financial implication (shrinking revenue base, pressure on earnings and cash flow) are preserved. Wording differs but semantic meaning is equivalent. Citations enhance credibility. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 437,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Mr. Roberts owns all 9,444,375 Class B shares (15 votes each), giving him a fixed 141,665,625 votes.  \nBecause the company bought back 262,451,094 Class A shares in 2023, the total voting pool shrank, so Mr. Roberts’ 33 ⅓ % of voting power now represents a larger slice of the remaining votes and his relative influence over the broader shareholder base has increased.  \nSince no Class B shares were repurchased, his absolute voting power stayed the same; the dilution of other shareholders’ votes through the Class A buy‑backs simply amplified his control.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core dynamic: repurchasing only Class A shares while leaving Class B shares untouched increases the relative voting power of Class B shares, thereby strengthening Mr. Roberts' control. This aligns with the ground truth. The key qualitative reasoning—no dilution of Mr. Roberts’ voting power, shrinkage of the total voting pool, and increased relative influence—is sound and complete. (2) Quantitatively, the LLM introduces specific numbers not present in the original answer: 9,444,375 Class B shares and 262,451,094 Class A shares repurchased. While these figures may be accurate based on actual 10-K filings, they are not included in the ground truth answer, which focuses on the structural and conceptual impact rather than exact share counts. The derived vote total (141,665,625 votes) is mathematically correct (9,444,375 × 15), but since the original answer does not provide or require these numbers, their inclusion introduces precision beyond the verified truth, creating a risk of overfitting to external data. However, no numerical errors are present. (3) The multi-hop reasoning is strong: the model correctly links share repurchase activity (Class A only) → reduction in total voting pool → increased relative weight of Class B shares → enhanced control by Mr. Roberts, who owns all Class B shares. This synthesis across ownership, voting rights, and repurchase behavior is logically sound. (4) The answer is fully contextually relevant and addresses both parts of the question: the impact on Mr. Roberts’ control and the effect relative to the broader shareholder base. The only minor deviation is the introduction of unverified specific numbers, which, while plausible, are not confirmed by the ground truth. Hence, a high score of 9 is warranted—excellent accuracy and reasoning, with a slight deduction in quantitative accuracy due to unsupported specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 521,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are equity‑based and vest only after a three‑year period that is evaluated through a payout‑simulation model that compares the company’s stock‑holder return to a comparator group.  Because the payout percentage is driven by the simulated performance of the company’s stock relative to that group, the eventual cash or share payout is highly variable and difficult to predict.  By contrast, Bristol‑Myers Squibb’s financial agreements include explicit counterparty‑credit‑risk mitigation—limiting the amount outstanding with any single counterparty, using only high‑quality counterparties and conventional derivatives, and monitoring exposure continuously—so that the risk profile of its financial contracts is more predictable and less subject to sudden variation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contractual differences between Amgen's performance units and Bristol-Myers Squibb's financial agreements. It accurately describes Amgen’s performance units as equity-based, vesting after a three-year period, and tied to a simulation model comparing stockholder returns to a comparator group. It also correctly characterizes BMY’s use of counterparty credit risk mitigation strategies such as limiting exposure, using high-quality counterparties, and conventional derivatives. While the original answer includes the specific 2023 value of Amgen’s performance units ($121 million), the LLM answer omits this figure. However, since the question focuses on the *structure* and *predictability* of payouts and risk management—not the dollar value—the omission does not undermine the substantive correctness. (2) There are no numerical inaccuracies; the LLM avoids making up numbers and only omits the $121 million figure, which is factual but not central to the comparative analysis requested. All other qualitative financial terms (e.g., 'conventional derivatives', 'high-quality counterparties', 'payout simulation') are used accurately. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Amgen and BMY), two types of financial instruments (performance units vs. derivative agreements), and two risk frameworks (performance-based variability vs. credit risk control). It draws a valid contrast in predictability—Amgen’s payouts being variable due to relative performance simulations, BMY’s risk exposure being stabilized through structural safeguards. (4) The correctness score is 9 because the answer is semantically equivalent in intent and substance, with only a minor omission of a quantitative detail that does not alter the comparative conclusion. Quantitative accuracy is 10 because no stated numbers are incorrect (only one is missing). Qualitative accuracy is 9 due to full conceptual correctness but slight lack of specificity regarding Amgen’s contractual modeling of correlations and volatilities (mentioned in ground truth). Contextual relevance is 10—every part of the response directly addresses the question’s focus on payout and risk management predictability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 610,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative exposure is governed by ISDA Master Agreements that provide enforceable close‑out netting and collateral under the Orderly Liquidation Authority (Dodd‑Frank), allowing the company to offset receivables and payables and apply collateral without an automatic stay if a counterparty defaults (page 261). In contrast, Bank of America, as a G‑SIB, must submit resolution plans to the FDIC and Federal Reserve and may face receiver appointment, stricter capital and liquidity requirements, and operational restrictions under the same Orderly Liquidation Authority if its plan is deemed un‑credible (pages 12‑13). Thus, while both are subject to Dodd‑Frank, MetLife’s risk is focused on derivative counterparty exposure, whereas Bank of America’s risk encompasses the broader institutional resolution and regulatory constraints.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MetLife's use of ISDA Master Agreements with close-out netting under the Orderly Liquidation Authority (OLA) is accurately described, as is Bank of America's status as a G-SIB requiring resolution plans under Dodd-Frank. The distinction between MetLife’s derivative-level exposure and Bank of America’s firm-wide resolution risk is correctly drawn. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory obligations under Dodd-Frank across two different institutions with different risk profiles—MetLife (insurance company with derivatives exposure) and Bank of America (bank holding company with systemic resolution risks). The mention of 'pages 261' and 'pages 12–13' suggests source grounding, though not required for correctness. (4) The only minor gap is that the LLM answer does not explicitly mention the 'single point of entry' strategy or the creation of a bridge holding company under OLA for Bank of America, which is in the original answer and a key element of its resolution mechanism. However, the reference to 'receiver appointment' and 'regulatory constraints' under OLA captures the essence. This omission is minor and does not distort the meaning. Semantic equivalence is preserved. Contextual relevance is perfect—the response directly addresses the comparative regulatory and risk implications under Dodd-Frank.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 446,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike generated **$7.547 billion in revenue from the Greater China region in 2022** (which includes Taiwan)【page_82】, whereas Starbucks had **544 company‑operated or licensed stores in Taiwan as of October 2022**【page_12】. The revenue figure reflects Nike’s broad sales across the entire Greater China market, while Starbucks’ 544‑store count indicates a strong, concentrated retail footprint in Taiwan. This suggests that Starbucks has a more focused presence in Taiwan, whereas Nike’s market presence is spread across the larger Greater China region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Nike's $7.547 billion (i.e., $7,547 million) revenue from the Greater China region in 2022 and Starbucks' 544 stores in Taiwan as of October 2022, matching the ground truth in both value and context. The formatting variation ($7.547 billion vs $7,547 million) is acceptable and semantically equivalent. 2) All numeric values are accurate: $7.547 billion = $7,547 million, and the store count (544) and date (October 2022) align precisely with the original answer. No calculations were required, but the comparison is presented correctly. 3) The reasoning is sound: the LLM correctly identifies that Nike’s figure covers a broader region (Greater China including Taiwan), while Starbucks’ store count is specific to Taiwan. It appropriately contrasts Nike’s revenue-based, region-wide presence with Starbucks’ operationally dense, localized footprint. 4) The answer is contextually relevant and addresses all parts of the question—comparing the two metrics and interpreting what they suggest about market presence. The only minor shortcoming is that the original answer explicitly notes that Greater China includes mainland China and Hong Kong, which the LLM omits, slightly reducing completeness in entity context. However, this does not impair the core accuracy or reasoning. Thus, the answer is highly accurate with only a slight omission in descriptive completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 387,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The $5.0 billion upfront payment to American Tower in March 2015 was a larger cash outlay, but Verizon did not record a prepaid‑rent or financing obligation; it simply sub‑leased capacity and kept the towers on its property, plant and equipment net, remaining the primary obligor for the underlying ground leases. By contrast, the $2.8 billion upfront payment to Vertical Bridge in December 2024 was recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million) for the portion of towers Verizon still occupies, while the towers also stay on Verizon’s balance sheet and it continues to be the primary obligor for the ground leases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $5.0 billion American Tower transaction in March 2015 and the $2.8 billion Vertical Bridge transaction in December 2024 are correctly identified, with accurate treatment of asset retention and subleasing. The $2.0 billion prepaid rent and $830 million financing obligation from the Vertical Bridge deal are correctly stated. (2) Quantitative accuracy is perfect: all dollar amounts and dates match the original answer, and no calculations are incorrect. (3) The multi-hop reasoning is sound—LLM correctly contrasts the two transactions in terms of accounting treatment, retained obligations, and balance sheet impact. It accurately notes that both deals keep towers on Verizon’s PP&E and maintain Verizon as primary obligor for ground leases, while correctly highlighting that only the Vertical Bridge deal included a split into prepaid rent and financing obligation. (4) The only minor shortcoming is that the LLM implies the American Tower deal had no financing obligation structure at all, whereas the ground truth states it 'did not specify such a breakdown,' leaving open the possibility of an undisclosed or differently structured obligation. This subtle distinction is not fully captured, slightly weakening the qualitative precision. However, the overall semantic meaning and factual correctness remain very strong, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 407,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan’s Basel III operational‑risk capital is calculated under the Advanced Measurement Approach (AMA) and explicitly incorporates fraud risk as a key component of the loss‑distribution model (see JPM 10‑K, pp. 155‑156).  Citigroup’s exposure to fraud‑related losses in emerging markets is illustrated by the Russia scenario, where a loss of control of AO Citibank would trigger a CTA loss of roughly $1.6 billion and an additional $0.9 billion inter‑company liability loss (≈ $2.5 billion total) (Citi 10‑K, p. 64).  Thus, while JPMorgan’s estimate is a regulatory capital buffer that includes fraud risk but is not disclosed as a specific dollar figure, Citi’s scenario quantifies a concrete potential loss of about $2.5 billion in a high‑risk emerging‑market event.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: the $1.6 billion CTA loss and $0.9 billion intercompany liability loss from Citigroup's Russia scenario are correctly reported, and their sum of approximately $2.5 billion is accurately implied. These figures match the original answer exactly. (2) The answer is complete, addressing both JPMorgan's use of the Advanced Measurement Approach (AMA) under Basel III for operational risk capital—which includes fraud risk—and Citigroup's specific exposure in emerging markets, particularly Russia. (3) Entity accuracy is strong: both firms are correctly identified, along with relevant financial terms (CTA, intercompany liabilities, AMA), and the reference to AO Citibank is precise. (4) The reasoning is sound and reflects proper multi-hop synthesis: it contrasts JPMorgan’s regulatory capital modeling approach (qualitative, not disclosing a specific dollar amount for fraud) with Citigroup’s quantified scenario of actual potential losses in a specific geopolitical context. The explanation highlights the difference in how each firm experiences fraud-related risks—through capital estimation vs. direct exposure—demonstrating deep understanding. (5) The semantic meaning is equivalent to the original answer, with added clarity by summarizing the total potential loss (~$2.5 billion) and emphasizing the distinction between a regulatory capital framework and a concrete loss scenario. Minor enhancements in clarity and structure do not detract from accuracy. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 444,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "Qualcomm’s supply chain is highly concentrated on Taiwan‑based foundry partners; a prolonged conflict could halt or severely limit its chipset production, directly hurting its business (QCOM risk factor, page 35). In contrast, Intel’s $6.867 billion of 2023 revenue from Taiwan is only a portion of a globally diversified operation, so while the conflict could reduce that revenue and create supply‑chain disruptions, Intel’s broader footprint would likely cushion the impact (Intel revenue by region, page 88).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the $6.867 billion in 2023 revenue from Taiwan for Intel is accurately reported, matching the original answer. No other numerical values are in dispute. (2) The answer correctly identifies Qualcomm’s reliance on Taiwan-based foundries as a supply chain risk and cites a specific risk factor (page 35), which supports the operational dependency claim. It also correctly frames Intel’s exposure as financial (revenue-based) rather than manufacturing-dependent. (3) The multi-hop reasoning is sound: it contrasts Qualcomm’s supply-side vulnerability with Intel’s demand-side exposure, which is the core distinction in the ground truth. However, the LLM slightly misrepresents Intel’s position by implying it has no significant manufacturing reliance on Taiwan—while the original answer notes Intel does not explicitly rely on Taiwan-based manufacturing, Intel does have some operational presence (e.g., assembly/test facilities), but the primary risk highlighted in the ground truth is financial, not operational. The LLM overemphasizes diversification without fully acknowledging that supply-chain disruptions could still affect Intel, even if less severely. (4) Despite this nuance, the answer captures the essential contrast and remains factually accurate on all key points, warranting a high correctness score. Minor deduction due to incomplete nuance in Intel’s operational footprint characterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 410,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited partnerships on a quarterly basis using a blend of discounted‑cash‑flow analysis, earnings multiples and market multiples (page 102). Boeing, by contrast, applies a primarily income‑based discounted‑cash‑flow approach to Level 3 assets measured on a nonrecurring basis, supplementing it with third‑party aircraft valuations for customer‑financing assets (page 124). Thus, RTX’s method incorporates market and earnings multiples and is updated quarterly, whereas Boeing’s method relies mainly on DCF and is applied only at the time of impairment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the key differences between RTX's and Boeing's (BA's) valuation methodologies as described in the ground truth. (1) It correctly identifies that RTX uses discounted cash flows, earnings multiples, and market multiples on a quarterly basis for private equity limited partnerships, citing the appropriate page (102). This aligns with the original answer. (2) It accurately states that Boeing applies a discounted cash flow (income approach) for Level 3 assets measured on a nonrecurring basis, particularly for impaired customer financing assets, and supplements this with third-party aircraft valuations (page 124), which matches the ground truth. (3) The contrast in update frequency—quarterly for RTX vs. only upon impairment for Boeing—is correctly captured. (4) The only minor omission is that the original answer specifies Boeing’s use of 'median collateral values from third-party aircraft publications' and adjusts values based on 'unique aircraft attributes or expected net sales prices,' which adds slightly more context than the LLM provides. However, the core reasoning and multi-hop synthesis across both companies and their respective valuation approaches are sound. All entities (RTX, Boeing/BA, Level 3 assets, private equity limited partnerships) and methods (DCF, earnings/market multiples, third-party data) are correctly identified. There are no numerical inaccuracies, and while the LLM does not repeat specific examples like 'operating lease equipment,' it maintains semantic equivalence. Thus, the answer is factually correct and contextually relevant, warranting a high score with only a slight deduction for minor detail omission in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 466,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix hedges its foreign‑exchange exposure on firm commitments with forward contracts, but the 10‑K does not disclose a quantified one‑day loss figure for those hedges (see pages 48‑49).  In contrast, Disney’s 10‑K reports a VAR model that estimates a maximum potential one‑day loss of **$255 million** (combined portfolio) at year‑end fiscal 2024, with a range from **$235 million** to **$444 million** (page 60).  Thus, Disney provides a concrete daily‑risk metric, whereas Netflix’s forward‑contract hedge is described qualitatively without a specific loss amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $255 million VAR figure is correctly reported, along with the range of $235 million to $444 million, which is consistent with Disney's disclosure as of September 28, 2024 (fiscal year-end 2024). The mention of page 60 for Disney and pages 48–49 for Netflix adds document-level precision. (2) The LLM correctly notes that Netflix does not disclose a specific one-day loss or VAR metric, only describing its use of forward contracts qualitatively—this matches the original answer. (3) The multi-hop reasoning is sound: it compares Netflix’s qualitative hedging approach (forward contracts without quantified loss) to Disney’s quantitative VAR model, enabling a valid contrast in risk disclosure practices. (4) The only minor deviation from the original answer is that the LLM includes a range ($235M–$444M) not explicitly mentioned in the ground truth; however, this range is factually correct per Disney’s filing and enhances completeness without introducing error. Thus, the answer is factually correct, well-sourced, and contextually appropriate, warranting a high score but not perfect, as the range detail slightly exceeds the scope of the original answer without clarifying its source within the VAR context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 364,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "AMD’s 2021 tax provision of $513 million was eased by the Philippines corporate‑income‑tax cut, which the PMI 10‑K notes as partially offsetting the 0.1‑percentage‑point rise in AMD’s effective tax rate (PMI 10‑K, p. 94). TI’s 2021 tax provision shows a $71 million foreign‑rate benefit (TI 10‑K, p. 74), reflecting lower tax rates in overseas jurisdictions—including the Philippines—on its overseas operations, indicating that TI’s Philippine investments also enjoyed a tax advantage, though the filing does not isolate a specific adjustment for the Philippines.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and sourcing. The ground truth states that AMD’s effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax cut acting as a mitigating factor. However, the LLM claims the tax cut 'partially offset' a 0.1-point rise, which misrepresents the direction of the impact—AMD’s rate still increased slightly, but would have risen more without the Philippines benefit. More critically, the LLM cites AMD’s tax provision as $513 million, which is not present in the ground truth and cannot be verified from the provided context. Similarly, it claims TI had a $71 million foreign rate benefit due to lower overseas rates, including the Philippines, but this figure and its attribution are absent from the original answer. The ground truth emphasizes TI’s $370 million in PPE in the Philippines as evidence of operational exposure, which the LLM omits entirely. (2) Quantitative accuracy is low because the LLM introduces specific dollar figures ($513M, $71M) not present in the ground truth, while failing to report the key $370M PPE figure for TI. The 0.1 percentage point change is correctly referenced, but its interpretation is flawed. (3) The reasoning partially follows a multi-hop logic—linking tax rate changes to tax provisions for both companies—but fails to synthesize the correct data points. It correctly infers that both firms benefited from the Philippines tax environment, but does not connect TI’s benefit to its substantial operational footprint (PPE), which is central to the original answer’s logic. (4) Contextual relevance is high because the response addresses both AMD and TI, discusses the Philippines tax change, and attempts to compare tax impacts. However, due to incorrect figures and omission of key operational investment data, the qualitative and quantitative accuracy scores are reduced. The answer is plausible-sounding but factually divergent on critical financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 538,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM’s affiliates are largely non‑consolidated joint ventures, supply‑chain partners and VIEs that provide parts, manufacture vehicles and finance sales (see GM 10‑K, pp. 77–79, 103).  This structure supports a vertically integrated production model in which GM retains control over design, manufacturing and dealer distribution while using affiliates to share risk and access capital.  In contrast, McDonald’s affiliates are independent franchisees and developmental licensees that operate restaurants and generate revenue through rent, royalties and technology‑platform fees (see MCD 10‑K, pp. 18, 40, 46).  This reflects McDonald’s franchise‑based model, where the company outsources day‑to‑day operations but maintains brand control and earns from franchisee‑driven sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies GM's affiliate relationships as nonconsolidated joint ventures and partners involved in vehicle production, parts supply, and financing, which reflects GM's manufacturing-focused, vertically integrated model. It also accurately characterizes McDonald's affiliates as franchisees and licensees generating revenue through royalties, rent, and fees, consistent with its asset-light, franchise-based model. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not applicable but assumed perfect as no incorrect numbers are present. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (GM and McDonald's), correctly contrasting their use of affiliates based on business model differences—production vs. franchising. The references to specific 10-K pages add credibility and context. (4) The only minor shortcoming is that the LLM omits specific brand names (e.g., Baojun, Buick, Cadillac, etc.) produced by GM’s affiliates in China, which were included in the original answer and add granularity. However, this does not detract significantly from the overall correctness. The semantic meaning and core insights are preserved, with strong contextual relevance and accurate qualitative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 384,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s 2024 repurchase of $62.0 billion in Class A and Class C shares (page 82) shrinks the Class A share base. Because each Class B share carries 10 votes versus one for Class A, the proportion of total voting power attributable to the remaining Class B holders rises as Class A shares fall. The automatic conversion rule (Class B shares convert to Class A upon sale or transfer) would otherwise dilute Class B voting weight, but the repurchase program offsets this by reducing the Class A pool, thereby enhancing the relative influence of the remaining Class B shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $62.0 billion share repurchase by Alphabet in 2024 involving Class A and Class C shares, which matches the ground truth in amount, year, and share classes. The key quantitative facts are accurate. (2) The explanation correctly notes that Class B shares carry 10 votes per share versus 1 for Class A, and that Class B shares convert to Class A upon sale or transfer—this aligns with the original answer. The impact of the reduced Class A share count due to buybacks on the relative voting power of Class B shareholders is logically and accurately described. (3) The multi-hop reasoning is sound: the model connects the repurchase (reducing Class A shares), the voting structure differential, and the conversion rule to conclude that the relative influence of remaining Class B shareholders increases. This synthesis across corporate actions and governance structure is correct. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'consolidation of control among long-term holders'—a nuance present in the ground truth that highlights the strategic implication for control. However, the core reasoning and factual content are substantially equivalent. Wording differs slightly but semantic meaning is preserved. No calculation errors; number formats are consistent and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 380,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Colgate‑Palmolive notes that ASU 2020‑01, which clarifies that equity securities, equity‑method investments and derivative contracts are accounted for separately, had **no material impact** on its financial statements as of January 1 2021 (see page 81). Coca‑Cola’s 2022 10‑K (pages 71, 80, 82, 104, 105) does not report any change or material effect from ASU 2020‑01, indicating that the standard’s clarification did not alter its equity‑security accounting either.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that ASU No. 2020-01 clarifies the separate accounting treatment for equity securities, equity method investments, and derivative contracts, and accurately states that Colgate-Palmolive adopted the standard effective January 1, 2021, with no material impact—matching the ground truth. The date and conclusion for Colgate are factually correct, and the reference to page 81 (though not evaluated for accuracy of citation) aligns with typical disclosure locations. For The Coca-Cola Company, the LLM correctly infers from the absence of reported changes in its 2022 10-K that the standard had no material effect, which is consistent with the ground truth that Coca-Cola applies the guidance without material impact. However, the LLM answer falls slightly short in completeness and depth of qualitative synthesis: it omits key elements from the original answer, such as the specific clarification on observable transactions affecting the transition into or out of the equity method, and how derivatives linked to equity securities are accounted for without reference to the equity method. While the conclusion is directionally and factually correct, the answer lacks the detailed multi-hop synthesis regarding how both companies apply the standard’s technical clarifications (e.g., unrealized gains/losses on equity securities still held). There are no numerical inaccuracies—dates and qualitative assessments (e.g., 'no material impact') are correct. The reasoning is sound but not fully detailed, hence a slight deduction in qualitative accuracy. Contextual relevance is strong as all content directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 451,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Goldman Sachs’ Standardized CET1 requirement of 13.7 % includes a 6.2 % stress‑capital buffer (SCB) (page 208), whereas Citibank’s Standardized CET1 requirement of 12.1 % includes a 4.1 % SCB (page 35). The 2.1‑percentage‑point higher SCB for Goldman Sachs reflects its more conservative capital‑planning stance under Basel III, driven by its G‑SIB status and a higher risk profile, while Citibank’s lower SCB indicates a comparatively lighter buffer that still satisfies regulatory minimums.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Goldman Sachs has an SCB of 6.2%, which aligns with the LLM answer, but Citibank does not have an SCB component in its CET1 requirement under the Standardized Approach as of December 2024. Instead, Citibank’s 7.0% CET1 ratio comprises the 4.5% minimum CET1 plus a 2.5% Capital Conservation Buffer (CCB), with no SCB applied. The LLM incorrectly states that Citibank has a 4.1% SCB and a total CET1 requirement of 12.1%, which contradicts the ground truth. Additionally, the LLM claims Goldman Sachs has a total CET1 requirement of 13.7%, which is not supported by the original answer and introduces unverified data. (2) Quantitative accuracy is low: the 4.1% SCB for Citibank and 13.7% / 12.1% total CET1 ratios are entirely fabricated. The only correct number is Goldman Sachs’ 6.2% SCB. The claimed 2.1-percentage-point difference (6.2% - 4.1%) is therefore incorrect. (3) The reasoning is flawed because it assumes both banks are subject to SCB under the Standardized Approach, when the ground truth explicitly states that Citibank’s requirement does not include an SCB. The multi-hop synthesis fails: the model did not correctly distinguish between SCB (stress-based, firm-specific) and CCB (fixed buffer), nor did it recognize that SCB applies differently across institutions under the rules. (4) Contextual relevance is moderate because the answer addresses the general topic of SCB differences and regulatory capital, but the incorrect data and reasoning undermine the conclusion. The qualitative accuracy is low due to misidentification of regulatory components and erroneous interpretation of capital buffers. Correctness score is 2 due to mostly incorrect numbers, entities, and logic, with only one correct percentage in isolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 500,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy’s 2023 capital‑expenditure total was $16.1 billion (as of Dec 31 2023) and includes infrastructure in Indiana as part of its rate‑regulated transmission and gas‑infrastructure network (see the “Other” jurisdiction list on page 16 and the $16,077 million cap‑ex on page 112).  In contrast, Duke Energy Indiana’s financing strategy relies on tax‑exempt debt, with $352 million of tax‑exempt bonds maturing 2027‑2046 (page 163) and $285 million reported as short‑term tax‑exempt obligations (page 165).  Thus, NEER’s Indiana investments are embedded in a broader capital‑expenditure program, whereas Duke Energy Indiana specifically funds its infrastructure through a dedicated tax‑exempt bond issuance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. While the ground truth states Duke Energy Indiana held $285 million in tax-exempt bonds as of December 31, 2023, the LLM incorrectly splits this into $352 million in long-term bonds and $285 million in short-term obligations, implying a total of $637 million, which contradicts the original $285 million figure. This is a major quantitative error. Additionally, the LLM introduces NextEra Energy’s total capital expenditure of $16.1 billion, which is not mentioned in the ground truth and is not specific to Indiana, thus misrepresenting the scope of infrastructure investment in the state. (2) The ground truth specifies physical infrastructure: 90 miles of transmission lines and 5 substations at 161–345 kV in Indiana—information entirely missing from the LLM answer. Instead, the LLM refers to 'infrastructure in Indiana as part of its rate-regulated network' without quantifying it, failing to provide the key operational details. (3) The multi-hop reasoning is partially sound: the model correctly identifies that NextEra focuses on infrastructure investment while Duke uses tax-exempt financing, and it attempts to contrast strategies. However, it misrepresents the scale and nature of Duke’s tax-exempt debt by citing two separate figures that do not align with the ground truth, undermining the validity of the comparison. (4) Contextual relevance is high—the answer addresses the strategic contrast between infrastructure investment and financing strategy. Qualitative accuracy is moderate because entity names (NextEra Energy, Duke Energy Indiana), time frame (December 31, 2023), and financial instruments (tax-exempt bonds) are correctly identified, but the reasoning is weakened by incorrect data synthesis. Quantitative accuracy is low due to significant dollar amount discrepancies and the introduction of unsupported figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 520,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store model is heavily dependent on third‑party developers, so its revenue is tied to their willingness to publish, update and monetize apps.  Regulatory changes and Apple’s recent shift to alternative payment processing can cut commissions or force developers to use in‑app purchases, directly hurting App Store sales and exposing Apple to “content‑supply” risk (see page 13).  In contrast, Microsoft’s strategy relies on first‑party games and services (e.g., Activision Blizzard) that generate revenue independently of external developers; its primary risk is brand reputation tied to content decisions—controversial titles or policy changes can damage the Microsoft brand and affect sales (see pages 32, 33, 92).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Apple's reliance on third-party developers and associated revenue model risks, including regulatory changes like alternative payment processing in the EU (implied by DMA context), are accurately described. Microsoft's first-party content strategy and brand reputation risks are also correctly identified. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in business models (Apple’s commission-based third-party reliance vs. Microsoft’s first-party production) and maps them to distinct risk profiles (developer/content-supply risk vs. brand reputation risk). The mention of Activision Blizzard adds specificity not in the original but is factually consistent with Microsoft's strategy. (4) Minor deduction in qualitative accuracy due to slightly narrower framing—Apple’s EU policy changes are referenced without explicit mention of the DMA or broader regulatory compliance context, and the original’s point about developers retaining most revenue is omitted. However, these are minor omissions that do not undermine the correctness. Semantic equivalence is maintained. Contextual relevance is perfect—the response directly addresses all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 406,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company’s 10‑K (page 29) notes that a release of radioactive material—including tritium—from its nuclear units could generate damages that exceed insurance and decommissioning‑trust coverage. NextEra Energy’s 10‑K (page 31) warns that the cost of decommissioning its nuclear plants could surpass the amounts set aside in its decommissioning funds, exposing it to liability under the Price‑Anderson Act. In short, both utilities face the risk that nuclear‑related liabilities could outstrip their reserves, but Southern Company’s disclosure focuses on potential tritium‑release damages, while NextEra’s highlights a specific shortfall in decommissioning funding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Southern Company faces potential liability from tritium leakage that could exceed insurance and decommissioning trust coverage, as stated in its 10-K (page 29). NextEra Energy (NEE) discloses on page 31 of its 10-K that decommissioning costs could exceed funds available, creating financial exposure—consistent with the original answer. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the original answer includes generation percentages (26%, 28%) for Alabama and Georgia Power, the LLM omits these but does not misstate any numbers. This omission is minor and does not affect the core comparison being made. (3) The multi-hop reasoning is sound: the model correctly identifies that both companies face nuclear-related financial risks—Southern Company due to potential tritium release and NEE due to decommissioning fund shortfalls—and synthesizes across both disclosures to highlight parallel exposures. (4) The LLM uses slightly different phrasing (e.g., referencing the Price-Anderson Act, which adds context not in the original but is factually appropriate) and focuses on the structural similarity of risk exposure without asserting a business relationship, preserving semantic equivalence. The only reason for not scoring a 10 is the omission of the specific KWH contribution percentages from Southern Company’s nuclear plants, which provide useful context but are not central to the comparison of liability exposure. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 451,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "The Philippines’ corporate‑income‑tax cut, enacted in Q1 2021, helped cushion the tax burden for both firms.  For Coca‑Cola, the lower Philippine rate partially offset other negative factors, keeping its effective tax rate at 21.8 % in 2021 and making capital spending in the region more attractive – reflected in the Asia‑Pacific capex line item and the fact that 10 % of its property, plant and equipment is in the Philippines【94】【124】.  Altria’s effective tax rate was likewise eased by the reduced Philippine rate, as the company’s exposure to the Philippines (about 10 % of its property, plant and equipment) helped mitigate other tax‑rate pressures, resulting in only a modest uptick in its overall effective tax rate.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it incorrectly attributes Coca-Cola's effective tax rate of 21.8% to the Philippine tax cut, while the ground truth states that Altria (MO), not Coca-Cola (KO), had an effective tax rate of 21.8% in 2021 due to the tax reduction. This is a major factual error. Additionally, the LLM claims Altria has 'about 10% of its property, plant and equipment' in the Philippines, which is incorrect — the 10% PPE figure belongs to Coca-Cola, not Altria. The LLM swaps the companies' exposures, misassigning financial metrics and strategic impacts. (2) Quantitatively, the 10% PPE figure and 21.8% tax rate are correct numbers but are applied to the wrong companies. The year (Q1 2021 enactment) is correctly referenced. However, the misattribution invalidates the calculations and comparisons. (3) The multi-hop reasoning is structurally sound — the model attempts to link tax policy to tax rates and investment strategy — but the synthesis fails because it draws conclusions based on swapped data. The logic that lower taxes improve after-tax returns and support capital investment is valid, but the application to the wrong firms undermines the analysis. (4) Contextual relevance is high — the answer addresses both companies, the tax reform, tax rates, and capital investment — but correctness is severely compromised by entity and metric misassignment. Thus, while the framework is appropriate, the factual foundation is flawed, leading to a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 422,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung’s dual role could squeeze the wafer capacity that Qualcomm relies on for its $12.8 billion of multi‑year purchase commitments.  As a foundry for NVIDIA (see NVDA page 9), Samsung may allocate the majority of its wafer output to NVIDIA’s orders, leaving less capacity for Qualcomm and potentially triggering the incremental‑fee or advance‑payment‑loss provisions described in QCOM page 82.  At the same time, Samsung’s own integrated‑circuit product line (see QCOM page 19) competes with Qualcomm, which could reduce Qualcomm’s demand and make some of those commitments harder to fill, forcing Qualcomm to renegotiate terms or seek alternative suppliers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the $12.8 billion multi-year capacity purchase commitments by Qualcomm (Quantitative Accuracy: 10), and accurately references Samsung's role as a supplier to NVIDIA and competitor to Qualcomm. However, there are key reasoning inaccuracies: the claim that Samsung may allocate 'the majority of its wafer output to NVIDIA’s orders' is not supported by the ground truth and introduces an unsupported prioritization between NVIDIA and Qualcomm. The ground truth focuses on Samsung prioritizing its *own product lines* over external customers like Qualcomm—not favoring NVIDIA over Qualcomm. This misrepresents the nature of the conflict (internal vs. external demand), which is a significant qualitative error in multi-hop reasoning. Additionally, the mention of 'incremental-fee or advance-payment-loss provisions described in QCOM page 82' and 'see NVDA page 9' adds external document references not present in the original context, potentially hallucinated. While the conclusion about renegotiation or seeking alternative suppliers aligns with the original answer, the flawed intermediate logic reduces qualitative accuracy. Contextual relevance remains high as the response addresses the core concern of capacity pressure on Qualcomm’s commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 357,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s commercial‑customer receivables of $665 million (part of the $2.351 billion receivables net) represent revenue from ULA’s commercial launch services. That revenue is incorporated into Lockheed Martin’s share of ULA earnings, which is reported as part of its operating profit. Because Boeing holds a 50 % equity stake in ULA, Boeing reports a proportional share of that income in its own financial statements, thereby reinforcing ULA’s asset base and overall financial position. (See LMT 10‑K, Note 71 on ULA and page 76 on receivables net.)",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's $665 million in commercial customer receivables, which aligns with the ground truth. However, it incorrectly frames this amount as 'revenue from ULA’s commercial launch services,' implying that ULA is the source of the receivables, whereas the ground truth states that ULA is a *customer* of Lockheed Martin (i.e., Lockheed provides goods/services to ULA), not that ULA generates revenue for Lockheed through its own services. This misrepresents the direction of the financial relationship. Additionally, the LLM claims the $665M is 'part of the $2.351 billion receivables net'—a figure not present in the ground truth and unverifiable here—introducing unsupported data. (2) The $665M figure is accurate and matches the ground truth; however, the $2.351B receivables net and its connection are not corroborated, reducing quantitative accuracy. Boeing’s equity stake (50%) is correctly identified, but the LLM fails to mention Boeing’s reported $125M equity income from ULA in 2024—a key fact in the original answer that demonstrates ULA’s financial performance. (3) The multi-hop reasoning is partially sound: the model recognizes the joint venture structure and equity accounting, but it fails to synthesize the full chain—Lockheed’s receivables from ULA as a commercial customer, combined with shared ownership, create dual exposure (credit risk + equity performance). The answer misses the risk implication: financial strain on ULA could impact both Lockheed’s receivables and Boeing’s income. Instead, it claims the revenue 'reinforces ULA’s asset base,' which reverses the flow—Lockheed, not ULA, recognizes revenue from transactions with ULA. (4) Contextual relevance is strong—the answer addresses the core entities and financial relationships. However, due to factual misrepresentation of the revenue flow, omission of key data (Boeing’s $125M income), and introduction of unverified figures, the correctness score is limited to 5—partially correct but with significant errors in reasoning and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 559,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The Federal Circuit’s finding that the “190 Patent” was invalid removed the need to amortize the portion of the Kite‑acquired intangible asset that was tied to that patent.  As a result, Gilead’s amortization expense from the Kite acquisition fell – the axicabtagene ciloleucel asset (gross $7.1 B, accumulated amortization $1.5 B) is no longer amortized, reducing the $1.7 B of finite‑life intangible amortization reported for 2021【page_82】, after the invalidation decision noted on the CAR T litigation page【page_156】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and logical errors that contradict the ground truth. (1) Quantitatively, it incorrectly states that amortization expense fell due to the patent invalidation, claiming the axicabtagene ciloleucel asset 'is no longer amortized' and implying a reduction in the $1.7B amortization expense. However, the ground truth states that amortization expense *increased* from $1.2B in 2020 to $1.7B in 2021, reflecting a *higher* amortization due to improved asset valuation and clearer monetization prospects post-invalidation. The cited numbers ($7.1B gross, $1.5B accumulated amortization) may be plausible but are not confirmed in the ground truth and are used to support an incorrect conclusion. (2) The reasoning is fundamentally flawed: invalidation of the '190 Patent removed royalty risk, which *improved* the value of the acquired intangible assets, leading to higher amortization (not cessation), as the assets now had a clearer path to revenue. The LLM incorrectly assumes patent invalidation reduces asset value or amortization, when in this context it had the opposite effect. (3) The entity identification (Kite, Yescarta/axicabtagene ciloleucel, Gilead) and event (Federal Circuit invalidation in August 2021) are correct, and the reference to finite-lived intangible amortization is accurate, but the causal logic is reversed. (4) Contextually, the answer addresses the question’s domain and cites relevant documents, but the core conclusion is incorrect. The answer fails the multi-hop synthesis: it does not correctly link patent invalidation → reduced contingent liabilities → improved intangible asset valuation → increased amortization. Instead, it asserts the opposite causal relationship. Due to major factual and reasoning errors, the correctness score is low despite some accurate entities and contextual elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 503,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s Greater China segment generated **$74.2 billion** in net sales in 2022 (Apple 10‑K, page 52).  \nIntel reported **$13.5 billion** in revenue from Taiwan in 2021 (Intel 10‑K, page 87).  \nThus, Apple’s Greater China revenue was roughly **$60.7 billion higher**—about **5½ times** Intel’s Taiwan revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The numbers are correctly reported—Apple's $74.2 billion (i.e., $74,200 million) in 2022 from Greater China and Intel's $13.5 billion (rounded from $13,461 million) in 2021 from Taiwan are accurate and properly attributed to their respective 10-K filings. The difference of approximately $60.7 billion is correctly calculated ($74.2B - $13.5B = $60.7B). The comparison stating Apple’s revenue was about 5.5 times Intel’s is also accurate (74.2 / 13.5 ≈ 5.5). (2) Completeness: The answer addresses both companies, correct years, correct regions, and provides a direct comparison as required. (3) Entity accuracy: Apple, Intel, Greater China, Taiwan, 2022, 2021, and the financial metric 'net sales/revenue' are all correctly identified and contextualized. (4) Reasoning: The multi-hop synthesis across two different companies, geographies, and years is sound. The inclusion note that Greater China includes Taiwan is implicitly acknowledged in the comparison without overclaiming. (5) Semantic equivalence: The LLM conveys the same core conclusion as the original answer—that Apple’s revenue from Greater China was significantly higher than Intel’s from Taiwan—with enhanced precision via exact calculations and proper sourcing. Minor formatting differences (e.g., $74.2 billion vs $74,200 million) are acceptable and equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 395,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its foreign‑currency and interest‑rate derivatives using pricing models that rely on observable market inputs—primarily yield curves, foreign‑currency exchange rates and forward‑price levels—so its derivatives are classified as Level 2 (page 136‑137). Boeing, by contrast, values its fixed‑income holdings (including interest‑rate swaps) with models that use observable data such as benchmark yields, credit spreads and interest‑rate curves (page 102 and page 89). Both companies depend on observable market data, but UPS focuses on yield‑curve‑based valuation for derivatives, while Boeing incorporates both credit‑spread and interest‑rate information for fixed‑income investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both UPS and Boeing use observable market data for Level 2 classifications, with UPS focusing on derivatives using yield curves and foreign exchange rates, and Boeing on fixed income instruments including interest rate swaps using interest rates, yield curves, and credit spreads. The mention of specific pages (e.g., 136-137 for UPS, 89 and 102 for Boeing) adds precision and matches the source context. (2) There are no numerical values requiring calculation, but the qualitative metrics (e.g., Level 2 classification, types of observable inputs) are correctly reported. Format and terminology are consistent with the original answer. (3) The multi-hop reasoning is sound—correctly comparing two companies' valuation practices across different instruments (derivatives vs. fixed income), identifying common reliance on observable inputs, and distinguishing focus areas (UPS on yield curves and FX, Boeing on credit spreads and interest rate curves). (4) Semantic equivalence is strong: the LLM captures the core comparison, correct entities, and correct classification logic. The only minor limitation is that the original answer explicitly notes both companies classify these as Level 2 'when observable inputs are available,' a slight nuance not fully emphasized in the LLM response, but implied through context. This justifies a 9 instead of 10 in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 415,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "META uses discounted‑cash‑flow (DCF) models to test impairment of its operating‑lease ROU assets and leasehold improvements, relying on unobservable Level‑3 inputs such as expected downtime before subleases, projected sublease income over the remaining lease terms, and risk‑adjusted discount rates. Disney, in contrast, applies DCF models to value Level‑2 derivatives, basing the valuation on observable market inputs—interest rates, yield curves, and foreign‑currency exchange rates—while counterparty credit risk is considered but deemed immaterial. Thus, META’s DCF inputs are largely internal, non‑observable assumptions tied to asset cash‑flow projections, whereas Disney’s DCF inputs are externally observable market data used for derivative fair‑value measurement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: META uses DCF models with Level 3 (unobservable) inputs for impairment testing of ROU assets and leasehold improvements, including assumptions like expected downtime, projected sublease income, and risk-adjusted discount rates. DIS uses DCF models with Level 2 (observable) inputs—interest rates, yield curves, foreign exchange rates—for valuing derivatives, with counterparty credit risk noted as immaterial. (2) There are no numeric values requiring calculation, but the classification of inputs by fair value hierarchy level (Level 2 vs Level 3) is correctly applied and consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (META and DIS), two applications (impairment testing vs derivative valuation), and contrasts input types (observable vs unobservable), reflecting different financial reporting contexts. (4) The answer is complete, contextually relevant, and conveys the same comparative insight as the original: while both firms use DCF models, the nature of inputs differs significantly due to application and required accounting standards. Wording differs slightly but meaning is preserved with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 369,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The global semiconductor shortage has tightened IQOS device supply (page 28) and, coupled with the ITC import ban, prevents PM USA from shipping IQOS devices or consumables into the U.S., so the company cannot commercialize heated‑tobacco products until supply improves and the FDA has granted the necessary PMTA/MRTP authorizations (page 47).  PM USA’s guarantor role under Altria’s debt structure (page 51) is absolute and independent of product sales, so the supply constraint does not alter its guarantee obligations, though it may reduce PM USA’s cash flow available to meet those obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies the global semiconductor shortage as a supply constraint (from PM's 2022 filing, page 28), links it to the ITC import ban, and explains that this prevents PM USA from shipping IQOS devices or consumables to the U.S., thereby halting commercialization—this aligns with the original answer’s timeline and causality, including the cessation of sales after November 29, 2021, though the date is not explicitly repeated in the LLM answer. (2) All referenced document pages (28, 47, 51) support the claims, and there are no incorrect numbers, dates, or financial figures—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: it connects supply constraints, regulatory dependency (FDA PMTA/MRTP authorization), and financial structure (PM USA as guarantor). It correctly notes that the guarantee obligation is unaffected by sales performance but acknowledges potential strain on cash flow, which matches the original’s concern about dividend distributions and insolvency risk under fraudulent conveyance laws. (4) The only minor omission is not explicitly stating that PM USA is the exclusive U.S. commercialization partner or that IQOS 3 is under FDA review—details present in the original that add context. However, the LLM implies regulatory dependency accurately. The answer is semantically equivalent in key aspects and fully contextually relevant. A score of 9 is justified due to high accuracy with slight incompleteness on PM USA's exclusive role and specific device under review.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 439,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMS’s 2023 10‑K risk factors note that generic and biosimilar competition could erode volumes and prices across its product portfolio, but the company does not provide a specific revenue‑impact figure (pages 27, 28, 31).  In contrast, AbbVie’s 2023 10‑K shows that Humira alone accounted for roughly 27 % of its net revenues and is under direct biosimilar pressure worldwide, indicating a more material and quantifiable exposure to biosimilar competition (pages 8, 80).  Thus, while BMS faces a similar threat, its revenue impact is less defined, whereas AbbVie’s exposure is more pronounced because a single product represents a sizable share of its sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 27% figure for Humira's contribution to AbbVie's 2023 net revenues is accurately cited, and no incorrect figures are introduced. The absence of a specific revenue impact for BMY is correctly noted, consistent with the original answer's implication of less concentrated risk. (2) The LLM correctly identifies both companies (BMY/BMS and ABBV/AbbVie), the relevant year (2023), and the key product (Humira), satisfying entity accuracy. (3) The reasoning is sound: it contrasts BMS's broad, less quantifiable biosimilar risk across its portfolio (e.g., Eliquis, Revlimid implied via context) with AbbVie's concentrated, material exposure via Humira. While the LLM does not explicitly name Eliquis or Revlimid, it captures the essence of BMY's broader portfolio risk. (4) The answer is contextually relevant, directly addressing the comparative exposure question and synthesizing risk across both companies. The only minor shortcoming is the lack of explicit mention of specific BMY products under threat, which slightly reduces qualitative accuracy, but the core comparative insight—diffuse vs. concentrated risk—is preserved. Wording differs but semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 360,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM’s RSU awards vest on a fixed schedule – the third anniversary of the grant date – and the dividend equivalents that accrue are treated as part of the award’s value and paid out in cash when the shares vest.  \nIn contrast, PepsiCo’s RSU awards vest at the end of the vesting period (which may be tied to performance) and the dividend equivalents are paid out in cash separately at that time.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core facts but omits key differentiating details present in the ground truth, particularly around vesting triggers. (1) Correct elements: Both PM and PEP accrue dividend equivalents on RSUs; payouts occur upon vesting; PM’s RSUs typically vest after three years; PEP’s may be performance-based. The treatment of dividend equivalents as cash payouts at vesting is accurately described for both. (2) Quantitative accuracy: No specific numbers (e.g., dollar amounts) are involved, but timeframes like 'third anniversary' align with the three-year vesting in the ground truth. (3) Multi-hop reasoning: The model correctly synthesizes differences in payout structure—PM includes dividend equivalents as part of the RSU settlement value, while PEP pays them in cash upon vesting. However, it fails to mention PM’s additional vesting triggers such as death, disability, or reaching age 58, which is a key distinction from PEP’s strict service- or performance-based vesting. This omission weakens the qualitative accuracy. (4) The answer remains contextually relevant and captures the main structural difference in payout timing and form, but lacks completeness on vesting conditions, which are central to the question. Hence, correctness is reduced to 7 due to missing critical comparative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 368,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s $1,410 million run‑off‑insurance investment is concentrated in limited‑partnership real‑estate funds that are not redeemable and only pay distributions when the general partner liquidates underlying assets, making the position highly illiquid (GE 10‑K, p. 51). Boeing’s broader real‑estate strategy, as disclosed in its 10‑K, covers a diversified mix of real‑estate and real‑asset funds—often structured as closed‑end vehicles with varying lock‑up periods and a range of property types—which provides a more diversified exposure and can mitigate liquidity risk relative to GE’s single‑asset‑class, highly illiquid position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1,410 million figure for GE's investment is correctly stated, and no other numerical data contradicts the original answer. Format variations (e.g., $1,410 million vs $1.41 billion) are acceptable and consistent. (2) The answer correctly identifies both companies (GE and BA/Boeing), their respective investment structures (limited partnerships/fund structures), and the key distinction in liquidity: GE’s position is non-redeemable and dependent on general partner discretion, while BA’s is more diversified across property types and fund vehicles. (3) Multi-hop reasoning is sound—comparing GE’s run-off insurance real estate exposure to BA’s broader real asset strategy requires synthesizing information across two different corporate filings and investment philosophies. The LLM correctly infers that GE’s concentration increases liquidity risk relative to BA’s diversified, closed-end fund approach. (4) The only minor shortcoming is that the LLM does not explicitly mention BA’s integration of real estate within a broader asset allocation strategy including private equity and hedge funds, which slightly reduces completeness. However, the reference to 'real-asset funds' and diversified exposure captures the essence. Wording differs but semantic meaning matches. Contextual relevance is excellent—directly addresses liquidity risk, fund structure, and strategic scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 405,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "BAC’s 10‑K does not disclose a notional amount for equity‑market derivatives; the only equity‑risk figure reported is a 99‑percent VaR of **$18 million** (page 78), implying a modest exposure. In contrast, MetLife reports a **$23.6 billion** notional of equity‑market derivatives and a **$522 million** sensitivity to a 10 % decline in equity prices (page 129). Thus, MetLife’s notional exposure and potential loss from a 10 % equity fall are far larger than BAC’s reported equity‑risk exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that BAC reports a 99-percent VaR of $18 million for equity-market risk is incorrect — the ground truth does not mention this figure, and no such number appears in the provided context. This number is hallucinated or misattributed, severely impacting quantitative accuracy. (2) While MET's notional value ($23,595 million ≈ $23.6 billion) and sensitivity ($522 million) are correctly reported (allowing for rounding), the comparison to BAC is flawed because the LLM introduces a specific VaR number not present in the original answer, creating a false basis for comparison. (3) The original answer states that BAC does not specify exact notional amounts and only discusses its use of equity-linked derivatives qualitatively, whereas the LLM incorrectly asserts a precise risk figure, failing the multi-hop synthesis by inventing data. (4) The reasoning is partially sound in structure — comparing disclosed notional values and sensitivities — but collapses due to reliance on an unsupported number. (5) Entity names (BAC, MET) and financial terms (notional value, sensitivity to 10% decline) are used correctly, and the contextual relevance is high as the response addresses the core question about comparative exposure. However, the hallucinated $18M VaR figure leads to a major factual error, warranting a low correctness and quantitative accuracy score despite correct reporting of MET's data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 410,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s Greater China segment generated $74.2 billion in 2022, about 19 % of its $394.3 billion total net sales, indicating a sizable but diversified regional presence【page_25】. In contrast, AMD’s Taiwan sales were $2.09 billion, roughly 13 % of its $16.4 billion external sales, showing a higher concentration in that single market【page_78】. These figures suggest Microsoft pursued a broad, multi‑region strategy with a strong but balanced Greater China focus, while AMD’s 2022 strategy relied more heavily on Taiwan for a significant share of its revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Microsoft operates a regional center in Singapore supporting Greater China, but does not provide any revenue figure for Microsoft's Greater China segment. However, the LLM claims Microsoft’s Greater China segment generated $74.2 billion (19% of $394.3 billion) in 2022 — this data is not present in the original answer and contradicts the known public record (Microsoft does not break out Greater China as a standalone segment with that revenue). This is a significant fabrication. Additionally, while AMD’s $2,091 million in sales to Taiwan is correctly cited in the original (rounded to $2.09 billion), the LLM incorrectly states this is 13% of AMD’s $16.4 billion external sales — the math is off: $2.09B / $16.4B ≈ 12.75%, which rounds to 12.8%, not 13%, but more importantly, the original answer does not make this percentage claim, nor does it state AMD’s total external sales as $16.4B, so this is an unsupported inference. (2) Quantitative accuracy is poor: the Microsoft revenue numbers are entirely fabricated, and the percentage calculation for AMD, while close, is not verifiable from the original answer and introduces data not present in the ground truth. (3) Multi-hop reasoning is flawed: the original answer compares Microsoft’s operational footprint (a structural, logistical fact) with AMD’s revenue concentration (a financial exposure), emphasizing different strategic models — hub-based support vs. market dependency. The LLM instead shifts to a quantitative revenue comparison that is not supported by the source, missing the operational aspect of Microsoft’s strategy entirely. It fails to mention the Singapore regional center or Microsoft’s broader Asia-Pacific structure, which is central to the original reasoning. (4) Contextual relevance is moderate because the LLM attempts to compare regional strategies and mentions both companies and regions correctly, but the reasoning is based on incorrect data and omits key qualitative insights from the original. The conclusion about AMD relying heavily on Taiwan is partially valid, but the contrast with Microsoft is undermined by factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 592,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "META’s dual‑class structure concentrates voting power in the hands of its controlling shareholder, who can dictate corporate‑governance matters even when owning less than a majority of the combined Class A and Class B shares【page_50】. In contrast, NFLX’s single‑class common‑stock structure gives every share one vote on all matters, so ordinary investors have a more direct influence on board and policy decisions【page_61】. Thus, investors at META have limited influence relative to those at NFLX, where voting power is more evenly distributed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies META's dual-class structure as concentrating voting power with controlling shareholders (e.g., Mark Zuckerberg, though not named in the LLM answer, the concept is accurate), limiting influence of Class A stockholders. It accurately contrasts this with NFLX's one-share-one-vote policy, ensuring equal voting rights. (2) There are no numeric values, dates, or financial figures requiring verification; thus, quantitative accuracy is 10. (3) The multi-hop reasoning—comparing corporate governance structures across two companies—is sound and correctly synthesizes information from both entities. The only minor omission is that the original answer specifies 'board composition and change-of-control transactions' as key decisions affected, while the LLM answer generalizes to 'board and policy decisions,' which is slightly less precise but still correct in substance. (4) Contextual relevance is perfect: the response directly addresses the comparison of investor influence over corporate governance. The use of citation placeholders ['page_50', 'page_61'] suggests source grounding, though not required for scoring. Overall, the answer is excellent with only slight room for added specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 363,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "Johnson & Johnson’s 10‑K notes that when a product’s patents expire, the company “loses market exclusivity and is exposed to generic, biosimilar or other competing products, which typically results in a rapid decline in sales” (page 6, risk factors).  In contrast, Eli Lilly’s filing emphasizes that it relies on regulatory exclusivity extensions—such as data‑package protection, orphan‑drug exclusivity, pediatric exclusivity and the BPCIA for biologics—to extend market exclusivity beyond the life of its patents, thereby preserving a competitive advantage in the U.S. market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that JNJ faces loss of market exclusivity and rapid sales decline post-patent expiration due to generic competition, citing a direct quote from its 10-K. It also accurately notes that LLY relies on regulatory exclusivity mechanisms—specifically naming data-package protection, orphan-drug exclusivity, pediatric exclusivity, and the BPCIA—to extend market protection beyond patent life. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly contrasts JNJ’s vulnerability to patent expiration with LLY’s strategic use of regulatory exclusivity, synthesizing concepts across two companies and regulatory frameworks. The only minor omission is that the LLM answer does not mention BMY’s 10-K as a source for the general principle that regulatory exclusivity can outlast patents—this contextual support is in the ground truth but missing in the LLM response, slightly weakening the provenance of one claim. However, the substantive content remains correct. (4) The answer is fully relevant to the question, directly addressing both parts: JNJ’s exposure due to patent expiry and LLY’s reliance on regulatory extensions. Wording differs slightly from the original but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a minor gap in sourcing completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 443,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD’s 2021 interest expense dropped by **$13 million** versus 2020, mainly because holders converted its 2.125 % convertible senior notes due 2026, cutting debt balances and interest costs. In contrast, Microsoft’s 10‑K shows only **$1 million** of the former Nuance convertible senior notes still outstanding after the acquisition. This contrast indicates AMD is actively converting debt to reduce leverage and interest expense, while Microsoft has largely retired such debt, reflecting a more conservative, low‑leverage capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's $13 million reduction in interest expense from $47M to $34M between 2020 and 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, which matches the ground truth. It also accurately states that only $1 million of Nuance's convertible senior notes remained outstanding post-acquisition by Microsoft, aligning with the redemption of $985 million out of $986 million issued. (2) All numeric values are correct: the $13M decrease is accurate ($47M - $34M), and the $1M remaining liability for Nuance is factually consistent with the original answer. Number formats are clear and acceptable. (3) The multi-hop reasoning is sound—LLM synthesizes AMD’s debt conversion strategy with Nuance’s post-acquisition liability under Microsoft, correctly contrasting their capital structure approaches. It infers that AMD is proactively reducing leverage via conversions, while Microsoft (post-acquisition) has largely retired the debt, reflecting a conservative stance. This aligns with the original conclusion, though it omits Nuance’s own redemption actions prior to full retirement and slightly simplifies the narrative by attributing the retirement directly to Microsoft without noting Nuance’s prior redemptions. (4) Despite this minor omission in background detail, the core facts, calculations, entities, and implications are correct and well-reasoned. The answer is contextually precise, directly addressing the comparison and strategic implication. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall due to slight simplification of Nuance’s pre-acquisition redemption activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 469,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "American Tower paid **$5.0 billion** in 2015 for exclusive lease‑and‑operate rights to 11,300 Verizon towers, a little higher than Crown Castle’s **$4.827 billion** transaction in 2013 for exclusive rights to 9,048 AT&T towers (plus a $4.827 billion purchase of 627 towers)【page_73】. In both deals the seller retained ownership of the tower assets and continued to record depreciation on them, while the buyer assumed the lease‑sublease capacity and related financing obligations【page_73】【page_90】. Thus the American Tower deal was roughly $173 million larger, but the ownership and depreciation treatment were essentially identical.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $5.0 billion American Tower payment in 2015 for 11,300 Verizon towers and the $4.827 billion Crown Castle transaction in 2013, which is factually accurate. However, it incorrectly states that the $4.827 billion included 'a $4.827 billion purchase of 627 towers', which is a significant error — the ground truth specifies that Crown Castle paid $4.827 billion for exclusive rights to 9,048 AT&T towers *and separately* purchased 627 towers, but does not state that the entire $4.827 billion was allocated to the 627 towers. This misrepresents the structure of the deal and introduces a major quantitative inaccuracy. (2) The comparison that the American Tower deal was '$173 million larger' is mathematically correct ($5.0B - $4.827B = $173M), but the flawed explanation of the Crown Castle transaction undermines confidence in this calculation's basis. (3) The reasoning around ownership and depreciation is sound: both Verizon and AT&T retained ownership, continued depreciation, and subleased capacity back — this multi-hop synthesis across companies and years is accurate. The mention of leaseback terms (Verizon for 10 years, AT&T for ~20 years) is missing from the LLM answer, which is a notable omission affecting completeness. (4) Despite the critical error in describing the Crown Castle transaction, the core comparison and financial treatment are mostly correct, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized more heavily (6) due to the misallocation of the $4.827B figure. Qualitative accuracy is higher (8) because the conceptual framework and reasoning are solid. Contextual relevance is perfect (10) — the answer directly addresses the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 481,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power uses tax‑equity partnerships for its wind (and other) projects, with the partner assuming almost all of the federal tax benefits (ITC/PTC) and the projects tied to long‑term PPAs of up to 25 years (see page 97 and page 270).  Duke Energy structures its renewable VIEs through tax‑equity arrangements that finance projects eligible for tax credits, but the VIEs are not consolidated because control is shared (page 204) and the filings do not detail how the tax partner monetizes the PTCs, implying a less disclosed monetization strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies and omissions that affect the overall correctness. (1) Quantitatively, the mention of 'up to 25 years' for Southern Power's PPAs matches the ground truth and is accurate. Page references (97, 270, 204) appear consistent with source documentation, though exact page numbers are not evaluated for correctness. (2) However, a critical error lies in the claim that Duke Energy's VIEs 'are not consolidated because control is shared'—this contradicts the ground truth, which states Duke is the primary beneficiary and consolidates the VIEs. This misrepresents the control structure and consolidation logic, undermining the qualitative accuracy. (3) The LLM incorrectly implies that Duke’s monetization of PTCs is less disclosed or structurally different due to lack of detail, whereas the ground truth confirms Duke does use third-party tax equity investors to finance eligible assets and monetize credits—similar to Southern Power—but within a VIE framework where it retains decision-making control. The LLM fails to recognize this parallel structure and incorrectly infers a difference based on disclosure limitations. (4) Additionally, the LLM omits the key comparative insight that Southern Power explicitly aligns its PPA terms with the 10-year PTC window, while Duke focuses on broader VIE financing and guarantees—this nuance is central to the original answer and missing here. (5) While both companies use tax equity and PPAs for monetization, the LLM does not adequately synthesize the multi-hop comparison: it overemphasizes disclosure differences rather than structural similarities and distinctions in how tax benefits are captured. (6) Semantic equivalence is partially achieved on basic facts (use of tax equity, long-term PPAs), but the reasoning breakdown on consolidation and monetization strategy reduces correctness. Thus, the answer is partially correct but flawed in key qualitative aspects, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 541,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "At Comcast, Class B common stock is largely non‑voting – holders can vote only on a few defined matters (e.g., exit of the core payments business, certain mergers, or amendments to the certificate of incorporation)【page_90】, so control of major corporate decisions rests almost entirely with Class A shareholders. Alphabet’s dual‑class structure gives each Class A share one vote, each Class B share ten votes, and no voting rights to Class C shares【page_82】, concentrating decision‑making power in the hands of insiders (Class B) and the publicly held Class A shareholders while limiting the influence of the majority of Class C shareholders. Thus, Comcast’s model centralizes voting power in a single class, whereas Alphabet’s model distributes it across two voting classes, giving insiders and Class A holders a decisive role in major corporate actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: CMCSA's Class B stock has no voting rights except in limited circumstances (e.g., exit from core payments business, merger), and GOOGL's dual-class structure assigns 10 votes to Class B, 1 vote to Class A, and 0 to Class C. These voting rights are accurately described. (2) There are no numerical values requiring calculation, but the vote ratios (10:1 and 1:1) are correctly stated. (3) The multi-hop reasoning is sound—comparing two companies' voting structures and their implications on corporate governance. The LLM correctly identifies that GOOGL concentrates power among insiders (Class B holders) while CMCSA centralizes voting power in Class A, with Class B largely disenfranchised. (4) The only minor shortcoming is that the LLM slightly underemphasizes the contrast in governance models: the original answer explicitly notes that CMCSA maintains a 'more uniform governance structure among its voting shareholders,' whereas the LLM says 'centralizes voting power in a single class,' which is accurate but less nuanced. Also, the LLM refers to 'core payments business'—likely a misstatement, as CMCSA (Comcast) is a media/telecom company, not payments-focused; this may be a transcription error from source material (e.g., 'core businesses' misread). Despite this, the overall reasoning and factual content remain strong. Semantic equivalence is preserved, and the answer fully addresses the question on shareholder influence and governance implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 429,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "GOOGL’s dual‑class structure gives Class B holders ten votes per share, so the $62.2 billion of Class A and C share buy‑backs (page 81) shrink the voting pool of Class A shares and raise the proportion of votes held by the Class B group, allowing insiders to retain control even after large repurchases. NFLX, which has only one voting class (page 61), has no such concentration; its $6 billion repurchase (page 58) simply reduces the total number of voting shares but does not shift control away from the largest shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies GOOGL's dual-class structure (10 votes for Class B vs 1 for Class A) and contrasts it with NFLX's single-vote structure. The $62.2 billion share repurchase by GOOGL in 2023 is accurately cited, and the effect of shrinking the Class A voting pool—thereby increasing relative control of Class B shareholders—is logically explained. (2) The only minor issue is the mention of NFLX's $6 billion repurchase, which is not present in the original answer and not confirmed by the ground truth; this introduces a number not supported by the provided context, though it may be factually correct elsewhere. This slightly affects quantitative accuracy but does not undermine the core comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes how capital actions (repurchases) interact with ownership structures to affect control dynamics across two companies. (4) The answer is contextually relevant, directly addressing the impact of voting structures and repurchases on control. Wording differs but semantic meaning matches the original. The unsupported $6B NFLX figure prevents a perfect score, but overall correctness is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 347,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMY’s retained royalty rights from the divestiture of its diabetes portfolio—including the Byetta brand—continue to be a major revenue source, generating roughly **$1.9 billion of pretax income in 2021**.  Although BMY no longer owns the product line, the Byetta trademark is now held by Amylin (a subsidiary of Eli Lilly), so BMY receives royalty payments from a brand that is under LLY ownership.  Thus the royalties represent a significant ongoing cash‑flow stream even after the divestiture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial significance of BMY's retained royalty rights related to Byetta*. (1) Quantitatively, the $1.9 billion pretax income figure from 2021 is correctly stated, matching the ground truth from BMY's 2022 10-K. (2) The entity relationships are mostly correct: BMY retains royalty rights post-divestiture, and LLY (via its subsidiary Amylin) owns the Byetta trademark. However, there is a minor inaccuracy in stating that 'the Byetta trademark is now held by Amylin (a subsidiary of Eli Lilly)'—while technically Amylin was acquired by LLY, it is more precise to say LLY holds the trademark, as Amylin operates as part of LLY post-acquisition. This does not invalidate the reasoning but slightly affects entity precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across the divestiture event, current trademark ownership, and ongoing royalty income, linking BMY’s financial exposure to LLY despite no longer owning the business. (4) The answer is contextually relevant and captures the financial significance—highlighting the magnitude of royalty income and its importance as a cash flow stream. The omission of the forward-looking risk ('a decline could adversely affect') slightly reduces completeness, but the core financial impact is well conveyed. Overall, the answer is factually strong with only minor qualitative refinements needed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 395,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab’s banking subsidiary (CSC/CSB) must hold a total risk‑based capital ratio of **10.5 %** that already incorporates a 2.5 % stress‑capital buffer and a 2.5 % capital‑conservation buffer【page 122】.  \nJPMorgan Chase Bank, N.A. is required to maintain a total risk‑based capital ratio of **17.6 %** that includes only the 2.5 % capital‑conservation buffer (plus the GSIB surcharge)【page 291】.  \nThus, Schwab’s additional stress buffer lowers its required ratio relative to JPMorgan, which must meet a higher minimum ratio because it does not include that buffer.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, both Schwab and JPMorgan Chase have the same minimum total risk-based capital ratio requirement of 10.5%. However, the LLM incorrectly states that JPMorgan Chase's requirement is 17.6%, which is factually wrong. This number may reflect JPMorgan's actual capital ratio or a figure including the GSIB surcharge, but it does not represent the 'minimum total risk-based capital ratio requirement' as defined in the question. (2) The quantitative accuracy is severely compromised: while Schwab's 10.5% is correct (2.5% stress + 2.5% conservation + 5.5% base minimum), JPMorgan's stated 17.6% is not the regulatory minimum and contradicts the ground truth. The comparison is therefore invalid. (3) The reasoning is flawed: the conclusion that 'Schwab’s additional stress buffer lowers its required ratio relative to JPMorgan' is illogical and incorrect—buffers increase required capital, and the premise that JPMorgan has a higher requirement due to lacking a stress buffer is false per the original answer. (4) Contextual relevance is moderate because the answer addresses the right topic and mentions relevant buffers, but the synthesis across entities fails due to incorrect data. The model appears to confuse actual capital levels or GSIB-adjusted requirements with the defined minimums. Entity accuracy is acceptable (Schwab, JPMorgan, buffer types), but the core financial comparison is wrong, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 419,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "The LIBOR phase‑out will trigger the fallback clauses in Lockheed Martin’s credit facility, which replace USD LIBOR with SOFR plus a spread, and GE’s floating‑rate debt and preferred stock will likewise switch to SOFR plus spread.  Under ASU 2020‑04, both companies can apply optional expedients and exceptions to contract modifications and hedge accounting, so the transition does not require remeasurement of the debt or derivatives and is expected to have no material impact on operating results, financial position or cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: both LMT and GE transition to SOFR plus spread; ASU 2020-04 provides accounting relief that avoids remeasurement and limits financial impact. The statement that the transition is expected to have 'no material impact' aligns with the original answer's 'minimal financial impact'. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) Multi-hop reasoning is sound: the model correctly synthesizes the impact on LMT’s credit facility, GE’s debt and preferred stock, and the role of ASU 2020-04 across both firms. The only minor shortcoming is that the LLM does not explicitly mention New York law governing GE’s transition, which is a small but relevant legal detail in the original. However, this omission does not affect the financial or accounting substance. (4) The answer is contextually fully relevant, directly addressing all parts of the question with precise, concise, and semantically equivalent information. Wording differs slightly but meaning is preserved. A score of 9 is justified due to high accuracy with a minor omission in legal context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 360,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 issuance of 9,444,375 Class B shares—each carrying 10 votes—creates a small pool of high‑voting equity that the company can use for corporate purposes such as employee compensation or strategic transactions, but the shares remain high‑voting unless the holder elects to convert them【page_69】. Alphabet’s dual‑class structure, by contrast, automatically converts any Class B shares to Class A shares (one vote each) upon sale or transfer, ensuring that new owners receive only the lower‑voting Class A shares and that control stays with the original holders【page_81】. Thus, while both firms use high‑voting Class B shares, Comcast’s shares are convertible at the holder’s option and not automatically converted, whereas Alphabet’s shares are automatically converted to preserve voting control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the number of shares issued by CMCSA—9,444,375—is correctly stated, and the year 2023 is accurate. The $62.2 billion share repurchase by GOOGL is not mentioned in the LLM answer, but this omission does not introduce inaccuracy; it only reduces completeness slightly. (2) The qualitative analysis correctly identifies that CMCSA’s Class B shares carry 10 votes and are convertible at the holder’s option, while GOOGL’s Class B shares automatically convert to Class A upon sale or transfer. This distinction in conversion mechanics is correctly highlighted and is central to the comparison. (3) The multi-hop reasoning is sound: the model synthesizes information about CMCSA’s issuance purpose and contrasts it with GOOGL’s structural control mechanism. (4) The LLM omits CMCSA’s lack of a buyback program and GOOGL’s $62.2B repurchase, which is a minor gap in completeness but does not affect the core correctness of the comparison. Wording differs from the original answer but maintains semantic equivalence. The answer is contextually relevant and directly addresses both parts of the question: the significance of the issuance and the structural comparison. Minor deduction from 10 to 9 due to omission of GOOGL’s buyback context, which is part of the ground truth’s comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 382,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDLZ’s multi‑employer pension plan commitments are made as annual contributions ($4‑5 million in 2021‑2023) and recorded as expense in the period incurred, with a separate 19‑year withdrawal liability that requires monthly payments.  The cost is recognized immediately for the contribution and then as interest and other plan‑related expenses as the liability accrues.  \n\nWalmart’s equity‑compensation awards vest over defined periods—RSUs over four years (25 % per year), performance‑based RSUs over 1‑3 years, and options over a weighted‑average of 1.2 years.  The related expense is recognized ratably over each award’s vesting period, with unrecognized compensation cost expected to be recognized over 1.2–1.3 years.  Thus, MDLZ’s commitments are short‑term contributions with a long‑term liability, while Walmart’s vesting schedules are longer (up to 4 years) and the expense is spread gradually over the vesting horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core contrast between MDLZ's multiemployer pension obligations and WMT's equity compensation vesting schedules in terms of duration and cost recognition. However, there are key quantitative inaccuracies: the ground truth states MDLZ has a $526 million withdrawal liability paid over 19 years and $11 million in 2021 contributions, while the LLM claims $4–5 million in annual contributions for 2021–2023, which underreports the actual amount. The LLM also introduces 'monthly payments' for the withdrawal liability, which is not mentioned in the original answer. For WMT, the LLM correctly identifies the 25% annual vesting over four years for RSUs and ratable expense recognition, but adds details not in the ground truth—such as performance-based RSUs vesting over 1–3 years and options with a 1.2-year weighted average term—which, while plausible, are not supported by the provided truth. The '1.2–1.3 years' for unrecognized cost is inconsistent with the 4-year vesting pattern emphasized in the original.\n\n2) Quantitative accuracy is compromised: $4–5 million vs. $11 million in contributions is a significant underreporting. The $526 million liability is entirely omitted in dollar amount, weakening cost magnitude assessment. The 1.2-year vesting average for options and unrecognized cost period conflicts with the original’s focus on 4-year RSU vesting.\n\n3) Qualitatively, the reasoning is sound in distinguishing MDLZ’s collective bargaining-driven, long-duration liabilities with interest accruals from WMT’s internally structured, shorter, fixed equity vesting with ratable expensing. The synthesis of cost recognition patterns—immediate vs. gradual—is logically presented and aligns with the question.\n\n4) Contextual relevance is high: the response directly compares duration and cost recognition across the two companies as asked. Despite missing the $526M figure and misstating contribution amounts, it retains the structural contrast. The added details on WMT’s performance awards and option terms go beyond the ground truth but do not contradict it outright, though they introduce unverified information. Overall, the answer is partially correct with significant but not critical quantitative errors, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 607,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "BAC’s combined capital buffer requirement above the minimum risk‑based capital ratios under the Advanced Approach is 5.5 % (2.5 % Capital Conservation Buffer + 3.0 % G‑SIB surcharge + 0 % Countercyclical Buffer)【page_146】. Morgan Stanley’s requirement is identical at 5.5 % above the minimum ratios, also incorporating a 2.5 % Capital Conservation Buffer and a zero Countercyclical Buffer【page_54】. Thus, both banks have the same combined buffer requirement under the Advanced Approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative components. While both banks apply the 2.5% Capital Conservation Buffer and face a 0% Countercyclical Buffer (correctly stated), the LLM incorrectly assigns a 3.0% G-SIB surcharge to BAC and implies MS has the same, whereas the ground truth specifies a 2.5% G-SIB surcharge for both institutions. This leads to an incorrect total buffer of 5.5% instead of the correct 5.0%. (2) The calculation itself is arithmetically correct (2.5 + 3.0 + 0 = 5.5), but the inputs are wrong—using 3.0% instead of 2.5% for G-SIB surcharge invalidates the result. The ground truth clearly states both banks have a 2.5% G-SIB surcharge, summing to 5.0% total buffer. (3) The multi-hop reasoning is partially sound—the model correctly identifies that the total buffer is the sum of Conservation, G-SIB, and Countercyclical buffers, and correctly notes both banks apply the same Conservation and Countercyclical Buffers. However, it fails in accurately retrieving the G-SIB surcharge values, which is central to the comparison. (4) Contextual relevance is high as the answer addresses the right entities (BAC, MS), regulatory components, and correctly attempts comparison. However, due to the critical error in the G-SIB surcharge percentage, the conclusion of 'same requirement' is based on incorrect numbers, undermining factual correctness. Thus, correctness and quantitative accuracy are penalized heavily, while qualitative reasoning and relevance retain moderate scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 424,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO’s $56.3 billion of fixed‑rate senior notes would change in fair value by about $1.7 billion for a 50‑basis‑point swing in market rates – roughly $34 million per basis point – showing a high sensitivity to interest‑rate movements. Oracle, by contrast, uses interest‑rate swaps to convert parts of its debt between fixed and floating, producing effective rates of 8.76 % (fixed‑to‑floating) and 4.74 % (floating‑to‑fixed) and thereby dampening the impact of rate changes. Cisco’s $0.5 billion swap demonstrates the same strategy, converting fixed‑rate notes into SOFR‑based floating debt to hedge against rate volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies AVGO's $56.3 billion fixed-rate debt and the $1.7 billion fair value sensitivity to a 50-basis-point rate change, which matches the ground truth. It also correctly states ORCL's effective interest rate of 4.74% after swaps for fiscal 2023/2024 and references CSCO's $0.5 billion swap. However, it introduces an incorrect figure of '8.76%' as an effective rate for 'fixed-to-floating' swaps for ORCL, which is not present in the original answer and contradicts the ground truth that ORCL used swaps to achieve a stable 4.74% rate by converting floating to fixed. This is a significant quantitative error. 2) The $1.7 billion sensitivity and $56.3 billion debt are accurate. The derived $34 million per basis point (1.7B / 50) is mathematically correct but not mentioned in the original and may be misleading without context. The 4.74% rate is correct. The 8.76% rate is unsupported and likely erroneous. CSCO's $0.5 billion swap is correctly cited. 3) The multi-hop reasoning is mostly sound: the model connects AVGO's sensitivity, ORCL's use of swaps for stabilization, and CSCO's swap as an illustrative example. However, the incorrect 8.76% rate undermines the accuracy of the ORCL analysis and suggests a misunderstanding or data error in the synthesis. 4) Despite the incorrect rate, the overall structure, intent, and qualitative comparison are valid—AVGO has high sensitivity, ORCL uses swaps to reduce volatility, and CSCO's example illustrates the mechanism. The answer remains contextually relevant and mostly aligned with the question’s intent, but the factual error in a key financial metric limits the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 454,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s Class B common shares carry 10 votes each, giving them a substantial voting advantage over the one‑vote Class A shares. Alphabet’s repurchase program, however, targets only Class A and non‑voting Class C shares, leaving Class B shares untouched; thus the program does not dilute the voting power of Class B holders but could shift relative influence by reducing the number of Class A shares【page 82】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Meta’s Class B shares carry 10 votes per share, but the ground truth specifies 15 votes per share. This is a critical error in quantitative and qualitative accuracy. Additionally, the LLM omits the key fact that Meta’s Class B shares represent exactly 33 1/3% of combined voting power and are non-dilutable—central to the governance structure. Regarding GOOGL, the LLM correctly notes that repurchases target Class A and Class C shares, but fails to mention the $62.0 billion repurchase amount in 2024, a major quantitative omission. It also does not mention that GOOGL’s Class B shares have 10 votes and are convertible, which is essential for comparison. (2) The dollar amount of GOOGL’s repurchases ($62.0 billion in 2024) is entirely missing, and the vote count for Meta’s Class B shares is incorrect (10 vs. 15). These are direct factual errors, not formatting issues. (3) The reasoning about GOOGL’s repurchase strategy preserving Class B voting power is logically sound and reflects correct multi-hop understanding of how repurchasing non- or low-vote shares can consolidate control. However, the failure to include key structural details (non-dilutable control at Meta, exact vote ratios, repurchase scale) undermines the synthesis. (4) Correctness is scored 4 due to partial correctness on GOOGL’s repurchase targeting and governance implications, but major errors on Meta’s voting structure and missing financial figures. Quantitative accuracy is low (3) due to wrong vote counts and missing $62B figure. Qualitative accuracy is moderate (5) because the conceptual logic about voting power preservation is valid, but entity-level details are flawed. Contextual relevance is high (8) as the answer addresses the core theme of voting control vs. repurchase strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 504,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm’s forecast that 46 % of smartphones sold in 2027 will be generative‑AI‑capable signals a shift toward building AI‑enabled chipsets, RF modules and edge‑computing platforms that can run large language models on‑device, while simultaneously advancing 5G/5G‑Advanced connectivity to meet the low‑latency, high‑bandwidth demands of those models. In contrast, Salesforce is channeling its resources into generative and agentic AI across its cloud‑based CRM suite to deliver smarter, autonomous customer interactions, positioning AI as a software‑centric, cloud‑driven capability rather than a hardware‑centric one.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Qualcomm's projection that 46% of smartphones sold in 2027 will be generative AI-capable, accurately reflecting the ground truth (up from 19% in 2024, though the 19% figure is omitted in the LLM response). All other numeric values and timeframes (2027, 5G/5G-Advanced) are correct. (2) Quantitative accuracy is perfect: the 46% figure is correctly cited, and no incorrect numbers are introduced. The absence of the 19% baseline is a minor omission but does not affect the core quantitative claim. (3) The multi-hop reasoning is sound: the LLM correctly links Qualcomm’s market projection to its strategic focus on on-device AI, edge computing, and advanced connectivity (5G/5G-Advanced), while contrasting Salesforce’s cloud-based, software-centric AI integration into CRM via generative and agentic AI (e.g., Agentforce is not named, but the concept is accurately described). The distinction between hardware- and software-driven AI strategies is well articulated. (4) The answer is contextually fully relevant and semantically equivalent to the ground truth, with only minor completeness gaps (e.g., not naming Agentforce or explicitly stating the lack of direct business relationship between the companies). These omissions do not detract from the core factual accuracy or strategic comparison. Hence, a high score of 9 is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 402,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe’s Creative Cloud, powered by generative‑AI models such as Firefly (page 34, 12), is built to give designers instant, high‑quality content and a seamless, cross‑product UI that runs directly on the user’s device. Qualcomm projects that by 2027 roughly 46 % of smartphones will be generative‑AI‑capable, driven by on‑device AI engines (Hexagon NPU, AI Engine) that deliver low‑power, high‑performance inference (page 8, 9, 10). The convergence of Adobe’s AI‑driven creative tools with Qualcomm’s on‑device AI hardware will enable faster, more responsive interfaces and real‑time creative workflows on future edge devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Adobe's use of generative AI in Creative Cloud, specifically mentioning Firefly and on-device execution, which aligns with the ground truth emphasis on AI-driven digital media tools and user experience. It accurately cites Qualcomm's projection that 46% of smartphones in 2027 will be generative AI-capable, matching the original answer. The reference to on-device AI processing via Qualcomm’s Hexagon NPU and AI Engine supports the theme of edge AI enhancing responsiveness and efficiency. (2) Quantitatively, the 46% figure for 2027 is correct and matches the ground truth; the implied comparison to 19% in 2024 is omitted in the LLM answer but not misrepresented. No calculations are required, and all numbers are accurate. (3) The multi-hop reasoning is sound: the LLM connects Adobe’s AI-driven UI/UX strategy with Qualcomm’s hardware advancements, concluding that their convergence enables faster, more responsive creative workflows—this synthesizes across both companies’ strategic directions as required. The only minor gap is the absence of explicit mention of privacy and personalization benefits highlighted in the original answer, which are part of Qualcomm’s value proposition for on-device AI. (4) The answer is highly factually accurate, contextually relevant, and well-reasoned. The slight deduction in qualitative accuracy is due to the omission of privacy and personalization aspects, but the core alignment between Adobe and Qualcomm is correctly captured. Wording differs but semantic meaning is equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 433,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s directors’ RSU awards can be paid after January 1, 2018, together with any dividend equivalents, on the first business day of April following the one‑year anniversary of the grant【page_100】. In contrast, Honeywell’s RSU awards vest over three‑to‑six‑year periods and are paid in common stock upon vesting; the plan does not provide for dividend equivalents on those awards【page_93】.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies key vesting and payment terms for both Lockheed Martin and Honeywell RSUs, with accurate dates and timeframes (e.g., 'first business day of April', 'one-year anniversary', 'three-to-six-year periods'), satisfying quantitative accuracy. However, it introduces a factual error by stating that Honeywell’s plan 'does not provide for dividend equivalents on those awards', which contradicts the ground truth indicating that Honeywell does not specify a delayed payment schedule but does not exclude dividend equivalents entirely—instead, the focus is on performance-based vesting and payment in stock. The ground truth also notes Lockheed Martin’s DMICP credits dividend equivalents as stock units at dividend payment times, a detail omitted in the LLM response. While the LLM captures the delayed payment structure for Lockheed Martin and the vesting periods for Honeywell, it fails to fully synthesize the multi-hop aspect regarding dividend equivalents treatment across both companies. The reasoning is partially sound but contains a critical misrepresentation about Honeywell, reducing qualitative accuracy. Contextually, the answer remains relevant and addresses the core comparison, hence high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 349,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments sources roughly 40 % of its assembly and test services from subcontractors (TXN page 9), a sizable but partial reliance. NVIDIA, by contrast, outsources all wafer fabrication, assembly, test and packaging to third‑party foundries and contract manufacturers, making its exposure broader (NVDA pages 24‑25). Both companies face similar risks—capacity constraints, price volatility, and quality issues—underscored by AMD’s own disclosures that third‑party manufacturing can materially affect supply and costs (AMD pages 22‑23, 25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 40% subcontracting figure for Texas Instruments is correctly cited and matches the original answer. While the original does not specify NVIDIA's exact percentage, the LLM correctly states that NVIDIA outsources all fabrication, assembly, test, and packaging—consistent with industry knowledge and implied by the ground truth’s emphasis on NVDA’s broad third-party reliance. No calculations were required. (2) The answer addresses all parts of the multi-hop question: TXN's 40% reliance, NVDA's exposure, comparison of risks, and reference to AMD’s experience. It correctly identifies AMD’s supply chain issues as affecting supply and costs, which is consistent with the risk themes in the ground truth (capacity constraints, financial penalties). (3) Entities are accurate: TXN, NVDA, AMD, and their respective dependencies are correctly attributed. Page references (e.g., NVDA pages 24–25) suggest proper sourcing, though not required for scoring. (4) Reasoning is sound: the LLM draws a valid comparison, noting that while both firms face similar risks (capacity, quality, pricing), NVIDIA’s exposure is broader due to full outsourcing—this goes slightly beyond the original but is a reasonable inference. The only minor gap is that the original emphasizes NVDA’s risk amplification due to product complexity and global supply chain, which the LLM does not explicitly mention, slightly reducing qualitative completeness. However, the core multi-hop synthesis across three companies and risk dimensions is robust and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 446,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "Duke Energy Florida’s Clean Energy Connection program will cost roughly **$1 billion** to build 10 new solar facilities over the next three years.  The project is financed in a way that mirrors Southern Power’s strategy, which treats renewable‑energy PPAs as **operating leases with terms up to 25 years**, providing a long‑term, lease‑based financing structure for similar solar and wind projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities and accurately states that Southern Power uses PPAs treated as operating leases with terms up to 25 years. These key facts match the ground truth. (2) Quantitatively, the dollar amount ($1 billion) and time frame (up to 25 years) are correct. The LLM does not introduce any incorrect numbers or miscalculations. Format variations (e.g., $1 billion vs $1 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model connects Duke Energy Florida’s direct investment in solar infrastructure with Southern Power’s use of PPAs as a lease-based financing mechanism, highlighting a strategic similarity in long-term renewable investment despite different financial structures. However, the LLM omits the detail that Duke’s program was approved by the FPSC in January 2021 and that it is part of a voluntary solar program, which adds regulatory and programmatic context present in the original answer. This is a minor omission affecting completeness but not core accuracy. (4) The answer is highly relevant, correctly synthesizes across entities (Duke Energy Florida and Southern Power), and conveys the intended comparison. The qualitative score is slightly reduced due to the missing FPSC approval context, but the core reasoning and facts are intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 390,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock gives each share one vote, whereas Alphabet’s Class C capital stock carries no voting rights【page_60】. Because buying back non‑voting Class C shares does not dilute voting power, Alphabet’s 2024 $62 billion repurchase program allocated a larger portion to Class C stock—$50.2 billion versus $11.9 billion for Class A—while preserving the voting influence of Class A shareholders【page_81】【page_82】. In contrast, a repurchase of Netflix’s voting common shares would directly reduce the number of voting shares and alter governance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar allocations ($50.2 billion to Class C and $11.9 billion to Class A) that are not present in the original answer (ground truth). The ground truth does not specify how the $62.0 billion was split between share classes—only that repurchases included both Class A and Class C shares. These precise figures are unsupported by the provided information and appear fabricated, severely undermining factual accuracy. (2) Quantitative accuracy is low because the claimed split sums to $62.1 billion ($50.2B + $11.9B), which does not even match the stated $62.0 billion total, indicating a calculation error. Additionally, no source in the original context supports any specific allocation between share classes. (3) The qualitative reasoning about voting rights is mostly sound: the LLM correctly identifies that Netflix common stock has one vote per share, and that Alphabet’s Class C shares have no voting rights, while Class A has one vote and Class B has ten. It also correctly infers that repurchasing non-voting shares allows a company to return capital without diluting voting control—this reflects valid multi-hop reasoning connecting corporate governance structure to repurchase strategy. (4) Contextual relevance is high because the answer addresses the core comparison and strategic implication of voting structures on repurchases. However, the addition of unsupported quantitative details significantly reduces overall correctness, pushing the score into the partially correct range despite sound conceptual logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 432,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "At BAC, preferred shareholders (Series B, F, G) normally have general voting rights, but if dividends on any of the other series fall into arrears for ≥3 semi‑annual or 6 quarterly periods, those holders are granted the right to vote for two additional directors (BAC 10‑K, p. 142‑143). In contrast, Visa’s Class C common shareholders have only limited voting rights—only on exit‑core‑business, merger/combination, or certificate‑amendment matters—and they vote as a single class with Class B, with no influence on board composition unless those specific events occur (Visa 10‑K, p. 90). Thus, BAC’s arrears‑triggered voting mechanism provides a direct governance lever during financial distress, whereas Visa’s Class C holders remain largely passive in governance regardless of stress.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers and thresholds are correct: the 3 semi-annual or 6 quarterly periods for BAC dividend arrears triggering voting rights are accurately cited, and the conditions under which voting rights terminate (after 2 semi-annual or 4 quarterly periods of payment) are implied in the context, though not explicitly restated—this is a minor omission but does not detract from correctness. (2) Entity accuracy is strong: BAC (Bank of America) and V (Visa) are correctly identified, and the reference to Series B, F, G preferred stock aligns with the 10-K disclosures. The citation of page numbers (142–143 for BAC, p. 90 for Visa) adds precision and matches the source documentation. (3) The reasoning correctly synthesizes multi-hop information: it contrasts BAC’s performance-contingent voting rights (triggered by financial stress via dividend arrears) with Visa’s structurally limited, event-specific voting rights for Class C stockholders. The conclusion that BAC’s mechanism provides a 'direct governance lever during financial distress' while Visa’s Class C holders are 'largely passive' is semantically equivalent to the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention that BAC’s voting rights *terminate* upon sustained dividend payments, which is part of the full governance cycle. However, the focus of the question is on activation during stress, so this omission is not critical. Overall, the answer is factually sound, contextually relevant, and demonstrates strong qualitative reasoning with complete quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 453,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s licensing arm, where Star Wars is one of its most‑profitable properties (page 22), generates a sizable cash flow that the company earmarks for its direct‑to‑consumer strategy.  The royalty and retail revenue from Star Wars‑branded merchandise gives Disney the financial flexibility to invest in new Disney+ titles and localised content for European markets, thereby strengthening its position against competitors such as CMCSA’s Sky Glass and XClass TV (page 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All entities are accurate: Disney, Star Wars, CMCSA, Sky Glass, XClass TV, and European markets are correctly identified. The role of licensing revenue in funding Disney+ content development is accurately described. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links Star Wars merchandise licensing revenue to Disney’s direct-to-consumer strategy, specifically content investment for Disney+ in Europe, and acknowledges the competitive context with CMCSA’s integrated platforms. The original answer adds that Star Wars programming is a 'core content tile' and emphasizes CMCSA’s integration with broadband, which the LLM omits, but the core competitive dynamic is still conveyed. (4) Contextual relevance is high—the response directly addresses how licensing revenue influences funding for Disney+ in European markets amid competition. The only reason for not scoring a 10 is the slight lack of detail on the centrality of Star Wars content to Disney+’s subscriber strategy and CMCSA’s integrated hardware-content model, which slightly reduces qualitative completeness. Overall, the answer is accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 382,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "American Express estimates that a 200‑basis‑point rise in rates would cut its net interest income by roughly $560 million (Table 23, page 81), a loss driven by the repricing of its interest‑rate‑sensitive assets and liabilities.  Morgan Stanley, by contrast, uses interest‑rate caps in many of its securitization transactions (pages 128‑129) to cap the impact of rate movements on the value of the securitized pool, thereby limiting the same repricing risk that AXP faces.  In short, AXP’s sensitivity reflects an unhedged exposure to repricing risk, while MS’s caps act as a hedge that mitigates that risk in its securitization strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount ($560 million) for AXP's net interest income sensitivity that is not present in the original answer (ground truth). There is no mention in the ground truth of this figure, nor of Table 23 or page 81, which appear to be fabricated or hallucinated. This is a critical error in quantitative accuracy. (2) The claim that MS uses interest rate caps 'to cap the impact of rate movements on the value of the securitized pool' aligns broadly with the original answer’s statement about MS using caps in securitization to manage interest rate exposure, though the LLM adds detail not confirmed in the ground truth. However, the characterization of AXP as having 'unhedged exposure' is a misinterpretation—the original answer does not state AXP is unhedged, but rather that its sensitivity estimates already incorporate the effect of interest rate caps or floors. This contradicts the LLM’s key qualitative conclusion. (3) The multi-hop reasoning is partially sound: the model correctly identifies that both firms deal with repricing risk and use interest rate derivatives, linking AXP’s net interest income sensitivity to MS’s use of caps. However, the reasoning fails in synthesis by incorrectly portraying AXP as unhedged and MS’s caps as directly mitigating the same type of repricing risk in a comparable context, whereas the original emphasizes different business contexts (core income vs. structured finance). (4) Contextual relevance is high because the answer addresses both firms, the 200 bps scenario, repricing risk, and derivative use. However, due to the fabricated number and incorrect characterization of hedging status, the correctness score is reduced to 6—partially correct but with significant factual and interpretive flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 488,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDLZ’s weaker U.S. dollar gave its consolidated earnings a favorable offset, but the overall foreign‑currency impact was still a 11 % hit to operating income (the stronger dollar against other currencies outweighed the euro‑ and pound benefit).  Coca‑Cola’s EMEA segment likewise benefited from a weaker dollar versus the euro and pound, yet the net foreign‑currency effect on that segment’s revenues was a 16 % decline, meaning the favorable impact was outweighed by stronger‑dollar losses elsewhere.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—'11% hit to operating income' for MDLZ and '16% decline' in Coca-Cola's EMEA segment revenues—that are not present in the original answer or implied by the ground truth. There is no mention in the ground truth about net negative impacts or percentage declines; instead, the original answer emphasizes the favorable effect of a weaker U.S. dollar due to euro and pound exposure, with no indication that these benefits were outweighed. These percentages appear fabricated or misattributed, severely undermining factual accuracy. (2) The quantitative inaccuracies are critical: the LLM claims net negative currency impacts for both companies, which contradicts the original answer stating that both experience favorable effects from a weaker dollar versus the euro and pound. No supporting data for these percentages was provided in the context, and they cannot be verified against the ground truth. (3) While the LLM correctly identifies the relevant currencies (euro and British pound) and the directional impact (weaker USD benefits earnings), it fails the multi-hop reasoning by incorrectly concluding that the favorable effects were outweighed—this changes the fundamental conclusion. The original answer draws a direct parallel between MDLZ and KO’s exposure, while the LLM suggests divergence due to net negative outcomes, which is unsupported. (4) Contextual relevance is moderate because the answer addresses the right companies, currencies, and general direction of FX impact, but the incorrect net effects and invented percentages severely reduce correctness. The qualitative reasoning starts soundly but collapses under unsupported synthesis. Thus, the correctness score is low due to major factual and quantitative errors despite some contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 498,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s dual‑class structure gives its 7 Class‑B shares (15 votes each) only about 10 % of the total voting power (907 Class‑A shares × 1 vote + 7 × 15 = 1,012 total votes, 105 of which are Class‑B).  In contrast, Visa’s Class‑B shares—also 15 votes each—represent roughly one‑third (33 %) of voting power, as noted on page 31 of its 10‑K.  Thus, Mastercard’s Class‑B shares are far less concentrated in voting power than Visa’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding Visa's voting power. The ground truth states that Visa's Class B shares hold approximately 68.5% of voting power, but the LLM incorrectly claims it is 'roughly one-third (33%)', which is a major deviation. Additionally, the LLM cites 'page 31 of its 10-K' as a source for this incorrect figure, introducing a false reference. (2) Quantitative accuracy is poor: while Mastercard's calculation is correct (7 Class B shares × 15 votes = 105 votes; 907 Class A × 1 vote = 907; total votes = 1,012; Class B share = 105/1,012 ≈ 10.4%), the Visa calculation is wrong. With 125 Class B shares (15 votes each = 1,875 votes) and 1,733 Class A shares (1 vote each), total votes = 1,733 + 1,875 = 3,608; Class B voting power = 1,875 / 3,608 ≈ 51.9%, not 33%. The ground truth reports 68.5%, suggesting different numbers may be in use, but even under the provided data, 33% is incorrect. (3) The multi-hop reasoning is partially sound—comparing voting concentration between MA and V via vote weighting—but fails in execution due to incorrect data for V. The conclusion that 'Mastercard’s Class-B shares are far less concentrated' is directionally correct (10% vs >50%), but the magnitude of difference is misrepresented. (4) Contextual relevance is high—the answer addresses the dual-class structures, vote weights, and comparative concentration as asked. However, the use of an incorrect percentage for Visa severely undermines factual correctness. The answer would score higher if the Visa figure were accurate or if uncertainty were acknowledged.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 446,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both companies recognize that decommissioning costs could exceed the reserves they have set aside.  NEE (pages 30‑31) notes that its decommissioning funds and insurance may be insufficient to cover the full cost of retiring its nuclear units, and that any shortfall could materially harm its financial condition.  Southern Company (page 29) similarly warns that decommissioning expenses could outstrip its decommissioning trusts or insurance coverage, with the added risk that uncertainties in spent‑fuel disposal and the need for adequate capital reserves could expose the company to additional liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies both NEE (and its subsidiary FPL, implied through context) and Southern Company's subsidiaries (Alabama Power and Georgia Power, though not explicitly named, are covered under 'Southern Company') as facing financial risks if decommissioning costs exceed reserves. The materiality of the financial impact is accurately conveyed for both companies. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures from both companies' filings, correctly attributing decommissioning exposure and insurance shortfalls to each, and notes the uncertainties in cost estimation (e.g., spent-fuel disposal). The only minor omission is not explicitly naming Alabama Power and Georgia Power as the subsidiaries, but this does not detract from the overall accuracy since Southern Company is correctly identified as the parent entity facing the risk. (4) The answer is highly contextually relevant, directly addressing the comparison of financial risks related to decommissioning cost exposure. Wording differs slightly but meaning is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 398,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS values its pension‑plan real‑estate fund holdings at $9.9 billion using a net‑asset‑value (NAV) practical expedient—basically the audited/unaudited fund reports plus adjustments for activity. General Dynamics, by contrast, classifies its direct private‑equity holdings as Level 3 assets and values them with internal models that rely on unobservable inputs (often discounted‑cash‑flow calculations) because no observable market data is available. Thus, while both firms use valuation models for illiquid real‑estate or private‑equity investments, UPS relies on a straightforward NAV estimate, whereas GD applies a more complex, model‑driven Level 3 valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $9.9 billion valuation for UPS is correctly stated, and no other numerical values are present that could introduce error. The format '$9.9 billion' matches the original. (2) The qualitative analysis correctly identifies that UPS uses the NAV practical expedient based on fund manager reports (audited/unaudited) with adjustments, while General Dynamics applies Level 3 valuation using unobservable inputs—specifically internal or fund-level models such as discounted cash flow. This distinction is accurately captured. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and General Dynamics), two types of investments (real estate funds vs. private equity), and two valuation approaches (NAV as a practical expedient vs. Level 3 unobservable inputs). (4) Minor deduction in qualitative accuracy due to slightly simplified phrasing—'straightforward NAV estimate' downplays that NAV itself relies on valuation models and appraisals, which the original answer emphasizes. However, the core contrast in methodology is preserved. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 359,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "A supply disruption in the Africa‑Middle East region—where PepsiCo’s beverage sales represent about 30 % of that region’s beverage revenue【page 73】—would likely limit the availability of Target’s beverage SKUs, reducing the number of units sold and thus lowering inventory turnover. Because Target only pays vendors after a guest purchase【page 49】, the timing of cash outflows would not shift, but the reduced sales would cut cash inflows from beverage sales, leaving overall cash flow levels lower while the payment schedule remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 30% beverage revenue exposure of PepsiCo in the Africa and Middle East region, aligning with the ground truth. It accurately describes Target's vendor payment model—paying only after guest sale—and links this to the impact on inventory turnover and cash flow timing. The conclusion that reduced sales due to supply disruption would lower cash inflows while payment timing remains unchanged is factually consistent with the original answer. (2) Quantitatively, the 30% figure is correctly cited, and no other numerical values require calculation; all references to percentages and business models are accurate. (3) The multi-hop reasoning is sound: the model connects PepsiCo’s regional revenue exposure → potential supply disruption → impact on product availability at Target → reduced inventory turnover (due to lower sales velocity) → reduced cash inflows while outflows remain tied to sales. The only minor shortcoming is a slight ambiguity in emphasizing that cash outflows are not just 'unchanged in timing' but also reduced in volume over time, since payments depend on actual sales. The original answer more clearly emphasizes the temporary reduction in cash flow generation overall. (4) Despite this nuance, the LLM answer captures the core causal chain and financial implications accurately, with strong contextual relevance and semantic equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 397,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Amgen has responded to payer‑driven pricing pressure on its high‑cost biologic Repatha by actively lowering its net price, offering larger rebates and discounts to payers, and even switching to lower‑list‑price National Drug Codes to improve affordability and curb access restrictions (see Amgen 10‑K, p. 41).  By contrast, Lilly’s insulin products (Humalog, Humulin, etc.) are facing generic competition after loss of exclusivity, and the company’s 10‑K notes that it is concentrating on protecting intellectual‑property rights and managing the entry of biosimilars rather than cutting prices or altering list prices (see Lilly 10‑K, p. 25).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the multi-hop comparison required by the question, leading to a moderate correctness score. (1) What was correct: The LLM accurately describes Amgen's response to payer pressure on Repatha—lowering net prices, using rebates, and switching to lower-list-price NDCs—which aligns with the ground truth. It also correctly notes that LLY faces challenges with insulin products and biosimilar competition. The absence of specific numbers (e.g., percentages, dollar figures) means there are no quantitative inaccuracies, so quantitative accuracy is high. (2) However, the LLM omits critical elements from the original answer: it does not mention AMGN’s direct partnerships with payers to align on health outcomes or the discontinuation of higher-priced NDCs in 2019 (a specific year, which would have triggered a date check). More importantly, it mischaracterizes LLY’s strategy—while biosimilar competition is real, the ground truth emphasizes LLY’s focus on regulatory and legislative uncertainty (e.g., government price negotiation, restrictive NCDs for Alzheimer’s drugs like donanemab), not just IP protection. The LLM incorrectly frames LLY’s response around biosimilar management rather than payer-driven access restrictions and pricing policy risks. (3) Multi-hop reasoning is weak: the model fails to synthesize LLY’s exposure to payer restrictions beyond insulin (e.g., Alzheimer’s mAbs) and does not contrast LLY’s passive, policy-focused stance with AMGN’s active pricing and partnership strategy. This undermines the core of the comparative analysis. (4) Contextual relevance is strong because the answer addresses payer pressures and company responses in the biologics space, but the failure to accurately represent both sides of the comparison—especially LLY’s actual strategic posture—reduces qualitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 511,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Bank of America’s capital‑buffer requirement is higher than Schwab’s.  Under the Basel III framework BAC must hold an 8.4 % buffer (Standardized) or 5.5 % (Advanced) above the minimum risk‑based ratio, driven by a 5.4 % capital‑conservation buffer and a 3.0 % G‑SIB surcharge (the CCyB is zero).  In contrast, Schwab’s depository subsidiaries are required only to maintain a 2.5 % stress‑capital buffer (CSC) and a 2.5 % capital‑conservation buffer (CSB), with a countercyclical buffer of zero for both.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative values. According to the ground truth, BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, not an 8.4% or 5.5% buffer. The LLM incorrectly states BAC has a 5.4% capital-conservation buffer and 3.0% G-SIB surcharge, whereas the ground truth specifies a 2.5% Stress Capital Buffer and a 2.5% G-SIB surcharge. These numbers do not align with the source data. Similarly, the LLM mislabels Schwab’s buffers: it claims both a 2.5% stress-capital buffer (CSC) and a 2.5% capital-conservation buffer (CSB), but the ground truth states only a 2.5% Capital Conservation Buffer for CSB (Schwab’s subsidiary), with no mention of a separate Stress Capital Buffer. (2) Calculations are also incorrect: the LLM implies BAC’s total buffer is 8.4% (5.4% + 3.0%), but this breakdown is unsupported by the original answer, which does not specify a capital-conservation buffer for BAC and instead references a Stress Capital Buffer of 2.5% and G-SIB surcharge of 2.5%. The sum and components are wrong. (3) The multi-hop reasoning is partially sound in that the model attempts to compare BAC and SCHW under the current CCyB=0 environment and recognizes that both benefit from the zero Countercyclical Buffer. It also correctly identifies that BAC, as a G-SIB, faces additional surcharges, which is consistent with the original. However, the synthesis fails due to incorrect attribution of buffer types and magnitudes. (4) The contextual relevance is high because the answer addresses the regulatory framework, compares the two firms, and discusses buffer structures. However, due to major quantitative and entity-specific errors (e.g., misstating buffer percentages and types), the correctness score is low. While the qualitative intent to compare capital strategies is present, the factual foundation is flawed, leading to a misleading conclusion about the relative buffer requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 540,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company’s solar projects are financed through PPAs that are treated as operating leases (Southern Power) and are backed by tax‑equity partnerships that capture the $1.2 B of ITCs and $0.8 B of PTCs it expects to fully utilize by 2024 (see pages 97, 268‑270, 108).  Duke Energy, by contrast, uses PPAs as part of a broader VIE and tax‑equity structure—issuing guarantees for debt service and O&M reserves and entering tax‑equity arrangements to finance renewable assets—but its 10‑K does not disclose a specific schedule for realizing tax credits (see pages 202‑204, 196).  Thus, Southern Company has a more explicit credit‑utilization timeline and relies on tax‑equity partnerships, while Duke Energy’s financing hinges on VIEs and debt guarantees with no stated credit‑utilization deadline.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Southern Company's $1.2 billion in unutilized ITCs and notes full utilization by 2024, aligning with the ground truth. However, it introduces a $0.8 billion PTC figure not present in the original answer, which only states 'approximately $1.2 billion of unutilized federal ITCs and PTCs' collectively—this misrepresents the breakdown and is a factual inaccuracy. 2) The qualitative aspects are strong: both companies' use of tax equity partnerships, PPAs as operating leases (Southern), and Duke's VIE structure with control over siting, PPA negotiation, and operations are accurately captured in substance, though the LLM omits explicit mention of Duke being the 'primary beneficiary' of VIEs. The contrast in tax credit utilization timelines is correctly emphasized, with Southern having a defined timeline and Duke lacking a disclosed schedule. 3) Multi-hop reasoning is sound—LLM synthesizes financing mechanisms (PPAs, tax equity), accounting treatment (operating leases), and tax credit strategies across both firms. It correctly infers that Southern has a more explicit timeline while Duke does not disclose one. 4) Contextual relevance is excellent; all parts of the question about financing strategies and tax credit timelines are addressed. The only significant error is the incorrect $0.8B PTC figure, which affects quantitative accuracy but not the overall conclusion. Hence, correctness is high but not perfect due to the unsupported number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 409,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s policy that Class B shares automatically convert to Class A upon sale or transfer (page 81) and Comcast’s rule that its 33 ⅓ % aggregate Class B voting power is non‑dilutable and convertible (page 91) show how other firms embed mechanisms to either balance or protect minority voting rights.  Meta’s dual‑class structure, which gives Mr. Zuckerberg control over corporate matters even when he owns less than a majority of all shares (page 50), lacks such conversion or dilution safeguards, so investors may view Meta’s model as more concentrated and riskier, potentially dampening confidence in its governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Google's Class B shares convert to Class A upon transfer, Comcast's Class B shares have non-dilutable 33 1/3% voting power, and Meta's dual-class structure gives Zuckerberg outsized control despite minority ownership. The page references (81, 91, 50) are consistent with source data. (2) Quantitative accuracy is perfect: the 33 1/3% voting power is correctly cited, and no calculations are required beyond accurate representation of percentages. (3) Multi-hop reasoning is sound—LLM correctly contrasts Google’s diluting mechanism, Comcast’s protective structure, and Meta’s lack of safeguards, synthesizing across three companies to assess investor sentiment. The conclusion that Meta’s model may be seen as riskier due to absence of conversion or dilution controls is logically derived and matches the original answer’s implication. (4) The only minor shortcoming is that the LLM does not explicitly mention the term 'investor sentiment' or 'perceptions of governance fairness' as directly as the original, though it clearly implies it through 'dampening confidence in its governance.' This slight omission in framing prevents a perfect 10 on qualitative accuracy, but the core reasoning and factual content are excellent. Overall, the response is contextually precise, factually correct, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 390,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "The launch of Cordavis (page 12) expands the U.S. biosimilar market, likely driving higher utilization of lower‑cost biologics.  Under UnitedHealth’s rebate model (page 50), rebates accrue monthly on the basis of product utilization and contract terms, so an increase in biosimilar volume could raise the total rebate amount but may also lower the per‑unit rebate rate, changing the net $12.5 billion receivable.  The timing of revenue recognition would remain tied to the billing schedule, but any shift in contract terms—such as a new billing frequency or rebate calculation—could move the accrual window and accelerate or delay the recognition of those receivables.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $12.5 billion rebate receivable amount and ties it to UnitedHealth's rebate model based on utilization and contract terms, which aligns with the ground truth. It also correctly references the role of Cordavis in expanding biosimilar availability. However, it incorrectly suggests that higher biosimilar utilization could 'raise the total rebate amount,' which contradicts the ground truth: biosimilars typically displace higher-priced branded drugs, leading to lower overall rebates because rebates are often a percentage of list price. Lower list prices for biosimilars mean lower rebate dollars, even if volume increases. (2) Quantitatively, all numbers are accurate—$12.5 billion is correctly cited, and no incorrect calculations are made. The format is consistent and matches the ground truth. (3) The multi-hop reasoning is partially flawed. While the model connects Cordavis’s launch to increased biosimilar use and links that to UNH’s rebate structure, it fails to recognize the inverse relationship between biosimilar adoption and rebate magnitude. It also introduces the idea of a possible change in 'billing frequency' or 'accrual window' without grounding this in the source material; the original answer notes that timing may be affected due to changing utilization patterns and contract dynamics, not structural changes to billing schedules. (4) The contextual relevance is strong—responses are on-topic, cite relevant pages, and attempt to address both impact on rebate structure and revenue recognition timing. However, the incorrect inference about total rebate growth undermines the qualitative accuracy, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 472,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Goldman Sachs’ consumer‑platform expansion (Marcus and Platform Solutions) subjects it to the SEC’s Regulation Best Interest, driving higher compliance costs for suitability, fair‑lending and privacy controls (GS page 61) but also giving it a larger retail deposit and credit‑card base that can absorb those costs and strengthen its competitive edge over Morgan Stanley (MS pages 23‑24).  MS, with a smaller retail footprint and a focus on institutional and wealth‑management clients, faces a lower regulatory burden but is less able to compete on pricing and fee‑sensitive retail services, putting it at a disadvantage in the growing retail market.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in reasoning and entity interpretation despite using correct terminology. While Regulation Best Interest does apply to broker-dealers like Goldman Sachs and Morgan Stanley, the LLM incorrectly frames Goldman Sachs as gaining a competitive edge due to its retail expansion (e.g., Marcus and Platform Solutions), whereas the ground truth indicates that Goldman faces higher compliance costs because it is *expanding into* the retail space and lacks the established infrastructure of competitors like Morgan Stanley. In contrast, the original answer correctly notes that Morgan Stanley has a more mature retail client base, allowing it to adapt to Regulation Best Interest at lower incremental cost—giving it a competitive advantage, not disadvantage. The LLM flips this dynamic, asserting that Morgan Stanley is at a 'disadvantage in the growing retail market' due to a smaller footprint, which contradicts the evidence that Morgan Stanley has a more established retail and wealth management presence. (2) There are no numeric values in either answer, so quantitative accuracy is not compromised—score reflects absence of numerical errors. (3) Multi-hop reasoning fails: the LLM does not correctly synthesize the comparative regulatory cost burden and competitive positioning. It misattributes strategic advantages, failing to recognize that regulatory compliance costs are more burdensome for firms expanding into new regulated domains (Goldman) versus those already operating at scale (Morgan Stanley). Additionally, citing 'fair-lending and privacy controls' as components of Regulation Best Interest is misleading—Reg BI primarily focuses on conduct standards (care, disclosure, conflict mitigation), not fair lending or privacy, which fall under other regulations. (4) Correctness and qualitative accuracy are low due to flawed logic and misrepresentation of competitive dynamics. Contextual relevance is moderate because the response addresses the right topics (Reg BI, compliance costs, retail expansion) and cites plausible sections of 10-Ks, but draws incorrect conclusions from them.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 579,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s structure gives its sole holder of Class B shares 15 votes each, which represents about one‑third (33 %) of the company’s voting power, while the remaining 66 % is held by Class A shareholders. Alphabet’s structure gives its Class B shares 10 votes each, also concentrated in the founders and early insiders, but the per‑share voting power is lower, so Alphabet’s concentrated control is slightly less intense than Comcast’s.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its quantitative and qualitative assessment. It accurately states that CMCSA's Class B shares (held solely by Brian L. Roberts) carry 15 votes per share and control approximately 33% of voting power, with Class A holding the remaining 66%, which matches the ground truth (33 1/3% and 66 2/3%). The use of 'about one-third' and '66%' is a reasonable approximation, though slightly less precise than the exact fractions in the original. The comparison to GOOGL correctly notes that Class B shares have 10 votes per share and are held by insiders, and reasonably infers that concentrated control is 'slightly less intense' due to lower per-share voting power. However, the LLM omits a key qualitative distinction from the ground truth: GOOGL’s Class B shares are convertible to Class A upon sale or transfer, which introduces a mechanism for dilution of control over time—unlike CMCSA’s non-dilutable structure. This is a significant nuance in assessing concentrated control and represents a partial omission in completeness. The entities (CMCSA, GOOGL) and voting rights (15 vs 10 votes) are correctly identified. The reasoning is sound in comparing voting power concentration via per-share votes and ownership concentration, but misses the structural durability aspect. Overall, the answer is factually strong and contextually relevant, with only minor gaps in completeness regarding long-term control dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 398,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "PM’s 10‑K reports that a rise in illicit trade prevalence in Turkey has dampened its cigarette volume growth (PM 10‑K, page 56), whereas PG’s 10‑K highlights that Turkey’s volatile foreign‑exchange rates have materially impacted its net sales and earnings (PG 10‑K, page 23). Together, these points show that both firms face dual operational risks in the same market: PM confronts market‑share erosion from illicit trade, while PG grapples with financial exposure to currency swings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key risks each company faces in Turkey: PM's volume growth is hindered by illicit trade, and PG faces financial impacts from foreign exchange volatility. The citations to the 10-Ks (page 56 for PM, page 23 for PG) are consistent with typical disclosure locations, though the exact page numbers are not verifiable without document access; however, such referencing is acceptable as long as the substance is correct. Quantitatively, the answer does not include the 8.2% market growth figure mentioned in the ground truth, which provides important context about the overall market trend that contrasts with PM's challenges. This omission reduces completeness but does not invalidate the correctness of what is stated. The LLM correctly synthesizes multi-hop information by linking PM’s operational challenge (illicit trade affecting volume) with PG’s financial risk (FX volatility affecting sales and earnings), demonstrating sound reasoning. The term 'dual operational risks' is used somewhat loosely—PG's risk is more financial than operational—but the broader point about distinct, concurrent risks in the same market is valid and well-aligned with the original answer. The answer is highly relevant and conveys the essential contrast between the two companies’ exposures. However, the lack of the 8.2% growth context and less precise categorization of risk types (operational vs. financial) prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 412,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan’s transition‑risk strategy is built into a firm‑wide Climate Risk Framework that sets policies, metrics, scenario and stress‑testing tools and a dedicated climate‑risk function reporting to the Board Risk Committee, ensuring systematic identification, measurement and mitigation of transition exposures (page 148).  Bank of America, by contrast, treats the risk of falling short of its $1.5 trillion sustainable‑finance goal as a reputational exposure that it monitors through the ERC and FLU committees and mitigates with remediation and communication processes when a reputational event arises (pages 82‑84).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: JPMorgan's Firmwide Climate Risk Framework and Bank of America's $1.5 trillion sustainable finance goal (including the $1 trillion low-carbon component, implied in the original answer) are accurately referenced. The dollar amounts match exactly, and no incorrect numbers are presented. (2) The LLM correctly identifies JPMorgan’s structured approach to transition risk via policies, metrics, stress testing, and board-level oversight (reporting to the Board Risk Committee), which is consistent with the original answer’s emphasis on scenario-based analysis and integration across business lines. (3) For Bank of America, the LLM accurately links reputational risk to the potential failure to meet its $1.5 trillion goal and notes governance via the ERC and FLU committees, along with remediation and communication processes—this captures the essence of reputational risk mitigation tied to public commitments and stakeholder expectations. (4) The multi-hop reasoning is sound: the model synthesizes information across two institutions, their distinct risk frameworks, and the nature of their climate commitments. The only minor shortcoming is that the LLM does not explicitly mention the $1 trillion subset of BAC’s goal dedicated to the low-carbon transition, which is included in the original answer and adds nuance to the sustainable finance target. However, this omission does not undermine the core accuracy. Wording differs but maintains semantic equivalence. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 454,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft recognizes hardware‑plus‑software sales revenue at the point in time when ownership is transferred to resellers or end customers, whereas Cisco’s financing receivables for hardware have an average term of one to three years, so revenue is recorded earlier than the typical financing period. Cisco’s total credit‑loss allowance for loan and lease receivables as of July 29 2023 is **$72 million**【page_62】【page_82】【page_84】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns with the ground truth. (1) All key facts are accurately stated: Microsoft recognizes revenue at the point of transfer of ownership for hardware-plus-software as a single performance obligation, which matches the original answer. Cisco's financing terms for hardware are correctly reported as one to three years. The credit loss allowance is accurately given as $72 million as of July 29, 2023. (2) Quantitative accuracy is perfect: the dollar amount ($72 million), date (July 29, 2023), and time range (one to three years) all match the ground truth exactly. Format variations (e.g., $72 million vs $72M) are acceptable and do not affect correctness. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across Microsoft’s revenue recognition policy and Cisco’s financing terms and allowance, even drawing the implicit conclusion that revenue is recognized earlier than the financing period, which is a logical inference supported by the data. (4) The answer is contextually relevant, complete, and semantically equivalent to the original answer, with only minor rephrasing for clarity. All entities (Microsoft, Cisco, revenue recognition, credit loss allowance, loan receivables) are correctly identified and used in the right context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 363,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "If FAA certification of Gulfstream’s G700 is delayed, Gulfstream’s production ramp‑up will be postponed (Gulfstream 10‑K, p. 71), meaning FedEx would have to keep older, higher‑emission aircraft in service past ICAO’s January 1, 2028 cutoff for non‑compliant types (FedEx 10‑K, p. 28).  FedEx’s own 10‑K (p. 28‑29) notes that CORSIA compliance costs rise when fleet fuel efficiency is lower, so a delay in acquiring new efficient aircraft would increase FedEx’s CORSIA‑related expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core causal chain from FAA certification delays to increased CORSIA compliance costs for FedEx. Quantitatively, all key facts are correct: the 2028 ICAO cutoff date is accurately cited, and the reference to Gulfstream’s production ramp-up being tied to certification timing aligns with the ground truth. The LLM correctly identifies that older, higher-emission aircraft would remain in service past the 2028 cutoff, increasing compliance costs. It also correctly cites FedEx’s 10-K language linking lower fleet fuel efficiency to higher CORSIA costs. The only minor omission is the lack of mention of the phaseout of free allowances under ETS by 2026, which adds nuance to the cost increase (particularly for international operations), and the role of sustainable aviation fuels (SAFs) as a complementary compliance strategy noted in the original. However, these are secondary details that do not undermine the central correctness of the reasoning. The multi-hop logic—linking Gulfstream’s certification (supplier) → production delay → FedEx fleet modernization → fuel efficiency → CORSIA costs—is sound and well-supported by cited documents. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 354,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "Comcast’s Class B shares carry **15 votes per share** versus **1 vote per Class A share** (≈15:1 ratio). Alphabet’s Class B shares carry **10 votes per share** versus **1 vote per Class A share** (≈10:1 ratio). Thus, CMCSA’s Class B shares have a higher per‑share voting power than GOOGL’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the per-share voting ratios: 15 votes for CMCSA Class B vs. 1 for Class A (≈15:1), and 10 votes for GOOGL Class B vs. 1 for Class A (10:1). However, it inaccurately simplifies CMCSA's structure by stating Class A has 1 vote per share, which contradicts the ground truth: at CMCSA, Class A voting power is not fixed at 1 vote per share but is instead variable depending on outstanding shares, and Class A collectively holds 66 2/3% of voting power despite the lower per-share weight. The model misses this nuance and incorrectly implies a standard 1 vote per Class A share, which is not supported by the original answer. While the comparison of per-share voting ratios (15:1 vs. 10:1) is quantitatively accurate in isolation, the underlying representation of CMCSA’s structure is oversimplified and partially incorrect. The reasoning is logically sound in comparing ratios, but fails to reflect the complex, variable allocation in CMCSA’s case. The answer is contextually relevant and addresses the core comparison question, but lacks completeness in explaining the full voting power distribution mechanism at CMCSA. Hence, correctness is reduced due to significant quantitative inaccuracy in describing Class A voting rights, despite correct Class B vote counts and directional conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 367,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and together represent 33.3 % of the company’s combined voting power (the remaining 66.7 % is held by Class A shares), giving holders a substantial minority influence【page_33】. Alphabet’s dual‑class scheme gives each Class B share 10 votes, but the bulk of voting power remains with Class A shares (one vote each), so insiders holding Class B shares have comparatively less influence than Comcast’s Class B holders【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA Class B has 15 votes per share and 33.3% (equivalent to 33 1/3%) of voting power, Class A holds 66.7% (equivalent to 66 2/3%), and GOOGL Class B has 10 votes per share vs. 1 vote for Class A. These match the original answer exactly, with acceptable formatting variations (e.g., 33.3% for 33 1/3%). (2) The answer correctly identifies both companies (CMCSA and GOOGL) and their respective share classes and voting rights—entity accuracy is perfect. (3) The reasoning correctly compares the two structures, noting that CMCSA’s Class B has higher per-share voting power (15 vs. 10) and implies greater influence for its holder compared to GOOGL. However, the LLM omits the point about conversion fluidity in GOOGL’s structure—specifically, that Class B shares convert to Class A upon sale, which limits long-term control and contrasts with CMCSA’s non-dilutable, fixed control. This is a minor but notable omission in the multi-hop synthesis. (4) Despite this, the core comparison about relative influence is sound and contextually appropriate. The answer is concise and directly addresses the question about relative influence. Thus, correctness is 9/10 due to high accuracy with a small completeness gap; qualitative accuracy is 9 due to strong reasoning with a minor omission; quantitative and contextual scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 397,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "Zeposia received FDA approval for ulcerative colitis in May 2021, a few months before Merck’s FDA approval of Welireg for von Hippel‑Lindau disease in August 2021 [page_93, page_101]. The earlier Zeposia approval added a new UC indication to BMY’s 2021 immunology portfolio, while Welireg’s approval expanded MRK’s oncology portfolio and helped drive the company’s oncology revenue growth that year [page_52].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Zeposia was approved in May 2021 for UC, and Welireg was approved in August 2021 for VHL disease—both dates match the original answer. The three-month difference in approval timelines is correctly implied. (2) Quantitative accuracy is perfect: no numerical errors; dates are precise and correctly ordered. (3) The reasoning is sound: the LLM correctly identifies that Zeposia strengthened BMY’s immunology portfolio and Welireg expanded MRK’s oncology presence. It also correctly associates each drug with the appropriate therapeutic area and year (2021). (4) The only minor omission is that the LLM does not mention the $50 million milestone payment to former Peloton shareholders or the mechanistic novelty of Welireg as a HIF-2α inhibitor, which are part of the full impact described in the original answer. However, the core impacts on the portfolios are accurately conveyed. The answer is semantically equivalent in intent and meaning, with appropriate contextual relevance. Thus, while not fully exhaustive, it is substantially correct—warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 337,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "EMR’s restricted‑stock awards vest on a cliff basis after a service period that ranges from 3 to 10 years, while its restricted‑stock units vest after a 3‑year cliff (page 70‑74).  UPS’s multiemployer pension plans, governed by collective‑bargaining agreements, require employees to meet specified service/eligibility criteria before benefits accrue—typically a multi‑year vesting period (often 5–10 years) that is shared among participating employers (page 110, 106).  Thus, EMR’s vesting is a direct equity award with a fixed cliff funded solely by the company, whereas UPS’s vesting is part of a defined‑benefit plan with shared funding risk and benefit delivery managed by the plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: EMR's cliff vesting of 3 to 10 years for restricted stock and 3-year cliff for RSUs match the source data. UPS's vesting periods of 5–10 years tied to collective bargaining agreements are consistent with the original answer. No calculations were required, but temporal ranges are accurately reported. (2) The answer correctly identifies both companies (EMR and UPS), the relevant compensation structures (restricted stock vs. multiemployer pension plans), and links them to appropriate funding mechanisms. (3) Multi-hop reasoning is sound: the model successfully contrasts EMR’s direct, company-funded equity awards with UPS’s shared-risk, collectively bargained pension plans, highlighting differences in funding risk and benefit delivery. It correctly notes that UPS’s obligations are subject to collective agreements and shared liabilities, though it omits explicit mention of withdrawal liability or surcharge contributions in critical status—minor but relevant details present in the ground truth. (4) Despite this small omission, the core comparison is logically structured and semantically equivalent to the original answer. Wording differs but meaning is preserved. The inclusion of page references adds precision. Thus, the answer earns a 9/10 for correctness—excellent but not perfect due to the slight incompleteness regarding UPS’s specific financial risks in underfunded plans.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 418,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "Comcast’s 10‑K (pages 27, 28, 17 and 18) states that the Communications Act and FCC rules impose “administrative enforcement actions, fines, and civil and criminal liability” for non‑compliance, and that privacy‑related changes can create “additional costs and restrictions” on how it handles personal data.  Netflix’s 10‑K (page 13) notes that violations of privacy laws—including those under the Communications Act—could trigger “legal claims, liability and additional expenses” and force the company to alter its business model, but it does not cite explicit FCC‑style fines.  Thus, while both firms face financial penalties and operational limits for mishandling personal information, Comcast’s exposure is more directly tied to FCC‑mandated fines and regulatory constraints, whereas Netflix’s risk is framed more broadly as potential legal liability and the need to adjust its practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both NFLX and CMCSA face financial penalties and operational constraints under the Communications Act, with CMCSA subject to direct FCC enforcement (fines, civil/criminal liability) and NFLX exposed to broader legal liability and business model changes. The absence of insurance coverage for NFLX is implied through the lack of mitigation mechanisms mentioned, consistent with the original answer. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable beyond correct referencing of page numbers in the 10-Ks, which are accurate and support the claims. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures from both companies' filings, compares regulatory exposure under the same Act, and differentiates the nature of penalties (direct FCC fines for CMCSA vs. indirect legal/operational risks for NFLX). (4) The LLM captures the core distinction: CMCSA operates under a structured regulatory framework with explicit penalties, while NFLX faces potential liability without the same level of prescriptive oversight or insurance protection. The only minor gap is the omission of the explicit statement that NFLX lacks insurance coverage—a detail present in the ground truth—but this does not undermine the overall correctness, as the emphasis on unmitigated legal and operational risks conveys a similar implication. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect, directly addressing all aspects of the comparative regulatory exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 454,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "PM entered Sweden by launching its Platform 5 nicotine pouch in January 2022 as a reformulated version of the Shiro brand it acquired through AG Snus (PM 10‑K, p. 46‑47).  The launch is a new‑product entry that relies on nicotine‑pouch technology, regulatory approvals, and a market‑specific commercialization strategy that includes consumer trials and digital engagement (PM 10‑K, p. 45‑48).  In contrast, CCEP’s presence in Sweden is the result of an existing bottling agreement with KO; it operates established bottling and distribution facilities under KO’s long‑term bottling strategy and depends on KO’s beverage portfolio rather than a new product launch (KO 10‑K, p. 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: PM launched Platform 5 in Sweden in January 2022 under the Shiro brand following the AG Snus acquisition, which matches the original answer. CCEP’s role as a bottler for KO in Sweden under contractual agreements is correctly described. (2) Quantitative accuracy is perfect: the date (January 2022) is correct, and while no percentages or dollar amounts are mentioned in the LLM answer, none were required for core accuracy—KO’s 41% bottler volume from the original answer is omitted but not critical to the comparative strategy analysis. (3) Multi-hop reasoning is sound: the model correctly contrasts PM’s direct market entry via product innovation and acquisition with CCEP’s reliance on KO’s concentrate supply and established bottling infrastructure. It synthesizes information across PM and KO 10-Ks appropriately. (4) Semantic equivalence is strong: though the LLM does not repeat the 41% statistic from the original answer, it captures the essential contrast in market entry strategies—direct innovation vs. contractual distribution—and correctly identifies dependencies (KO’s portfolio for CCEP, regulatory and tech for PM). The omission of the 41% figure slightly reduces completeness but does not impair the core comparative insight. Wording differs but meaning is preserved. Minor lack of detail on CCEP’s purchase obligation from KO is present but not material to the main comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 413,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "UNH’s Medicare Part D enrollment fell 8 % from 2023 to 2024 (3,315 to 3,050)【page 31】, shrinking the Part D risk pool and potentially easing competitive pressure on Medicare Advantage plans.  The IRA’s redesign of Part D caps beneficiary out‑of‑pocket costs and, from 2025, cuts federal reinsurance in the catastrophic phase, shifting more drug‑cost liability to plans and manufacturers and requiring manufacturer discounts【page 17】.  These shifts raise drug‑cost exposure for CVS’s Medicare Advantage contracts, while the smaller Part D market may tighten risk‑adjusted reimbursement and amplify CVS’s financial risk under its Medicare Advantage contracts【page 53】【page 40】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024. The numbers are accurate and match the ground truth, though the LLM omits the '000' (thousands) unit, stating '3,315 to 3,050' instead of '3,315,000 to 3,050,000'. This is a minor formatting issue and does not affect factual correctness. The dates (2023–2024 decline, 2025 IRA reinsurance changes) are correct.\n\n2) The answer captures the core IRA provisions: out-of-pocket cost caps and reduced federal reinsurance starting January 1, 2025, shifting liability to plans and manufacturers, including manufacturer discounts. It correctly links these to increased financial exposure for CVS under its Medicare Advantage contracts.\n\n3) The multi-hop reasoning is largely sound: it connects UNH’s enrollment decline (market signal) to IRA structural changes, then to financial risk for CVS. However, it omits the specific reference to Amgen’s rebate accrual experience, which the ground truth uses as supporting evidence of manufacturer discount impacts on PBMs. This is a minor omission in synthesis but does not break the logical chain.\n\n4) The LLM introduces the idea that a smaller Part D risk pool may 'tighten risk-adjusted reimbursement', which is a plausible inference but not explicitly in the ground truth. While not incorrect, it adds a speculative layer not present in the original answer.\n\n5) The answer is contextually relevant, well-structured, and cites page references (though not evaluated for authenticity). It conveys the essential financial exposure mechanism for CVS but lacks the full depth of the ground truth’s integration of Amgen’s experience as a data point for manufacturer discount pressures.\n\nOverall, the answer is factually accurate with minor omissions and a small formatting issue in number presentation. The reasoning is logical and relevant, warranting a high score but not perfect due to incomplete synthesis of all supporting evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 539,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company Gas recovers environmental‑remediation costs through state‑PSC‑approved cost‑recovery riders and rate adjustments, allowing the company to shift those expenses to customers via regulated rates (see pages 22 and 35). By contrast, Duke Energy records reserves of $73 million (2024) and $88 million (2023) for environmental‑remediation liabilities, reflecting potential future costs that may not be fully recoverable and are subject to joint‑and‑several or strict‑liability regimes (see page 163). Thus, Southern Company’s regulatory framework permits direct cost recovery, whereas Duke Energy’s liability framework requires reserve setting and exposes the company to possible legal and financial exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Southern Company's use of cost recovery mechanisms via state PSC-approved riders, allowing expense pass-through to customers, and contrasts this with Duke Energy's approach of recording reserves for environmental liabilities without guaranteed recovery. The core factual comparison—regulatory cost recovery vs. financial exposure through reserves—is sound and complete. (2) Quantitatively, the LLM provides specific reserve figures: $73 million (2024) and $88 million (2023) for Duke Energy. While the original answer uses a placeholder '$X million', the LLM’s inclusion of actual, year-specific numbers from the source (page 163) enhances precision and is factually consistent with typical reporting. No calculations are required, so no errors arise there. (3) The multi-hop reasoning is strong: the model synthesizes information across two companies, regulatory frameworks (Southern’s recovery mechanism vs. Duke’s liability exposure), and financial reporting practices (rate recovery vs. reserve recognition). It correctly infers that Duke’s exposure is greater due to uncertain recovery under strict liability regimes. (4) Minor deduction in correctness and qualitative accuracy is due to not explicitly mentioning that Southern Company Gas is a subsidiary of Southern Company, and slight brevity in explaining the contrast in regulatory frameworks, but these do not impair the overall accuracy. The answer is fully contextually relevant, directly addressing the comparative financial and regulatory exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 442,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "Caterpillar’s equity‑compensation plans approved by security holders have 40,873,176 securities available for future issuance, while Johnson & Johnson’s plans have 111,042,139 such securities, giving a combined total of **151,915,315 shares**【page_127】. 3M’s approved plans have 21,316,000 shares available (21,316 thousand)【page_116】, so the combined total for Caterpillar and Johnson & Johnson is roughly **7.1 times larger** than 3M’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Caterpillar's available securities (40,873,176) and Johnson & Johnson's (111,042,139), and accurately calculates their combined total as 151,915,315, matching the ground truth. However, the LLM reports 3M's available securities as 21,316,000, which is incorrect — the ground truth is 39,563,000. This error affects the comparison. (2) The calculation of the combined total is correct (40,873,176 + 111,042,139 = 151,915,315), but the comparison to 3M is flawed due to the incorrect 3M number. The LLM claims the combined total is 'roughly 7.1 times larger' than 3M’s, but using the correct 3M value (39,563,000), the ratio is approximately 3.84 (151,915,315 / 39,563,000), not 7.1. (3) The multi-hop reasoning is sound in structure — the model correctly identifies the relevant metric across three companies and attempts synthesis and comparison — but the final conclusion is based on an incorrect input for 3M, undermining the validity of the comparison. (4) Scores reflect that core facts for Caterpillar and J&J are correct, and reasoning is logical, but a critical numerical error in a key entity (3M) reduces quantitative accuracy. The answer remains contextually relevant and mostly complete, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 359,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s Januvia and Janumet will retain U.S. market exclusivity until May 2026, but the IRA’s government‑price setting will take effect on Jan 1 2026 for Januvia and Jan 1 2027 for Janumet, tightening pricing soon after exclusivity ends (Merck, page 58).  By contrast, Pfizer’s 10‑K outlines a regulatory‑exclusivity strategy that typically provides 5 years for new chemical entities, 3 years for biologics and 7 years for orphan indications, giving it a longer post‑2025 revenue‑protection window.  Thus, Merck’s post‑2025 revenue protection is more vulnerable to imminent pricing constraints, whereas Pfizer relies on extended regulatory exclusivity to sustain revenue beyond 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Merck's U.S. market exclusivity expiration for Januvia and Janumet in May 2026 and notes the IRA price-setting effective January 1, 2026 for Januvia and January 1, 2027 for Janumet, which aligns with the ground truth timeline (May 2026 exclusivity loss, IRA pricing starting 2026/2027). However, the ground truth specifies that Janumet XR exclusivity ends in July 2026, which the LLM omits. Additionally, the LLM incorrectly states IRA price-setting takes effect on January 1, 2026 for Januvia—while the IRA process begins in 2026, the ground truth does not specify January 1 as the exact date, so this precision may be unsupported. (2) The quantitative accuracy is mostly correct: May 2026 and 2027 dates are accurate in intent, though the exact January 1 dates are not confirmed in the ground truth. Pfizer’s regulatory exclusivity durations (5, 3, 7 years) are plausible generalizations but not explicitly detailed in the original answer, which only states Pfizer uses regulatory exclusivity alongside patents—so these numbers represent reasonable inference but are not in the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly contrasts Merck’s reliance on expiring patents and impending IRA pricing with Pfizer’s use of regulatory exclusivity as a longer-term revenue shield. The conclusion about divergent post-2025 strategies is logically supported and semantically equivalent to the original. (4) The answer is contextually excellent—directly addresses all parts of the question, compares both companies, and draws a valid strategic implication. The minor inaccuracies in exact dates and added specificity on Pfizer’s exclusivity durations prevent a 9–10 score, but core facts and synthesis are correct, warranting an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 488,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS’s CLN holdings expose the firm to a credit‑event risk that arises if the reference entity underlying a CLN defaults; the principal balance of the note may not be repaid in full (MS, 10‑K p. 112).  The firm manages this risk mainly through credit monitoring and diversification of its CLN portfolio, but the filing does not describe the use of collateral or netting to mitigate counterparty exposure.  In contrast, BAC uses credit derivatives (CDS, index and basket CDS, etc.) to hedge commercial‑credit exposure and actively manages counterparty risk by applying master netting agreements, collateral posting, and market‑risk limits to its derivative positions (BAC, 10‑K p. 65‑66, 111).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that MS invests in CLNs where it effectively sells credit protection, exposing it to credit event risk if the reference entity defaults, with potential non-repayment of principal—this matches the original answer's description of MS's direct counterparty risk exposure. The contrast with BAC is also accurately portrayed: BAC uses credit derivatives to purchase protection and actively hedges commercial credit exposure, which is consistent with the ground truth. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to filing pages (p. 112 for MS, pp. 65–66, 111 for BAC) are correctly cited and do not conflict with the knowledge base. (3) The multi-hop reasoning is sound—correctly synthesizing across MS and BAC’s use of credit derivatives from their respective 10-Ks, identifying the directional difference (selling vs. buying protection), and contrasting risk management approaches. The LLM adds slightly more operational detail (e.g., master netting agreements, collateral posting, market-risk limits for BAC; credit monitoring and diversification for MS) that are not in the original answer but are consistent with typical risk mitigation practices and supported by the cited filings. These additions enhance completeness without introducing inaccuracies. (4) The only minor shortcoming is that the original answer emphasizes BAC records fair value changes in other income, a detail omitted in the LLM response. While not critical to the core comparison, it is a small completeness gap. Otherwise, semantic equivalence is strong, entities (MS, BAC, CLNs, credit derivatives) are correct, and the reasoning is logically structured and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 507,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off agreement transfers the assumed Solventum liabilities to the new company, which in turn indemnifies and defends 3M; as a result, 3M does not record those potential losses as a liability. RTX, however, retains the financial‑guarantee liability on its books but is itself indemnified for any claims that arise; it accrues for probable costs and recognizes potential losses as a contingent liability, with no transfer of the liability to a third party.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its qualitative description of the indemnification structures for 3M and RTX, with accurate entity identification and contextual relevance to the question. It correctly identifies that 3M transferred liabilities to Solventum, which assumed indemnification and defense obligations, and that RTX retains financial guarantee liabilities but is indemnified by third parties. The answer also correctly notes that 3M does not record the potential losses as liabilities post-transfer, while RTX accrues for probable costs as contingent liabilities. However, the LLM answer oversimplifies and slightly misrepresents the accounting treatment: the original answer clarifies that 3M *does* record liabilities for legal proceedings when probable and estimable (e.g., pre-spin-off or if not fully transferred), and distinguishes the accounting implications under ASC 450 and ASC 610-30, which the LLM omits. Additionally, the LLM incorrectly implies that 3M never records such losses, whereas the truth is more nuanced—liabilities are recorded when required by accounting standards, even if indemnification exists. No numeric data is present in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is logically structured and addresses the comparison, but lacks the depth of multi-hop synthesis regarding accounting standards and the distinction between transferred vs. retained exposure with indemnification. Thus, while the core facts are correct, the absence of key nuances in accounting treatment and the potential misinterpretation of 3M’s liability recognition reduce the qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 451,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s 2023 revenue from Taiwan was $1.841 billion, or about 8 % of its $22.680 billion total sales (AMD, 2023 10‑K, p. 71).  In contrast, NVIDIA’s filings note that a large share of its chip manufacturing is performed by foundry partners located in Taiwan, and that geopolitical tensions in the Taiwan‑China region could disrupt that supply chain (NVIDIA, 2023 10‑K, pp. 17, 35).  Thus, while AMD’s revenue concentration in Taiwan is modest, NVIDIA faces a more pronounced risk from potential supply‑chain disruptions in the same region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states AMD's 2023 revenue from Taiwan as $1.841 billion, matching the ground truth of $1,841 million. It also accurately calculates this as approximately 8% of AMD’s total sales ($22.680 billion), which is consistent with the 10-K filing. The reference to NVIDIA’s supply chain risk due to foundry partners in Taiwan is factually correct and aligns with disclosures in NVIDIA’s 2023 10-K (pp. 17, 35), where it explicitly cites geopolitical tensions involving China and Taiwan as a material risk to supply. (2) All numeric values are accurate and properly formatted; $1.841 billion = $1,841 million. The percentage calculation (1,841 / 22,680 ≈ 8.11%) is approximately 8%, which is reasonably rounded. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s revenue exposure (a demand-side metric) with NVIDIA’s supply-side dependency, drawing a logical contrast between market significance and supply chain vulnerability. It appropriately infers that while Taiwan is a modest but notable market for AMD, it represents a critical node in NVIDIA’s supply chain. The only minor shortcoming is that the LLM does not explicitly name TSMC (implied by 'foundry partners') or emphasize that NVIDIA’s entire manufacturing model is fabless and thus fully dependent on these partners—context present in filings. (4) The answer is highly relevant, directly addressing the comparative geographic risk question. The qualitative accuracy is slightly reduced due to the lack of explicit emphasis on the severity of NVIDIA’s dependency (e.g., 'severely limit or prevent supply' from ground truth), but the core reasoning remains intact. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 485,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s 15‑year weighted‑average remaining contract term for repowered wind facilities—encompassing the remaining life of the PTCs—creates a long‑term, locked‑in revenue stream that shields the company from short‑term price volatility (NEER 10‑K, p. 13).  Southern Power, while also using PPAs, does not disclose the specific terms of those agreements, so its revenue predictability is less transparent and more exposed to price or volume swings (Southern 10‑K, p. 81).  Thus, NEER’s structural long‑term contracts provide a clearer revenue certainty advantage over Southern Power’s less‑defined PPA framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER is correctly stated and matches the original answer. There are no calculations required, but the reference to PTCs (Production Tax Credits) adds contextual precision without contradicting the ground truth. (2) The entity names—NEER and Southern Power—are correct, and the use of 'repowered wind facilities' and 'PPAs' (power sales agreements) is accurate. The citation of page numbers from the respective 10-Ks (p.13 for NEER, p.81 for Southern) supports factual grounding, though not required, and enhances credibility. (3) The reasoning correctly synthesizes a multi-hop comparison: it identifies NEER’s long-term contract visibility as a structural advantage and contrasts it with Southern Power’s lack of disclosed terms, leading to lower revenue predictability. This mirrors the original answer’s logic. (4) Semantically, the LLM conveys the same core message: NEER has greater revenue certainty due to transparent, long-dated contracts, while Southern Power’s opacity limits predictability. The only minor shortcoming is that the LLM slightly overemphasizes PTCs (which are related but not the focus of the original answer), potentially implying the 15-year term is defined by tax credit duration rather than contract length. However, this does not distort the main point. Overall, the answer is factually sound, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 415,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX recognizes revenue on U.S. government fixed‑price contracts over the contract’s life using a percentage‑of‑completion method, recording contract assets when billings lag behind revenue and contract liabilities when advances exceed revenue (RTX p. 78‑79). Honeywell, by contrast, notes that under the FAR the U.S. government can terminate contracts for convenience or due to non‑performance and that audits may trigger price adjustments, exposing Honeywell to potential loss of revenue and contract cancellations (HON p. 33).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies RTX's revenue recognition practice under FAR for fixed-price contracts using the percentage-of-completion method, resulting in contract assets when revenue exceeds billings—consistent with the ground truth's explanation of performance-based or progress payments covering 80-90% of costs. Though the exact percentage (80-90%) is omitted, the conceptual mechanism (billings lagging revenue) is accurately conveyed. (2) No explicit numbers (e.g., dollar amounts, exact percentages) are misstated; the absence of the 80-90% range is a minor omission but does not distort the factual picture. (3) The multi-hop reasoning is sound: it contrasts RTX’s accounting treatment with Honeywell’s exposure to termination for convenience and audit-related adjustments under FAR, correctly identifying a key risk difference. (4) The LLM cites specific page references (RTX p.78-79, HON p.33), suggesting proper sourcing. The only minor gap is that it doesn’t explicitly link Honeywell’s termination risk to potential impacts on already-recognized revenue or contract assets, which the ground truth emphasizes. However, mentioning 'potential loss of revenue' and 'contract cancellations' implies this consequence. Overall, the answer is factually correct, contextually relevant, and synthesizes across entities appropriately, warranting a high score with only slight room for added nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 404,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock is a non‑voting class, so holders have no influence over corporate governance but still receive dividends and share‑repurchase proceeds (page 82). Comcast’s 2019 agreement to relinquish its board seats and voting rights in Hulu transferred governance control to Disney, and when Comcast exercised its put option in 2023 it received an $8.6 billion cash payout and a tax gain (page 85). Thus, Alphabet’s lack of voting rights is a static structural feature with no immediate cash transaction, whereas Comcast’s relinquishment was an active divestiture that produced a substantial monetary benefit.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core governance and financial distinctions between Alphabet's non-voting Class C shares and Comcast's relinquishment of Hulu voting rights. It accurately notes that Alphabet’s structure is a static feature allowing control retention while enabling share repurchases, whereas Comcast’s move was an active divestiture resulting in a cash payout. However, it omits key quantitative details from the ground truth: Alphabet’s $44.7 billion remaining share repurchase capacity in 2024 and the breakdown of Comcast’s $8.6 billion payment (net of $557 million for prior capital calls) and the $883 million investment value as of December 31, 2024. (2) The $8.6 billion payout is correctly stated, and the 2019 and 2023 dates are accurate. But the absence of the $44.7 billion repurchase authorization and the $883 million carrying value of the investment reduces quantitative completeness. The tax gain mentioned is not in the ground truth and may be extraneous or unverified. (3) The multi-hop reasoning is sound—correctly linking Alphabet’s capital structure to governance control and contrasting it with Comcast’s strategic exit from Hulu. The synthesis across companies and mechanisms is logical and well-articulated. (4) The answer is highly relevant and captures the essence of the comparison. The omission of specific financial figures and carrying value details prevents a top score, but the qualitative reasoning and entity accuracy (Alphabet, Comcast, Hulu, Disney, correct years) are strong. Minor deduction in quantitative accuracy due to missing numbers and potential addition of unverified 'tax gain' detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 456,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "LLY’s intermittent delays in delivering its incretin drugs—Mounjaro, Zepbound and Trulicity—stem from its reliance on third‑party manufacturers and the difficulty of scaling production (LLY, 2023 p. 45).  Thermo Fisher’s $26.92 billion of remaining performance obligations are largely tied to contract‑manufacturing, clinical‑research and warranty services that span 3–5 years (TMO, 2023 p. 49).  Because both companies depend on external suppliers for quality‑controlled, timely production, any supply‑chain disruption or quality‑assurance failure could delay deliveries, inflate costs and jeopardize long‑term revenue recognition for both firms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: TMO's $26.92 billion in remaining performance obligations is correctly cited, and the 3–5 year duration of contracts matches the original. The reference to LLY’s 2023 10-K (p. 45) and TMO’s 2023 10-K (p. 49) supports the data, though exact page numbers are not part of the knowledge graph truth and are treated as plausible. (2) The LLM correctly identifies both companies (LLY and TMO, though TMO is correctly interpreted as Thermo Fisher Scientific, which uses the ticker TMO), their reliance on third-party manufacturers, and the associated risks in supply chain and quality assurance. (3) The multi-hop reasoning is sound: it connects LLY’s production delays due to third-party manufacturing constraints with TMO’s long-duration contract obligations, and infers shared vulnerabilities in supply chain execution and quality control. (4) The answer is contextually relevant and addresses the core of the question—how shared supply chain and quality risks could impact both firms’ ability to fulfill long-term commitments. One minor shortcoming is that the LLM mentions Trulicity as facing supply delays, which is not stated in the ground truth (only Mounjaro and Zepbound are specified). Additionally, the ground truth emphasizes regulatory actions, recalls, and approval delays more explicitly, and notes that AMD also highlights such risks—this added context is missing in the LLM response, slightly reducing completeness and qualitative accuracy. However, the core facts, synthesis, and implications are correctly conveyed, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 454,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "NextEra Energy Resources’ cumulative impairment charge on its XPLR equity‑method investment as of December 31 2024 is $2.0 billion ($1.2 billion in 2023 plus $0.8 billion in 2024).  The investment’s carrying value before the 2024 impairment was about $2.6 billion, so the cumulative impairment ($2.0 billion) is $0.6 billion less than that pre‑impairment carrying amount, leaving a post‑impairment book value of roughly $1.8 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the cumulative impairment charge of $2.0 billion is correctly calculated as the sum of the $1.2 billion impairment in 2023 and the $0.8 billion impairment in 2024. The pre-2024 impairment carrying value of $2.6 billion and the post-impairment book value of $1.8 billion are both accurate. (2) Quantitative accuracy is perfect: $1.2B + $0.8B = $2.0B, and $2.6B - $0.8B = $1.8B, with correct comparison stating the cumulative impairment is $0.6B less than the pre-2024 carrying value. (3) Multi-hop reasoning is sound—information from two different time points (September 30, 2023, and December 31, 2024) is correctly synthesized across years and entities (NextEra Energy Resources and its investment in XPLR). (4) The answer addresses both parts of the question: total cumulative impairment and its comparison to the pre-2024 carrying value. Wording differs slightly but meaning is identical. All entities, metrics, and dates are correct. No factual or logical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 309,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE’s 2024 10‑K notes that it adopted ASU 2022‑04 on January 1, 2023, but the company states the change “did not have a material impact on the Company’s consolidated financial statements” and does not provide a separate disclosure of confirmed invoice balances or a distinct presentation of supplier‑finance amounts in the notes (see GE Note 15 reference on page 47). In contrast, 3M (MMM) explicitly discloses the confirmed invoice balances under its supplier‑finance program—$0.30 billion as of December 31 2024 and $0.30 billion as of December 31 2023—and presents those balances within accounts payable on the consolidated balance sheet (see MMM Note 16 on page 77). Thus, GE’s adoption of the standard yields less detailed transparency on confirmed invoices compared with MMM’s explicit reporting and presentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: MMM's confirmed invoice balances of $0.30 billion as of December 31, 2024 and 2023 are accurately reported, and GE's adoption date of January 1, 2023, is correctly stated. The format variation ($0.3 billion vs $0.30 billion) is acceptable. (2) The answer correctly identifies that GE adopted ASU 2022-04 in 2023 but did not provide detailed disclosures on confirmed invoice balances, while MMM explicitly discloses the $0.3 billion balances for both years and includes them in accounts payable. (3) The multi-hop reasoning is sound: the model correctly compares GE’s lack of specific disclosures with MMM’s explicit reporting, drawing a valid conclusion about relative transparency. (4) The only minor shortcoming is that the LLM answer does not mention that GE will begin providing roll-forward disclosures prospectively from January 1, 2024, as noted in the ground truth. This contextual nuance about future disclosure timing is omitted, slightly reducing completeness in qualitative terms. However, the core facts, entities, and comparative analysis are correct and relevant, making the answer highly accurate overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 349,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria’s equity‑method accounting for its stake in Cronos means it records its share of Cronos’s earnings and any impairment of the investment. Because Cronos’s cannabis operations are subject to FDA regulations (alongside the Controlled Substances Act and anti‑money‑laundering laws), a regulatory enforcement or failure to comply could cut Cronos’s profitability or trigger an impairment, directly reducing Altria’s reported earnings and carrying value (pages 4, 60). In contrast, Walmart’s pharmacy operations are directly regulated by the FDA and other federal agencies; non‑compliance can lead to fines, product recalls or operational shutdowns that hit Walmart’s pharmacy revenue and cash flows, representing a direct operational risk rather than an indirect investment‑based risk (pages 10, 26).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Altria uses equity-method accounting for Cronos, exposing it to Cronos's financial performance, which is tied to FDA and other regulatory compliance; Walmart faces direct regulatory exposure through its pharmacy operations. The distinction between indirect investment risk (Altria) and direct operational risk (Walmart) is correctly identified and well-articulated. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10 by default—no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesizes how equity-method accounting transmits financial risk from Cronos to Altria, and contrasts it with Walmart’s direct regulatory exposure. The mention of additional regulations (Controlled Substances Act, anti-money-laundering laws) adds context not in the original but is factually appropriate and enhances accuracy without distorting the core comparison. (4) The answer is fully contextually relevant, addressing both companies, the role of FDA regulations, and the structural differences in exposure. The only minor shortcoming is that the original emphasizes the 'mirroring' of regulatory risk profiles despite different business models, a nuance slightly underemphasized in the LLM response. However, the core comparison remains intact and accurate. Thus, correctness is 9—excellent but not perfect in reflective nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 418,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "LLY’s U.S. distribution is handled by Cardinal Health, which is also CVS’s 50 % partner in the Red Oak Sourcing VIE.  CVS consolidates Red Oak as the primary beneficiary, but its exposure is limited to the contractual payments Cardinal makes to CVS—$183 million each year—recorded as cost of goods sold and not as a liability.  Thus, while Cardinal’s dual role means that a disruption in its distribution could affect Red Oak’s sourcing ability, CVS’s consolidated financial exposure remains confined to the payment stream and the VIE’s financial performance, not to LLY’s distribution arrangement.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: the $183 million annual payment from Cardinal to CVS is correctly cited, matching the original answer's reference to 2021 data. No other numeric values (e.g., percentages of LLY’s revenue) are included in the LLM response, but this is not a factual error—just a difference in completeness. (2) The entity identification is correct: LLY (Eli Lilly), Cardinal Health, CVS, and Red Oak Sourcing are properly named and their relationships (Cardinal as 50% partner in Red Oak, CVS as primary beneficiary) are accurately described. (3) The reasoning is sound: the LLM correctly traces the chain of relationships—Cardinal’s role in distributing LLY products, its joint venture with CVS in Red Oak, and the financial implications of Cardinal’s performance on CVS’s consolidated exposure. However, it omits a key multi-hop insight from the ground truth: that a disruption in LLY distribution could impair Cardinal’s financial health, which could then affect its ability to make the $183M payments to CVS via Red Oak. While the LLM notes that disruption could affect Red Oak’s sourcing, it doesn’t fully connect the dots to how this impacts CVS’s financial exposure through reduced payments or VIE performance. (4) Despite this omission, the answer remains semantically close and contextually relevant, correctly framing CVS’s exposure as limited to the payment stream and VIE performance. The absence of the forward-looking risk linkage slightly reduces completeness and qualitative accuracy, but not enough to undermine the core correctness. Hence, a score of 8 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 458,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle’s $6 billion commercial‑paper program is a purely short‑term financing tool – it allows the company to issue unsecured promissory notes, of which $401 million were outstanding as of May 31 2024, and the proceeds are used for general corporate purposes (Oracle, p. 90).  Cisco, by contrast, has issued $13.5 billion in senior fixed‑rate notes that rank pari‑passu with its commercial‑paper obligations, meaning the long‑term notes and the short‑term paper have the same priority in the capital structure (Cisco, p. 89‑92).  Thus, while Oracle relies solely on short‑term debt, Cisco blends long‑term senior notes with short‑term paper at equal ranking, creating a more diversified debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Oracle's $6.0 billion commercial paper program, $401 million outstanding as of May 31, 2024, unsecured nature, and use for general corporate purposes; Cisco's $13.5 billion senior fixed-rate notes issued in February 2024 (implied by context), and the pari passu ranking with commercial paper. (2) Quantitative accuracy is perfect: dollar amounts ($6.0B, $401M, $13.5B), dates (May 31, 2024), and financial terms are correctly reported. Format variations (e.g., $6 billion vs $6.0 billion) are acceptable. (3) Multi-hop reasoning is sound: the model correctly contrasts Oracle’s reliance on short-term commercial paper with Cisco’s blended approach using long-term senior notes that rank equally (pari passu) with commercial paper. (4) The only minor shortcoming is that the LLM omits the detail about Cisco’s notes being redeemable with a makewhole premium and hedged via interest rate swaps—information present in the ground truth that adds depth to Cisco’s debt management strategy. However, this omission does not undermine the core comparison. The conclusion that Cisco has a more diversified debt mix is valid and well-supported. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses the comparative debt structure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 382,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment lists wind as one of several resources it uses—alongside solar, fuel cells and batteries—but the filing does not disclose a specific wind‑capacity or long‑term contract.  In contrast, Southern Company’s Southern Power has a concrete, long‑term wind commitment: the Skookumchuck project is a 136‑MW facility with a 20‑year PPA, illustrating a defined, sizable wind investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's Commercial Renewables segment includes wind among other sources but does not disclose specific wind capacity or long-term contracts; Southern Company (via Southern Power) has a 136 MW wind project at Skookumchuck with a 20-year PPA. (2) Quantitative accuracy is perfect: the 136 MW nameplate capacity and 20-year PPA term are correctly reported. (3) The multi-hop reasoning is sound—comparing Duke’s broad, undisclosed renewable mix with Southern’s specific, contracted wind investment demonstrates valid synthesis across entities and disclosure levels. (4) The only minor limitation is that the LLM does not explicitly name the geographic location (Lewis and Thurston Counties, WA) mentioned in the original answer, which slightly reduces completeness but does not affect the core comparison. Otherwise, the answer captures the essential contrast in strategic commitment and transparency. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent as it directly addresses the comparative strategic commitment to wind energy as framed by capacity and contract.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 341,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under the Advanced Approach, Morgan Stanley’s capital buffer requirement is 5.5 % (2.5 % capital‑conservation buffer + 3 % G‑SIB surcharge + 0 % CCyB)【page_134】, whereas Charles Schwab’s buffer is only a 2.5 % stress/capital‑conservation buffer with no G‑SIB surcharge and a 0 % CCyB【page_122】. Because the countercyclical buffer is set at zero by the Federal Reserve, it adds nothing to either firm, so the difference in total buffer requirements comes solely from Morgan Stanley’s G‑SIB surcharge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: MS has a 2.5% Capital Conservation Buffer, a G-SIB surcharge (implied as 3%, consistent with public data), and a 0% CCyB, totaling 5.5%; SCHW has only the 2.5% buffer and no G-SIB surcharge, with CCyB also at 0%. These values match the regulatory framework and the current zero CCyB setting by the Federal Reserve as of the relevant period (December 31, 2023). (2) The calculation logic is sound—since CCyB is zero, it does not affect either firm, and the difference in total buffer is correctly attributed to the G-SIB surcharge. (3) The multi-hop reasoning is strong: the model correctly synthesizes that both firms are subject to the same CCyB policy and Conservation Buffer, but only MS, as a G-SIB, faces the additional surcharge. (4) The only minor limitation is that the exact G-SIB surcharge percentage (3%) is not explicitly confirmed in the ground truth, which only states that MS is subject to the surcharge without specifying the rate. While 3% is plausible and consistent with public data, the original answer does not provide that figure, so including it introduces a precise number not present in the source. However, this does not undermine the overall correctness, as the core structural comparison remains valid. Wording differs but semantic meaning matches. All entities (MS, SCHW, CCyB, G-SIB, Conservation Buffer) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 410,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney uses internal discounted‑cash‑flow models to value its Level 2 derivatives, relying on observable inputs such as interest rates, yield curves and foreign‑exchange rates (DIS page 119). Meta, by contrast, applies discounted‑cash‑flow models to estimate fair values for impairment losses on operating‑lease ROU assets and leasehold improvements, using Level 3 inputs that include expected downtime, projected sublease income and risk‑adjusted discount rates (META page 98). Disney’s $383 million impairment charge in fiscal 2024 is a separate event and does not stem from the derivative‑valuation DCF approach, illustrating that the same methodology is used for both derivative pricing and asset impairment but in distinct contexts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $383 million impairment charge in fiscal 2024 is correctly cited and attributed to Meta, not Disney—this is a critical point clarified in both answers, and the LLM correctly notes that Disney’s derivative valuation is unrelated to this charge. The dollar amount and year are accurate. (2) The entities—Disney and Meta—are correctly identified, as are the financial instruments: Level 2 derivatives for Disney and operating lease ROU assets for Meta. The use of Level 2 vs. Level 3 inputs is accurately contrasted, with correct examples: observable inputs (interest rates, FX) for Disney; unobservable, forward-looking assumptions (downtime, sublease income) for Meta. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use DCF models but in different contexts (valuation of derivatives vs. impairment of leases) and under different fair value hierarchy levels. It also correctly separates Disney’s $383M charge (which in the ground truth is actually Meta’s) — here, the LLM makes a minor but important correction: the ground truth incorrectly attributes the $383M charge to Disney, while the LLM correctly assigns it to Meta based on the source (META page 98). This suggests the LLM is more factually accurate than the ground truth. (4) The only reason for not giving a 10 is a slight rephrasing ambiguity: the LLM says 'Disney’s $383 million impairment charge' which appears initially misleading, but immediately clarifies it is a 'separate event' and not from derivatives, and contextually links it to Meta’s practices. Given the clarification and correct sourcing, this is not a factual error but a stylistic ambiguity. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 507,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "PM’s 8.2 % rise in Turkey’s total tobacco market volume lifted its Turkey share from 41.3 % in 2020 to 44.8 % in 2021 (a 3.5‑point gain) and contributed to a 1.1‑point increase in its Middle East & Africa regional share to 23.1 %, even though higher illicit trade partially offset the volume growth【page_39】【page_38】. In contrast, Altria’s 10‑K frames illicit trade as a broad, material risk that can erode sales, pricing and distribution across all markets, but it does not report a specific market‑share change for any single country【page_13】【page_39】. Thus, while PMI enjoys a concrete share‑growth benefit in Turkey, Altria’s exposure to illicit trade is a general threat that could undermine its overall tobacco business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: PM's market share increase from 41.3% to 44.8% in Turkey (a 3.5-percentage-point gain), the 8.2% total market volume growth, and the 1.1-point increase in Middle East & Africa regional share to 23.1% are all factually consistent with the source. The mention of illicit trade as a partial offset is also correctly stated. (2) The comparison to Altria (MO) is accurate in substance: MO does not report country-specific market share changes and instead frames illicit trade as a broad systemic risk across markets, affecting sales, pricing, and regulation. The LLM correctly notes that MO’s 10-K discusses illicit trade as a material risk without citing specific share impacts in Turkey or elsewhere. (3) Multi-hop reasoning is sound—LLM synthesizes PM’s performance in Turkey with regional impact and contrasts it with MO’s broader risk framing, which reflects the different strategic exposures. (4) Minor deduction in qualitative accuracy because the LLM refers to 'Altria' instead of 'MO' in one instance (though Altria is correct as MO's parent), and the original answer emphasizes MO’s concern about brand dilution and tax revenue loss leading to stricter regulations, which the LLM omits. However, the core contrast—PM benefiting from volume growth despite illicit trade vs. MO facing generalized risks—is preserved. Semantic equivalence is maintained, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 414,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The IRA’s redesign of Medicare Part D shifts claim liability from the federal government to private plans, which could reduce CVS’s exposure to government‑backed liabilities but increase its exposure to plan‑based costs and tighter reimbursement rules (page_57, page_59). For AbbVie, the IRA introduces government‑set price caps on drugs such as Imbruvica starting in 2026 and replaces the 70 % coverage‑gap discount with a 10 % manufacturer discount for beneficiaries below $2,000 and a 20 % discount for those above $2,000, forcing the company to adjust its pricing strategy and accept lower reimbursements under Medicare Part D (page_15, page_19).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core impacts of the Inflation Reduction Act (IRA) on both CVS and AbbVie. For CVS, it accurately notes the shift in claim liability to private plans, increasing CVS's exposure to plan-based costs—consistent with the ground truth’s point about increased financial risk. For AbbVie, it correctly states that government-set price caps on drugs like Imbruvica begin in 2026 and that reimbursement will be lower, aligning with the original answer. However, the LLM introduces specific details not present in the ground truth—namely the 10% and 20% manufacturer discounts based on beneficiary spending thresholds—which, while plausible under the IRA, are not mentioned in the original answer and may over-specify the mechanism. This introduces a minor factual discrepancy in emphasis, though not a direct contradiction. (2) Quantitatively, the dates (2026) and percentages (70%, 10%, 20%) are internally consistent and plausible under the IRA framework, but the 70% coverage-gap discount and the new 10%/20% structure are not referenced in the ground truth, making their inclusion potentially misleading. The ground truth focuses on statutory price caps reducing revenue, not discount restructuring. Thus, while the numbers themselves are accurate representations of certain IRA provisions, their centrality in the LLM answer shifts focus from the core pricing cap mechanism emphasized in the original. (3) The multi-hop reasoning is sound: the LLM connects CVS’s role as a plan sponsor to increased liability and links AbbVie’s drug pricing to new government controls. It synthesizes across entities and regulatory changes appropriately. However, it adds granular policy mechanics not present in the ground truth, slightly distorting the emphasis. (4) The correctness score is 8 because the core financial and strategic impacts are accurately conveyed for both companies, with only minor over-specification of discount mechanics. Quantitative accuracy is 8 due to correct use of dates and percentages, though some figures are extraneous. Qualitative accuracy is 8 due to strong reasoning and entity identification (CVS, AbbVie, Imbruvica, 2026). Contextual relevance is 10—fully on point with the question’s focus on financial exposure and pricing strategy under the IRA.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 619,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values impaired customer‑financing assets by taking a median collateral value from a set of third‑party aircraft‑valuation publications and then applying only modest, condition‑based adjustments (Level 3 inputs) — the bulk of the valuation comes from observable market data 【page_124】【page_125】.  \nRTX, in contrast, re‑values its private‑equity limited partnerships each quarter using discounted‑cash‑flow, earnings‑multiple and market‑multiple models, which rely heavily on unobservable inputs such as discount rates, growth assumptions and other management‑estimates 【page_102】.  Thus, Boeing’s method is less dependent on unobservable inputs than RTX’s quarterly valuation approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Boeing uses a median value from third-party aircraft valuation publications, with only modest adjustments based on aircraft condition, and that this approach incorporates Level 3 inputs but relies heavily on observable market data. This matches the original answer's emphasis on Boeing's use of consistent third-party data. (2) For RTX, the LLM accurately describes the quarterly valuation of private equity limited partnerships using discounted cash flows, earnings multiples, and market multiples, all involving significant unobservable inputs like discount rates and growth assumptions—this is consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly compares the two companies' methodologies, noting that Boeing’s approach is more anchored in third-party market data while RTX’s relies more heavily on forward-looking, management-driven assumptions—this synthesis across entities is accurate and logically presented. (4) The only minor shortcoming is that the LLM slightly downplays Boeing’s use of unobservable inputs by implying its method is 'less dependent' without fully acknowledging that both are Level 3 valuations and thus both rely on unobservable inputs to some degree, as emphasized in the original answer. However, this nuance does not invalidate the overall correctness. All entities (Boeing, RTX, customer financing assets, private equity partnerships), methodologies, and timeframes (quarterly) are correct. No numerical inaccuracies; all non-numeric data is semantically equivalent. The answer is contextually precise and directly responsive to the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 468,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "At META, 343 million Class B shares each carry 10 votes versus one vote per Class A share, giving Class B holders roughly 3.4 billion votes against 2.19 billion for Class A (page 1). Alphabet’s Class B shares also carry 10 votes per share, and its recent repurchases of Class A and Class C shares have reduced the total number of voting shares, further concentrating control in the hands of the Class B holders (page 82). Thus, the voting‑rights structure at both companies concentrates corporate control in the minority of Class B shareholders, a concentration amplified by GOOGL’s share‑repurchase program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains major factual and quantitative errors that severely undermine its correctness. (1) It incorrectly states that META's Class B shares have 10 votes each and Class A have 1 vote — in reality, the opposite is true per the ground truth: at META, Class A has full voting rights and Class B has no voting rights except in limited circumstances. The LLM reverses the voting structure entirely. (2) The LLM claims META Class B has 343 million shares with 10 votes each, implying 3.4 billion votes for Class B, but this is false because Class B has no voting power. The 343,761,117 figure is correct for the number of Class B shares outstanding, but the voting rights are misrepresented. (3) The Class A share count (2.19 billion) is approximately correct (ground truth: 2,189,898,148), but the LLM incorrectly assigns it fewer votes, when in fact Class A holds all voting power. (4) Regarding GOOGL, the LLM correctly identifies that Class B has 10 votes per share and that repurchases of Class A and Class C shares concentrate control among Class B holders — this part is accurate and aligns with the ground truth. (5) The $62.0 billion repurchase amount in 2024 is omitted in the LLM answer, a significant quantitative omission. (6) The reasoning is flawed due to the incorrect attribution of voting rights at META, leading to a completely incorrect synthesis of how control is concentrated. While the answer attempts multi-hop reasoning by comparing both companies' structures and repurchase effects, the reversal of META's voting structure invalidates the conclusion. Contextually, the answer addresses the right topic (voting disparity and control concentration), so relevance is moderate. However, due to fundamental factual and quantitative errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 486,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PEP’s convenient‑foods unit grew 19 % in APAC, with Taiwan contributing only low‑single‑digit growth【48】.  In contrast, Procter & Gamble’s Greater China segment is a broader regional classification that explicitly includes Taiwan as part of its market structure, indicating that Taiwan is integrated into PG’s Greater China strategy rather than reported as a separate growth metric.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports PEP's 19% convenient foods unit volume growth in APAC and accurately notes that Taiwan contributed low-single-digit growth, which aligns with the ground truth. It also correctly states that PG includes Taiwan in its Greater China segment, matching the entity structure described. However, the LLM answer omits the key qualitative insight from the original answer that PG holds a leadership or significant market share position in Greater China, which is central to comparing PEP's modest growth in Taiwan versus PG's stronger overall market position. (2) All numeric values—19% and low-single-digit—are factually accurate and properly attributed. No calculations are required, and the time frame (implied 2022 via context) is consistent. (3) The multi-hop reasoning is mostly sound: the model connects PEP’s APAC growth with Taiwan’s sub-contribution and contrasts it with PG’s regional structure. However, it fails to fully synthesize the competitive implication—that PG has a stronger market presence—thus weakening the comparative analysis. (4) Scores reflect high factual accuracy and relevance, with a moderate deduction in qualitative accuracy due to the missing market position insight, which is essential for a complete comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 359,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel III PCA updates raise the minimum CET‑1 ratio for a well‑capitalized insured depository institution to 6.5 % (and the supplementary leverage ratio to 3 %).  Bank of America’s subsidiary, Bank of America, N.A., reports a CET‑1 ratio of 7.0 % (Standardized/Advanced) and a supplementary leverage ratio of 6.0 %, comfortably above the new thresholds and therefore classified as well‑capitalized.  Capital One Bank, N.A. likewise reports a CET‑1 ratio of 7.0 % and a supplementary leverage ratio of 3.0 %, meeting the updated minimums and also being deemed well‑capitalized, though its ratios are only marginally above the new requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details and entity-specific capital requirements. (1) QUANTITATIVE INACCURACY: The ground truth states that under Basel III and the updated PCA framework, banks must maintain a CET1 ratio of 6.5% or more to be well-capitalized, which the LLM correctly identifies. However, the LLM introduces specific reported CET1 ratios (7.0%) and supplementary leverage ratios (6.0% for BAC, 3.0% for COF) that are not present in the original answer and cannot be verified from the provided ground truth. These figures appear fabricated or incorrectly sourced. Moreover, the original answer does not mention the supplementary leverage ratio (SLR) at all—this is an addition not supported by the ground truth. (2) COMPLETENESS: The question asks how the updated PCA thresholds affect capital requirements for BAC and COF in terms of CET1 ratios and classification. The LLM addresses classification and ratios but fails to explain the regulatory minimums (e.g., 4.5% CET1 under Basel III) versus the higher PCA thresholds (6.5% for well-capitalized), which is a core part of the original answer. It omits the Tier 1 and total capital ratio requirements entirely. (3) ENTITY ACCURACY: The LLM refers to 'Bank of America, N.A.' and 'Capital One Bank, N.A.' as the entities being assessed, but the original answer discusses BAC and COF at the holding company level. This shift to subsidiary banks introduces a misalignment in scope. (4) REASONING: The LLM implies both banks meet the thresholds with specific numbers, but it does not perform or explain the multi-hop synthesis of regulatory requirements (Basel III + PCA) versus firm-specific capital levels as required. It asserts compliance without grounding in the source data. (5) SEMANTIC EQUIVALENCE: While the general idea—that PCA thresholds under Basel III require higher capital to be well-capitalized—is correct, the inclusion of unverified metrics and omission of key comparative structure (regulatory minimum vs. well-capitalized threshold) reduces factual fidelity. The answer is contextually relevant but factually flawed in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 579,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Netflix’s audit notes report that sensitivity analyses were performed to see how changes in estimated viewing‑pattern assumptions would alter the amount and timing of content amortization (page 40). AT&T’s audit notes describe sensitivity testing around the discount rates used for defined‑benefit pension obligations and the forward‑looking assumptions (terminal growth, EBITDA margins, WACC) used in goodwill impairment tests, noting that such changes can materially affect pension liability and goodwill valuation (page 44). In short, both companies use sensitivity analysis to gauge the impact of judgmental assumptions, but Netflix focuses on content amortization timing while AT&T focuses on pension discount rates and goodwill impairment assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's sensitivity analysis focuses on viewing-pattern assumptions affecting content amortization timing, and T's (AT&T's) analyses cover pension discount rates and goodwill impairment assumptions (terminal growth, EBITDA margins, WACC). The LLM correctly identifies both companies and the nature of their respective sensitivity tests. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the description of financial concepts is precise. (3) The multi-hop reasoning is sound—comparing two different companies' audit-level sensitivity analyses across distinct accounting domains—and the synthesis is appropriate and accurate. (4) The only minor shortcoming is that the LLM refers to 'AT&T' instead of using the ticker 'T' consistently, though this does not reduce clarity or accuracy, as T is widely recognized as AT&T. Otherwise, the answer is semantically equivalent to the original, with appropriate contextual detail and correct emphasis on the contrast in focus between consumption-based amortization (NFLX) and long-term financial assumptions (T).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 357,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe keeps a single local field office in Taiwan as part of its worldwide network of sales and support sites (see the list of field‑office locations on page 15).  Apple, by contrast, does not treat Taiwan as a separate market; it is folded into its Greater China segment—which also includes mainland China and Hong Kong—and that segment generated $74.2 billion in net sales in 2022 (page 52).  Thus, Adobe’s approach is a focused, localized presence, while Apple’s strategy is a broader, region‑wide integration that drives a substantial portion of its revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, while Apple includes Taiwan in its Greater China segment, which generated $74.2 billion in net sales in 2022. The dollar amount and year match the original answer. (2) Quantitative accuracy is perfect: $74.2 billion is correctly cited with acceptable formatting (using $74.2  billion). (3) Multi-hop reasoning is sound—LLM correctly contrasts Adobe’s localized operational model with Apple’s consolidated regional reporting, synthesizing information about geographic strategy and financial performance across two companies. (4) The answer addresses all parts of the question: it compares Adobe’s direct presence in Taiwan to Apple’s broader regional strategy, explains the composition of Greater China, and contextualizes Apple’s revenue scale. Wording differs slightly but meaning is preserved, and references to document pages (e.g., page 15, 52) suggest proper sourcing. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 310,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin discloses that its credit facility and some derivatives are LIBOR‑based, but the facility contains fallback provisions and the company is monitoring the transition, expecting no material impact by the end of 2022 (page 85). 3M, by contrast, has reviewed all relevant contracts under ASU 2020‑04, will apply the guidance to any that are modified, and likewise expects no material impact, indicating a proactive preparedness for reference‑rate reform (page 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Lockheed Martin has LIBOR-based credit facilities and derivatives with fallback provisions, expects no material impact by end of 2022; 3M reviewed contracts under ASU 2020-04 and similarly expects no material impact. (2) Quantitative accuracy is perfect: the date 'end of 2022' matches the ground truth's 'by December 31, 2022'; no numerical errors. (3) Multi-hop reasoning is sound—correctly synthesizes information across both companies and links their responses to ASU 2020-04, though it does not explicitly mention ISDA 2020 IBOR Fallbacks Protocol (a minor omission). (4) The answer shows parallel preparedness despite different financial structures, aligning with the original conclusion. The only slight gap is not naming SOFR or explicitly stating that both use ASU 2020-04 to reduce accounting burden, but the essence of equivalent low-impact expectations and proactive monitoring is preserved. Wording differs but semantic meaning matches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 305,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "At CMCSA, Class A common stock holds 66 ⅓ % of the combined voting power, while Class B common stock holds 33 ⅓ %. Because each Class B share carries 15 votes, the 9.4 million shares held by Brian L. Roberts translate into a large, non‑dilutable voting bloc that effectively gives the controlling shareholder a majority influence over board elections and corporate decisions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Class B common stock has 33⅓% of the combined voting power and carries 15 votes per share, and it accurately describes the disproportionate control this confers. However, it incorrectly states that Class A holds '66⅓%' of voting power, whereas the ground truth specifies '66⅔%'. This is a critical numerical error affecting quantitative accuracy. (2) The mention of '9.4 million shares held by Brian L. Roberts' introduces specific data not present in the original answer; while potentially true, it is extraneous and not supported by the provided ground truth, making it an unsupported addition. The core calculation of voting power distribution is off due to the incorrect Class A percentage—66⅔% + 33⅓% = 100%, but 66⅓% + 33⅓% = 99⅔%, which fails mathematically. (3) The reasoning about disproportionate control and non-dilutable voting influence is sound and reflects correct multi-hop synthesis of voting rights and control implications. (4) Despite the significant quantitative error in the Class A voting percentage and the introduction of unverified specifics, the answer captures the essential structure and intent of the original response, hence a correctness score of 7. Contextual relevance is perfect as it directly addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 368,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "CMCSA uses sensitivity analyses as part of its interest‑rate risk management (page 60), evaluating how changes in rates affect its debt and derivative positions.  \nNetflix, by contrast, applies sensitivity analyses to its content‑amortization model (page 40), testing how shifts in viewing‑pattern assumptions alter amortization timing and expense.  \nAlthough both companies are audited by the same firm, the differing focus of the analyses—market‑rate exposure for CMCSA versus revenue‑recognition risk for Netflix—highlights their distinct financial risk profiles.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the distinct uses of sensitivity analyses by CMCSA and NFLX, aligning with the ground truth: CMCSA focuses on interest rate risk related to debt and derivatives, while NFLX applies it to content amortization driven by viewing pattern assumptions. The mention of the same auditor is implied through context but not explicitly stated, which is a minor omission. Quantitatively, the answer does not include the $56 million reduction in interest expense for CMCSA in 2023—a specific figure present in the ground truth. While this number is missing, no incorrect numbers are provided, so quantitative accuracy remains high. The reasoning is sound and reflects appropriate multi-hop synthesis: linking each company's use of sensitivity analysis to its unique financial risk exposure (market-rate risk vs. judgment-heavy amortization). The characterization of NFLX's risk as 'revenue-recognition risk' slightly misrepresents the issue—content amortization affects expense timing more directly than revenue recognition, though viewing patterns do influence revenue forecasting indirectly. This nuance reduces qualitative accuracy slightly. Contextually, the response is highly relevant, directly addressing the core comparison and risk differentiation. Overall, the answer captures the key contrast accurately and concisely, with only minor gaps in completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 387,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer’s Enbrel formulation patent expires on 10/19/2037 (page_11), after which biosimilar competition is likely to erode its market share. AbbVie, by contrast, relies on regulatory exclusivity under the Biologics Price Competition and Innovation Act, which grants up to 12 years of exclusivity (plus a 180‑day pediatric extension) that can extend beyond patent expiry (page_9). Thus, AbbVie’s longer exclusivity window gives it a stronger competitive position than Pfizer, whose Enbrel exposure to biosimilar competition begins earlier.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a few key discrepancies. (1) Quantitatively, the expiration date of Enbrel's formulation patent is cited as '10/19/2037', which is more specific than the ground truth's general '2037'. While this level of precision may come from a source, the ground truth does not confirm it, so this introduces unverified specificity—minor issue. The 12-year exclusivity and 180-day pediatric extension for AbbVie under BPCIA are accurate. (2) The answer incorrectly implies that Pfizer’s exposure to biosimilars begins in 2037 *because* the patent expires then, but the ground truth clarifies that Pfizer markets Enbrel *outside the U.S. and Canada*, while the U.S. formulation patent still offers protection—this nuance is missing. The LLM suggests Pfizer will face erosion in 2037, but doesn't clarify that Enbrel is not primarily a U.S. product for Pfizer, weakening the competitive comparison. (3) The reasoning correctly contrasts patent-based protection (Pfizer) with regulatory exclusivity (AbbVie), but oversimplifies by stating AbbVie has a 'longer exclusivity window' and 'stronger competitive position' without acknowledging that the strategies differ in nature—AbbVie’s approach is layered (patents + regulatory), while Pfizer’s relies on a single long-term patent. This misses the qualitative distinction emphasized in the ground truth. (4) Despite these issues, the core facts—patent expiration in 2037, AbbVie’s BPCIA exclusivity, pediatric extension, and the general competitive implication—are present and directionally correct. The answer is contextually relevant and synthesizes across entities, but lacks completeness in nuance and entity-specific context, particularly regarding Enbrel’s geographic market. Hence, correctness is reduced to 7 for missing key contextual details, though quantitative and qualitative accuracy remain above average.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 510,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "The 0.1‑percentage‑point increment would cut the incremental capital charge by a factor of five compared with the current 0.5‑percentage‑point step.  In a bankruptcy resolution the surcharge would still be applied to JPMorgan’s entire eligible long‑term debt ($162.5 bn, 35.6 % of RWA), which is the loss‑absorbing layer that would first absorb parent‑company losses, so the capital requirement would rise but at a lower rate, preserving the loss‑absorbing structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and unsupported specifics not present in the ground truth. Most critically, it introduces a precise figure of $162.5 billion for JPMorgan's eligible long-term debt and states it is 35.6% of RWA (risk-weighted assets), which is not mentioned or verifiable from the original answer. These numbers appear fabricated or hallucinated, severely undermining quantitative accuracy. (2) The claim that the 0.1-percentage-point increment 'would cut the incremental capital charge by a factor of five' misrepresents the regulatory mechanism: the change allows for finer gradations in surcharge application but does not inherently reduce or 'cut' the charge—rather, it enables more precise calibration. This reflects a flawed understanding of how G-SIB surcharges work. (3) While the LLM correctly identifies the relevance of the G-SIB surcharge to capital requirements and references the loss-absorbing role of long-term debt in resolution, it mischaracterizes the impact as a definite 'rise' in capital requirements, whereas the ground truth emphasizes uncertainty—JPM could face either a marginal increase or decrease depending on its G-SIB score. This shows incomplete reasoning and failure to capture the conditional nature of the outcome. (4) The mention of the 'single point of entry' strategy is missing in the LLM answer, a key element in the original answer’s explanation of how losses are absorbed. However, the LLM does correctly associate eligible long-term debt with loss absorption in a parent bankruptcy, showing partial understanding of resolution mechanics. (5) Overall, while the LLM attempts multi-hop reasoning connecting regulatory change, capital requirements, and resolution structure, it introduces false precision and incorrect causal logic, leading to a partially correct but significantly flawed response. The contextual relevance is moderate because it addresses the core topic but distorts key mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 536,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin’s Level 3 fixed‑income investments are valued with a discounted‑cash‑flow model that relies on projected annuity payments and a discount rate applied to those payments (page 87/88). Honeywell’s goodwill and indefinite‑life intangible‑asset impairments are also estimated with a discounted‑cash‑flow approach, but the company explicitly performs sensitivity analyses on key estimates—including projected cash flows and the discount rate (page 47). Thus, while both firms use DCF, Honeywell’s methodology is more explicitly sensitive to changes in cash‑flow and discount‑rate assumptions, whereas Lockheed Martin’s approach is more straightforward and does not detail sensitivity testing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both LMT and HON use a discounted cash flow (DCF) approach for valuation purposes—LMT for Level 3 fixed income investments and HON for goodwill and indefinite-lived intangible assets. It accurately references the use of projected annuity payments and discount rates for LMT (with page citation) and notes HON’s use of DCF with sensitivity analyses on key estimates like cash flows and discount rates (also with page citation). There are no numeric inaccuracies, and the entities (companies, valuation methods, asset types) are correctly identified, supporting a high quantitative accuracy score.\n\nHowever, the qualitative reasoning contains a significant misinterpretation. The original answer states that *both* companies rely on forward-looking projections and perform sensitivity analyses, making their valuations sensitive to assumptions. The LLM answer incorrectly implies that only HON performs sensitivity analysis and that LMT’s approach is 'more straightforward' and lacks sensitivity testing—this is not supported by the ground truth, which indicates LMT’s valuation is also sensitive to changes in cash flows and discount rates, even if not explicitly labeled as formal 'sensitivity analyses.' This mischaracterization affects the correctness of the comparison, which is the core of the multi-hop question.\n\nThus, while the individual facts are mostly accurate and contextually relevant, the synthesis and comparative reasoning are flawed, leading to a partially correct answer. The LLM introduces an unsupported contrast in methodology rigor that isn’t present in the ground truth, reducing the correctness and qualitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 460,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T’s pension discount rates are built from the credit quality of corporate bonds, so the auditor must evaluate the bonds’ ratings and the correlation between their cash inflows and the timing of future benefit payments.  \nNetflix’s content amortization is driven by forecasted viewing‑hour patterns, requiring the auditor to test the historical and projected consumption assumptions and the accuracy of the underlying data.  \nBoth involve significant judgment and are subject to auditor scrutiny, but AT&T’s focus is on market credit risk and cash‑flow alignment, whereas Netflix’s focus is on internal consumption forecasts and amortization timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, there are no numerical errors—the LLM does not introduce any incorrect figures and avoids making claims about specific dollar amounts like the $67,854 million in goodwill and postretirement liabilities mentioned in the original. While it omits this number, it does not misstate it, so quantitative accuracy remains high. (2) The entities—AT&T, Netflix, pension obligations, content amortization, discount rates, forecasted viewing patterns—are all correctly identified and contextually used. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly links AT&T’s use of corporate bond credit quality to auditor evaluation of cash-flow timing and market risk, and Netflix’s reliance on viewing forecasts to auditor testing of consumption assumptions. It accurately contrasts the nature of the assumptions (market-based vs. internal forecasts) while affirming their shared subjectivity and audit scrutiny. (4) The only shortcoming is the omission of the explicit parallel drawn in the original answer regarding how both companies manage subjectivity in long-term reporting despite different industries and asset types. This reduces completeness slightly but does not impair factual correctness. The answer remains semantically equivalent in intent and substance, with strong contextual relevance and precise qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 415,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "Altria Group adopted ASU 2023‑07 for the year ended December 31 2024 and, as a result, expanded its segment footnote disclosures to provide the disaggregated expense information required by the update. Philip Morris International adopted the same update for the year ended December 31 2024, added expanded footnote disclosures in Note 17, and will begin interim segment disclosures in the first quarter of 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both adoption timelines and reporting changes, reversing key details between MO and PM. Quantitatively, it incorrectly states that MO adopted ASU 2023-07 for the year ended December 31, 2024, when MO actually adopted it in 2024 with interim disclosures starting Q1 2025. It also incorrectly attributes Note 17 expanded disclosures to PM, when the ground truth assigns Note 17 to MO. Conversely, the interim disclosure timeline (Q1 2025) is correctly attributed to MO in the original answer but mistakenly assigned to PM in the LLM response. Qualitatively, the LLM fails to capture the critical multi-hop detail that PM integrated the Swedish Match segment into its four geographic segments starting January 2024—a major operational change absent from the LLM answer. Instead, it incorrectly claims PM added disclosures in Note 17, which belongs to MO. The reasoning is flawed due to entity confusion: the LLM swapped the specific reporting changes between the two companies. While the general context of expanded disclosures is relevant, the reversal of key facts—dates, entities, and reporting actions—undermines the answer's correctness. Semantic equivalence is not achieved because the core facts are misattributed. Minor credit is given for correctly identifying that both companies adopted the standard around 2024 and enhanced disclosures, but the critical differences in timing and implementation are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 405,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "Bristol‑Myers Squibb’s inclusion of **Pomalyst** in the IRA’s Part D price‑negotiation program means the company could face a mandatory discount and potential revenue erosion beginning in 2027—one year before the drug’s 5‑year regulatory exclusivity (approved 2023) expires (BMY 10‑K, p. 43).  In contrast, Pfizer’s exposure is already in effect for **Eliquis** (approved 2012), which the IRA will require price negotiation starting in 2026, after its exclusivity period has long since lapsed (PFE 10‑K, p. 17).  Because both companies generate a sizable share of sales from Medicare Part D, the earlier IRA impact on Eliquis will likely reduce Pfizer’s revenue sooner and more sharply than the later, but still significant, impact on BMY’s Pomalyst.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, Pomalyst was approved in 2013, not 2023—its 5-year regulatory exclusivity expired long before 2027, making the claim about exclusivity incorrect. Second, the drug selected for IRA negotiation from BMY is Pomalyst, which is correct, but the reasoning around its exclusivity timeline is flawed. Third, the LLM incorrectly identifies Eliquis as the Pfizer drug in the IRA price negotiation program starting in 2026; however, the ground truth specifies Ibrance and Xtandi (not Eliquis) as PFE’s drugs selected for negotiation in 2027. Eliquis is subject to other IRA-related Part D redesign impacts, but it is not one of the drugs undergoing price negotiation. (2) Quantitative accuracy is low: the original answer cites a $1 billion net unfavorable revenue impact for PFE in 2025 due to Part D redesign, which the LLM omits entirely. The LLM invents a timeline for Eliquis (2026) not supported by the ground truth and misattributes the 2027 negotiation start to Eliquis instead of Ibrance/Xtandi. (3) Multi-hop reasoning is partially sound—LLM correctly identifies that both companies are exposed to IRA via Part D and price negotiation—but fails to accurately synthesize which drugs are involved and when. It incorrectly narrows PFE’s exposure to Eliquis rather than acknowledging the broader portfolio impact including Ibrance and Xtandi. (4) Contextual relevance is high because the answer addresses Medicare Part D reliance, regulatory exclusivity, and revenue impact timelines. However, due to major factual errors in entities and dates, and omission of key financial figures, the overall correctness score is low. The answer misrepresents the core facts despite maintaining a relevant structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 482,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDLZ’s Argentine operations generated $401 million in net revenues in 2021, representing about 1.4 % of its consolidated net revenues. KO’s exposure to Argentina comes through Arca Continental, one of its five largest bottlers that operates in northern Argentina, but the filing does not disclose a separate revenue figure for that region. The fact that Arca Continental is a top bottler suggests a significant, though unspecified, exposure to Argentina relative to MDLZ’s $401 million contribution.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDLZ's Argentine operations generated $401 million in net revenues in 2021, matching the ground truth. It also accurately notes that Arca Continental is one of KO's top five bottlers operating in northern Argentina. However, the LLM adds that this represents 'about 1.4%' of MDLZ's consolidated revenues—a calculation not present in the original answer and not verifiable from the provided ground truth, which weakens completeness and accuracy. (2) Quantitatively, the $401 million figure is correct, and no other numbers are misstated. The 1.4% figure is likely derived from external data and introduces unsupported precision, but does not contradict the ground truth directly. (3) The multi-hop reasoning is partially sound: the model correctly identifies MDLZ's direct exposure and contrasts it with KO's indirect exposure via Arca Continental. However, it omits key qualitative details from the ground truth—specifically, the $13 million remeasurement loss due to currency risk in Argentina for MDLZ and the contractual exclusivity (Arca must source concentrates only from KO), which are critical to understanding the nature of exposure. (4) The answer remains contextually relevant and captures the core comparison: MDLZ has a direct, quantified presence while KO’s is indirect through a major bottler. Missing the financial impact of inflation and contractual details reduces qualitative accuracy, but the central facts are correct. Hence, correctness is 7 due to omissions of key risk and contractual elements, despite accurate core numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 437,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY’s 10‑K notes that the FDA’s Fast‑Track designation is a key tool for speeding development (BMY, p. 17).  LLY’s Prevail acquisition includes PR006, which already has Fast‑Track status, and the deal’s contingent‑value right (CVR) pays up to $4 per share only when a product receives regulatory approval—ideally before the December 31 2024 deadline (LLY, p. 70).  Thus, the Fast‑Track designation makes timely approval more likely, allowing LLY to capture the full CVR payment and thereby increasing the strategic value of the acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong multi-hop reasoning. (1) All key facts are correct: BMY's mention of Fast Track as an accelerator (p.17), PR006's Fast Track status, the $4.00 per share CVR (equating to ~$160M total), and the December 31, 2024 deadline (LLY, p.70) are all correctly cited. The dollar amount, date, and regulatory designation match the ground truth. (2) Quantitative accuracy is perfect: $4 per share and the 2024 deadline are correctly reported; while the total ~$160M is omitted in the LLM answer, the per-share amount is the key contractual term, and the total can be inferred. (3) Reasoning is sound: the LLM correctly links Fast Track status to increased likelihood of timely approval, which enhances the probability of triggering the CVR, thus increasing the strategic value of the acquisition—this synthesizes BMY’s regulatory insight with LLY’s transaction structure. (4) The only minor omission is not explicitly stating that PR006’s Fast Track designation was specifically for frontotemporal dementia with GRN mutations, and that the CVR is tied to 'first regulatory approval in specified countries.' However, these details are contextual rather than central to the strategic logic. The answer remains semantically equivalent in intent and factual core. Hence, a score of 9 is warranted—excellent accuracy with negligible detail loss.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 393,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "Visa’s equity base grew by 139 Class A shares (from 1,594 to 1,733, an ~8.7 % increase) through a direct issuance reported on page 58. In contrast, Mastercard’s Class B‑to‑A conversion mechanism is largely dormant – only 7 Class B shares were outstanding in 2024 (page 68), so any conversion would add at most 7 Class A shares, a negligible change relative to its total equity (page 92). Thus, Visa is actively expanding its shareholder base, while Mastercard’s structure remains essentially static with minimal conversion activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in V's Class A shares from 1,594 to 1,733, a difference of 139 shares, and calculates the percentage increase as ~8.7%, which is accurate (139 / 1,594 ≈ 0.0871 or 8.71%). It also correctly states that MA had only 7 Class B shares outstanding in 2024, matching the ground truth. All numeric values and calculations are correct. (2) The LLM cites specific page numbers (58, 68, 92), which are not part of the ground truth but do not contradict it and may reflect actual document locations; their inclusion does not affect factual accuracy. The statement that Mastercard’s conversion mechanism is 'largely dormant' is a reasonable interpretation given the minimal number of Class B shares left. (3) The multi-hop reasoning is sound: the model correctly contrasts V's direct issuance and growth in Class A shares with MA's near-exhausted Class B conversion mechanism, synthesizing information across both companies and their respective shareholder structures. (4) The core insight—that V is actively expanding its shareholder base while MA’s structure is static due to minimal conversion potential—aligns semantically with the ground truth. The only minor shortcoming is that the LLM does not explicitly mention MA's requirement for converted shares to be divested, which adds nuance to the 'conversion and divest' dynamic noted in the original answer. However, this does not invalidate the overall correctness. Thus, the answer is factually accurate, well-reasoned, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 434,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Saudi Arabia’s data‑localization rules would require that any data processed by NVIDIA’s H100 or L40S GPUs be stored and processed within Saudi Arabia【page_23】. Because U.S. export controls now mandate a license for shipping those high‑performance chips to Saudi Arabia (Country Group D5)【page_27】, NVIDIA would need to obtain a license and also ensure the chips are installed in Saudi‑based facilities that meet the data‑residency requirement. The dual compliance burden could restrict or delay deployment, limiting NVIDIA’s ability to offer those chips in Saudi Arabia unless it can satisfy both U.S. licensing and Saudi data‑residency rules.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth. It correctly identifies Saudi Arabia's data localization requirements and U.S. export controls as dual constraints on NVIDIA's deployment of H100 and L40S chips. The mention of licensing requirements under U.S. export rules (referencing Country Group D5) is accurate, though the ground truth specifies Country Group D4—this is a minor discrepancy in classification but does not undermine the overall correctness, as both designations indicate heightened export controls. The LLM correctly infers that NVIDIA must comply with both Saudi data residency rules and U.S. licensing, creating a compliance burden that could delay or restrict deployment. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is logically sound, demonstrating proper multi-hop synthesis between geopolitical regulations and corporate operations. The answer is contextually relevant and captures the key risk to market access. The slight deduction in qualitative accuracy is due to the Country Group mismatch and the absence of explicit mention that NVIDIA has not received such licenses, which weakens the strength of the conclusion slightly compared to the ground truth. However, the semantic meaning remains largely equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 370,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s 2023 10‑K notes that the FASB’s ASU 2020‑04 and its extension ASU 2022‑06 provide optional relief for LIBOR‑referenced contracts, but that “there has been no material effect … and we continue to monitor our contracts and transactions for potential application of these ASUs” (page 93). In contrast, GE’s 10‑K states that LIBOR ceased on June 30 2023, that it “evaluated the financial impact in accordance with ASU 2020‑04 … and the overall impact to our financial statements is immaterial” (page 17) and does not invoke the extended relief, implying the relief was not needed. Thus FedEx is still in a monitoring phase, whereas GE concluded the relief was immaterial and did not elect to apply it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FedEx's disclosure of 'no material effect' and ongoing monitoring of ASU 2020-04 and ASU 2022-06 is accurately represented, as is GE's statement that the impact under ASU 2020-04 is 'immaterial.' The LLM correctly identifies that GE does not invoke the extended relief (ASU 2022-06), implying it was not needed, which is consistent with the ground truth. (2) Quantitative accuracy is perfect: dates (June 30, 2023 for LIBOR cessation), page numbers (93 for FedEx, 17 for GE), and references to ASUs (2020-04 and 2022-06) are all correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures from two different companies, compares their application of the same accounting standards, and infers differing approaches—FedEx’s caution vs. GE’s conclusion of immateriality. (4) The only minor shortcoming is that the LLM slightly overreaches by stating GE 'did not elect to apply' the relief, while the ground truth only says GE concluded the impact was immaterial—this is a subtle distinction, but not factually incorrect, as concluding immateriality often implies non-application. Wording differences are semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 380,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Apple’s manufacturing is largely outsourced to partners in Taiwan, and geopolitical tensions could disrupt production, delay shipments, and raise costs for its devices (AAPL_10k_2023, pages 5, 8, 9, 10, 19). NVIDIA relies on foundry partners such as TSMC in Taiwan to produce its GPUs, so tensions could similarly hamper chip supply, increase lead times, and elevate prices (NVDA_10k_2023, pages 17, 18, 19). Both companies face material adverse impacts if tensions lead to factory shutdowns, export restrictions, or supply‑chain disruptions in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key points are correct: Apple's reliance on Taiwanese manufacturing partners and NVIDIA's dependence on TSMC for GPU production are accurately described, with correct implications of geopolitical tensions—disruptions, delays, cost increases, and material adverse impacts. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond the absence of errors—scored 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks to both Apple and NVIDIA based on their shared dependency on Taiwan-based manufacturing and foundry operations, drawing logical conclusions about supply chain vulnerabilities. (4) The LLM adds slightly more detail (e.g., mentioning TSMC by name and specifying export restrictions) that is consistent with 10-K disclosures and enhances clarity without introducing inaccuracies. The only minor difference from the original answer is the inclusion of page citations, which do not affect correctness. Overall, the response is complete, contextually relevant, and conveys the same core risk assessment as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 345,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s entire $24,156 million of developed‑technology intangible assets from the VMware acquisition is tied to VMware Cloud Foundation, representing 100 % of that asset. In contrast, Oracle’s net developed‑technology value of $1,893 million is only about 10 % of its $18,791 million total intangible assets, a far smaller proportion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The claim that '100% of Broadcom's $24,156 million developed technology intangible asset is tied to VMware Cloud Foundation' is incorrect — the original answer states only that a 'significant portion' is tied to VCF, with no exact percentage disclosed. Presenting it as 100% is a severe misrepresentation. (2) Quantitative errors are significant: Oracle's net developed technology value is stated as $1,893 million in the LLM answer, but the ground truth is $1,276 million. Similarly, Oracle's total intangible assets are reported as $18,791 million by the LLM, whereas the correct figure is $6,890 million. The resulting percentage (10%) is therefore also wrong — the correct value is approximately 18.4%. These numbers are not close and suggest fabrication or confusion with unrelated data. (3) Multi-hop reasoning is flawed: the LLM fails to correctly synthesize the uncertainty around Broadcom's VCF allocation and invents precise figures where none exist. While it attempts the comparison with Oracle, the use of incorrect base numbers invalidates the analysis. (4) Contextual relevance is moderate — the answer addresses the right companies and general topic (developed technology as % of intangible assets), but due to severe factual and quantitative errors, the conclusion about differing strategic valuations is unsupported. The answer conveys a false sense of precision and misleads on key facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 407,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "CMCSA’s Class B common stock represents 33 ⅓ % of the company’s combined voting power, with each share carrying 15 votes and the allocation being non‑dilutable, giving Chairman Brian Roberts significant control (see CMCSA pages 35–38). Alphabet’s (GOOGL) non‑affiliate market value was about $1.45 trillion (page 2), and its dual‑class structure gives voting rights only to Class A shares (1 vote per share) while Class C shares have no voting rights, concentrating control in the hands of insiders (see GOOGL pages 1 and 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth with only minor omissions. (1) Quantitatively, all numbers are correct: CMCSA's Class B has 33⅓% voting power (correctly stated), and GOOGL's non-affiliate market value is reported as $1.45 trillion, which matches the ground truth of $1,451.1 billion when rounded (acceptable format variation). The 300,754,904 Class A shares outstanding at GOOGL are not mentioned in the LLM answer, but this detail is secondary and does not undermine the core comparison. (2) The entity identification is accurate—CMCSA and GOOGL are correctly referenced with appropriate structural details. (3) The reasoning is sound: the LLM correctly identifies that CMCSA’s Class B shares carry 15 votes and are non-dilutable, leading to concentrated control (with a nod to Brian Roberts), while GOOGL’s dual-class structure (Class A with 1 vote, Class C with none) concentrates control among insiders, contrasting with broader non-affiliate market ownership. (4) The answer addresses the core of the question—comparing voting power concentration at CMCSA versus the more market-dispersed ownership at GOOGL—even if it doesn’t explicitly use the phrase 'non-affiliate market value' in the same structural context. The synthesis across both companies is logical and relevant. The only minor shortcoming is the lack of explicit mention that GOOGL’s non-affiliate ownership implies a more dispersed *market-based* control mechanism compared to CMCSA’s structural entrenchment, which slightly reduces qualitative completeness. However, the implication is present. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 472,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "CMCSA’s 2024 equity shows 4.65 billion Class A shares issued versus only 9.44 million Class B shares, with each Class B share carrying 10 votes—concentrating voting power in a very small group of shareholders.  \nMeta reports 2.19 billion Class A shares and 344 million Class B shares; although the Class B shares are a larger fraction of the total, they are non‑voting, so voting power remains with Class A holders but the share concentration is less extreme than CMCSA’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer contains mostly accurate numbers: CMCSA's 4.65 billion Class A and 9.44 million Class B shares are correctly rounded from the ground truth (4,651,093,045 and 9,444,375). META's figures (2.19 billion Class A and 344 million Class B) are also accurate approximations of 2,189,898,148 and 343,761,117. However, the critical qualitative error is the misattribution of voting rights: the LLM incorrectly states that CMCSA's Class B shares carry 10 votes (no such detail is in the ground truth for CMCSA), and falsely claims META's Class B shares are non-voting—when the ground truth explicitly states that META's Class B shares carry 10 votes per share. This reverses the entire logic of the equity concentration analysis.\n\n2) Quantitatively, the numbers are correctly rounded and comparable. The LLM uses 'billion' and 'million' appropriately and preserves the relative magnitudes between companies and share classes. No calculation errors in presentation.\n\n3) The multi-hop reasoning fails due to incorrect attribution of voting rights. The ground truth uses Alphabet's (META's) filing to clarify that Class B shares have 10 votes and convert to Class A upon transfer—this is central to the conclusion about voting concentration. The LLM inverts this by assigning enhanced voting to CMCSA’s Class B and stripping it from META’s, leading to an incorrect conclusion that CMCSA has more concentrated voting power, when the evidence shows the opposite. The synthesis across entities is therefore flawed.\n\n4) Contextually, the answer addresses the question about equity structure concentration and attempts comparison, so relevance is moderate. However, due to the critical error in voting rights assignment, the qualitative accuracy is very low, dragging down the overall correctness. The conclusion is factually inverted from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 501,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health is exposed to Medicare reimbursement risk because a large share of its revenue comes from Medicare/Medicare‑Advantage plans, and the business faces potential reductions in Medicare reimbursement rates or rule changes that could cut its earnings (CVS 10‑K, p. 47).  AbbVie’s exposure under the IRA is to government price‑setting for Medicare Part B and Part D drugs, which can cap prices and reduce reimbursements for certain products, potentially accelerating revenue erosion (AbbVie 10‑K, p. 37; p. 19).  Thus, CVS’s risk is primarily rate‑adjustment and regulatory changes, whereas AbbVie faces a direct price‑cap mechanism that can directly lower its product revenues.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong factual and semantic alignment. (1) All key facts are correct: CVS's Oak Street Health relies on Medicare/Medicare Advantage revenue and faces reimbursement and regulatory risks; AbbVie is exposed to IRA-mandated price-setting for Part B and Part D drugs, which can reduce revenues. The LLM correctly identifies the mechanisms—reimbursement adjustments for CVS and direct price caps for AbbVie. (2) There are no numeric values, dates, or calculations in the LLM answer, but it does not introduce any inaccuracies. The ground truth mentions Imbruvica being selected for price-setting in 2026, and while the LLM omits this specific example and timeline, it still accurately describes the general mechanism and impact of the IRA on AbbVie. This omission prevents a perfect score but does not undermine the overall correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two companies (CVS and AbbVie), two types of Medicare exposure (reimbursement vs. price-setting), and correctly links both to the IRA’s impact on Medicare. It distinguishes the nature of exposure clearly. (4) The answer is contextually relevant and directly addresses the comparative question. The only minor gap is the lack of specific mention of Imbruvica and the 2026/2028 timeline, which are present in the ground truth and add precision. However, the absence does not distort the meaning. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 444,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft reports operating systems as a core component of its product revenue (Microsoft 10‑K, Item 8, § Revenue – “Product revenue includes sales from operating systems” – page 62).  AMD’s own 10‑K (page 28) notes that its x86‑based microprocessors and graphics products “depend on Microsoft designing and developing its operating systems to run on or support our x86 instruction sets or ... to support our graphics products.”  Because Microsoft’s OS sales represent a significant portion of its revenue, the scale of that ecosystem underscores the strategic importance of Microsoft’s continued support, certification and development of its operating systems for AMD’s products—any change in Microsoft’s OS strategy could materially affect AMD’s product adoption and market performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) There are no numeric values in the question or original answer, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies the relationship between Microsoft's operating system revenue and AMD's dependency on OS support, citing both companies' 10-Ks appropriately. It accurately reflects that Microsoft’s product revenue includes operating systems (per Microsoft 10-K, p. 62) and that AMD explicitly states its reliance on Microsoft to design OS support for its x86 and graphics products (AMD 10-K, p. 28). (3) The multi-hop reasoning is sound: it connects Microsoft’s revenue structure to the strategic importance of its OS ecosystem, then links that to AMD’s business risk if support were withdrawn. The logic mirrors the original answer’s causal chain—Microsoft’s OS dominance affects software vendor behavior and customer adoption, thereby impacting AMD. (4) The only minor shortcoming is that the LLM does not explicitly mention the downstream effect on independent software vendors or customer purchasing behavior as stated in the original answer, which slightly reduces completeness in qualitative terms. However, the core dependency and material business impact are clearly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the influence of Microsoft’s revenue model on AMD’s strategic dependency.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 408,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑training and inference infrastructure is built on high‑density routers, switches and high‑performance optics, coupled with a unified management platform that extends policy and operations across on‑premise and cloud environments to enable multicloud architectures (Cisco 10‑K, p. 4). Broadcom, through VMware Cloud Foundation, delivers an integrated private‑cloud stack that includes native Kubernetes for both VMs and containers, supports enterprise‑scale AI and machine‑learning workloads, and offers license portability for multicloud deployments (Broadcom 10‑K, p. 8‑9). While Cisco focuses on networking hardware and unified policy for multicloud, Broadcom’s VMware Cloud Foundation explicitly integrates Kubernetes and provides a turnkey platform for AI workloads across hybrid and multicloud environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Cisco's use of high-density routers, switches, and high-performance optics for AI workloads is accurately described, as is its focus on unified policy and operations across multicloud environments. Broadcom’s VMware Cloud Foundation (VCF) is correctly characterized as providing native Kubernetes support, enabling both VMs and containers, supporting enterprise-scale AI/ML workloads, and offering license portability across hybrid and multicloud deployments. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from Cisco’s and Broadcom’s respective 10-K filings to compare their approaches—Cisco on networking infrastructure and operational consistency, Broadcom via VCF’s integrated platform and Kubernetes integration. The comparison highlights complementary aspects of multicloud enablement. (4) The only minor shortcoming is that the LLM omits the detail about Broadcom valuing VCF using the multi-period excess earnings method, which appears in the original answer and reflects the strategic valuation of VCF in supporting AI workloads. This is a small but relevant point related to Broadcom’s internal assessment of VCF’s value, though not central to the functional comparison asked. Otherwise, the answer is semantically equivalent, well-structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 432,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal’s derivatives are priced with observable market inputs—currency rates, yield curves, volatility and equity prices—and are classified as Level 2, with no significant unobservable inputs required for fair‑value measurement【page_93】.  \nBy contrast, Morgan Stanley’s Level 3 valuations are applied to assets where significant unobservable inputs (such as discount rates, cash‑flow forecasts and other assumptions) are required, making the fair‑value measurement more subjective【page_97】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that PayPal uses observable inputs (currency rates, yield curves, volatility, equity prices) and classifies its derivatives as Level 2, with no reliance on significant unobservable inputs—aligning with the original answer's claim that PayPal had no Level 3 assets or liabilities as of December 31, 2024. The absence of a specific date in the LLM answer is a minor omission but does not affect factual correctness since the classification context is implied from the filing. (2) Quantitatively, there are no numerical errors; the answer avoids incorrect figures and correctly reflects the absence of Level 3 classifications for PayPal and their presence for Morgan Stanley. (3) The multi-hop reasoning is sound: it contrasts PayPal’s reliance on observable data with Morgan Stanley’s use of Level 3 valuations involving unobservable inputs like discount rates and cash-flow forecasts, which matches the original answer’s emphasis on Morgan Stanley’s greater subjectivity due to internal assumptions. (4) The LLM answer is contextually relevant and focused, directly addressing the comparison in valuation techniques and reliance on unobservable inputs. The only minor shortcoming is the lack of explicit mention that PayPal had *zero* Level 3 assets/liabilities as of a specific date (Dec 31, 2024), which slightly reduces completeness but does not undermine the overall correctness. Hence, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 419,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "At Meta, the 343 million Class B shares are largely non‑voting (or only vote on a narrow set of matters), so even a sizable block of these shares would have limited influence over most corporate decisions. By contrast, Comcast’s 3.78 billion Class A shares constitute the primary voting class, giving shareholders a much larger and more direct voting power to steer governance. Thus, shareholder‑driven governance changes are far more feasible at Comcast than at Meta for holders of the respective share classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the numbers are correctly represented: 343 million approximates 343,761,117 and 3.78 billion matches 3,778,302,017—rounding is acceptable and common in financial communication. (2) The entity identification is correct: Meta (META) and Comcast (CMCSA) are accurately referenced with their respective share classes (Class B non-voting at Meta, Class A voting at CMCSA). (3) The reasoning correctly synthesizes the multi-hop concept: it contrasts Meta’s limited voting rights for Class B shares with CMCSA’s broad voting rights for Class A, and draws the logical conclusion that shareholder-driven governance changes are more feasible at CMCSA. (4) The only minor shortcoming is that the LLM does not explicitly mention the specific corporate actions (e.g., exiting core payments business or certain mergers) where Class B shares at Meta do have voting rights, which slightly reduces completeness in qualitative detail. However, stating that voting rights are 'only on a narrow set of matters' captures the essence. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 345,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "KO reports that 71 % of its non‑U.S. unit case volume is attributable to sparkling soft drinks in the territories where CCEP operates (page 7). In contrast, PMI’s 10‑K notes only that it has a manufacturing facility in Portugal—a key CCEP market—but does not disclose a unit‑case‑volume percentage for that country (page 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: 71% of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in CCEP-operated territories, matching the ground truth exactly. This number is accurately cited and attributed. The answer also correctly notes that PM (PMI) has a manufacturing facility in Portugal, a key CCEP market, based on the 10-K reference. However, the LLM answer omits the specific detail from the ground truth that PM's Portugal facility is among its largest and produces over 30 billion units (cigarettes and heated tobacco combined). While the presence of the facility is correctly stated, the additional context about scale and output is missing, which weakens the comparative analysis between KO's distribution reliance on CCEP and PM's direct production footprint. This omission affects completeness and qualitative depth but does not introduce factual errors. All entities (KO, CCEP, PM/PMI, Portugal) are correctly identified, and the multi-hop reasoning—linking KO’s volume dependence in CCEP markets to PM’s operational presence in one of those same markets—is partially addressed but less developed than in the original. The answer remains semantically aligned and factually accurate where it does respond, with no incorrect claims. Number formatting (71 %) is acceptable, and source page references add credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 381,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s allowance for credit loss on loan receivables fell from $103 million in 2022 to $53 million in 2023 (page 83).  Because loan receivables include financing for hardware, software, and “technical support and advanced services” (page 82), the lower reserve increases net receivables by roughly $50 million, improving liquidity and freeing capital that can be deployed to finance or extend support‑service contracts.  The reduction also signals better credit quality, potentially allowing Cisco to offer more favorable financing terms for technical support services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth. The implied $50 million increase in net receivables (difference between $103M and $53M) is accurate, though the percentage decrease (48.5%) is not explicitly mentioned but not required for correctness. (2) All numeric values and years are correct; the $50 million capital release is a valid approximation of the $50 million difference. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly links the reduced allowance to improved credit quality, connects loan receivables to financing for technical support services (citing 'technical support and advanced services'), and infers that improved liquidity and confidence could enable expanded or more favorable financing terms—aligning with the ground truth’s conclusion. (4) The answer is highly relevant, complete, and semantically equivalent to the original answer, with only minor omission of the explicit percentage decrease, which does not detract from the core insight. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 336,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred stock gives holders voting power only on a narrow set of merger‑related matters (each series votes as a single class and can vote only on those limited issues)【page_90】, whereas Netflix’s common stockholders enjoy universal voting rights—one vote per share on **all** matters【page_61】.  As a result, AT&T’s preferred shareholders have a much more restricted influence on corporate governance compared with Netflix’s fully voting common shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately states that AT&T’s Series B Preferred Stockholders have voting rights only on specific merger-related matters, while Netflix common stockholders have one vote per share on all matters. The description of AT&T’s voting structure (voting as a single class on limited issues) and Netflix’s universal voting rights is correct. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not applicable beyond correct representation of voting rights, which is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two different companies (AT&T and Netflix) and contrasts their voting frameworks. It identifies the key difference—limited vs. universal voting rights—and draws the correct conclusion about relative governance influence. (4) The only minor shortcoming is a slight lack of detail compared to the original answer (e.g., not explicitly stating that AT&T preferred holders vote 'equal to the number of shares held'), but this does not affect the core accuracy. Wording differences are acceptable and do not alter meaning. The answer is highly relevant, directly addressing the comparative corporate governance question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 374,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal’s 10‑K (page 18) lists virtual currencies, distributed‑ledger and other emerging payment methods—including BNPL and crypto—as a source of technological risk that could erode its product relevance if it fails to adopt them. In contrast, Visa’s 10‑K (page 16) treats the same alternative payment providers as both partners and competitors, integrating them into its network (e.g., Visa Direct, B2B Connect) while also vying for transaction volume, thereby positioning itself to capture value rather than merely defend against disruption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies PayPal's exposure to technological disruption from BNPL and cryptocurrency as a risk highlighted in its 10-K (page 18), aligning with the original answer's claim about obsolescence risk. It also accurately contrasts Visa's dual role as both partner and competitor, citing its 10-K (page 16) and referencing specific network integrations like Visa Direct and B2B Connect, which demonstrates strong multi-hop reasoning across both companies' filings. There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable but assumed correct. The only minor limitation is that the LLM answer does not explicitly state Visa's 'global network and security advantages' or PayPal's need for 'heavy investment' to keep pace—details present in the ground truth—making it slightly less comprehensive but still capturing the core strategic contrast accurately. Wording differs but meaning is preserved, satisfying semantic equivalence. Contextual relevance is perfect, directly addressing the comparative strategic positioning question with evidence from both 10-Ks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 343,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s common stock grants **one vote per share** (see the “Voting Rights” section on page 61). Alphabet’s Class A common stock also grants **one vote per share** (see the “Class A and Class B Common Stock” description on page 81). Thus, the voting power per share is identical for both companies.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that both Netflix's common stock and Alphabet's Class A Common Stock provide one vote per share, matching the original answer. (2) There are no numerical values requiring calculation, but the voting rights (1 vote per share for both) are correctly reported with no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (Netflix and Alphabet) and compares their voting rights per share, concluding equivalence despite Alphabet's multi-class structure (which the LLM implicitly acknowledges by specifying Class A). (4) The answer is concise but complete, addressing all parts of the question with precise, relevant information. Minor formatting differences (e.g., page references, bolding) do not affect factual accuracy. All entities (Netflix, Alphabet, Class A Common Stock) and their respective voting rights are correctly identified and compared.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 293,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "PM’s 2023 10‑K (p. 81) shows that its parametric delta‑gamma VAR is calculated under normal market conditions with a 95 % confidence level and a one‑day horizon, producing fair‑value impacts of $297 m (interest rates) and $77 m (foreign currency) at year‑end, with averages of $332 m and $74 m and highs of $505 m and $82 m. MDLZ’s 2023 10‑K (p. 64) uses the same technique and assumptions but also includes commodity exposure, reporting a one‑day VAR of $119 m (interest rates) and $14 m (currency) at year‑end, with averages of $144 m and $17 m and highs of $234 m and $18 m, plus a commodity VAR of $21 m at year‑end. Thus, while both firms apply the parametric delta‑gamma method under identical market‑condition assumptions, PM’s VAR estimates for interest‑rate and currency risk are markedly higher, and MDLZ’s model is broader, incorporating commodity‑price risk in addition to the same interest‑rate and currency exposures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer (ground truth) states that PM does *not* disclose a specific VAR figure, but the LLM claims PM reported year-end VAR impacts of $297M (interest rates) and $77M (foreign currency), along with averages and highs—none of which appear in the ground truth. Similarly, the LLM attributes specific VAR numbers to MDLZ ($119M interest rate, $14M currency, $21M commodity), but the ground truth only confirms that MDLZ *discloses* VAR amounts at year-end without specifying the actual figures. Thus, all quantitative values in the LLM answer are fabricated or hallucinated. (2) There is no verification possible for calculations because the numbers do not exist in the ground truth; their inclusion constitutes a major factual error. (3) The multi-hop reasoning is partially sound in structure—comparing PM and MDLZ on method (parametric delta-gamma), confidence level (95%), and holding period (one-day)—and correctly identifying that MDLZ includes commodity risk while PM does not. However, the conclusion that 'PM’s VAR estimates are markedly higher' is unsupported by the ground truth, which does not provide any numerical VAR estimates for either company. (4) While the LLM captures some qualitative aspects (methodology, risk factors, disclosure differences), the hallucination of precise financial figures severely undermines factual correctness. The contextual relevance is fair because it addresses the comparison question and identifies key differences in risk coverage, but the made-up numbers render the answer misleading. Correctness score is low due to critical quantitative inaccuracies despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 473,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One’s exposure to the Market Risk Rule is triggered when its aggregate trading assets and liabilities equal at least 10 % of total assets or $1 billion; once triggered the rule requires the firm to adjust its Basel III capital ratios to reflect the market‑risk exposure in its trading book (page 86). By contrast, JPMorgan Chase’s Basel III regulatory capital is driven by a single VaR framework that calculates a one‑day, 95 % confidence “Risk‑Management VaR” and a ten‑day, 99 % confidence “Regulatory VaR” for all Basel‑III‑covered positions, with the latter used to derive the market‑risk capital charge (page 145). Thus, Capital One’s requirement is threshold‑based and applies only when the trading book meets the 10 %/$1 B cut‑off, whereas JPMorgan’s capital charge is continuously applied through its VaR model regardless of a specific asset threshold.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy in the VaR methodology description for JPMorgan Chase. The ground truth states that JPM uses a ten-business-day holding period at a 99% confidence level for Regulatory VaR, which the LLM correctly identifies. However, the LLM introduces a 'one-day, 95% confidence Risk-Management VaR' that is not mentioned in the original answer and appears to conflate internal risk management practices with regulatory requirements—this detail is extraneous and not part of the Basel III regulatory capital charge as described in the ground truth. Additionally, while the LLM correctly identifies Capital One’s $1 billion or 10% threshold for triggering the Market Risk Rule, it does not mention COF’s use of the Basel III standardized and proposed Expanded Risk-Based Approaches, nor the 2028 phase-in timeline, which are key differentiators in the original answer. These omissions reduce completeness and qualitative accuracy. Quantitatively, all figures (10%, $1 billion, 99%, ten-day) are accurate and correctly attributed. The reasoning is logically structured and addresses the comparative framework between threshold-based applicability (COF) vs. continuous model-based application (JPM), supporting a relevant and contextually appropriate response. However, the failure to include COF’s evolving Basel III compliance framework and the introduction of an unsupported internal VaR metric for JPM prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 404,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco records a $50 million allowance for credit losses on its loan receivables, many of which are financing arrangements that include technical‑support and advanced‑services contracts (see CSCO 10‑K, p. 90 and p. 84).  By contrast, Salesforce’s 10‑K (p. 19) notes that it “works with third parties to increase the breadth of capability and depth of capacity for delivery of these services,” exposing it to operational/service‑delivery risk rather than a quantified credit‑loss provision.  Thus, Cisco’s exposure is measured as a potential financial loss on receivables tied to support services, while Salesforce’s exposure is an operational risk from relying on external providers to deliver those same services.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in content and reasoning but contains a minor quantitative inaccuracy. The ground truth states Cisco's credit loss allowance is $53 million as of July 29, 2023, while the LLM reports $50 million. This $3 million discrepancy, though relatively small, affects the quantitative accuracy. All other qualitative elements are correct: Cisco's allowance relates to financing arrangements including technical support services, and Salesforce relies on third parties for service delivery, creating operational rather than credit risk. (2) The dollar amount is the only numerical error—$50M vs. $53M. No other numbers, dates, or percentages are present, and the fiscal period is implied correctly through document citation. The comparison does not involve calculations, so no computational errors exist beyond the incorrect figure. (3) The multi-hop reasoning is sound: the model correctly identifies that Cisco bears direct financial (credit) risk via financing of support services, while Salesforce faces operational risk due to third-party reliance. It synthesizes information from both 10-Ks appropriately and draws a valid contrast in risk types. (4) The correctness score is 8 because the core facts and reasoning are accurate, and the answer fully addresses the comparative risk exposure question. The $3M error prevents a 9–10 score. Quantitative accuracy is 7 due to the incorrect dollar figure. Qualitative accuracy is 9—reasoning, entity identification (Cisco, Salesforce, technical support, third-party providers), and synthesis are excellent. Contextual relevance is 10—the response directly and fully addresses the question’s focus on comparing risk exposures related to service delivery.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 474,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "META’s dual‑class structure gives its controlling shareholder (Mr. Zuckerberg) the power to dictate board and shareholder decisions, a governance arrangement that the 10‑K notes say could make Class A shares less attractive and erode investor confidence (page 50). In contrast, CMCSA issues a separate Class B class that is issued but not convertible into Class A shares and is not tied to any governance‑related conversion rights, so its Class A shares face lower governance risk (page 69).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and reasoning. (1) It accurately captures the core contrast: META's dual-class structure gives Mr. Zuckerberg disproportionate control, which the 10-K explicitly states could make Class A shares less attractive due to reduced governance protections—this matches the original answer's emphasis on investor confidence. The reference to page 50 (though not evaluated for exactness here) supports contextual grounding. (2) Quantitatively, while the original answer includes a specific figure (9,444,375 Class B shares for CMCSA), the LLM omits this number. However, since the question does not explicitly ask for share counts and the absence does not distort the comparison, this is a minor omission rather than a factual error. (3) The LLM correctly identifies that CMCSA’s Class B shares are not convertible into Class A and lack governance-linked conversion rights—this is consistent with the ground truth that CMCSA does not tie governance or conversion to investor restrictions. However, the LLM slightly oversimplifies by stating CMCSA’s Class B is 'not convertible' without clarifying whether such a mechanism exists at all; the original answer notes there is 'no indication' of such ties, which is a more cautious and accurate phrasing. (4) The multi-hop reasoning—comparing governance risks in META’s controlled company structure versus CMCSA’s less restrictive dual-class setup—is sound and relevant. The conclusion that CMCSA’s Class A shares face lower governance risk is logically supported. The answer is semantically equivalent in intent and meaning, though slightly less detailed in nuance. Hence, correctness is high but not perfect due to the omitted quantitative detail and slight simplification of CMCSA's structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 493,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG’s RMBS are valued with discounted‑cash‑flow models that rely on several unobservable inputs—constant pre‑payment rate, loss severity, constant default rate and yield—whose ranges are disclosed in the 2024 10‑K (page 120).  Morgan Stanley also uses discounted‑cash‑flow for some fair‑value assets and notes that Level 3 fair‑value measurements require significant unobservable inputs, but the firm does not provide the same level of detail or explicit ranges for those inputs in the pages supplied (page 42).  Thus, AIG’s approach is more transparent about the specific unobservable assumptions, whereas MS acknowledges reliance on such inputs but does not disclose them in detail.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AIG uses discounted cash flow models with unobservable inputs for RMBS valuation and that MS uses DCF for fair value estimation involving Level 3 assets. It accurately notes AIG's disclosure of specific input ranges (though without repeating the exact numbers from the ground truth: CPR 4.10%-9.26%, loss severity 40.81%-76.72%). However, the LLM does not include the specific quantitative figure for MS's Level 3 assets (0.9% of total assets as of December 31, 2024), which is a key part of the original answer and a concrete metric for comparing the degree of reliance on unobservable inputs. (2) Quantitative accuracy is partially compromised because while AIG’s use of unobservable inputs is correctly described in kind, the exact ranges are omitted, and MS’s Level 3 percentage is missing—both are specific, verifiable numbers in the ground truth. The LLM mentions MS’s use of Level 3 inputs but fails to report the 0.9% figure, which weakens direct comparability. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AIG and MS filings, comparing their use of DCF models and reliance on unobservable inputs. It draws a valid qualitative distinction about transparency, noting AIG provides explicit ranges while MS does not disclose them in detail—this is consistent with the documents and adds insight. (4) The answer is contextually highly relevant and conveys much of the same meaning, though with less numerical precision. The omission of key percentages prevents a top score in correctness and quantitative accuracy, but the reasoning and entity identification (AIG, MS, RMBS, DCF, Level 3, unobservable inputs) are accurate. Thus, the answer is substantially correct but lacks full completeness on quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 494,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables fell from $53 million to $50 million (a $3 million decline) between FY 2023 and FY 2024, indicating a modest improvement in the credit quality of its hardware‑financing receivables (see pages 84‑85). Microsoft, by contrast, treats hardware that is highly dependent on software as a single performance obligation and recognizes revenue at the point of ownership transfer, bundling the hardware and software license into one transaction (see page 62). The two approaches show that Cisco’s integrated hardware‑software exposure is measured through credit‑risk provisions on financing, while Microsoft’s exposure is reflected in revenue‑recognition timing and bundling, highlighting different risk profiles for the same type of product integration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. The ground truth states that Cisco's allowance decreased from $103 million in FY2022 to $53 million in FY2023, but the LLM incorrectly reports a decrease from $53 million to $50 million between FY2023 and FY2024—both the values and the fiscal years are wrong. This represents a major quantitative error that undermines the financial comparison. (2) The calculation of a '$3 million decline' is based on incorrect data and does not align with the ground truth, which shows a $50 million reduction ($103M to $53M). The LLM's numbers are not supported by the original data. (3) While the qualitative reasoning about Microsoft’s revenue recognition approach is largely accurate—correctly identifying that Microsoft treats interdependent hardware-software as a single performance obligation and recognizes revenue at point of sale—the synthesis between the two companies’ risk exposures is only partially correct. The LLM correctly contrasts Cisco’s credit-risk provisioning with Microsoft’s revenue-timing exposure, which shows sound multi-hop reasoning in concept, but the flawed data weakens the conclusion. (4) Contextual relevance is high because the answer addresses the core comparison between Cisco and Microsoft regarding financial treatments of integrated hardware-software offerings. However, due to the critical errors in financial figures and timeframes, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the conceptual framework is valid, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 448,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG’s 2024 loss on embedded derivatives was $75 million (page 144).  By contrast, Morgan Stanley’s exposure to hybrid instruments with embedded derivatives—primarily CLNs and CDOs—is reflected in about $377 billion of credit protection sold to issuers (page 108, “Credit protection sold”), a magnitude far larger than AIG’s loss.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a significant factual error in quantitative accuracy: it claims Morgan Stanley has '$377 billion of credit protection sold,' which is not supported by the original answer (ground truth) and introduces a number absent from the provided context. The ground truth does not specify any dollar amount for MS's exposure—only the structural similarity to AIG’s risk through CDOs and CLNs with embedded derivatives. This invalidates the core comparison, as there is no basis for stating $377 billion. While the AIG $75 million loss figure is correctly cited with a plausible source (page 144), the MS figure lacks corroboration in the original answer and distorts the comparison. Qualitatively, the model correctly identifies both firms' involvement in hybrid instruments (CDOs, CLNs) with embedded derivatives and recognizes that credit risk stems from potential non-repayment due to credit events—this shows partial multi-hop reasoning. However, it fails to emphasize the conceptual parallel in risk structure (both face principal loss upon credit events), instead substituting an unsupported quantitative comparison. Contextually, the response addresses the question's focus on comparing exposures and structured credit involvement, but the erroneous statistic undermines the conclusion. The answer would have been stronger by focusing on qualitative parallels, as the original answer does, rather than introducing unverified numerical scale.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 401,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s policy allows it to hedge forecasted foreign‑currency transactions for up to **four years** (page 121). In contrast, Google’s cash‑flow hedges—forward and option contracts used for forecasted revenue—have maturities of **24 months or less** (page 70). Thus, Disney’s hedges cover a longer horizon than Google’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers and durations are correct: Disney's hedge duration of up to four years and Google's 24 months or less are accurately reported. The LLM correctly identifies that both companies use option contracts (implied in the context of cash flow hedges), though it does not mention the specific dollar amounts ($9.9 billion for Disney and $731 million for Google) from the original answer. However, since the question does not explicitly ask for hedge values, this omission does not detract significantly from correctness. (2) The comparison in hedge durations is logically sound and correctly concludes that Disney’s hedges cover a longer horizon. (3) Multi-hop reasoning is properly executed—information from two different companies is synthesized to compare hedge maturity periods. (4) Entity accuracy is strong: both Disney and Google are correctly identified with accurate time horizons. The only minor shortcoming is the lack of explicit mention of option contracts for both firms (though Google’s use is implied via 'option contracts'), but the core of the question—duration comparison—is fully addressed. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 365,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "Qualcomm expects the OECD’s 15 % global minimum tax (Pillar Two) to have no material effect on its FY 2025 tax liabilities, even though it operates in many jurisdictions [page_71].  \nIntel, whose income is largely U.S.-taxed, also does not anticipate a material impact under the Pillar Two Model Rules, and its exposure is likely lower because most of its operations are domestic [page_43].",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of Intel's (INTC) exposure to Pillar Two. While it correctly states that Qualcomm (QCOM) expects no material impact due to its operations not being in low-tax jurisdictions, it incorrectly claims that Intel's income is 'largely U.S.-taxed' and that it 'does not anticipate a material impact.' This contradicts the ground truth, which states that INTC has a significant portion of its income taxed in non-US jurisdictions and is still evaluating the impact, facing more immediate uncertainty. (2) Quantitatively, there are no explicit numerical errors (e.g., percentages like 15% are correct, fiscal year 2025 is correctly referenced), so quantitative accuracy is high. (3) The multi-hop reasoning is flawed: the question asks for a comparison based on differing geographic distributions, but the LLM incorrectly asserts that Intel’s operations are mostly domestic, undermining the synthesis. The ground truth emphasizes INTC’s broad international footprint as a key differentiator, which the LLM answer misses entirely. (4) Contextual relevance is moderate because the answer addresses the right companies, the right policy (Pillar Two), and the right timeframe (FY2025), but the core comparative analysis is inverted—portraying INTC as less exposed when it is in fact more exposed. This fundamental error severely reduces correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 402,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s Class B shares give each holder 10 votes (vs. 1 vote for Class A) and can be converted to Class A shares at the holder’s option, automatically converting on sale or transfer【page_81】. This structure lets founder Mark Zuckerberg retain a majority‑level voting bloc while still allowing him to reduce his influence by converting shares. In contrast, Comcast’s Class B shares carry 15 votes each and collectively represent a non‑dilutable 33 ⅓ % of voting power【page_91】, giving the founder a stable minority block that cannot grow but also cannot exceed that 33 ⅓ % share of control. Thus, Alphabet’s founder enjoys more flexible, potentially majority control, whereas Comcast’s founder holds a fixed but limited minority voting stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several critical factual errors that undermine its correctness. (1) It incorrectly attributes Alphabet's Class B shares to Mark Zuckerberg, who is not associated with Alphabet (Google); the correct founders are Larry Page and Sergey Brin. This is a major entity error. (2) The claim that Comcast’s Class B shares carry '15 votes each' is incorrect — the ground truth states they collectively hold 33⅓% of voting power in a non-dilutable structure, not per-share voting rights. The original answer does not specify a per-share vote ratio for Comcast, so asserting '15 votes' is unsupported and likely false. (3) The LLM incorrectly states that Alphabet’s Class B shares can be converted to Class A 'at the holder’s option' — the ground truth specifies that conversion happens automatically upon sale or transfer, not at the holder’s discretion. (4) While both structures are contrasted in terms of flexibility vs. fixed control, the LLM mischaracterizes Comcast’s structure as a 'minority block that cannot grow but also cannot exceed 33⅓%' — the original emphasizes that this 33⅓% is non-dilutable and preserved regardless of share issuance, which the LLM partially captures but distorts with incorrect mechanics. (5) The core contrast — Alphabet allowing dynamic, potentially diminishing control vs. Comcast guaranteeing fixed, insulated control — is partially correct and shows some valid reasoning, earning moderate qualitative and contextual scores. However, due to major quantitative and entity inaccuracies, the correctness score is low. Semantic equivalence fails on key points: wrong founder, incorrect vote ratios, and flawed conversion mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 456,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The distribution‑agreement indemnification means that PMI will cover Altria and PM USA for liabilities arising from PMI‑manufactured products, and Altria records no related liability on its balance sheet because the fair value of the indemnification is insignificant【page_108 of PM_10k_2022】【page_108 of MO_10k_2022】. In contrast, PMI retains obligations through the deconsolidation of RBH, which are reflected in PMI’s other comprehensive losses and remain on PMI’s books, potentially increasing PMI’s exposure【page_106 of PM_10k_2022】. Thus, Altria’s financial exposure to tobacco‑related litigation is effectively reduced by the indemnification, while PM’s retained RBH obligations stay on PMI’s balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the indemnification structure under the Distribution Agreement: PMI indemnifies Altria and PM USA for liabilities related to PMI-manufactured products, and Altria does not record a liability due to the insignificant fair value—this aligns with the ground truth. However, the LLM incorrectly states that 'PMI retains obligations through the deconsolidation of RBH' and that these are reflected in 'PMI’s other comprehensive losses'. In the ground truth, it is PM (Philip Morris USA), not PMI (Philip Morris International), that retains obligations tied to the RBH deconsolidation, which involved reclassifications from accumulated other comprehensive losses. This is a key entity confusion between PM USA and PMI. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is partially sound: the model correctly links the indemnification agreement to reduced Altria exposure and references balance sheet treatment. However, it fails to correctly attribute the RBH-related obligations to PM USA rather than PMI, undermining the qualitative accuracy of the synthesis. This misattribution affects the comparison central to the question. (4) Contextual relevance is high because the answer addresses both indemnification and deconsolidation impacts on financial exposure, and cites relevant 10-K pages. The core financial conclusion about Altria’s reduced exposure is correct, but the error in entity assignment limits the correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 448,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables dropped from $103 million in 2022 to $53 million in 2023 (page 84), which lifted net loan receivables from about $5.76 billion to $5.86 billion (page 82). Because these loan receivables finance the sale of hardware, software and technical‑support arrangements, the lower allowance reduces expected write‑offs and strengthens the cash‑flow position for Cisco’s technical‑support services. Adobe, in contrast, funds its technical‑support offerings through subscription and annual maintenance fees that are built into the product price or support contracts (page 17), rather than relying on financing receivables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the decline in Cisco's allowance for credit losses from $103 million in 2022 to $53 million in 2023 is accurately reported, and the resulting increase in net loan receivables (from $5.76B to $5.86B) is consistent with the reduction in allowance. These figures are correctly attributed to the relevant pages (84 and 82), indicating proper sourcing. (2) The answer correctly identifies that Cisco uses loan receivables to finance the sale of hardware, software, and technical support services, and that a lower allowance improves cash flow by reducing expected write-offs—this reflects sound reasoning about the financial impact. (3) The comparison with Adobe is accurate: Adobe funds technical support through subscription and maintenance fees built into contracts (page 17), not through financing receivables. This correctly contrasts Adobe’s model with Cisco’s. (4) The only minor shortcoming is that the LLM does not explicitly mention Adobe’s 1- to 3-year terms for support, which is included in the ground truth and adds slight contextual depth. However, this omission does not detract from the core accuracy or completeness of the comparison. Multi-hop reasoning is strong—information is correctly synthesized across Cisco and Adobe, and across financial structure and support funding models. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 424,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Citibank, N.A. is the administrative agent in both agreements.  Caterpillar’s 5‑Year Facility (originally dated Sept 1 2022) was amended on Aug 31 2023, whereas Boeing’s 2019 Five‑Year Credit Agreement (dated Oct 30 2019) was amended on Aug 25 2022【page_129】【page_126】.  The Caterpillar facility is part of a syndicate of banks (three global credit facilities totaling $10.5 B) but does not name a syndication agent【page_103】【page_129】, while Boeing’s agreement names JPMorgan Chase as the syndication agent and joint lead arranger/book manager alongside Citibank【page_126】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Citibank, N.A. is correctly identified as administrative agent in both agreements; Caterpillar's 2022 facility was amended on August 31, 2023, and Boeing's 2019 agreement was amended on August 25, 2022—both dates match the ground truth. The original dates (Sept 1, 2022 vs. Sept 1, 2022 implied in ground truth; Oct 30, 2019) are accurate. (2) Quantitative accuracy is perfect: no numerical errors in dates or dollar amounts. While the LLM mentions 'three global credit facilities totaling $10.5B' for Caterpillar—a detail not in the ground truth—it is contextually relevant and does not contradict it. (3) Multi-hop reasoning is sound: the model correctly compares amendment timelines (within one year vs. nearly three years post-initial agreement) and syndication structures—highlighting JPMorgan Chase Bank, N.A.'s role as syndication agent and joint lead arranger for Boeing, while noting Caterpillar lacks such a named syndication agent. (4) The only minor shortcoming is that the LLM does not explicitly name MUFG Bank, Ltd. as a co-agent in Caterpillar’s syndicate, which is mentioned in the ground truth. However, stating that Caterpillar’s facility 'does not name a syndication agent' and involves a syndicate of banks is factually consistent. The omission is minor and does not impair the overall correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 433,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "A prolonged conflict in Taiwan could shut down or limit the capacity of the region’s semiconductor foundries that both NVIDIA and Qualcomm depend on for wafer fabrication and assembly.  NVIDIA’s risk‑factor notes that “foundry partners in Taiwan” are critical to its supply continuity and that a conflict could materially harm its ability to meet demand (NVDA 10‑K, p. 17‑18, 35).  Qualcomm similarly warns that its “product components and final assembly are concentrated in Taiwan (and Korea)” and that geopolitical tensions there could disrupt manufacturing, logistics and increase costs (QCOM 10‑K, p. 31, 35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual information is correct: both NVIDIA and Qualcomm are correctly identified as relying on foundry partners in Taiwan, and the risks to supply chain reliability due to a geopolitical conflict are accurately described. The LLM cites specific risk factors from each company's 10-K (NVDA p.17-18, 35; QCOM p.31, 35), which supports the claims and matches the intent of the ground truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (NVIDIA and Qualcomm), identifies their shared dependency on Taiwanese foundries, and links geopolitical risk to supply chain disruption. The reasoning reflects an accurate understanding of supply chain concentration risks. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing and includes document citations not in the original, the core meaning—geopolitical instability in Taiwan threatening supply chains for both firms due to regional manufacturing concentration—is fully preserved. The only minor limitation is that the LLM does not explicitly mention 'revenue loss' or 'production delays' as consequences, which are included in the original answer, making it slightly less complete but still substantially accurate. Hence, a score of 9/10 for correctness and qualitative accuracy is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 443,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing’s indemnification exposure comes from potential U.S.‑government indemnity for liabilities that may arise under its federal contracts; the company notes that insurance may be inadequate and that it faces ongoing government inquiries and investigations that could trigger legal proceedings (see page 20). 3M’s spin‑off of Solventum transferred specific litigation liabilities—Bair Hugger and Federal False Claims Act/Qui Tam cases—to Solventum, which will indemnify and defend 3M (see page 84 and the transfer of liabilities noted on page 70).  Thus, Boeing’s risk is broader and uncertain, tied to government‑issued indemnity that may be limited, whereas 3M’s risk is narrowly defined, with the liabilities and defense obligations assumed by the new entity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Boeing's indemnification risk is tied to U.S. government contracts, including pension cost allocations under CAS, and the company faces uninsurable risks and government investigations (as noted on page 20 of its filing). 3M transferred specific liabilities—Bair Hugger and Federal False Claims Act/Qui Tam cases—to Solventum in the spin-off effective April 1, 2024, with Solventum assuming defense and indemnification obligations (referenced on pages 70 and 84). These details match the original answer. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect; the mention of page numbers is consistent with source documentation and does not affect factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Boeing’s and 3M’s disclosures, comparing ongoing government contract risks (Boeing) with post-spin-off liability transfers (3M). The conclusion that Boeing’s exposure is broader and uncertain while 3M’s is now narrowly defined and transferred is logically supported. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'government-issued indemnity that may be limited' vs. 'pension cost allocations under CAS'), the core meaning regarding Boeing’s exposure remains accurate. One minor point preventing a perfect 10 is that the LLM does not explicitly mention CAS (Cost Accounting Standards) or the link between pension allocations and contract profitability, which is a nuanced but relevant detail in the original answer. However, this omission does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 470,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "CMCSA’s Class B shares – all owned by Brian L. Roberts – carry 15 votes each and represent 33 % of the combined voting power, a non‑dilutable block that gives Roberts control over board and corporate decisions (page 33).  This concentrated voting structure illustrates the governance risk that a dual‑class scheme can create for minority shareholders, a risk that META faces as a controlled company whose dual‑class structure concentrates voting power in the hands of Mark Zuckerberg (page 50).  Accordingly, META’s Class A shareholders may have limited influence over governance and may be exposed to conflicts of interest and reduced board independence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B stock owned by Brian L. Roberts carries 15 votes per share and represents 33⅓% of voting power; the LLM correctly reports this as '33%'—a negligible rounding acceptable under semantic equivalence. (2) The answer correctly identifies both companies (CMCSA and META), their dual-class structures, and the key individuals (Roberts and Zuckerberg), satisfying entity accuracy. (3) The reasoning correctly draws a parallel between CMCSA’s concentrated voting structure and META’s governance risks, noting that both involve outsized control by a single individual through high-vote shares, which limits influence for Class A shareholders. It appropriately references the controlled company status and reduced board independence, consistent with META’s 10-K disclosures. (4) The only minor omission is that the LLM does not explicitly mention the 35% threshold at which META’s Class B voting control would weaken—a detail present in the original answer—but this does not undermine the core correctness. The synthesis across CMCSA and META is logically sound and contextually relevant. Overall, the answer conveys the same meaning as the ground truth with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 360,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s beverage distribution in northern Argentina is handled by its bottling partner Arca Continental, as noted on page 7 of the 10‑K.  Procter & Gamble, meanwhile, warns on page 23 that it has both translation and transaction foreign‑exchange exposure in Argentina, where currency fluctuations have already impacted sales, costs and earnings.  Thus, while Coca‑Cola’s exposure in the region is operational—relying on a local bottler whose performance is tied to the Argentine peso—P&G’s risk is financial, stemming from the same currency volatility that can affect both companies’ profitability in that market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Coca-Cola relies on Arca Continental for distribution in northern Argentina, and Procter & Gamble explicitly cites foreign exchange exposure in Argentina. The LLM correctly identifies Coca-Cola’s indirect operational exposure via its bottling partner and P&G’s direct financial exposure due to currency volatility. (2) There are no numeric values in the original or LLM answer that conflict—both avoid specific percentages or dollar amounts beyond what’s in the source, so quantitative accuracy is preserved. The mention of 'page 7' and 'page 23' may refer to actual 10-K sections and do not contradict the knowledge graph. (3) Multi-hop reasoning is sound: the model connects Coca-Cola → Arca Continental → Argentina operations → macroeconomic risk, and separately P&G → Argentina → FX exposure, then synthesizes that both face risks from Argentina’s economic environment, albeit through different channels. (4) The only minor shortcoming is that the LLM omits the detail about Coca-Cola’s 17% worldwide unit case volume through bottlers (including Arca), which adds contextual depth to the scale of reliance. However, this omission does not undermine the core correctness. Wording differs but semantic meaning matches. Thus, high scores across all dimensions with a 9 on correctness due to partial completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 392,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Alimta’s patent expiration is expected to trigger a rapid, severe decline in Lilly’s oncology revenue, as generics can enter the market quickly under the Hatch‑Waxman framework (Alimta revenue fell 12 % in 2021【page_44】, and Lilly notes a “rapid and severe decline” following loss of exclusivity【page_25】). In contrast, Amgen’s biologics are protected by a 12‑year exclusivity period under the BPCIA, so biosimilar competition is slower and subject to an abbreviated approval pathway, but patent litigation and potential earlier biosimilar entry still pose a material risk to its biologic revenue streams【page_45】【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Alimta's patent expiration leads to a rapid and severe decline in Eli Lilly's oncology revenue due to generic competition under the Hatch-Waxman Act, which governs small molecule drugs. This matches the original answer’s emphasis on immediate revenue erosion for small molecules. The LLM cites a 12% revenue decline in 2021 (from page 44) and quotes Lilly’s 'rapid and severe decline' language (page 25), which supports the claim and adds specific evidence not in the ground truth but consistent with it. (2) Quantitatively, the 12% decline in 2021 is accurately reported, and while the ground truth doesn’t include this number, it doesn’t contradict it. The LLM adds value by including a specific data point. No calculations are required, and all references to regulatory timelines (e.g., 12-year exclusivity under BPCIA) are correct. (3) For Amgen, the LLM correctly explains that biologics face slower biosimilar entry due to the BPCIA framework, manufacturing complexity, and abbreviated approval pathways. It notes ongoing risks from patent litigation and potential earlier biosimilar entry (citing pages 45–46), which reflects the ground truth’s point about material adverse effects despite regulatory barriers. The mention of 'umbrella exclusivity' is missing from the LLM answer, but the core reasoning about slower biosimilar uptake and persistent risk is preserved. (4) The multi-hop reasoning is sound: the model contrasts small molecule vs. biologic regulatory frameworks (Hatch-Waxman vs. BPCIA), links them to company-specific risks (Lilly’s Alimta vs. Amgen’s biologics), and evaluates the differing speed and severity of revenue impact. The answer is semantically equivalent to the ground truth, with slightly more detail on regulatory mechanisms and specific citation of revenue trends. Only a minor deduction is made for not explicitly mentioning 'umbrella exclusivity' or FDA regulatory uncertainties highlighted in the original, but the overall qualitative and quantitative accuracy remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 568,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel’s non‑US tax benefits are not expected to be materially affected by the OECD’s Pillar Two rules because it has no material operations in jurisdictions with tax rates below the 15 % minimum (page 75). Microsoft, by contrast, acknowledges the OECD’s global minimum‑tax proposal and could face higher tax costs, although the filing does not quantify the exposure (page 30). The two companies’ international tax strategies differ: Intel’s focus on higher‑rate jurisdictions limits Pillar Two impact, whereas Microsoft’s broader global footprint may expose it to the minimum‑tax regime.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in entity exposure and reasoning. According to the ground truth, Intel is actively evaluating the impact of Pillar Two and may see changes starting in 2024 due to its non-US income presence, implying potential exposure. However, the LLM incorrectly states that Intel has 'no material operations in jurisdictions with tax rates below the 15%' and thus minimal impact, which contradicts the original answer's implication of meaningful exposure due to its international tax strategy. Conversely, the LLM claims Microsoft 'could face higher tax costs', but the ground truth states Microsoft does *not* expect a material increase in tax costs due to limited operations in low-rate jurisdictions—directly contradicting the LLM's assertion. (2) Quantitatively, the percentages (15%) and page references (75, 30) may be accurate in format, but the underlying data they support is misaligned with the ground truth; no incorrect calculations are present, but the numbers are applied to incorrect conclusions. (3) The multi-hop reasoning fails: the model reverses the exposure profiles—Intel is portrayed as low-risk when the original answer suggests it has significant non-US tax benefits at risk, while Microsoft is portrayed as potentially exposed when the original answer says it expects no material impact. This inversion undermines the core comparison. (4) Contextual relevance is high because the answer addresses both companies, Pillar Two, and international tax strategies, but the qualitative inaccuracy in reasoning and entity exposure severely limits correctness. Thus, the correctness score is low despite proper structure and context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 466,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 transfer of $523 million of surplus international pension assets to general assets removes those assets from the pension trust, thereby cutting the pension plan’s allocation to limited‑partnership vehicles and lowering KO’s overall exposure to that structure. In contrast, PEP continues to invest in limited partnerships as part of its pension strategy, so its exposure to that asset class remains unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The $523 million amount and 2024 timeframe are correctly stated, matching the original answer. No calculations were required, but the transfer amount and year are accurate. (2) Completeness: The LLM addresses both parts of the multi-hop question—KO's reduced exposure due to the asset transfer and PEP's continued use of limited partnerships. It correctly infers that removing surplus pension assets reduces exposure to limited partnerships, which is consistent with the ground truth reasoning. (3) Entity accuracy: KO and PEP are correctly identified, along with the relevant financial instruments (limited partnerships) and the correct year (2024). (4) Reasoning: The logic is sound—transferring surplus pension assets to general assets implies those funds are no longer invested in pension vehicles like limited partnerships, thus reducing exposure. The contrast with PEP’s ongoing use of such investments is accurately presented. (5) Semantic equivalence: While the LLM omits some contextual details present in the original (e.g., reference to NEE’s strategy as supporting evidence, or mention of private credit funds and NAV valuation), these omissions do not affect the core factual accuracy. The key comparison—KO reducing exposure vs. PEP maintaining it—is correctly conveyed. The answer is slightly less detailed than the ground truth but remains semantically equivalent on all critical points. Hence, a score of 9 is appropriate, with full marks on quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 438,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion rise in income from continuing operations in 2021 was largely driven by higher revenues, which the company attributes to its robust patent portfolio and regulatory exclusivities that extend market exclusivity (see PFE page 36).  This mirrors Eli Lilly’s strategy of using 12‑year U.S. biologic data protection to extend exclusivity beyond the life of its patents and safeguard revenue after patent expiration (see LLY pages 10, 12, 16, 17).  Both companies illustrate how patent rights and data‑protection mechanisms are critical for maintaining market exclusivity and sustaining earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $17.3 billion increase in PFE's income from continuing operations and the 12-year U.S. biologic data protection period relevant to LLY, both of which are factually accurate. However, the LLM misattributes the primary cause of PFE's income increase to 'higher revenues' driven by its patent portfolio and regulatory exclusivities, while the ground truth states the increase was partly due to lower asset impairment charges and higher net gains on equity securities—factors unrelated to patent strength or revenue from patented products. This is a significant factual misrepresentation of causality. (2) Quantitatively, all numbers are correct: the $17.3 billion figure and the 12-year data protection period are accurately cited. No calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model connects PFE's financial performance to patent rights and links LLY's use of data protection to revenue protection post-patent expiration. However, it fails to correctly synthesize the actual drivers of PFE's income increase, thus breaking the logical chain. The model incorrectly implies that PFE's income surge was due to market exclusivity mechanisms like patents, when in fact it was due to non-operational accounting items. (4) Contextual relevance is strong because the answer addresses both companies, the financial figure, and the role of exclusivity mechanisms. But due to the incorrect causal explanation for PFE's income increase, the qualitative accuracy is low, dragging down the overall correctness score. The answer gives a plausible but factually inaccurate narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 459,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 financials record that Hulu pays Disney (via ESPN) for the right to air ESPN content on Hulu Live, a fee that is eliminated in consolidated revenue (see page 38).  That fee stream is part of Disney’s Hulu business – the same platform that Comcast sold its stake in – and the $8.6 billion payment Comcast received in late 2023 was the proceeds from Disney buying out Comcast’s Hulu interest (see page 85).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $8.6 billion payment from Disney to Comcast in late 2023 is accurately reported, and there are no incorrect figures. The reference to page 38 and page 85 suggests document-specific sourcing, which does not contradict the ground truth. (2) The answer correctly identifies the revenue-sharing mechanism—Hulu pays ESPN for content rights, and this fee is eliminated in Disney’s consolidated financials, as per standard intercompany elimination treatment. This matches the original answer’s point about the elimination section in Disney’s 2024 financials. (3) The multi-hop reasoning is sound: it connects ESPN’s fee income from Hulu to Disney’s broader Hulu business and correctly links that to the $8.6 billion buyout of Comcast’s stake. The only minor omission is that the LLM does not mention the put option mechanism, the $9.2 billion minimum equity value, or the $557 million adjustment—details included in the ground truth that explain *how* the $8.6 billion was derived. While this doesn’t invalidate the answer, it slightly reduces completeness in explaining the valuation linkage. (4) Entities are correct: Disney, ESPN, Hulu, Comcast, 2024 financials, and the 2023 transaction are all accurately named and contextualized. The answer is semantically equivalent in conveying that ESPN’s revenue-sharing contributes to Hulu’s value, which underpinned the buyout price. Thus, the answer is factually correct and contextually relevant, with only a slight gap in depth of financial mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 442,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "KO applies its financial‑assumption framework—primarily Black‑Scholes parameters—to its stock‑based‑compensation awards (options, performance share units, restricted stock).  The related expense is spread on a straight‑line basis over the typical vesting period (about four years), with any unvested cost amortized over a weighted‑average period of roughly 1.7 years.  \n\nMDLZ, by contrast, uses discount‑rate and trend assumptions for its post‑retirement health‑care benefit plans (and for equity‑method investments) and records the resulting net periodic costs each year over the life of the benefit plan (e.g., 2024‑2033).  Its stock‑option expense is also recognized over a weighted‑average period of about 1.7 years.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and misalignments with the ground truth. (1) Correct aspects: Both KO and MDLZ are correctly identified, and the use of financial assumptions for stock-based compensation (KO) and postretirement benefits (MDLZ) is generally accurate. The four-year vesting period for KO is mentioned in the original answer as 'typical,' and the LLM references a 'typical vesting period (about four years),' which aligns reasonably. (2) Quantitative inaccuracies: The LLM states that KO's unvested cost is amortized over a 'weighted-average period of roughly 1.7 years'—this figure is not in the original answer and contradicts the four-year straight-line recognition; it appears to be either misplaced or incorrectly inferred. Similarly, the LLM claims MDLZ's stock-option expense is recognized over 'about 1.7 years,' but the original answer does not mention MDLZ applying assumptions to stock options at all—instead, MDLZ applies them to postretirement healthcare costs. This is a major factual error. Additionally, the LLM introduces a specific time range '2024-2033' for MDLZ's benefit plan life, which is not present in the original answer and lacks support. (3) Multi-hop reasoning: The model attempts to compare KO and MDLZ's use of assumptions but fails in key synthesis—KO applies assumptions to equity instruments with fixed expense periods; MDLZ applies them to actuarial-based, annually recalculated liabilities. The LLM incorrectly attributes stock-option expense recognition to MDLZ using the same 1.7-year period, undermining the core distinction. It also incorrectly suggests MDLZ uses assumptions for equity-method investments, which is not in the original. (4) Despite these issues, the answer retains some relevance and structure, correctly identifying the types of instruments (stock comp vs. postretirement) and the annual measurement for MDLZ. However, the introduction of unsupported numbers and misattribution of expense recognition periods reduces factual correctness. Hence, correctness is scored at 5 due to partial accuracy with significant errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 571,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Pfizer’s Enbrel patents in the U.S. expire in 2028, 2029 and 2037 (page 14). Because Pfizer markets Enbrel only in the United States and Canada (page 10), the loss of these patents will not directly reduce its international revenue. Nonetheless, AbbVie’s strategy of pursuing Hatch‑Waxman patent‑term restoration and relying on the 12‑year biologic exclusivity granted under the Biologics Price‑Competition and Innovation Act (page 9) can postpone biosimilar entry worldwide, thereby protecting any international sales Pfizer might have had from erosion for a longer period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies despite some correct dates. It correctly identifies Enbrel patent expirations in 2028 and 2037, aligning with the ground truth (composition in 2028, formulation in 2037). However, it incorrectly states that Pfizer markets Enbrel in the U.S. and Canada — in reality, Pfizer markets Enbrel *outside* the U.S. and Canada, while AbbVie handles the U.S. market. This is a critical entity and factual error that undermines the entire reasoning. Additionally, the LLM misattributes the Hatch-Waxman Act strategy to AbbVie’s global impact, but Hatch-Waxman applies only in the U.S., limiting its international effect. The mention of 12-year biologic exclusivity under the BPCIA is accurate in isolation but misapplied, as this also pertains only to the U.S. and does not directly protect Pfizer’s international revenue.\n\n2) Quantitatively, the dates (2028, 2029, 2037) are mostly accurate — the ground truth mentions 2028 and 2037, so 2029 is an extra, unsupported year. This minor addition does not severely impact scoring, but the core error lies in interpretation, not numbers.\n\n3) The multi-hop reasoning fails: the model incorrectly assumes Pfizer’s geographic market, leading to flawed logic about international revenue impact. The chain of reasoning — that AbbVie’s U.S.-focused patent strategies protect Pfizer’s international sales — is invalid because regulatory exclusivity under Hatch-Waxman and BPCIA does not extend internationally. The synthesis across entities (Pfizer, AbbVie, patent laws) is therefore incorrect.\n\n4) The answer is contextually relevant in discussing patent expiration and biosimilar delays, but the conclusion is factually inverted due to the market mix-up. While it attempts to address the question’s components, the core misunderstanding of roles and jurisdictions results in a partially correct but ultimately misleading response. Hence, correctness is scored low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 532,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MetLife’s liquidity model explicitly stresses early policy‑holder withdrawal scenarios; when such withdrawals generate cash outflows beyond the forecasted needs, the company can tap global funding sources—including commercial paper—to bridge the gap (page 123). This creates a contingency reliance on commercial paper that is triggered only under stressed conditions. In contrast, Capital One’s liquidity framework is built around a diversified funding base and a sizable liquidity reserve (cash, securities, credit lines) that is designed to absorb shocks, reducing dependence on any single source such as commercial paper (page 96).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) It correctly identifies MET's stress testing approach involving early policyholder withdrawals and its reliance on global funding sources like commercial paper when outflows exceed forecasts—consistent with the original answer. It also accurately describes COF's diversified funding strategy and liquidity reserves, highlighting reduced dependence on commercial paper. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not applicable but assumed perfect as no figures were misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes MET’s contingent reliance on commercial paper under stress with COF’s more structural reliance on diversified sources and reserves. The only minor omission is the reference to AIG’s defined liquidity stress scenarios, which the original answer includes as a comparative point, but this does not detract significantly from the overall correctness. (4) Contextual relevance is excellent—the response directly addresses the comparative influence of stress testing frameworks on funding source reliance. The use of page citations adds precision. The LLM uses slightly different phrasing (e.g., 'contingency reliance') but maintains factual fidelity. One point deducted from qualitative accuracy for missing the AIG linkage, though it does not undermine the central comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 415,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "ASU 2022‑04 requires a buyer that uses supplier‑finance programs to disclose the program’s key terms, the balance‑sheet presentation of related amounts, the confirmed amount outstanding at year‑end and a roll‑forward of amounts due in future periods.  Caterpillar adopted the standard in 2023 and began providing the roll‑forward information in 2024 (Note 15, pages 112‑113).  General Electric also started applying the roll‑forward requirement in 2024, which brings its supplier‑finance disclosures into line with Caterpillar’s and improves comparability of the two companies’ obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: ASU 2022-04 requires key terms, balance-sheet presentation, year-end confirmed amounts, and a roll-forward; both CAT and GE began applying the roll-forward requirement in 2024. The LLM correctly states that Caterpillar adopted the standard in 2023 and began providing roll-forwards in 2024 (citing Note 15, pages 112–113), which aligns with the original answer’s reference to CAT_10k_2024.pdf:page_111. GE’s implementation of the roll-forward in 2024 is accurately noted. (2) Quantitative accuracy is perfect: while no specific dollar amounts are mentioned in the LLM answer (e.g., CAT’s $830 million), this omission does not detract from the central point about comparability due to standardized disclosures. The absence of the exact figure is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies now follow the same disclosure framework post-ASU 2022-04, enhancing comparability—this is the central inference required. (4) The answer is contextually relevant and semantically equivalent to the original, with only slight differences in detail (e.g., not citing CL’s explanation or GE’s exact adoption date of Jan 1, 2023). The LLM implies alignment without explicitly stating GE adopted the standard in 2023 and applied roll-forwards prospectively in 2024, but this nuance is reasonably inferred. Overall, the answer is factually correct, well-reasoned, and highly comparable to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 437,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ’s Level 1 assets—exchange‑traded commodity futures and listed options—are valued at the quoted price on the commodity exchange (MDLZ p. 96), and the futures are cash‑settled daily, so they are excluded from the derivatives table (MDLZ p. 106). PepsiCo’s commodity derivative contracts are also marked to market using national‑exchange prices and recent transactions (PEP p. 119), but the filing does not indicate daily cash settlement; the contracts are included in the derivatives table and valued at market prices.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it scores highly by default. The answer is contextually relevant and addresses the comparison between MDLZ and PEP regarding valuation of exchange-traded commodity futures. However, it contains a critical factual error: it incorrectly states that MDLZ excludes its exchange-traded commodity futures from the derivatives table due to daily cash settlement. In fact, according to the ground truth, it is PEP—not MDLZ—that excludes these instruments due to daily cash settlement. The LLM reverses the companies' treatments. The ground truth states that MDLZ *does* include these Level 1 assets in fair value hierarchy tables using quoted prices, while PEP excludes them due to daily cash settlement. The LLM incorrectly attributes this exclusion behavior to MDLZ, undermining the core multi-hop comparison. Additionally, the LLM claims PEP does not indicate daily cash settlement, which contradicts the ground truth stating PEP explicitly notes daily cash settlement as the reason for exclusion. Thus, while the answer attempts the correct structure and references appropriate concepts (quoted prices, cash settlement, fair value hierarchy), the reversal of key accounting treatments between the two companies results in a substantively incorrect comparison. This failure in entity-specific reasoning severely impacts qualitative accuracy and overall correctness despite proper contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 417,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "Comcast’s dual‑class structure gives each Class B share 15 votes (about one‑third of the combined voting power), while Class A shares hold the remaining voting power and are generally voted as one class.  \nThe 10‑K pages supplied for Meta do not disclose the specific voting rights of its dual‑class shares, so a direct numerical comparison cannot be made from the provided material.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct and conveys the essential comparison between CMCSA and META's dual-class structures. (1) It correctly states that CMCSA's Class B shares have 15 votes per share and that Class B holds about one-third of the combined voting power, while Class A holds the remainder—this aligns with the ground truth (66 2/3% for Class A, 33 1/3% for Class B). (2) The quantitative accuracy is high: the 15 votes per Class B share at CMCSA is correctly reported, and the approximate one-third voting power for Class B is a reasonable simplification of 33 1/3%. However, the LLM omits the exact percentage breakdown (66 2/3% vs 33 1/3%) and does not mention the specific number of META Class B shares outstanding (343,761,117 as of January 24, 2025), which is part of the ground truth. (3) The reasoning is sound: the model correctly infers that a direct numerical comparison with META cannot be made due to lack of disclosed vote ratio, which is accurate per the evidence. (4) The answer is contextually relevant and directly addresses the comparative structure question. The omission of META's Class B share count and the precise CMCSA voting percentages prevents a perfect score, but core facts and multi-hop synthesis are correct, warranting a high but not full score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 357,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "AIG treats its CLO holdings as part of its fixed‑maturity securities AFS and applies a CECL‑based allowance for credit losses (the allowance is added to the amortized cost at acquisition for PCD CLOs and is subsequently adjusted each period; the resulting credit‑loss expense is recorded in net realized gains/losses【page_128】【page_130】).  \nMetLife, by contrast, classifies CLOs within Level 3 fixed‑maturity securities AFS, values them at fair value, and any unrealized loss (or gain) is recognized in other‑comprehensive income rather than in earnings【page_84】【page_82】.  \nThus, AIG’s methodology relies on an allowance that impacts earnings, whereas MetLife’s approach relies on fair‑value measurement with unrealized changes flowing through OCI.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of accounting treatments and correctly identifies that AIG uses a CECL-based allowance approach impacting earnings, while MetLife records unrealized gains/losses in OCI due to fair value accounting for Level 3 AFS securities. All referenced disclosures (e.g., page citations) align with the expected methodology and classification, and there are no numerical inaccuracies—since the question does not involve specific dollar amounts, dates, or percentages, quantitative accuracy is scored as 10. However, the LLM omits key qualitative distinctions present in the original answer: (1) AIG’s detailed cash flow modeling based on delinquency rates, default expectations, loss severity, and structural features like credit enhancement; (2) MetLife’s explicit emphasis on being a passive investor without substantial equity or active management involvement in CLO trusts; and (3) the point that AIG separates credit-related impairments from non-credit fair value changes, with only the former affecting the allowance. While the LLM captures the high-level difference in recognition (allowance vs. OCI), it fails to convey the depth of AIG’s forward-looking cash flow analysis and MetLife’s reliance on limited exposure due to passive investment status. This missing nuance reduces qualitative accuracy. Contextual relevance remains high because the response directly addresses the core comparison in methodology and recognition. Thus, the correctness score is 7—core facts are correct, but important details about evaluation methodologies beyond accounting treatment are omitted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 443,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The IRA’s overhaul of Medicare Part D—shifting more claim liability to plans, imposing new cost‑reporting rules, capping out‑of‑pocket limits and reducing federal reinsurance—creates greater uncertainty for CVS in forecasting medical‑cost trends, because its fixed‑premium pricing relies on accurate predictions of utilization and cost shifts that the redesign may alter (see CVS page 53 and page 40). For Bristol‑Myers Squibb, the same redesign complicates the calculation of Medicare Part D rebate accruals, as the GTN liabilities now depend on additional assumptions about legal interpretations, contract terms and the timing of rebates under the new IRA rules (see BMY page 125).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the IRA's redesign of Medicare Part D shifts more costs to manufacturers like BMY and increases uncertainty for CVS in forecasting medical costs. The mention of increased complexity in BMY’s gross-to-net (GTN) rebate accruals due to new assumptions about legal interpretations, contracts, and timing is consistent with the impact on rebate liabilities starting in 2025. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer that conflict—both correctly imply the changes take effect in 2025 (though the LLM doesn’t explicitly state the year, it references the same structural changes). The absence of the specific year '2025' is a minor omission but does not detract significantly from correctness, as the focus is on the mechanism of change. (3) Multi-hop reasoning is sound: the model correctly links IRA provisions → impact on manufacturer rebates (BMY) and separately → forecasting challenges for insurers (CVS), synthesizing implications across two companies and domains. (4) Semantic equivalence is strong: while the LLM adds detail not in the original (e.g., 'fixed-premium pricing', 'cost-reporting rules'), these are contextually appropriate and supported by typical implications of such policy changes. The reference to specific pages (e.g., CVS p.53, BMY p.125) suggests grounding in source documents, enhancing credibility. Only a 9 is given because the original emphasizes the reduction in federal reinsurance specifically in the catastrophic phase and the direct increase in manufacturer liability, which the LLM mentions but could have highlighted more precisely. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 487,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase’s 5.4 % Stress Capital Buffer (SCB) is part of a larger 8.4 % capital‑buffer requirement that also includes a 3.0 % G‑SIB surcharge and a 0 % countercyclical buffer (page 134). Because the SCB is higher than Schwab’s 2.5 % Capital Conservation Buffer (CCB) for its CSB subsidiary (page 122), JPMorgan must hold more Common Equity Tier 1 above the regulatory minimum, tightening its limits on dividends, share repurchases and discretionary bonuses. Schwab’s lower, fixed CCB means its capital‑distribution constraints are less restrictive, and its buffer does not vary with stress‑loss estimates as JPMorgan’s SCB does.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative reasoning and contextual relevance, accurately contrasting JPMorgan Chase’s dynamic Stress Capital Buffer (SCB) with Charles Schwab Bank’s (CSB) fixed Capital Conservation Buffer (CCB). It correctly identifies that JPMorgan’s SCB is tied to stress testing outcomes and imposes tighter, variable capital distribution constraints, while Schwab’s CCB is static. This aligns with the ground truth’s core message about the forward-looking vs. floor-based nature of the buffers.\n\nHowever, the quantitative accuracy is slightly compromised. The LLM states JPMorgan’s SCB as 5.4%, G-SIB surcharge as 3.0%, and CCyB as 0%, summing to 8.4%. While these figures may reflect a specific year’s data (e.g., 2023), the original answer does not include these specific percentages, and the question does not specify a year. Since the ground truth does not confirm these exact numbers, introducing them without sourcing from the provided context risks inaccuracy. The original answer emphasizes the structural difference (dynamic vs. fixed) rather than specific percentages, so the inclusion of precise figures not in the ground truth reduces quantitative fidelity.\n\nEntity accuracy is strong: JPMorgan Chase, Charles Schwab Bank (CSB), SCB, CCB, G-SIB surcharge, and CCyB are all correctly identified and attributed. The reasoning correctly synthesizes the multi-hop concept that higher and variable buffers lead to tighter distribution constraints, which is the essence of the comparison.\n\nThe answer is contextually relevant and directly addresses the question’s focus on how buffer composition influences capital distribution limits. Despite the unsupported specific percentages, the conclusion that JPMorgan faces tighter constraints due to a higher, variable buffer is logically sound and consistent with regulatory frameworks.\n\nThus, the answer earns a high score but is penalized slightly on quantitative accuracy due to unverified numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 536,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics excludes state‑ and local‑income taxes that are allocable to U.S. government contracts from its tax provision, treating them as operating costs that are not subject to federal income tax.  Raytheon, in contrast, records those taxes in its income‑tax expense but recovers them through contract pricing under FAR cost‑allowability rules, allocating the amounts to specific contracts and classifying them as SG&A when paid.  Consequently, GD’s exposure to these taxes is effectively neutralized in its tax provision, whereas RTX’s exposure is reflected in the tax expense but mitigated by recoverability mechanisms tied to FAR‑governed cost allowability and pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision and instead treats them as operating costs, which matches the original answer. It also accurately states that Raytheon Technologies records these taxes in income tax expense but recovers them through FAR cost-allowability mechanisms, incorporating them into contract pricing—this reflects the core distinction in financial exposure. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all qualitative financial treatments are correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes information about two companies' differing tax treatments under the same regulatory framework (FAR), correctly contrasting GD’s expense classification with RTX’s recovery via pricing mechanisms. (4) The only minor deviation from the original answer is that the LLM suggests RTX records the taxes in 'income-tax expense' before recovering them, while the ground truth emphasizes RTX’s structuring of pricing under FAR with performance- and progress-based payments influencing revenue recognition. However, the LLM’s characterization of recoverability under FAR is consistent with the principle of cost allowability. The answer is semantically equivalent and contextually precise, with only slight nuance missing regarding RTX’s broader pricing mechanisms. Thus, the correctness score is 9 due to this minor omission, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 459,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "META’s dual‑class structure gives each Class A share one vote and each Class B share ten votes, and the company has just launched a dividend program that applies to both classes (page 57, 120). Alphabet’s structure also gives Class B shares ten votes, but they automatically convert into Class A shares upon sale or transfer, so the voting power ultimately consolidates into Class A shares with one vote per share (page 81). Alphabet’s dividend policy is not disclosed in the provided pages.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that META's Class B shares have 10 votes each, but the ground truth specifies 15 votes per Class B share. It also fails to mention the non-dilutable 33 1/3% aggregate voting power for Class B, a key structural feature. The dividend initiation is correctly noted as applying to both classes, but the LLM omits the specific $0.50 per share quarterly amount and the 2024 initiation date. For GOOGL, the 10 votes per Class B share is correct, as is the automatic conversion upon transfer, but the LLM incorrectly implies that Alphabet’s voting power consolidates into Class A upon conversion (which is true) but does not clarify that this mechanism is designed to preserve founder control—missing a key comparative insight. The comment that Alphabet’s dividend policy is not disclosed is partially correct but irrelevant since GOOGL has never initiated a dividend, making the omission less critical. (2) Quantitative accuracy is low: vote count for META Class B is wrong (10 vs 15), dividend amount ($0.50) and year (2024) are missing, and the 33 1/3% voting power floor is omitted. These are significant numerical omissions and errors. (3) The multi-hop reasoning is partially sound—comparing structural differences in voting and transfer rules—but fails to synthesize key nuances like the non-dilutable voting floor and dividend equality post-2024. The comparison lacks depth on how each structure serves founder control. (4) Scores reflect partial correctness: core idea of dual-class systems and conversion upon transfer is right, but major factual errors in numbers and omissions of critical details reduce correctness. Contextual relevance is high as the answer addresses the structural comparison directly, even if inaccurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 493,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both Philip Morris and Mondelez use a VaR model that assumes normal market conditions, a 95 % confidence interval, and a one‑day holding period (PM – page 66; MDLZ – pages 65‑77).  The parametric delta‑gamma approximation technique is applied to the first‑ and second‑order sensitivities of their interest‑rate, currency and commodity derivative positions to estimate the expected return distribution, allowing the calculation of a one‑day potential loss in fair value or earnings.  Thus, the 95 % confidence interval under normal market conditions standardizes the one‑day loss estimates for both companies, ensuring that the VaR figures represent the maximum expected daily loss with 95 % confidence for their respective derivative exposures.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Philip Morris (PM) and Mondelez (MDLZ) use a VaR model under normal market conditions with a 95% confidence interval and a one-day holding period, which aligns with the ground truth. The mention of the parametric delta-gamma approximation technique being applied to first- and second-order sensitivities for interest rate, currency, and commodity derivatives is factually accurate and consistent with the methodology described. All quantitative elements—95%, one-day horizon, normal market assumptions—are correctly stated. (2) There are no numerical inaccuracies; the percentages and modeling assumptions are correctly reported. The LLM even cites page numbers (PM – p.66; MDLZ – pp.65–77), which, while not part of the ground truth, suggest plausible sourcing and do not detract from accuracy. (3) However, the LLM answer omits key differentiating details present in the original answer that are critical to fully addressing the multi-hop aspect of the question. Specifically, it fails to note that Philip Morris excludes anticipated transactions and hedges in its VaR calculation, while Mondelez includes currency and commodity instruments and accounts for the non-linear behavior of options. This omission weakens the comparative analysis and misses a core nuance in how each company applies the same general methodology differently. Additionally, the LLM does not mention the limitation of the model during market stress, which is a key implication in the ground truth. (4) Despite these omissions, the answer captures the core shared methodology and correctly synthesizes the use of VaR and delta-gamma across both firms. The reasoning is sound but incomplete in comparative depth. Hence, the correctness score is 7—core facts are right, but important contextual and differentiating details are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 506,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s embedded derivatives are found in its CLNs and CDOs (page 109), where a credit event on the reference entity can cause the principal balance of the note to be unrepaid, exposing the firm to credit‑event losses that could impair its market‑making activities. Bank of America’s structured liabilities that contain embedded derivatives are accounted for under the fair‑value option (page 164); credit events can trigger gains or losses on those derivatives that are reflected in market‑making performance, and the firm actively monitors and hedges these exposures as part of its market‑making risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Morgan Stanley's exposure via embedded derivatives in CDOs/CLNs where credit events can lead to principal loss is accurately described, as is Bank of America's use of fair-value option accounting for structured liabilities with embedded derivatives. The role of credit events impacting market-making activities is addressed for both firms. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) Multi-hop reasoning is sound: the model correctly synthesizes risk exposure from embedded derivatives across two different firms (Morgan Stanley and Bank of America), identifies the structural differences (CDOs vs. structured liabilities), and links them to market-making implications. The mention of hedging in the ground truth is slightly more explicit, but the LLM’s reference to Bank of America 'actively monitoring and hedging these exposures' captures the same idea. (4) Semantic equivalence is strong—wording differs but meaning aligns closely. The only minor gap is that the LLM does not explicitly state that Bank of America's gains/losses are offset by hedging instruments, though the implication is present. This does not undermine the overall correctness. Contextual relevance is excellent, directly addressing the comparative risk exposure in the context of credit events and market-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 421,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce’s effective tax rate was 18% in FY 2024 and 19% in FY 2023, and the company expects the OECD Pillar Two global minimum tax to have no material impact on its tax cost because it has no material operations in jurisdictions below the 15 % threshold【page_47】. Microsoft, which will be subject to Pillar Two from FY 2025, does not currently estimate a material impact on its projected tax liability and is monitoring the implementation as jurisdictions adopt the rules, reflecting uncertainty around timelines and jurisdictional adoption【page_75】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While Microsoft's position aligns with the ground truth—expecting Pillar Two to apply from fiscal 2025 and not currently estimating a material impact—Salesforce's portrayal is incorrect. The original answer states that Salesforce 'may have a material impact' due to Pillar Two, indicating potential risk, whereas the LLM claims Salesforce 'expects... no material impact' and has 'no material operations in jurisdictions below the 15% threshold,' which contradicts the cautious, uncertain tone of the ground truth. (2) Quantitatively, the LLM incorrectly assigns Salesforce an effective tax rate of 18% in FY2024 and 19% in FY2023; this data is not present in the original answer and is factually unsupported by the provided ground truth. Microsoft’s effective tax rate (19%, down to 18% in FY2024) is correctly reflected in the original, but the LLM fabricates equivalent precision for Salesforce without basis. (3) The multi-hop reasoning is partially sound—both companies are correctly linked to Pillar Two and the uncertainty around implementation—but the synthesis fails because it contradicts the original assessment of Salesforce’s exposure. The LLM incorrectly asserts a definitive 'no material impact' conclusion for Salesforce, while the ground truth emphasizes uncertainty and potential material impact. (4) Contextual relevance is high as the answer addresses OECD Pillar Two, both companies, tax rates, and implementation uncertainty. However, due to key factual errors in both quantitative data and qualitative risk assessment—especially the false claim about Salesforce’s operations and impact—the correctness score is low. The answer misrepresents a core part of the comparison, undermining the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 489,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s 5‑year credit agreement names JPMorgan Chase Bank, N.A. as the sole syndication agent, with Citibank N.A. serving as the administrative agent and both banks acting as joint lead arrangers and book managers. Honeywell’s agreement, by contrast, lists JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. as syndication agents, with Bank of America N.A. as the administrative (and swing‑line) agent. Thus Boeing’s structure involves one syndication agent and one administrative agent, while Honeywell’s involves two syndication agents and a separate administrative agent.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the syndication agents, administrative agents, and key roles for both Boeing and Honeywell. It accurately states that Boeing's agreement includes JPMorgan Chase Bank, N.A. as syndication agent and Citibank N.A. as administrative agent, with both as joint lead arrangers and book managers. For Honeywell, it correctly identifies JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. as co-syndication agents and Bank of America N.A. as administrative and swing line agent. However, the LLM incorrectly describes JPMorgan as the 'sole syndication agent' for Boeing — while true that JPMorgan is a syndication agent, the ground truth does not state it is the 'sole' one, and in fact, syndication agent roles can be shared or dual; more importantly, the original answer does not specify 'sole', so this addition introduces an unsupported precision. (2) There are no numeric values, dates, or calculations in the LLM answer, so quantitative accuracy is high by default — no errors in numbers or dates since none were cited. The original answer includes dates (October 30, 2019, and March 20, 2023), which the LLM omits, but since the question did not explicitly ask for dates, this is a minor completeness issue rather than a quantitative error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and compares their credit agreement structures. The comparison of syndication structure and key banking partners is accurate in substance. (4) The answer is contextually relevant and focused on the question. The slight overstatement of 'sole syndication agent' prevents a perfect score, but the core facts and comparison are correct. Hence, correctness is 8 due to minor overprecision, qualitative accuracy 8 for the same reason, quantitative accuracy 9 (no numbers wrong, but some omitted), and contextual relevance 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 517,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the Countercyclical Capital Buffer (CCyB) is zero, the Advanced‑Approaches capital buffer for each firm is simply the sum of the 2.5 % Capital Conservation Buffer and the firm’s G‑SIB surcharge.  \n- **Bank of America**: 2.5 % SCB + 3.0 % G‑SIB surcharge = **5.5 %** total buffer.  \n- **Morgan Stanley**: 2.5 % SCB + 2.5 % G‑SIB surcharge = **5.0 %** total buffer.  \n\nThus, the absence of CCyB keeps BAC’s buffer at 5.5 % and MS’s at 5.0 %, lower than it would be if a CCyB were applied.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the G-SIB surcharge for Bank of America, stating it as 3.0% instead of 2.5% as specified in the original answer. This leads to an incorrect total buffer of 5.5% for Bank of America instead of 5.0%. For Morgan Stanley, the G-SIB surcharge is correctly stated as 2.5%, and the calculation (2.5% + 2.5% = 5.0%) is accurate. However, the original answer notes that Morgan Stanley's G-SIB surcharge is 'not quantified in the provided data but assumed to be included,' which the LLM treats as confirmed data, introducing an assumption not fully supported. (2) Calculations: The math itself is correct given the inputs, but the inputs are flawed for Bank of America. The use of 'SCB' (possibly meant to be CCB) instead of 'Capital Conservation Buffer' is a minor terminology error but does not obscure meaning. (3) Multi-hop reasoning: The model correctly identifies that the absence of CCyB means only the G-SIB surcharge and CCB contribute to the total buffer, which shows sound structural understanding. However, it fails to match the ground truth data for Bank of America’s G-SIB surcharge, breaking the chain of accuracy. (4) The answer is contextually relevant and addresses the core question about how the absence of CCyB affects total buffer requirements, but due to the incorrect percentage for Bank of America and unsupported assumption for Morgan Stanley, the correctness and quantitative accuracy scores are significantly reduced. Semantic equivalence is partially achieved but undermined by key numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 436,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA’s 2022 effective tax rate was **1.9 %**【page_56】.  \nApple’s operating income margin in Greater China for fiscal 2022 was **41.9 %** (operating income of $31.153 bn on sales of $74.200 bn)【page_52】. Thus, Apple’s margin in Greater China was markedly higher than NVIDIA’s effective tax rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NVIDIA's effective tax rate in fiscal year 2022 as 1.9%, matching the ground truth. It also accurately reports Apple's operating income ($31.153 billion) and net sales ($74.200 billion) in the Greater China region for the same period. The calculated operating income margin of 41.9% is correct (31,153 / 74,200 ≈ 0.4198, or 41.98%, which rounds to 41.9% or approximately 42% as in the original answer). The minor difference in rounding (41.9% vs 42%) is acceptable and does not affect factual accuracy. (2) All numeric values are accurate and correctly formatted, with acceptable variations (e.g., $31.153 bn = $31,153 million). Calculations are sound. (3) The multi-hop reasoning is solid: the model correctly synthesizes data from two different companies (NVIDIA and Apple), two different financial metrics (tax rate vs. operating margin), and compares them appropriately in the context of fiscal year 2022. The citation of page numbers suggests proper sourcing from documents. (4) The answer is contextually complete and relevant, addressing both parts of the question and making a valid comparison. The only minor shortcoming is the lack of brief explanatory context present in the original (e.g., why NVIDIA's rate is low), but this does not detract from factual correctness. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 381,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing’s Level‑2 assets are mainly fixed‑income securities and interest‑rate swaps, and the company uses pricing models that rely on verifiable observable market data such as interest rates, yield curves, credit spreads, broker bids, and prices of similar securities. UPS, by contrast, treats its Level‑2 assets as foreign‑currency and interest‑rate derivatives, valuing them with models that emphasize observable inputs like yield curves, foreign‑currency exchange rates, and investment forward prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities—Boeing (BA) and UPS—are correctly identified, and the assets (Level 2 fixed income vs. derivatives) are accurately described. The observable inputs emphasized by each company are correctly reported: Boeing’s use of credit spreads, yield curves, broker bids, and prices of similar securities aligns with the ground truth’s mention of benchmark yields, swap curves, and inter-dealer broker rates. UPS’s reliance on yield curves, foreign currency exchange rates, and investment forward prices matches the original answer exactly. (2) There are no numeric values, dates, or financial amounts in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative data points are factually correct. (3) The multi-hop reasoning is sound—LLM correctly synthesizes differences in pricing model inputs between two companies’ Level 2 assets based on their distinct asset types (fixed income vs. derivatives). (4) The only minor shortcoming is that the LLM answer does not explicitly mention Boeing’s use of rating agency data or structured cash flow analysis, which are part of the income-based models noted in the ground truth. However, this omission does not distort the overall comparison and is a minor detail in the broader context. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 431,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s dual‑class structure gives Class B shares ten times the voting power of Class A shares (10 votes per share versus 1 vote per share), a disparity that remains unchanged by the 2023 $62.2 billion repurchase of Class A (and Class C) shares, which simply reduces the number of Class A shares outstanding without altering the per‑share vote ratio【page_81】. In contrast, Netflix’s common stock is a single class with one vote per share on all matters, so all shareholders enjoy identical voting rights【page_61】. Thus, while Alphabet’s repurchase may shift the relative influence of its two classes, the fundamental voting‑power imbalance persists, whereas Netflix maintains a uniform voting structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $62.2 billion repurchase amount and the 10:1 voting ratio between Class B and Class A shares at GOOGL are accurately reported. The format '$62.2 billion' matches the original. (2) The entity identification is correct—GOOGL (Alphabet) and NFLX (Netflix) are properly referenced, with accurate descriptions of their share classes and voting rights. (3) The reasoning is sound: the LLM correctly explains that the repurchase of Class A and C shares does not change the per-share voting ratio but affects the relative influence by reducing the pool of non-controlling shares, thus preserving Class B's control—this captures the core multi-hop insight linking capital structure, share repurchases, and voting power dynamics. (4) The comparison to Netflix’s uniform one-vote-per-share structure is correctly stated. The only minor shortcoming is that the LLM does not explicitly mention that Class B shares convert to Class A upon transfer (a nuance in the original about why retiring Class A shares indirectly preserves Class B control), but it does convey the outcome—preservation of voting imbalance—accurately. Thus, the answer is semantically equivalent with only slight omission of mechanistic detail, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 383,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "ACN reports its U.S. government, state and local debt securities as Level 2 assets (page 96), indicating they are valued with observable inputs rather than directly quoted market prices. AVGO classifies its U.S. treasuries as Level 2 as well (page 78), so both companies use the same fair‑value hierarchy for these securities. Consequently, ACN’s Level 2 treatment does not materially affect comparability with AVGO’s disclosures, even though the usual classification for such securities would be Level 1 based on active market pricing.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims AVGO classifies U.S. treasuries as Level 2 assets, which directly contradicts the ground truth stating that AVGO differentiates Level 1 and Level 2 securities and values Level 1 securities based on quoted prices in active markets—implying U.S. treasuries are Level 1. This misrepresentation undermines the entire conclusion. The dollar amount ($9,765 million) from ACN is not mentioned in the LLM answer, reducing quantitative completeness. (2) While the LLM correctly identifies ACN’s classification of U.S. government debt as Level 2, it incorrectly asserts that AVGO does the same, likely misreading or misinterpreting AVGO’s disclosures. There are no calculations in this question, but the comparison hinges on accurate characterization of both firms’ practices—this fails due to the AVGO error. (3) The multi-hop reasoning is flawed: the question requires comparing ACN’s atypical Level 2 classification with AVGO’s more standard (Level 1) treatment, using UPS evidence about typical classification. The LLM fails this synthesis by incorrectly aligning AVGO with ACN, thus reversing the correct inference about comparability. (4) Despite the incorrect reasoning and conclusion, the answer remains contextually relevant by addressing the fair value hierarchy, classification practices, and comparability. Some terminology (Level 1 vs Level 2, observable inputs) is used accurately, and the focus on valuation methodology is appropriate, warranting moderate scores in contextual relevance and partial quantitative accuracy for correctly citing ACN’s Level 2 classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 451,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive adopted ASU 2022‑04 on January 1 2023 and began reporting roll‑forward information on January 1 2024 (page 57). Target’s supplier‑finance disclosures appear in its 2024 10‑K, with a confirmed amount outstanding at year‑end of $3.666 billion (page 54). Thus, Colgate‑Palmolive implemented the ASU earlier, while Target’s disclosed year‑end balance is $3.666 billion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Colgate-Palmolive adopted ASU 2022-04 on January 1, 2023, and began roll-forward disclosures on January 1, 2024 (aligned with ground truth), it falsely claims that Target disclosed a 'confirmed amount outstanding at year-end of $3.666 billion'. The original answer explicitly states that 'exact confirmed amounts are not quantified in the provided excerpt', meaning the $3.666 billion figure is not supported by the source. This is a critical quantitative error. (2) The LLM invents a specific dollar amount that does not appear in the ground truth, failing the quantitative accuracy check. There is no mention of $3.666 billion in the original answer, nor is there any indication that Target quantified its confirmed obligations in the excerpt used. (3) The reasoning is partially sound in comparing adoption timelines, but the conclusion that 'Target’s disclosed year-end balance is $3.666 billion' reflects a failure in multi-hop synthesis—instead of acknowledging the absence of a quantified amount, the model fabricates one, undermining the integrity of the comparison. (4) The contextual relevance is moderate because the response addresses the right companies and topic (ASU 2022-04 and supplier finance disclosures), but the inclusion of a false figure severely damages correctness. The qualitative accuracy is low because the model fails to accurately represent the extent of Target's disclosure, incorrectly implying precise quantification where none was made.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 432,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock’s 10‑K (pages 28, 30‑34) notes that its Aladdin platform is hosted on Microsoft Azure, exposing it to infrastructure, security, execution and regulatory risks that could damage reputation; the firm mitigates these through a risk‑based migration strategy, continuous monitoring of third‑party performance and robust controls. In contrast, Mastercard identifies information security and operational resilience as key risk factors (page 25) and relies on internal control over financial reporting and disclosure controls (page 109) to manage reputational risk arising from its own operational‑resilience strategies, though the 10‑K does not detail specific third‑party technology dependencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described, including the associated operational risks (infrastructure, security, regulatory) and potential reputational impact. Mastercard's framing of 'Reputational Impact' as a named risk and its integration of 'Operational Resilience' into risk management is correctly captured. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two companies (BlackRock and Mastercard), contrasting third-party dependency (BlackRock) with internal operational resilience (Mastercard). It accurately infers that BlackRock’s risk stems externally from cloud dependencies, while Mastercard proactively manages reputational risk through internal controls and operational resilience, even citing relevant page numbers from the 10-Ks. (4) The only minor shortcoming is that the LLM does not explicitly state that Mastercard structures operational resilience as a *core component* of its *reputational risk mitigation strategy*, a nuance emphasized in the ground truth. However, the answer implies this by linking operational resilience to reputational risk management. Wording differs slightly but semantic equivalence is preserved. Contextual relevance is perfect—every part of the question is addressed with precise, on-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 435,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "Cardinal Health was a major customer for BMY in 2021, accounting for roughly 20 % of BMY’s gross product sales to the three largest U.S. wholesalers (BMY 10‑K, p. 107). In CVS’s generic‑pharmaceutical sourcing strategy, Cardinal co‑owns Red Oak Sourcing, LLC (50 % each with CVS) and, together with CVS, uses Red Oak to source and negotiate generic supply contracts for both companies, leveraging their combined supply‑chain expertise while Red Oak holds no inventory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the 20% figure for Cardinal Health's contribution to BMY's revenue in 2021 is correct, matching the original answer. The ownership split in Red Oak Sourcing, LLC (50% each between CVS and Cardinal) is also accurately stated. (2) The answer correctly identifies all key entities: Cardinal Health, BMY (Bristol-Myers Squibb), CVS, and Red Oak Sourcing, LLC, with correct relationships and time context (2021). (3) Multi-hop reasoning is sound: it connects Cardinal’s role as a major customer of BMY with its strategic partnership with CVS via Red Oak, demonstrating an understanding of Cardinal’s dual role in the pharmaceutical supply chain. (4) The only minor shortcoming is the slightly narrower phrasing of 'gross product sales to the three largest U.S. wholesalers' instead of 'BMY's revenue,' which adds context but could imply a subset of total revenue. However, this detail is consistent with typical 10-K disclosures and does not contradict the ground truth. The explanation of Red Oak’s function—negotiating supply contracts without holding inventory—is fully accurate and semantically equivalent. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 361,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "META’s Class B shares carry ten votes each (page 120) but may vote only on a narrow set of matters (e.g., core‑payments exit, mergers, or certificate amendments) and, when they do, the votes equal the shares held multiplied by the conversion rate in effect on the record date (page 90). By contrast, Netflix’s common stock is a single class with one vote per share on all matters, with no such restrictions or conversion‑rate multipliers (page 61). Thus, META’s Class B holders have higher nominal voting power per share, but their ability to exercise that power is limited to specific scenarios, whereas Netflix holders enjoy unrestricted one‑to‑one voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that META Class B shares have restricted voting rights applicable only in specific scenarios (e.g., exiting the core payments business, mergers, or certificate amendments), and that voting power is determined by multiplying shares held by the conversion rate on the record date. It also correctly states that NFLX common stockholders have one vote per share on all matters with no restrictions or multipliers. (2) The mention of 'ten votes each' for META Class B shares introduces a specific numeric value not present in the ground truth; however, the ground truth does not specify the exact conversion rate, only that it is based on the conversion rate in effect. Since the conversion rate could be ten (as historically accurate for META), and the LLM cites a source (page 120), this is likely a correct detail from the filing and does not contradict the ground truth—it adds precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting structure differences between two companies (META and NFLX), compares conditional vs unconditional voting rights, and contrasts variable influence (with multiplier) vs consistent one-vote-per-share. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., citing 'ten votes'), and fully addresses the comparative voting power question. The only minor deviation is the specificity of 'ten votes' without clarifying it may vary by conversion rate, but the answer still correctly frames it as tied to the conversion rate. Hence, all scores are high, with correctness at 9 due to the slight risk of over-specificity without qualification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 470,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Alphabet’s charter allows each Class B share to be converted at the holder’s option and **automatically converts on any sale or transfer to Class A** (GOOGL Note 11, p. 81‑82), effectively dissolving the dual‑class structure for those shares.  Meta’s certificate, by contrast, requires that **any transaction that would change control of the company be approved by a majority of the outstanding Class B voting rights until those shares fall below 35 % of combined voting power** (META Note 50, p. 50), preserving dual‑class control.  Mastercard’s amendment adds a **mandatory post‑conversion transfer rule that obliges Class B holders to sell or otherwise transfer any Class A shares received upon conversion** (MA Note 16, p. 100), preventing consolidation of voting power and serving as a key governance safeguard when evaluating dual‑class structures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon sale or transfer; META requires majority Class B approval for change-of-control transactions until Class B shares fall below 35% of combined voting power; Mastercard mandates that converted Class B shares (now Class A) must be sold or transferred. (2) Quantitative accuracy is perfect: the 35% threshold is correctly cited, and no calculations are required beyond accurate percentage reporting. (3) Multi-hop reasoning is sound: the answer synthesizes governance mechanisms across three companies (GOOGL, META, Mastercard), correctly contrasting META’s control-preserving structure with GOOGL and Mastercard’s dilutive mechanisms. (4) The answer addresses all parts of the question: it contrasts GOOGL’s automatic conversion with META’s approval requirement and explains Mastercard’s post-conversion transfer rule and its governance implications. Wording differs slightly but meaning is preserved, and all citations (e.g., note numbers and pages) align with the source data. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 338,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck’s 2022 filing notes that certain products may qualify for a 6‑month pediatric exclusivity extension (page 17, 18), which can add to any patent‑term restoration and extend market exclusivity beyond the standard 5‑year data protection. In contrast, Amgen warns that recent policy shifts—such as the removal of a 10‑year data‑exclusivity requirement for biologics and the possibility that umbrella exclusivity may not apply—could shorten the 12‑year BPCIA exclusivity period (pages 44‑46), raising the risk of earlier biosimilar entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers and timeframes are correct: the 6-month pediatric exclusivity for Merck (MRK) and the 12-year BPCIA exclusivity period for Amgen (AMGN) are accurately cited. The mention of policy shifts affecting biologic data exclusivity, including the potential inapplicability of umbrella exclusivity, matches the original. (2) The LLM correctly identifies the relevant regulatory frameworks—pediatric exclusivity extending beyond data protection for MRK, and risks to AMGN from changes in biologics exclusivity under BPCIA. (3) The multi-hop reasoning is sound: it contrasts MRK’s strategic use of existing exclusivity mechanisms with AMGN’s exposure to regulatory uncertainty, synthesizing information across both companies’ filings. (4) Minor deduction in qualitative accuracy due to slightly more emphasis on policy details (e.g., removal of 10-year requirement) not explicitly detailed in the ground truth, though these are plausible interpretations consistent with the risk narrative. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original, with only slight elaboration beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 349,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s dual‑class structure consists of roughly 1.7 billion Class A shares and about 4.8 million Class B‑1 shares, with the Class B shares held by a small group of shareholders and carrying limited voting power relative to the majority of Class A shares (page 2). Visa’s structure has 622 million Class A shares and 4.8 million Class B‑1 shares that are subject to transfer restrictions until litigation is resolved and can be converted into Class A shares only upon transfer to a non‑Visa member, concentrating voting power in the hands of a small group of shareholders (page 89). Thus, while both companies have a small Class B component, Visa’s restrictive transfer and conversion rules create a more pronounced control concentration compared to Mastercard’s more modest Class B shareholding.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and entity identification. It refers to 'Mastercard' (MA) and 'Visa' (V), but misrepresents their dual-class structures. According to the ground truth, MA (which refers to Comcast, not Mastercard) has Class B shares with 15 votes per share held entirely by Mr. Brian L. Roberts, giving him 33⅓% of voting power, while Class A holds 66⅔%. The LLM instead claims Mastercard has 1.7 billion Class A and 4.8 million Class B-1 shares with limited voting power — information not supported by the ground truth and based on a misattribution of MA to Mastercard rather than Comcast. Similarly, V (Visa) is inaccurately described: the ground truth states that Visa’s Class B shares are tied to litigation resolution and conversion adjustments, with an exchange program allowing partial release of restrictions on Class B shares and unrestricted Class C shares. The LLM mentions transfer restrictions and conversion upon transfer to non-members but omits the litigation-dependent conversion rates, follow-on offering adjustments, and the role of Class C shares. (2) Quantitative inaccuracies include fabricated numbers: 1.7 billion Class A shares for Mastercard and 622 million for Visa are not in the ground truth, nor are the share class labels 'Class B-1'. The correct voting ratios (15:1) and precise voting power distribution (33⅓% vs 66⅔%) are entirely missing. (3) Multi-hop reasoning fails: the model does not synthesize the correct control mechanisms — MA’s static high-vote concentration vs V’s dynamic, litigation-contingent structure. Instead, it constructs a false comparison based on assumed share counts and vague 'restrictive transfer' rules without capturing the core differentiating mechanisms. (4) Contextual relevance is moderate because the answer attempts to compare dual-class structures and control concentration, which aligns with the question’s intent, but the factual foundation is flawed, leading to a misleading conclusion. The model confuses companies, invents figures, and misses key differentiators, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 571,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX’s FAR‑regulated fixed‑price contracts generate contract assets because revenue is recognized in excess of billings (page 79) and the company notes audit risk that could lead to repayments, fines, penalties or debarment (page 113). Lockheed Martin’s disclosures focus on audit risk and potential civil or criminal liabilities, but the provided pages do not report a significant contract‑asset balance from such contracts, indicating that its exposure is reflected mainly in potential audit‑related liabilities rather than a balance‑sheet item. Thus, RTX’s exposure is visible on its balance sheet through contract assets, whereas LMT’s risk profile is highlighted through potential audit‑related liabilities without a comparable contract‑asset balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that RTX recognizes revenue in excess of billings under FAR-regulated fixed-price contracts, resulting in contract assets on the balance sheet—a key financial exposure. It also notes audit risks (e.g., repayments, fines, penalties, debarment), citing page 113, which matches the qualitative risk profile in the original answer. For LMT, it accurately states that the primary risk is audit-related liabilities (civil or criminal) without a significant contract-asset balance, emphasizing a compliance/enforcement-oriented risk rather than a balance-sheet exposure. (2) There are no numerical inaccuracies; the answer avoids making up figures and relies on correct qualitative disclosures. The absence of specific dollar amounts is consistent with the original answer, which also does not quantify the contract assets or liabilities. (3) The multi-hop reasoning is sound: it synthesizes information across two companies (RTX and LMT), compares their risk profiles under similar FAR-regulated contracts, and correctly differentiates the nature of exposure—balance sheet (RTX) vs. potential liabilities (LMT). The use of page references adds credibility. (4) The only minor shortcoming is that it does not explicitly mention that both companies are subject to FAR’s cost-allowability rules or that LMT’s dependence on U.S. government contracts amplifies its risk, which is included in the original answer. However, the core contrast in risk mechanisms is clearly and correctly conveyed. Thus, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight omission of contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 472,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "META’s 10‑K shows that each Class A share has one vote while each Class B share has ten votes, giving Class B holders ten‑times the voting power of Class A shares【page_120】. Alphabet (GOOGL) has a single voting class – its Class A shares each carry one vote – and its Class C shares carry no voting rights, so all voting power is concentrated in the Class A shares【page_81】. Thus, META’s dual‑class structure concentrates voting power in the higher‑vote Class B shares, whereas GOOGL’s structure concentrates all voting power in the single‑vote Class A shares with the non‑voting Class C shares holding none.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that at META, Class B shares have 10 votes per share and Class A shares have 1 vote per share. The ground truth specifies that Class B shares at META have 15 votes per share, not 10. Additionally, the LLM misrepresents the voting power distribution: it fails to mention that Class B holds 33 1/3% of total voting power and Class A holds 66 2/3%, which is a key quantitative point. Instead, it falsely claims Class B has 'ten-times the voting power' of Class A, which misinterprets both the per-share vote count and the actual aggregate voting power distribution. (2) For GOOGL, the LLM incorrectly states that there is only one voting class (Class A) and that Class C shares have no votes—while technically true—implies there is no Class B, when in fact GOOGL does have Class B shares with 10 votes per share, as per the original answer. The LLM omits this entirely and falsely concludes that GOOGL concentrates voting power in Class A, when in reality, Class B (held by insiders) holds superior voting rights. This is a critical error in entity and structure identification. (3) The multi-hop reasoning is flawed: the comparison between META and GOOGL’s dual-class structures fails because the LLM misunderstands both companies’ capital structures. It does not correctly synthesize the fact that both companies use high-vote Class B shares to concentrate control, and incorrectly frames GOOGL as having a single voting class. (4) Despite these major errors, the answer is contextually relevant—it addresses the question of voting power distribution and attempts to compare the two companies’ structures. However, due to severe inaccuracies in numbers, entities, and reasoning, the correctness score is low. Minor credit is given for recognizing that META has a dual-class structure with higher voting power in Class B and that GOOGL has non-voting shares (Class C), even if the overall synthesis is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 538,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "BMY’s Opdivo is protected by 12‑year regulatory data protection; when that period ends, generic competitors can file ANDAs and submit Paragraph IV certifications to challenge the remaining patents (BMY, page 8).  This demonstrates that the loss of regulatory exclusivity often triggers a surge of Paragraph IV challenges, a precedent that could raise JNJ’s litigation exposure for Stelara as its patents near expiry (JNJ, pages 5 and 108).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that Opdivo has a '12-year regulatory data protection' period, which is incorrect. The ground truth from BMY's 2022 10-K indicates that five-year regulatory data protection is the relevant framework, with Paragraph IV ANDA filings frequently occurring after four years of that period. There is no mention of a 12-year term in the original answer or typical for drugs like Opdivo (biologics under the BPCIA have 12 years, but this context is not clearly established). This undermines quantitative accuracy. (2) The dollar amount ($8 billion in Stelara sales) and specific year (2022) are omitted in the LLM answer, reducing completeness and precision. While the general risk to JNJ is noted, the financial magnitude of Stelara’s exposure is missing. (3) The multi-hop reasoning is partially sound: the model correctly infers that expiration of regulatory protection leads to Paragraph IV challenges, and that this pattern could apply to JNJ’s Stelara. It appropriately cites BMY and JNJ 10-Ks as sources. However, it fails to reference AbbVie’s example, which is a key part of the original answer’s logic in demonstrating precedent. (4) Despite these issues, the LLM answer remains contextually relevant and captures the core causal mechanism—loss of exclusivity triggering Paragraph IV litigation—thus earning high marks for contextual relevance and decent qualitative accuracy in reasoning structure, though weakened by factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 418,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "Meta’s dual‑class scheme gives Mr. Zuckerberg’s Class B shares a special veto: until those shares represent less than 35 % of the combined voting power, any change‑of‑control transaction requires a majority of Class B votes (see page 50). Alphabet’s dual‑class structure, by contrast, allocates 10 votes per Class B share but those shares automatically convert to Class A upon sale or transfer, so the controlling shareholder’s voting power can shift as shares change hands (see page 81). Thus, Meta retains a fixed veto tied to a voting‑power threshold, whereas Alphabet relies on automatic conversion to maintain control while allowing Class B shares to become Class A after transfer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: META's Class B veto requiring majority approval for change-of-control until voting power drops below 35% is accurately stated, as is GOOGL's 10-vote Class B shares that automatically convert to 1-vote Class A upon transfer. (2) Quantitative accuracy is perfect: the 35% threshold and 10 votes per share are correctly reported with no calculation errors. (3) Multi-hop reasoning is sound—LLM correctly contrasts the structural differences in governance durability, highlighting META’s threshold-based veto versus GOOGL’s transfer-triggered conversion. (4) The only minor shortcoming is a slight lack of explicit synthesis regarding 'enduring governance insulation' as phrased in the original, though the concept is implied by describing Meta’s 'fixed veto' versus Alphabet’s conversion mechanism. Wording differs slightly but semantic equivalence is strong. References to page numbers (50, 81) suggest document grounding but do not detract from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 306,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS elected not to use the practical expedients under ASU 2020‑04, so it fully transitioned its debt and contracts to SOFR in 2023 and will continue to assess any re‑classification of gains or losses through 2024 (UPS 10‑K, p. 74). In contrast, 3M’s interest‑rate swaps and other hedging relationships were originally tied to LIBOR and have been amended to SOFR, and the company likely applied the optional relief that extends through December 31 2024, allowing it to preserve hedge accounting and avoid re‑classifying gains or losses until the sunset date (MMM 10‑K, p. 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that UPS did not apply the practical expedients under ASU 2020-04, consistent with the original answer. It also accurately contrasts this with MMM's likely use of the optional relief extended by ASU 2022-06 through December 31, 2024. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the original answer mentions $152 million reclassified from AOCI, the LLM answer does not include this figure but does not contradict it either—this omission is minor and does not affect correctness. All dates (2023 transition, December 31, 2024 sunset) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes UPS’s explicit non-election of expedients with MMM’s implied use based on hedging disclosures and the extended relief window. The inference that MMM likely applied relief to preserve hedge accounting is logically supported. (4) The LLM answer conveys the same core contrast as the original: UPS took a direct transition approach without relief, while MMM likely used the available optional relief. The only minor shortcoming is the absence of specific quantitative evidence (e.g., the $152M reclassification) that strengthens the original answer’s argument, but this does not undermine the overall correctness. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 395,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "MDLZ classifies exchange‑traded commodity futures as Level 1 assets and values them at the quoted price on the commodity exchange. Because those futures are cash‑settled daily, MDLZ’s fair‑value calculation is simply the current market price each day, eliminating the need for a valuation model. PEP, which holds a similar exposure, also treats the futures as cash‑settled and notes that they are not included in its fair‑value table, underscoring that both companies rely on the daily market price for Level 1 valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: MDLZ classifies exchange-traded commodity futures as Level 1 assets, values them using quoted market prices, and the daily cash-settlement mechanism supports this approach. The reference to PEP’s similar treatment—specifically that such instruments are not included in the fair-value table due to daily cash settlement—is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; the absence of specific numbers is appropriate given the nature of the disclosure. (3) The multi-hop reasoning is sound: the model correctly links MDLZ’s valuation methodology to the characteristics of exchange-traded commodity futures, uses PEP’s disclosure as corroborating evidence of daily cash settlement and off-balance-sheet treatment, and infers that this practice validates the use of daily market prices for fair value. (4) The only minor shortcoming is that the LLM does not explicitly state that the daily cash-settlement 'directly supports' MDLZ’s use of quoted prices in the same causal language as the original, though the implication is clearly conveyed. Wording differences are acceptable under semantic equivalence, and the core logic and facts align perfectly. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 423,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s structure gives each Class B share 15 votes (vs. one vote for Class A), and the 9.4 million Class B shares account for about one‑third (≈33 %) of the company’s total voting power—a non‑dilutable block held by a single owner. Alphabet, by contrast, gives each Class B share 10 votes, so the Class B shares represent a smaller share of voting power relative to the far larger pool of Class A shares, and they can be converted to Class A, potentially diluting that advantage.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the essential comparison between CMCSA and GOOGL's voting structures. (1) It correctly states that CMCSA Class B shares have 15 votes per share and account for approximately one-third (33%) of total voting power, while Class A has one vote per share—this aligns with the ground truth (66 2/3% for Class A, 33 1/3% for Class B). The statement about Brian L. Roberts holding the Class B shares is omitted, but the core quantitative distribution is accurate. (2) For GOOGL, it correctly notes that Class B shares carry 10 votes per share versus 1 for Class A, and that Class C has no voting rights (though the latter is not mentioned in the LLM answer, it's implied by focusing on A and B). The LLM correctly observes that Class B shares represent a smaller portion of voting power due to the larger pool of Class A shares, which is consistent with reality. However, it introduces a detail not in the original—convertibility of Class B to Class A potentially diluting control—which, while factually true, was not part of the ground truth comparison and slightly extends beyond the provided information. (3) The multi-hop reasoning is sound: the model synthesizes voting power distribution and per-share vote weight across two companies, correctly inferring that CMCSA’s Class B has higher relative concentration of voting power due to 15x voting rights and fixed ownership. (4) Minor omissions (exact 66 2/3% split, explicit mention of Class C having no votes) and slight overreach on dilution keep it from a perfect score, but overall the answer is factually strong, contextually relevant, and semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 458,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "Bank of America’s 2024 10‑K shows that the firm earned **$4.228 billion** in net gains from market‑making and related activities that involve embedded derivatives in structured liabilities (page 164).  Those gains are largely offset by hedging gains on the embedded derivatives and on securities that back the liabilities.  \n\nMorgan Stanley, by contrast, reports that it has **invested in collateral‑linked notes (CLNs) and CDOs that are hybrid instruments containing embedded derivatives**.  The firm notes that if a credit event occurs on the reference entity underlying a CLN, the principal balance may not be repaid in full (pages 108–109, 127).  No realized gain figure is disclosed; the exposure is a potential loss tied to credit‑event risk.  \n\nThus, while both banks face credit‑event risk in structured notes, BAC’s position is a realized, hedged gain, whereas MS’s CLNs represent an exposure that could generate losses if a credit event materializes.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and reasoning, accurately capturing the key distinction between BAC and MS regarding their treatment of embedded derivatives in structured notes. It correctly states that BAC's market-making gains from embedded derivatives are offset by hedging activities, while MS structures CLNs as hybrid instruments where it faces principal loss risk upon a credit event. This aligns with the ground truth's emphasis on BAC hedging exposures versus MS retaining risk.\n\nHowever, there is a critical quantitative inaccuracy: the LLM claims BAC earned $4.228 billion in net gains from market-making activities involving embedded derivatives in structured liabilities. This specific figure is not present in the original ground truth, which does not provide any numerical value for BAC’s gains. The introduction of a precise dollar amount unsupported by the source constitutes a significant factual error, even if the general direction (gains being hedged) is correct. No such figure was mentioned in the knowledge graph, so this appears to be hallucinated or misattributed data.\n\nEntity accuracy is strong—BAC and MS are correctly identified, and the financial instruments (embedded derivatives, CLNs, hybrid instruments) are accurately described. The reasoning across both firms is sound and synthesizes the multi-hop comparison well: both face credit-event risk, but differ in risk management approach. Contextual relevance is excellent, directly addressing the comparison asked in the question.\n\nDue to the fabricated number, the correctness and quantitative accuracy scores are reduced. Without that error, the answer would have scored 9–10. The rest of the content demonstrates strong understanding and accurate synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 481,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Salesforce’s 10‑K notes that the OECD’s Pillar Two rules are a “global tax development.”  Intel’s own filing shows that a large share of its income is taxed outside the U.S. and that the company is still assessing the impact of Pillar Two in those jurisdictions (Intel Note 5, page 75).  If the 15 % minimum tax is applied to Intel’s non‑U.S. operations, the effective tax rate could rise, offsetting the lower rate it achieved in 2023 from higher non‑U.S. tax exposure and R&D credits (Intel Note 4, page 44; Intel Note 5, page 43).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 15% global minimum tax under OECD Pillar Two is accurately cited, and the reference to Intel's non-U.S. income exposure and ongoing assessment is consistent with the original. The mention of Intel's 2023 effective tax rate being lowered due to non-U.S. tax exposure and R&D credits matches Intel's disclosures (e.g., Note 4 and Note 5), and while the exact page numbers (e.g., page 75, 44, 43) may vary by filing version, they are plausible and do not affect factual accuracy. (2) The answer correctly identifies both companies (Salesforce/CRM and Intel/INTC), the relevant tax development (Pillar Two), and the potential impact on Intel’s effective tax rate—core entities and concepts are accurate. (3) Multi-hop reasoning is sound: the model connects Salesforce identifying Pillar Two as a material tax development → Intel’s significant non-U.S. income → Intel’s active evaluation of Pillar Two → potential application of 15% minimum tax → likely upward pressure on effective tax rate. This synthesis across entities and filings is logically coherent. (4) The LLM omits some contextual detail present in the ground truth—such as the specific mention of EU Member States enacting legislation in 2024 and the explicit explanation that Pillar Two constrains benefits from low-tax jurisdictions—but the core causal mechanism (non-U.S. operations subject to 15% floor → higher effective tax rate) is correctly conveyed. Wording differs but semantic meaning is equivalent. No calculation errors. Minor omission prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 459,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX recognizes revenue from FAR‑regulated U.S. government fixed‑price contracts on a percentage‑of‑completion basis, with performance‑based and progress payments that often leave revenue in excess of billings and are recorded as contract assets (RTX 10‑K, p. 79). Boeing, by contrast, notes that its U.S. government contracts can be terminated at the government’s convenience or for default, which may cut revenue and trigger additional costs (Boeing 10‑K, p. 7). Consequently, RTX’s systematic, over‑time recognition provides a more predictable cash‑flow trajectory once contracts mature, whereas Boeing’s exposure to termination risk introduces volatility and uncertainty into its cash‑flow timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: RTX recognizes revenue on a percentage-of-completion basis under FAR-regulated fixed-price contracts, leading to revenue in excess of billings and contract assets (supported by RTX 10-K, p. 79). The explanation of performance-based and progress payments covering a significant portion of costs (implied 80–90% in ground truth) is consistent, though the exact percentage range is omitted in the LLM answer—this is a minor omission, not an error. Boeing’s exposure to termination at convenience or for default is correctly cited (Boeing 10-K, p. 7), with appropriate implications on revenue and potential costs. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or misstatements. The absence of the explicit 80–90% payment coverage from the LLM answer does not introduce inaccuracy, as it does not contradict it—this is a slight completeness gap, not a quantitative flaw. (3) Multi-hop reasoning is sound: the model correctly synthesizes across two companies (RTX and Boeing), two types of contractual risks (cash flow timing vs. termination risk), and links them to cash flow predictability under the same FAR framework. The conclusion that RTX has more predictable cash flows due to systematic recognition, while Boeing faces volatility due to termination risk, is logically derived and matches the ground truth. (4) Contextual relevance is excellent—the response directly addresses the comparison and its implications for cash flow predictability. The only reason for not scoring a 10 is the omission of the specific detail about PBPs/progress payments covering 80–90% of costs, which slightly reduces completeness but does not impair overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 484,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s $119 million of floating‑rate notes with 2025 put provisions represent about 6 % of its $1.9 B current‑portion long‑term debt (page 69), whereas GE’s $315 million of fixed/floating‑rate notes with 2025 put options represent roughly 16 % of its $1.95 B current‑portion long‑term debt (page 55).  Thus, GE’s exposure to near‑term put‑able debt is more than twice the absolute amount and proportionally larger than MMM’s, even though GE’s notes mature after 2025 and would only become immediate obligations if the puts are exercised.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MMM's $119 million and GE's $315 million exposure to notes with 2025 put options, which matches the ground truth. However, it introduces specific percentages (6% and 16%) and total current-portion long-term debt figures ($1.9B for MMM, $1.95B for GE) that are not present in the original answer or implied by it. These calculations may be factually correct based on source filings (e.g., page 69 and 55 references), but they go beyond the provided ground truth knowledge and introduce unverified specifics. (2) The comparison that GE’s exposure is 'more than twice the absolute amount' is accurate (315M vs 119M ≈ 2.65x), though the original answer states 'more than 2.5 times,' which is more precise. The LLM’s proportional claim (16% vs 6%) adds detail not in the original, which focused on absolute exposure and overall risk. (3) The multi-hop reasoning is sound—correctly linking put options exercisable in 2025 to near-term liquidity risk for both companies, noting contractual maturities beyond 2025, and comparing relative exposures. (4) While the core facts (dollar amounts, put provisions, 2025 timing, increased risk) are correct and well-synthesized, the addition of unsupported quantitative details (percentages, total debt figures) reduces quantitative accuracy. The answer remains contextually relevant and qualitatively strong, hence a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 395,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PEP values its exchange‑traded commodity futures by daily cash settlement – the fair value is implicitly the daily settlement price and the contracts are not separately disclosed in the fair‑value table【107†L1-L4】.  \nMDLZ, in contrast, classifies exchange‑traded commodity futures as Level 1 assets and explicitly values them at quoted market prices on commodity exchanges【95†L1-L4】.  \nBoth rely on daily market pricing, but MDLZ’s method is more explicitly disclosed within the fair‑value hierarchy, whereas PEP’s is implicit through daily settlement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that PEP does not disclose exchange-traded commodity futures in its fair value table due to daily cash settlement, while MDLZ includes them as Level 1 assets valued at quoted market prices. Both companies rely on daily market pricing, but PEP's treatment is implicit through settlement, whereas MDLZ explicitly classifies them in Level 1—this distinction is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of numerical errors supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and MDLZ), compares their valuation methodologies, and identifies the key difference in disclosure approach despite shared reliance on daily pricing. The only minor shortcoming is that the LLM does not explicitly mention PEP's 'exclusion from the fair value table' as a deliberate methodological choice due to daily settlement, which is slightly more nuanced than just being 'implicit.' This nuance is present in the ground truth but only partially reflected in the LLM answer. (4) The answer is highly relevant, directly addressing the comparison asked in the question, with precise and appropriate context from both companies' reporting practices. Thus, correctness is rated 9 for near-perfect alignment, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 431,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s Greater China net sales were **$74.2 billion** in 2022 (which includes China mainland, Hong Kong and Taiwan)【page_52】, whereas Intel’s revenue from its Taiwan operations was **$13.5 billion**【page_87】.  Thus, Apple’s Greater China revenue is roughly **$60.7 billion higher**—about **5½ times** larger—than Intel’s Taiwan‑specific revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in Greater China net sales and Intel's $13.5 billion (rounded from $13,461 million) in Taiwan-specific revenue are correctly reported, with acceptable rounding. (2) The calculation of the difference (~$60.7 billion) and the multiplicative comparison (about 5.5 times) are mathematically sound: 74.2 / 13.5 ≈ 5.5. (3) The multi-hop reasoning is correct—Apple’s revenue is from a broader region (Greater China, which includes Taiwan), while Intel’s is specific to Taiwan; the comparison appropriately highlights the scale difference despite differing geographic scopes. (4) All entities (Apple, Intel, Greater China, Taiwan, 2022) and metrics (net sales/revenue) are correctly identified and contextualized. (5) The answer is semantically equivalent to the original, with added clarity in rounding and comparison. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 296,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "MMM’s net property, plant and equipment in the Americas was **$5.864 billion** (2021, page 140).  \nGeneral Dynamics’ revenue from South America that same year was **$234 million** (page 80).  \nThus, MMM’s PP&E investment is roughly **25 times** larger than GD’s South‑American revenue contribution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $5.864 billion (equivalent to $5,864 million) for MMM's net property, plant, and equipment in the Americas in 2021, and $234 million for GD's South America revenue in the same year. The format variation ($5.864 billion vs $5,864 million) is acceptable and semantically equivalent. (2) The calculation comparing the two values (approximately 25 times larger) is correct: 5,864 / 234 ≈ 25.06. (3) The multi-hop reasoning is sound—correctly identifying that MMM's Americas segment includes South America, and comparing it to GD's revenue from the same subregion, despite the different metrics (PP&E vs revenue) and companies. (4) All entities—MMM (3M), General Dynamics (GD), the correct financial metrics, geographic regions, and fiscal year 2021—are accurately identified and synthesized. The answer is concise, factually precise, and contextually appropriate, fully addressing the comparative investment vs revenue question across the shared geographic footprint.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 308,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "NFLX’s auditor applies sensitivity analyses as an audit procedure to test how changes in management’s viewing‑pattern assumptions would alter the company’s content amortization, thereby assessing the potential impact on the financial statements. In contrast, CMCSA uses sensitivity analyses as part of its interest‑rate risk‑management framework to monitor how shifts in rates affect the value of its debt and derivative positions and the resulting interest expense. Thus, NFLX’s use is focused on validating accounting estimates, while CMCSA’s is aimed at managing market‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses to evaluate content amortization assumptions related to viewing patterns, impacting financial reporting; CMCSA uses sensitivity analyses for interest rate risk management, assessing effects on debt and derivatives. The distinction in purpose—accounting estimate validation vs. market risk management—is correctly identified. (2) Quantitative accuracy is perfect: while the LLM answer does not mention the $56 million reduction in interest expense by derivatives in 2023, this omission does not distort the overall accuracy, as the focus of the question is on the *use* of sensitivity analyses, not specific financial impacts. The absence of this figure is a minor completeness gap but does not affect correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (NFLX and CMCSA), two distinct financial processes (content amortization auditing vs. interest rate risk management), and two applications of sensitivity analysis (audit validation vs. risk monitoring). (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original answer. The LLM captures the conceptual contrast accurately, just without the specific derivative impact figure. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this slight omission, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 426,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PEP uses exchange‑traded commodity futures—Level 1 instruments—as part of its hedging strategy; the company notes that these cash‑settled futures are not shown in its fair‑value table because they are Level 1 (PEP, 10‑K, p. 107). In contrast, COST’s 2022 10‑K states that it held no Level 1 financial assets or liabilities on a recurring basis (COST, 10‑K, p. 51). Thus, while both firms apply the same fair‑value hierarchy, PEP actively employs Level 1 futures for risk management, whereas COST reports no Level 1 liabilities at all.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP uses exchange-traded commodity futures (Level 1 instruments) for risk management, which are cash-settled and excluded from the fair value table (consistent with PEP's 10-K disclosure). COST reports no Level 1 financial assets or liabilities on a recurring basis as of its 2022 filing. The dates (implied by fiscal years 2021 for PEP and 2022 for COST) are contextually accurate even if not explicitly stated. (2) There are no numerical values requiring calculation, and all references to fair value hierarchy levels (Level 1) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two different companies (PEP and COST), compares their use (or non-use) of Level 1 instruments under the same fair value framework, and draws a valid contrast in risk management strategies. (4) The only minor shortcoming is that the LLM does not explicitly mention PEP's use of these futures in relation to deferred compensation liabilities, which adds contextual depth in the original answer. However, this omission does not undermine the central factual accuracy or the comparative insight. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the comparative aspect of the question under the fair value hierarchy framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 397,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 10‑K shows that the U.S. patents covering Enbrel’s core fusion protein and composition expire on 11/22/2028, with related DNA‑encoding and formulation patents expiring in 2029 and 2037 (p. 11).  Once the 2028 expiration occurs, the U.S. market will open to biosimilar entrants—a scenario Merck warns will erode sales and heighten pricing pressure, potentially weakening its competitive positioning (Merck 10‑K, p. 33).  Pfizer, which runs a dedicated international commercial division (p. 10), can continue to manufacture Enbrel abroad where the later‑expiring formulation patent remains in force—potentially until 2037—thereby sustaining its international presence and mitigating the impact of U.S. patent loss.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor inaccuracies and omissions. (1) Quantitatively, the dates are mostly accurate: the fusion protein patent expiration is correctly cited as November 2028 (specifically 11/22/2028), DNA-encoding in 2029 (ground truth specifies April 2029; LLM only says '2029'), and formulation in 2037 (ground truth specifies October 2037; LLM omits month). These are minor omissions, not errors, so quantitative accuracy is high. (2) Completeness: The LLM addresses Merck’s exposure to biosimilar competition and pricing pressures, citing its 10-K, which is correct. However, it does not mention the 340B Drug Discount Program, a key element in the original answer that contextualizes Merck’s pricing pressures. This is a notable omission affecting completeness. (3) Entity accuracy is strong: Amgen, Merck, and Pfizer are correctly identified with appropriate roles. Pfizer’s international production strategy is accurately described, and the reference to its dedicated international commercial division supports the reasoning. (4) Reasoning is sound: The LLM correctly infers that U.S. patent expirations will allow biosimilar entry, affecting Merck’s positioning, and that Pfizer can maintain international production due to later-expiring patents. However, it incorrectly implies that the formulation patent (expiring 2037) applies internationally to protect Pfizer’s production, while the ground truth emphasizes that Pfizer already produces Enbrel *outside* the U.S. and Canada and will face biosimilar competition *sooner* in those markets—meaning patent protection there may not extend until 2037. This misrepresents the strategic implication for Pfizer. (5) Despite this, the answer remains contextually relevant and semantically close to the original, with strong multi-hop synthesis across Amgen, Merck, and Pfizer. The core facts are correct, but the reasoning around Pfizer’s international strategy is slightly flawed, and some key details are missing, justifying a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 555,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports roughly **$90 million** in unfunded commitments to private‑equity funds, while UPS reports about **$2.7 billion** in unfunded commitments to private‑equity and other limited partnerships. Both companies value these investments at NAV, so EMR’s exposure is negligible—only about 0.003 % of UPS’s commitments—highlighting a vastly smaller commitment size.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies EMR and UPS as the companies involved and accurately reports the $2.7 billion unfunded commitment for UPS. However, it incorrectly states EMR's unfunded commitment as $90 million instead of $90—this is a critical error, as the original answer specifies $90 (likely $90 thousand or another unit, but not million). The LLM's comparison calculation (0.003%) is based on this incorrect magnitude: $90 million is 3.33% of $2.7 billion, not 0.003%. The correct ratio using $90 would be approximately 0.0000033% (negligible), but the LLM's error in scale invalidates the calculation.\n\n2) Quantitative accuracy is compromised due to the 'million' misstatement. While $2.7 billion is correct, the $90 figure is misrepresented. Dates (September 30, 2024, and December 31, 2024) are omitted in the LLM answer, which reduces completeness. The percentage comparison is incorrectly calculated due to the unit error.\n\n3) The reasoning correctly identifies that both companies measure investments at NAV, supporting a valid comparison in accounting treatment. The conclusion about scale difference is directionally correct (EMR much smaller than UPS), but the magnitude of difference is severely misrepresented due to the unit error.\n\n4) The answer is contextually relevant and addresses the core comparison question. It synthesizes across both companies and correctly frames the accounting treatment. However, the numerical inaccuracy in EMR’s commitment amount and the resulting flawed percentage undermine the quantitative correctness. The omission of exact dates slightly reduces completeness but does not invalidate the comparison.\n\nOverall, the answer captures the intent and direction of the comparison but fails on precise quantitative accuracy due to the $90 vs. $90 million error and the incorrect percentage derivation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 501,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC segment generated $7.296 bn in 2024, of which $525 mn came from beverages – about **7.2 %** of the APAC segment revenue (PEP 10‑K, page 121).  \nMondelēz reported **$1.096 bn** in total beverage revenue for 2024, which is more than twice PepsiCo’s APAC beverage sales (MDLZ 10‑K, page 120/121).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, PepsiCo's APAC segment revenue in 2024 was $10 million, with $2.3 million (23%) from beverages. However, the LLM claims APAC revenue was $7.296 billion and beverage revenue was $525 million (7.2%), which is entirely inconsistent with the ground truth. These numbers are off by orders of magnitude. Mondelēz's total beverage revenue is correctly stated as $1.096 billion (or $1,096 million), matching the ground truth. (2) Calculations: The LLM's percentage (7.2%) is based on incorrect inputs and is therefore wrong; the correct percentage is 23%. The comparison that Mondelēz's beverage revenue is 'more than twice' PepsiCo's APAC beverage sales is misleading — in reality, Mondelēz's $1,096 million is about 477 times larger than PepsiCo's $2.3 million, making the magnitude of difference vastly underrepresented. (3) Multi-hop reasoning: While the model attempts to synthesize data from both companies and compare them, it fails at the foundational step of retrieving correct values for PepsiCo's APAC segment, undermining the entire analysis. (4) Scores justified: Correctness is low (2/10) due to severe numerical errors. Quantitative accuracy is poor (2/10) because only Mondelēz's figure is correct. Qualitative accuracy is slightly higher (3/10) because the structure and intent to compare are present. Contextual relevance is moderate (6/10) as the response addresses the right question framework but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 419,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported $623 million in delinquent loans as of December 31 2023, a portion of its $2.86 billion loan portfolio that is not performing (page 161). Because MetLife only acquires reperforming loans that have been performing for at least 12 months after a modification (page 240), a larger delinquent balance at a source such as Capital One limits the number of loans that can become reperforming and thus reduces the supply of loans MetLife can purchase. Conversely, a smaller delinquent balance would expand the pool of potential reperforming loans available to MetLife.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly identifies Capital One's delinquent loans as $623 million as of December 31, 2023, matching the ground truth. It also accurately references MetLife's policy of purchasing reperforming loans that have been performing for at least 12 months after modification. However, the LLM introduces a claim not present in the original answer or supported by the provided context: that Capital One's total loan portfolio is $2.86 billion (this figure is not in the ground truth and cannot be verified from the given information). This undermines the validity of the reasoning. 2) Quantitatively, the $623 million figure is correct, and no calculations are performed, so quantitative accuracy is high. 3) The reasoning is flawed: the LLM asserts that a larger delinquent balance 'limits' the number of reperforming loans, which contradicts the ground truth that delinquent loans form the source pool for future reperforming loans. A higher volume of delinquencies should, all else equal, increase the potential future supply of reperforming loans (after they reperform), not reduce it. This misrepresents the causal relationship. The original answer correctly frames delinquencies as contributing to the pool of potential reperforming loans. 4) Contextual relevance is strong—the answer addresses the relationship between Capital One's delinquencies and MetLife's purchasing opportunities, and correctly identifies the multi-hop link between delinquent loans and future reperforming status. However, the incorrect logic and unsupported portfolio size reduce qualitative accuracy significantly. Thus, the answer is partially correct but contains a critical reasoning error and an unverified data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 463,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s pension plan includes limited‑partnership interests in real‑estate investments that are valued at NAV (see Note 57).  The 10‑K does not disclose the dollar amount of that exposure.  UPS, by contrast, reports roughly $3.3 billion in unfunded commitments to similar limited‑partnership real‑estate structures, also valued at NAV (page 89), indicating a materially larger and more explicitly quantified exposure.  Both companies rely on NAV‑based valuations for these illiquid assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $3.3 billion unfunded commitment by UPS is correctly reported, and the absence of a disclosed dollar amount for UNP’s exposure is accurately noted. No calculations were required, and all numeric references are correct. (2) The LLM correctly identifies that both companies use NAV-based valuations for illiquid assets in limited partnerships, with UPS specifying long lock-up periods (10–15 years), though it omits explicit mention of UPS’s redemption limitations, which slightly weakens completeness. (3) The multi-hop reasoning is sound: it compares UNP’s NAV-valued but unquantified real estate LP holdings to UPS’s quantified unfunded commitments in similar structures, correctly concluding that UPS has a more explicitly defined exposure. (4) The answer is contextually precise, directly addressing the comparison of exposure levels and valuation methods. The only minor omission is not noting that UPS’s commitments span private equity, private debt, and real estate (not just real estate), which slightly affects qualitative completeness but does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 350,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s 10‑K notes that it relies on third‑party foundries—primarily TSMC for all 7 nm and smaller‑node wafers—to fabricate its microprocessors and GPUs. Because the foundries control the process steps, any yield loss, defect, or production delay at the foundry directly jeopardises AMD’s product quality and supply, and the company has limited ability to enforce its own quality standards. In contrast, Cisco’s manufacturing strategy is built around automated testing, burn‑in, comprehensive inspection and statistical process controls that are certified under ISO 9001, giving it a formal, internally‑managed quality‑control system that reduces exposure to such manufacturing‑quality risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD relies on third-party foundries like TSMC for 7 nm and smaller nodes, which introduces risks in yield, defects, and delays, with limited control over quality enforcement. Cisco’s use of automated testing, burn-in, inspection, and ISO 9001-certified processes is accurately described as an internally managed quality control system. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AMD’s external manufacturing model and Cisco’s internal quality assurance approach, drawing a valid contrast in exposure to quality control risks. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'manufacturing variability' or 'product reliability'—phrases present in the original answer—but it conveys the same meaning through 'product quality,' 'defect,' and 'production delay.' Wording differences do not affect semantic equivalence. The answer is contextually precise, fully addressing the comparative risk exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 354,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s Atairos investment is an equity‑method VIE in which it has no voting rights and only limited consent rights, so it has no governance influence over Atairos; its financial exposure is limited to the $5.1 billion investment balance and a $1.4 billion unfunded capital commitment (page 85). Alphabet’s Class C capital stock also carries no voting rights, but shareholders still receive dividends and can benefit from share repurchases, while governance power remains with Class A and B holders (page 82). Thus, Comcast’s non‑voting stake in Atairos restricts both control and financial risk to the investment amount, whereas Alphabet separates voting control from financial participation by offering non‑voting shares that still provide economic exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions and one potential discrepancy in the investment balance figure. (1) Quantitative Accuracy: The unfunded capital commitment of $1.4 billion matches the original answer and is correct. However, the LLM states the investment balance as $5.1 billion, while the original answer does not specify this number—though it may be accurate based on external data, it introduces a figure not confirmed in the ground truth, creating a slight risk of inaccuracy. The original emphasizes financial exposure 'up to' the investment and commitment, which the LLM captures well. (2) Completeness: The LLM addresses both Comcast's lack of voting rights in Atairos and Alphabet's Class C stock structure, comparing governance versus financial exposure. However, it omits Alphabet's $62.0 billion in share repurchases in 2024, a key detail showing active management of non-voting shares, weakening the comparative analysis slightly. (3) Entity Accuracy: Both companies and stock classes (Class C Capital Stock, VIE classification) are correctly identified. The reference to 'equity-method VIE' is accurate and adds precision. (4) Reasoning: The multi-hop reasoning is sound—correctly contrasting Comcast’s passive, non-consolidated investment with Alphabet’s active dual-class control structure. The conclusion that Alphabet separates voting from economic rights while maintaining control is logically supported. (5) Semantic Equivalence: The core message is preserved—Comcast lacks governance and cannot direct Atairos despite financial exposure, while Alphabet retains control via share structure. Wording differences are acceptable. The omission of Alphabet’s repurchase amount and the unverified $5.1B figure prevent a top score, but overall the answer is factually strong and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 506,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC’s 2022 10‑K lists a bottling and distribution operation in Austria, indicating a concrete physical distribution footprint in that market【page 7 of KO_10k_2022】.  In contrast, Philip Morris’s 2022 10‑K notes that it has a market share of at least 15 % in Austria (among 100 markets with ≥15 % share) but does not describe a specific distribution network【page 7 of PM_10k_2022】.  Thus, Coca‑Cola HBC’s disclosure highlights an active distribution presence in Austria, whereas Philip Morris’s disclosure signals a strong market presence measured by share rather than by a detailed distribution footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Philip Morris's market share of at least 15% in Austria is accurately reported, and the reference to ~100 markets with ≥15% share matches the disclosure context. While the ground truth mentions Coca-Cola HBC contributing to 41% of Coca-Cola’s total worldwide unit case volume via its five largest bottlers, the LLM answer does not include this specific statistic but correctly identifies Coca-Cola HBC's operational presence in Austria. This omission is minor and does not distort the core comparison. (2) The entity names (Coca-Cola HBC, Philip Morris), document years (2022 10-K), and metrics (market share, distribution footprint) are accurate. (3) The reasoning is sound: the LLM correctly synthesizes information across two different 10-K filings, distinguishing between physical distribution infrastructure (Coca-Cola HBC) and market share presence (Philip Morris). It appropriately infers that Coca-Cola HBC has a tangible distribution operation while Philip Morris emphasizes market performance without detailing logistics. (4) The answer is contextually relevant and directly addresses the comparative aspect of the question—distribution footprint vs. market presence. The only slight gap is the missing reference to Coca-Cola HBC’s broader contribution to global volume, which adds context but does not undermine the correctness of the response. Overall, the answer is semantically equivalent in intent and fact, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 428,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "BAC’s 2023 10‑K notes that commercial‑real‑estate credit quality deteriorated, with non‑performing loans and reservable‑criticized exposure rising “primarily driven by the commercial real‑estate office property type”【65】.  This signals a broader economic slowdown that can alter future claim experience for insurance products.  MetLife therefore relies on the Bornhuetter‑Ferguson method—combining historical experience with expected loss ratios—and revises the unpaid‑claims assumptions for Protection Life and Health each year to reflect any emerging trends in claim experience that may arise from the deteriorating economic environment【197】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) It correctly identifies BAC's deterioration in commercial real estate credit quality in 2023, specifically citing office properties as the primary driver, aligning with the ground truth. (2) No specific numerical values (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is not compromised—none are misstated. (3) The LLM correctly links BAC's credit trends to broader macroeconomic deterioration and explains that MET uses the Bornhuetter-Ferguson method, which relies on historical data and expected loss ratios sensitive to economic shifts. It also notes MET’s annual updates to unpaid claims assumptions for Protection Life and Health products in response to emerging trends, which matches the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention how adverse claim experience might be passed through to sponsors in experience-rated contracts or the particular sensitivity of long-duration Protection Health claims—details present in the ground truth that add nuance to the transmission mechanism. However, the essential causal chain—BAC's credit deterioration as an indicator of macroeconomic stress affecting MET’s actuarial assumptions via the Bornhuetter-Ferguson method—is preserved. Wording differs but semantic meaning and factual content are substantially equivalent. Contextual relevance is perfect: the response directly addresses the influence of BAC’s credit trends on MET’s methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 429,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s common stock gives each share one vote on all matters (page 60). Meta’s Class A common stock is the primary voting class and likewise entitles each share to one vote, but Meta also has a dual‑class structure in which Class B shares carry ten votes each, giving those shareholders additional influence over governance. Thus, while the per‑share voting power of the Class A shares is identical in both companies, Meta’s overall structure allows a subset of shareholders to wield greater voting power. (Meta: page 1)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Netflix's common stock provides one vote per share, and that Meta's Class A Common Stock also provides one vote per share, while Meta's Class B shares carry ten votes per share—this matches the original answer exactly in substance. (2) All quantitative elements are correct: 'one vote per share' for Netflix and Meta Class A, 'ten votes per share' for Meta Class B—no calculations are required, but the comparison of voting power is accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Netflix and Meta), compares their voting structures, and draws the valid conclusion that while Class A shares have equal voting weight, Meta’s dual-class structure enables concentrated control. (4) The answer is fully relevant, directly addressing the comparative governance framework question, citing appropriate structural differences, and concluding with the implication of disproportionate influence in Meta’s case. Minor wording differences (e.g., 'dual-class structure' vs 'multi-tiered stock structure') do not affect meaning and are semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 347,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "PEP’s fair‑value table excludes exchange‑traded commodity futures because they are cash‑settled daily, so they do not appear in the Level 1 column (PEP, page 107).  \nMDLZ, on the other hand, lists these futures as Level 1 liabilities and values them at quoted market prices on commodity exchanges (MDLZ, page 112).  \nThus, while both firms cash‑settle the contracts and hold them in their liability portfolios, MDLZ records them at fair value in the table, whereas PEP does not.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that PEP excludes exchange-traded commodity futures from its fair value hierarchy table due to daily cash settlement, while MDLZ includes them in Level 1 based on quoted market prices. These facts match the original answer exactly. (2) There are no numeric values (e.g., dollar amounts, dates like December 25, 2021) in the LLM answer, but the absence is acceptable because the original answer’s key data points are qualitative. The LLM correctly references page numbers (107 for PEP, 112 for MDLZ), which supports source accuracy, though the ground truth does not require page numbers. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies cash-settle these instruments but differ in reporting—PEP excludes them from Level 1 tables, while MDLZ reports them as Level 1 liabilities. This reflects proper cross-company comparison. (4) The only minor shortcoming is that the LLM does not explicitly state that both companies still treat the instruments as Level 1 in substance, but PEP omits them from the table due to settlement timing. This nuance is present in the original answer and slightly strengthens the explanation, but the LLM captures the practical difference in reporting. Wording differs but semantic meaning is equivalent. Scores reflect high accuracy with a small deduction in qualitative accuracy for slight incompleteness in conceptual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 410,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Merck and Gilead’s collaboration on the islatravir‑lenacapavir long‑acting HIV therapy shares global development and commercialization costs 60 %/40 % and revenue 50 / 50 % until the products hit $2.0 B (oral) or $3.5 B (injectable) in sales, after which Gilead’s share rises to 65 % (Merck / Gilead / Pfizer 10‑K, page 74).  By contrast, Pfizer’s cost‑reduction initiatives are broad enterprise‑wide programs—such as cost realignment and manufacturing optimization—that cut overall operating expenses but are not tied to any single product (Pfizer 10‑K, page 30).  Consequently, Merck and Gilead directly limit their financial exposure to the long‑acting HIV therapy through shared R&D and revenue terms, whereas Pfizer’s exposure remains linked to the therapy’s commercial success and the general benefit of lower operating costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the 60/40 cost split (Gilead/Merck), 50/50 revenue sharing until thresholds of $2.0B (oral) and $3.5B (injectable), and the increase in Gilead's revenue share post-threshold are correctly stated. The mention of Pfizer’s enterprise-wide cost realignment and manufacturing optimization from its 10-K is accurate and contextually appropriate. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and splits match the original answer. The reference to page 74 and page 30 adds specificity and aligns with expected sourcing. (3) The multi-hop reasoning is sound—correctly contrasting Merck/Gilead’s product-specific risk-sharing collaboration with Pfizer’s general cost-cutting initiatives. The implication about differing financial exposure is logically derived and consistent with the ground truth. (4) Minor deduction in qualitative accuracy because the LLM omits explicit mention that Gilead’s revenue share increases *after* the thresholds (though implied), and does not specify that Pfizer’s initiatives carry risks like disruption to pipeline delivery, which is in the original. However, the core strategic contrast is well conveyed. Wording differences are acceptable under semantic equivalence. Contextual relevance is full—directly addresses all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 388,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx reports that ASU 2022‑06 has had no material effect on its financial condition and that it is only monitoring contracts and hedging relationships that reference LIBOR (page 93).  UPS’s 10‑K pages provided do not disclose any LIBOR‑related hedging adjustments, implying that its hedging relationships are not affected by the ASU (pages 52, 73).  The extended sunset date to December 31, 2024 gives both companies a window to transition any LIBOR‑based contracts to alternative reference rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant misinterpretation in reasoning and completeness. (1) Quantitatively, all dates and references are accurate: the sunset date of December 31, 2024, is correctly stated, and there are no numerical errors. (2) However, the qualitative analysis is flawed: while FDX's disclosure of no material effect and ongoing monitoring is accurately reported (aligned with ground truth), the LLM incorrectly infers from UPS's lack of disclosure that its hedging relationships are 'not affected by the ASU.' This contradicts the ground truth, which states that UPS *does* use hedging relationships (cash flow and fair value hedges) and could be *actively leveraging* the extended relief under ASU 2022-06. The absence of explicit LIBOR-related adjustments does not imply no impact or use—rather, the extension helps companies like UPS manage transitions without disruptions, which may explain the lack of adjustments. (3) The multi-hop synthesis fails: the question asks for a comparison between FDX's exposure and UPS's use of hedging under ASU 2022-06. The LLM does not recognize that UPS’s established hedging practices make it more likely to be using the relief, whereas FDX has seen no material impact. Instead, it draws an unsupported conclusion from silence in disclosures. (4) Contextual relevance is high as the response addresses both companies and the sunset date, but the reasoning undermines the correctness. Thus, while facts are present, the interpretation and synthesis are significantly flawed, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 432,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "META’s dual‑class structure gives Mr. Zuckerberg the ability to control corporate matters even when he owns less than a majority of shares, and the company’s status as a “controlled” Nasdaq issuer means minority shareholders receive fewer protections such as board independence and amendment approvals (see META page 50). Alphabet’s Class B shares, by contrast, carry ten votes per share, giving a 10:1 voting advantage, but they automatically convert to Class A (one vote each) upon sale or transfer, so the differential is limited to the period before conversion (see GOOGL pages 81‑82). Thus, META’s structure concentrates long‑term control in a single shareholder, whereas Alphabet’s structure provides a temporary voting premium that is neutralized by automatic conversion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's dual-class structure enables Mark Zuckerberg to maintain control with minority ownership, reducing governance protections for Class A shareholders; GOOGL's Class B shares have 10 votes vs. 1 for Class A, but convert to Class A upon sale or transfer. These points match the original answer exactly. (2) There are no numeric inaccuracies—'10:1 voting advantage' correctly reflects the 10 votes per share vs. 1, and no incorrect figures are introduced. Format and phrasing differences (e.g., 'temporary voting premium' vs. 'differential is limited') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly contrasts long-term concentrated control at META with the time-limited control at GOOGL due to conversion mechanics. It synthesizes implications for investor protections and governance balance across both companies. (4) The only minor omission is that the original answer specifies a 35% combined voting power threshold for META’s Class B shares to maintain control, which the LLM answer does not mention. This is a small but notable detail affecting completeness. However, the core comparison and conclusion about long-term vs. temporary control are fully supported. Overall, the response is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 385,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "Coca‑Cola uses option contracts as formal cash‑flow hedges of forecasted foreign‑currency transactions; the fair‑value gains or losses on those options are held in AOCI and reclassified into earnings only when the underlying transaction occurs, thereby offsetting changes in the U.S. dollar value of the forecasted exposure.  \nMiller‑Lafayette, by contrast, reports “forecasted‑transaction” gains and losses as part of its economic‑hedge activity, with the amounts ($106 m in 2024, $17 m in 2023, $117 m in 2022) recognized directly in net earnings. Thus, KO’s strategy provides a deferred, offsetting hedge, while MDLZ’s approach records the impact immediately in earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states that MDLZ recognized $106 million in gains in 2024, $17 million in 2023, and $117 million in 2022. However, the ground truth only confirms $106 million in gains in 2024 through cost of sales and $17 million through interest and other expense in the same year (2024), with no mention of 2023 or 2022 figures. The inclusion of $117 million in 2022 is entirely fabricated. 2) The entity name 'Miller-Lafayette' is incorrect; the correct company is Mondelez International (MDLZ). This is a critical error in entity accuracy. 3) The qualitative reasoning about KO’s hedging strategy is accurate: KO uses option contracts as cash flow hedges with gains/losses deferred in AOCI and reclassified upon transaction occurrence. The contrast in accounting treatment—deferred vs. immediate recognition—is conceptually correct and reflects sound multi-hop reasoning across the two companies’ disclosures. 4) The LLM misrepresents MDLZ’s disclosure by implying that all gains are recognized directly in net earnings as part of economic hedges, whereas the original answer specifies that MDLZ disclosed realized gains on forecasted transactions through specific line items (cost of sales, interest and other expense), not necessarily bypassing AOCI. The original does not confirm whether these are cash flow hedges or economic hedges, so the LLM overinterprets. 5) Despite incorrect numbers and a wrong company name, the core conceptual comparison—KO defers gains/losses while MDLZ reports realized impacts in earnings—is partially aligned with the ground truth, justifying a moderate correctness score. 6) Contextual relevance is high because the answer addresses both hedging strategies and financial impact as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 480,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "TMO’s fixed‑income pension assets are valued at the fund’s net‑asset value and are listed in the “Not subject to leveling” column of its fair‑value table (page 57), meaning they are not classified in the fair‑value hierarchy and rely on a practical expedient rather than market‑observable inputs【page_57】.  \nBy contrast, BMY classifies its fixed‑income funds as Level 2 assets, valuing them at the NAV of the fund’s shares but using observable market data—such as interest‑rate curves, bond yields and quoted prices for similar securities—to determine that NAV【page_112】【page_110】.  \n\nThus, TMO’s approach indicates a lower reliance on observable market data for pension asset valuation, whereas BMY’s Level 2 classification shows a greater dependence on observable market inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: TMO's fixed income funds are reported as 'not subject to leveling,' meaning they are valued using net asset value (NAV) as a practical expedient and excluded from the fair value hierarchy, which implies less reliance on observable market inputs. BMY classifies its fixed income funds under Level 2, indicating use of observable market data such as interest rate curves, bond yields, and prices for similar securities—consistent with Level 2 definition. (2) There are no numerical values requiring calculation in this question, so quantitative accuracy is not applicable in terms of sums or percentages; however, the references to page numbers (e.g., page 57, 112, 110) do not contradict the ground truth and serve as plausible sourcing. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies' pension asset valuation methodologies, synthesizing information about their respective classification approaches and inferring the correct implication about reliance on observable data. (4) The only minor limitation is that the LLM slightly expands on the method BMY uses (mentioning NAV of fund shares), which, while plausible, is not explicitly detailed in the ground truth. However, this does not introduce inaccuracy but adds nuance. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 408,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Under FAR, cost‑plus‑fixed‑fee contracts must recognize revenue as the government obtains control of work in process, so Lockheed Martin records most of its U.S.‑government revenue over time (LMT, page 77). Boeing also follows FAR for its U.S.‑government contracts (BA, page 19), but its 10‑K does not specify that cost‑plus contracts are always recognized over time; instead, Boeing’s policy generally recognizes revenue when the work is performed or the contract is completed, which can lead to timing differences compared with Lockheed Martin’s continuous‑transfer approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity synthesis that affect the overall correctness. (1) Quantitatively, there are no numeric values to verify (e.g., dollar amounts, percentages), so the score is 10 by default—no incorrect numbers were presented. (2) The LLM correctly identifies that both LMT and BA follow FAR for U.S. Government contracts and cites appropriate page numbers from their 10-Ks, showing proper source grounding. However, it incorrectly suggests a material difference in revenue recognition timing between LMT and BA, stating that Boeing does not specify over-time recognition for cost-plus contracts and may recognize revenue at completion. This contradicts the ground truth: both companies recognize revenue over time due to FAR-mandated termination for convenience clauses, which result in continuous transfer of control. The original answer emphasizes that both companies have comparable revenue recognition patterns under FAR, with only minor differences due to contract-specific terms. (3) The multi-hop reasoning is flawed—the model fails to synthesize the key point that FAR’s termination provisions lead to similar accounting treatment at both firms, despite differences in wording of disclosures. It overinterprets Boeing’s more general revenue recognition policy as implying different treatment for cost-plus contracts, without evidence that BA departs from over-time recognition for such contracts. (4) Contextual relevance is high because the answer addresses the core issue—revenue recognition timing under FAR cost-plus contracts—and references correct documents. However, the conclusion of meaningful timing differences is not supported by the ground truth, which states the patterns are comparable. Thus, while some facts are right, the key comparative insight is incorrect, warranting a mid-range score of 5 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 521,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s indentures (see Exhibit 4.1‑4.9 on page 107 and supplemental indentures 6‑9 on page 108) list U.S. Bank National Association as the trustee for notes issued directly by AbbVie, with maturities ranging from 2025 to 2046 and new notes issued from 2015 through 2020.  In contrast, Abbott’s debt structure (see Indenture 4.24 and supplemental indentures 4.25‑4.26 on page 87, with earlier indentures on page 86) uses a special‑purpose issuer, Abbott Ireland Financing DAC, with Abbott Laboratories as guarantor and U.S. Bank as trustee; the notes (e.g., 1.500% due 2026, 0.100% due 2024, 0.375% due 2027, and later 1.150% due 2028/1.400% due 2030) were issued in 2018‑2019 with supplemental indentures in 2019‑2020.  Thus, both companies employ U.S. Bank as trustee, but AbbVie issues notes directly while Abbott uses a separate issuer/guarantor structure, and AbbVie’s note issuances span a longer, earlier period compared to Abbott’s more recent, clustered issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Correct elements: Both companies use U.S. Bank National Association as trustee; AbbVie issues notes directly under its name with multiple supplemental indentures (Nos. 6–9) between 2019–2020, aligning with the ground truth dates of September 26, 2019, November 21, 2019, and May 14, 2020. Abbott Ireland Financing DAC is correctly identified as a special-purpose issuer with Abbott Laboratories as guarantor, and specific notes like the 1.500% due 2026 and 0.100% due 2024 are accurately cited. The issuance timelines (2018–2019 for Abbott, up to 2020 for AbbVie) are consistent. (2) Quantitative accuracy: All dates, percentages, and maturities are correct. The LLM adds extra notes (0.375% due 2027, 1.150% due 2028, 1.400% due 2030) not in the original answer, but these do not contradict the ground truth—they may reflect additional data and are plausible within the timeline. No calculation errors. (3) Multi-hop reasoning is sound: The model correctly synthesizes trustee roles, issuer structures, timelines, and agent relationships across two corporate entities. It draws the correct contrast—AbbVie issues directly with U.S. Bank as trustee and uses Elavon (implied via context), while Abbott uses a DAC issuer with a guarantor structure. (4) Minor deduction in correctness and qualitative accuracy due to slight over-extension with additional note series not in the ground truth, though not factually incorrect. Otherwise, the answer is complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 436,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVDA’s 10‑K notes that all of its 7 nm and smaller process‑node wafers are produced by TSMC, making GPU and CPU performance heavily dependent on TSMC’s advanced‑node capacity and yield (NVDA, p. 21‑19). AMD also uses TSMC for 7 nm or smaller nodes, but its risk disclosures emphasize reliance on larger‑wafer processes from other foundries (e.g., GlobalFoundries) for competitive IC production, and warn that any shortfall in TSMC’s 7 nm supply could harm its business (AMD, p. 24). Thus, while both firms are exposed to TSMC’s fabrication capabilities, NVDA’s product differentiation is more tightly coupled to advanced‑node production, whereas AMD balances advanced nodes with larger‑wafer processes for cost‑effective IC manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both NVDA and AMD rely on TSMC for 7nm and smaller process nodes, with NVDA fully dependent on TSMC for these advanced nodes, as correctly cited from NVDA’s 10-K (p. 21-19). AMD also uses TSMC for advanced nodes but supplements with larger-wafer processes from other foundries like GlobalFoundries, which matches the original answer’s emphasis on AMD’s use of larger wafers for cost efficiency. (2) There are no numeric values requiring calculation (e.g., dates, percentages, dollar amounts), so quantitative accuracy is not compromised—references to '7nm and smaller' are consistent across both answers. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ disclosures, compares their differing strategies (NVDA’s tight coupling to advanced nodes vs. AMD’s hybrid approach), and identifies shared exposure to TSMC. The only minor shortcoming is that the original answer emphasizes the shared supply chain vulnerability more explicitly, particularly around yield issues, per-unit costs, and product launch delays, which the LLM answer implies but does not fully elaborate. (4) Semantic equivalence is strong—wording differs but meaning is preserved. The LLM adds specific page references (p. 21-19, p. 24), which are plausible but not verifiable without source documents; however, they do not detract from accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight underdevelopment in elaborating shared risks, justifying a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 458,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "Colgate‑Palmolive operates manufacturing and warehousing facilities in Thailand (see page 25).  Because Thailand has not yet fully complied with the WTO panel’s ruling on customs valuation and tax treatment of cigarette imports, the country’s customs and tax regime remains in flux (see page 68).  If Thai authorities tighten enforcement or revise valuation rules, Colgate could face higher import duties on raw materials or altered tax treatment of its products, raising operating costs and increasing its regulatory‑compliance burden and risk of penalties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that Thailand has not fully complied with the WTO panel decision on customs valuation (page 68 reference), which creates regulatory uncertainty. It accurately notes Colgate-Palmolive's manufacturing and warehousing presence in Thailand (page 25), and logically infers that non-compliant or inconsistent customs practices could lead to higher import duties, increased operating costs, and greater regulatory risk. There are no numeric values requiring verification, so quantitative accuracy is 10. The qualitative reasoning is sound and reflects multi-hop synthesis between Philip Morris’s WTO case and Colgate-Palmolive’s operational exposure. The only minor shortcoming is that the LLM does not explicitly mention the inoperability of the WTO Appellate Body as a reason for ongoing non-compliance, which slightly weakens the causal chain but does not undermine the core conclusion. Contextual relevance is full, as the response directly addresses how unresolved customs issues in Thailand may impact Colgate-Palmolive’s costs and compliance risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 325,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "The $265,000 drop in UnitedHealth’s Medicare Part D stand‑alone enrollment (3,050 in 2024 versus 3,315 in 2023, page 31) reflects an early, modest impact of the IRA’s Part D redesign, which capped beneficiary out‑of‑pocket costs and shifted more cost burden to plans and manufacturers.  The same redesign also forces manufacturers to provide larger discounts and rebates, leading Pfizer to forecast an approximate $1 billion revenue loss in 2025 (page 17).  Thus, both the enrollment decline for UNH and Pfizer’s projected loss stem from the same policy changes, with UNH seeing a small enrollment hit and Pfizer facing a much larger revenue hit.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error: it misinterprets the enrollment numbers. It states that UnitedHealth had 3,050 thousand (or 3.05 million) enrollees in 2024 and 3,315 thousand (3.315 million) in 2023, implying a decline of 265,000 — which matches the stated $265,000 decline in the question (a likely typo in the question, as enrollment is measured in people, not dollars). However, the LLM incorrectly presents the absolute enrollment figures as being in the thousands (e.g., 3,315), which is factually wrong — UnitedHealth’s Medicare Part D enrollment is in the millions. The correct interpretation should be a decline of 265,000 enrollees (e.g., from 4.1 million to 3.835 million, or similar), not from 3.315 million to 3.05 million. The use of '3,050' and '3,315' without units and in a context suggesting thousands is misleading and numerically inaccurate. (2) The $1 billion revenue loss for Pfizer in 2025 is correctly cited and aligns with the ground truth. The reference to the IRA’s redesign — including the out-of-pocket cap and increased manufacturer discounts — is accurate and well-linked to Pfizer’s projected loss. (3) The multi-hop reasoning is sound: the LLM correctly connects the IRA’s structural changes to both UNH’s enrollment trends and Pfizer’s revenue outlook, recognizing that both are downstream effects of the same policy shift. It synthesizes across entities (UNH, PFE) and mechanisms (enrollment, pricing, discounts). (4) While the core qualitative insight — that both the enrollment decline and Pfizer’s revenue loss stem from IRA-driven changes — is correct and well-articulated, the quantitative inaccuracy in reporting enrollment figures reduces confidence in the data foundation. The answer also omits mention of the Manufacturer Discount Program’s 10% and 20% phases, a specific mechanism in the ground truth. Overall, the reasoning and relevance are strong, but the numerical misrepresentation lowers the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 545,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin’s NAV‑practical‑expedient valuation covers **$4.863 billion** of private‑equity funds, whereas FedEx’s NAV‑practical‑expedient is applied to only **$37 million** of equity securities that lack readily determinable fair values. Thus Lockheed Martin’s NAV‑based investment is roughly 130‑times larger and relates to private‑equity vehicles, while FedEx’s is a much smaller amount tied to ordinary equity holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors, particularly in quantitative accuracy. The claim that FedEx applies the NAV practical expedient to only $37 million in equity securities is not supported by the original answer (ground truth), which does not specify any dollar amount for FedEx’s investments under the NAV expedient. This $37 million figure is therefore fabricated or incorrectly sourced. Additionally, the comparison stating that Lockheed Martin’s investment is '130-times larger' is based on this incorrect data and thus invalid. The original answer emphasizes qualitative differences in how each company applies the NAV practical expedient and notes that FedEx’s impairments are immaterial, but does not provide a quantitative comparison. While the LLM correctly identifies that Lockheed Martin uses the NAV expedient for $4,863 million (or $4.863 billion) in private equity funds, it misrepresents FedEx’s position by introducing a specific dollar figure absent in the source. The reasoning is flawed due to this unsupported comparison, undermining the multi-hop synthesis. Contextually, the answer addresses the right topic and companies, and correctly notes Lockheed Martin’s use of NAV for private equity funds, so it retains partial relevance. However, the introduction of false quantitative data severely compromises correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 375,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each, but the aggregate voting power of all Class B shares is fixed at 33 ⅓ % of total voting power and cannot be diluted by new issuances; converting a Class B share to Class A simply shifts that share’s voting weight while preserving the 33 ⅓ % ratio. Alphabet, by contrast, gives each Class B share 10 votes with no fixed aggregate voting share, so the Class B voting power can rise or fall with the number of shares outstanding. Alphabet’s 2024 $62 billion repurchase of Class A (voting) and Class C (non‑voting) shares cuts the overall voting‑share base, thereby increasing the relative proportion of voting power held by the remaining Class B shares without changing their per‑share vote count.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the key differences between CMCSA's and GOOGL's dual-class structures with strong factual grounding. Quantitatively, all numbers are accurate: the $62 billion repurchase by GOOGL in 2024, the 33⅓% non-dilutable voting power of CMCSA Class B shares, and the correct per-share vote weights (10 for GOOGL Class B, implied 15 per share for CMCSA Class B to achieve the 33⅓% cap) are properly represented. However, the original answer does not state that CMCSA Class B shares have 15 votes each—the 15-vote figure is an inference based on structural mechanics and not explicitly confirmed in the ground truth, making this a minor over-assertion. The core mechanism—that CMCSA Class B has a fixed aggregate voting power of 33⅓%, non-dilutable and preserved upon conversion—is correctly explained. For GOOGL, the answer accurately notes that the $62B repurchase of Class A (1 vote) and Class C (0 votes) reduces the total voting share base, thereby increasing the relative voting power concentration of Class B shares (10 votes each), even though the per-share voting rights remain unchanged. This reflects sound multi-hop reasoning across corporate structure and capital allocation effects. The comparison is logically sound and contextually complete, addressing both structural differences and the impact of repurchases. The only shortfall is the unsupported specificity about '15 votes' per CMCSA Class B share, which, while plausible, isn't confirmed in the ground truth and slightly exceeds available information. Hence, high scores for quantitative and qualitative accuracy, with a minor deduction in correctness for that detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 454,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s 50 % stake in Red Oak Sourcing, LLC is a sourcing partnership that lets CVS and Cardinal Health negotiate generic contracts, but the filing does not disclose any specific revenue share or percentage of CVS’s sales tied to that arrangement【page_18】. By contrast, LLY notes that Cardinal Health is a top‑three distributor that generated 15–20 % of LLY’s consolidated revenue in recent years【page_7】. Thus, CVS’s revenue exposure to Cardinal Health is indirect and not quantified, whereas LLY’s revenue is directly and substantially dependent on Cardinal Health.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: LLY’s reliance on Cardinal Health as a top-three distributor contributing 15–20% of consolidated revenue is accurately reported, and the absence of a quantified revenue exposure for CVS through Red Oak Sourcing is correctly noted. (2) The LLM correctly identifies the entities: CVS, Red Oak Sourcing, LLC, Cardinal Health, Inc., and LLY, and accurately describes their relationships—CVS’s 50% ownership in Red Oak as a sourcing joint venture for generic pharmaceuticals, and Cardinal’s role as a major distributor for LLY. (3) The reasoning is sound: the LLM correctly synthesizes that CVS’s exposure is indirect (via sourcing, not revenue) while LLY’s is direct and substantial (15–20% of revenue), which captures the core comparison in the question. (4) The only minor shortcoming is that the LLM does not explicitly mention that Red Oak is a joint venture with Cardinal Health or that it serves both companies, though this is implied in the description of the partnership. It also omits mention of McKesson and AmerisourceBergen as the other two distributors, which adds context to LLY’s distribution reliance. However, these omissions do not detract significantly from the correctness or relevance. The answer is semantically equivalent in conveying the key contrast: indirect, unquantified exposure for CVS vs. direct, substantial exposure for LLY.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 405,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS’s Class B common stock carries 10 votes per share (UPS Note 11, page 82), whereas Honeywell’s common stock carries 1 vote per share (Honeywell Note 18, page 96). The difference in voting rights is therefore **9 votes per share**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: UPS Class B common stock has 10 votes per share, and Honeywell common stock has 1 vote per share. The difference is correctly calculated as 9 votes per share. (2) The answer is complete, addressing both companies' voting rights and computing the difference as required by the question. (3) Entity accuracy is correct—UPS and Honeywell are properly identified, and the years (implied 2024, consistent with the filing context) are appropriate. (4) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies’ filings (citing specific notes and pages), compares the voting rights, and derives the correct differential. (5) The semantic meaning is equivalent to the original answer, with added citation details that enhance credibility without altering the factual content. All scores are maximized due to full factual accuracy, correct calculation, proper entity identification, and logical synthesis across sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 312,
        "total_tokens": 1418
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "AMGN’s 3.625% 2024 Notes mature in 2024, and their repayment triggered the termination of $1.4 billion of associated interest‑rate swap contracts (page 149). In contrast, AbbVie’s interest‑rate swap contracts were designated as fair‑value hedges to cover long‑term debt that matures through 2051, so the swaps span a longer horizon and were not terminated in 2024 (page 82).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AMGN's 3.625% 2024 Notes maturing in 2024 and the $1.4 billion termination of associated interest rate swaps, which matches the ground truth. These quantitative details are accurate. However, the LLM incorrectly states that AbbVie’s interest rate swaps were designated as fair-value hedges with maturities through 2051, which contradicts the ground truth that ABBV had $0 in cash flow hedges in 2024. The original answer explicitly states ABBV had no active interest rate swap contracts designated as cash flow hedges in 2024, whereas the LLM implies they had active swaps, just of a different hedge type. This is a critical factual error. (2) Quantitative accuracy is high: $1.4 billion and 2024 are correct; no calculations were required. (3) Multi-hop reasoning is partially sound—linking AMGN’s note maturity to swap termination is correct, but the comparison to ABBV fails because it misrepresents ABBV’s hedging activity. The model does not acknowledge the $0 exposure in 2024, which is central to the contrast. Instead, it fabricates or misclassifies ABBV’s hedge usage. (4) Scores reflect that core facts for AMGN are correct (hence not low), but the ABBV comparison is fundamentally flawed, undermining the multi-hop analysis. The answer is contextually relevant but conveys an incorrect conclusion about ABBV’s 2024 hedge activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 385,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "Capital One’s adoption of ASU 2022‑02 eliminated the TDR accounting guidance and re‑classified every loan modification that gives a concession to a borrower in financial difficulty as a **financial‑difficulty modification (FDM)**.  The types of concessions – principal forgiveness, interest‑rate reductions, term extensions, and payment delays – did not change, but the company now reports FDMs on a rolling 12‑month basis; for 2023 residential‑real‑estate FDMs totaled **$136 million**, extending weighted‑average life by 20 years and lowering the weighted‑average contractual rate from 7.21% to 4.44%【page 245】.  By contrast, JPMorgan’s prior TDR disclosures presented similar concessions as TDRs and disclosed their financial effects mainly as charge‑offs, principal deferred, forgiven, and redefault amounts (e.g., $362 million in 2022 and $866 million in 2021)【page 245】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant quantitative inaccuracies that undermine the overall correctness. (1) Quantitatively, the LLM incorrectly attributes the $136 million FDM figure to Capital One, while the ground truth states this amount was reported by JPMorgan for 2023. This is a critical error, as it misassigns a key financial figure between two different companies. Additionally, the LLM cites page 245 as a source multiple times, which may be fabricated or unverifiable in this context. (2) The modification types (interest rate reductions, term extensions, etc.) are correctly identified and align with the original answer, showing accurate qualitative understanding of the types of concessions. (3) The reasoning correctly captures the shift from TDRs to FDMs under ASU 2022-02 and explains the conceptual change in reporting framework. However, the multi-hop synthesis fails because it misattributes JPMorgan’s data to Capital One, breaking the comparative structure of the question. (4) The mention of Capital One’s rolling 12-month reporting is plausible but not present in the ground truth, introducing unverified detail. While the explanation of prior TDR disclosures by JPMorgan referencing charge-offs and redefaults adds context, the dollar amounts cited ($362M in 2022, $866M in 2021) are not in the original answer and thus introduce unsupported data. Overall, the answer demonstrates strong contextual understanding and relevant reasoning but is undermined by serious factual and quantitative errors, particularly the misassignment of financial figures between firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 445,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s hedging strategy explicitly matches swap maturities to the duration of its debt exposure – the notes state that “the dollar‑weighted two‑year average maturity of these instruments generally matches the duration of the activities that are at risk”【page_82】. UPS, by contrast, uses interest‑rate swaps only as an economic hedge of portions of its outstanding debt; the swaps are not designated as hedges and are periodically terminated and replaced, providing an economic offset rather than a duration‑matched hedge【page_159】. This shows GD prioritizes precise duration matching to mitigate interest‑rate risk, while UPS emphasizes flexibility and broader economic offsetting of debt exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: GD's hedging strategy includes a dollar-weighted two-year average maturity that matches the duration of the risk-exposed activities, as stated in the original. UPS uses swaps as economic hedges without formal hedge designation, and these are terminated and replaced to create economic offsets—this matches the ground truth's emphasis on offsetting positions and lack of specified maturity alignment. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the reference to 'dollar-weighted two-year average maturity' is correctly attributed to GD and matches the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (GD and UPS), compares their hedging approaches, and infers differing risk management priorities—duration matching vs. dynamic offsetting. (4) The only minor shortcoming is that the LLM slightly downplays UPS's explicit goal of eliminating market valuation effects, which is mentioned in the original but not fully reflected in the LLM's emphasis on 'flexibility.' However, 'economic offset' captures the essence. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and correct with only a minor nuance missing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 403,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 share‑repurchase program bought back 78 million Class A shares (the only voting class) and 450 million Class C shares, which are non‑voting【page_81】【page_84】.  By reducing the number of voting shares, the repurchase increases the proportion of total voting power that the remaining Class B shares (10 votes each) command, although their absolute vote count stays the same and could still be diluted if converted to Class A.  In contrast, Comcast’s Class B shares are fixed at 33 ⅓ % of the company’s combined voting power and that percentage is non‑dilutable under its charter【page_33】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in stating that Class A shares are the 'only voting class' at Alphabet, which contradicts the ground truth and known structure where Class B shares have 10 votes per share and Class A has 1 vote per share. Class C shares are correctly identified as non-voting. The claim that 78 million Class A and 450 million Class C shares were repurchased is not supported by the ground truth, which states a $62.2 billion repurchase but does not specify exact share counts—these numbers appear fabricated or misattributed. (2) The dollar amount of $62.2 billion from the ground truth is omitted entirely, a major quantitative omission. The LLM introduces precise share counts without citation to dollar values or prices per share, making verification impossible and reducing quantitative accuracy. (3) The reasoning about relative voting power increasing for Class B shares due to reduction in voting shares is logically sound and reflects correct multi-hop understanding of dual-class structures and repurchase effects. The comparison to Comcast’s non-dilutable 33 1/3% voting power is accurately framed and correctly attributed to charter protections. However, the flawed premise that Class A is the only voting class undermines the reasoning chain. (4) Despite strong contextual relevance and an attempt at meaningful comparison, the answer is partially incorrect due to fundamental errors in entity and structural understanding—especially misidentifying which classes have voting rights. This results in a mid-range correctness score: core logic is valid, but key facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 453,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Disney plan allows the sale of up to **372,412 shares** of common stock and is scheduled to terminate on **December 17, 2024**.  \nPeggy Alford’s Meta plan permits the sale of up to **$1.2 million worth of shares** (a value‑based limit) and will terminate on **November 15, 2025**.  \nThus, Iger’s plan is share‑count based with a shorter, earlier termination, whereas Alford’s plan is value‑based with a longer, later termination, both operating under the same Rule 10b5‑1 framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers and dates are accurate: Robert Iger's plan involves 372,412 shares with a termination date of December 17, 2024, and Peggy Alford's plan allows for the sale of up to $1.2 million worth of META stock, terminating on November 15, 2025. These values exactly match the original answer, with acceptable formatting (e.g., $1.2 million vs $1.2M). (2) The answer is complete, addressing both the structure (share-count vs value-based), the specific quantities, termination dates, and the shared regulatory framework (Rule 10b5-1). (3) Entity accuracy is perfect: DIS is correctly attributed to Disney, META to Meta (formerly Facebook), and both executives are correctly named and associated with their respective companies. (4) The reasoning is sound and synthesizes the multi-hop comparison effectively—highlighting the difference in plan structure (fixed shares vs fixed value), duration, and correctly noting the common regulatory basis under Rule 10b5-1(c). The semantic meaning and factual content are equivalent to the ground truth, with clear, concise, and relevant phrasing. No errors or omissions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 341,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards vest over the “requisite service period” (typically a 3‑year period), with the fair value of restricted‑stock units and options amortized ratably over that period【page_96】.  \nPhilip Morris International’s RSUs vest on the third anniversary of the grant date (a 3‑year restriction period) and the fair value is amortized to expense over a weighted‑average period of roughly 17 months【page_110】.  \n\nThus, CL recognises compensation expense throughout the entire vesting period, whereas PMI recognises it earlier, over a shorter weighted‑average period that is shorter than the full vesting horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: CL's 3-year ratable vesting, PM's 3-year cliff vesting with expense amortized over a 17-month weighted-average period (correctly cited as 'roughly 17 months' and matching the $160M unrecognized cost contextually). The December 31, 2023, data point is implied correctly through the 17-month expectation. (2) The LLM correctly identifies that CL amortizes expense evenly over the 3-year period, while PM recognizes it over a shorter, accelerated period—this matches the ground truth's emphasis on PM's earlier recognition due to triggering events like age 58, disability, or death. (3) Multi-hop reasoning is sound: the model synthesizes vesting schedules from both companies and draws the correct implication about compensation expense timing. (4) Minor omission: the LLM does not explicitly mention PM's contractual acceleration triggers (death, disability, age 58), which explain *why* the amortization period is shorter than three years. This contextual nuance is present in the ground truth and contributes to full qualitative accuracy. However, the core implication—that PM recognizes expenses earlier—is correctly inferred. Wording differences (e.g., 'weighted-average period of approximately seventeen months' vs 'roughly 17 months') are semantically equivalent. Overall, the answer is factually complete and contextually appropriate, missing only a minor explanatory detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 415,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Regulatory limits on product differentiation—such as flavor bans and plain‑packaging rules—force both PM and MO to reduce the number of distinct product attributes they can market, which weakens brand equity and squeezes pricing power.  PM notes that EU, Canada, Brazil and U.S. states with menthol or characterizing‑flavor bans will require reformulation and limit differentiation (PM 10‑K, pp 42 and 16), while MO’s state‑settlement agreements and federal rules that restrict advertising, product design and packaging similarly curb brand equity and pricing flexibility in key U.S. and international markets (MO 10‑K, pp 40‑42).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the impact of regulatory restrictions on brand equity and pricing power for both PM and MO. It accurately references flavor bans and plain packaging as key constraints and cites relevant jurisdictions (EU, Canada, Brazil, U.S. states) and regulatory mechanisms (advertising restrictions, product design limits). The citation of PM and MO 10-K pages adds credibility. However, the LLM omits several specific details present in the ground truth that are important for completeness: (1) it does not mention the EU's specific ban on characterizing flavors in cigarettes and roll-your-own tobacco; (2) it fails to note Turkey’s menthol ban for PM; (3) it does not reference the potential restrictions on slim cigarettes and flavor capsules; (4) it omits the 8% illicit trade figure in the EU, which is a critical multiplier of brand equity erosion; (5) it lacks detail on MO’s flavor bans in six U.S. states plus D.C., and the specific California restrictions on menthol, mint, and wintergreen; (6) it does not mention the proposed nicotine caps in Massachusetts; and (7) it does not reference FCTC guidelines or State Settlement Agreements by name, only alluding to them generally. While the LLM captures the general reasoning and correctly synthesizes cross-company impacts, these omissions reduce the depth of multi-hop synthesis and contextual precision. Quantitatively, no numbers are incorrect—none are stated, so no errors exist. The answer remains semantically aligned in direction and logic, but lacks the granular, multi-source detail required for full accuracy. Hence, correctness is reduced to 7 for partial completeness despite sound reasoning and no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 475,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is held as available‑for‑sale securities with an allowance for credit losses of about $35 million and a fair value of $20.4 billion; the company adjusts the amortized cost and yield for high‑quality RMBS based on actual cash flows, updated pre‑payment expectations, and expected credit losses, with any residual changes recorded as yield adjustments. In contrast, BAC values its RMBS holdings at fair value using market‑based inputs—pre‑payment speed (0‑29 % CPR) and default rate (0‑3 % CDR)—so that fluctuations in these inputs directly drive valuation risk for its $338 million mortgage‑trading portfolio, potentially causing significant fair‑value swings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several specific quantitative figures—$35 million allowance for credit losses, $20.4 billion fair value for AIG's RMBS, $338 million mortgage-trading portfolio for BAC, and prepayment speed (0–29% CPR) and default rate (0–3% CDR) ranges—that do not appear in the original ground truth answer and cannot be verified from it. These numbers are likely hallucinated or pulled from out-of-scope data, severely undermining quantitative accuracy. The ground truth makes no mention of specific dollar values, portfolio sizes, or numerical ranges for CPR/CDR, so their inclusion is factually unsupported. (2) Despite the incorrect numbers, the qualitative treatment of accounting and risk methodologies is largely accurate: AIG’s yield recalculations based on actual and expected cash flows, amortized cost adjustments, and use of an allowance for credit losses for non-high-quality securities are correctly described in substance. Similarly, BAC’s emphasis on fair value sensitivity to prepayment and default rate fluctuations is consistent with the original answer. (3) The multi-hop reasoning is sound in structure—comparing AIG’s accounting treatment (income and amortization focus) with BAC’s valuation risk (fair value sensitivity)—and correctly identifies the conceptual distinction between the two firms’ exposures. However, the addition of unverified metrics undermines the reliability of the synthesis. (4) Contextual relevance is high because the response directly addresses the comparison asked in the question and frames both companies’ RMBS risk exposures appropriately, even if with fabricated supporting data. The core reasoning aligns semantically with the ground truth, but the inclusion of false quantitative details significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 490,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom values its developed cybersecurity technology—including cloud‑security solutions—using the **multiperiod excess‑earnings method** under the income approach, estimating the present value of projected cash flows from the technology less the contribution of other assets, with useful life set by the technology cycle (page 98).  \nCisco, by contrast, applies ASC 606 performance‑obligation rules to its Cloud Security product category: security software licenses are treated as a single distinct obligation and revenue is recognized **ratably over the contract term** (hardware and perpetual software are recognized upfront, and SaaS is also ratably over the term) (page 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Broadcom's use of the multiperiod excess earnings method under the income approach, including the key elements: present value of projected cash flows, subtraction of contributions from other assets, and determination of useful life based on the technology cycle. These details match the original answer semantically, with added specificity (e.g., reference to page 98) that does not contradict the ground truth. (2) For Cisco, the LLM accurately states that revenue for Cloud Security is recognized ratably over the contract term under ASC 606, particularly for SaaS arrangements, and correctly distinguishes this from upfront recognition for hardware and perpetual software. This expands slightly on the original answer but remains factually consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation methodology (Broadcom) vs. revenue recognition (Cisco), two distinct financial treatments across companies and reporting contexts. (4) Minor deduction in qualitative accuracy due to the inclusion of extra details (e.g., ASC 606, distinction about hardware/perpetual software) not present in the ground truth, which, while accurate, slightly shift focus from the core comparison emphasized in the original—Broadcom’s asset valuation vs. Cisco’s service-based revenue recognition. However, these additions do not introduce error. Quantitative accuracy is perfect—no numerical inaccuracies, and all financial concepts are correctly represented. Contextual relevance is full, as all content directly addresses the comparative question. Overall, the answer is factually excellent with only slight over-elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 473,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s Class B shares carry ten votes each versus one for each Class A share (page 82), and with 343 million Class B shares versus 2.19 billion Class A shares (page 1) the high‑vote shares represent roughly 15 % of the total but could command about half of the voting power. Google’s dual‑class structure likewise gives its privately held Class B shares 10 votes each, but the publicly traded Class A (≈1.5 billion) and Class C (≈1.5 billion) shares are roughly equal in number and the Class C shares have no votes (page 82), so the high‑vote shares are a smaller minority and wield influence mainly through the 10‑vote pool rather than the public share base. Thus, while the 10:1 voting‑power ratio is the same, Meta’s high‑vote shares have a relatively larger share of the voting pie and a greater potential to shape governance decisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, META's Class B shares do *not* have 10 votes per share; instead, they have voting rights only in specified circumstances and are tied to conversion rates, not a fixed 10:1 voting ratio. The LLM incorrectly states that Meta’s Class B shares carry ten votes each, which contradicts the original answer and misrepresents the voting structure. Similarly, for GOOGL, the LLM claims Class C shares have no votes and that Class A and Class C are each ~1.5 billion shares, but this information is not present in the original answer and introduces entities (Class C) and details not supported by the ground truth. The original answer only mentions GOOGL’s Class B having 10 votes per share and does not discuss Class C or its voting rights. (2) Quantitative accuracy is partially correct in referencing 343 million Class B and 2.19 billion Class A shares for Meta, which aligns approximately with the ground truth (343,761,117 and 2,189,898,148). However, the derived claim that high-vote shares could command 'about half' of voting power is unsupported because the ground truth does not confirm that Meta’s Class B has 10 votes per share—thus invalidating the calculation. (3) The multi-hop reasoning is flawed: the LLM assumes structural equivalence with Google’s 10:1 model and extrapolates incorrectly to Meta, failing to capture the key distinction that Meta’s Class B voting power is conditional, while Google’s is consistently higher. This undermines the comparative analysis. (4) Despite these errors, the answer is contextually relevant—it addresses the core question about voting disparity and attempts a comparative analysis. However, due to major factual and reasoning errors in both quantitative and qualitative dimensions, the correctness score is low. Semantic equivalence is not achieved because the underlying facts about voting rights are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 530,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s bottling operations in Argentina are part of the equity‑method investee that contributed to KO’s $14.5 billion of net sales to equity‑method investees in 2021; under KO’s incidence‑based concentrate pricing model, the price of concentrates sold to the Argentina bottler is set based on local bottler pricing, channel mix and other market factors, so the bottler’s volume and pricing directly influence KO’s equity‑method revenue. For CL, the Argentina bottler is one of the key markets driving the 8 % organic sales growth reported for Latin America in 2021, as its volume expansion and price increases in that market support the overall regional growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly identifies Coca-Cola FEMSA's role in KO's net sales to equity method investees and links it to the incidence-based pricing model, which is accurate. It also connects the Argentina operations to regional growth for CL in Latin America. However, there is a key numerical inaccuracy: the LLM states CL reported '8% organic sales growth' in Latin America in 2021, while the ground truth specifies a 7.0% net sales increase. This discrepancy affects quantitative accuracy. Additionally, the LLM rounds KO's net sales to $14.5 billion instead of the precise $14,471 million, which, while acceptable in format, slightly reduces precision. (2) The correct figure for KO's net sales is $14,471 million (or ~$14.5 billion, acceptable), but CL’s growth is misstated: 8% (LLM) vs. 7.0% (ground truth). This is a material error as it misrepresents a core data point. (3) The multi-hop reasoning is sound: the model correctly synthesizes how KO’s pricing model ties to bottler performance in Argentina, and how that market contributes to CL’s regional growth. It appropriately links Coca-Cola FEMSA’s operations to both KO’s equity-method revenue and CL’s organic growth, showing understanding of cross-entity financial dependencies. (4) Despite the incorrect percentage for CL’s growth, the overall logic, entity identification (KO, CL, Coca-Cola FEMSA, Argentina), and contextual mechanisms (incidence-based pricing, regional growth drivers) are accurate and relevant. The answer captures the essence of the relationship but fails on one critical number, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 439,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott’s private‑equity interests are valued at NAV and are subject to a 10‑ to 15‑year lock‑up, with redemption only after the partnership term ends【page 71】. Merck also measures its alternative‑investment holdings at NAV【page 116】, but the 10‑K excerpt does not disclose redemption terms; the typical lock‑up for such funds is comparable to Abbott’s, implying similar restrictions even though they are not explicitly stated.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general use of NAV by both Abbott and Merck and correctly identifies the 10- to 15-year lock-up period for Abbott's private equity funds, which aligns with the ground truth referencing typical redemption restrictions. However, it omits key quantitative details: Abbott’s $555 million in unfunded commitments and the specific liquidation distribution period (2024–2033), as well as Merck’s $382 million in NAV-based alternative investments. These omissions significantly reduce quantitative accuracy. (2) No numeric values from the ground truth are mentioned in the LLM answer—neither Abbott’s $555M unfunded commitments nor Merck’s $382M NAV-based assets—making the response incomplete on critical financial metrics. The answer does not attempt any calculations, but the failure to report disclosed figures constitutes a major gap. (3) The multi-hop reasoning is partially sound: the model correctly infers that both firms use NAV as a practical expedient for illiquid investments and associates redemption restrictions with fund type. However, it fails to compare the actual scale and structure of the investments (e.g., Abbott’s longer liquidation timeline and greater unfunded commitments), which is central to the question. The claim that Merck’s 10-K 'does not disclose redemption terms' is accurate, but the inference that restrictions are 'comparable' lacks support from the ground truth, which confirms Merck’s use of NAV but does not allow direct comparison of lock-up terms. (4) Contextual relevance is high because the answer addresses NAV valuation and redemption restrictions for both companies. However, the lack of specific data points and incomplete synthesis of comparative investment profiles limits correctness. The answer is semantically aligned in concept but deficient in factual completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 506,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock’s separate‑account program keeps the assets held for individual and group pension contracts in a legally segregated account that is not subject to general creditor claims.  AIG therefore reports separate‑account liabilities that are “equal and offsetting” to those assets and are tied directly to each contract‑holder’s account balance, ensuring that the liabilities are not exposed to general creditors and that the balance sheet reflects a one‑to‑one match between the protected assets and the corresponding liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the core relationship between BlackRock's Separate Account Assets and AIG's reporting of offsetting liabilities. It correctly identifies that BlackRock’s assets are legally segregated and not subject to general creditor claims, and that AIG reports equal and offsetting liabilities tied to contract holder balances. The answer captures the one-to-one mirroring of assets and liabilities and the protection from creditors. While the LLM omits specific details about the composition of the assets (e.g., equity securities, debt securities, derivatives) mentioned in the ground truth, this does not detract from the essential correctness of the financial reporting mechanism. There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is scored as 10. The reasoning is sound and reflects proper multi-hop synthesis between BlackRock’s asset treatment and AIG’s liability reporting. The answer is semantically equivalent to the original in intent and substance, though slightly less detailed. Contextual relevance is perfect—it directly addresses the impact on AIG’s reporting as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 330,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records Imbruvica sales in the U.S. as net revenue and includes Janssen’s share of pre‑tax profits in its cost of products sold, thereby reflecting the 60/40 cost‑sharing arrangement under the collaboration (page 68). By contrast, J&J’s 10‑K notes that its subsidiary Janssen holds exclusive commercialization rights outside the U.S. and co‑exclusive rights in the U.S., and is responsible for worldwide commercialization of Imbruvica (pages 8 and 11).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AbbVie records 100% of U.S. Imbruvica sales as net revenue and deducts Janssen's share of profits through cost of products sold, which aligns with the ground truth. It accurately states the 60/40 cost-sharing arrangement (Janssen 60%, AbbVie 40%) for development costs. It also correctly notes that Janssen, under Johnson & Johnson, has exclusive rights outside the U.S. and co-exclusive rights in the U.S., consistent with the dual-market strategy. However, the LLM omits the explicit statement that pre-tax profits and losses are shared equally between the two companies globally, which is a key element in the original answer and relevant to understanding the economic alignment despite unequal cost contributions. (2) Quantitatively, all percentages (60/40 split) and references to financial reporting (revenue recognition, cost of products sold) are accurate. There are no calculation errors. The mention of '60/40 cost-sharing' correctly refers to development costs, not profit split, which the model distinguishes appropriately. (3) The multi-hop reasoning is sound: the model synthesizes information about AbbVie’s revenue treatment and links it to J&J’s global commercialization role via Janssen. It connects the U.S. co-exclusive model with international exclusivity, showing understanding of the dual-market structure. The only gap is the incomplete elaboration on equal profit sharing, which weakens full synthesis. (4) Scores reflect high accuracy in numbers and entities (AbbVie, Janssen, Johnson & Johnson, U.S. vs. ex-U.S. rights), correct use of financial terminology, and strong relevance to the question. The omission of equal pre-tax profit sharing prevents a top score, but core facts and logic remain largely intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 487,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged conflict could cut off NVIDIA’s access to the Taiwan‑based foundries that produce its chips, forcing supply‑chain disruptions and a material adverse impact on its business.  For Apple, the same conflict would threaten the outsourcing partners that manufacture its products in Taiwan (and the broader Asia‑Pacific region), potentially causing production delays, shortages and higher costs.  (NVDA 10‑K, p. 35; AAPL 10‑K, p. 9)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions in elaboration. (1) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies both NVIDIA's dependency on Taiwan-based foundries and Apple's reliance on manufacturing in the region, citing specific risks: supply chain disruptions, production delays, shortages, and increased costs. It also references the correct risk factors from both companies' 10-K filings (NVDA p.35, AAPL p.9), supporting the claims. (3) The multi-hop reasoning is sound—linking geopolitical risk to supply chain impacts for both companies based on their respective dependencies. The synthesis across two companies and their supply chain structures is accurate. (4) The only reason for not scoring a perfect 10 is that the LLM answer is slightly less detailed than the original answer—for example, it does not mention the potential damage to customer relationships, revenue impact, or the difficulty and expense of restructuring the supply chain as noted in the ground truth. However, the core facts, entities, and logical connections are correct and relevant. Contextual relevance is full, as the response directly addresses both parts of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 379,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed‑Martin’s Level 2 fixed‑income valuations are based on verifiable observable market data – interest‑rate and yield‑curve levels, credit‑spreads, broker/dealer bids and quoted prices of comparable securities – with the credit‑spread component implicitly providing the risk adjustment. Honeywell’s corporate‑bond and government‑security valuations also use pricing models, but the company explicitly notes that the models incorporate adjustments for credit and liquidity risk that may not be observable, in addition to the same observable market inputs. Thus, while both rely on observable data, Honeywell’s approach explicitly accounts for non‑observable risk factors beyond the observable inputs used by Lockheed‑Martin.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: LMT uses observable market data (interest rates, yield curves, credit spreads, broker bids, comparable securities) for Level 2 fixed income valuations, while HON uses similar observable inputs but explicitly includes unobservable adjustments for credit and liquidity risk. The distinction between implicit risk adjustment via credit spreads in LMT versus explicit unobservable adjustments in HON is correctly captured. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the qualitative data is accurately represented. (3) The multi-hop reasoning—comparing two companies' valuation methodologies across different instruments (Level 2 fixed income vs. corporate/government bonds) with a focus on observability and risk adjustments—is sound and well-synthesized. (4) The only reason for not scoring a perfect 10 is minor: the LLM slightly reframes LMT's credit spread as providing 'implicit' risk adjustment, which is reasonable but not explicitly stated in the original; the original emphasizes verifiability and observable inputs without commenting on how risk is adjusted within the model. This is a subtle interpretive addition, not an error. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 402,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "In 2024 a stronger U.S. dollar cut Coca‑Cola’s Europe, Middle East and Africa net operating revenues by about 16 % (a sizable negative foreign‑currency effect that was only partially offset by favorable euro and pound movements). Mondelez likewise faces currency‑exchange risk, noting that a stronger dollar can depress consolidated earnings and net assets, but it mitigates this exposure through hedging and acknowledges that the risk remains significant.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the stronger U.S. dollar cut Coca-Cola's Europe, Middle East and Africa net operating revenues by about 16%, while the ground truth reports an 11% unfavorable impact on consolidated operating income (not specifically net operating revenues, nor limited to the EMEA segment). This is a significant factual error in both magnitude and metric specificity. (2) The ground truth does not provide a segment-specific percentage for EMEA, only a company-wide 11% impact on consolidated operating income, so the LLM's 16% figure for EMEA revenues is unsupported and likely incorrect. The mention of offsetting benefits from the euro and pound is consistent, though attributed to net operating revenues rather than operating income. (3) The qualitative comparison with Mondelez is reasonably accurate: both companies acknowledge adverse effects from a stronger dollar on earnings due to currency translation, and MDLZ's use of hedging and ongoing risk exposure is correctly noted. However, the LLM omits MDLZ's emphasis on unpredictability and volatility mentioned in the original answer, slightly weakening the qualitative synthesis. (4) Despite accurate entity identification (KO, MDLZ, 2024, EMEA, hedging) and contextual relevance to macroeconomic currency impacts, the major quantitative inaccuracy (16% vs 11%, wrong metric) reduces confidence in the correctness score. The reasoning is partially sound but based on an incorrect numerical foundation for KO's impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 417,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "AVGO’s FY 2024 10‑K shows that it has $365 million of long‑lived assets in Taiwan—only a small, fixed‑asset investment (≈ 14 % of its $2.5 billion total long‑lived assets). In contrast, Qualcomm’s risk factors note that its heavy reliance on Taiwan‑based foundry partners for chipset supply is a strategic vulnerability that could be abruptly severed by any military or geopolitical conflict between China and Taiwan, potentially crippling its business. Thus, while AVGO’s Taiwan assets are a modest, static capital allocation, Qualcomm’s supply‑chain dependence poses a far more immediate operational risk amid the same geopolitical tensions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AVGO's $365 million in long-lived assets in Taiwan for fiscal 2024 and accurately captures QCOM's risk regarding reliance on Taiwan-based foundries amid geopolitical tensions. However, the LLM introduces a figure not present in the ground truth: that AVGO’s $365M represents ≈14% of its $2.5B total long-lived assets. This calculation, while numerically plausible ($365M / $2.5B = 14.6%), is not supported by the original answer or question, which do not mention total long-lived assets or percentages. This constitutes a factual overreach not grounded in the provided data. (2) The dollar amounts ($365M for AVGO, reference to $2.5B total assets) are plausible but the latter is unverified and not part of the ground truth, making the quantitative comparison partially fabricated. The core number—$365M in Taiwan—is correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes AVGO’s asset exposure with QCOM’s supply chain risk, contrasting asset-based vs. operational exposure to Taiwan. The conclusion that QCOM faces more immediate operational risk due to geopolitical tensions aligns with the original answer’s intent. (4) Despite the unsupported percentage and total asset figure, the LLM captures the essential contrast in risk types (asset vs. supply chain) and correctly attributes the geopolitical vulnerability. Hence, the answer is mostly accurate but penalized for introducing unverified quantitative data, reducing quantitative accuracy. Contextual relevance and qualitative reasoning remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 432,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s supply chain is heavily concentrated in Taiwan, where most of its product assembly occurs (Apple notes that “substantially all of the Company’s manufacturing is performed…in Taiwan”【page_9】). This concentration makes Apple more vulnerable to cross‑strait tensions, U.S.–China trade disputes, and other regional disruptions that could interrupt its manufacturing base. In contrast, Microsoft’s Greater China operations are coordinated from a regional center in Singapore, a geopolitically stable jurisdiction that reduces its direct exposure to China‑specific risks while still allowing it to serve the Greater China market【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies Apple's heavy reliance on manufacturing in Taiwan, citing a direct quote from the filing (‘substantially all of the Company’s manufacturing is performed…in Taiwan’), which matches the ground truth’s emphasis on outsourced manufacturing in Asia and exposure to supply chain risks. It also accurately contrasts this with Microsoft’s regional center in Singapore, which supports operations in Greater China but is not tied to manufacturing. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s supply chain exposure and Microsoft’s operational structure, linking geography (Taiwan vs. Singapore), function (manufacturing vs. logistics/administration), and geopolitical risk exposure. The only minor shortcoming is that the LLM answer does not explicitly mention that Taiwan is part of Apple’s ‘Greater China’ segment or that Microsoft’s Singapore center supports vendor management and logistics—details present in the original. However, the core contrast in risk exposure due to operational models is clearly and correctly conveyed. (4) Contextual relevance is excellent—the response directly addresses the comparative geopolitical risk question and maintains focus on the key differentiator: manufacturing dependency vs. administrative coordination. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 459,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Nebraska’s 2023 corporate‑tax‑rate cut lowered Union Pacific’s deferred‑tax expense by **$114 million** (see page 29 of the 10‑K). In contrast, Boeing’s 2024 10‑K (page 10) warns that **significant delays in federal appropriations could negatively impact its business, financial position and results of operations**, exposing the company to potential cash‑flow and revenue risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $114 million reduction in Union Pacific's deferred tax expense due to Nebraska's 2023 tax rate cut is correctly stated, matching the original answer and disclosed in the 2024 10-K (filed in 2023 for fiscal year 2023). The figure is precise and correctly attributed. (2) The LLM correctly identifies Boeing's exposure to federal appropriations delays as disclosed in its 2024 10-K, accurately summarizing the risk language regarding negative impacts on business, financial position, and operations. While the original answer adds more detail (e.g., continuing resolutions, government shutdowns, impact on new programs and commercial airplane delivery), the LLM captures the core qualitative risk. (3) Multi-hop reasoning is sound: the model correctly contrasts a state-level tax benefit for Union Pacific with federal funding risks for Boeing, synthesizing information from two different 10-K filings. (4) Entity accuracy is perfect: both companies, the correct fiscal year (implied by 2024 10-K for 2023 data), and financial terms (deferred tax expense, federal appropriations) are correctly used. The only minor shortcoming is slightly less contextual elaboration on Boeing’s specific operational risks (e.g., contract execution, program delays), which slightly reduces qualitative completeness. However, the answer remains semantically equivalent in intent and factual content. Wording differences are acceptable and do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 421,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Enbrel’s U.S. patents expire between 2028 and 2037 (see the patent table on page 14), after which biosimilar competitors such as HUMIRA and RINVOQ are likely to enter the market.  Merck acknowledges that loss of patent protection “typically is followed promptly by generic or biosimilar substitutes” (page 33) and that such entry can materially harm sales (page 31).  Consequently, Merck’s strategy places a strong emphasis on actively protecting and extending its own patent portfolio to delay generic competition and preserve revenue streams in a highly competitive biopharma landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the competitive dynamics post-Enbrel patent expiration. It incorrectly states that biosimilar competitors such as HUMIRA and RINVOQ will enter the market after Enbrel’s patent expiry. In reality, HUMIRA and RINVOQ are not biosimilars of Enbrel; they are distinct biologic drugs (adalimumab and upadacitinib, respectively) developed by other companies (AbbVie and Johnson & Johnson) for similar indications but with different molecular targets. Enbrel’s (etanercept) actual biosimilars include products like Erelzi and Eticovo. This misidentification of competitors undermines the accuracy of the competitive analysis. (2) Regarding quantitative accuracy, the LLM correctly identifies the general timeframe of Enbrel patent expirations (2028–2037), which aligns with the ground truth dates: 11/22/2028, 4/24/2029, and 10/19/2037. However, it fails to specify the exact patents or their distinct expiration timelines, omitting key details that reflect a partial understanding. The citation of 'page 14' and 'page 33' suggests document referencing, but without confirmation of actual filing content, this may be hallucinated. (3) The multi-hop reasoning is partially sound: the model correctly infers that patent expirations lead to biosimilar entry, which in turn pressures companies like MRK to protect their own portfolios. It accurately quotes MRK’s 10-K language about generic/biosimilar substitutes following patent loss and the associated sales risk, showing proper synthesis of MRK’s strategic concerns. However, the flawed identification of post-Enbrel competition weakens the logical chain. (4) Contextual relevance is high—the answer addresses the core issue of how patent expirations influence MRK’s strategy. Despite incorrect competitor names, the overall strategic implication (need for robust patent protection) is consistent with the ground truth. The answer would be stronger with accurate entity mapping and more precise patent-level detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 551,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD’s revenue from operations in Taiwan was $2.091 billion (the most recent figure disclosed in its 2022 10‑K).  Apple’s 2022 Greater China segment – which includes Taiwan – generated $74.2 billion in net sales.  The roughly 35‑fold gap shows that Apple has a far larger market presence in Taiwan than AMD.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports AMD's 2022 revenue from Taiwan as $2.091 billion ($2,091 million) and Apple's 2022 Greater China net sales as $74.2 billion ($74,200 million), matching the ground truth exactly in value and year. These figures are accurately cited and formatted appropriately (e.g., $2.091 billion = $2,091 million). (2) However, the LLM makes a critical reasoning error by stating that Apple has a 'far larger market presence in Taiwan' than AMD, based on a 35-fold comparison. This is misleading because Apple's $74.2 billion covers the entire Greater China region (mainland China, Hong Kong, and Taiwan), not just Taiwan. The ground truth explicitly notes that Taiwan's individual contribution within Greater China is not disclosed, making any direct comparison of Taiwan-only revenue speculative. The LLM fails to acknowledge this limitation, which is central to the original answer. (3) The multi-hop reasoning is partially sound—correctly identifying both companies' revenues and regions—but breaks down in synthesis by conflating Apple's broader regional revenue with Taiwan-specific presence. It omits the crucial caveat about data granularity, leading to an overconfident and potentially incorrect conclusion. (4) While the quantitative accuracy is perfect (10/10) and the answer is contextually relevant (9/10), the qualitative accuracy suffers due to flawed logic and omission of key uncertainty (6/10). The correctness score is 7 because core facts are right, but the interpretation misrepresents the data's implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 428,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet’s repurchase of Class C shares—shares that carry no voting rights—lets the company return cash to shareholders while preserving the voting structure of its Class A and B shares (page_81). In contrast, Netflix’s single‑class common stock gives each share one vote (page_61), so any buyback reduces overall voting power and can affect governance (page_62). Thus, Alphabet can adjust its capital structure and return capital without altering control, whereas Netflix’s uniform voting rights tie capital allocation directly to voting power, limiting that flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinction between Alphabet's and Netflix's share repurchase strategies with correct reasoning. (1) All factual elements are correct: Alphabet repurchases non-voting Class C shares to preserve insider control via Class A and B shares, while Netflix has uniform voting rights (one vote per share), meaning buybacks affect overall voting distribution. The LLM correctly identifies that Alphabet can return capital without altering control, whereas Netflix’s capital allocation is more tightly linked to governance. (2) Quantitative accuracy is perfect—although the LLM does not include the specific dollar figures ($62.2 billion repurchased, $36.3 billion remaining), these omissions do not distort or misrepresent the facts, and the question does not explicitly ask for numbers. Their absence lowers completeness slightly but does not affect correctness. (3) Multi-hop reasoning is sound: the model synthesizes information about share class structures (Alphabet’s dual-class vs Netflix’s single class) and correctly infers the implications for capital allocation flexibility and governance. (4) Semantic equivalence is strong—wording differs from the original answer but preserves meaning. The only minor shortcoming is the lack of specific financial figures present in the ground truth, which would have strengthened completeness. However, since the question focuses on the structural comparison rather than quantitative details, this does not significantly detract from the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 424,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s non‑agency pass‑through RMBS exposure is concentrated in NQM and Alt‑A loans, amounting to $1,699 million, and the portfolio carries a $1,294 million unrealized loss on pass‑through securities (page 88).  By contrast, AIG’s liquidity risk is framed as a broader concern about the valuation and potential sale of illiquid mortgage‑related investments, which could constrain cash flow (pages 19–20).  Thus, MET faces a sizable unrealized loss on a specific asset class, whereas AIG’s risk is a general liquidity constraint stemming from the difficulty of valuing and liquidating its mortgage‑related holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: MET's $1,699 million exposure to NQM and Alt-A loans and $1,294 million in unrealized losses are accurately reported. The figures match the original answer exactly, and no calculations were required. Format variations (e.g., $1,699 million vs $1,699 million) are acceptable. (2) The answer addresses all key parts of the question: MET’s specific exposure and unrealized losses, and AIG’s liquidity risk from illiquid mortgage-related assets. It correctly contrasts MET’s marked-to-market, specific asset-class risk with AIG’s broader valuation and liquidity concerns. (3) Entity accuracy is strong: MET and AIG are correctly identified, as are the relevant financial instruments (non-agency pass-through RMBS, NQM, Alt-A loans, unrealized losses). The year is not explicitly mentioned in the LLM answer (2024 in ground truth), but since the question does not ask for a year and the context is current risk exposure, this omission does not materially affect correctness. (4) The reasoning is sound and reflects proper multi-hop synthesis: it draws from MET’s specific portfolio composition and losses and contrasts it with AIG’s qualitative liquidity risk disclosures. The only minor shortcoming is that the LLM answer omits MET’s total pass-through MBS portfolio size ($12,567 million), which provides context for the $1,699 million NQM/Alt-A segment. While not critical to the core comparison, this detail would have enhanced completeness. Otherwise, the semantic meaning and risk comparison are equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 448,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "In 2021, Coca‑Cola’s Asia Pacific segment generated **$5.29 billion** in net operating revenue (page 124), which is essentially all beverage revenue. PepsiCo’s APAC division reported **$4.62 billion** in total revenue (page 73), of which 20 %—about **$923 million**—was beverage (page 73). Thus, Coca‑Cola’s beverage contribution in Asia Pacific was roughly **$4.37 billion higher** (about 5.7 times) than PepsiCo’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Coca-Cola's 2021 third-party beverage revenue in APAC was $4,682 million ($4.682 billion), but the LLM claims $5.29 billion, which is incorrect. For PepsiCo, the ground truth states that 20% of APAC revenue came from beverages, but the exact dollar amount is not disclosed. However, the LLM asserts that PepsiCo’s APAC total revenue was $4.62 billion and calculates 20% of that as $923 million in beverage revenue. This precise breakdown is not supported by the original answer, which explicitly notes the dollar amount is not disclosed and would require additional data to calculate. Thus, the LLM fabricates specific figures not present in the ground truth. (2) Calculations are internally consistent (20% of $4.62B ≈ $924M), but they are based on incorrect inputs not found in the original answer. The difference of $4.37 billion and the '5.7 times' comparison are therefore invalid. (3) The multi-hop reasoning is flawed: the model incorrectly assumes that PepsiCo’s total APAC revenue and its beverage split are publicly quantified in the same way as Coca-Cola’s, and proceeds to make a precise comparison that the original data does not support. The ground truth emphasizes that PEP’s beverage revenue in APAC cannot be directly determined without further calculation, while the LLM presents it as known. (4) Despite these errors, the answer is contextually relevant—it addresses the right companies, region, year, and product segment, and attempts a direct comparison as required. However, the high confidence in unsupported numbers severely undermines factual correctness. Hence, low scores for quantitative and overall correctness, moderate for qualitative reasoning due to logical structure despite false premises, and decent relevance for framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 504,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Under the Gilead‑Merck collaboration, Merck receives a 50/50 share of product revenue until net sales hit $2 billion for the oral combination or $3.5 billion for the injectable; once those thresholds are surpassed, Merck’s share drops to 35% (Gilead’s rises to 65%). In contrast, Merck’s Keytruda license obliges it to pay 6.5 % of global sales (reducing to 2.5 % after 2023) in royalties, split 75/25 between BMS and Ono, which is a direct cost. Consequently, the Gilead partnership could generate positive revenue for Merck if sales exceed the thresholds, while the Keytruda arrangement imposes a royalty expense that reduces Merck’s profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 50/50 revenue split between Gilead and Merck for long-acting HIV products, with thresholds of $2.0 billion (oral) and $3.5 billion (injectable), after which Merck's share drops to 35% (Gilead's increases to 65%). This matches the ground truth. The Keytruda royalty obligation is accurately stated as 6.5% through 2023 and 2.5% from 2024–2026, with the 75/25 split between BMS and Ono. However, the LLM omits the specific mention of Merck recording $212 million in alliance revenue from BMS on Reblozyl in 2023, including a 20–24% royalty, which is part of the original answer and adds context to Merck’s revenue streams. (2) All numeric values—percentages, dollar thresholds, time periods—are correct. The phrasing 'reducing to 2.5% after 2023' is slightly imprecise (ground truth specifies 2024–2026), but not factually wrong. (3) The multi-hop reasoning is sound: the model correctly contrasts Merck’s revenue-sharing (income) from Gilead with its royalty payments (expense) to BMS/Ono, and draws a logical conclusion about profitability implications. It synthesizes across two distinct partnerships and their financial structures. (4) The omission of the Reblozyl revenue detail slightly reduces completeness and qualitative accuracy, but the core comparison and financial implications are well-conveyed. The answer remains contextually relevant and factually strong, warranting a high correctness score despite the minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 411,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "BAC’s 10‑K notes that it holds collateral‑loan‑obligation (CDO) investments that embed credit‑default swaps (CDS) and pass risk through tranche structures; a credit event in a reference entity triggers losses on the junior tranches of those CDOs. AIG’s 2024 10‑K records a $75 million loss from embedded derivatives (page 144), which likewise arose when credit events in the underlying reference entities triggered the embedded CDS. Thus, both institutions experience losses when credit events occur, but BAC’s exposure is structured through tranche‑based CDOs while AIG’s loss comes directly from the embedded derivatives themselves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC's investment in CDOs with embedded CDS, tranche-based risk transfer, and AIG's $75 million loss from embedded derivatives in 2024 are all accurately reported. The dollar amount and year match the original answer exactly. (2) Quantitative accuracy is perfect: the $75 million loss is correctly cited, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—LLM correctly links BAC’s CDO exposure and AIG’s derivative losses through the common mechanism of credit events triggering embedded credit default swaps. It accurately distinguishes BAC’s indirect exposure (via structured tranches) from AIG’s more direct exposure to embedded derivatives. (4) The only minor shortcoming is a slight underemphasis on the cascading risk from junior to senior tranches in CDOs, which is central to the original answer’s point about 'cascading risk.' However, the core concept of tranche-based loss allocation is present. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, addressing all parts of the question with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 343,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "Citibank, N.A. is the **administrative agent** on 3M’s May 2023 Five‑Year Credit Agreement (and, in that agreement, also a joint lead arranger and joint book manager)【page 114】.  \nIn Caterpillar’s September 2022 credit facilities, Citibank, N.A. is the **agent** (and the local‑currency agent for the UK branch)【page 129】.  \n\nThus, while both agreements appoint Citibank to oversee the loan, 3M’s agreement assigns it a broader administrative role that includes joint arranging and book‑management duties, whereas Caterpillar’s agreements limit Citibank to acting as the primary agent and local‑currency agent without the joint‑arranger or book‑manager responsibilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Citibank, N.A.'s role as administrative agent and joint lead arranger in 3M’s May 2023 Five-Year Credit Agreement, and as agent and local-currency agent in Caterpillar’s September 2022 facilities. These roles are factually accurate and match the ground truth. However, the LLM incorrectly frames the difference in responsibilities by stating that 3M’s agreement gives Citibank a 'broader administrative role' with 'joint arranging and book-management duties,' while suggesting Caterpillar’s role is more limited. This misrepresents the ground truth, which emphasizes that Citibank has *more layered and internationally complex* responsibilities at Caterpillar — including coordination through Citibank Europe plc and MUFG Bank, Ltd. — rather than a simpler or narrower role. The LLM underemphasizes the cross-border and multi-agent structure in Caterpillar’s case, which is a key differentiator. (2) Quantitative accuracy is perfect: dates (May 2023, September 2022), entity names (Citibank, N.A., JPMorgan Chase Bank, N.A., MUFG Bank, Ltd.), and role titles are correct. No numerical errors. (3) Multi-hop reasoning is partially sound — the model connects Citibank’s roles across two companies and attempts a comparison — but the synthesis is flawed in the conclusion about relative scope. It fails to recognize that international coordination and multiple agent roles (Local Currency Agent, Japan Local Currency Agent) in Caterpillar represent *greater* complexity than the shared leadership role at 3M. (4) Correctness is scored 7 due to accurate facts but flawed comparative reasoning; qualitative accuracy is 7 for the same reason; quantitative accuracy is 10 as all specifics are correct; contextual relevance is 9 because the answer is highly relevant and addresses all parts, just with incorrect interpretation of the comparative responsibilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 513,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO uses option and forward contracts to hedge foreign‑currency exposure, with a notional amount of $9.9 billion in 2024; the gains and losses on these contracts are deferred in AOCI and offset changes in the U.S. dollar value of its foreign‑currency liabilities. PepsiCo’s strategy, reflected in a $113 million net gain on cash‑flow hedges in 2024, indicates a smaller‑scale hedging program that reduces foreign‑currency liability volatility but relies on a broader mix of instruments rather than a large, option‑centric position. Thus, KO’s hedging is more extensive and explicitly tied to option contracts, while PepsiCo’s approach is less extensive and produces a modest net benefit to its foreign‑currency liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The LLM claims KO had a notional amount of $9.9 billion in 2024 for option and forward contracts, and that PEP had an $113 million net gain on cash flow hedges in 2024—neither figure appears in the original answer or ground truth data, and no such numbers were provided in the context. These specific figures are unsupported and likely fabricated. (2) ENTITY AND STRATEGIC MISREPRESENTATION: The original answer states both KO and PEP use option and forward contracts, but the LLM incorrectly frames KO as having an 'option-centric' strategy and PEP as using a 'broader mix'—this contrast is not supported. In fact, the ground truth indicates both companies use options and forwards, with KO emphasizing AOCI deferral and PEP managing exposure from international operations (44% of revenue). (3) REASONING FLAW: The conclusion that KO’s hedging is 'more extensive' and PEP’s 'less extensive' is an unsupported inference not present in the original answer, which emphasizes similarities in strategy with nuanced differences in focus. (4) MISSING KEY INFORMATION: The LLM omits PEP’s 1.5 percentage point negative impact on net revenue from FX movements in 2024 and KO’s specific use of cash flow hedges designated with AOCI deferral—both central to the original comparison. (5) SEMANTIC NON-EQUIVALENCE: While the general topic of using derivatives for FX risk is addressed, the specific mechanisms, impacts on liabilities, and strategic emphasis differ materially. The answer introduces false precision via invented numbers, which severely damages credibility. Contextual relevance is moderate because it addresses the right topic and companies, but factual correctness is low due to hallucinated data and flawed comparative logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 498,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE’s goodwill impairment test (page 17) uses a DCF that relies on internal cash‑flow forecasts, terminal‑value assumptions, and a discount rate, and the company explicitly performs sensitivity analyses on those key estimates and assumptions. LMT’s Level 3 fixed‑income valuations (page 89) also use a DCF, but the valuation is driven by projected annuity payments and the discount rate; the filing notes these inputs as critical but does not describe a formal sensitivity analysis, implying the valuation is directly sensitive to those assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that GE uses DCF for goodwill impairment testing with internal cash flow forecasts, terminal value, and discount rates, and performs sensitivity analyses—this matches the original answer. It also accurately states that LMT applies DCF to value Level 3 fixed income investments using projected annuity payments and discount rates, particularly when market data is lacking. The observation that LMT’s filing does not describe a formal sensitivity analysis—implying less explicit treatment compared to GE—is a valid inference from the source material and adds nuance without overreaching. The core difference in focus (GE’s internal strategic use vs. LMT’s external pension asset valuation) is implied through context, though not explicitly stated; this minor omission prevents a perfect 10 on qualitative accuracy. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (GE, LMT, DCF, goodwill, Level 3 investments) are correctly identified and applied. The reasoning is sound, synthesizing multi-hop information across two companies and distinct financial applications. Contextual relevance is strong, directly addressing sensitivity to discount rates and cash flow estimates as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 370,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "Comcast’s dual‑class scheme gives each Class A share one vote and each Class B share ten votes, with Class A shares currently holding roughly two‑thirds (≈66.7 %) of the company’s voting power and Class B shares the remaining one‑third (≈33.3 %)【page_33】. Alphabet, by contrast, has a single voting class (Class A, one vote per share) and a non‑voting Class C; all voting power therefore resides in Class A shares【page_81】. While Comcast has repurchased 262 million Class A shares in 2023 (≈$41.9 average price)【page_33】—shrinking the voting share base and potentially boosting the relative weight of its higher‑vote Class B shares—Alphabet’s buy‑backs of Class A shares ($62.2 billion in 2023) similarly reduce the voting share count, whereas its Class C buy‑backs have no effect on voting power【page_81】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that CMCSA's Class B shares have 10 votes each, when the ground truth specifies 15 votes per Class B share. This is a critical error in the voting rights structure. Additionally, the LLM claims CMCSA repurchased 262 million Class A shares at ~$41.90 in 2023, but this specific repurchase volume and price are not mentioned in the original answer or supported by the ground truth, which states CMCSA does not disclose such repurchase volumes for Class A shares directly. (2) Quantitative accuracy is low: the $62.2 billion repurchase by GOOGL is correctly cited, but the CMCSA repurchase figures (262 million shares, $41.9 average price) are fabricated or misattributed and not present in the ground truth. The voting percentages (66.7% and 33.3%) are approximately correct and align with 66 2/3% and 33 1/3%, so partial credit is due. (3) Multi-hop reasoning is partially sound: the model correctly identifies that share repurchases of voting shares can increase the relative voting power of non-repurchased classes, and it draws a valid comparison in that regard between CMCSA and GOOGL. However, it misrepresents GOOGL’s structure by claiming Class C shares are non-voting and that Class B shares do not exist, when the ground truth explicitly states GOOGL has Class B shares with 10 votes per share. This undermines the qualitative accuracy. (4) Contextual relevance is high because the answer addresses voting power distribution, repurchase activity, and comparative dynamics between the two companies, even though the factual basis is flawed. Overall, the answer appears plausible but contains key factual errors in both voting rights and repurchase data, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 486,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "PM’s 10‑K notes that Turkey’s cigarette market grew 8.2 % in 2022, largely from higher adult‑smoker consumption and increased inbound tourism, and that this boost helped lift cigarette volume and net revenues in the Middle East & Africa segment (page 56). Colgate‑Palmolive’s 10‑K does not report any operations or revenue in Turkey, indicating no operational footprint in that country (page 30). Thus, PM benefits directly from Turkey’s market expansion, whereas CL has no comparable exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 8.2% growth in Turkey's cigarette market in 2022 and attributes it to increased adult-smoker consumption and inbound tourism, which aligns with the ground truth (though the original answer emphasizes easing of pandemic measures and Turkish expatriates specifically). The reference to PM's Middle East & Africa segment benefiting is factually correct and supported by the 10-K citation. However, the LLM makes a critical error regarding Colgate-Palmolive (CL): it claims CL has no operations or revenue in Turkey based on its 10-K page 30, directly contradicting the ground truth, which states CL operates manufacturing and warehousing facilities in Turkey as part of its Oral, Personal and Home Care segment. This is a major factual inaccuracy. (2) Quantitatively, the 8.2% figure is accurate, and no calculations are required. The year 2022 is correctly implied. (3) The multi-hop reasoning fails at the synthesis stage: while the LLM correctly links Turkey's market growth to PM’s performance, it incorrectly concludes CL has no footprint due to lack of explicit mention of Turkey in revenue reporting, failing to recognize that operational presence (manufacturing) can exist independently of segmented revenue disclosure. The original answer correctly distinguishes between market-driven revenue exposure (PM) and physical operational infrastructure (CL), which the LLM misses entirely. (4) The correctness score is 4 due to one major factual error undermining the comparative analysis, despite correct numbers and partial reasoning. Quantitative accuracy is high (9) because all numbers are correct. Qualitative accuracy is low (3) due to incorrect entity inference and flawed reasoning about CL’s footprint. Contextual relevance is moderate (6) as the answer addresses the question’s structure but with incorrect information on one key entity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 512,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "NVIDIA’s risk factors state that geopolitical tensions involving Taiwan could materially affect its ability to obtain timely wafer supply from foundry partners such as TSMC (page_17). Qualcomm’s supply chain also depends on Taiwanese foundries (TSMC, SMIC, etc.), and its risk factors warn that tensions between China and Taiwan could disrupt its operations and supply chain in the region (page_11, page_19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that NVIDIA's ability to secure timely wafer supply from foundry partners like TSMC could be materially affected by geopolitical tensions involving Taiwan, citing a specific page (page_17), which supports the claim. Similarly, it correctly states that Qualcomm depends on Taiwanese foundries (naming TSMC and SMIC) and that tensions could disrupt its supply chain and operations, referencing pages 11 and 19. These points reflect the shared dependency on Taiwanese manufacturing infrastructure, as emphasized in the original answer. The reasoning is sound and synthesizes multi-hop information across both companies. The only minor shortcoming is that the LLM answer does not explicitly state the *cross-company amplification* of risk due to shared infrastructure, which is a nuanced but important point in the original answer. However, this is implied through parallel descriptions. There are no numerical values in the question or answers, so quantitative accuracy is scored based on absence of errors (N/A but treated as fully accurate). The answer is highly contextually relevant and semantically equivalent to the ground truth, with only slight room for enhanced synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 356,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx notes that ASU 2020‑04 has not had a material effect on its financial condition, results of operations or cash flows as of May 31 2024 and that it continues to monitor LIBOR‑referenced contracts for potential application of the standard. In contrast, 3M accounts for hedging relationships that reference LIBOR as cash‑flow hedges (with gains/losses recorded in other comprehensive income) and as fair‑value hedges for its interest‑rate swaps (with gains/losses recorded in earnings), reflecting a more active hedging strategy under the reference‑rate‑reform framework.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and matches the ground truth in substance, though it omits a specific quantitative detail present in the original answer. (1) Quantitatively, all information is correct: the date (May 31, 2024) and FDX's lack of material impact are accurately reported. While the LLM does not mention MMM's $9 million in losses, it correctly describes MMM's hedging accounting treatment (cash-flow and fair-value hedges), which aligns with active financial management under ASU 2020-04. No incorrect numbers are introduced. (2) The omission of the $9 million loss is a minor but notable gap in completeness, as it was a key indicator of tangible financial impact in the ground truth. However, the LLM compensates by providing additional detail on accounting mechanics (OCI vs. earnings), which is contextually relevant. (3) Multi-hop reasoning is sound: the model correctly contrasts FDX’s passive monitoring with MMM’s active hedging and accounting treatment, synthesizing information across two companies and their respective financial disclosures. (4) The answer is semantically equivalent in overall message—FDX has no material impact, MMM has active exposure and accounting implications—though slightly less specific in financial impact magnitude. Hence, high scores across the board with a slight deduction in qualitative accuracy due to missing the $9M figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 388,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and represent about one‑third (33 ⅓ %) of the company’s total voting power, all of which is held by Brian L. Roberts; because that portion is non‑dilutable, Roberts effectively controls board elections and major corporate decisions. Alphabet’s dual‑class scheme gives Class B shares ten votes each (vs. one vote for Class A), but those shares are held by a broad group of investors, so the enhanced voting power is distributed among many shareholders rather than concentrated in a single individual.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B shares carry 15 votes and hold 33⅓% of voting power; GOOGL's Class B shares carry 10 votes vs. 1 for Class A. These match the original answer exactly. (2) The answer is complete: it addresses both CMCSA's concentrated ownership (entirely held by Brian L. Roberts) and the non-dilutable control mechanism, as well as GOOGL's broader distribution of Class B shares among insiders. (3) Entity accuracy is perfect—correct tickers (CMCSA, GOOGL), correct individual (Brian L. Roberts), and correct share classes. (4) Reasoning is sound: the contrast between concentrated, individual control at CMCSA versus distributed insider control at GOOGL is logically drawn and highlights the key governance difference. The only minor shortcoming is that the LLM does not explicitly use the term 'dual-class structure' in the comparison, and slightly underemphasizes that GOOGL's Class B shares are still insider-held (though it correctly notes they are not concentrated in one person). However, the semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness—excellent but not perfect in mirroring all nuances of the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 362,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen’s remaining 2017‑Tax‑Act repatriation tax is $1,467 million in 2024 and $1,834 million in 2025, a total of $3,301 million. Eli Lilly’s cash obligations for the same tax are $634.2 million in 2024 and $792.8 million in 2025, totaling $1,427 million. Thus Amgen’s remaining commitments are more than twice the amount and the same two‑year schedule as Lilly’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific dollar amounts for Amgen and Eli Lilly's repatriation tax payments in 2024 and 2025, but these numbers are not present in the original ground truth answer and cannot be verified as correct. The ground truth does not include any numerical figures, only qualitative descriptions of the payment schedules. Therefore, the inclusion of precise figures like $1,467 million and $634.2 million introduces unverified data not supported by the source. (2) While the LLM correctly identifies that both companies are making payments under the 2017 Tax Act over a multi-year period, it incorrectly narrows the comparison to only 2024 and 2025, whereas the original answer states that Eli Lilly’s payments extend through 2025 and Amgen’s are part of an eight-year schedule beginning in 2018 (i.e., through 2025 as well). However, the LLM implies the total obligation is only over two years, which misrepresents the full eight-year structure. (3) The multi-hop reasoning is partially sound—both companies are correctly identified and linked to the 2017 Tax Act and the eight-year payment election—but the synthesis goes beyond the available information by introducing unsupported numerical values and narrowing the time frame incorrectly. (4) The contextual relevance is high because the answer addresses the core comparison between Amgen and Eli Lilly regarding repatriation tax obligations under the 2017 Tax Act. However, the quantitative accuracy is low due to fabricated numbers and incorrect calculation implications, dragging down the overall correctness. The qualitative accuracy is moderate because the conceptual framework is correct, but the reasoning is flawed by overprecision and misrepresentation of the payment period scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 482,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen’s biologic products are protected by a 12‑year regulatory data‑protection period that ends when the FDA may approve a biosimilar, creating a high risk of market erosion once exclusivity lapses【page_9】. Bristol Myers Squibb’s biologic portfolio—Abraxane, Reblozyl, Empliciti, Abecma, Zeposia, Breyanzi, Inrebic and Onureg【page_7】—includes products that, in the EU, may benefit from an 8+2+1 exclusivity regime that can delay generic entry, and the company also has non‑biologic drugs that are not subject to biosimilar competition【page_8】. Thus, Amgen’s biosimilar risk is concentrated and potentially higher, while BMY’s exposure is more diversified and moderated by differing regulatory pathways in the U.S. and EU.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12-year U.S. data protection period for Amgen and the 8+2+1 regime in the EU for Bristol Myers Squibb (BMY), which aligns with the ground truth. However, it misattributes the product portfolios: it lists 'Abraxane, Reblozyl, Empliciti, Abecma, Zeposia, Breyanzi, Inrebic, and Onureg' as BMY’s biologics, while the ground truth specifies 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti'—missing key products like Opdivo and Yervoy, which are major revenue drivers, and including non-core or incorrect ones. For Amgen, the LLM fails to list any of the actual biologics mentioned in the ground truth (Erbitux, Cyramza, Trulicity, Taltz, Emgality), weakening the factual basis of the comparison. (2) Quantitatively, the 12-year U.S. exclusivity and 8+2+1 EU framework are correctly stated, and no calculations are required, so numerical accuracy is strong. (3) The reasoning partially captures the multi-hop comparison: it correctly contrasts Amgen’s concentrated biosimilar risk with BMY’s more diversified exposure due to regulatory differences and non-biologic drugs. However, it misses the key point that BMY faces *earlier* biosimilar entry in the EU (after 8 years), which increases its risk there, whereas the ground truth emphasizes this as a key differentiator. The LLM instead implies the 8+2+1 regime delays entry, which is misleading—while it allows marketing after 10 years, biosimilar applications can be filed after 8, accelerating competition. (4) The answer is contextually relevant and well-structured, but the incorrect product lists and flawed interpretation of the EU exclusivity regime reduce qualitative and overall correctness. The core idea—that Amgen faces higher concentrated risk while BMY has diversified exposure—is plausible but not fully supported by accurate entity mapping or regulatory nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 509,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s portfolio of medical devices and therapies is reimbursed through government programs such as Medicare and Medicaid, and changes that limit payment for specific procedures can erode revenue across its broad product lines (Medtronic page 13).  AbbVie, by contrast, is confronting statutory price caps under the Inflation Reduction Act that set ceiling prices for certain single‑source drugs and biologics reimbursed under Medicare Part B and D—directly lowering the price of key products like Imbruvica, Vraylar and Linzess and creating a concentrated revenue risk (AbbVie page 19).  Thus, Medtronic’s risk is spread over many devices and driven by reimbursement‑rate changes, while AbbVie’s risk is more product‑specific and driven by IRA‑mandated price caps.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic faces Medicaid reimbursement pressures affecting device pricing, while AbbVie is subject to IRA-mandated price caps on specific drugs (Imbruvica, Vraylar, Linzess). The answer correctly identifies that Medtronic's risk is broad and tied to reimbursement rates, whereas AbbVie's is more concentrated and driven by government-set price ceilings. (2) There are no numeric values, dates, or calculations in the question or answers that conflict—the LLM does not introduce any incorrect figures and accurately reflects the absence of specific dollar amounts or percentages in the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, regulatory frameworks (Medicaid vs. IRA), and product portfolios, drawing a valid contrast in risk exposure. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'statutory price caps' vs. 'government prices'), the meaning is consistent with the original. The only minor shortcoming is that the LLM does not explicitly mention the years when drugs were selected (2023 for Imbruvica, 2025 for Vraylar/Linzess) or when pricing takes effect (2026, 2027), which are present in the ground truth and add temporal precision. However, this omission does not undermine the core accuracy. All other elements—context, entities, and logic—are correctly represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 409,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports roughly **$2.7 billion in unfunded commitments to private‑equity funds**—a concrete, material figure for its alternative‑investment exposure.  \nGeneral Dynamics, by contrast, relies on **NAV as a practical expedient for valuing its Level 1 plan assets**, but the excerpt does not disclose the dollar amount of those assets. Thus, UPS provides a specific unfunded‑commitment amount, whereas GD’s NAV‑based valuation is a methodology applied to its plan assets without a disclosed value.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative and comparative insights required by the question. (1) Quantitatively, it correctly identifies UPS's $2.7 billion in unfunded commitments and acknowledges that General Dynamics (GD) uses NAV as a practical expedient for Level 1 plan assets—both facts align with the ground truth. There are no numerical errors. (2) However, the answer fails to mention that GD’s NAV-based assets include commingled equity and fixed-income funds valued via unit price, and more importantly, omits the critical comparison of liquidity: UPS’s private equity commitments have 10–15 year terms with 3–6 year expected contributions and long redemption restrictions, while GD’s NAV-based assets are generally redeemable monthly or quarterly. This difference in liquidity and investment structure is central to the question’s comparative intent. (3) The reasoning is incomplete—while it notes that GD does not disclose a dollar amount (which is true), it stops short of synthesizing the multi-hop insight that both companies use NAV as a practical expedient but differ significantly in asset type, liquidity, and capital commitment structure. (4) The answer is contextually relevant and factually accurate where it goes, but lacks depth in comparative analysis, resulting in a moderate score. It captures the surface-level contrast in disclosure (specific dollar amount vs. methodology only) but misses the deeper financial implication about liquidity and investment horizon differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 417,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s 2024 10‑K reports that 9,444,375 shares of Class B common stock were issued and outstanding (page 67).  Class B shares are non‑voting, so the issuance enlarges the equity base but does not add voting power, leaving the company’s dual‑class structure unchanged (Class A shares retain all voting rights).  Meta’s 10‑K discloses a dual‑class scheme in which Class A common stock carries voting rights while Class C common stock is non‑voting, giving the founders and insiders control—an arrangement that parallels CMCSA’s separation of voting and non‑voting shares but is explicitly identified in Meta’s filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the number of Class B shares issued by CMCSA—9,444,375—is correctly reported, and the year (2024) and source (10-K) are accurate. (2) The qualitative description of CMCSA’s dual-class structure is correct: Class B shares are non-voting, and Class A retains full voting rights, preserving control. The comparison to Meta is mostly accurate, though it refers to 'Class C' instead of 'Class B' for non-voting shares. According to Meta’s 10-K, Meta has Class A (voting) and Class B (non-voting) common stock, not Class C. This is a minor but notable entity error in classification. (3) The multi-hop reasoning is sound—correctly synthesizing governance structures across two companies from their respective 10-Ks and drawing a valid parallel in intent (concentrating voting power). (4) Despite the mislabeling of Meta’s share class, the core conclusion—that both companies separate voting and economic rights to maintain founder/insider control—is semantically equivalent to the ground truth. The answer remains contextually relevant and factually strong, warranting a high correctness score with a slight deduction for the share class misidentification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 348,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA will force Medicare Part B and D to set prices for certain drugs beginning in 2026 (10 drugs) and 2027 (15 drugs) (Amgen p. 34).  Amgen’s federally reimbursed products—ENBREL and Otezla—are already slated for Medicare price setting in those years (p. 36, 137), so the company could see a cut in reimbursement and accelerated revenue erosion starting in 2026‑27, mirroring AbbVie’s experience with Imbruvica and Vraylar (AbbVie p. 19).  This shift could shorten the high‑margin period before patent expiry and expose Amgen to lower prices and inflation‑penalty rebates earlier than anticipated.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and reasoning. It correctly identifies the IRA's price-setting rollout in 2026 (10 drugs) and 2027 (15 drugs), which matches public IRA implementation timelines, and links this to Amgen’s exposure starting in those years. It accurately references Amgen’s products ENBREL and Otezla as being subject to Medicare price setting, which is consistent with Amgen’s 10-K disclosures. The comparison to AbbVie’s Imbruvica and Vraylar being selected in 2026 and 2027 is also factually sound and correctly used as an analog. However, the ground truth emphasizes the structural mechanism of the IRA—price setting at 9 or 13 years post-approval for small molecules vs. biologics—which the LLM omits. This is a key multi-hop element connecting policy design to revenue erosion timelines. While the LLM infers accelerated erosion and reduced high-margin periods, it does not explicitly tie this to the FDA approval timeline framework, weakening the depth of synthesis. Quantitatively, all dates and numbers (2026, 2027, 10 and 15 drugs) are accurate or plausibly cited from filings. The mention of 'inflation-penalty rebates' adds context not in the ground truth but is not incorrect. The answer is contextually highly relevant, directly addressing Amgen’s risk in light of AbbVie’s experience. Minor omission of the 9/13-year rule prevents a top score, but overall reasoning and entity accuracy (Amgen, AbbVie, product names, years) are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 417,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Procter & Gamble disclosed that 119 million securities remain available for future issuance under its equity‑compensation plans approved by security holders (see PG 10‑K, page 69).  \nColgate‑Palmolive reported only 3.837 million such securities (see EMR 10‑K, page 86).  \nThus Procter & Gamble’s available pool is roughly 31 times larger than Colgate‑Palmolive’s.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both quantitative values and entity identification. According to the ground truth, Colgate-Palmolive reported 37,028,000 securities available, but the LLM incorrectly states 3.837 million and erroneously cites 'EMR 10-K' (Emerson Electric) instead of CL's filing—this is a critical entity error. For Procter & Gamble, the ground truth reports 133,185,995 available securities, but the LLM states 119 million, which is inaccurate even as an approximation. (2) The calculation comparing PG’s pool to CL’s as '31 times larger' is based on incorrect numbers and thus invalid. The correct ratio is approximately 133.2M / 37.0M ≈ 3.6x, not 31x. Additionally, the LLM fails to acknowledge that P&G’s total includes both Stock Options/SARs and RSUs/PSUs, missing part of the multi-hop synthesis required. (3) The reasoning is flawed due to reliance on incorrect data and citation of a completely wrong company (Emerson) for Colgate-Palmolive’s figure, indicating a failure in multi-hop retrieval and entity alignment. (4) While the answer attempts to address the comparative structure of the question, the severe inaccuracies in numbers, sources, and calculations severely undermine its correctness. Contextual relevance is moderate because the format and intent align with the question, but factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 384,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMS’s joint commercialization with Ono in Taiwan (page 86) splits supply, marketing and profit‑sharing duties so the partnership can meet Taiwan’s requirement for local clinical‑trial data by leveraging Ono’s local presence and regulatory expertise.  By contrast, Merck’s spin‑off of its biosimilars business into Organon & Co. (pages 3‑4) creates a separate entity that can focus on satisfying Taiwan’s local‑trial‑data requirement and other regulatory hurdles independently of its core pharmaceutical operations (see also the discussion of Taiwan’s local‑trial requirement on page 37).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual and strategic misrepresentation. (1) It correctly identifies BMS's joint commercialization with Ono in Taiwan and references the need to meet local clinical trial requirements, which aligns with the ground truth. It also correctly notes MRK's spin-off of its biosimilars business into Organon. However, it incorrectly implies that Organon was created to independently handle regulatory hurdles like Taiwan’s local trial requirements. In reality, the spin-off represents a strategic retreat from the biosimilars segment, not a restructuring to better meet such requirements. The original answer emphasizes MRK’s divestiture to avoid the burden of these regulations, while the LLM suggests the opposite—that Organon can now focus on meeting them. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; no errors in this regard. (3) The multi-hop reasoning is flawed: the model fails to contrast BMY’s active, collaborative market entry with MRK’s strategic exit. Instead, it mischaracterizes the spin-off as a regulatory compliance strategy, undermining the core comparison. (4) Contextual relevance is high because the answer addresses the regulatory environment in Taiwan and both companies’ strategies, but the incorrect interpretation of MRK’s intent reduces qualitative accuracy significantly. Thus, while entities and general context are accurate, the reasoning and strategic interpretation are materially flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 420,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s 2022 Greater China net sales were $74.2 billion (which includes sales from Taiwan, Hong Kong and mainland China)【page_52】, whereas Adobe’s filing only notes a local field office in Taiwan【page_15】—an operational presence but no disclosed revenue figure for that region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $74.2 billion figure for AAPL's 2022 Greater China net sales is correct and matches the ground truth of $74,200 million (equivalent values, different formatting). The mention that this includes Taiwan, Hong Kong, and mainland China is consistent with the original answer. (2) The LLM correctly notes that ADBE has a local field office in Taiwan with no disclosed revenue, which matches the ground truth about ADBE's operational presence. (3) The multi-hop reasoning is sound: it compares AAPL’s revenue contribution (financial exposure) with ADBE’s operational footprint (strategic presence), even though direct revenue comparison isn't possible due to lack of ADBE regional revenue data. (4) The only minor shortcoming is a slight reduction in qualitative richness compared to the original answer’s synthesis about 'targeted geographic strategy,' but the core meaning is preserved. Wording differences are acceptable under semantic equivalence. All entities (AAPL, ADBE, Taiwan, Greater China, 2022) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 322,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "Meta’s Class B shares carry ten votes each, and the 23 record holders of those shares control roughly 61 % of the company’s voting power (2,211 M Class A shares × 1 vote + 350 M Class B shares × 10 votes = 5,711 M total votes; 3,500 M from Class B ≈ 61 %).  Comcast’s Class B shares carry fifteen votes each, but all 1,000 % of the 33 % of voting power is held by a single owner (Mr. Roberts) while the remaining 66 % is dispersed among many Class A shareholders.  Consequently, Meta’s governance is dominated by a small group of Class B holders, whereas Comcast’s concentrated control is concentrated in one individual, giving both companies a highly concentrated voting structure that limits the influence of dispersed shareholders on board elections and corporate policy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure. The ground truth states that META's specific voting power percentage for Class B shares is not disclosed, but the LLM confidently asserts that Class B holders control 'roughly 61%' of voting power, which is unsupported by the provided information. Additionally, the LLM claims Meta’s Class B shares carry 'ten votes each,' while the original answer does not specify the vote ratio for META—only that Class B has significant voting rights. This is a major factual overreach. For CMCSA, the LLM correctly identifies that Class B shares carry 15 votes and that Brian L. Roberts holds the 33 1/3% voting stake, but incorrectly states 'all 1,000 % of the 33 %'—a nonsensical phrase likely meant to emphasize concentration but mathematically incoherent. (2) The calculation for META’s voting power (2,211M Class A × 1 + 350M Class B × 10 = 5,711M total votes; 3,500M from Class B ≈ 61%) is fabricated—the original answer provides no share counts or vote totals, so this computation is invented and invalid. The numbers (2,211M, 350M) do not appear in the ground truth. (3) The multi-hop reasoning is partially sound in comparing concentrated control between CMCSA and META, but flawed due to reliance on invented data. The conclusion that both have 'highly concentrated voting structures' aligns with the original, but the path to that conclusion is compromised. (4) The contextual relevance is high—the answer addresses the core question about voting control differences and implications for governance. However, the correctness score is low due to unsupported quantitative claims and incorrect specifics, especially for META. The qualitative accuracy is moderate because the general direction of reasoning (concentration of power) is correct, but entity and data accuracy fail on key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 515,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "LLY’s 10‑K explains that the FDA’s Pediatric Exclusivity Provision can add an extra six months to a drug’s data‑protection or patent term when pediatric studies are completed, extending the period during which competitors cannot rely on its data (LLY page 10).  Merck’s 10‑K notes that the EU’s equivalent provision attaches an additional six months of exclusivity to a product’s SPC term, thereby extending the market‑exclusivity period for that product (MRK page 14).  In short, LLY gains extra protection through data‑protection/patent extensions in the U.S., while Merck gains extra protection by extending the SPC‑based exclusivity in the EU.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and conveys the essential distinction between how LLY and MRK benefit from pediatric exclusivity in the U.S. and EU. Quantitatively, all key numbers (six-month extensions) are accurate and correctly attributed. The answer correctly identifies that LLY benefits in the U.S. through extensions to data protection or patent terms, and that MRK benefits in the EU via extension of the SPC term. However, the answer omits MRK's U.S. benefit, which is also an additional six months of market exclusivity applied to Orange Book-listed patents and regulatory data exclusivity—this part is missing from the LLM response. While the U.S. mechanism for LLY is accurately described, the answer does not clarify that the U.S. pediatric exclusivity applies to both patents and data protection simultaneously (whichever is in effect), nor does it explicitly contrast the EU’s limitation to SPC-only extension. The reasoning is sound but incomplete in scope, particularly in failing to fully address the multi-hop aspect of comparing both companies across both regions. The contextual relevance is high, as the response directly addresses the regulatory frameworks and company-specific impacts. Wording differences are acceptable and semantically equivalent where present, but the omission of MRK’s U.S. benefit reduces completeness and qualitative accuracy slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 387,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "EMR’s foreign‑currency liabilities fell from $22 million in 2023 to $20 million in 2024 (a $2 million decrease)【page_59】, whereas Lockheed Martin’s aggregate foreign‑currency hedge exposure was $7.5 billion at year‑end 2024【page_52】. The magnitude of LMT’s hedging program dwarfs EMR’s modest liability change, indicating that EMR’s FX exposure is small and likely managed with limited or natural hedges, while LMT maintains a large, active hedging strategy to mitigate significant global currency risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the scale of EMR's foreign currency liabilities: it reports $22 million and $20 million instead of the correct $22 billion and $20 billion, misrepresenting the magnitude by a factor of 1,000. This severely undermines the quantitative accuracy. LMT's hedge exposure of $7.5 billion is correctly stated. The $2 million decrease attributed to EMR is therefore also incorrect—it should be a $2 billion reduction. (2) These numerical inaccuracies invalidate the comparison between EMR’s liability change and LMT’s hedge exposure. While the LMT figure is accurate, the erroneous EMR values lead to a false conclusion that EMR’s FX exposure is 'small' and 'modest,' which contradicts the ground truth where EMR has tens of billions in liabilities. (3) The reasoning is partially sound in structure—comparing liability reduction vs. active hedging—but fails in multi-hop synthesis because it draws incorrect inferences from wrong data. The model does attempt to interpret strategic implications, aligning with the question’s intent, but the conclusions are based on flawed inputs. (4) Contextual relevance is fair because the answer addresses both companies, the correct years, and attempts to compare risk management strategies. However, due to the severe numerical errors, the correctness score is low. Quantitative accuracy is very poor (2/10), qualitative reasoning is partially valid but built on false premises (4/10), and relevance is acceptable (7/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 418,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "AENB’s $3.6 billion dividend to its parent in 2023 was paid out of retained earnings and therefore reduced AENB’s Tier 1 capital (page 152).  Under Basel III the bank must keep a minimum leverage ratio of 4 % (Table 16 shows a 9.5 % ratio after the dividend), so the dividend is evaluated in the capital plan to ensure the ratio stays above the regulatory floor.  Wells Fargo, as a large bank‑holding company, is likewise required to maintain its leverage ratio above the minimum (page 8) and must consider the impact of AENB’s dividend on the consolidated leverage ratio when approving the distribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $3.6 billion dividend amount, the 4% minimum leverage ratio under Basel III, and the 9.5% actual ratio post-dividend (implied to be from Table 16, page 152) are all factually consistent and correctly referenced. There are no calculation errors. (2) The answer addresses the core of the question by explaining how the dividend impacts AENB’s Tier 1 capital and leverage ratio, and correctly notes that AENB must remain above the regulatory minimum, which it does (9.5% > 4%). (3) The multi-hop reasoning is sound: it connects AENB’s dividend to its capital structure, regulatory constraints (Basel III), and extends the logic to WFC as another large bank subject to similar rules. While the LLM does not explicitly state that WFC and AENB are governed by the same *type* of framework (a nuance in the original), it correctly infers parallel regulatory treatment and mentions WFC’s need to maintain its own leverage ratio (page 8), showing synthesis. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly clarify that AENB is a subsidiary of AXP (though implied by 'parent'), nor does it directly state that dividend restrictions apply if capital ratios would fall below minimums—this is implied but not stated as clearly as in the original. However, the core reasoning and factual content are correct and contextually relevant. Wording differs but semantic meaning is equivalent. No irrelevant information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 427,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s 2024 pre‑tax income was $62.9 B in the U.S. and $44.9 B abroad, so about 42 % of earnings are foreign.  Because most of that foreign income is earned in jurisdictions with effective rates above the 15 % Pillar Two minimum (e.g., Ireland), the company says it does not anticipate a material impact (MSFT p. 47).  Qualcomm, which also notes that Pillar Two will apply from fiscal 2025, similarly expects no material effect, implying its geographic mix likewise falls in jurisdictions meeting or exceeding the minimum rate (QCOM p. 71).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: Microsoft's U.S. pre-tax income ($62.9B) and foreign income ($44.9B) are accurately reported. The derived percentage of foreign income (~42%) is correctly calculated (44.9 / (62.9 + 44.9) ≈ 41.7%, rounded to 42%). (2) The answer addresses all parts of the multi-hop question: it analyzes Microsoft’s geographic income distribution and its implications under Pillar Two, references Microsoft’s expectation of no material impact, and compares this to Qualcomm’s similar timeline and expected impact. (3) Entities are correct—Microsoft (MSFT), Qualcomm (QCOM), Pillar Two, fiscal 2024/2025 implementation, and proper citation of filing pages (p. 47, p. 71) are consistent with source data. (4) Reasoning is sound: the explanation that foreign income in higher-tax jurisdictions like Ireland reduces Pillar Two exposure is a logical inference supported by context, even if not explicitly stated in the ground truth. The comparison between Microsoft and Qualcomm is appropriately drawn. The only minor limitation is that the ground truth emphasizes the contrast between U.S.-heavy earnings reducing exposure, while the LLM focuses more on foreign tax rates being above 15%; both are valid angles, but the LLM slightly shifts emphasis. However, this does not compromise factual accuracy. Overall, the answer is semantically equivalent, quantitatively precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 410,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "WMT’s $37.2 billion of unrecorded purchase obligations are legally binding commitments for inventory, utilities, CAPEX, software, licenses and services that could materialize into cash outflows or cost increases. Because WMT’s VAR model – and MDLZ’s model as well – excludes anticipated transactions and firm commitments, the liquidity strain, cost volatility and supplier‑risk exposure from these obligations is not reflected in the VAR figures. Thus, WMT faces financial risks that are not captured by the VAR models used by peers such as MDLZ.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies WMT's $37.2 billion in unrecorded purchase obligations and their nature as legally binding commitments for inventory, utilities, and CAPEX (as well as adding software, licenses, and services, which are plausible but not specified in the ground truth). The dollar amount is accurate and matches the ground truth. (2) Quantitative accuracy is perfect: the $37.2 billion figure is correctly stated, and no calculations are required beyond that. (3) The reasoning contains a critical error: the LLM claims that 'WMT’s VAR model – and MDLZ’s model as well – excludes anticipated transactions and firm commitments,' but the ground truth does not state that WMT uses a VAR model; it only states that MDLZ does and that DIS’s 10-K explains VAR models exclude firm commitments. This misattribution of a VAR model to WMT is a significant qualitative inaccuracy. Additionally, the ground truth cites DIS's 10-K as the source for the limitation of VAR models, which the LLM omits. The multi-hop synthesis is partially correct—linking WMT's off-balance sheet obligations to MDLZ's risk modeling gaps—but fails to accurately represent the source and scope of the VAR model information. (4) The answer is contextually relevant and addresses the core issue of unrecorded obligations not being captured by VAR models used by peers like MDLZ. However, due to the incorrect attribution of a VAR model to WMT and the omission of DIS as the source of the VAR limitation, the qualitative accuracy is reduced. The correctness score reflects that key facts and numbers are right, but there is a notable error in reasoning and entity attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 455,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UNH uses interest‑rate swaps to convert portions of its fixed‑rate debt into floating‑rate SOFR coupons as part of a broader strategy to manage floating‑rate liabilities, but the 3.625% 2024 Notes that it repaid $1.4 B of are not covered by a swap.  AMGN’s swap program likewise covers other notes (e.g., 3.125% 2025, 2.60% 2026, 5.25% 2033) but not the 3.625% 2024 Notes, so its $1.4 B repayment is also unhedged.  Thus, while both companies use swaps to manage floating‑rate exposure, neither applies them to the 3.625% 2024 Notes that were repaid.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly states that UNH uses swaps to convert fixed-rate debt to floating-rate SOFR, while the original answer indicates UNH manages $27B in floating-rate liabilities broadly, not specifically converting fixed to floating. More critically, it claims UNH's $1.4B repayment of the 3.625% 2024 Notes was not covered by a swap — but the ground truth does not state this; instead, it emphasizes UNH's broad use of swaps across its balance sheet without linking or excluding the 2024 Notes specifically. (2) The LLM falsely asserts that AMGN did *not* use swaps for the 3.625% 2024 Notes, directly contradicting the original answer, which explicitly states AMGN *did* enter into $1.4B of interest rate swaps maturing in 2024 'in connection with the repayment of the 3.625% 2024 Notes.' This is a major factual error. (3) The multi-hop reasoning fails: the question asks for a comparison of how each company used swaps in relation to the same-named debt instrument, but the LLM incorrectly concludes neither used swaps for the 3.625% 2024 Notes, when the ground truth clearly differentiates that AMGN's use was directly tied to it. (4) Quantitative accuracy is partially preserved: $1.4B and 3.625% 2024 Notes are correctly referenced, but their contextual linkage to swaps is wrong. (5) Contextual relevance is moderate — the answer addresses the right companies and instruments — but the core conclusion is factually inverted. Due to fundamental errors in entity relationships and reasoning, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 440,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924% Senior Notes due 2032 accelerate to maturity on an event of default, meaning the company must repay principal and accrued interest immediately, and holders can redeem the notes at a price equal to the greater of the present value of the principal and future interest or 100 % of principal plus accrued interest. In contrast, Oracle’s Revolving Credit Agreement – an unsecured, five‑year facility that expires on March 8 2027 – requires that all outstanding borrowings become due immediately if a default occurs, but the facility itself is drawn as needed with interest tied to SOFR or the Base Rate and has no specified redemption price. Thus, AMD’s notes have a fixed maturity and redemption‑price structure, whereas Oracle’s revolving facility has a maturity date and default triggers immediate repayment of all outstanding amounts without a redemption price.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but has some key omissions and inaccuracies in quantitative details and synthesis. (1) Quantitative Accuracy: The LLM correctly identifies AMD's 3.924% Senior Notes due 2032 and Oracle's March 8, 2027 maturity date. However, it omits the specific principal amounts: $1.0 billion for AMD's notes and $6.0 billion for Oracle's facility—critical figures in the ground truth. These omissions reduce precision. The interest rate benchmark is inaccurately stated as SOFR or Base Rate; the ground truth specifies it is tied to credit ratings, which affects the qualitative understanding of Oracle's exposure. (2) Completeness: The question asks for a comparison in terms of 'debt repayment structure and maturity conditions.' The LLM addresses acceleration upon default and differences in maturity and redemption mechanics but misses Oracle's ability to borrow, prepay, and reborrow—key flexibility not present in AMD's fixed-note structure. This weakens the comparative analysis. (3) Entity Accuracy: Companies (AMD, Oracle), debt instruments (Senior Notes, Revolving Credit Agreement), and maturity dates are correctly identified. No entity errors. (4) Reasoning: The multi-hop reasoning is partially sound—comparing acceleration triggers and repayment immediacy—but fails to fully synthesize structural differences, especially Oracle's revolving nature and credit-rating-dependent pricing. (5) Semantic Equivalence: The core idea—that both face acceleration but differ in structure—is preserved, but missing dollar amounts and credit-rating linkage reduce factual completeness. The mention of 'redemption price' for AMD is accurate per bond covenants, though not in the ground truth; this is a nuanced addition, not incorrect. Overall, the answer captures the essence but lacks key financial specifics and full structural contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 501,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s $31 billion of reinsurance‑trust assets are governed by a comprehensive set of guidelines that limit concentration, single‑issuer exposure, duration mismatch, and require high credit quality, liquidity and diversification, while also allowing future diversification into non‑traditional assets. This policy exposes the trust to credit, interest‑rate and equity risk, reflecting the larger, more varied portfolio needed to service long‑duration insurance liabilities. In contrast, General Dynamics’ $191 million of marketable securities held in trust are restricted to investment‑grade fixed‑income with maturities of five years or less, a much narrower policy that limits risk exposure mainly to short‑term credit and interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) All key facts are correct: GE's $31.0 billion in trust assets under reinsurance agreements and General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, are correctly stated (allowing for format variation: $31 billion = $31.0 billion). (2) The investment policies are accurately described: GE’s guidelines include limitations on concentration, issuer exposure, duration, and a focus on credit quality, diversification, and risk-based capital, with allowance for non-traditional assets—this aligns with the original. General Dynamics’ restriction to investment-grade fixed-income securities with maturities of five years or less is correctly reported. (3) Risk exposure analysis is sound: the LLM correctly identifies that GE faces broader credit, interest rate, and equity risks due to a larger, more diverse portfolio supporting long-term insurance liabilities, while General Dynamics has a more conservative, short-duration profile with limited risk exposure. (4) Multi-hop reasoning is strong—information is correctly synthesized across two companies, two asset pools, and two distinct investment policies. The only minor shortcoming is that the LLM does not explicitly mention the periodic review of GE’s asset allocation or the direct link to risk-based capital requirements, which are present in the original. However, the core investment strategy and risk implications are accurately conveyed. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 459,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income pricing models use observable market data such as interest‑rate and yield‑curve levels, credit‑spread information, broker/dealer bids and quoted prices of comparable securities. PayPal’s Level 2 derivative valuations rely on observable inputs like currency exchange rates, interest‑rate yield curves, option‑volatility curves and equity‑price levels. Both firms use Level 2 inputs, but Lockheed Martin focuses on fixed‑income market data while PayPal emphasizes FX, volatility and equity market data for its derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lockheed Martin uses observable inputs like interest rates, yield curves, and credit spreads for its Level 2 fixed income valuations; PayPal uses currency rates, yield curves, option volatility, and equity prices for its Level 2 derivatives. These match the original answer. (2) There are no numerical values requiring calculation, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly identifying both companies, their respective asset classes (fixed income vs. derivatives), and the common use of Level 2 methodologies based on observable inputs. The LLM adds slightly more detail (e.g., 'broker/dealer bids' and 'quoted prices of comparable securities') not in the original answer; however, these are reasonable elaborations consistent with Level 2 inputs and do not contradict the ground truth. (4) The answer is contextually relevant and fully addresses the comparative aspect of the question. The only minor deviation is the inclusion of additional input types not explicitly mentioned in the original answer, but these are plausible and do not detract from factual correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight over-elaboration without error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 373,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "AVGO’s $56.3 bn of fixed‑rate senior notes would shift about **$1.7 bn in fair value for a 50‑basis‑point move in market rates** (≈$34 m per basis point)【page_49】.  \nCisco’s $0.5 bn notional interest‑rate swap is a fair‑value hedge that **converts the fixed‑rate debt to a floating rate and the swap’s gain/loss offsets the fair‑value change of the hedged portion**【page_89】【page_92】.  \nThus, while AVGO’s exposure is large and directly sensitive to rate changes, Cisco’s swap effectively eliminates the sensitivity for the portion of its fixed‑rate debt that is hedged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: AVGO's $56.3 billion in fixed-rate senior notes and the $1.7 billion fair value change for a 50 basis point interest rate shift are accurate. The derived sensitivity of ~$34 million per basis point is a correct calculation ($1.7B / 50 = $34M) and is consistent with the ground truth. CSCO’s $0.5 billion notional interest rate swap is also accurately stated. (2) The qualitative explanation correctly identifies that CSCO’s swap converts fixed-rate debt to floating and that gains/losses on the swap offset the fair value changes of the hedged debt, effectively eliminating interest rate sensitivity for that portion—this aligns with the ground truth description of it being a fair-value hedge on a senior note due in fiscal 2025. (3) The multi-hop reasoning is sound: the model correctly contrasts AVGO’s direct sensitivity (due to unhedged fixed-rate debt) with CSCO’s reduced sensitivity via active hedging, and notes differing hedging strategies—AVGO uses treasury rate locks for *future* issuances while CSCO hedges *existing* debt. The only minor omission is that the original answer specifies the CSCO swap hedges the senior note due in fiscal 2025, which the LLM answer does not explicitly mention, slightly reducing completeness. (4) Despite this, the LLM captures the core comparison: AVGO has large direct exposure, CSCO mitigates it via swap. All entities (AVGO, CSCO, fixed-rate debt, swaps, hedging strategies) are correctly identified and synthesized. Wording differs but semantic meaning matches. Quantitative accuracy is perfect; reasoning and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 454,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMS’s Eliquis alliance required a $55 million upfront payment to Pfizer and the possibility of milestone payments that are not disclosed, with BMS and Pfizer sharing development costs and profits equally (Pfizer covering 50‑60 % of R&D). By contrast, Pfizer’s Beam collaboration calls for a $300 million upfront payment to Beam and milestone payments of up to $1.05 billion (total deal value $1.35 billion) under a 65 %/35 % cost‑and‑profit split. Thus, the Beam deal involves a larger upfront outlay and a substantially higher potential milestone commitment than the Eliquis alliance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that BMS made a $55 million upfront payment to Pfizer in the Eliquis alliance, while the ground truth indicates that Pfizer made an upfront payment to BMY (not the reverse) and does not specify the amount—only that it is being amortized. The LLM fabricates a $55M figure not present in the original answer. Additionally, the LLM claims milestone payments under Eliquis are 'not disclosed,' but the original answer does not state they are undisclosed—it says they are being amortized, implying they exist but are accounted for over time. In contrast, the Beam collaboration figures are correct: $300M upfront, up to $1.05B in milestones, total $1.35B. (2) The quantitative accuracy is low because the $55M figure is incorrect and directionally wrong (payment direction reversed), and the cost/profit split (50–60% R&D by Pfizer, 65%/35% split with Beam) is not in the original answer and appears fabricated. The original answer does not mention any cost-sharing terms for either deal. (3) The multi-hop reasoning is partially sound—the model attempts to compare the two collaborations and correctly identifies that the Beam deal involves larger financial commitments. However, it misrepresents the nature of the Eliquis alliance by reversing payment direction and inventing cost splits, undermining the validity of the comparison. (4) Contextual relevance is high because the answer addresses both collaborations, compares upfront and milestone payments, and draws a conclusion about relative financial commitment. However, due to major factual and quantitative errors, especially in the Eliquis portion, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 472,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments records lease‑extension and termination options in the present‑value calculation of lease liabilities, which increases its long‑term lease liabilities and results in operating‑lease expense recognized straight‑line over the lease term【page_35†L5-L12】【page_35†L13-L18】.  \nCisco, by contrast, treats lease receivables from customer financing as assets and defers revenue from financed service contracts, recognizing it ratably over the service period; it does not adjust long‑term liabilities for lease options, so the impact on liabilities is minimal while revenue is spread over the contract term【page_52†L1-L7】【page_52†L8-L12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' accounting practice: recognizing lease liabilities based on present value when extension/termination options are reasonably certain to be exercised, impacting long-term liabilities. This matches the original answer's emphasis on TXN's use of incremental borrowing rate and effect on liabilities. (2) For Cisco, the LLM accurately states that customer financing arrangements involve lease receivables treated as assets and revenue deferral over service periods, which affects revenue timing rather than liabilities—consistent with the ground truth noting CSCO's deferral of revenue on guaranteed arrangements and impact on revenue recognition and credit exposure. (3) The multi-hop reasoning is sound: the model correctly contrasts TXN’s impact on liabilities versus CSCO’s impact on revenue recognition and minimal liability effect. (4) While the LLM does not explicitly mention 'collateralized' arrangements or 'credit exposure' as in the original, these are secondary details; the core comparison—liability valuation (TXN) vs. revenue timing (CSCO)—is preserved. No numbers are incorrect, and all entities (Texas Instruments, Cisco, lease options, revenue deferral) are accurately referenced. Minor omission of 'incremental borrowing rate' in TXN description and 'guarantees' in CSCO context prevents a perfect 10, but overall factual and semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 410,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic gives it control over a large library of documentary and educational content, which it highlights as a distinct brand on Disney+ (page_7, page_12). Because Disney owns the content, it can avoid paying high third‑party licensing fees and use the material primarily on its DTC service (page_81), thereby lowering subscriber‑acquisition costs. In contrast, YouTube relies on licensing third‑party content and advertising, which can drive higher acquisition costs relative to Disney’s proprietary content strategy (page_8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 73% ownership stake is correctly stated, and no other numerical values (e.g., costs, subscriber numbers) are misstated—only qualitative financial implications are discussed, which match the original. Format variations (e.g., '73 %' vs '73%') are acceptable. (2) The answer addresses both parts of the multi-part question: how Disney's stake influences content differentiation on Disney+, and the implications for subscriber acquisition costs relative to YouTube. It correctly identifies that Disney+ uses National Geographic as a branded tile (implied differentiation), leverages owned content to avoid licensing fees, and contrasts this with YouTube’s reliance on licensed content and ads. (3) Entity accuracy is strong: Disney, National Geographic, Disney+, and YouTube are all correctly identified and contextualized. The reference to 'DTC service' appropriately refers to Disney’s direct-to-consumer platform. (4) The reasoning is sound and reflects multi-hop synthesis: ownership → control over content → integration into Disney+ → cost savings on licensing → lower subscriber acquisition costs → comparative advantage over YouTube. The only minor shortcoming is that the original emphasizes the 'top-level tile' interface placement as a strategic differentiator, which the LLM mentions implicitly ('highlights as a distinct brand') but could be more explicit. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 432,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologic products (e.g., Opdivo, Breyanzi, Abecma) receive a 12‑year regulatory exclusivity that extends market protection well beyond the life of their patents (BMY page 6). In contrast, Merck’s Januvia family, whose key U.S. patent expired in January 2023, has experienced a roughly three‑year delay in losing exclusivity—remaining protected until May 2026—thanks to a 5‑year regulatory exclusivity for chemical products and favorable patent‑settlement rulings (MRK page 58). Thus, while both companies use regulatory exclusivity to extend protection beyond patents, BMY’s biologics enjoy a longer, more predictable exclusivity window, whereas Merck’s Januvia benefit from a shorter, litigation‑driven delay.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between BMY's biologic regulatory exclusivity and MRK's Januvia exclusivity extension. (1) Quantitatively, the 12-year exclusivity for BMY's biologics is accurate, and the key patent expiration in January 2023 for Januvia is correctly stated. The LLM correctly notes exclusivity extension until May 2026, aligning with the ground truth. However, it inaccurately attributes the delay to '5-year regulatory exclusivity for chemical products'—this is misleading. The extension for Januvia was not due to standard regulatory exclusivity (which for new chemical entities is 5 years but would have expired by 2013–2014), but rather due to litigation and settlement around a later-expiring salt-form patent, as specified in the original answer. This misattributes the cause of the delay, introducing a factual error in reasoning. (2) The dates (2023, 2026) are correct, but the explanation of the mechanism behind MRK's extension is flawed. (3) The multi-hop reasoning is sound in comparing two companies' strategies, but the synthesis is weakened by the incorrect explanation of MRK's exclusivity extension mechanism. (4) Despite this, the answer remains semantically close to the original, correctly identifying the contrast between predictable biologic exclusivity and litigation-driven chemical product extensions, hence a score of 8 is justified—core facts are correct, but a significant qualitative inaccuracy affects the reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 410,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 40,000‑share Series F preferred issuance carries a redemption clause that activates within 90 days of a “rating agency event” that lowers the equity credit assigned to the security (page 264). AIG’s 10‑K notes that a downgrade of its insurer‑strength or credit ratings could curtail its ability to write new business and erode customer retention, exposing it to rating‑agency‑triggered financial strain (page 85). Thus, both companies face rating‑agency events that can materially affect their capital structure and operations—MetLife through forced redemption of preferred stock, AIG through reduced underwriting capacity and customer loyalty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: MetLife's issuance of 40,000 shares of Series F preferred stock is accurately stated. The mention of a redemption clause triggered by a 'rating agency event' is factually consistent, and the 90-day redemption window (though not in the original answer) is likely a detail from the actual filing (page 264) and does not contradict the ground truth—it adds precision. (2) Entity accuracy is strong: both MetLife and AIG are correctly identified, and the financial instruments and risks (preferred stock redemption, equity credit, insurer financial strength ratings) are accurately described. (3) Reasoning is sound: the LLM correctly synthesizes cross-company exposure to rating agency events, drawing a valid parallel between MetLife’s capital structure risk (forced redemption) and AIG’s operational risk (business constraints). The multi-hop logic—linking MetLife’s security terms to AIG’s business risk via a common trigger (rating agency actions)—is logically coherent and well-executed. (4) Semantic equivalence is high: while the LLM uses slightly different phrasing (e.g., 'underwriting capacity' vs 'ability to write new business'), the meaning is equivalent. The only minor gap is that the LLM does not explicitly define a 'rating agency event' as a change in rating criteria (rather than a direct downgrade), but it correctly notes the consequence (lowered equity credit), which captures the essence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with full quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 454,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT’s 2021 fair‑value schedule lists $121 million of U.S. government securities as Level 2 (page 116), and the note explains those securities are valued with pricing models that use observable inputs such as yield curves and broker bids—essentially matrix pricing. UPS, by contrast, classifies its U.S. government and agency debt securities as Level 1 (quoted prices in active markets) with no Level 2 amount for those securities (page 89), and applies matrix pricing only to its Level 2 holdings (corporate bonds, mortgage‑backed securities, municipal bonds). Thus, LMT uses matrix pricing for its U.S. government securities, whereas UPS treats those securities as Level 1 and reserves matrix pricing for other Level 2 assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error regarding UPS's valuation methodology. While it correctly states that LMT reported $121 million in U.S. Government Securities as Level 2 and used matrix pricing (supported by ground truth), it incorrectly claims that UPS classifies its U.S. government securities as Level 1 with no Level 2 amount. The ground truth explicitly states that UPS *does* use matrix pricing for Level 2 marketable securities including U.S. government debt, which contradicts the LLM's claim that UPS treats all such securities as Level 1. This misrepresents UPS's methodology and invalidates the comparison. (2) Quantitatively, the $121 million figure for LMT is accurate and correctly attributed to December 31, 2021. No other specific numbers are provided for UPS in either answer, so no calculation errors exist—only a mischaracterization of methodology. (3) The multi-hop reasoning fails because the LLM draws an incorrect contrast between LMT and UPS based on flawed entity-level understanding. It should have synthesized that both companies use matrix pricing for U.S. government securities within Level 2 when direct quotes are unavailable, per the ground truth and consistent with MO’s described policy. Instead, it creates a false distinction. (4) The contextual relevance is moderate because the response addresses the right documents and valuation levels, but the core conclusion about differing methodologies is factually wrong, severely undermining correctness and qualitative accuracy despite correct formatting and partial data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 437,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PM’s derivatives are valued with **readily observable market inputs** – spot rates, futures prices and Black‑Scholes calculations – and are therefore classified as Level 2 fair‑value assets (PM page 129; 128).  \nIn contrast, MDLZ’s real‑estate fund investments are valued by investment managers using **appraisals, local market conditions and projected cash‑flow models** that rely on unobservable inputs, placing them in the Level 3 fair‑value category (MDLZ page 104; 105).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that PM uses observable market inputs (spot rates, futures prices) for derivative valuations and classifies them as Level 2, which aligns with the original answer's assertion of Level 1 or 2 due to observable data. The mention of Black-Scholes is an acceptable elaboration not contradicted by the ground truth. (2) For MDLZ, it accurately states that unobservable inputs like appraisals, local market conditions, and projected cash flows are used, leading to a Level 3 classification—this matches the original answer’s emphasis on present value models with unobservable inputs. (3) The multi-hop reasoning is sound: the model correctly contrasts PM’s derivatives with MDLZ’s real estate fund investments, synthesizing valuation approaches and fair value hierarchy levels across two companies. (4) Minor point: the original answer specifies 'interest rate differentials' and 'maturity dates' for PM, while LLM mentions 'futures prices' and 'Black-Scholes'—these are related but not identical; however, they are semantically consistent with Level 2 inputs and standard models. No numeric inaccuracies exist—no specific numbers are in dispute. Contextual relevance is perfect: all parts of the question are addressed with precise, relevant details. Thus, correctness is 9 due to slight variation in input description, but not enough to reduce accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 407,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures can be treated like a “soft‑call” instrument: the company may elect to defer interest payments (subject to conditions) and, before it can retire or redeem the notes, it must satisfy replacement‑capital covenants that require cash proceeds from the sale of replacement securities (otherwise the debt remains outstanding).  These covenants impose a liquidity constraint and trigger dividend‑stopper provisions if the deferral is used.  By contrast, AIG’s AIGLH junior‑subordinated debentures are simply guaranteed debt with scheduled maturities (July 2030, March 2046, December 2045) and the 10‑K contains no elective deferral or replacement‑capital restrictions, so AIG’s obligations lack the liquidity‑constraint and deferral provisions that MetLife has.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between MetLife and AIG regarding junior subordinated debentures. (1) Quantitatively, all maturities and dollar amounts are correctly represented: $54M 8.5% due 2030 (July), $142M 8.125% due 2046 (March), and $31M 7.57% due 2045 (December) — these match the ground truth exactly in value and year, with only minor month-level specificity added in the LLM answer (e.g., July 2030), which is consistent with typical 10-K disclosures and not contradictory. (2) The LLM correctly identifies that MetLife has deferral provisions triggering dividend stoppers and is bound by replacement capital covenants, which impose liquidity constraints — this aligns fully with the original answer. (3) For AIG, the LLM accurately notes the absence of deferral or replacement-capital covenants, emphasizing scheduled maturities and parent guarantees, and correctly infers a different liquidity risk profile. The only minor shortcoming is that the LLM does not explicitly state that AIG does *not guarantee* AIGLH borrowings post-distribution — a nuance present in the ground truth that affects the interpretation of credit risk. However, by stating these are 'guaranteed debt' without noting the limitation post-distribution, there is a slight omission in entity obligation scope. (4) The reasoning is sound, synthesizing multi-hop elements: comparing deferral rights, covenant structures, and liquidity implications across two firms. Wording differs but semantic meaning is equivalent. Overall, the answer is factually correct, contextually precise, and well-reasoned, meriting a 9 due to the partial omission on AIG's guarantee limitation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 459,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA’s own listing of Samsung as a competitor in SoC and GPU markets (NVDA p. 15) signals Samsung’s strong manufacturing and product capabilities.  That same Samsung competitor is a key rival for Intel’s IFS Foundry Services (INTC p. 54), and Intel’s historical manufacturing delays and capacity constraints (INTC p. 53) make scaling IFS to match Samsung’s performance and time‑to‑market even more difficult.  Intel’s IDM 2.0 investment plan (INTC p. 14) is aimed at addressing these pressures, but it must contend with the entrenched position of Samsung in the foundry space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions in elaboration. (1) All entities—NVIDIA, Samsung, Intel, IFS Foundry Services, IDM 2.0—are correctly identified and their competitive relationships accurately described. The citation of page numbers (e.g., NVDA p.15, INTC p.54) aligns with the source-based reasoning expected, though the ground truth does not include page references; this does not detract from accuracy. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links NVIDIA competing with Samsung in SoC/GPU markets → Samsung being a foundry competitor to Intel’s IFS → Intel’s manufacturing delays hindering IFS scaling. It also correctly notes Intel’s IDM 2.0 strategy as a response. The only minor gap is that the LLM does not explicitly mention how NVIDIA’s pressure on Samsung indirectly affects Intel (i.e., Samsung being a 'dual threat'), which is a nuanced but important point in the original answer. However, the core logic chain is preserved. (4) The answer is highly contextually relevant, directly addressing how competitive dynamics impact Intel’s foundry ambitions. Wording differs but meaning is preserved. A score of 9 is justified due to high factual and reasoning accuracy, with a slight deduction in qualitative accuracy for not fully articulating the indirect competitive pressure mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 419,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s Class A shares carry one vote while its Class B shares carry ten votes (Class C shares are non‑voting)【page 82】, so the company’s $62 billion 2024 repurchase program targeted only Class A and Class C shares to avoid buying the high‑voting Class B stock that is largely held by insiders.  Comcast’s Class A shares also carry one vote, but its Class B shares carry fifteen votes and are concentrated in a single owner, Brian L. Roberts【page 31】; accordingly, Comcast’s $8.64 billion 2024 repurchase program focused solely on Class A shares, leaving the heavily‑voted Class B shares untouched to preserve the existing control structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024 (correctly stated as $62 billion), and these classes have 1 vote and 0 votes respectively, while Class B has 10 votes and is held by insiders. The LLM correctly notes that Class B shares are not repurchased to preserve voting control. For Comcast, the LLM accurately states that Class B shares carry 15 votes and are owned entirely by Brian L. Roberts, and that repurchases focused on Class A shares. (2) Quantitatively, all numbers are correct: $62 billion for Alphabet’s repurchase is accurate; the mention of Comcast’s $8.64 billion repurchase is not in the original answer but is factually correct based on external knowledge and does not contradict the ground truth—it adds detail not present in the original but is not erroneous. (3) The multi-hop reasoning is sound: the LLM correctly infers that avoiding repurchases of high-vote shares (Class B at both firms) preserves insider control, linking ownership structure to repurchase strategy at both companies. (4) The only minor shortcoming is that the LLM does not explicitly mention the automatic conversion of Alphabet Class B to Class A upon sale, which is a nuance in the governance mechanism noted in the ground truth. However, the core reasoning about preserving control is still correctly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent but missing one subtle point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 430,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s oncology pipeline centers on oral small‑molecule agents that target genetically defined NSCLC subtypes—Krazati (adagrasib) for KRAS‑mutated NSCLC and Augtyro (repotrectinib) for ROS1‑positive NSCLC and NTRK‑positive solid tumors—offering expansion into those specific genetic populations【page_4】. In contrast, Bristol‑Myers Squibb’s newly approved Opdivo Qvantig is a subcutaneously administered PD‑1 inhibitor that broadens the adult solid‑tumor market by providing a convenient SC formulation for most previously approved Opdivo indications, including NSCLC, melanoma, and other solid tumors【page_4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Amgen's focus on NSCLC through targeted oral therapies—Krazati for KRAS-mutated NSCLC and Augtyro for ROS1/NTRK-positive tumors—which aligns with Amgen's strategic emphasis on precision oncology. It accurately contrasts this with Bristol Myers Squibb's (BMS) FDA approval of Opdivo Qvantig, highlighting the subcutaneous (SC) administration route, which matches the ground truth. The answer correctly notes that Opdivo Qvantig expands access across most previously approved adult solid tumor indications, including NSCLC, melanoma, and others. (2) There are no numeric values, dates, or financial figures in the LLM answer that conflict with the ground truth. While the original answer specifies the December 2024 FDA approval, the LLM omits the exact date but refers to it as 'newly approved,' which is contextually acceptable and does not constitute a factual error—hence quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model synthesizes Amgen’s NSCLC strategy (from its pipeline) with BMS’s delivery innovation in Opdivo Qvantig, correctly contrasting mechanism of action (targeted oral vs. systemic immunotherapy) and administration (oral vs. subcutaneous). It captures the strategic divergence: Amgen expands via genetic segmentation, BMS via improved delivery convenience. (4) The LLM answer is semantically equivalent to the ground truth in substance, though slightly less detailed in describing the combination regimens (e.g., with chemotherapy or cabozantinib). However, this omission does not undermine the core accuracy. The contextual relevance is excellent, directly addressing administration method and market expansion as asked. Minor deduction in qualitative accuracy due to slightly less comprehensive detail on Opdivo Qvantig’s usage contexts, but overall highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 507,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "Comcast’s charter guarantees that the 33 ⅓ % of voting power held by Class B shares is fixed and cannot be diluted by new issuances (note 12, p. 91).  Because Class B shares are convertible share‑for‑share into Class A shares only at the holder’s option and under restrictive terms (note 11, p. 81), a holder of Class A stock—such as Alphabet—cannot convert its shares to increase the Class B voting bloc or alter the 33 ⅓ % allocation.  Thus Alphabet’s stake in Class A shares is limited to the proportion of Class A voting power it owns, while the protected Class B voting weight remains unchanged, curbing Alphabet’s overall influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B shares have non-dilutable 33 1/3% voting power, conversion to Class A is 1:1 and restricted, and GOOGL (referred to as Alphabet) holds Class A shares. The percentage (33 1/3%) is correctly stated and central to the explanation. (2) Quantitative accuracy is perfect—no calculations are required, but the critical percentage is correctly cited and contextualized. (3) The reasoning is sound: the LLM correctly explains that Alphabet’s Class A stake cannot affect the protected Class B voting bloc because conversion is holder-initiated and restricted, thus preserving the 33 1/3% control. This captures the multi-hop logic: structural protection + conversion mechanism + impact on external influence. (4) The only minor shortcoming is that the LLM slightly reframes the conclusion—focusing on Alphabet’s inability to increase the Class B bloc—whereas the original emphasizes that even full conversion wouldn’t dilute the 33 1/3% protection. This is a nuance in emphasis, not a factual error. Semantic equivalence is maintained. Contextual relevance is excellent, directly addressing how the capital structure limits GOOGL’s influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 350,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2 % rise in South Africa’s tobacco market volume—partly offset by a higher illicit‑trade prevalence (page 56)—boosts PepsiCo’s revenue from the Pioneer Foods acquisition but also increases its merger‑related integration charges, including liabilities to fund socioeconomic programs in South Africa (page 115). For MO, the elevated illicit‑trade prevalence heightens its risk exposure to illicit trade in its international operations, potentially triggering regulatory scrutiny, tax‑revenue losses and enforcement costs (page 41).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly identifies PEP as PepsiCo, when PEP refers to Pioneer Foods (acquired by PepsiCo), not PepsiCo itself in this context. The socioeconomic obligations are tied to PEP's merger-related charges, not PepsiCo's revenue from the acquisition. This misidentification fundamentally undermines the reasoning. Additionally, the LLM introduces 'page 115' and 'page 41' references not present in the original answer or question, suggesting fabricated sourcing. (2) Quantitatively, the 13.2% increase and the mention of higher illicit trade prevalence are correctly stated and match the ground truth. No calculations are required, so numerical accuracy is preserved. (3) The multi-hop reasoning fails because the model does not correctly link PEP’s merger obligations to the socioeconomic programs—instead, it reframes the issue around PepsiCo’s revenue, which is not mentioned in the original answer. For MO, the mention of regulatory scrutiny and tax-revenue losses is consistent with the original’s 'legal or regulatory actions' and 'lost sales', though 'enforcement costs' is an extrapolation. However, the core link between increased illicit trade and MO’s risk exposure is partially valid. (4) The correctness score is low due to the major entity confusion (PepsiCo vs PEP), which breaks the logical chain. Quantitative accuracy is perfect. Qualitative accuracy is poor due to incorrect entity mapping and reasoning. Contextual relevance is moderate because the answer addresses market growth and illicit trade impacts, but misattributes them to the wrong company for PEP’s obligations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 453,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑litigation has remained largely procedural: after a motion to dismiss was partially granted, the case was appealed to the Ninth Circuit and then to the U.S. Supreme Court, which vacated the Ninth Circuit’s ruling and remanded; the Ninth Circuit later reversed the district court’s order and instructed dismissal with prejudice, leaving no disclosed settlement or monetary award. In contrast, Meta’s privacy‑related lawsuits have produced substantial financial liabilities— a $725 million settlement with a consumer class action and a $5 billion FTC penalty—alongside ongoing litigation that could add further costs, and the cases have reached settlement or court‑approved decisions rather than remaining purely procedural.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Slack's IPO-related securities litigation was ultimately dismissed with prejudice after a Ninth Circuit reversal, and no monetary settlement was disclosed. Meta's $725 million consumer privacy class action settlement (approved in 2023) and $5.0 billion FTC penalty (paid in 2020) are correctly cited. The LLM accurately notes that Meta faces ongoing litigation and regulatory scrutiny, unlike Slack, whose exposure was significantly reduced after dismissal. (2) Quantitative accuracy is perfect: $725 million and $5 billion figures match the original answer; no incorrect numbers or dates are introduced. The LLM does not specify the 2020 and 2025 dates for Slack’s litigation milestones but captures the procedural outcome accurately. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, legal domains (securities vs. privacy litigation), and procedural vs. financial outcomes. It contrasts procedural dismissal (Slack) with binding settlements and penalties (Meta), which is the core of the comparison. (4) Minor deduction in qualitative accuracy due to omission of the 2020 motion-to-dismiss detail and the 2025 reversal date, though the overall procedural trajectory is correctly conveyed. The mention of a Supreme Court vacatur is not in the ground truth and may be extraneous or slightly inaccurate, but it does not contradict the final outcome. Overall, the answer is factually correct, contextually relevant, and effectively communicates the key contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 440,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "PM’s RSU awards vest on the third anniversary of the grant, so the $160 million of unrecognized compensation costs are amortized over a weighted‑average period of roughly 17 months. Walmart’s change from a 25 % annual vesting schedule to 8 % quarterly vesting over three years shortens the weighted‑average vesting period from about two years to roughly 1½ years, accelerating the recognition of its share‑based compensation expense relative to the prior schedule.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core structure of both companies' RSU vesting schedules and their impact on compensation cost recognition, but contains significant quantitative inaccuracies. It correctly notes PM's $160 million in unrecognized costs and 17-month weighted-average recognition period, which aligns with the ground truth. However, it incorrectly calculates the effect of WMT's vesting change, claiming the weighted-average vesting period shortened from 'about two years' to 'roughly 1½ years'—this is unsupported by the original data. The ground truth states WMT shifted from 25% annual vesting over four years (implying full vesting at year 4) to 8% quarterly over three years (full vesting at year 3), but does not provide weighted-average periods. The LLM's derivation of 2-year and 1.5-year periods is speculative and incorrect: under standard accounting, 25% annual cliff over 4 years yields a weighted-average period of 2.5 years, while 8% quarterly over 3 years (12 quarters) yields approximately 1.5 years—so only the new period is roughly accurate, and even that requires assumption of straight-line vesting. (2) The $160 million figure is correct; the 17-month period for PM is accurate. But the WMT quantitative comparison is flawed—no source in the original answer supports the 'two years to 1.5 years' claim. The original emphasizes the shift from back-loaded (25% per year) to more evenly distributed (8% per quarter), not a specific change in weighted-average period. (3) The multi-hop reasoning is partially sound: the model connects vesting schedules to cost recognition timing and contrasts PM’s cliff vesting with WMT’s more frequent vesting. However, it fails to mention key elements like PM’s event-based vesting triggers (death, disability, age 58) and mischaracterizes the accounting impact by introducing unsourced calculations. (4) Scores reflect that core facts about PM are correct and WMT’s policy change is accurately described in direction (more frequent vesting), but the introduction of incorrect quantitative metrics undermines factual accuracy. The answer remains contextually relevant and captures the qualitative contrast in cost recognition patterns, justifying a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 602,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing notes that, “within the next 12 months, unrecognized tax benefits related to federal tax matters under audit may decrease by up to $620 million” (page 75).  In contrast, Lockheed Martin’s 2023 filing states that the OECD’s Pillar 2 global‑minimum‑tax framework, which will take effect in parts on Jan 1 2024 and other parts on Jan 1 2025, is not expected to have a material impact on its effective tax rate or consolidated results (page 36).  Thus, Boeing faces a specific, potentially sizable audit‑related tax‑benefit loss, whereas Lockheed Martin views Pillar 2 as a negligible or non‑material risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: Boeing's $620 million unrecognized tax benefit risk is accurately cited, and Lockheed Martin’s assessment of Pillar 2 taking effect in parts on January 1, 2024, and January 1, 2025, matches the original answer. The 15% global minimum tax rate is omitted in the LLM answer but is not critical to the core comparison. (2) The LLM correctly identifies both companies and their respective tax risk assessments—Boeing’s audit-related exposure and Lockheed Martin’s expectation of no material impact from Pillar 2. (3) The reasoning is sound: it contrasts Boeing’s near-term, specific tax risk with Lockheed Martin’s broader, forward-looking assessment of Pillar 2, which reflects valid multi-hop synthesis across the two firms’ filings. (4) The only minor omission is the lack of mention that Boeing also expects minimal impact from Pillar 2 due to lack of material operations in low-tax jurisdictions, and the reference to General Electric’s evidence about national implementation variability is missing. However, these do not undermine the core correctness of the comparison. The answer remains semantically equivalent in its key claims and is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 360,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "PepsiCo will recast its segment reporting at the start of Q1 2025, grouping its North‑American food businesses into PepsiCo Foods North America and creating new Latin America Foods, EMEA, and Other International Foods segments while reporting International Beverages Franchise and the EMEA bottling segment separately【page_7】. Under ASU 2023‑07, PepsiCo will be required to disclose disaggregated expense information for each of these new reportable segments and to provide interim segment disclosures in its condensed financial statements beginning Q1 2025【page_54】. Altria adopted the same standard for the year ended December 31 2024 and will likewise include interim segment disclosures from Q1 2025 onward【page_62】【page_63】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo will reorganize its segments effective Q1 2025, combining FLNA and QFNA into PepsiCo Foods North America and restructuring international food segments into Latin America Foods, EMEA, and Other International Foods. The LLM correctly notes that International Beverages Franchise and EMEA bottling are reported separately, which is consistent with the source. (2) Quantitative accuracy is perfect: the timeline for adoption—Q1 2025 for interim disclosures—is correctly stated for both PepsiCo and Altria. Altria’s adoption in 2024 and interim implementation in Q1 2025 are accurately reflected. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PepsiCo’s segment reorganization and Altria’s adoption timeline under ASU 2023-07, linking both to the standard’s requirements for disaggregated expense disclosures and interim reporting. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'retrospective recast' of historical financials, which is a key component of ASU 2023-07 and included in the ground truth. However, stating that PepsiCo will 'recast its segment reporting' and provide disclosures from Q1 2025 implies this. The answer captures all required elements with high precision and contextual fidelity, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 397,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s MK‑7962 (sotatercept) basic compound patent is set to expire in 2027, while its method‑patents for treating pulmonary arterial hypertension are projected to expire in 2037 and the product will receive 12 years of data exclusivity—potentially extending protection to 2039【page_16】.  Pfizer’s 10‑K shows that its biologics rely on a mix of basic patents plus pending patent‑term extensions (PTEs) and supplementary protection certificates (SPCs) that can extend exclusivity beyond the original term; the table of key product expirations lists biologics whose protection dates run into the late 2020s and 2030s, with the company actively pursuing these extensions【page_14】【page_15】.  Thus, while Merck’s MK‑7962 has a shorter basic‑patent horizon, its overall exclusivity window is prolonged by method patents and data exclusivity, whereas Pfizer’s broader biologics strategy seeks to maintain market protection through multiple extension mechanisms across a wider portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Merck's base patent expiration for MK-7962 (sotatercept) as 2027 and acknowledges potential extended protection, but introduces a discrepancy by stating method patents expire in 2037 and data exclusivity could extend protection to 2039. The ground truth specifies potential extension to 2037 via patent term extensions (PTEs), not 2039 via data exclusivity. This overstates the timeline and conflates data exclusivity (12 years from approval, not from patent grant) with patent term extensions. The mention of '2039' is unsupported by the ground truth and likely incorrect. (2) Quantitatively, the 2027 base expiration is accurate, but the 2037 method patent and 2039 data exclusivity claims lack corroboration and contradict the ground truth’s 2037 upper limit via PTEs. Pfizer’s strategy is accurately described with reference to PTEs and SPCs extending into the 2020s and 2030s, though no specific product dates are given, aligning generally with the original answer. (3) The multi-hop reasoning is sound: the model compares Merck’s single-product timeline with Pfizer’s broader biologics portfolio strategy, correctly identifying both companies’ use of extensions and lifecycle management. It synthesizes across entities (Merck vs. Pfizer) and mechanisms (patents, PTEs, SPCs, data exclusivity). However, the incorrect extension of Merck’s protection to 2039 weakens the quantitative precision. (4) The answer is contextually relevant and well-structured, addressing both companies and the comparison of patent strategies. Despite the error in the outer expiration date, the core insight—that both companies use layered IP strategies with extensions—is preserved, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 480,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin’s fixed‑price contracts expose it to “reach‑forward” losses when actual costs exceed the negotiated price, which lowers profit‑booking rates and can materially cut operating profit and cash flow (see LMT Note 3, p. 62‑64; cumulative $270 M loss, p. 67).  \nGE faces a similar risk, but the impact is framed in terms of operational execution: high inflation and complex projects raise material, labor and supplier costs, and because many of its government and commercial contracts are fixed‑price, overruns can trigger penalties, liquidated damages and unanticipated expenses that impair delivery, quality and cash‑flow performance (GE 2023 10‑K, p. 34; operational‑risk discussion, p. 32).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly identifies Lockheed Martin's cumulative reach-forward loss of $270 million as of December 31, 2023, matching the original answer. However, it omits the second $280 million loss also mentioned in the ground truth, which slightly reduces completeness. All other financial and contractual impacts are described accurately. (2) The qualitative reasoning is sound: it correctly links cost overruns on fixed-price contracts to reduced profitability and cash flow for Lockheed Martin, and to operational execution risks for GE, including penalties and cost overruns due to inflation and complexity. It appropriately references inflationary pressures and supplier costs, consistent with RTX’s 10-K insight about material and labor cost increases. (3) The multi-hop synthesis across Lockheed Martin and GE is logically structured, connecting financial performance (LMT) with operational execution (GE), and both are tied to fixed-price contract risks under inflation and project complexity. (4) Contextual relevance is excellent—the response directly addresses all parts of the question, uses appropriate terminology (e.g., 'reach-forward losses', 'liquidated damages'), and cites relevant sections of the 10-Ks. The only minor shortcoming is the omission of the $280 million loss figure, which prevents a perfect score but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 402,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ uses exchange‑traded commodity futures and options to hedge the price risk of raw‑material purchases; these instruments are measured at fair value with Level 1 inputs (quoted market prices) and are not used for speculation.  COST reports a $251 million derivative exposure, of which $46 million is in Level 1 commodity contracts and $15 million in Level 1 currency‑exchange contracts, also valued at fair value using Level 1 inputs.  Thus, MDLZ’s commodity futures are a focused hedging tool for raw‑material costs, whereas COST’s Level 1 liabilities reflect a broader mix of commodity and currency derivatives all measured at fair value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, COST disclosed *no* Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022. However, the LLM claims COST has $46 million in Level 1 commodity contracts and $15 million in Level 1 currency-exchange contracts, totaling $61 million in Level 1 derivative liabilities — this is directly contradicted by the original answer. These numbers are entirely fabricated or misattributed. (2) Quantitative accuracy is severely compromised: the $251 million total derivative exposure, $46 million in commodity contracts, and $15 million in currency contracts for COST are all incorrect and unsupported by the ground truth. There are no such figures in the original answer, and no indication that COST held any Level 1 liabilities. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the key contrast: MDLZ uses Level 1 commodity futures for hedging, while COST has *no* Level 1 financial liabilities, indicating no such exposure. Instead, the LLM incorrectly portrays both companies as having Level 1 derivative exposures, undermining the core comparative insight. (4) Contextual relevance is moderate because the answer addresses fair value measurement, derivative instruments, and the comparison between MDLZ and COST — but the factual foundation is wrong. While the description of MDLZ’s use of commodity futures with Level 1 inputs aligns with the original answer, the misrepresentation of COST’s disclosures invalidates the comparison. Thus, despite correct terminology and structure, the answer is factually incorrect on the critical point of COST’s derivative holdings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 475,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS has 4.6 billion Class A shares that are fully convertible into Class B shares (page 116).  \nLockheed Martin’s nonqualified pension trust held $658 million in assets as of December 31 2024 (page 89). Thus, while the convertible shares number in the billions, the trust’s assets represent a monetary value of roughly two‑thirds of a billion dollars.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 4.6 billion UPS Class A shares and $658 million in Lockheed Martin's nonqualified pension trust assets as of December 31, 2024, are correctly reported. Minor formatting differences (e.g., '4.6 billion' vs '4.6 billion') are acceptable and do not affect meaning. (2) The answer is complete, addressing both parts of the multi-part question: the number of convertible shares and the pension trust assets. (3) Entity accuracy is perfect—UPS and Lockheed Martin are correctly identified, along with the correct financial instruments (Class A to Class B convertible shares, nonqualified pension trust) and the correct date (December 31, 2024). (4) The reasoning is sound: the LLM correctly synthesizes information from two separate companies and filings, and the qualitative comparison (billions vs two-thirds of a billion) is logically valid and adds contextual clarity without introducing error. All elements demonstrate full factual and semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 312,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "AVGO’s $56.3 B of fixed‑rate senior notes are highly sensitive to rate moves – a 50‑basis‑point change in market rates would shift their fair value by roughly $1.7 B.  By contrast, CSCO has used a $0.5 B notional interest‑rate swap as a fair‑value hedge of a portion of its fixed‑rate senior notes; the swap’s gain/loss offsets the fair‑value change of the hedged debt, effectively neutralizing that exposure in earnings and cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All key facts are correct: AVGO's $56.3 billion in fixed-rate debt, $1.7 billion fair value sensitivity to a 50 bps rate change, and CSCO's $0.5 billion notional interest rate swap are all accurately reported. The format variations (e.g., $56.3B vs $56.3 billion) are acceptable. (2) Quantitative accuracy is perfect—no calculation errors or misstatements of numbers. (3) The reasoning correctly contrasts AVGO's unhedged exposure with CSCO's use of a fair-value hedge via an interest rate swap tied to SOFR (implied in the ground truth by 'floating rates based on SOFR', though not explicitly mentioned in the LLM answer). The LLM correctly identifies that the swap offsets fair value changes, effectively neutralizing exposure. (4) The only minor omission is that the LLM does not explicitly name SOFR as the floating rate benchmark, nor does it emphasize that CSCO’s strategy targets a portion of its smaller fixed-rate debt base in contrast to AVGO’s large unhedged exposure—context that strengthens the comparative insight. However, the semantic meaning and financial implication are preserved. The answer is fully relevant, directly addressing the comparison of sensitivity and hedging strategies as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 363,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "PM’s VAR model applies a parametric delta‑gamma approximation to capture the observed interrelationships between interest‑rate and currency movements and to gauge the risk of its interest‑rate‑sensitive and foreign‑currency‑sensitive derivatives.  \nMDLZ’s VAR model also uses the same technique, but it is applied to estimate the expected return distribution for interest rates, currencies **and commodity prices**, explicitly noting that currency and commodity options are valued separately from the underlying and that the method covers fixed‑income, currency and commodity VAR.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key differences between PM and MDLZ in their use of the parametric delta-gamma approximation within VAR models. It correctly identifies that PM applies the technique to interest rates and currency movements, while MDLZ extends it to include commodity prices. The mention that MDLZ separately values currency and commodity options and covers fixed-income, currency, and commodity VAR aligns with the ground truth. However, the LLM answer omits specific details about the time periods used for parameter estimation: both companies use the preceding quarter for year-end VAR, and the four preceding quarters for average, high, and low VAR amounts (PM) or average VAR (MDLZ). While the core factual elements (entities, metrics, and model enhancements) are accurate, this omission of temporal scope reduces completeness. There are no numerical inaccuracies (quantitative accuracy is perfect as no explicit numbers are involved), and the reasoning is sound in comparing the two firms' modeling approaches. The answer remains contextually relevant and semantically close to the original, but lacks full multi-hop synthesis regarding time horizons, which limits it from a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 343,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s 10‑K stresses that “patients around the world deserve access to our life‑saving products” and that the company is using its local presence and scale to expand adoption globally (page 6). In contrast, Amgen’s 10‑K notes that payers—particularly PBMs such as Express Scripts—are demanding deeper discounts and rebates, which limit patient affordability and access to products like Repatha (page 37). Thus, while Medtronic is proactively broadening reach, Amgen is contending with payer‑driven price pressure that can curtail patient use.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core contrast between Medtronic's proactive global access strategy and Amgen's challenges with payer-driven affordability pressures. It correctly identifies Express Scripts as a key PBM exerting pricing pressure on Amgen, impacting access to Repatha. All entities (Medtronic, Amgen, Express Scripts, Repatha), their roles, and the general dynamics (local presence, rebates, formulary restrictions) are accurately represented. There are no numeric inaccuracies—the response avoids citing specific percentages or figures not present in the original answer, so quantitative accuracy is perfect. However, the LLM omits key contextual details from the ground truth: (1) the statistic that the top six PBMs control 94% of U.S. pharmacy prescriptions, (2) the role of Rebate Management Organizations, (3) the specific impact on Medicare patients and prescription abandonment due to high co-pays, and (4) Amgen’s list price reduction efforts for Repatha. These omissions reduce completeness and slightly weaken the multi-hop synthesis, particularly in explaining *how* Express Scripts’ market power translates into reduced patient access. While the reasoning is sound and semantically aligned, the answer provides a more high-level comparison without fully unpacking the structural payer dynamics emphasized in the original. Thus, it earns a strong but not perfect score due to missing granular, impactful details that are central to the original answer’s depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 413,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back plan is limited to Class A and Class C shares – it does not include Class B shares, even though Class B holders can convert those shares into Class A at any time (page 81).  By repurchasing Class A shares, Alphabet reduces the number of voting shares and limits the dilution that could arise if Class B holders convert, while the non‑voting Class C shares are also being retired (page 82).  Because Class A shares are also listed on another major corporation’s exchange, the program could shift voting power away from that external entity, helping Alphabet consolidate control over its voting‑capable equity.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The original answer states that Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023 with $36.3 billion remaining under authorization, but the LLM answer omits all dollar amounts and years entirely, failing the quantitative accuracy check. There is no mention of the $62.2B repurchase or the $36.3B remaining authorization, which are central to the ground truth. (2) While the LLM correctly identifies that repurchases are limited to Class A and Class C shares and that Class B shares are not included, it misrepresents the rationale. It claims repurchasing Class A shares limits dilution from conversion — however, since Class B can convert to Class A at will, buying back Class A actually reduces voting power in circulation, which helps preserve relative control for remaining Class B holders. The LLM’s reasoning about dilution is flawed. (3) The LLM correctly identifies the conversion right of Class B shares into Class A and notes that Class A shares are publicly traded by another major corporation — correctly implying governance implications. It correctly infers that avoiding repurchase of Class B preserves their relative voting weight. However, it fails to name Comcast Corporation (CMCSA), reducing entity accuracy. (4) The statement that Class A shares are 'listed on another major corporation’s exchange' is imprecise — the point is that Comcast *issues* Class A common stock as well, not that it's listed on a different exchange. Despite this, the core multi-hop reasoning — connecting Alphabet’s repurchase strategy to voting control and referencing the broader use of Class A shares by other firms like Comcast — is partially sound. (5) Overall, while the qualitative logic around voting control is directionally correct and contextually relevant, the absence of key financial figures and incorrect reasoning on dilution significantly reduce correctness. The answer captures part of the strategic implication but lacks precision and full synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 559,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s formulary restrictions on high‑cost biologics, as shown by Repatha’s access challenges, can curtail patient uptake and raise out‑of‑pocket costs, thereby reducing sales volumes for Eli Lilly’s biologic therapies (GILD page_29). Because Lilly’s revenue growth is tightly linked to patient access, such restrictions could erode its growth trajectory by limiting market penetration and encouraging shifts to lower‑cost alternatives (LLY page_24, 25, 26, 29, 35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately captures the core dynamic: UnitedHealth Group's formulary restrictions on high-cost biologics (exemplified by Repatha) can limit patient access, increase out-of-pocket costs, and reduce sales volume for Eli Lilly's biologics. The answer correctly cites Eli Lilly's dependence on patient access for revenue growth and notes the risk of market penetration limitations and substitution with lower-cost alternatives. While the original answer includes additional context about UnitedHealth’s systemic market power (controlling 94% of U.S. pharmacy prescriptions via top six PBMs), this quantitative detail is not strictly necessary to answer the question about impact on Eli Lilly. The LLM references specific document pages (e.g., LLY page_24, 25, etc.), which supports its claims and aligns with evidence-based reasoning. No numeric inaccuracies are present—there are no explicit numbers in either answer, so quantitative accuracy is scored as 10. The reasoning is sound and reflects multi-hop synthesis: connecting UHC’s actions on Repatha → broader payer restrictions → impact on Lilly’s access-dependent revenue. The only minor shortcoming is the lack of explicit mention of prior authorization and formulary exclusions by name (though 'formulary restrictions' and access limitations are implied), which slightly reduces qualitative accuracy. Overall, the answer is highly relevant, factually sound, and conveys the same conclusion as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 424,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s $3.0 billion commercial‑paper program is a short‑term, unsecured financing tool that the company can tap at any time to meet working‑capital or other liquidity needs, and its interest expense is tied to market rates. Cisco’s $9.0 billion of senior fixed‑rate notes are longer‑term debt that can be called or refinanced, but the company treats them as part of its short‑term financing strategy; the fixed rate provides a hedge against interest‑rate swings that Oracle’s commercial paper does not. Thus, both firms are exposed to short‑term debt mechanisms, but Oracle relies on a highly liquid, market‑rate instrument, whereas Cisco uses a larger, fixed‑rate note that offers more stability in interest expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in reasoning and completeness. (1) Quantitatively, the dollar amounts ($3.0 billion for Oracle's commercial paper program and $9.0 billion for Cisco's senior notes) are correct, and no incorrect calculations are made—this supports a high quantitative accuracy score. However, the LLM omits key facts from the ground truth: Oracle had *no outstanding commercial paper* as of May 31, 2022, and Cisco uses *interest rate swaps on $1.5 billion* of its fixed-rate notes to convert to floating rates based on LIBOR—both critical details missing. (2) The claim that Cisco 'treats' its long-term fixed-rate notes as part of its 'short-term financing strategy' is misleading and not supported by the original answer; rather, the notes rank at par with future commercial paper, meaning they are structurally aligned in seniority, not that they are used as short-term financing. This misrepresents Cisco’s debt structure and hedging strategy. (3) The multi-hop synthesis is flawed: while both companies use short-term debt mechanisms, the LLM incorrectly frames Cisco’s fixed-rate notes as a tool for short-term financing, when in fact they are long-term instruments with credit hierarchy implications. It also fails to mention Cisco’s active use of derivatives for interest rate risk management, a key differentiator. (4) Contextually, the response stays on topic and compares the two companies’ debt instruments as asked, earning high relevance. However, due to missing key facts and incorrect characterization of Cisco’s strategy, the qualitative accuracy and overall correctness are significantly reduced. Semantic equivalence is partially achieved but undermined by omissions and misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 480,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "FedEx and Caterpillar can both keep using their LIBOR‑based interest‑rate contracts and hedging accounting unchanged until the end of 2024, because ASU 2022‑06’s optional relief is now extended to that date.  FedEx notes that the relief applies to contracts and hedges that reference LIBOR and can be applied through December 31, 2024 (FedEx Note 93).  Caterpillar’s interest‑rate hedging policy—using fixed‑to‑floating contracts tied to the benchmark interest rate (i.e., LIBOR) as a fair‑value hedge (Cat Note 74)—is likewise unaffected by re‑pricing or re‑classification until the end of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key date — December 31, 2024 — is correctly stated, and the extension of ASU 2022-06 is accurately described. The references to FedEx Note 93 and Caterpillar Note 74, while not explicitly confirmed in the ground truth, are plausible and consistent with typical 10-K footnote labeling, suggesting accurate sourcing. (2) The answer correctly identifies that both companies benefit from the extension by maintaining unchanged accounting for LIBOR-based hedging relationships through 2024. (3) Multi-hop reasoning is sound: it synthesizes the impact of the ASU extension on both FedEx and Caterpillar, correctly linking the accounting relief to their respective hedging instruments and risk management practices. (4) The only minor shortcoming is that the LLM does not explicitly mention that FedEx has not yet experienced a material impact, a nuance present in the original answer. However, stating that FedEx 'notes that the relief applies' implies ongoing monitoring without material disruption, which is semantically close. Overall, the answer captures the core factual and conceptual content with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 342,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s Five‑Year Credit Agreement names Citibank, N.A. as the administrative agent, with JPMorgan Chase Bank, N.A. serving as the syndication agent and joint lead arranger, creating a two‑tier syndication structure【page_126】.  Caterpillar’s multi‑facility arrangements list Citibank, N.A. as the agent for each facility but do not identify a separate syndication agent, implying a simpler syndicate of banks【page_103】【page_128】.  In amendment activity, Boeing executed a single amendment in 2022 and had no amendments in 2023, whereas Caterpillar amended and extended its three‑year and five‑year facilities and added a new 364‑day facility in 2023【page_103】【page_128】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Boeing and Caterpillar, Citibank, N.A., JPMorgan Chase Bank, N.A., and the relevant timeframes (2022–2023). The syndication roles are accurately described—Boeing’s two-tier structure with Citibank as administrative agent and JPMorgan as syndication agent and joint lead arranger matches the original. Caterpillar’s lack of a named syndication agent and the implication of a simpler syndicate is a reasonable interpretation based on the absence of such a role in the filing. (2) Quantitative accuracy is perfect: Boeing’s single amendment in 2022 (August 25, 2022, per ground truth) is correctly noted; no 2023 amendments for Boeing. Caterpillar’s 2023 activity—amending and extending its 3-year and 5-year facilities and adding a 364-day facility—is factually correct and matches the multi-facility amendment activity described. (3) Multi-hop reasoning is sound: the model correctly synthesizes across Boeing’s and Caterpillar’s credit agreements, comparing syndication structure and amendment activity across years and facilities. The observation about Caterpillar’s more complex international components (implied by Citibank Europe plc and MUFG Bank, Ltd. in the ground truth) is partially reflected in the LLM’s focus on multiple facilities but not explicitly mentioned—this minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is contextually relevant, directly addressing syndication structure and amendment activity as asked. Wording differs but semantic meaning is equivalent. Minor deduction from 10 due to lack of explicit mention of international/local currency roles in Caterpillar’s case, which is part of the ground truth differentiation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 481,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s dual‑class scheme concentrates 33 % of voting power in a small Class B pool that is largely controlled by Zuckerberg, and the company notes that this can make its Class A shares less attractive and harm the stock price (page 50). Comcast also has a dual‑class structure, but its Class B shares hold 15 votes each and represent 33 % of voting power while being convertible into Class A shares (pages 69‑91). The conversion option gives investors a way to obtain voting rights and may mitigate concerns about concentrated control, potentially supporting investor confidence relative to Meta’s structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. It incorrectly states that Meta's Class B holds '33%' of voting power — the ground truth does not specify a percentage for Meta’s voting split, only that Class B has disproportionate control (e.g., Zuckerberg controls a supermajority via Class B shares). This number appears to be conflated with CMCSA’s 33⅓% voting power for Class B, which the LLM rounds to 33%, which is acceptable. However, the claim that CMCSA’s Class B shares have '15 votes each' is incorrect — the original answer makes no mention of vote-per-share ratio, only total voting power and convertibility. This is a significant quantitative error. (2) The LLM cites specific page numbers (e.g., 50, 69–91), which are not present in the ground truth and cannot be verified; their inclusion suggests fabrication or hallucination, reducing quantitative accuracy. (3) The reasoning partially captures the multi-hop comparison: both companies have dual-class structures with disproportionate voting and convertibility at CMCSA, potentially affecting investor confidence. The LLM correctly identifies that CMCSA’s conversion mechanism may mitigate governance concerns more than Meta’s, which is a valid qualitative inference. However, it fails to mention key details from the ground truth — such as the actual number of CMCSA Class B shares outstanding (9,444,375), which contextualizes the scale of control — and incorrectly implies Meta discloses that its structure harms stock price, when the original answer only states it 'could make Class A less attractive.' (4) Despite these errors, the answer addresses the core comparison about investor confidence and structural similarities, showing relevant reasoning and contextual understanding, warranting moderate scores in qualitative accuracy and high in contextual relevance. The correctness score is limited by major quantitative inaccuracies and hallucinated specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 537,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "In 2021, Coca‑Cola reported net sales to equity‑method investees of **$14,471 million**.  \nCoca‑Cola FEMSA’s bottling and distribution network covers **Mexico (central, southeast and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia (most of the country), Venezuela, Brazil (major parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina and portions of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas) and Uruguay**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales figure of $14,471 million in 2021 is accurately reported with correct formatting. (2) The regions covered by Coca-Cola FEMSA are completely and correctly listed: Mexico (central, southeast, northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (with accurate sub-regional detail), Argentina (Buenos Aires and surrounding areas), and Uruguay. The addition of 'most of the country' for Colombia and 'major parts' in Brazil does not contradict the ground truth and adds reasonable clarification without introducing error. (3) The multi-hop reasoning is sound—correctly identifying both the financial data from The Coca-Cola Company's 2021 reporting and synthesizing geographic operational details of Coca-Cola FEMSA. (4) All entities (The Coca-Cola Company, equity-method investees, Coca-Cola FEMSA) and the year 2021 are correctly referenced. The answer is semantically equivalent to the original, with no factual discrepancies, omissions, or inaccuracies. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 321,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s immunology segment revenue fell by roughly $31 million in 2021—about a 9 % drop in Remicade sales to $299 million (Simponi was flat), which is the only product in that segment that declined (see Merck 10‑K, page 141).  In contrast, AbbVie’s Humira—accounting for roughly 37 % of its 2021 net revenues (AbbVie 10‑K, page 6)—is under direct biosimilar competition in Europe and other markets, representing a much larger share of AbbVie’s top line and a more substantial biosimilar risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses both parts of the multi-hop question: the impact of biosimilar competition on Merck's immunology segment via Remicade and the comparison with AbbVie's exposure through Humira. Quantitatively, the LLM correctly states that Remicade sales declined by 9% in 2021 to $299 million, aligning with the ground truth. However, the ground truth also notes a 20% decline in 2020, which the LLM omits—this is a minor gap in completeness but does not undermine the core accuracy. The claim of a $31 million revenue drop in the immunology segment is plausible but not directly verifiable from the provided ground truth, which does not quantify the total segment decline. This introduces a small calculation assumption that slightly affects quantitative accuracy. The LLM correctly identifies Simponi as part of the segment and notes it was flat, consistent with the ground truth that both drugs face biosimilar pressure but only Remicade declined significantly. On AbbVie, the LLM accurately highlights Humira’s 37% share of net revenues in 2021 and its exposure to biosimilars in Europe and other markets, correctly contrasting the scale of risk relative to Merck. However, it omits AbbVie’s strategic response (patent protection, regulatory exclusivity, infrastructure investment) mentioned in the ground truth, which weakens qualitative completeness. Despite this, the core reasoning—comparing the relative size and risk of biosimilar exposure between the two firms—is sound and contextually relevant. Semantic equivalence is maintained on key facts. Minor omissions prevent a top score, but the answer is factually solid and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 455,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s Garrett Series B Preferred Stock, granted as full and final satisfaction of the Garrett Indemnity and Tax Matters Agreement, was recorded as long‑term receivables. The first partial redemption of $211 million in late 2021 reduced those receivables by that amount, leaving $423 million in long‑term receivables for the investment, and the present value of the remaining unredeemed Series B Preferred Stock as of December 31 2021 was $400 million.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Honeywell's investment in Garrett's Series B Preferred Stock was tied to indemnification matters and was recorded in long-term receivables, and that a partial redemption of $211 million occurred in late 2021, reducing the receivables. However, it incorrectly states the present value of the remaining unredeemed shares as $400 million, whereas the ground truth specifies $423 million as of December 31, 2021. This is a significant quantitative error. (2) The original answer states that Honeywell initially received $375 million and 834.8 million shares, with a $211 million redemption in December 2021 and a planned $200 million redemption in 2022. The present value of the remaining redemptions after the first was $423 million. The LLM answer omits the initial $375 million and misstates the present value of the remaining obligation as $400 million instead of $423 million. The $423 million figure is critical and directly contradicted by the $400 million claim. (3) The multi-hop reasoning is partially sound: the model connects the redemption event to the reduction in receivables and understands the ongoing nature of the obligation. However, it fails to accurately synthesize the financial impact post-redemption, likely due to incorrect calculation or data retrieval. (4) The contextual relevance is high as the answer addresses the core issue—impact on receivables and present value. Qualitative accuracy is fair due to correct conceptual framing, but quantitative accuracy is low due to the material error in the key financial figure. Correctness score reflects partial accuracy with a major factual flaw.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 456,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "Comcast’s Class B shares, wholly owned by Brian L. Roberts, carry 15 votes each and account for roughly one‑third of the company’s voting power; the company’s share‑repurchase program is limited to Class A shares, so Roberts’ voting influence is not diluted by repurchases. Alphabet’s dual‑class structure gives Class A shares one vote, Class B shares ten votes, and Class C shares none; its repurchase program targets only Class A and Class C shares, leaving the Class B voting power unchanged while reducing the total number of voting Class A shares and thereby potentially increasing the relative influence of Class B holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting power of CMCSA's Class B stock (15 votes per share, one-third of voting power) and its ownership by Brian L. Roberts. It accurately states that CMCSA's repurchase program is limited to Class A shares, preserving Roberts' voting control. For GOOGL, it correctly describes the voting structure: Class A (1 vote), Class B (10 votes), Class C (no votes), and notes that repurchases target only Class A and C shares, thus preserving Class B control. (2) While the original answer includes specific dollar figures ($62.2 billion repurchased, $36.3 billion remaining), the LLM answer omits these numbers. However, it does not misstate any quantitative data—just lacks the precise figures. All other numerical references (vote counts, ownership percentages) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between dual-class structures, insider control, and share repurchases across both companies. It draws the correct conclusion that repurchasing lower-vote shares amplifies relative control of high-vote share holders. (4) The omission of exact repurchase amounts slightly reduces completeness, but the core logic and factual structure are preserved. Hence, correctness is high (9), quantitative accuracy is 10 (no incorrect numbers, only missing ones), qualitative accuracy 9 (minor omission in synthesis depth), and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 402,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "Both MDLZ (page 64) and PMI (page 81) use a 95 % confidence interval and a one‑day holding period for their VAR calculations. They observe interest‑rate and currency movements over the preceding quarter for the December 31 calculation and over each of the four prior quarters for average, high and low amounts; MDLZ additionally incorporates commodity price movements in its model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both MDLZ and PM use a 95% confidence interval and a one-day holding period, observe interest rate and currency movements over the preceding quarter for point-in-time VAR, and use data from each of the four prior quarters for average (and high/low in PM's case) VAR amounts. The mention of MDLZ including commodity prices is an additional accurate detail supported by the original. (2) Quantitative elements—95%, one-day holding period, quarterly observations—are all correctly reported with no calculation or numeric errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes VAR methodology across two companies from their respective filings, comparing time horizons and confidence levels appropriately. (4) The only minor shortcoming is that the LLM answer refers to 'PMI' instead of 'PM', which is a slight entity inaccuracy (though PMI is commonly understood as Philip Morris International, the ticker used in the question is PM). Otherwise, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 327,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater China segment is largely a manufacturing hub: the company outsources most of its production to partners in China mainland, and its long‑lived assets in the region are “primarily related to product manufacturing, retail stores and related infrastructure” (AAPL 10‑K, pp. 9, 40, 52). In contrast, Microsoft’s Greater China footprint is support‑centric; it runs an operations center in Singapore that handles order processing, credit, logistics and customer support for the region, and it “localizes many of our products to reflect local languages and conventions” (MSFT 10‑K, pp. 16). Thus, Apple relies on China mainland for manufacturing and retail infrastructure, while Microsoft relies on a regional support center and localized software offerings rather than local manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Apple's reliance on China Mainland for manufacturing as part of its Greater China segment, citing long-lived assets related to manufacturing and retail infrastructure, which matches the original answer's emphasis on supply-chain intensity. It also accurately contrasts this with Microsoft's support-centric model, noting the operations center in Singapore that handles order processing, credit, logistics, and customer support for Greater China and other regions. The mention of product localization (e.g., language and conventions) is consistent with the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all descriptive data is correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes information from both Apple’s and Microsoft’s 10-K filings to compare their operational footprints across manufacturing, regional support, and localization strategies. The only minor omission is that the original answer explicitly names Hong Kong and Taiwan as part of Apple’s Greater China segment, which the LLM answer does not mention—this slightly reduces completeness but does not undermine the core accuracy. (4) The answer is contextually relevant, directly addressing all parts of the question: manufacturing reliance, regional support infrastructure, and localized product offerings. Wording differs but semantic meaning is equivalent. Thus, the correctness score is 9 due to the minor omission; all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 455,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS’s foreign‑currency derivatives are priced with internal models that use observable market data—yield curves, FX spot and forward rates, and other market‑observable inputs—so the instruments fall into Level 2 of the fair‑value hierarchy (UPS, Note 17, p. 137). In contrast, GE’s insurance and pension liabilities are measured using actuarial assumptions (mortality, morbidity, discount rates, etc.) that are not observable in the market, placing those obligations in Level 3 and requiring significant management judgment and unobservable inputs (GE, Note 46, p. 46; definition of Level 3, p. 47). Thus, UPS relies on observable inputs for its Level 2 derivatives, while GE’s Level 3 insurance and pension valuations depend heavily on unobservable inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that UPS uses observable market inputs (yield curves, FX spot/forward rates) for its foreign currency derivatives, classifying them as Level 2, while GE uses unobservable inputs (actuarial assumptions like mortality, morbidity, discount rates) for its insurance and pension liabilities, placing them in Level 3. (2) There are no numerical values requiring calculation in this question; all references to valuation levels and input types are consistent with the original answer and SEC filing concepts. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies (UPS and GE), two financial instruments (derivatives vs. insurance/pension liabilities), and two levels of the fair value hierarchy (Level 2 vs. Level 3), synthesizing the distinction based on observability of inputs. (4) The answer matches the original in both technical precision and conceptual clarity, citing appropriate note numbers and correctly applying FASB fair value hierarchy definitions. Minor wording differences (e.g., 'actuarial assumptions' vs. 'discounted cash flow methodologies') do not affect correctness, as both reflect valid Level 3 techniques. All entities, classifications, and conceptual contrasts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 373,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola’s 2022 10‑K notes that Swire Beverages is the bottling and distribution partner for its Hong Kong operations, showing a clear reliance on an independent bottler (page 7).  Colgate‑Palmolive does not report Hong Kong figures separately; its Asia‑Pacific segment – which includes Greater China – grew 6 % in net sales and 9 % in operating profit in 2021 (page 42), indicating overall regional strength but no specific distribution partner is highlighted.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key details from the ground truth. It correctly identifies that Coca-Cola relies on Swire Beverages for distribution in Hong Kong, citing the 2022 10-K, which aligns with the original answer. However, it fails to mention that Swire is one of Coca-Cola’s top bottling partners contributing to 83% of non-U.S. unit case volume in 2021—a critical multi-hop data point. For Colgate-Palmolive, the LLM states that Hong Kong figures are not reported separately and uses Asia-Pacific data, but incorrectly cites 6% net sales growth and 9% operating profit growth in 2021, whereas the ground truth reports $2,867 million in Asia Pacific net sales and 3.0% organic sales growth (not 6%), with no mention of 9% operating profit growth in the original. These numbers do not match the ground truth and appear to be fabricated or misattributed. (2) Quantitative accuracy is compromised: the $2,867 million net sales figure is omitted, and incorrect growth percentages (6%, 9%) are introduced instead of the correct 3.0% organic sales growth. The year 2021 is correctly used for Colgate, but Coca-Cola data is cited from 2022 instead of 2021, creating a mismatch in the comparative analysis. (3) Multi-hop reasoning is partially sound—linking Coca-Cola’s distribution model to Swire and contrasting it with Colgate’s direct operations is valid—but the synthesis is weakened by missing the core financial metric for Colgate and misrepresenting growth figures. The absence of direct comparison on operational performance (e.g., volume vs. cost savings) limits depth. (4) Contextual relevance is strong as the answer addresses both companies and the Hong Kong/Asia-Pacific context, but completeness and factual accuracy reduce overall correctness. The answer acknowledges reporting limitations but substitutes unsupported metrics, undermining reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 515,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "BAC’s CDO holdings are reported as part of its other debt securities and contain embedded derivatives that include credit protection sold to the issuer, so the bank’s exposure is largely credit‑loss risk that is mitigated by that protection. JPMorgan’s structured notes with embedded derivatives are valued by discounted‑cash‑flow analysis that incorporates the embedded derivative via option‑pricing models (Black‑Scholes, simulation, etc.) and then adjusts the base value for the firm’s own credit risk (DVA)【186】【187】. Thus, BAC’s approach focuses on credit‑protection‑based risk mitigation, whereas JPM’s approach relies on model‑driven valuation and explicit credit‑risk adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: BAC's CDOs contain embedded derivatives with credit protection sold to the issuer, leading to credit-loss risk exposure; JPM values structured notes using discounted cash flow models incorporating Black-Scholes or simulation techniques and adjusts for DVA (own credit risk). These points align precisely with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect figures supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across BAC’s risk exposure in CDOs with embedded derivatives and JPM’s valuation methodology for similar instruments, drawing a valid contrast between BAC’s focus on credit protection and JPM’s model-driven, DVA-adjusted approach. (4) The only minor shortcoming is that the LLM omits BAC’s connection to VIEs and non-consolidation of these vehicles, which adds contextual depth to its risk exposure in the original answer. While this is a small omission, it slightly reduces completeness in the qualitative dimension. Otherwise, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 380,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "Comcast’s Class B common stock is largely non‑voting; holders may vote only on a handful of defined matters—such as exiting the core payments business, a merger/combination or certain amendments to the certificate of incorporation—and they vote together with Class A common stock as a single class, casting votes equal to the number of shares held times the applicable conversion rate【page_90】. In contrast, Netflix’s common stock holders have unrestricted voting rights—one vote per share on all matters to be voted upon【page_61】. Thus, CMCSA’s Class B shares are limited to specific, infrequent votes, whereas NFLX’s common shares vote on every corporate matter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B Common Stock has limited voting rights on specific matters (e.g., exiting core payments business, mergers, charter amendments), votes are calculated using the conversion rate, and they vote together with Class A as a single class. NFLX provides one vote per share on all matters. These points match the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, share counts), so quantitative accuracy is not compromised—no errors in dates, numbers, or financial metrics. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures from two different companies (CMCSA and NFLX) and contrasts their voting frameworks based on disclosed limitations. (4) The only minor omission is that the LLM does not explicitly mention that CMCSA's Class B shares were 'issued and outstanding as of 2023,' which reinforces the current applicability of the structure. However, this does not detract significantly from the core comparison. Wording differs slightly (e.g., 'largely non-voting' vs 'limited voting rights'), but this is semantically acceptable. Overall, the answer is factually correct, complete in substance, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 370,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley’s 10‑K (page 109) describes its CDOs as hybrid instruments that contain embedded derivatives and notes that credit protection is sold to the issuer, but it does not disclose a specific valuation method for those embedded derivatives.  By contrast, JPMorgan Chase’s 10‑K (page 187) outlines a formal valuation approach for structured notes that includes discounted‑cash‑flow analysis, option‑pricing models such as Black‑Scholes, and credit‑risk adjustments (DVA).  Thus, Morgan Stanley’s treatment is largely descriptive and risk‑focused, while JPMorgan provides a detailed, model‑based valuation framework for similar instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Morgan Stanley treats CDOs as hybrid instruments with embedded derivatives and sells credit protection to the issuer, matching the original answer. It also accurately states that JPMorgan Chase uses discounted cash flow analyses, Black-Scholes or simulation models, and includes DVA adjustments—key points from the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms’ 10-K disclosures, comparing Morgan Stanley’s descriptive, risk-focused treatment with JPMorgan’s model-based valuation framework. The only minor shortcoming is that the LLM implies Morgan Stanley does not disclose *any* valuation method for embedded derivatives, while the ground truth does not make that claim—it only contrasts the nature of the disclosures. This slight overstatement prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison of valuation methodologies for embedded derivatives in structured notes between the two firms. Overall, the LLM captures the core contrast accurately and with appropriate nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 398,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott’s 10‑K notes that the loss or invalidation of its patents could materially reduce future revenues (page 12) and that it is currently litigating patent‑infringement claims with DexCom (page 17).  AbbVie, through its wholly‑owned subsidiary Forest Laboratories Holdings Limited, is similarly engaged in patent enforcement to block generic versions of Vraylar (page 136).  Consequently, both companies’ pharmaceutical earnings are tied to the outcome of these IP disputes: Abbott faces potential revenue erosion if its patents are found invalid or infringed, while AbbVie seeks to preserve Vraylar sales by securing exclusivity, making each firm’s revenue streams vulnerable to litigation results.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) It correctly identifies Abbott's exposure to IP risks, citing its 10-K page 12, and AbbVie's patent enforcement via Forest Laboratories Holdings Limited to protect Vraylar, citing page 136—both consistent with the original answer. It also accurately notes that both companies' revenue streams are tied to IP litigation outcomes. However, it omits specific details present in the ground truth: the December 2019 filing date, the names of the generic challengers (Sun Pharmaceutical and Aurobindo Pharma), and the U.S. District Court for the District of Delaware. These omissions reduce completeness but do not undermine the central facts. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures are stated. The LLM avoids fabricating data and sticks to correctly cited disclosures. (3) The multi-hop reasoning is sound—linking Abbott’s general IP risk to AbbVie’s specific Vraylar litigation and inferring shared vulnerability in pharmaceutical revenue. However, the synthesis could be deeper; the original answer emphasizes the interplay between the two companies’ IP strategies, while the LLM treats them in parallel rather than exploring their structural relationship (e.g., Abbott’s spin-off of AbbVie). (4) Contextual relevance is excellent: every sentence addresses the question’s focus on IP risks, patent enforcement, and revenue implications. The mention of Abbott’s DexCom litigation, while not in the ground truth, is factually correct per Abbott’s 10-K and adds context without distraction. Overall, the answer is semantically close to the original, with minor gaps in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 476,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup uses foreign‑currency forwards and cross‑currency swaps as **net‑investment hedges**—recording fair‑value changes in AOCI under ASC 815/830—to offset the translation risk of equity investments in non‑U.S. subsidiaries (page 153).  \nMorgan Stanley, by contrast, relies on a 95 % one‑day VaR model—built on historical simulation and Monte‑Carlo—to **measure and monitor** aggregate market‑risk exposure across its trading book, using VaR as a risk‑management tool rather than a hedging instrument (pages 59‑60).  \nThus, Citigroup’s approach is derivative‑centric hedging of specific FX exposures, whereas Morgan Stanley’s approach is risk‑measurement‑centric, with VaR guiding but not directly implementing hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Citigroup's use of foreign currency forwards and cross-currency swaps as net investment hedges under ASC 815/830, with fair value changes recorded in AOCI—consistent with the original answer's reference to ASC 815 and CTA in AOCI. The mention of hedging equity investments in non-U.S. subsidiaries matches exactly. (2) For Morgan Stanley, the LLM accurately states the use of a 95% one-day VaR model based on historical simulation and Monte Carlo methods to measure aggregate market risk in trading portfolios, which is semantically equivalent to the ground truth’s description of VaR as a key tool incorporating diversification and hedging effects. The clarification that VaR is used for monitoring, not direct hedging, adds precision. (3) The multi-hop reasoning is sound: it contrasts Citigroup’s derivative-based hedging strategy with Morgan Stanley’s risk-measurement approach, capturing the core comparative intent of the question. (4) The only minor omission is the reference to Southern Company Gas and its use of weather derivatives, which appears in the original answer as a connecting example of broader risk management practices. However, this detail is tangential to the primary comparison between Citigroup and Morgan Stanley, so its absence does not undermine the core correctness. All entities, accounting standards, and financial instruments are accurately named. Number formats and percentages (e.g., 95%, one-day VaR) are correct. The LLM provides additional page references (e.g., page 153, 59–60), which, while not in the ground truth, suggest plausible sourcing and do not detract from accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight reduction in completeness due to the omitted Southern Company Gas linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 517,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive uses option and forward contracts to hedge its foreign‑currency exposures, with net FX cash‑flow hedges of about $9.9 billion in 2024 that offset currency‑related changes and help smooth cash flows (see page 121). Walmart’s firm commitments—legal contracts for inventory, utilities, capital expenditures, etc.—are part of its purchase obligations and are not hedged, creating predictable but potentially volatile cash outflows that can increase cash‑flow variability (see page 45). Thus, Colgate’s hedging strategy stabilizes cash flows, whereas Walmart’s unhedged firm commitments expose it to greater cash‑flow swings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Colgate-Palmolive's use of option and forward contracts to hedge foreign exchange risk and Walmart's lack of hedging on firm commitments, aligning with the ground truth's core comparison. However, there are key quantitative discrepancies. The LLM states Colgate had 'net FX cash-flow hedges of about $9.9 billion in 2024,' but this figure is not present in the original answer and cannot be verified against the provided ground truth, which does not specify the dollar value of Colgate's hedges. This introduces a potentially inaccurate number. In contrast, the original answer provides specific figures for Walmart's unrecorded purchase obligations: $37.2 billion total as of January 31, 2025, with $15.9 billion due within one year. The LLM only generically references 'purchase obligations' without citing these exact figures, missing a key quantitative detail. (2) The calculation and number verification fails on Colgate's hedge value ($9.9B) and omits Walmart's precise obligation amounts. While format variations are acceptable, invented or unverified numbers reduce accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Colgate uses financial instruments (options/forwards) to stabilize cash flows, while Walmart’s unhedged firm commitments create exposure to volatility. The logic that hedging reduces cash-flow variability versus unhedged obligations increasing it is consistent with the ground truth and demonstrates proper comparative analysis. (4) The contextual relevance is perfect—the answer directly addresses the comparison of cash flow stability impacts between the two companies’ strategies. Due to the inclusion of an unsupported quantitative figure and omission of specific Walmart obligation amounts, the quantitative accuracy is reduced to 6. Qualitative accuracy is high (8) due to correct entities, correct characterization of instruments and exposures, and valid reasoning. Correctness score is 7 because the core conclusion is accurate and well-reasoned, but the answer lacks full quantitative fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 572,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "Thermo Fisher (TMO) adopted ASU 2023‑07 for fiscal‑year 2024 (effective Jan 1 2024) and applied it retrospectively, with interim reporting required for all subsequent interim periods (see page 44).  CVS adopted the same standard on Jan 1 2024 for FY reporting but only for interim periods in fiscal years beginning after Dec 15 2024 (page 133).  Under the new standard, TMO must disclose significant segment‑level expenses and other items by reportable segment and provide information on its chief operating decision maker, whereas CVS must disclose the CODM’s title and position, explain how the CODM uses segment operating results to evaluate performance and allocate resources, and align interim and annual segment‑reporting disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor inaccuracy regarding TMO's implementation timeline. The ground truth states TMO adopted ASU No. 2023-07 for its 2024 annual report (not necessarily effective Jan 1, 2024), while the LLM claims it was effective Jan 1, 2024—this detail is not explicitly confirmed in the original answer and may conflate CVS's stated effective date. However, both companies did apply the standard retrospectively, and the LLM correctly identifies that TMO enhanced disclosures in segment reporting, including segment-level expenses and CODM information (aligned with Note 11 in original). For CVS, the LLM accurately notes adoption on Jan 1, 2024, and specifies required disclosures: CODM’s title, use of segment results, and alignment of interim reporting—consistent with Note 19. The LLM correctly captures that CVS applies interim requirements for fiscal years beginning after Dec 15, 2024, which matches the original. All entities (TMO, CVS, ASU 2023-07, CODM) are accurate, and the multi-hop comparison across companies is well-reasoned. The answer is semantically equivalent in most aspects, with only slight overprecision on TMO’s effective date preventing a higher score. Quantitative accuracy is high—dates and timeframes are correctly cited with only contextual nuance differences. Contextual relevance is perfect: all parts of the question are addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 392,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "ACN’s 2021 effective tax rate was lowered by **0.1 percentage point** as a result of the Philippines corporate income‑tax rate reduction, whereas AMD reported **no tax‑reform effect** on its effective tax rate in 2021.  \n\n**Sources**  \n- ACN 10‑K, page 30 (discussion of the Philippines tax‑rate reduction and its impact on the effective tax rate)  \n- AMD 10‑K, page 74 (tax‑reform act entry showing $0 impact in 2021)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that ACN benefited from the Philippines' corporate income tax rate reduction and that AMD reported no impact from tax reform in 2021, which aligns with the ground truth. The qualitative reasoning and entity accuracy (ACN, AMD, 2021, Philippines tax change, tax reform) are sound and contextually relevant. However, the quantitative accuracy is flawed: the LLM states the impact on ACN’s effective tax rate was '0.1 percentage point,' but the original answer (ground truth) does not specify a precise numerical impact—only that the reduction 'favorably impacted' the 21.8% rate. Since the knowledge graph does not provide a 0.1 percentage point figure, this specific number is unsupported and likely incorrect. Additionally, the LLM omits key context about GILTI-related foreign tax credit limitations that partially offset the benefit for ACN, reducing completeness. While the sources cited (ACN 10-K p.30, AMD 10-K p.74) may support the claims, the addition of a precise 0.1-point impact not present in the ground truth undermines quantitative accuracy. Thus, the answer is partially correct with minor factual overprecision and some contextual omissions, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 344,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell’s pension plans use observable market data for Level‑2 fixed‑income securities (e.g., yield curves and credit spreads) and rely on a discounted‑cash‑flow model that incorporates unobservable inputs—such as projected annuity payments and discount rates—for Level‑3 assets (page 110). 3M also values Level‑2 holdings with observable inputs (yields on comparable securities) and applies a discounted‑cash‑flow approach for Level‑3 assets, but the model is built on observable inputs and then adjusted for credit and liquidity risks that are not directly observable (page 75). Thus, Honeywell explicitly relies on unobservable inputs for Level‑3 valuations, whereas 3M’s methodology blends observable inputs with adjustments for non‑observable risk factors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of valuation methodologies and correctly identifies that both Honeywell and 3M use pricing models and discounted cash flow techniques, with distinctions between Level 2 and Level 3 inputs. It accurately states that Honeywell uses unobservable inputs (e.g., projected annuity payments and discount rates) for Level 3 assets and that 3M uses observable inputs adjusted for non-observable credit and liquidity risks. However, the LLM misattributes the source of these adjustments: the original answer indicates that Honeywell applies adjustments for credit and liquidity risks when using pricing models, not necessarily within a discounted cash flow model for Level 3 assets, whereas the LLM implies Honeywell’s DCF model for Level 3 relies on unobservable inputs like annuity payments—this part is plausible but not fully aligned with the ground truth, which does not specify that Honeywell’s DCF is limited to Level 3 or uses those exact inputs. Conversely, the LLM correctly captures that 3M blends observable inputs with unobservable adjustments, which matches the original. The answer is strong on contextual relevance and correctly addresses the comparison between observable vs. unobservable inputs. There are no numerical inaccuracies (quantitative accuracy is perfect), but the qualitative reasoning has minor misalignments in attributing modeling approaches to specific levels and companies. The original emphasizes that 3M explicitly categorizes by hierarchy levels while Honeywell focuses on adjustment types—a nuance missing in the LLM response, reducing completeness in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 450,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each and are share‑for‑share convertible into Class A, but the 33 ⅓ % of total voting power that B holders hold is fixed and cannot be diluted by new issuances (page 91).  Alphabet’s strategy, by contrast, is to buy back large amounts of Class A and non‑voting Class C shares (≈$50‑$62 bn in 2021‑23, page 81), which shrinks the equity base and boosts earnings per share but does not change the voting‑right per share—Class C shares have none, and Class A shares remain one vote each.  Thus, CMCSA’s conversion mechanism gives B holders a fixed but potentially adjustable voting stake, while Alphabet’s repurchases alter the size of the equity pool without reshaping the relative voting power among its classes.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies, particularly in quantitative details and voting rights. It incorrectly states that CMCSA’s Class B shares carry '15 votes each'—the ground truth does not specify vote multiples per share but instead emphasizes that Class B holders collectively control 33 1/3% of voting power, which is non-dilutable. This is a major error. Additionally, the dollar amount for GOOGL’s repurchases is inaccurately reported as '≈$50-$62 bn in 2021-23', while the ground truth specifies $62.2 billion in 2023 alone, with an additional $36.3 billion authorized. The LLM conflates multiple years and underreports the scale and timing. 2) Quantitative accuracy is low: the $62.2B figure for 2023 is precise in the original, but LLM generalizes it across 2021–2023 and reduces accuracy. The '15 votes' claim has no support in the ground truth. 3) Qualitatively, the LLM captures the contrast in strategic approaches—CMCSA’s structural protection of voting power vs. GOOGL’s use of repurchases to alter ownership concentration—but misrepresents the mechanisms. It correctly notes that GOOGL repurchases reduce the equity base and that Class C shares are non-voting, but fails to mention the key point that Class B shares (with 10 votes) automatically convert to Class A upon sale, which is central to control dynamics. Also, the LLM incorrectly suggests CMCSA’s voting stake is 'potentially adjustable,' while the ground truth emphasizes its non-dilutable, fixed nature. 4) Contextual relevance is high—the response addresses the comparative equity structure and control implications as asked, synthesizing across both companies and mechanisms. However, due to significant factual and numerical errors, especially regarding voting rights and repurchase amounts, the overall correctness is only partial.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 494,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K notes that the WHO Framework Convention on Tobacco Control (FCTC) has encouraged many signatories to impose partial or total bans on advertising, marketing, promotions and sponsorships, so Altria’s exposure is largely to potential restrictions in markets that adopt those guidelines (Altria, 2022, p. 42).  In contrast, Philip Morris International’s 10‑K reports that Australia and Russia have already imposed bans on the display of tobacco products at the point of sale – a concrete advertising restriction that has forced PMI to adjust its marketing mix in those markets (PMI, 2022, p. 42).  Consequently, PMI must actively redesign its international strategy to comply with strict bans and focus on product innovation and alternative promotion channels, while Altria’s strategy is more about monitoring evolving FCTC‑driven restrictions and preparing compliance plans for markets that may adopt similar bans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Altria’s 2022 10-K correctly notes that the U.S. is a signatory but not a party to the FCTC, limiting direct regulatory impact, and acknowledges FCTC’s global influence on advertising restrictions (p. 42 reference aligns with typical risk factor disclosures). PMI’s exposure in Australia and Russia to point-of-sale display bans is accurately reported, consistent with its 2022 10-K (p. 42). (2) There are no numeric values requiring calculation, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the model correctly contrasts Altria’s anticipatory, monitoring-based strategy with PMI’s need for active adaptation due to implemented bans. The synthesis across two companies and regulatory environments is logical and well-supported. (4) The LLM omits a minor but relevant detail from the original answer: it does not explicitly state that Altria’s primary market (the U.S.) is less affected by current FCTC enforcement, which contextualizes its lower immediate constraint. However, this is implied in the focus on 'potential' restrictions. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; minor omission prevents a perfect 10. Contextual relevance is full—directly addresses comparative exposure and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 384,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that Dodd‑Frank’s ban on proprietary trading and limits on certain hedge‑fund investments constrain its ability to offer cryptocurrencies, leaving it at a competitive disadvantage to JPMorgan, which enjoys greater flexibility in those areas (GS 10‑K, p. 13).  In contrast, Morgan Stanley’s 10‑K highlights that regulatory uncertainty, sanctions and enforcement risks in emerging markets could impede its cross‑border cryptocurrency‑related activities, as local laws may be inconsistent with U.S. rules and transactions may not be enforceable (MS 10‑K, p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank restrictions (specifically proprietary trading bans and hedge-fund investment limits) is accurately cited from its 2024 10-K, and the comparison to JPMorgan's greater flexibility is consistent with the original answer. Morgan Stanley's exposure to regulatory uncertainty, sanctions, and enforcement risks in emerging markets affecting cross-border cryptocurrency activities is also correctly drawn from its 2024 10-K. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both responses reference the correct fiscal year (implied as 2024 via context) and proper document sources (10-K filings). Format and citation style (e.g., page numbers) are acceptable variations. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different firms (Goldman Sachs and Morgan Stanley), identifies distinct types of regulatory constraints (U.S.-based structural vs. foreign jurisdictional risks), and contrasts them appropriately in the context of cryptocurrency offerings. (4) The only minor shortcoming is the lack of explicit mention that Goldman’s constraints are 'self-imposed' due to U.S. regulatory frameworks, a nuance present in the original answer. However, the reference to Dodd-Frank as a binding constraint implies this, so the omission does not materially distort the meaning. Semantic equivalence is maintained. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 466,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "3M adopted ASU 2022‑04 in 2023 and, from 2024 onward, must disclose roll‑forward information on its supplier‑finance programs.  In its 2024 10‑K (Note 16 on pages 69 and 77) 3M reports that $1.5 B of invoices were confirmed and $1.5 B were paid in 2024, with a $0.3 B balance outstanding at year‑end.  GE’s 2024 10‑K (pages 6, 37, 39, 46, 47) contains no note on supplier‑finance obligations, so the ASU’s roll‑forward requirement does not affect GE’s disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but has significant factual and reasoning errors. (1) Quantitatively, the $0.3 billion year-end balance and $1.5 billion confirmed invoices for 3M are correct and match the ground truth. However, the LLM incorrectly states that $1.5 billion were both confirmed and paid during 2024, while the ground truth specifies that $1.5 billion were confirmed and paid during the year — this subtle distinction may imply a conflation of flows, but the numbers themselves are directionally accurate. (2) The major error lies in the claim that GE’s 2024 10-K contains no note on supplier-finance obligations and thus the ASU does not affect GE. This contradicts the ground truth, which explicitly states that GE adopted the standard on January 1, 2023, and began providing the required annual roll-forward disclosures in 2024 as mandated. The LLM’s conclusion that the ASU does not affect GE is factually incorrect — the standard does impact GE’s disclosures, and the absence of a specific note does not equate to non-compliance or exemption. (3) Multi-hop reasoning is flawed: the model fails to synthesize the phased implementation timeline of ASU 2022-04, particularly the prospective requirement for roll-forward information starting in 2024, which applies to both companies. It incorrectly infers from document structure (missing note) that there is no impact, rather than recognizing that GE is complying with the new disclosure requirements. (4) While the answer is relevant and attempts to cite specific filings, the qualitative inaccuracy — especially the incorrect conclusion about GE — severely undermines the correctness. The answer gets partial credit for accurate 3M figures and correct identification of the 2024 roll-forward requirement’s applicability to 3M.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 490,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "Medtronic’s 2024 net sales from “Other Countries” totaled $32.3 billion—about 36 % of total sales (MDT p. 105)—so a large portion of its revenue comes from foreign markets that are subject to the same regulatory and reimbursement pressures that Amgen faces abroad.  Medtronic’s exposure to government‑funded health systems, price‑control mechanisms and coverage restrictions is described on pages 20‑21, while Amgen’s international drug‑pricing challenges are outlined on page 18, where government‑sponsored payers impose downward price pressure and limit coverage.  Thus, shifts in foreign health‑policy or reimbursement rules can materially affect Medtronic’s revenue and profitability, mirroring the pricing constraints Amgen encounters in international markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its reasoning and captures the core parallel between MDT and AMGN regarding international regulatory and reimbursement challenges. It correctly identifies that MDT has significant revenue exposure outside the U.S. and faces government price controls and coverage restrictions, similar to AMGN. However, there is a minor quantitative inaccuracy: the LLM states MDT's 'Other Countries' sales as $32.3 billion, while the ground truth specifies $32.251 billion from 'Total other countries, excluding Ireland'. Though close, the LLM rounds up and omits the important qualifier 'excluding Ireland', which affects precision. Additionally, the 36% figure is not present in the ground truth and cannot be verified without total revenue—this introduces an unsupported calculation. 2) The ground truth does not mention a percentage of total sales, so the 36% claim lacks sourcing and may be incorrect. The dollar amount is approximately accurate ($32.3B vs $32.251B), so minor rounding is acceptable, but the missing 'excluding Ireland' context reduces quantitative accuracy. 3) The multi-hop reasoning is sound: the LLM correctly links MDT's geographic revenue concentration to regulatory risks and draws a valid comparison to AMGN’s international pricing constraints. It references the correct types of pressures (price controls, coverage limits) and ties them to government-funded systems, aligning with both companies’ disclosures. 4) The answer is contextually excellent—directly addresses the question, synthesizes across two companies, and explains the shared risk environment despite different healthcare sectors. The omission of specific mechanisms like 'reference pricing' and 'mandatory licensing' (mentioned in the ground truth) is a minor gap but doesn't undermine the overall correctness. Thus, the answer earns a high score but is penalized slightly for unsupported numbers and minor factual imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 523,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "Schwab’s combined buffer requirement above the minimum risk‑based capital ratios is **8.4 %** under the Basel III Standardized approach (5.4 % SCB + 3.0 % G‑SIB surcharge) and **5.5 %** under the Advanced approach (2.5 % capital‑conservation buffer + 3.0 % G‑SIB surcharge). JPMorgan Chase’s corresponding buffers are **6.9 %** (Standardized: 2.9 % SCB + 4.0 % G‑SIB surcharge) and **6.5 %** (Advanced: 2.5 % capital‑conservation buffer + 4.0 % G‑SIB surcharge). Thus, Schwab’s Standardized buffer is higher, while Chase’s Advanced buffer is slightly higher; both firms apply a countercyclical buffer of 0 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that SCHW has a stress capital buffer (SCB) of 2.5% and a capital conservation buffer (CCoB) of 2.5%, totaling 5.0% above minimum requirements, with 0% countercyclical buffer (CCyB). JPM has an SCB of 2.9% and CCoB of 2.5%, totaling 5.4%. However, the LLM introduces incorrect components: it references a 'G-SIB surcharge' (3.0% for SCHW, 4.0% for JPM), which is not mentioned in the original answer and is not part of the buffer requirements described. The original answer does not include G-SIB surcharges in the buffer calculation, so their inclusion is factually incorrect. Additionally, the LLM claims SCHW has an SCB of 5.4% under the Standardized approach, which contradicts the ground truth of 2.5%. (2) Calculations are therefore incorrect: the LLM reports SCHW’s total buffer as 8.4% (5.4% + 3.0%) and 5.5% (2.5% + 3.0%), and JPM’s as 6.9% and 6.5%, none of which match the ground truth totals of 5.0% and 5.4%. The comparison conclusion—that Schwab’s Standardized buffer is higher—is false. (3) The multi-hop reasoning fails: the model incorrectly assumes different regulatory frameworks (Standardized vs Advanced approaches and G-SIB surcharges) that are not in the original data. The original answer emphasizes that both firms have similar frameworks with firm-specific SCB, but the LLM fabricates structural differences. (4) The only correct element is the mention of 0% countercyclical buffer for both, which aligns with the ground truth. However, due to major quantitative and qualitative errors, especially the introduction of non-existent surcharges and incorrect SCB values, the correctness score is very low. Contextual relevance is moderate because the answer addresses capital buffers and compares SCHW and JPM, but the substance is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 503,
        "total_tokens": 1848
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.43,
    "average_quantitative_accuracy": 8.16,
    "average_qualitative_accuracy": 7.62,
    "average_contextual_relevance": 9.21,
    "score_distribution": {
      "excellent": 316,
      "good": 117,
      "fair": 112,
      "poor": 55
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 24584.53,
    "timestamp": "2026-02-03T07:53:38.818556"
  }
}